Equibles

8-K

Inflection Point Acquisition Corp. III (IPCX)

8-K 2025-08-25 For: 2025-08-20
View Original
Added on April 11, 2026

UNITED STATESSECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORTPursuant to Section 13 or Section 15(d)of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):August 20, 2025

INFLECTION POINT ACQUISITION CORP. III

(Exact name of registrant as specified in its charter)

Cayman Islands 001-42614 N/A
(State or other jurisdiction of<br><br>incorporation or organization) (Commission File Number) (IRS Employer <br><br>Identification No.)

167 Madison Avenue Suite 205 #1017

New York, New York 10016

(Address of registrant’s principal executive offices, including zip code)

(212) 476-6908

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbols Name of each exchange onwhich registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one right to receive one-tenth (1/10) of one Class A ordinary share IPCXU The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 par value IPCX The Nasdaq Stock Market LLC
Rights, each entitling the holder to receive one tenth (1/10) of one Class A ordinary share IPCXR The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material DefinitiveAgreement.

Business Combination Agreement

On August 25, 2025 (the “Effective Date”) Inflection Point Acquisition Corp. III, a Cayman Islands exempted company (“Inflection Point”), Air Water Ventures Holdings Limited, a Cayman Islands exempted company (the “Company”), Air Water Ventures Limited, a Cayman Islands exempted company (“PubCo”) and IPCX Merger Sub Limited, a Cayman Islands exempted company (“Merger Sub”), entered into a Business Combination Agreement (the “Business Combination Agreement”). The transactions contemplated by the Business Combination Agreement are referred to herein as the “Transactions.” Unless otherwise indicated, capitalized terms used but not defined in this Current Report on Form 8-K (this “Report”) have the respective meanings given to them in the Business Combination Agreement.

Pursuant to terms of the Business Combination Agreement and subject to the terms and conditions set forth therein: (a) Inflection Point will be merged with and into PubCo, as a result of which the separate corporate existence of Inflection Point shall cease and PubCo shall continue as the surviving company (the “First Merger”), and (b) one Business Day after the First Merger, the Company will be merged with and into Merger Sub, as a result of which the separate corporate existence of the Company shall cease and Merger Sub shall continue as the surviving company and a wholly owned direct subsidiary of PubCo (the “Second Merger” and, together with the First Merger, the “Mergers”).

The Business Combination Agreement and the transactions contemplated thereby were unanimously approved by the board of directors of each of Inflection Point, the Company, PubCo and Merger Sub, and by the sole shareholder of each of PubCo and Merger Sub. The closing of the Transactions is targeted to be consummated in the first quarter of 2026, after receipt of the required approval by the shareholders of Inflection Point (the “Inflection Point Shareholder Approval”), the required approval of the shareholders of the Company (the “Company Shareholder Approval”) and the fulfilment of certain other terms and conditions set forth in the Business Combination Agreement.

Conversion of Securities

One day prior to the date of the First Merger Effective Time:

● each SPAC Unit that is issued and outstanding at such time shall be<br>automatically detached into one (1) SPAC Class A Ordinary Share and one SPAC Right;
● each SPAC Class B Ordinary Share that is issued and outstanding at such time shall be automatically converted<br>into one (1) SPAC Class A Ordinary Share; and
--- ---
● each SPAC Right that is issued and outstanding at such time shall be automatically converted into one-tenth<br>(1/10) of one SPAC Class A Ordinary Share (provided, that if a holder of SPAC Rights would be entitled to receive a fraction of a SPAC<br>Class A Ordinary Share upon the Rights Conversion, the number of SPAC Class A Ordinary Shares issued to such holder upon the Rights Conversion<br>will be rounded down to the nearest whole number of SPAC Class A Ordinary Shares without cash settlement for such rounded fraction).
--- ---

At the First Merger Effective Time, by virtue of the First Merger and without any action on the part of any party or the holders of securities of Inflection Point or PubCo:

● each SPAC Class A Ordinary Share (other than any Excluded Shares, SPAC Dissenting Shares and Redeeming<br>SPAC Shares), which is issued and outstanding immediately prior to the First Merger Effective Time, shall be converted into the right<br>to receive one (1) PubCo Ordinary Share; and
● each PubCo Ordinary Share that is issued and outstanding immediately<br>prior to the First Merger Effective Time all of which shall be standing in the name of the PubCo Sole Shareholder in the register of members<br>of PubCo shall be irrevocably surrendered by the PubCo Sole Shareholder to PubCo for cancellation and for consideration equal to the subscription<br>price (if any) that the PubCo Sole Shareholder paid for such PubCo Ordinary Share.
--- --- 
1

At the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any party or the holders of securities of the Company or PubCo:

● each Company Ordinary Share that is issued and outstanding immediately<br>prior to the Second Merger Effective Time shall be converted into the right to receive a number of PubCo Ordinary Shares equal to (i)<br>that number of PubCo Ordinary Shares determined by dividing (x) $300,000,000 by (y) the Redemption Price; divided by (ii) the total<br>number of Company Ordinary Shares (including the Company Ordinary Shares underlying the Company RSUs) issued and outstanding immediately<br>prior to the Second Merger Effective Time (the “Exchange Ratio”);
● each Company Series A-1 Preferred Share that is issued and outstanding<br>immediately prior to the Second Merger Effective Time shall be converted into the right to receive a number of PubCo Preferred Shares<br>equal to (i) the aggregate Accrued Value attributable to such Company Series A-1 Preferred Share divided by (ii) the PubCo Preferred<br>Share Issue Price;
--- ---
● each Company Series A-2 Preferred Share that is issued and outstanding<br>immediately prior to the Second Merger Effective Time shall be converted into the right to receive a number of PubCo Preferred Shares<br>equal to (i) the aggregate Accrued Value attributable to such Company Series A-2 Preferred Share divided by (ii) the PubCo Preferred<br>Share Issue Price;
--- ---
● each Company Warrant that is issued and outstanding immediately prior<br>to the Second Merger Effective Time that was issued pursuant to a Pre-Funded PIPE Subscription Agreement or PIPE Agreement, will be converted<br>into the right to receive a PubCo Series A Investor Warrant exercisable for a number of PubCo Ordinary Shares equal to (x) the number<br>of Company Ordinary Shares issuable upon conversion of the applicable Pre-Funded PIPE Investor’s or PIPE Investor’s Company<br>Series A Preferred Shares upon a hypothetical conversion of such Company Series A Preferred Shares immediately prior to the Second Merger<br>multiplied by (y) the Exchange Ratio;
--- ---
● each Company Warrant that is issued and outstanding immediately prior<br>to the Second Merger Effective Time which was not issued pursuant to a Pre-Funded PIPE Subscription Agreement or PIPE Agreement, will<br>be converted into the right to receive a PubCo Series A Investor Warrant exercisable for a number of PubCo Ordinary Shares equal to the<br>number of Company Ordinary Shares issuable upon a hypothetical conversion of such Company Warrant as of immediately prior to the Second<br>Merger;
--- ---
● each Company RSU that is issued and outstanding immediately prior to<br>the Second Merger Effective Time shall be converted into the right to receive restricted stock units subject to PubCo Ordinary Shares<br>on the same terms and conditions (including applicable vesting, settlement and termination provisions) as are in effect with respect to<br>each such award of Company RSUs; provided, that each award of Exchanged RSUs will be subject to the number of PubCo Ordinary Shares<br>equal to the product of (x) the number of whole Company Ordinary Shares that were subject to such award of Company RSUs (with any fractional<br>share otherwise resulting rounded down to the nearest whole share) immediately prior to the Second Merger Effective Time, multipliedby (y) the Exchange Ratio;
--- ---
● each Company PSU that is issued and outstanding and unvested immediately<br>prior to the Second Merger Effective Time shall be assumed and converted into the right to receive performance-based restricted stock<br>units subject to PubCo Ordinary Shares on the same terms and conditions (including applicable performance vesting criteria and other applicable<br>settlement and termination provisions) as are in effect with respect to each such award of Company PSUs immediately prior to the Second<br>Merger Effective Time; provided, that each award of Exchanged PSUs will be subject to a number of PubCo Ordinary Shares, determined<br>based on the pro-rata portion of Company Earnout Shares attributable to such PSU Holder’s Company RSUs, subject to achievement of<br>the applicable Triggering Event (with any fractional share otherwise resulting rounded down to the nearest whole share); and
--- ---
● each Merger Sub Share that is issued and outstanding immediately prior to the Second Merger Effective<br>Time shall be converted into and become one validly issued, fully paid and non-assessable ordinary share of the Second Surviving Company.
--- --- 
2

Earnout

Following the Closing, PubCo will issue to Eligible Company Equityholders and the PSU Holders up to 30,000,000 additional PubCo Ordinary Shares in the aggregate (the “Earnout Shares”) in four tranches of 7,500,000, respectively, if:

● (a) with respect to any full fiscal quarter of PubCo ending on or prior<br>to June 30, 2026, the Revenue for such fiscal quarter exceeds $25,000,000, or (b) PubCo or any of its consolidated subsidiaries enters<br>into a binding and definitive agreement on or prior to June 30, 2026 with the US Federal Emergency Management Agency (FEMA), the US Department<br>of Defense or other US federal agency or Regenerate1 LLC that provides for minimum annual and recurring Revenue of at least $100,000,000;
● with respect to any full fiscal quarter of PubCo ending on or prior to December 31, 2026, the Revenue<br>for such fiscal quarter exceeds $50,000,000;
--- ---
● with respect to any full fiscal quarter of PubCo ending on or prior to December 31, 2026, the EBITDA for<br>such fiscal quarter exceeds $12,500,000; and
--- ---
● within the time period beginning on the date that is the 6-month anniversary of the Closing Date and ending<br>on the date that is the 18-month anniversary of the Closing Date, the Ordinary Share Price is greater than or equal to $20.00, subject<br>to Equitable Adjustment.
--- ---

Representations and Warranties

Under the Business Combination Agreement, Inflection Point has made customary representations and warranties to the Company and PubCo relating to, among other things, organization and standing, due authorization and binding agreement, governmental approvals, non-contravention, capitalization, Securities and Exchange Commission (the “SEC”) filings, financial statements, internal controls, absence of certain changes, compliance with laws, litigation, actions, orders and permits, taxes and returns, employees and employee benefit plans, properties, material contracts, transactions with related persons, the U.S. Investment Company Act of 1940, as amended (the “Investment Company Act”), and the Jumpstart Our Business Startups Act of 2012, finders’ and brokers’ fees, sanctions and certain business practices, private placements, insurance, no misleading information supplied, the Trust Account and receipt of a fairness opinion.

Under the Business Combination Agreement, Merger Sub has made customary representations and warranties to PubCo and the Company relating to, among other things, organization and standing, due authorization and binding agreement, governmental approvals, non-contravention, capitalization, limited activities, finders’ and brokers’ fees, the Investment Company Act, no misleading information supplied and Merger Sub’s U.S. tax classification.

Under the Business Combination Agreement, PubCo has made customary representations and warranties to Inflection Point and the Company relating to, among other things, organization and standing, due authorization and binding agreement, governmental approvals, non-contravention, capitalization, limited activities, finders’ and brokers’ fees, the Investment Company Act, no misleading information supplied and the dormancy of one of the Company’s Subsidiaries.

Under the Business Combination Agreement, the Company has made customary representations and warranties (regarding itself and its subsidiaries) to Inflection Point relating to, among other things, organization and standing, due authorization and binding agreement, capitalization, company subsidiaries, governmental approvals, non-contravention, financial statements, absence of certain changes, compliance with laws, permits, litigation, material contracts, intellectual property, taxes and returns, real property, personal property, employee matters, benefit plans, environmental matters, transactions with related persons, insurance, material customers and suppliers, data protection and cybersecurity, sanctions and certain business practices, the Investment Company Act, finders’ and brokers’ fees and no misleading information supplied.

3

Covenants

The Business Combination Agreement includes customary covenants of the parties including, among other things, (i) the conduct of their respective business operations prior to the consummation of the Transactions, (ii) the parties’ obligations to obtain relevant approvals and comply with all applicable listing requirements of the Nasdaq in connection with the Transactions and (iii) the parties’ obligations to consummate the Transactions and to comply as promptly as practicable with all requirements of governmental authorities applicable to the Transactions. The Business Combination Agreement also contains additional covenants of the parties, including covenants providing for Inflection Point and the Company to use commercially reasonable efforts to (i) consummate the PIPE Investment, (ii) agree to and adopt a new equity incentive plan and a new employee share purchase plan, and (iii) file, and to cooperate with each other to prepare the registration statement of PubCo required to be filed in connection with the Transactions (the “Registration Statement”), which will contain a proxy statement of Inflection Point.

Conditions to Closing

The respective obligations of each party to consummate the Transactions are subject to the satisfaction, or written waiver (where permissible), by the Company and Inflection Point of the following conditions:

● Inflection Point’s shareholders having approved and adopted the Shareholder Approval Matters;
● the Company Shareholder Approval having been obtained;
--- ---
● the absence of any law or governmental order, inquiry, proceeding or other action that would prohibit<br>the Transactions;
--- ---
● If applicable, the HSR waiting period has expired or been terminated;
--- ---
● the PubCo Ordinary Shares having been conditionally approved for listing on Nasdaq, subject only to official<br>notice thereof; and
--- ---
● the Registration Statement (and any amendments and supplements) shall have become effective in accordance<br>with the provisions of the Securities Act of 1933, as amended (the “Securities Act”), no stop order shall have been<br>issued by the SEC that remains in effect with respect to the Registration Statement, and no proceeding seeking such a stop order shall<br>have been threatened or initiated by the SEC and not withdrawn.
--- ---

Conditions to the Obligations of the Company

The obligations of the Company to consummate the Transactions are subject to the satisfaction, or written waiver (by the Company, where permissible) of the following conditions:

● the representations and warranties of Inflection Point being true and<br>correct as of the Closing Date, subject to applicable standards as determined in accordance with the Business Combination Agreement;
● the<br>representations and warranties of Merger Sub being true and correct as of the Closing Date, subject to applicable standards as determined<br>in accordance with the Business Combination Agreement;
--- ---
● Inflection Point having performed in all material respects all of its obligations and complied in all<br>material respects with all of its agreements and covenants under the Business Combination Agreement to be performed or complied with by<br>it on or prior to the Closing Date;
--- ---
● Inflection Point having delivered to the Company a certificate dated as of the Closing Date, signed by<br>an officer of Inflection Point, certifying as to the satisfaction of certain conditions specified in the Business Combination Agreement;
--- ---
● no Material Adverse Effect shall have occurred with respect to Inflection Point that is continuing and<br>uncured;
--- ---
● Inflection Point having made all necessary and appropriate arrangements<br>with the trustee to have all of the funds held in the Trust Account disbursed to Inflection Point on the Closing Date, and all such funds<br>released from the Trust Account be available to PubCo; and
--- ---
● the Ancillary Documents required to be executed by Inflection Point according to the Business Combination<br>Agreement at or prior to the Closing Date shall have been executed and delivered to the Company.
--- --- 
4

Conditions to the Obligations of Inflection Point

The obligations of Inflection Point to consummate the Transactions are subject to the satisfaction, or written waiver (by Inflection Point where permissible) of the following conditions:

● the<br>representations and warranties of the Company being true and correct as of the Closing Date, subject to applicable standards as determined<br>in accordance with the Business Combination Agreement;
● the<br>representations and warranties of PubCo being true and correct as of the Closing Date, subject to applicable standards as determined<br>in accordance with the Business Combination Agreement;
--- ---
● each<br>of the Company and PubCo having performed in all material respects all of their respective obligations and complied in all material respects<br>with all of their respective agreements and covenants under the Business Combination Agreement to be performed or complied with by them<br>on or prior to the Closing Date;
--- ---
● the<br>Company having delivered to Inflection Point a certificate dated as of the Closing Date, signed by the Company, certifying as to the<br>satisfaction of certain conditions specified in the Business Combination Agreement;
--- ---
● no<br>Material Adverse Effect shall have occurred with respect to the Company that is continuing and uncured; and
--- ---
● the<br>Ancillary Documents required to be executed by the Company and PubCo according to the Business Combination Agreement at or prior to the<br>Closing Date shall have been executed and delivered to Inflection Point.
--- ---
● all<br>of the indebtedness outstanding under certain specified Contracts will have been discharged in full.
--- ---

Termination

The Business Combination Agreement may be terminated and the Transactions may be abandoned at any time prior to the Closing Date, notwithstanding receipt of any requisite approval and adoption of the Business Combination Agreement and the Transactions by the shareholders of Inflection Point or any other party, as follows:

● by<br>mutual written consent of Inflection Point and the Company;
● by<br>written notice by either Inflection Point or the Company if any of the closing conditions set forth in the Business Combination Agreement<br>have not been satisfied or waived by August 25, 2026 (the “Outside Date”); provided, however, that the Business Combination<br>Agreement may not be terminated under such provision of the Business Combination Agreement by or on behalf of any party that either directly<br>or indirectly through its affiliates (or with respect to the Company, the Company Shareholders or PubCo) is in breach or violation of<br>any representation, warranty, covenant or obligation contained therein, with such breach or violation being the principal cause of the<br>failure of a condition set forth in the Business Combination Agreement on or prior to the Outside Date; provided, further, that<br>the Outside Date shall automatically be extended by one (1) calendar day for each day after October 31, 2025 that the PCAOB Financial<br>Statements or the Interim Financial Statements are not delivered by the Company to Inflection Point in accordance with the terms of the<br>Business Combination Agreement.
--- ---
● by<br>written notice by either Inflection Point or the Company if any governmental authority of competent jurisdiction shall have enacted,<br>issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) or Order that is then in effect and which<br>has the effect of making the Transactions illegal or otherwise prohibiting the transactions contemplated by the Business Combination<br>Agreement, and such order or other action has become final and non-appealable; provided, however, that the right to terminate the Business<br>Combination Agreement pursuant to such section will not be available to a party if the failure by such party or its affiliates (or with<br>respect to the Company, the Company Shareholders or PubCo) to comply with any provision of the Business Combination Agreement was the<br>principal cause of such order, action or prohibition;
--- ---
● by<br>written notice by the Company to Inflection Point upon a breach of any representation, warranty, covenant or agreement on the part of<br>Inflection Point set forth in the Business Combination Agreement, or if any representation or warranty of Inflection Point becomes untrue<br>or inaccurate, in any case such that the related closing conditions contained in the Business Combination Agreement are not satisfied,<br>subject to customary exceptions and cure rights;
--- --- 
5
● by<br>written notice by Inflection Point to the Company upon a breach of any warranty, covenant or agreement on the part of the Company or<br>PubCo set forth in the Business Combination Agreement, or if any representation or warranty of such parties becomes untrue or inaccurate,<br>in any case such that the related closing conditions contained in the Business Combination Agreement are not satisfied, subject to customary<br>exceptions and cure rights;
● by<br>written notice by the Company to Inflection Point if the Company Funding Threshold has not been achieved on or prior to the date that<br>is two (2) Business Days following the Effective Date;
--- ---
● by<br>written notice by the Company to Inflection Point if Inflection Point or the SPAC Securities are no longer listed on the Nasdaq or another<br>national securities exchange;
--- ---
● by<br>written notice by either Inflection Point or the Company if the special meeting of shareholders is held and has concluded, Inflection<br>Point shareholders have duly voted, and the Required Shareholder Approval is not obtained; or
--- ---
● by<br>Inflection Point if the Company Shareholder Approval is not obtained within ten (10) Business Days after the Registration Statement Effective<br>Date (subject to certain conditions).
--- ---

The foregoing summary of the Business Combination Agreement is qualified in its entirety by reference to the entire text of the Business Combination Agreement, which is attached as Exhibit 2.1 hereto, and the Ancillary Documents, the terms of each of which are incorporated herein by reference. The Business Combination Agreement contains representations, warranties and covenants that the respective parties thereto made to each other as of the date of the Business Combination Agreement or other specific dates. The assertions embodied in those representations, warranties and covenants were made for purposes of the contract among the respective parties and are subject to important qualifications and limitations agreed to by the parties in connection with negotiating such agreement. In particular, the assertions embodied in the representations and warranties in the Business Combination Agreement were made as of a specified date, are modified or qualified by information in one or more confidential disclosure letters prepared in connection with the execution and delivery of the Business Combination Agreement, may be subject to a contractual standard of materiality different from what might be viewed as material to investors, or may have been used for the purpose of allocating risk between the parties. Accordingly, the representations and warranties in the Business Combination Agreement are not necessarily characterizations of the actual state of facts about Inflection Point, PubCo, Merger Sub, the Company Shareholders or the Company at the time they were made or otherwise and should only be read in conjunction with the other information that Inflection Point makes publicly available in reports, statements and other documents filed with the SEC.

Company Support Agreement

Concurrently with the execution of the Business Combination Agreement, Inflection Point entered into Company Support Agreements (each, a “Company Support Agreement”) with the Company, PubCo and certain shareholders of the Company (collectively, the “Supporting Stockholders”), pursuant to which each Supporting Stockholder has agreed to, among other things, (a) vote the Company Ordinary Shares held by such Supporting Stockholder (together with any other equity securities thereafter acquired by such Supporting Stockholder the “Company Subject Securities”) in favor of the Business Combination Agreement and the transactions contemplated thereby, (b) be bound by certain other covenants and agreements related to the Transactions (c) be bound by certain transfer restrictions with respect to the Company Subject Securities and (d) waive its dissenter rights under Section 238 of the Cayman Act and any other similar statute.

The foregoing description of the Company Support Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the Company Support Agreement filed as Exhibit 10.1 hereto and incorporated by reference herein.

The Company Support Agreement expires upon the earlier of the Second Merger Effective Time and the termination of the Business Combination Agreement.

Sponsor Support Agreement

In connection with the execution of the Business Combination Agreement, Sponsor has entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”) with Inflection Point, PubCo and the Company, pursuant to which Sponsor has agreed to, among other things, (a) vote the SPAC Class B Ordinary Shares and the SPAC Class A Ordinary Shares held by Sponsor (together with any other equity securities thereafter acquired by Sponsor, the “Sponsor Subject Securities”) in favor of the Shareholder Approval Matters at any meeting of Inflection Point shareholders to be called for approval of the Transactions (b) waive its anti-dilution rights in the SPAC Charter, (c) waive its dissenter rights under Section 238 of the Cayman Act and any other similar statute, (d) be bound by certain other covenants and agreements related to the Transactions and (e) be bound by certain transfer restrictions with respect to the Sponsor Subject Securities, in each case, on the terms and subject to the conditions set forth in the Sponsor Support Agreement. The Sponsor Support Agreement also provides that Sponsor has agreed irrevocably to waive its redemption rights in connection with the consummation of the Transactions with respect to any Sponsor Subject Securities they may hold.

6

The foregoing summary of the Sponsor Support Agreement is qualified in its entirety by reference to the full text of the Sponsor Support Agreement, which is attached as Exhibit 10.2 hereto and the terms of which are incorporated herein by reference.

The Sponsor Support Agreement expires upon the earlier of the First Merger Effective Time and the termination of the Business Combination Agreement.

Lock-Up Agreements

In connection with the Closing, each holder of the Company Ordinary Shares will each enter into an agreement (the “Company Shareholder Lock-Up Agreement”) providing that each holder of the Company Ordinary Shares will not, subject to certain customary exceptions, transfer its Restricted Securities (as defined in the Company Shareholder Lock-Up Agreements) during the period commencing from the Closing Date until the earlier of (i) six months after the Closing or (ii) the date following the Closing on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction in which all of its shareholders have the right to exchange their shares of common stock for cash, securities or other property.

In connection with the Closing, Sponsor and certain other SPAC Shareholders who are members of Inflection Point’s board of directors and/or management team (such individuals, the “Insiders”) will enter into an agreement (the “Sponsor Lock-Up Agreement”) providing that Sponsor and the Insiders will not, subject to certain customary exceptions, transfer (i) the General Restricted Securities (as defined below) during the period commencing from the Closing Date until the date that is the earlier of (x) six months after the Closing and (y) the date following the Closing on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of its shareholders having the right to exchange their shares of common stock for cash, securities or other property or (ii) the Private Placement Restricted Securities (as defined below) during the period commencing from the Closing Date until the date that is the earliest of (x) 30 days after the Closing and (y) the date following the Closing on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of its shareholders having the right to exchange their shares of common stock for cash, securities or other property. For purposes of the Sponsor Lock-Up Agreement, (a) the “Private Placement Restricted Securities” means the PubCo Ordinary Shares issued to the Sponsor pursuant to the Business Combination Agreement in exchange for the 500,000 units consisting of one SPAC Class A Ordinary Share and one right to receive one-tenth of one SPAC Class A Ordinary Share upon Closing following the unit separation (together with any dividends or distributions with respect to such securities or into which such securities are changed or exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions), and (b) the “General Restricted Securities” means the PubCo Ordinary Shares issued to the Sponsor or the Insiders in exchange for the SPAC Class A Ordinary Shares received by Sponsor or the Insiders upon conversion of the SPAC Class B Ordinary Shares, pursuant to the terms of the Business Combination Agreement (together with any dividends or distributions with respect to such securities or into which such securities are changed or exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions).

The foregoing summaries of the Company Shareholder Lock-Up Agreement and the Sponsor Lock-Up Agreement are qualified in their entirety by reference to the full text of the form of Sponsor Lock-Up Agreement and the form of Company Shareholder Lock-Up Agreement, which are attached as Exhibits 10.3 and 10.4 hereto, respectively, and the terms of which are incorporated herein by reference.

New Registration Rights Agreement

The Business Combination Agreement contemplates that, at the Closing, PubCo, certain Company equityholders, Sponsor, Inflection Point, and the other parties signatory thereto will enter into a Registration Rights Agreement (the “New Registration Rights Agreement”), pursuant to which PubCo will agree to register for resale certain shares of PubCo Registrable Securities that are held by the parties thereto from time to time. Pursuant to the New Registration Rights Agreement, among other things, PubCo will agree to file a shelf registration statement registering the sale or resale of all of the Registrable Securities (as defined in the New Registration Rights Agreement) no later than 30 days after the Closing Date. Pursuant to the New Registration Rights Agreement, PubCo will also provide customary “piggyback” registration rights, subject to certain requirements and customary conditions. The New Registration Rights Agreement also provides that PubCo will pay certain expenses relating to such registrations and indemnify the shareholders against certain liabilities.

The foregoing summary of the New Registration Rights Agreement is qualified in its entirety by reference to the full text of the form of New Registration Rights Agreement, which is attached as Exhibit 10.5 hereto and the terms of which are incorporated herein by reference.

7

Series A Preferred Shares Investment

In connection with the transactions contemplated by the Business Combination Agreement, the Company entered into (i) the Pre-Funded PIPE Subscription Agreement with certain investors identified on the signature pages thereto (collectively, the “Series A-1 Investors”), pursuant to which the Pre-Funded PIPE Investors have agreed to purchase approximately $32.5 million (the “Series A-1 Investment”) of Company Series A-1 Preferred Shares and Company Warrants (the “Signing PIPE Securities”), which transactions have been consummated concurrently with the execution of the Business Combination Agreement and (ii) the Closing PIPE Subscription Agreement (together with the Pre-Funded PIPE Subscription Agreement, the “Subscription Agreements”) with certain investors identified on the signature pages thereto, pursuant to which the Closing PIPE Investors have agreed to purchase approximately $31 million (the “Series A-2 Investment” and together with the Series A-1 Investment, the “Series A Investments”) of Company Series A Preferred Shares and Company Warrants (together with the Signing PIPE Securities, the “Securities”), which transactions will be consummated immediately prior to the Second Merger Effective Time.

The Subscription Agreements include customary representations and warranties from the Company and the Series A Investors and customary closing conditions. The Subscription Agreements also include customary covenants and agreements related to transfer restrictions and indemnification. In addition, PubCo and the Series A Investors will enter into registration rights agreements providing for customary registration rights for the Securities.

Dividends: The PubCo Series A Preferred Shares will accrue dividends daily at the rate of 12% per annum of the Accrued Value (as defined in the PubCo A&R Articles) (if paid in kind), or 10% per annum of the Accrued Value (if paid in cash). Such dividends will compound semi-annually.

Liquidation Preference: Upon a Deemed Liquidation Event, Disposal or on a distribution of assets on a liquidation, dissolution or winding up of the Company (whether voluntarily or involuntarily) or a return of capital (other than a conversion, redemption, buyback or purchase of PubCo securities), the holders of PubCo Series A Preferred Shares will be entitled to receive out of the available proceeds, before any distribution is made to holders of ordinary shares or any other junior securities, an amount per share equal to the greater of (i) 100% of the Accrued Value (as defined in the PubCo A&R Articles) or (ii) such amount per share as would have been payable had all shares of PubCo Series A Preferred Shares been converted into PubCo Ordinary Shares immediately prior to such event.

Voting: The PubCo Series A Preferred Shares votes together with the PubCo Ordinary Shares on an as-converted basis, except as required by law and as noted below under “Protective Provisions.” Each holder of PubCo Series A Preferred Shares shall be entitled to cast the number of votes equal to the number of whole shares of PubCo Ordinary Shares into which the shares of PubCo Series A Preferred Shares held by such holder are convertible as of the record date for determining shareholders entitled to vote on such matter.

8

Protective Provisions: For as long as Inflection Point Asset Management LLC, Newtyn Management, LLC and their respective Affiliates hold at least 20% of the PubCo Series A Preferred Shares on issue as of Closing, the Company shall not, without the Series A Majority Consent (as defined therein) (the “Requisite Holders”), take any of the following actions: (a) liquidate, dissolve or wind-up the affairs of PubCo, (b) create any equity security, authorise the creation of any equity security, classify any equity security, reclassify any equity security, or issue any other security convertible into or exercisable for any equity security, unless such security ranks junior to the PubCo Series A Preferred Shares with respect to its rights, preferences and privileges (including rights to receive dividends and participate in distributions or payments upon liquidation, dissolution or winding up), (c) increase the authorised share capital of the PubCo Series A Preferred Shares, (d) purchase or redeem or pay any cash dividend on any PubCo security ranking junior to the PubCo Series A Preferred Shares (with respect to rights to receive dividends and participate in distributions or payments upon liquidation, dissolution or winding up), except for PubCo securities being repurchased by the Company at cost from employees in connection with the cessation of their service or pursuant to the terms of any equity incentive plan adopted by PubCo, (e) enter into any transaction with an affiliate, other than the issuance of equity or awards to eligible participants under an incentive plan, equity plan or equity-based compensation plan adopted by PubCo, or with respect to employment, consulting or award agreements with respect to executive officers or directors of PubCo, in each case regardless of whether such person (or such person’s affiliates) would be considered an affiliate of PubCo, or (f) incur or guarantee any new indebtedness other than equipment leases or trade payables incurred in the ordinary course of business.

Conversion: Each PubCo Series A Preferred Share will be convertible into PubCo Ordinary Shares at any time at the option of the holder at a rate equal to the Accrued Value, divided by the then-applicable conversion price. The conversion price will initially be $12.00, subject to equitable adjustment and adjustments for stock dividends, splits, combinations and similar events and customary anti-dilution adjustments, including with respect to future issuances or sales of PubCo Ordinary Shares at prices less than the lesser of (x) $10.00 (subject to equitable adjustment) and (y) the conversion price then in effect. In addition, if the 20-day volume-weighted average price of the PubCo Ordinary Shares commencing on the date that is six months after the Closing Date is less than the conversion price then in effect, the conversion price will be subject to a one-time downward adjustment equal to the greater of (i) such volume weighted average price and (ii) $5.00 (subject to equitable adjustment).

Put Rights: Unless prohibited by applicable law governing distributions to shareholders, the PubCo Series A Preferred Shares shall be redeemable at the option of the Requisite Holders commencing any time after the fifth anniversary of the Closing at a price equal to the 100% of the Accrued Value.

Call Rights: Unless prohibited by applicable law governing distributions to shareholders, the PubCo Series A Preferred Shares shall be redeemable at the option of PubCo commencing any time (A) after the Closing but prior to the 1st anniversary of the Closing at a price equal to the 150% of the Accrued Value, (B) after the 1st anniversary but prior to the 2nd anniversary of the Closing at a price equal to the 140% of the Accrued Value, (C) after the 2nd anniversary of the Closing but prior to the 3rd anniversary of the Closing at a price equal to the 130% of the Accrued Value, (D) after the 3rd anniversary of the Closing but prior to the 4th anniversary of the Closing at a price equal to the 120% of the Accrued Value, (E) after the 4th anniversary of the Closing but prior to the 5th anniversary of the Closing at a price equal to the 110% of the Accrued Value, or (F) after the 5th anniversary of the Closing at a price equal to the 100% of the Accrued Value.

Share Purchase Warrants: The PubCo Series A Investor Warrant will be immediately exercisable upon issuance at Closing and will expire five years from the date of Closing. The PubCo Series A Investor Warrants include customary cash and cashless exercise provisions. Each PubCo Series A Investor Warrant is initially exercisable at $12.00 per PubCo Ordinary Share, subject to equitable adjustment and the same anti-dilution and other adjustments as the PubCo Series Preferred Shares.

The foregoing description of the Series A Investments, the PubCo Series A Preferred Shares, and the PubCo Series A Investor Warrants are subject to and qualified in its entirety by reference to the full text of the Subscription Agreements, copies of which is included as Exhibits 10.6 and 10.7 hereto, the PubCo A&R Articles, a copy of which is included as Exhibit 3.1, and the full text of the form of Company Warrants and the PubCo Series A Investor Warrants, copies of which is included as Exhibits 4.1 and 4.2 hereto, and the terms of each is incorporated herein by reference.

9

Item 3.02 Unregistered Sales of Equity Securities.

The disclosure set forth above in Item 1.01 of this Report is incorporated by reference herein. The PubCo Ordinary Shares to be issued to the Company’s shareholders in respect of the Company shares in connection with the Second Merger will not be registered under the Securities Act, in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder.

Item 5.02 Departure of Directors or CertainOfficers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 20, 2025, Daniel Hoffman resigned from the Board of Directors of the Company due to a potential conflict between his role as a director of the Company and his other professional commitments. The decision of Mr. Hoffman was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Effective upon Mr. Hoffman’s resignation as a director, the size of the Company’s Board of Directors was reduced from five to four.

Item 7.01 Regulation FD Disclosure.

Furnished herewith as Exhibit 99.1 and incorporated into this Item 7.01 by reference is the press release jointly issued by the parties announcing the Transactions. Furnished herewith as Exhibit 99.2 and incorporated into this Item 7.01 by reference is the investor presentation that was presented to certain potential investors in connection with the Transactions. Furnished as Exhibit 99.3 hereto and incorporated into this Item 7.01 by reference is certain projected financial information that the Company prepared in connection with Inflection Point’s consideration of the Business Combination and certain investors’ assessment of a potential investment in the Company.

The information set forth below under this Item 7.01, including the exhibits attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

Forward-Looking Statements

Certain statements made herein are not historical facts but may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the expectation that the Transactions between Inflection Point and the Company will occur and that PubCo will be listed on Nasdaq, the estimated or anticipated future results and benefits of PubCo following the Transactions, including its ability to successfully execute is business plan, the likelihood and ability of the parties to successfully consummate the Transactions and future opportunities for PubCo and other statements that are not historical facts.

These statements are based on the current expectations of Inflection Point’s and/or the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Inflection Point and the Company. These statements are subject to a number of risks and uncertainties regarding the Company’s business and the Transactions, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the inability of the parties to consummate the Transactions or the intended financing; the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement; the number of redemption requests made by Inflection Point’s shareholders in connection with the Transactions; the outcome of any legal proceedings that may be instituted against the parties following the announcement of the Transactions; the risk that the approval of Inflection Point’s shareholders for the potential transaction is not obtained; the anticipated capitalization and enterprise value of PubCo following the consummation of the Transactions; the ability of PubCo to issue equity, equity-linked or other securities in the future; expectations related to the terms and timing of the Transactions; failure to realize the anticipated benefits of the Transactions, including as a result of a delay in consummating the Transactions; the risk that the Transactions may not be completed by Inflection Point’s business combination deadline and the potential failure to obtain an extension of its business combination deadline, if sought by Inflection Point; the risks related to the rollout of the Company’s business and the timing of expected business milestones; the ability of PubCo to execute its growth strategy, manage growth profitably and retain its key employees; the ability of PubCo to obtain or maintain the listing of its securities on the Nasdaq following the Transactions; costs related to the Transactions; and other risks that will be detailed from time to time in filings with the SEC, including those risks discussed under the heading “Risk Factors” in Inflection Point’s final prospectus for its initial public offering filed with the SEC on April 25, 2025. The foregoing list of risk factors is not exhaustive. There may be additional risks that could also cause actual results to differ from those contained in these forward-looking statements. In addition, forward-looking statements provide Inflection Point’s expectations, plans or forecasts of future events and views as of the date of this Report. And while Inflection Point may elect to update these forward-looking statements in the future, Inflection Point specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Inflection Point’s assessments as of any date subsequent to the date of this Report. Accordingly, undue reliance should not be placed upon the forward-looking statements. Nothing herein should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that the results of such forward-looking statements will be achieved.

10

Additional Information and Where to Find It

In connection with the Transactions, Inflection Point, the Company and PubCo are expected to prepare the Registration Statement to be filed with the SEC by PubCo, which will include preliminary and definitive proxy statements to be distributed to Inflection Point’s shareholders in connection with Inflection Point’s solicitation for proxies for the vote by Inflection Point’s shareholders in connection with the Transactions and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to the Company’s shareholders in connection with the completion of the Transactions. After the Registration Statement has been filed and declared effective, Inflection Point will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the Transactions. Inflection Point’s shareholders and other interested persons are advised to read, once available, the preliminary proxy statement/prospectus and any amendments thereto and, once available, the definitive proxy statement/prospectus, in connection with Inflection Point’s solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the Transactions, because these documents will contain important information about Inflection Point, the Company, PubCo and the Transactions. This Report is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Inflection Point will send to its shareholders in connection with the Transactions.

INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTIONS AND THE PARTIES TO THE TRANSACTIONS. Investors and security holders will be able to obtain copies of these documents (if and when available) and other documents filed with the SEC free of charge at www.sec.gov. The definitive proxy statement/final prospectus (if and when available) will be mailed to shareholders of Inflection Point as of a record date to be established for voting on the business combination. Shareholders of Inflection Point will also be able to obtain copies of the proxy statement/prospectus without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: Inflection Point Acquisition Corp. III, 167 Madison Avenue Suite 205 #1017, New York, New York 10016.

Participants in the Solicitation

Inflection Point and its directors, executive officers, and other members of management, and consultants, under SEC rules, may be deemed participants in the solicitation of proxies from Inflection Point’s shareholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in Inflection Point is contained in the sections entitled “PrincipalShareholder” and “Management— Conflicts of Interest” of Inflection Point’s final prospectus (File 333-283427) for its initial public offering, filed with the SEC on March 10, 2025, and which is available free of charge at the SEC’s website at www.sec.gov, and at the following URL: sec.gov/Archives/edgar/data/2012318/000121390025035659/ea0222072-08.htm#T99012. Additional information regarding the interests of such participants will be contained in the Registration Statement when available.

The Company, PubCo, and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed participants in the solicitation of proxies of Inflection Point’s shareholders in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination will be included in the Registration Statement when available.

No Offer or Solicitation

This Report is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Transactions or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

11

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Description
2.1† Business Combination Agreement, dated as of August 25, 2025, by and<br>among Inflection Point Acquisition Corp. III, Air Water Ventures Holdings Limited, IPCX Merger Sub Limited, and Air Water Ventures Limited.
3.1 Amended and Restated Memorandum and Articles of Association of Air Water Ventures Limited
4.1 Form of Signing Share Purchase Warrant
4.2 Form of Closing Share Purchase Warrant
10.1 Company Support Agreement, dated as of August 25, 2025, by and among TAU Capital Holding Limited, Inflection Point Acquisition Corp. III, Air Water Ventures Holdings Limited and Air Water Ventures Limited
10.2 Sponsor Support Agreement, dated as of August 25, 2025, by and among Inflection Point Acquisition Corp. III, Air Water Ventures Holdings Limited and Air Water Ventures Limited.
10.3 Form of Sponsor Lock-Up Agreement.
10.4 Form of Company Lock-Up Agreement.
10.5 Form of New Registration Rights Agreement.
10.6 Form of Pre-Funded PIPE Subscription Agreement.
10.7 Form of Closing PIPE Subscription Agreement.
99.1 Press Release, dated August 25, 2025, issued by the parties announcing<br>the Transactions.
99.2 Investor Presentation.
99.3 Certain Projected Financial Information of the Company, dated August 2025.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
† Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.
--- --- 
12

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 25, 2025

INFLECTION POINT ACQUISITION CORP. III
By: /s/ Michael Blitzer
Name: Michael Blitzer
Title: Chief Executive Officer

13

Exhibit 2.1

Execution Version

BUSINESS COMBINATIONAGREEMENT

by and among

InflectionPoint Acquisition Corp. **III,**as SPAC

**AIRWATER VENTURES HOLDINGS LIMITED,**as the Company

**AirWater Ventures Limited,**as PubCo

and

IPCXMerger sub Limitedas Merger Sub

Dated as of August 25, 2025

TABLE OF CONTENTS

CONTENTS

Page
Article I MERGERS 4
1.1 Mergers. 4
1.2 Merger Effective Times. 5
1.3 Effect of the Mergers. 5
1.4 Organizational Documents. 6
1.5 Directors and Officers of Surviving Companies 6
Article II CONVERSION AND EXCHANGE OF SECURITIES 7
2.1 First Merger 7
2.2 Second Merger. 9
2.3 Satisfaction of Rights 12
2.4 Lost, Stolen or Destroyed SPAC or Company Certificates 12
2.5 Register of Members 12
2.6 Appointment of Transfer Agent 12
2.7 Exchange of Book-Entry Shares 12
2.8 Taking of Necessary Action; Further Action 13
2.9 Tax Consequences 14
2.10 Earnout Shares. 14
2.11 Fractional Shares 15
2.12 Release of Funds from Trust Account 15
2.13 Withholding 15
Article III MERGER CLOSING 15
3.1 Closing 15
Article IV REPRESENTATIONS AND WARRANTIES OF SPAC 16
4.1 Organization and Standing 16
4.2 Authorization; Binding Agreement 16
4.3 Governmental Approvals 17
4.4 Non-Contravention 17
4.5 Capitalization 17
4.6 SEC Filings; SPAC Financials; Internal Controls 18
4.7 Absence of Certain Changes 20
4.8 Compliance with Laws 20
4.9 Litigation 21
4.10 Actions; Orders; Permits 21
4.11 Taxes and Returns 21
4.12 Employees and Employee Benefit Plans 23
4.13 Properties 23
4.14 Material Contracts 23
4.15 Transactions with Affiliates 24 
i
4.16 Investment Company Act; JOBS Act 24
4.17 Finders and Brokers 24
4.18 Private Placements 24
4.19 Certain Business Practices 24
4.20 Insurance 25
4.21 Information Supplied 26
4.22 Trust Account 26
4.23 SPAC Acknowledgment 27
4.24 Fairness Opinion 27
Article V REPRESENTATIONS AND WARRANTIES OF MERGER SUB 28
5.1 Organization and Standing 28
5.2 Authorization; Binding Agreement 28
5.3 Governmental Approvals 28
5.4 Non-Contravention 29
5.5 Capitalization 29
5.6 Merger Sub Activities 29
5.7 Finders and Brokers 29
5.8 Investment Company Act 29
5.9 Information Supplied 30
5.10 U.S. Tax Classification 30
Article VI REPRESENTATIONS AND WARRANTIES OF PUBCO 30
6.1 Organization and Standing 30
6.2 Authorization; Binding Agreement 30
6.3 Governmental Approvals 31
6.4 Non-Contravention 31
6.5 Capitalization 31
6.6 PubCo Activities 31
6.7 Finders and Brokers 32
6.8 Investment Company Act 32
6.9 Information Supplied 32
6.10 U.S. Tax Classification 32
6.11 U.K. Tax Residency 32
Article VII REPRESENTATIONS AND WARRANTIES OF THE COMPANY 33
7.1 Organization and Standing 33
7.2 Authorization; Binding Agreement 33
7.3 Capitalization 34
7.4 Company Subsidiaries 35
7.5 Governmental Approvals 36
7.6 Non-Contravention 36
7.7 Financial Statements 36
7.8 Absence of Certain Changes 38
7.9 Compliance with Laws 38
7.10 Company Permits 38 
ii
7.11 Litigation 38
7.12 Material Contracts 38
7.13 Intellectual Property 41
7.14 Taxes and Returns 42
7.15 Real Property 45
7.16 Personal Property 45
7.17 Employee Matters 45
7.18 Benefit Plans. 46
7.19 Environmental Matters 48
7.20 Transactions with Related Persons 49
7.21 Insurance 49
7.22 Customers and Suppliers. 50
7.23 Data Protection and Cybersecurity 50
7.24 Certain Business Practices 51
7.25 Investment Company Act 51
7.26 Finders and Brokers 51
7.27 Information Supplied 52
7.28 Company Acknowledgment 52
7.29 Dormant Entity 52
Article VIII COVENANTS 53
8.1 Access and Information 53
8.2 Conduct of Business of the Company during the Interim Period 54
8.3 Conduct of Business of SPAC during the Interim Period 57
8.4 Conduct of Business of PubCo during the Interim Period 59
8.5 Interim Period Control 60
8.6 Preparation and Delivery of Additional Company Financial Statements 60
8.7 SPAC Public Filings 61
8.8 Stock Exchange Listing 61
8.9 Exclusivity 61
8.10 No Trading 62
8.11 Notification of Certain Matters 62
8.12 Regulatory Approvals 62
8.13 Further Assurances 64
8.14 Tax Matters 64
8.15 The Registration Statement; Special Shareholder Meeting 66
8.16 Public Announcements 67
8.17 Confidential Information 68
8.18 Indemnification of Directors and Officers; Tail Insurance 69
8.19 SPAC Transaction Expenses; Trust Account Proceeds 69
8.20 New Registration Rights Agreement 70
8.21 Lock-Up Agreements 70
8.22 PubCo Equity Incentive Plan; PubCo ESPP; Section 280G 70
8.23 Litigation 72
8.24 Termination of SPAC Agreements 72
8.25 FIRPTA Certificate 72 
iii
8.26 PIPE Investment 73
8.27 Company Shareholder Approval 73
8.28 Other Matters 73
Article IX SURVIVAL 73
9.1 Survival 73
Article X CONDITIONS TO OBLIGATIONS OF THE PARTIES 74
10.1 Conditions to Each Party’s Obligations 74
10.2 Conditions to Obligations of the Company 74
10.3 Conditions to Obligations of SPAC 76
10.4 Frustration of Conditions 77
Article XI TERMINATION AND EXPENSES 77
11.1 Termination 77
11.2 Effect of Termination 78
11.3 Fees and Expenses 79
Article XII WAIVERS AND RELEASES 79
12.1 Waiver of Claims Against Trust 79
12.2 Mutual Releases 80
Article XIII MISCELLANEOUS 80
13.1 Notices 80
13.2 Binding Effect; Assignment 81
13.3 Third Parties 81
13.4 Governing Law; Jurisdiction 81
13.5 Waiver of Jury Trial 81
13.6 Specific Performance 82
13.7 Severability 82
13.8 Amendment 82
13.9 Waiver 82
13.10 Entire Agreement 82
13.11 Interpretation 83
13.12 Counterparts 85
13.13 No Recourse 85
13.14 Legal Representation 86
Article XIV DEFINITIONS 87
14.1 Certain Definitions 87
14.2 Section References 100 
iv

EXHIBITS

Exhibit A – Reserved

Exhibit B – Company Warrants

Exhibit C – Sponsor Support Agreement

Exhibit D – Form of Company Support Agreement

Exhibit E – Form of First Plan of Merger

Exhibit F – Form of Second Plan of Merger

Exhibit G – Reserved

Exhibit H – PubCo Series A Investor Warrants

Exhibit I – Form of New Registration Rights Agreement

Exhibit J-1 – Form of Lock-Up Agreement (Company)

Exhibit J-2 – Form of Lock-Up Agreement (Sponsor)

Exhibit K – Form of PubCo A&R Articles

v

BUSINESS COMBINATION AGREEMENT

This Business Combination Agreement (this “Agreement”) is made and entered into as of August 25, 2025, by and among Inflection Point Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), Air Water Ventures Holdings Limited, a Cayman Islands exempted company (the “Company”), Air Water Ventures Limited, a Cayman Islands exempted company (“PubCo”) and IPCX Merger Sub Limited, a Cayman Islands exempted company (“Merger Sub”). SPAC, the Company, PubCo and Merger Sub are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.

RECITALS

WHEREAS, the Company owns all of the issued and outstanding shares in the capital of Air Water Ventures Ltd., a private limited company formed under the Laws of England and Wales (“Air Water UK”);

WHEREAS, PubCo is a newly incorporated Cayman Islands exempted company that is owned entirely by a nominee who is not a U.S. citizen or resident (the “PubCoSole Shareholder”);

WHEREAS, Merger Sub is a newly incorporated Cayman Islands exempted company that is a direct, wholly-owned Subsidiary of SPAC;

WHEREAS, SPAC is a Cayman Islands exempted company structured as a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses;

WHEREAS, prior to the date of this Agreement, (a) the shareholders of Air Water UK transferred 100% of their shares in Air Water UK to the Company in exchange for the allotment of shares in the Company and (b) as part of the same plan of reorganization as the share exchange described in clause (a), Air Water UK has elected or will elect to be treated as an entity disregarded as separate from the Company under Treasury Regulations Section 301.7701-3, effective as of the date immediately after such contribution and exchange (the transactions described in (a) and (b), together, the “Pre-SigningReorganization”);

WHEREAS, the Pre-Signing Reorganization was and is intended to be treated as a “reorganization” within the meaning of Section 368(a)(1)(F) of the Code;

WHEREAS, prior to the date of this Agreement, Inflection Point Fund I, LP, an affiliate of SPAC (“Inflection Point Fund”), became the holder of certain Company Series A1 Preferred Shares;

1

WHEREAS, as a condition and inducement to the Parties’ willingness to enter into this Agreement, simultaneously with the execution and delivery of this Agreement, the Company, Inflection Point Fund and the other investors named therein (each, a “Pre-Funded PIPE Investor” and collectively, the “Pre-Funded PIPE Investors”) have executed and delivered that certain subscription agreement, dated as of the date hereof (the “Pre-Funded PIPE Subscription Agreement”), pursuant to which the Pre-Funded PIPE Investors have agreed, among other things, to subscribe and purchase from the Company, and the Company has agreed, among other things, to issue and allot to the Pre-Funded PIPE Investors, a number of Company Series A1 Preferred Shares and warrants to purchase Company Ordinary Shares in substantially the form attached hereto as Exhibit B (the “Company Warrants”), which transactions will be consummated concurrently with the execution and delivery of this Agreement (such investment the “Pre-Funded PIPE Investment”);

WHEREAS, as a condition and inducement to the Parties’ willingness to enter into this Agreement, simultaneously with the execution and delivery of this Agreement, the Company and the other investors named therein (each, a “Closing PIPE Investor” and collectively, the “Closing PIPE Investors”) have executed and delivered that certain subscription agreement, dated as of the date hereof (the “Closing PIPE Subscription Agreement”), pursuant to which the Closing PIPE Investors have agreed, among other things, to subscribe and purchase from the Company, and the Company has agreed, among other things, to issue and allot to the Closing PIPE Investors, a number of Company Series A Preferred Shares and Company Warrants, which transactions will be consummated immediately prior to the Second Merger Effective Time (such investment the “PIPE Investment”);

WHEREAS, from time to time following the date hereof and prior to the Closing, the Company may enter into subscription, purchase or similar agreements (each a “Future PIPE Agreement” and collectively, the “Future PIPE Agreements”; and the Future PIPE Agreements, together with the Closing PIPE Subscription Agreement, the “PIPE Agreements”) with certain investors (each a “Future PIPE Investor” and collectively, the “Future PIPE Investors”; and the Future PIPE Investors together with the Closing PIPE Investors, the “PIPE Investors”), pursuant to which, and on the terms and subject to the conditions of which, such Future PIPE Investors will agree to participate in the PIPE Investment;

WHEREAS, Merger Sub has elected or will elect to be treated as an entity disregarded as separate from its owner under Treasury Regulations Section 301.7701-3, effective as of a date prior to the Second Merger;

WHEREAS, the Parties desire and intend to effect a business combination transaction whereby (a) SPAC will merge with and into PubCo (the “FirstMerger”), as a result of which (i) the separate corporate existence of SPAC shall cease and PubCo shall continue as the surviving company and (ii) each issued and outstanding SPAC Share shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive one (1) PubCo Ordinary Share (the “SPAC Per Share Merger Consideration”) and (b) one (1) Business Day after the date of the First Merger Effective Time, the Company will merge with and into Merger Sub (the “SecondMerger” and, together with the First Merger, the “Mergers”, and the Mergers together with the other transactions contemplated by this Agreement and the Ancillary Documents, the “Transactions”), as a result of which (i) the separate corporate existence of the Company shall cease and Merger Sub shall continue as the surviving company and a wholly owned direct subsidiary of PubCo and (ii) each issued and outstanding Company Ordinary Share, Company Series A Preferred Share, Company Warrant and Company RSU shall no longer be outstanding and shall automatically be cancelled in exchange for the right of the holder thereof to receive the consideration set forth in Section 2.2, in each case upon the terms and subject to the conditions set forth in this Agreement and in accordance with the provisions of applicable Law;

2

WHEREAS, concurrently with the execution and delivery of this Agreement, the Company, SPAC, PubCo and Inflection Point Holdings III LLC, a Delaware limited liability company (“Sponsor”) have entered into the Sponsor Support Agreement, a copy of which is attached hereto as Exhibit C (the “Sponsor Support Agreement”), pursuant to which, among other things, (a) Sponsor agreed to waive its anti-dilution rights in the SPAC Charter with respect to the SPAC Class B Ordinary Shares and (b) Sponsor agreed to vote its interests in favor of the Transactions, in each case, upon the terms and conditions set forth in the Sponsor Support Agreement;

WHEREAS, concurrently with the execution and delivery of this Agreement, the Company, SPAC, Tau Capital Holding Limited (f/k/a TAU Capital Holding – Sole Proprietorship LLC), a limited liability company organized and existing under the Laws of the Abu Dhabi Global Market (“TauCapital”), and certain other holders of Company Ordinary Shares, have each entered into a Company Support Agreement, in the form attached hereto as Exhibit D (the “Company Support Agreements”), pursuant to which, among other things, Tau Capital and such other parties thereto agreed to vote their respective interests in favor of this Agreement, the Second Merger and the Transactions, in each case, upon the terms and conditions set forth in the Company Support Agreements;

WHEREAS, the Board of Directors of the Company (the “Company Board”) has unanimously (a) determined that this Agreement, the Ancillary Documents to which it is party, the Mergers and the other Transactions are in the best interests of the Company, (b) approved this Agreement, the Ancillary Documents to which the Company is party, the Mergers and the other Transactions and (c) recommended the approval and adoption of this Agreement, the Ancillary Documents to which the Company is party, the Mergers and the Transactions by the Company Shareholders (the “Company Board Recommendation”);

WHEREAS, the Board of Directors of SPAC (the “SPAC Board”) has unanimously (a) determined that (i) this Agreement, the Ancillary Documents to which it is party, the Mergers and the other Transactions are in the best interests of SPAC and the holders of the SPAC Shares (the “SPAC Shareholders”) as a whole and (ii) the Transactions constitute a “Business Combination” as such term is defined in the SPAC Charter, (b) approved this Agreement, the Ancillary Documents to which SPAC is party, the Mergers and the other Transactions, and (c) recommended the approval and adoption of this Agreement, the Ancillary Documents to which SPAC is a party, the Mergers and the other Transactions by SPAC Shareholders (the “SPAC Board Recommendation”);

WHEREAS, the Board of Directors of PubCo (the “PubCo Board”) has unanimously (a) determined that this Agreement, the Ancillary Documents to which it is party and the Transactions are in the best interests of PubCo, (b) approved this Agreement, the Ancillary Documents to which it is party and the Transactions, and (c) recommended that the PubCo Sole Shareholder approve this Agreement, the Ancillary Documents to which PubCo is party, the Mergers and the other Transactions;

3

WHEREAS, the PubCo Sole Shareholder has approved this Agreement, the Ancillary Documents to which PubCo is a party, the Mergers and the other Transactions;

WHEREAS, the Board of Directors of Merger Sub has unanimously (a) determined that this Agreement, the Ancillary Documents to which it is party, the Second Merger and the other Transactions are in the best interests of Merger Sub and SPAC (as the sole shareholder of Merger Sub), (b) approved this Agreement and the Ancillary Documents to which Merger Sub is a party and declaring its and their advisability and approving the Second Merger and the other Transactions, and (c) recommended the approval and adoption of this Agreement, the Ancillary Documents to which Merger Sub is a party, the Second Merger and the other Transactions by SPAC (as the sole shareholder of Merger Sub);

WHEREAS, SPAC has approved and adopted a written resolution approving, in its capacity as the sole shareholder of Merger Sub, this Agreement, the Ancillary Documents to which Merger Sub is a party, the Second Merger and the other Transactions;

WHEREAS, the Parties intend that for U.S. federal, and applicable state and local, income Tax purposes, (i) the First Merger qualify as a “reorganization” within the meaning of Section 368(a)(1)(F) of the Code, (ii) the SPAC Class B Ordinary Share Conversion qualify as a “reorganization” within the meaning of Section 368(a)(1)(E) of the Code, (iii) the Second Merger qualify as a “reorganization” within the meaning of Section 368(a) of the Code, and (iv) this Agreement constitute, and is hereby adopted as, a “plan of reorganization” within the meaning of Sections 354, 361 and 368 of the Code and Treasury Regulations Sections 1.368-2(g) and 1.368-3(a); and

WHEREAS, certain capitalized terms used herein are defined in Article XIV hereof.

NOW, THEREFORE, in consideration of the premises set forth above, and the representations, warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Parties agree as follows:

Article I

MERGERS

1.1 Mergers.

(a) Subject to and upon the terms and conditions of this Agreement and the plan of merger to be filed relating to the First Merger substantially in the form attached hereto as Exhibit E, with such modifications, amendments or supplements thereto as may be required to comply with the Cayman Companies Law (the “First Plan of Merger”), and in accordance with the applicable provisions of the Cayman Companies Law, on the Business Day prior to the date of the Second Merger Effective Time, SPAC and PubCo shall consummate the First Merger, pursuant to which SPAC shall be merged with and into PubCo with PubCo being the surviving company, following which the separate corporate existence of SPAC shall cease and PubCo shall continue as the surviving company. PubCo, as the surviving company after the First Merger, is sometimes hereinafter referred to for the periods at and after the First Merger Effective Time as the “FirstSurviving Company”.

4

(b) Subject to and upon the terms and conditions of this Agreement and the plan of merger to be filed relating to the Second Merger substantially in the form attached hereto as Exhibit F, with such modifications, amendments or supplements thereto as may be required to comply with the Cayman Companies Law (the “Second Plan of Merger”), and in accordance with the applicable provisions of the Cayman Companies Law, on the Closing Date, the Company and Merger Sub and PubCo shall consummate the Second Merger, pursuant to which the Company shall be merged with and into Merger Sub with the Merger Sub being the surviving company, following which the separate corporate existence of the Company shall cease and the Merger Sub shall continue as the surviving company and a wholly owned direct subsidiary of PubCo. The Merger Sub, as the surviving company after the Second Merger, is sometimes hereinafter referred to for the periods at and after the Second Merger Effective Time as the “Second Surviving Company”.

1.2 Merger Effective Times.

(a) SPAC and PubCo shall cause the First Merger to be consummated by filing the executed First Plan of Merger and other documents and declarations as required to effect the First Merger pursuant to the Cayman Companies Law with the Registrar of Companies of the Cayman Islands as provided in the applicable provisions of the Cayman Companies Law. The First Merger shall become effective at the time when the First Plan of Merger has been registered by the Registrar of Companies of the Cayman Islands or at such later time (but at least one Business Day prior to the date of the Second Merger Effective Time) as may be agreed by SPAC and PubCo in writing, subject to the limitations specified in the Cayman Companies Law, and specified in the First Plan of Merger (the “First Merger Effective Time”).

(b) The Company, PubCo and Merger Sub shall cause the Second Merger to be consummated by filing the executed Second Plan of Merger and other documents and declarations as required to effect the Second Merger pursuant to the Cayman Companies Law with the Registrar of Companies of the Cayman Islands as provided in the applicable provisions of the Cayman Companies Law. The Second Merger shall become effective at the time when the Second Plan of Merger has been registered by the Registrar of Companies of the Cayman Islands or at such later time as may be agreed by the Company and Merger Sub in writing, subject to the limitations specified in the Cayman Companies Law, and specified in the Second Plan of Merger (the “Second Merger Effective Time”).

1.3 Effect of the Mergers.

(a) At the First Merger Effective Time, the effect of the First Merger shall be as provided in this Agreement, the First Plan of Merger and the applicable provisions of Cayman Companies Law. Without limiting the generality of the foregoing, and subject thereto, at the First Merger Effective Time, all the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of SPAC and PubCo shall become the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of the First Surviving Company (including all rights and obligations with respect to the Trust Account), which shall include the assumption by the First Surviving Company of any and all agreements, covenants, duties and obligations of SPAC and PubCo set forth in this Agreement to be performed after the First Merger Effective Time.

5

(b) At the Second Merger Effective Time, the effect of the Second Merger shall be as provided in this Agreement, the Second Plan of Merger and the applicable provisions of Cayman Companies Law. Without limiting the generality of the foregoing, and subject thereto, at the Second Merger Effective Time, all the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of the Company and Merger Sub shall become the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of the Second Surviving Company, which shall include the assumption by the Second Surviving Company of any and all agreements, covenants, duties and obligations of the Company and Merger Sub set forth in this Agreement to be performed after the Second Merger Effective Time.

1.4 Organizational Documents.

(a) At the First Merger Effective Time, PubCo shall adopt a new amended and restated memorandum and articles of association in substantially the form attached hereto as Exhibit K (the “PubCo A&R Articles”), which PubCo A&R Articles shall be the amended and restated memorandum and articles of association of PubCo until thereafter amended in accordance with the PubCo A&R Articles and applicable Law.

(b) The memorandum and articles of association of Merger Sub as in effect immediately prior to the Second Merger Effective Time shall be the memorandum and articles of association of the Second Surviving Company (except that references to the name of Merger Sub shall be changed to the name of the Company) following the Second Merger Effective Time until thereafter amended in accordance with such memorandum and articles of association and applicable Law.

1.5 Directors and Officers of Surviving Companies.

(a) FirstMerger.

(i) At the First Merger Effective Time, the directors of PubCo as of immediately prior to the First Merger Effective Time shall resign and, with effect from and after the Closing, and subject to the PubCo A&R Articles, the PubCo Board (the “Post-Closing PubCo Board”) shall initially consist of six (6) directors, of whom (A) two (2) shall be designated by SPAC, one (1) of which will qualify as an “independent director” as defined in Nasdaq rules and be eligible to serve on an audit committee, and (B) four (4) shall be designated by the Company, one of which shall be Peter Carr, and two (2) of which will qualify as “independent directors” as defined in Nasdaq rules and be eligible to serve on an audit committee (collectively, the “Post-Closing PubCo Directors”), each Post-Closing PubCo Director to hold office in accordance with the PubCo A&R Articles until his or her respective successor is duly elected or appointed and qualified or his or her earlier death, resignation or removal. For the avoidance of doubt, following the Second Merger Effective Time, nothing in this Section 1.5(a) shall impose or imply any obligations with respect to any future nomination, appointment, designation or election of directors to the Post-Closing PubCo Board, and all future vacancies on the Post-Closing PubCo Board shall be filled in accordance with the PubCo A&R Articles.

6

(ii) At the First Merger Effective Time, the officers of PubCo as of immediately prior to the First Merger Effective Time shall resign, and, with effect from and after the Closing, and subject to the PubCo A&R Articles, the individuals set forth in Section 1.5(a)(ii) of the Company Disclosure Letter shall be appointed as the officers of PubCo (the “Post-Closing PubCo Officers”), each Post-Closing PubCo Officer to hold office in accordance with the PubCo A&R Articles until his or her respective successor is duly appointed and qualified or his or her earlier death, resignation or removal.

(b) At the Second Merger Effective Time, the directors and officers of Merger Sub shall resign, and with effect from and after the Closing, the directors and officers of the Second Surviving Company shall be the Post-Closing PubCo Directors and the Post-Closing PubCo Officers, respectively, each to hold office in accordance with the Organizational Documents of the Second Surviving Company until their resignation or removal in accordance with the Organizational Documents of the Second Surviving Company or until their respective successors are duly elected or appointed and qualified. At the Second Merger Effective Time, the board of directors and officers of the Company shall automatically cease to hold office. Each Party shall take all necessary actions within its power so that the Post-Closing PubCo Directors and Post-Closing PubCo Officers are the same individuals at the First Merger Effective Time and the Second Merger Effective Time.

Article II

CONVERSION AND EXCHANGE OF SECURITIES

2.1 First Merger.

(a) SPACUnit Separation. One (1) day prior to the date of the First Merger Effective Time, each SPAC Unit that is issued and outstanding at such time shall be automatically detached and the holder thereof shall be deemed to hold one SPAC Class A Ordinary Share and one SPAC Right in accordance with the terms of the applicable SPAC Unit (the “Unit Separation”). The detached SPAC Securities shall be converted in accordance with the applicable terms of this Section  2.1.

(b) SPACClass B Ordinary Share Conversion. One (1) day prior to the date of the First Merger Effective Time, each SPAC Class B Ordinary Share that is issued and outstanding at such time shall be automatically converted into one (1) SPAC Class A Ordinary Share in accordance with the conversion mechanics set forth in Article 8.2 of the Articles of Association of the SPAC (without giving effect to the adjustments set forth in Article 8.3 thereof) (the “SPAC Class B Ordinary Share Conversion”), and following such conversion, each SPAC Class B Ordinary Share shall no longer be outstanding, and each former holder of SPAC Class B Ordinary Shares shall thereafter cease to have any rights with respect to such securities.

(c) SPACRights. One (1) day prior to the date of the First Merger Effective Time, but immediately after the Unit Separation, each SPAC Right that is then issued and outstanding at such time shall be automatically converted into one-tenth (1/10) of one SPAC Class A Ordinary Share in accordance with the SPAC Rights Agreement without any action on the part of any Party or the holders of SPAC Rights (the “RightsConversion”); provided that if a holder of SPAC Rights would be entitled to receive a fraction of a SPAC Class A Ordinary Share upon the Rights Conversion, the number of SPAC Class A Ordinary Shares issued to such holder upon the Rights Conversion shall be rounded down to the nearest whole number of SPAC Class A Ordinary Shares without cash settlement for such rounded fraction. For clarity, the above Rights Conversion shall apply notwithstanding any requirement to affirmatively exchange such SPAC Rights pursuant to Section 3.3.1 of the Rights Agreement, which requirement SPAC hereby waives.

7

(d) SPACShare**s. At the First Merger Effective Time, by virtue of the First Merger and without any action on the part of any Party or the holders of securities of SPAC or PubCo, after giving effect to the Unit Separation referred to in Section 2.1(a), each SPAC Class A Ordinary Share (other than any Excluded Shares, SPAC Dissenting Shares and Redeeming SPAC Shares), which is issued and outstanding immediately prior to the First Merger Effective Time, shall thereupon be converted into, and the holder of such SPAC Share shall be entitled to receive, the SPAC Per Share Merger Consideration. All of the SPAC Shares converted into the right to receive the SPAC Per Share Merger Consideration pursuant to this Section 2.1(d) shall no longer be outstanding and shall automatically be cancelled and shall cease to exist at the First Merger Effective Time, and each holder of a certificate previously representing any such SPAC Shares shall thereafter cease to have any rights with respect to such securities, except the right to receive the SPAC Per Share Merger Consideration into which such SPAC Shares shall have been converted in the Merger.

(e) ExcludedShares. At the First Merger Effective Time, by virtue of the First Merger and without any action on the part of any Party or the SPAC Shareholders, each Excluded Share that is issued and outstanding immediately prior to the First Merger Effective Time shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, without any conversion thereof and no consideration shall be paid with respect thereto.

(f) RedeemingSPAC Shares. At the First Merger Effective Time, by virtue of the First Merger and without any action on the part of any Party or the SPAC Shareholders, each Redeeming SPAC Share that is issued and outstanding immediately prior to the First Merger Effective Time (if any) shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and each holder of such Redeeming SPAC Shares shall thereafter cease to have any rights with respect to such securities except the right to be paid a pro rata share of the Redemption Amount in accordance with the SPAC Charter.

(g) PubCoShares. At the First Merger Effective Time, by virtue of the First Merger and without any action on the part of any Party or holders of securities of PubCo, each PubCo Ordinary Share that is issued and outstanding immediately prior to the First Merger Effective Time all of which shall be standing in the name of the PubCo Sole Shareholder in the register of members of PubCo (excluding, for the avoidance of doubt, any PubCo Ordinary Shares issued at the First Merger Effective Time in accordance with Section 2.1(d)) shall be irrevocably surrendered by the PubCo Sole Shareholder to PubCo for cancellation and for consideration equal to the subscription price (if any) that the PubCo Sole Shareholder paid for such PubCo Ordinary Share, and the Company and PubCo shall cause the PubCo Sole Shareholder (as the sole holder of such ordinary shares of PubCo being surrendered) to irrevocably consent to such surrender.

8

(h) NoLiability. Notwithstanding anything to the contrary in this Section 2.1, none of the First Surviving Company, PubCo, the Company or any other Party shall be liable to any Person for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar Law.

(i) SPACDissenting Shares. Notwithstanding any provision of this Agreement to the contrary, and subject at all times to applicable Law, SPAC Shares issued and outstanding immediately prior to the First Merger Effective Time and held by a SPAC Shareholder who is entitled to demand and has properly exercised in writing dissenter rights in respect of such shares in accordance with Section 238 of the Cayman Companies Law and who has otherwise complied with all of the provisions of the Cayman Companies Law relevant to the exercise and perfection of dissenters’ rights (such SPAC Shares being referred to collectively as the “SPAC Dissenting Shares” until such time as such holder fails to perfect or otherwise waives, withdraws, or loses such holder’s dissenter rights under the Cayman Companies Law with respect to such shares) shall not be converted into the right to receive the SPAC Per Share Merger Consideration. Each SPAC Dissenting Share shall no longer be outstanding and shall automatically be cancelled by virtue of the First Merger, and the holder of such SPAC Dissenting Share shall thereafter cease to have any rights with respect to such SPAC Dissenting Share, but instead shall be entitled to the right to be paid the fair value of such SPAC Dissenting Share and such other rights as are granted by Section 238 of the Cayman Companies Law; provided, however, that if, after the First Merger Effective Time, such holder fails to perfect, waives, withdraws, or loses such holder’s right to dissent pursuant to Section 238 of the Cayman Companies Law, or if a court of competent jurisdiction shall determine that such holder is not entitled to the relief provided by Section 238 of the Cayman Companies Law, such SPAC Shares shall cease to be SPAC Dissenting Shares and shall be treated as if they had been converted as of the First Merger Effective Time into the right to receive the SPAC Per Share Merger Consideration without interest thereon. During the period from the date of this Agreement through the Interim Period, SPAC shall provide PubCo written notice as promptly as practicable following receipt of any written objections to the First Merger, notices of election to dissent, demands received by SPAC for appraisal of SPAC Shares, any waiver or withdrawal of any such objections, notices or demands, and any other demand, notice, or instrument delivered to SPAC prior to the First Merger Effective Time that relates to the foregoing. Subject at all times to the Cayman Companies Law, except with the prior written consent of PubCo (which consent shall not be unreasonably conditioned, withheld, or delayed), SPAC shall not make any payment with respect to, or settle, or offer to settle, any such demands during the Interim Period.

2.2 Second Merger.

(a) CompanyOrdinary Shares. At the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Party or the holders of securities of the Company or PubCo, each Company Ordinary Share that is issued and outstanding immediately prior to the Second Merger Effective Time shall thereupon be converted into, and the holder of such Company Ordinary Share shall be entitled to receive, a number of PubCo Ordinary Shares equal to (i) the Company Consideration Shares divided by (ii) the total number of Company Ordinary Shares (including the Company Ordinary Shares underlying the Company RSUs) issued and outstanding immediately prior to the Second Merger Effective Time (the “Exchange Ratio”). All of the Company Ordinary Shares converted into the right to receive the Company Consideration Shares pursuant to this Section 2.2(a) shall no longer be outstanding and shall automatically be cancelled and shall cease to exist at the Second Merger Effective Time, and each holder of a certificate previously representing any such Company Ordinary Shares shall thereafter cease to have any rights with respect to such securities, except the right to receive the Company Consideration Shares into which such Company Ordinary Shares shall have been converted in the Second Merger.

9

(b) CompanySeries A1 Preferred Shares. At the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Party or the holders of securities of the Company or PubCo, each holder of (i) Company Series A1 Preferred Shares shall be entitled to receive, and the Company Series A1 Preferred Shares held by each such holder immediately prior to the Second Merger Effective Time shall be converted into, a number of PubCo Preferred Shares equal to (x) the aggregate Accrued Value attributable to such Company Series A1 Preferred Shares held by such holder divided by (y) the PubCo Preferred Share Issue Price. All of the Company Series A1 Preferred Shares converted into the right to receive the PubCo Preferred Shares pursuant to this Section 2.2(b) shall no longer be outstanding and shall automatically be cancelled and shall cease to exist at the Second Merger Effective Time, and each holder of a certificate previously representing any such Company Series A1 Preferred Shares shall thereafter cease to have any rights with respect to such securities, except the right to receive the PubCo Preferred Shares into which such Company Series A1 Preferred Shares shall have been converted in the Second Merger.

(c) CompanySeries A2 Preferred Shares. At the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Party or the holders of securities of the Company or PubCo, each holder of Company Series A2 Preferred Shares shall be entitled to receive, and the Company Series A2 Preferred Shares held by each such holder immediately prior to the Second Merger Effective Time shall be converted into, a number of PubCo Preferred Shares equal to (i) the aggregate Accrued Value attributable to such Company Series A2 Preferred Shares held by such holder divided by (ii) the PubCo Preferred Share Issue Price. All of the Company Series A2 Preferred Shares converted into the right to receive the PubCo Preferred Shares pursuant to this Section 2.2(c) shall no longer be outstanding and shall automatically be cancelled and shall cease to exist at the Second Merger Effective Time, and each holder of a certificate previously representing any such Company Series A2 Preferred Shares shall thereafter cease to have any rights with respect to such securities, except the right to receive the PubCo Preferred Shares into which such Company Series A2 Preferred Shares shall have been converted in the Second Merger

(d) CompanyWarrants. At the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Party or the holders of securities of the Company or PubCo, each Company Warrant that is issued and outstanding immediately prior to the Second Merger Effective Time shall thereupon be converted into, and the holder of such Company Warrant shall be entitled to receive, a PubCo Series A Investor Warrant exercisable for (i) with respect to each Company Warrant issued pursuant to a Pre-Funded PIPE Subscription Agreement or PIPE Agreement, a number of PubCo Ordinary Shares equal to (x) the number of Company Ordinary Shares issuable upon conversion of the applicable Pre-Funded PIPE Investor’s or PIPE Investor’s Company Series A Preferred Shares upon a hypothetical conversion of such Company Series A Preferred Shares immediately prior to the Second Merger multiplied by (y) the Exchange Ratio, and (ii) with respect to the Company Warrants set forth on Section 7.3(e) of the Company Disclosure Schedule, a number of PubCo Ordinary Shares equal to the number of Company Ordinary Shares issuable upon exercise of such Company Warrants as of immediately prior to the Second Merger, in each case, which PubCo Series A Investor Warrant shall be substantially in the form attached hereto as Exhibit H (the “PubCo Series A Investor Warrants”). All of the Company Warrants converted into the right to receive the PubCo Series A Investor Warrants pursuant to this Section 2.2(d) shall no longer be outstanding and shall automatically be cancelled and shall cease to exist at the Second Merger Effective Time, and each holder of a certificate previously representing any such Company Warrant shall thereafter cease to have any rights with respect to such securities, except the right to receive the PubCo Series A Investor Warrants into which such Company Warrant shall have been converted in the Second Merger.

10

(e) CompanyRSUs. At the Second Merger Effective Time, by virtue of the Second Merger and without any further action on the part of any Party or the holder thereof, each award of Company RSUs that is outstanding and unvested immediately prior to the Second Merger Effective Time shall be assumed and converted into the right to receive restricted stock units subject to PubCo Ordinary Shares on the same terms and conditions (including applicable vesting, settlement, and termination provisions) as are in effect with respect to each such award of Company RSUs immediately prior to the Second Merger Effective Time (each, an “Exchanged RSU”); provided that each award of Exchanged RSUs will be subject to the number of PubCo Ordinary Shares equal the product of (x) the number of whole Company Ordinary Shares that were subject to such award of Company RSUs (with any fractional share otherwise resulting rounded down to the nearest whole share) immediately prior to the Second Merger Effective Time, multiplied by (y) the Exchange Ratio; provided, further, that each award of Company RSUs shall be adjusted in a manner that complies with or is exempt from Section 409A of the Code, and any ambiguities or ambiguous terms herein will be interpreted to so comply or be exempt. All Exchanged RSUs that become vested will be settled via PubCo Ordinary Shares issued under the PubCo Equity Incentive Plan.

(f) CompanyPSUs. At the Second Merger Effective Time, by virtue of the Second Merger and without any further action on the part of any Party or the holder thereof, each award of Company PSUs that is outstanding and unvested immediately prior to the Second Merger Effective Time shall be assumed and converted into the right to receive performance-based restricted stock units subject to PubCo Ordinary Shares on the same terms and conditions (including applicable performance vesting criteria contemplated by Section 2.10 of this Agreement and other applicable settlement, and termination provisions) as are in effect with respect to each such award of Company PSUs immediately prior to the Second Merger Effective Time (each, an “Exchanged PSU”); provided that each award of Exchanged PSUs will be subject to a number of PubCo Ordinary Shares, determined based on the pro-rata portion of Earnout Shares attributable to such PSU Holder’s Company RSUs, subject to achievement of the applicable Triggering Event (with any fractional share otherwise resulting rounded down to the nearest whole share); provided, further, that each award of Company PSUs shall be adjusted in a manner that complies with or is exempt from Section 409A of the Code, and any ambiguities or ambiguous terms herein will be interpreted to so comply or be exempt. All Exchanged PSUs that become vested will be settled via PubCo Ordinary Shares issued under the PubCo Equity Incentive Plan.

(g) MergerSub Shares. At the Second Merger Effective Time, by virtue of the Second Merger and without any action on the part of any Party or the holders of securities of the Company or Merger Sub, each Merger Sub Share that is issued and outstanding immediately prior to the Second Merger Effective Time shall be converted into and become one validly issued, fully paid and non-assessable ordinary share of the Second Surviving Company.

11

(h) NoLiability. Notwithstanding anything to the contrary in this Section 2.2, none of the Second Surviving Company, PubCo, SPAC or any other Party shall be liable to any Person for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar Law.

2.3 Satisfaction of Rights. All securities issued upon the surrender of SPAC Securities and Company Securities in accordance with the terms hereof shall be deemed to have been issued in full satisfaction of all rights pertaining to such securities; provided that, to the extent required by U.S. federal securities law or other contractual arrangements, any restrictions on the sale and transfer of SPAC Securities shall also apply to the PubCo Securities so issued in exchange.

2.4 Lost, Stolen or Destroyed SPAC or Company Certificates. In the event any certificates representing SPAC Securities or Company Securities shall have been lost, stolen or destroyed, upon the making of an affidavit of such fact and indemnity by the Person claiming such certificate to be lost, stolen or destroyed, PubCo shall issue, in exchange for such lost, stolen or destroyed certificates, as the case may be, such securities, as may be required pursuant to Section 2.1 and 2.2, as applicable.

2.5 Register of Members. At the First Merger Effective Time, the register of members of SPAC shall be closed, and there shall be no further registration of transfers of SPAC Securities thereafter on the records of SPAC. At the Second Merger Effective Time, the register of members of the Company shall be closed, and there shall be no further registration of transfers of Company Securities thereafter on the records of the Company.

2.6 Appointment of Transfer Agent. Prior to the Closing, PubCo shall appoint a transfer agent acceptable to SPAC and the Company (the “Transfer Agent”), as its agent, for the purpose of recording the (a) exchange of the SPAC Securities for PubCo Securities and (b) exchange of Company Securities for PubCo Securities. The Transfer Agent shall take or cause to be taken such actions as are necessary to update PubCo’s register of members to reflect (i) the exchange of the SPAC Securities for PubCo Securities and (ii) the exchange of the Company Securities for PubCo Securities, in each case in accordance with the terms of this Agreement and, to the extent applicable, the First Plan of Merger, the Second Plan of Merger, the Cayman Companies Law and customary transfer agent procedures and the rules and regulations of the Depository Trust Company (“DTC”), in each case in a form approved by the Company.

2.7 Exchange of Book-Entry Shares.

(a) Issuance of PubCo Securities. At the First Merger Effective Time and Second Merger Effective Time, as applicable, PubCo shall issue all PubCo Securities to be issued as required pursuant to Section 2.1 and 2.2, respectively.

12

(b) Exchange Procedures for SPAC Shares. As soon as practicable after the First Merger Effective Time (and in no event later than five (5) Business Days after the First Merger Effective Time), PubCo shall cause the Transfer Agent to mail to each holder of record of SPAC Shares which were converted pursuant to Section 2.1(d) into the SPAC Per Share Merger Consideration instructions for use in effecting the surrender of the SPAC Shares in exchange for the SPAC Per Share Merger Consideration in a form acceptable to the Company. Upon receipt of an “agent’s message” by the Transfer Agent (or such other evidence, if any, of transfer as the Transfer Agent may reasonably request), the holder of a SPAC Share which was converted pursuant to Section 2.1(d) into the SPAC Per Share Merger Consideration shall be entitled to receive in exchange therefor, net of any required withholding Taxes, the SPAC Per Share Merger Consideration in book-entry form, without interest, for each SPAC Share surrendered. The PubCo Ordinary Shares to be delivered as the SPAC Per Share Merger Consideration shall be settled through DTC and issued in uncertificated book-entry form through the customary procedures of DTC, unless a physical PubCo Ordinary Share is required by applicable Law, in which case PubCo and the Company shall jointly cause the Transfer Agent to promptly send certificates representing such PubCo Ordinary Shares to such holder. If payment of the SPAC Per Share Merger Consideration is to be made to a Person other than the Person in whose name the surrendered SPAC Share in exchange therefor is registered, it shall be a condition of payment that (i) the Person requesting such exchange present proper evidence of transfer or shall otherwise be in proper form for transfer and (ii) the Person requesting such payment shall have paid any transfer and other Taxes required by reason of the payment of the SPAC Per Share Merger Consideration to a Person other than the registered holder of SPAC Share surrendered or shall have established to the reasonable satisfaction of PubCo and the Company that such Tax either has been paid or is not applicable.

(c) Distributions with Respect to Unexchanged PubCo Ordinary Shares. All PubCo Ordinary Shares to be issued hereunder shall be deemed issued and outstanding as of the First Merger Effective Time or Second Merger Effective Time, as applicable. Subject to the effect of escheat, Tax or other applicable Laws, the holder of whole PubCo Ordinary Shares issued pursuant to Section 2.1(d) and 2.2(a) will be promptly paid, without interest and net of any applicable withholding Tax, the amount of dividends or other distributions with a record date after the First Merger Effective Time and Second Merger Effective Time, as applicable, and theretofore paid with respect to such whole PubCo Ordinary Shares.

(d) Adjustments to Per Share Merger Consideration. The SPAC Per Share Merger Consideration shall be adjusted to reflect appropriately the effect of any share split, reverse share split, share dividend, reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to SPAC Shares occurring on or after the date of this Agreement and prior to the First Merger Effective Time and Second Merger Effective Time.

2.8 Taking of Necessary Action; Further Action. If, at any time after the First Merger Effective Time or the Second Merger Effective Time, as applicable, any further action is necessary or desirable to carry out the purposes of this Agreement and to vest the First Surviving Company following the First Merger and the Second Surviving Company following the Second Merger with full right, title and possession to all assets, property, rights, privileges, powers and franchises of SPAC, PubCo, the Company and Merger Sub, as applicable, the officers and directors (or their designees) of SPAC, PubCo, the Company and Merger Sub, as applicable, are fully authorized in the name of their respective companies or otherwise to take, and will take, all such lawful and necessary action, so long as such action is not inconsistent with this Agreement.

13

2.9 Tax Consequences. The Parties hereby agree and acknowledge that for U.S. federal (and applicable state and local) income tax purposes, it is intended that (a) the First Merger qualifies as a “reorganization” described in Section 368(a)(1)(F) of the Code, (b) the SPAC Class B Ordinary Share Conversion qualifies as a “reorganization” described in Section 368(a)(1)(E) of the Code, (c) the Second Merger qualifies as a “reorganization” within the meaning of Section 368(a) of the Code, and (d) this Agreement constitute, and hereby is adopted, as a “plan of reorganization” within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a) for purposes of Sections 354, 361 and 368 of the Code and the Treasury Regulations thereunder (collectively, the “Intended Tax Treatment”).

2.10 Earnout Shares.

(a) In addition to the issuance of the PubCo Securities pursuant to Section 2.2, as promptly as reasonably practicable (but in any event, within five (5) Business Days) after the occurrence of a Triggering Event, PubCo shall issue to the Eligible Company Equityholders and the PSU Holders the following aggregate number of PubCo Ordinary Shares (subject to Equitable Adjustment and including, for the avoidance of doubt, the PubCo Ordinary Shares issued pursuant to the Company PSUs, the “Earnout Shares”), upon the terms and subject to the conditions set forth in this Agreement, provided that the shares underlying Company PSUs shall be issued at the time set forth in the applicable award agreement evidencing the Company PSUs:

(i) Upon the occurrence of Triggering Event I, a one-time issuance of 7,500,000 Earnout Shares;

(ii) Upon the occurrence of Triggering Event II, a one-time issuance of 7,500,000 Earnout Shares;

(iii) Upon the occurrence of Triggering Event III, a one-time issuance of 7,500,000 Earnout Shares; and

(iv) Upon the occurrence of Triggering Event IV, a one-time issuance of 7,500,000 Earnout Shares.

(b) The Earnout Shares with respect to each Triggering Event shall be allocated among the Eligible Company Equityholders and PSU Holders as set forth in Section 2.10(b) of the Company Disclosure Schedules.

(c) For the avoidance of doubt, the Eligible Company Equityholders, and PSU Holders shall be entitled to receive Earnout Shares upon the occurrence of each Triggering Event; provided, however, that each Triggering Event shall only occur once, if at all, and in no event shall the sum of the Earnout Shares exceed 30,000,000.

(d) The PubCo Ordinary Share price target set forth in the definition of Triggering Event IV shall be subject to Equitable Adjustment.

14

(e) Any issuance and delivery of Earnout Shares to Eligible Company Equityholders shall be treated as an adjustment to the PubCo Ordinary Shares received in the Second Merger by the Parties for all applicable Tax purposes, unless otherwise required pursuant to a “determination” (as defined in Section 1313(a) of the Code or any similar provision of U.S. state, local or non-U.S. Law), and such issuance and delivery of Earnout Shares to Eligible Company Equityholders that are holders of Company Ordinary Shares is intended to comply with, and shall be effected in accordance with, IRS Rev. Proc. 84-42, 1984-1 C.B. 521.

2.11 Fractional Shares. Notwithstanding anything to the contrary contained herein, no fraction of a PubCo Ordinary Share will be issued, in any form, by virtue of this Agreement, the Mergers or the other Transactions, and each Person who would otherwise be entitled to a fraction of a PubCo Ordinary Share (after aggregating all fractional PubCo Ordinary Shares that would otherwise be received by such Person) shall instead have the aggregate number of PubCo Ordinary Shares issued to such Person rounded down to the nearest whole PubCo Ordinary Share. No cash settlements shall be made with respect to fractional shares eliminated by rounding.

2.12 Release of Funds from Trust Account. Subject to the terms and conditions of the Trust Agreement, each Party shall use commercially reasonable efforts, and shall cooperate fully with the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws and regulations to cause the funds held in the Trust Account to be released simultaneously with, or as promptly as practicable after, the Closing.

2.13 Withholding. Notwithstanding anything in this Agreement to the contrary, SPAC, PubCo, Merger Sub, the Company, the Transfer Agent and any other applicable withholding agent shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any amount payable pursuant to this Agreement such amounts as are required to be deducted and withheld under applicable Tax Law. To the extent that amounts are so deducted and withheld, such deducted and withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.

Article III

MERGER CLOSING

3.1 Closing. Subject to the satisfaction or waiver of the conditions set forth in Article X, the closing of the Transactions (the “Closing”) shall occur no later than the third (3^rd^) Business Day following the satisfaction or, to the extent legally permissible, waiver of the conditions set forth in Article X (other than those conditions that by their nature are to be fulfilled at the Closing), but subject to the satisfaction of or, to the extent legally permissible, waiver by the Party benefitting from, such conditions, or at such other date as SPAC, PubCo and the Company may agree in writing. The date of the Closing shall be referred to herein as the “ClosingDate”. The Closing shall take place virtually or at such place as SPAC, PubCo and the Company may agree in writing, and at such time on the Closing Date as SPAC, PubCo and the Company agree in writing.

15

Article IV

REPRESENTATIONS AND WARRANTIES OF SPAC

Except as set forth in (a) the disclosure schedules delivered by SPAC to the Company on the date hereof (the “SPAC Disclosure Schedules”), or (b) the SEC Reports that are available on the SEC’s website through EDGAR, but excluding disclosures referred to in “Special Note Regarding Forward-Looking Statements”, “Risk Factors” and any other disclosures therein to the extent they are of a predictive or cautionary nature or related to forward-looking statements (provided that nothing disclosed in such SEC Reports will be deemed to modify or qualify the representations and warranties set forth in Section 4.1, Section 4.2 or Section 4.5), SPAC represents and warrants to the Company and PubCo, as of the date hereof, and as of the Closing, as follows:

4.1 Organization and Standing. SPAC is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted, in each case, except where the failure to be in good standing or to have such corporate power and authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on SPAC. SPAC is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except in each case where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on SPAC. SPAC has made available to the Company accurate and complete copies of its Organizational Documents, each as amended to date and as currently in effect. SPAC is not in violation of any provision of its Organizational Documents in any material respect.

4.2 Authorization; Binding Agreement. SPAC has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform its obligations hereunder and thereunder and to consummate the Transactions, subject to obtaining the Required Shareholder Approval. The execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party and the consummation of the Transactions (a) have been duly and validly authorized by the SPAC Board and (b) other than the Required Shareholder Approval, no other corporate proceedings (including any vote of holders of any class or series of securities of SPAC), other than as set forth elsewhere in this Agreement, on the part of SPAC are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party or to consummate the Transactions. The SPAC Board, at a duly called and held meeting or in writing as permitted by SPAC’s Charter, has unanimously (i) determined that this Agreement, the Ancillary Documents to which it is or is required to be a party and the Transactions, including the Mergers, are advisable, fair to and in the best interests of SPAC Shareholders, (ii) approved and adopted this Agreement and the Ancillary Documents to which it is or is required to be a party, the Mergers and the other Transactions (iii) issued the SPAC Board Recommendation and (iv) directed that this Agreement, the Ancillary Documents to which it is or is required to be a party and the Shareholder Approval Matters be submitted to SPAC Shareholders for their approval. This Agreement has been, and each Ancillary Document to which SPAC is or is required to be a party has been or shall be when delivered, duly and validly executed and delivered by SPAC and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of SPAC, enforceable against SPAC in accordance with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws of general application affecting the enforcement of creditors’ rights generally and subject to general principles of equity (collectively, the “Enforceability Exceptions”).

16

4.3 Governmental Approvals. No Consent of or with any Governmental Authority, on the part of SPAC is required to be obtained or made in connection with the execution, delivery or performance by SPAC of this Agreement and each Ancillary Document to which it is or is required to be a party, or the consummation by SPAC of the Transactions, other than (a) such filings as contemplated by this Agreement, (b) any filings required with the Registrar of Companies in the Cayman Islands, Nasdaq Stock Market (“Nasdaq”) or the SEC with respect to the Transactions, (c) applicable requirements, if any, of the Securities Act, the Exchange Act, and any state “blue sky” securities Laws, and the rules and regulations thereunder, (d) the applicable requirements of any Antitrust Laws and the expiration or termination of the required waiting periods, or the receipt of other Consents, thereunder and (e) where the failure to obtain such Consents, or to make such filings or notifications, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on SPAC.

4.4 Non-Contravention. The execution and delivery by SPAC of this Agreement and each Ancillary Document to which it is or is required to be a party, the consummation by SPAC of the Transactions, and compliance by SPAC with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of SPAC’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 4.3, and any condition precedent to such Consent having been satisfied, conflict with or violate any Law, Order or Consent applicable to SPAC or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by SPAC under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make or increase payments or provide compensation under, (vii) result in the creation of any Lien (other than a Permitted Lien) upon any of the properties or assets of SPAC under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any SPAC Material Contract, except for any deviations from any of the foregoing clauses (b) or (c) that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on SPAC.

4.5 Capitalization.

(a) As of the date of this Agreement, the issued and outstanding SPAC Securities are set forth hereto in Section 4.5(a) of the SPAC Disclosure Schedules. As of the date of this Agreement, there are no issued or outstanding preference shares of SPAC. All outstanding SPAC Securities are duly authorized, validly issued, fully paid and non-assessable and not subject to (other than the SPAC Rights) or issued in violation of any purchase option, right of first refusal, pre-emptive right, subscription right or any similar right under the Cayman Companies Law, the SPAC’s Organizational Documents or any Contract to which SPAC is a party. None of the outstanding SPAC Securities has been issued in violation of any applicable securities Laws. Prior to giving effect to the Transactions, SPAC does not have any Subsidiaries or own any equity interests in any other Person.

17

(b) Other than the SPAC Rights, there are no (i) outstanding options, warrants, puts, calls, convertible or exchangeable securities, “phantom” share rights, share appreciation rights, share-based units, pre-emptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are convertible or exchangeable into securities (including SPAC Securities) having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued securities of SPAC (including SPAC Securities), (B) obligating SPAC to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased any options, shares or securities convertible into or exchangeable for any securities (including SPAC Securities), or (C) obligating SPAC to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such securities (including SPAC Securities). Other than with respect to the Redemption Rights or as expressly set forth in this Agreement, there are no outstanding obligations of SPAC to repurchase, redeem or otherwise acquire any securities of SPAC (including SPAC Securities) or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in Section 5.5(b) of the SPAC Disclosure Schedules, there are no shareholders agreements, voting trusts or other agreements or understandings to which SPAC is a party with respect to the voting or transfer of any securities of SPAC (including SPAC Securities).

(c) All of SPAC’s Indebtedness of the type described in clauses (a) –(c) of the definition thereof and all SPAC Transaction Expenses as of the date of this Agreement are disclosed in Section 4.5(c) of the SPAC Disclosure Schedules.

(d) Since the date of formation of SPAC and except as contemplated by this Agreement, SPAC has not declared or paid any distribution or dividend in respect of its securities (including SPAC Securities) and has not repurchased, redeemed or otherwise acquired any of its securities (including SPAC Securities), and the SPAC Board has not authorized any of the foregoing.

4.6 SEC Filings; SPAC Financials; Internal Controls.

(a) SPAC has filed all forms, reports, schedules, statements, registration statements, prospectuses and other documents required to be filed or furnished by SPAC with the SEC under the Securities Act and the Exchange Act, together with any amendments, restatements or supplements thereto (collectively, the “SEC Reports”), and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent to the date of this Agreement and prior to the Closing. Except to the extent available on the SEC’s web site through EDGAR, SPAC has delivered to the Company or made available copies in the form filed with the SEC of all of the following: (i) SPAC’s quarterly reports on Form 10-Q for each fiscal quarter since the IPO to disclose its quarterly financial results in each of the fiscal years of SPAC, (ii) SPAC’s annual reports on Form 10-K for each fiscal year since the IPO (if applicable) to disclose its annual financial results in each of the fiscal years of SPAC and (iii) all other forms, reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by SPAC with the SEC. The SEC Reports (x) were prepared in all material respects in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations thereunder and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC Reports) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. As used in this Section 4.6, the term “file” shall be broadly construed to include any manner permitted by SEC rules and regulations in which a document or information is furnished, supplied or otherwise made available to the SEC.

18

(b) (i) The SPAC Class A Ordinary Shares, the SPAC Rights and the SPAC Units are registered pursuant to Section 12(b) of the Exchange Act and are listed on Nasdaq, in the ticker of IPCX, IPCXR and IPCXU, respectively, (ii) SPAC has not received any written deficiency notice from Nasdaq relating to the continued listing requirements of such SPAC Securities, (iii) there are no Actions pending or, to the Knowledge of SPAC, threatened against SPAC by the Financial Industry Regulatory Authority, Nasdaq or the SEC with respect to any intention by such entity to suspend, deregister, prohibit or terminate the quoting of such SPAC Securities on Nasdaq, and (iv) SPAC is in material compliance with all of the applicable listing and corporate governance rules and regulations of Nasdaq.

(c) The financial statements and notes of SPAC contained or incorporated by reference in the SEC Reports (the “SPAC Financials”), fairly present in all material respects the financial position and the results of operations, changes in shareholders’ equity, and cash flows of SPAC at the respective dates of and for the periods referred to in such financial statements, all in accordance with (i) GAAP methodologies applied on a consistent basis throughout the periods involved, (ii) Regulation S-X or Regulation S-K, as applicable (except as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable), and (iii) audited in accordance with PCAOB standards.

(d) Except as and to the extent reflected or reserved against in the balance sheet of SPAC dated December 31, 2024 included in the SPAC Financials, SPAC has not incurred any Liabilities or obligations of the type required to be reflected on a balance sheet in accordance with GAAP, other than Liabilities of the type required to be reflected on a balance sheet in accordance with GAAP that have been incurred since SPAC’s formation in the ordinary course of business. SPAC does not maintain any “off-balance sheet arrangement” within the meaning of Item 303 of Regulation S-K of the Securities Act. As of the date of this Agreement, no financial statements of any Person other than those of SPAC are required by GAAP to be included in the financial statements of SPAC.

(e) Neither SPAC nor SPAC’s independent auditors has identified any (i) “significant deficiency” in the internal controls over financial reporting of SPAC, (ii) “material weakness” in the internal controls over financial reporting of SPAC, (iii) fraud that involves management or other employees of SPAC who have a role in the internal controls over financial reporting of SPAC or (iv) any written claim or allegation regarding any of the foregoing.

19

(f) Except as not required in reliance on exemptions from various reporting requirements by virtue of SPAC’s status as an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, (i) SPAC has established and maintained a system of internal controls over financial reporting (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) sufficient to provide reasonable assurance regarding the reliability of SPAC’s financial reporting and the preparation of SPAC’s financial statements for external purposes in accordance with GAAP, and (ii) SPAC has established and maintained disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) designed to ensure that material information relating to SPAC and other material information required to be disclosed by SPAC in the reports and other documents that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such material information is made known to SPAC’s principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act. Such disclosure controls and procedures are effective in timely alerting SPAC’s principal executive officer and principal financial officer to material information required to be included in SPAC’s periodic reports required under the Exchange Act.

(g) There are no outstanding loans or other extensions of credit made by SPAC to any executive officer (as defined in Rule 3b-7 under the Exchange Act) or director of SPAC. SPAC has not taken any action prohibited by Section 402 of SOX.

(h) To the Knowledge of SPAC, as of the date hereof, there are no outstanding SEC comments from the SEC with respect to the SEC Reports. To the Knowledge of SPAC, none of the SEC Reports filed on or prior to the date hereof is subject to ongoing SEC review or investigation as of the date hereof.

4.7 Absence of Certain Changes. From the date of SPAC’s formation to the date of this Agreement, (a) SPAC has conducted no business other than its formation, the public offering of its securities (and the related private offerings), public reporting and its search for an initial Business Combination as described in the IPO Prospectus (including the investigation of the Target Companies and the negotiation and execution of this Agreement) and related activities, and (b) there has not been a Material Adverse Effect with respect to SPAC.

4.8 Compliance with Laws. Except where the failure to be, or to have been, in compliance with such Laws, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on SPAC, (a) SPAC is and since the date of formation of SPAC has been, in compliance with, and not in conflict, default or violation of, any applicable Laws and (b) SPAC has not received, since the date of formation of SPAC, any written or, to the Knowledge of SPAC, oral notice of any conflict or non-compliance with, or default or violation of, any applicable Laws by which it is or was bound.

20

4.9 Litigation. As of the date of this Agreement, there is no (a) material Action of any nature currently pending or, to SPAC’s Knowledge, threatened (and no such Action has been brought or, to the Knowledge of SPAC, threatened since the date of formation of SPAC) or (b) material Order now pending or outstanding or that was rendered by a Governmental Authority since the date of formation of SPAC in either case of (a) or (b) by or against SPAC, its current or former directors, officers or equity holders in their capacity as such, its business, equity securities or assets. As of the date of this Agreement, none of the current or former officers, senior management or directors of SPAC have been charged with, indicted for, arrested for, or convicted of any felony or any crime involving fraud as it relates to the business of SPAC, except in each case where the charge, indictment arrest or conviction, individually or in the aggregate, has not had and would not reasonably be expected to be material to SPAC, or otherwise limit the ability of SPAC to perform on a timely basis its obligations under this Agreement or the Ancillary Documents to which it is or is required to be a party or otherwise bound.

4.10 Actions; Orders; Permits. SPAC (and its employees who are legally required to be licensed by a Governmental Authority in order to perform his or her duties with respect to his or her employment with SPAC), holds all Permits necessary to lawfully conduct in all material respects its business as presently conducted, and to own, lease and operate its assets and properties (collectively, the “SPAC Permits”), except where the failure to obtain or maintain the same, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on SPAC. Except in each case where the failure or violation, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on SPAC, (a) all of the SPAC Permits are in full force and effect, and no suspension or cancellation of any of the SPAC Permits is pending or, to SPAC’s Knowledge, threatened, (b) SPAC is not in violation in any material respect of the terms of any SPAC Permit and (c) since the date of formation of SPAC, SPAC has not received any written, or to the Knowledge of SPAC, oral notice of any Actions relating to the revocation or modification of any SPAC Permit.

4.11 Taxes and Returns.

(a) SPAC has timely filed, or caused to be timely filed, all material Tax Returns required by applicable Tax Law to be filed by it, which such Tax Returns are true, accurate, correct and complete in all material respects. SPAC has timely paid, or caused to be timely paid, all material Taxes required by applicable Tax Law to be paid by it, other than such Taxes being contested in good faith by appropriate proceedings and for which adequate reserves have been established in the SPAC Financials in accordance with GAAP.

(b) SPAC has complied in all material respects with all applicable Tax Laws relating to withholding and remittance of Taxes, and all material amounts of Taxes required by applicable Tax Laws to be withheld by SPAC have been withheld and timely paid over to the appropriate Governmental Authority, including with respect to any amounts owing to or from any employee, independent contractor, shareholder, creditor, or other Person.

21

(c) There are no material claims, assessments, audits, examinations, investigations or other Actions pending, in progress or threatened in writing against SPAC, in respect of Taxes, and SPAC has not been notified in writing of any material proposed Tax claims or assessments against SPAC by a Governmental Authority.

(d) There are no material Liens with respect to any Taxes upon any of SPAC’s assets, other than Permitted Liens. SPAC has no outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding written requests by SPAC for any extension of time within which to file any Tax Return or within which to pay any Taxes (other than customary extensions requested in the ordinary course of business). No written claim has been made by any Governmental Authority with respect to a jurisdiction in which SPAC does not file a Tax Return that SPAC is or may be subject to Tax in that jurisdiction that would be the subject of or covered by such Tax Return, which claim remains outstanding.

(e) SPAC does not have a permanent establishment, branch or representative office in any country other than the country of its organization (where it carries no activities and only has a registered office), and SPAC is not and has not been treated for any Tax purpose as a resident in a country other than the country of its incorporation.

(f) SPAC is not and has never been a member of any consolidated, combined, unitary or affiliated group of corporations for any Tax purposes. SPAC does not have any Liability for the Taxes of another Person under Treasury Regulation Section 1.1502-6 (or similar provision of state, local or non-U.S. Law), as a transferee or successor, or by Contract (other than, in each case, Liabilities for Taxes pursuant to customary commercial Contracts not primarily related to Taxes). SPAC is not a party to or bound by any Tax indemnity agreement, Tax sharing agreement, Tax allocation agreement or similar Contract with respect to Taxes (other than customary commercial Contracts not primarily related to Taxes).

(g) SPAC is not the subject of any private letter ruling, technical advice memorandum, closing agreement, settlement agreement or similar ruling, memorandum or agreement with any Governmental Authority with respect to Taxes, and there is no written request by SPAC outstanding for any such ruling, memorandum or agreement.

(h) SPAC has not distributed stock of another Person, nor has had its shares distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 or Section 361 of the Code.

(i) SPAC has not been a party to a transaction that is a “listed transaction” as such term is defined in Treasury Regulations Section 1.6011-4(b)(2) (or any analogous or similar provision under any U.S. state or local or non-U.S. Tax Law addressing tax avoidance transactions).

(j) SPAC will not be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any period (or any portion thereof) beginning after the Closing Date as a result of any (i) installment sale or open transaction disposition made by SPAC prior to the Closing, (ii) change in any method of accounting of SPAC for any taxable period (or portion thereof) ending on or prior to the Closing Date made or required to be made prior to the Closing, (iii) any “closing agreement” as described in Section 7121 of the Code (or any comparable, analogous or similar provision under any state, local or non-U.S. Tax Law) executed by SPAC prior to the Closing, or (iv) any prepaid amount or deferred revenue received or accrued prior to the Closing outside the ordinary course of business.

22

(k) SPAC has not taken, and has not agreed to take, any action that would reasonably be expected to prevent the relevant portions of the Transactions from qualifying for the Intended Tax Treatment. To the Knowledge of SPAC, there are no facts or circumstances that would reasonably be expected to prevent the relevant portions of the Transactions from qualifying for the Intended Tax Treatment. SPAC is not aware of any current plan or intention to cause PubCo to be liquidated following the Mergers.

4.12 Employees and Employee Benefit Plans. SPAC does not (a) have any employees or independent contractors who are entitled to any compensation, remuneration, fees or benefits or (b) maintain, sponsor, contribute to or otherwise have any Liability with respect to any Benefit Plans. Neither the execution and delivery of this Agreement or the Ancillary Documents nor the consummation of the Transactions will alone or in connection with other events (i) result in any payment or benefit (including severance, unemployment compensation, golden parachute, bonus or otherwise) becoming due to any director, officer or employee of SPAC, (ii) result in the acceleration of the time of payment, vesting or funding of any such payment or benefit or deceleration of the time of payment, vesting or, funding, or increase of any such payment or benefit or (iii) cause an amount to be received by any individual to fail to be deductible by reason of Code Section 280G or be subject to an excise Tax under Code Section 4999.

4.13 Properties. SPAC does not own, license or otherwise have any right, title or interest in or to any material Intellectual Property. SPAC does not own or lease any real property or Personal Property.

4.14 Material Contracts.

(a) Other than this Agreement and the Ancillary Documents, there are no Contracts to which SPAC is a party or by which any of its properties or assets may be bound, subject or affected, which (i) creates or imposes a Liability greater than $50,000, (ii) may not be cancelled by SPAC on less than 60 days’ prior notice without payment of a material penalty or termination fee, (iii) prohibits, prevents, restricts or impairs in any material respect any business practice of SPAC or any of its current or future Affiliates, any acquisition of material property by SPAC or any of its current or future Affiliates, or restricts in any material respect the ability of SPAC or any of its current or future Affiliates from engaging in any business or from competing with any other Person or (iv) is a “material contract” (as such term is defined in Regulation S-K of the Securities Act) (each, a “SPAC Material Contract”). All SPAC Material Contracts have been made available to the Company other than those that are exhibits to the SEC Reports.

(b) With respect to each SPAC Material Contract: (i) the SPAC Material Contract was entered into at arms’-length and in the ordinary course of business, (ii) the SPAC Material Contract is valid, binding and enforceable in all material respects against SPAC and, to the Knowledge of SPAC, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions), (iii) SPAC is not in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default in any material respect by SPAC, or permit termination or acceleration by the other party thereto, under such SPAC Material Contract, and (iv) to the Knowledge of SPAC, no other party to any SPAC Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default by such other party, or permit termination or acceleration by SPAC under any SPAC Material Contract.

23

4.15 Transactions with Affiliates. Section 4.15 of the SPAC Disclosure Schedules sets forth a true, correct and complete list of the Contracts and arrangements that are in existence as of the date of this Agreement under which there are any existing or future Liabilities or obligations between SPAC, on the one hand, and Sponsor, any other Affiliate of SPAC, or any present or former director, officer, employee, manager, direct equityholder of SPAC, Sponsor or any other Affiliate of SPAC, or any immediate family member of any of the foregoing, on the other hand.

4.16 Investment Company Act; JOBS Act. SPAC is not an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of a Person subject to registration and regulation as an “investment company”, in each case within the meaning of the Investment Company Act. SPAC constitutes an “emerging growth company” within the meaning of the JOBS Act.

4.17 Finders and Brokers. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from SPAC, PubCo, the Target Companies or any of their respective Affiliates in connection with the Transactions based upon arrangements made by or on behalf of SPAC, Sponsor or any of their respective Affiliates.

4.18 Private Placements. Other than the PIPE Agreements, there are no agreements, side letters, arrangements or other Contracts between SPAC, Sponsor or any of their respective Affiliates, on the one hand, and any PIPE Investor, on the other hand, or, to the Knowledge of SPAC, any of their respective Affiliates that would affect the obligation of such PIPE Investor to pay to PubCo the applicable portion of the PIPE Investment set forth in such PIPE Investor’s applicable PIPE Agreement. No fees, consideration (other than PubCo Ordinary Shares issued in connection with the PIPE Investment) or other discounts are payable or have been agreed by SPAC, Sponsor or any of their respective Affiliates to any PIPE Investor or, to the Knowledge of the SPAC, any of their respective Affiliates in respect of its portion of the PIPE Investment.

4.19 Certain Business Practices.

(a) Since the date of formation of SPAC, SPAC has been in compliance with the U.S. Foreign Corrupt Practices Act of 1977 (“FCPA”), and all other applicable anti-corruption and anti-bribery Laws, in all material respects. SPAC is not subject to any Action by any Governmental Authority involving any actual or, to the Knowledge of SPAC, suspected violation of any applicable anti-corruption Law.

(b) Since the date of formation of SPAC, neither SPAC nor any of its directors, officers or, to the Knowledge of SPAC, Representatives, when acting on behalf of SPAC, has used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity.

24

(c) Since SPAC’s formation, the operations of SPAC have been conducted at all times in material compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority, to the extent applicable, and no Action involving SPAC with respect to any of the foregoing is pending or, to the Knowledge of SPAC, threatened.

(d) None of SPAC or any of its directors, officers, employees or, to the Knowledge of SPAC, any other Representative acting on behalf of SPAC is currently (i) the target of economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by any Governmental Authority of the United States, (including those administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) or the U.S. Department of State), the United Nations Security Council, the European Union, any European Union member state, or the United Kingdom (“Sanctions”), including by being listed on the OFAC Specially Designated Nationals and Blocked Persons List, (ii) organized, resident, or located in a country, region or territory that is the subject of comprehensive territorial Sanctions (currently, Cuba, Iran, North Korea, and the Crimea region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic regions of Ukraine, as this list may be amended from time to time) (each a “Sanctioned Jurisdiction”), or (iii) is owned, in the aggregate, 50% or greater, directly or indirectly, or otherwise controlled, by a Person identified in clauses (i)-(ii) (collectively, a “Sanctioned Person”). None of SPAC or any of its directors, officers, employees or, to the Knowledge of SPAC, any other Representative acting on behalf of SPAC is a Person with whom transactions are prohibited or restricted under the applicable laws and regulations administered by the United States and other relevant Governmental Authorities with jurisdiction over SPAC relating to the export, reexport, transfer, and import of products, software or technology (“Customs & Export Control Laws”). SPAC has not, directly or knowingly indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any Sanctioned Jurisdiction or for the purpose of financing the activities of any Person currently the target of applicable Sanctions or Customs & Export Control Laws in violation of applicable Sanctions or Customs & Export Control Laws since SPAC’s formation. Neither SPAC nor any of its directors or officers, nor, to the Knowledge of SPAC, any other Representative acting on behalf of SPAC has, since SPAC’s formation, engaged in any conduct, activity, or practice in violation of any applicable Sanctions or Customs & Export Control Laws. No Action involving SPAC with respect to any of the foregoing is pending or, to the Knowledge of SPAC, threatened. Neither SPAC nor any of its directors or officers, nor, to the Knowledge of SPAC, any other Representative acting on behalf of SPAC has, since SPAC’s formation made any voluntary disclosure with respect to an apparent violation of applicable Sanctions or has been subject to civil or criminal penalties imposed by any Governmental Authority administering Sanctions.

4.20 Insurance. Section 4.20 of the SPAC Disclosure Schedules lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) held by SPAC relating to SPAC or its business, properties, assets, directors, officers and employees, copies of which have been provided to the Company. All premiums due and payable under all such insurance policies have been timely paid and SPAC is otherwise in material compliance with the terms of such insurance policies. All such insurance policies are in full force and effect, and to the Knowledge of SPAC, there is no threatened termination of, or material premium increase with respect to, any of such insurance policies. There have been no insurance claims made by SPAC. SPAC has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to be material to SPAC.

25

4.21 Information Supplied. None of the information supplied or to be supplied by SPAC or Sponsor or their respective Affiliates and Representatives expressly for inclusion or incorporation by reference: (a) in any current report on Form 8-K, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) with respect to the Transactions, (b) in the Registration Statement or (c) in the mailings or other distributions to SPAC Shareholders and prospective investors (including any actual or prospective PIPE Investors) with respect to the consummation of the Transactions or in any amendment to any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.

4.22 Trust Account. As of the date hereof, SPAC had an amount of assets in the Trust Account of not less than $253 million. The funds held in the Trust Account are invested in U.S. government securities with a maturity of 185 days or less or money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act and held in trust pursuant to the Trust Agreement. The Trust Agreement is in full force and effect and is a valid and binding obligation of SPAC and the Trustee, enforceable in accordance with its terms. SPAC has complied in all material respects with the terms of the Trust Agreement and is not in breach thereof or default thereunder and there does not exist any event which, with the giving of notice or the lapse of time, would constitute such a breach or default by SPAC or, to the Knowledge of SPAC, the Trustee. The Trust Agreement has not been terminated, repudiated, rescinded, amended, supplemented or modified, in any respect, and no such termination, repudiation, rescission, amendment, supplement or modification is contemplated. There are no separate Contracts, side letters or other arrangements or understandings (whether written or unwritten, express or implied) that would cause the description of the Trust Agreement in the SEC Reports to be inaccurate in any material respect or, to the Knowledge of SPAC, that would entitle any Person (other than (a) in respect of deferred underwriting commissions set forth in Section 4.22 of the SPAC Disclosure Schedules or Taxes, (b) SPAC Shareholders prior to the First Merger Effective Time who shall have elected to redeem their SPAC Shares pursuant to the SPAC’s Organizational Documents or in connection with an amendment thereof to extend SPAC’s deadline to consummate a Business Combination or (c) if SPAC fails to complete a Business Combination within the allotted time period and liquidates the Trust Account, subject to the terms of the Trust Agreement, in limited amounts to permit SPAC to pay the expenses of the Trust Account’s liquidation and dissolution, and then SPAC Shareholders) to any portion of the funds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account have been released, except to pay Taxes from any interest income earned in the Trust Account, and to redeem SPAC Shares pursuant to the SPAC’s Organizational Documents, or in connection with an amendment thereof to extend SPAC’s deadline to consummate a Business Combination. As of the date of this Agreement, there are no Actions pending or, to the Knowledge of SPAC, threatened with respect to the Trust Account. As of the date hereof, SPAC has no reason to believe that any of the conditions to the use of funds in the Trust Account will not be satisfied or funds available in the Trust Account will not be available to SPAC at the First Merger Effective Time. SPAC has made available to the Company true and complete copies of all Contracts, including engagement letters, with any Person that was, or is, entitled to any underwriting commission (including deferred underwriting commission) in respect of the IPO, including any amendments or other modifications thereto.

26

4.23 SPAC Acknowledgment. SPAC acknowledges and agrees that the representations and warranties expressly set forth in (i) Articles VI and VII (as qualified by the Company Disclosure Schedules) and (ii) the certificate delivered pursuant to Section 10.3(c) constitute the sole and exclusive representations and warranties of PubCo and the Company, respectively, to SPAC in connection with or relating to PubCo, the Target Companies, this Agreement, any Ancillary Document or the Transactions, and no other representations or warranties, oral or written, have been given by or on behalf of any of PubCo or the Target Companies. Except for the representations and warranties expressly set forth in Articles VI and VII (as qualified by the Company Disclosure Schedules) or the certificate delivered pursuant to Section 10.3(c) or in any Ancillary Document, SPAC (A) acknowledges that it is transacting with PubCo and the Company on an “as is” condition and on a “where is” basis and (B) disclaims reliance on, and confirms and acknowledges that it has not relied on and should not rely on and will not rely on, any other representations or warranties, either express or implied, at law or in equity, including representations of merchantability, suitability or fitness for any particular purpose, or other statements, whether written or oral, made by or on behalf of any person (including PubCo, the Target Companies or any Affiliate or Representative of the Company) in respect of the business, assets, liabilities, operations, prospects or condition (financial or otherwise) of PubCo, the Target Companies, including with respect to the accuracy or completeness of any confidential information memoranda, documents, projections or other prediction or forward-looking statements, material, or other information (financial or otherwise) regarding PubCo or the Target Companies furnished to SPAC or any of its Representatives in any “data rooms”, “virtual data rooms”, management presentations, or in any other form or in expectation of, or in connection with, the Transactions, or in respect of any other matter or thing whatsoever or on any person providing or not providing any information not specifically required to be provided or disclosed pursuant to the specific representations and warranties in Articles VI, VII and VIII or in the certificate delivered pursuant to Section 10.3(c) or any Ancillary Document.

4.24 Fairness Opinion. The board of directors of SPAC has received the opinion of Newbridge Securities Corporation, dated as of the date of this Agreement, that, as of such date and subject to certain assumptions, limitations, qualifications and other matters set forth therein, that the SPAC Per Share Merger Consideration to be issued is fair from a financial point of view to the SPAC’s public shareholders.

27

Article V

REPRESENTATIONS AND WARRANTIES OF MERGER SUB

Merger Sub represents and warrants to PubCo and the Company, as of the date hereof and as of the Closing, as follows:

5.1 Organization and Standing. Merger Sub is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted, in each case, except where the failure to be in good standing or to have such corporate power and authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on Merger Sub. Merger Sub is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except in each case where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Merger Sub. Merger Sub has made available to PubCo and the Company accurate and complete copies of its Organizational Documents, as currently in effect. Merger Sub is not in violation of any provision of its Organizational Documents in any material respect.

5.2 Authorization; Binding Agreement. Merger Sub has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party and the consummation of the Transactions have been duly and validly authorized by the board of directors and shareholder of Merger Sub and no other corporate proceedings, other than as expressly set forth elsewhere in this Agreement, on the part of Merger Sub are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party, to perform its obligations hereunder or thereunder or to consummate the Transactions. This Agreement has been, and each Ancillary Document to which Merger Sub is a party has been or shall be when delivered, duly and validly executed and delivered by Merger Sub and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of Merger Sub, enforceable against Merger Sub in accordance with its terms, subject to the Enforceability Exceptions.

5.3 Governmental Approvals. No Consent of or with any Governmental Authority, on the part of Merger Sub is required to be obtained or made in connection with the execution, delivery or performance by Merger Sub of this Agreement and each Ancillary Document to which it is or is required to be a party, or the consummation by Merger Sub of the Transactions, other than (a) such filings as are expressly contemplated by this Agreement, (b) any filings required with the Registrar of Companies in the Cayman Islands, Nasdaq or the SEC with respect to the Transactions, (c) any the applicable requirements of any Antitrust Laws and the expiration or termination of the required waiting periods, or the receipt of other Consents, thereunder, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and any state “blue sky” securities Laws, and the rules and regulations thereunder and (e) where the failure to obtain such Consents, or to make such filings or notifications, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on Merger Sub.

28

5.4 Non-Contravention. The execution and delivery by Merger Sub of this Agreement and each Ancillary Document to which it is or is required to be a party, the consummation by Merger Sub of the Transactions, and compliance by Merger Sub with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of Merger Sub’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 6.3 hereof, and any condition precedent to such Consent having been satisfied, conflict with or violate any Law, Order or Consent applicable to Merger Sub or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by Merger Sub under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien (other than a Permitted Lien) upon any of the properties or assets of Merger Sub under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person, or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any material Contract of Merger Sub, except for any deviations from any of the foregoing clauses (b) or (c) that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Merger Sub.

5.5 Capitalization. As of the date hereof and as of immediately prior to the Closing, Merger Sub is authorized to issue 50,000 ordinary shares. As of the date hereof through immediately prior to the First Merger Effective Time, Merger Sub has one ordinary share issued and outstanding, which is owned by SPAC. Prior to giving effect to the Second Merger, Merger Sub does not have any Subsidiaries or own any equity interests in any other Person.

5.6 Merger Sub Activities. Since its incorporation through immediately prior to the Second Merger Effective Time, Merger Sub (a) has not engaged in any business activities other than as contemplated by this Agreement, (b) has not owned directly or indirectly any ownership, equity, profits or voting interest in any Person, (c) other than fees in respect of its incorporation, has not had any Liabilities, (d) other than any de minimis amounts received from SPAC in exchange for the one ordinary share issued thereto, has not had any assets, and (e) other than its Organizational Documents and this Agreement, has not been party to or bound by any Contract.

5.7 Finders and Brokers. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from SPAC, PubCo, the Target Companies or any of their respective Affiliates in connection with the Transactions based upon arrangements made by or on behalf of Merger Sub.

5.8 Investment Company Act. Merger Sub is not an “investment company” or, a Person directly or indirectly “controlled” by or acting on behalf of a Person subject to registration and regulation as an “investment company”, in each case within the meaning of the Investment Company Act.

29

5.9 Information Supplied. None of the information supplied or to be supplied by Merger Sub expressly for inclusion or incorporation by reference: (a) in any current report on Form 6-K or Form 8-K or report on Form 20-F, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) with respect to the Transactions, (b) in the Registration Statement or (c) in the mailings or other distributions to SPAC Shareholders and prospective investors (including any actual or prospective PIPE Investors) with respect to the consummation of the Transactions or in any amendment to any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, Merger Sub does not make any representation, warranty or covenant with respect to any information supplied by or on behalf of SPAC, the Target Companies, the Company Shareholders or any of their respective Affiliates.

5.10 U.S. Tax Classification. Merger Sub has elected, or will elect prior to the Closing Date, to be treated, effective as of a date prior to the Second Merger, as a disregarded entity, pursuant to Treasury Regulations Section 301.7701-3.

Article VI

REPRESENTATIONS AND WARRANTIES OF PUBCO

PubCo represents and warrants to SPAC and the Company, as of the date hereof and as of the Closing, as follows:

6.1 Organization and Standing. PubCo is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted, in each case, except where the failure to be in good standing or to have such corporate power and authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on PubCo. PubCo is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except in each case where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on PubCo. PubCo has made available to SPAC and the Company accurate and complete copies of its Organizational Documents, as currently in effect. PubCo is not in violation of any provision of its Organizational Documents in any material respect.

6.2 Authorization; Binding Agreement. PubCo has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party and the consummation of the Transactions have been duly and validly authorized by the board of directors and the PubCo Sole Shareholder and no other corporate proceedings, other than as expressly set forth elsewhere in this Agreement (including the adoption of the PubCo A&R Articles), on the part of PubCo are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party, to perform its obligations hereunder or thereunder or to consummate the Transactions. This Agreement has been, and each Ancillary Document to which PubCo is a party has been or shall be when delivered, duly and validly executed and delivered by PubCo and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of PubCo, enforceable against PubCo in accordance with its terms, subject to the Enforceability Exceptions.

30

6.3 Governmental Approvals. No Consent of or with any Governmental Authority, on the part of PubCo is required to be obtained or made in connection with the execution, delivery or performance by PubCo of this Agreement and each Ancillary Document to which it is or is required to be a party, or the consummation by PubCo of the Transactions, other than (a) such filings as are expressly contemplated by this Agreement, (b) any filings required with the Registrar of Companies in the Cayman Islands, Nasdaq or the SEC with respect to the Transactions, (c) any the applicable requirements of any Antitrust Laws and the expiration or termination of the required waiting periods, or the receipt of other Consents, thereunder, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and any state “blue sky” securities Laws, and the rules and regulations thereunder and (e) where the failure to obtain such Consents, or to make such filings or notifications, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on PubCo.

6.4 Non-Contravention. The execution and delivery by PubCo of this Agreement and each Ancillary Document to which it is or is required to be a party, the consummation by PubCo of the Transactions, and compliance by PubCo with any of the provisions hereof and thereof, will not (a) subject to the adoption of the PubCo A&R Articles, conflict with or violate any provision of PubCo’ Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 6.3 hereof, and any condition precedent to such Consent having been satisfied, conflict with or violate any Law, Order or Consent applicable to PubCo or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by PubCo under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien (other than a Permitted Lien) upon any of the properties or assets of PubCo under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person, or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any material Contract of PubCo, except for any deviations from any of the foregoing clauses (b) or (c) that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on PubCo.

6.5 Capitalization. As of the date hereof and as of immediately prior to the Closing, PubCo is authorized to issue 50,000,000 PubCo Ordinary Shares. As of the date hereof through immediately prior to the First Merger Effective Time, PubCo has one PubCo Ordinary Share issued and outstanding, which is owned by the PubCo Sole Shareholder. Prior to giving effect to the First Merger, PubCo does not have any Subsidiaries or own any equity interests in any other Person.

6.6 PubCo Activities. Since its incorporation through immediately prior to the First Merger Effective Time, PubCo (a) has not engaged in any business activities other than as contemplated by this Agreement, (b) has not owned directly or indirectly any ownership, equity, profits or voting interest in any Person, (c) other than fees in respect of its incorporation, has not had any Liabilities, (d) other than any de minimis amounts received from the PubCo Sole Shareholder in exchange for the one PubCo Ordinary Share issued thereto, has not had any assets, (e) has not had any Tax attributes, including those specified in Section 381(c) of the Code, and (f) other than its Organizational Documents and this Agreement, has not been party to or bound by any Contract.

31

6.7 Finders and Brokers. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from SPAC, PubCo, the Target Companies or any of their respective Affiliates in connection with the Transactions based upon arrangements made by or on behalf of PubCo.

6.8 Investment Company Act. PubCo is not an “investment company” or, a Person directly or indirectly “controlled” by or acting on behalf of a Person subject to registration and regulation as an “investment company”, in each case within the meaning of the Investment Company Act.

6.9 Information Supplied. None of the information supplied or to be supplied by PubCo expressly for inclusion or incorporation by reference: (a) in any current report on Form 6-K or Form 8-K or report on Form 20-F, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) with respect to the Transactions, (b) in the Registration Statement or (c) in the mailings or other distributions to SPAC Shareholders and prospective investors (including any actual or prospective PIPE Investors) with respect to the consummation of the Transactions or in any amendment to any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, PubCo does not make any representation, warranty or covenant with respect to any information supplied by or on behalf of SPAC, the Target Companies, the Company Shareholders or any of their respective Affiliates.

6.10 U.S. Tax Classification. PubCo is, and has been since the date of its incorporation, treated as a corporation for U.S. federal income tax purposes. PubCo has not made any election under Treasury Regulations Section 301.7701-3. PubCo (i) is not treated as a “domestic corporation” (as such term is defined in Section 7701 of the Code) for U.S. federal income tax purposes, (ii) is not, nor has ever been, a “surrogate foreign corporation” within the meaning of Section 7874(a)(2)(B) of the Code, and (iii) is not treated as a “domestic corporation” under Section 7874(b) of the Code.

6.11 U.K. Tax Residency. PubCo is not, and has never been, treated as a Tax resident in the United Kingdom.

32

Article VII

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

Except as set forth in the disclosure schedules delivered by the Company to SPAC on the date hereof (the “Company Disclosure Schedules”), the Company hereby represents and warrants to SPAC as of the date hereof and as of the Closing, as follows:

7.1 Organization and Standing.

(a) The Company is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands and has all requisite corporate or other entity power and authority to own, lease and operate its properties and to carry on its business as now being conducted, in each case, except where the failure to be in good standing or to have such corporate power and authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on the Company.

(b) Each Target Company (other than the Company) is a corporation or other entity duly formed, validly existing and in good standing under the Laws of its jurisdiction of organization and has all requisite corporate or other entity power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each Target Company (other than the Company) is qualified or licensed and in good standing (to the extent such concept exists) to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except in each case where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on the Company.

(c) The Company has made available to SPAC accurate and complete copies of the Organizational Documents of each Target Company, each as amended to date and as currently in effect. No Target Company is in violation of any provision of its Organizational Documents in any material respect.

7.2 Authorization; Binding Agreement. The Company and each other Target Company has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform the Company’s or such other Target Company’s obligations hereunder and thereunder, and to consummate the Transactions, subject to obtaining Company Shareholder Approval. The execution and delivery of this Agreement and each Ancillary Document to which the Company or any other Target Company is or is required to be a party and the consummation of the Transactions (a) have been duly and validly authorized by the Company Board and the board of directors of such other Target Company (to the extent required) in accordance with the Company’s or such other Target Company’s Organizational Documents and any applicable Law and (b) other than the Company Shareholder Approval, no other corporate proceedings on the part of the Company or such other Target Company is necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is or is required to be a party or to consummate the Transactions. The Company Board, at a duly called and held meeting or in writing as permitted by the Organizational Documents of the Company, has unanimously (i) determined that this Agreement, the Ancillary Documents to which it is or is required to be a party and the Transactions, including the Mergers, are advisable, fair to and in the best interests of the holders of Company Shares, (ii) approved this Agreement and the Ancillary Documents to which it is or is required to be a party, the Mergers and the other Transactions, (iii) issued the Company Board Recommendation and (iv) directed that this Agreement, the Ancillary Documents to which it is or is required to be a party and the Company Shareholder Matters be submitted to Company Shareholders for their approval. This Agreement has been, and each Ancillary Document to which the Company or any other Target Company is or is required to be a party has been or shall be when delivered, duly and validly executed and delivered by the Company or such other Target Company, as applicable, and assuming the due authorization, execution and delivery of this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of the Company, in each case, enforceable against the Company and such other Target Companies in accordance with its terms, subject to the Enforceability Exceptions.

33

7.3 Capitalization.

(a) As of the date of this Agreement, the issued share capital of the Company consists of 30,025 Company Ordinary Shares, 607 Company Series A1 Preferred Shares and 0 Company Series A2 Preferred Shares. The Company has also issued 0 Company Warrants, and there are no other issued or outstanding equity interests of the Company.

(b) On the date of this Agreement, the Company Shareholders listed on Section 7.3(b) of the Company Disclosure Schedules are the legal and beneficial owners of all of the Company Ordinary Shares, with each such Company Shareholder owning the Company Ordinary Shares set forth opposite the name of such Company Shareholder in the corresponding column of Section 7.3(b) of the Company Disclosure Schedules. The Company Ordinary Shares are owned by each such Company Shareholder free from any Liens other than those imposed under the Company’s Organizational Documents, which can be removed by the Company without penalty or applicable securities Laws.

(c) On the date of this Agreement, the Company Shareholders listed on Section 7.3(c) of the Company Disclosure Schedules are the legal and beneficial owners of all of the Company Series A1 Preferred Shares, with each such Company Shareholder owning the Company Series A1 Preferred Shares set forth opposite the name of such Company Shareholder in the corresponding column of Section 7.3(c) of the Company Disclosure Schedules. The Company Series A1 Preferred Shares are owned by each such Company Shareholder free from any Liens other than those imposed under the Company’s Organizational Documents, which can be removed by the Company without penalty or applicable securities Laws.

(d) All of the issued Company Shares have been duly authorized and are fully paid and not in violation of any purchase option, right of first refusal, pre-emptive right, subscription right or any similar right under any provision of the Cayman Companies Law, any other applicable Law, the Company’s Organizational Documents or any Contract to which the Company is a party or by which the Company or its securities are bound.

34

(e) As of the date of this Agreement, no Target Company currently has any stock option or other equity incentive plans. As of the date of this Agreement, other than the securities contemplated in connection with the Pre-Funded PIPE Investment or the PIPE Investment, there are no Company Convertible Securities or pre-emptive rights or rights of first refusal or first offer, except for those rights as provided in the Company’s Organizational Documents which have been disapplied and waived by the Company Shareholders, nor are there any Contracts, commitments, arrangements or restrictions to which the Company or any of the Company Shareholders or any of their respective Affiliates are a party or bound relating to any equity securities of the Company, whether or not outstanding, other than the Company’s Organizational Documents. As of the date of this Agreement, other than the Pre-Funded PIPE Subscription Agreement, there are no outstanding or authorized equity appreciation, phantom equity or similar rights with respect to the Company and there are no voting trusts, proxies, shareholder agreements or any other written agreements or understandings with respect to the voting or transfer of any of Company Ordinary Shares other than the Company’s Organizational Documents or the Shareholders Agreement. As of the date of this Agreement, other than the Pre-Funded PIPE Investment or as set forth in the Company’s Organizational Documents, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any of its equity interests or securities, nor has the Company granted any registration rights to any Person with respect to its equity securities. As of the date of this Agreement, all of the issued and outstanding securities of the Company have been granted, offered, sold and issued in compliance with all applicable Laws. As a result of the consummation of the Transactions, no equity interests of the Company are issuable and no rights in connection with any interests, warrants, rights, options or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).

(f) Since January 1, 2022, the Company and Air Water UK have not declared or paid any distribution or dividend in respect of their equity interests, and have not repurchased, redeemed or otherwise acquired any equity interests of the Company or Air Water UK, as applicable, and neither the Company Board nor the board of directors of Air Water UK has authorized any of the foregoing.

7.4 Company Subsidiaries. Section 7.4 of the Company Disclosure Schedules sets forth the name of each Company Subsidiary, and with respect to each Company Subsidiary on the date of this Agreement (a) its jurisdiction of organization, (b) the class(es) of its authorized shares or other equity interests (if applicable), and (c) the ownership percentage of issued and outstanding shares or other equity interests by the record holders thereof. The foregoing represents all of the issued and outstanding equity interests of the Target Companies as of the date of this Agreement. All of the outstanding equity securities of each Company Subsidiary are duly authorized and validly issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered in compliance with all applicable Laws, and owned by one or more of the Target Companies free and clear of all Liens (other than those, if any, imposed by such Company Subsidiary’s Organizational Documents or applicable Laws), except where the failure to be would not, individually or in the aggregate, reasonably be expected to be material to the Target Companies, taken as a whole. As of the date of this Agreement, there are no Contracts to which the Company or any of the Company Subsidiaries is a party or bound with respect to the voting (including voting trusts or proxies) or transfer of the equity interests of any Company Subsidiary other than the Organizational Documents of any such Company Subsidiary. As of the date of this Agreement, there are no outstanding or authorized options, warrants, rights, agreements, subscriptions, convertible securities or commitments to which any Company Subsidiary is a party or which are binding upon any Company Subsidiary providing for the issuance or redemption of any equity interests of any Company Subsidiary. As of the date of this Agreement, there are no outstanding equity appreciation, phantom equity, profit participation or similar rights granted by any Company Subsidiary. No Company Subsidiary has any limitation, whether by Contract, Order, or applicable Law, on its ability to make any distributions or dividends to its equity holders or repay any debt owed to another Target Company. As of the date of this Agreement, other than the Company Subsidiaries, no Target Company has any Subsidiaries. Except for the equity interests of the Company Subsidiaries listed on Section 7.4 of the Company Disclosure Schedules, as of the date of this Agreement: (i) no Target Company owns or has any rights to acquire, directly or indirectly, any equity interests of, or otherwise Control, any Person, (ii) no Target Company is a participant in any joint venture, partnership or similar arrangement and (iii) there are no outstanding contractual obligations of a Target Company to provide funds to or make any loan or capital contribution to any other Person.

35

7.5 Governmental Approvals. No Consent of or with any Governmental Authority on the part of any Target Company is required to be obtained or made in connection with the execution, delivery or performance by the Company or any Target Company of this Agreement or any Ancillary Documents to which the Company or any Target Company is or required to be a party or otherwise bound, or the consummation by the Company or the Target Companies of the Transactions other than (a) any filings required with Nasdaq or the SEC with respect to the Transactions, (b) applicable requirements, if any, of the Securities Act, the Exchange Act, and any state “blue sky” securities Laws, and the rules and regulations thereunder, (c) applicable requirements of any Antitrust Laws and the expiration or termination of the required waiting periods, or the receipt of other Consents, thereunder, and (d) where the failure to obtain such Consents, or to make such filings or notifications, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on the Company.

7.6 Non-Contravention. The execution and delivery by the Company (or any other Target Company, as applicable) of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party, and the consummation by any Target Company of the Transactions and compliance by any Target Company with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of such Target Company’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 7.5 hereof and any condition precedent to such Consent having been satisfied, conflict with or violate any Law, Order or Consent applicable to such Target Company or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by such Target Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make or increase payments or provide compensation under, (vii) result in the creation of any Lien (other than a Permitted Lien) upon any of the properties or assets of such Target Company under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of any Company Material Contract, except for any deviations from any of the foregoing clauses (b) or (c) that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on the Company.

7.7 Financial Statements.

(a) The Company has made available to SPAC true, correct and complete copies of (i) the audited consolidated financial statement of financial position of Air Water Units Trading Limited and its Subsidiaries, and the related audited consolidated statements of comprehensive income, changes in equity and cash flows of Air Water Units Trading Limited and its wholly-owned Subsidiaries as of and for the year ended December 31, 2023 (the “Audited Company Financial Statements”), (ii) the unaudited consolidated financial statement of financial position of Air Water Ventures Limited and its Subsidiaries, and the related unaudited consolidated statements of comprehensive income, changes in equity and cash flows of Air Water Ventures Limited and its Subsidiaries as of and for the year ended December 31, 2024 (the “2024 Unaudited Company Financial Statements”) and (iii) the unaudited consolidated financial statement of financial position of Air Water Ventures Limited and its Subsidiaries, and the related unaudited consolidated statements of comprehensive income, changes in equity and cash flows of Air Water Ventures Limited and its Subsidiaries as of and for the three-month period ended March 31, 2025 (the “Interim Unaudited Company Financial Statements” and, collectively with the Audited Company Financial Statements and the 2024 Unaudited Company Financial Statements, the “Company Financial Statements”).

36

(b) The Company Financial Statements (i) fairly present in all material respects the consolidated financial position of the applicable Target Companies, as at the respective dates thereof, and the consolidated results of their operations, their consolidated incomes, their consolidated changes in shareholders’ equity and their consolidated cash flows for the respective periods then ended, (ii) were prepared in conformity with IFRS applied on a consistent basis during the periods involved, except as may be indicated in the notes thereto and with respect to the 2024 Unaudited Company Financial Statements and the Interim Unaudited Company Financial Statements, subject to the absence of footnotes and normal year-end adjustments (none of which would be material, individually or in the aggregate), (iii) were prepared from, and are in accordance with, in all material respects, the books and records of the applicable Target Companies and (iv) with respect to the Audited Company Financial Statements, contain an unqualified report of the Company’s auditor in connection with such Audited Company Financial Statements, Grant Thornton UAE. The PCAOB Financial Statements, when delivered after the date hereof by the Company for inclusion in the Registration Statement and the Proxy Statement for filing with the SEC following the date of this Agreement in accordance with Section 8.6, will have been audited in accordance with the standards of the Public Company Accounting Oversight Board and will comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant in effect as of the respective dates thereof.

(c) The Company has not identified, and has not received from any independent auditor of the Company any written notification of, (i) any significant deficiency or material weakness in the system of internal accounting controls utilized by the Target Companies, (ii) any fraud, whether or not material, that involves the management or other employees of the Target Companies who have a role in the preparation of financial statements or the internal accounting controls utilized by the Target Companies or (iii) any written claim or allegation regarding any of the foregoing.

(d) There are no outstanding loans or other extensions of credit made by the Target Companies to any executive officer (as defined in Rule 3b-7 under the Exchange Act) or director of the Target Companies.

(e) As of the date hereof, the Target Companies do not have any Indebtedness of the type referred to in clauses (a)-(e) of the definition thereof.

(f) Except for those that will be reflected or reserved on or provided for in the statement of financial position of the Target Companies contained in the Company Financial Statements, no Target Company has any Liabilities of a nature required to be disclosed on a balance sheet in accordance with IFRS, except for (i) those that were incurred after March 31, 2025 in the ordinary course of business, none of which are material, individually or in the aggregate, (ii) obligations for future performance under any contract to which any Target Company is a party, or (iii) Liabilities incurred for transaction expenses in connection with this Agreement, any Ancillary Document or the Transactions.

37

7.8 Absence of Certain Changes. Except for actions expressly contemplated by this Agreement, Ancillary Documents and the Transactions, since December 31, 2024, (a) the Target Companies have conducted their business only in the ordinary course of business, (b) there has not been a Material Adverse Effect and (c) has not taken any action or committed or agreed to take any action that would be prohibited by Section 8.2(b) (without giving effect to Section 8.2(b) of the Company Disclosure Schedules) if such action were taken on or after the date hereof without the consent of SPAC.

7.9 Compliance with Laws. (a) Each Target Company is and, since January 1, 2022 has been, in compliance in all material respects with, and not in conflict, default or violation in each case in any material respect of, any applicable Laws and (b) no Target Company has received, since January 1, 2022, any written or, to the Knowledge of the Company, oral notice of any material conflict or material non-compliance with, or material default or material violation of, any applicable Laws by which it is or was bound.

7.10 Company Permits. The applicable Target Company (and its employees who are legally required to be licensed by a Governmental Authority in order to perform his or her duties with respect to his or her employment with any Target Company), holds all Permits necessary to lawfully conduct in all material respects its business as presently conducted, and to own, lease and operate its assets and properties (collectively, the “Company Permits”), except where the failure to obtain or maintain the same, individually or in the aggregate, has not had and would not reasonably be expected to be material to the Target Companies, taken as a whole or otherwise limit the ability of any Target Company to perform on a timely basis its obligations under this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound. As of the date of this Agreement, each material Company Permit is in full force and effect, and (a) no suspension or cancellation of any of the Company Permits is pending or, to the Company’s Knowledge, threatened, (b) no Target Company is in violation in any material respect of the terms of any material Company Permit and (c) since January 1, 2022, no Target Company has received any written, or to the Knowledge of the Company, oral notice of any Actions relating to the revocation or material modification of any Company Permit.

7.11 Litigation. As of the date of this Agreement, there is no (a) material Action of any nature currently pending or, to the Company’s Knowledge, threatened (and no such Action has been brought or, to the Knowledge of the Company, threatened in the past three (3) years) or (b) material Order now pending or outstanding or that was rendered by a Governmental Authority in the past three (3) years in either case of (a) or (b) by or against any Target Company, its current or former directors, officers or equity holders in their capacity as such, its business, equity securities or assets. As of the date of this Agreement, none of the current or former officers, senior management or directors of any Target Company have been charged with, indicted for, arrested for, or convicted of any felony or any crime involving fraud as it relates to the business of any Target Company, except in each case where the charge, indictment arrest or conviction, individually or in the aggregate, has not had and would not reasonably be expected to be material to the Target Companies, taken as a whole, or otherwise limit the ability of the Company to perform on a timely basis its obligations under this Agreement or the Ancillary Documents to which it is or is required to be a party or otherwise bound.

7.12 Material Contracts.

(a) Section 7.12(a) of the Company Disclosure Schedules sets forth a true, correct and complete list of, and the Company has made available to SPAC (including written summaries of oral Contracts), true, correct and complete copies of, each Contract to which any Target Company is a party or by which any Target Company, or any of its properties or assets, are bound (each Contract required to be set forth on Section 7.12(a) of the Company Disclosure Schedules, a “Company Material Contract”) that:

(i) contains covenants that limit the ability of any Target Company (A) to compete in any line of business or with any Person or in any geographic area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee and customer non-solicit covenants, exclusivity restrictions, rights of first refusal or first offer or most-favored pricing clauses (in each case other than pursuant to confidentiality arrangements entered into in the ordinary course of business) or (B) to purchase or acquire an interest in any other Person;

38

(ii) relates to the formation, creation, operation, management or control of any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement;

(iii) evidences Indebtedness of the type referred to in clauses (a) through (e) of the definition thereof of any Target Company having an outstanding principal amount in excess of $500,000;

(iv) involves any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other derivative financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever, whether tangible or intangible, including currencies, interest rates, foreign currency and indices other than those entered into in the ordinary course of business of the Target Companies on behalf of a customers or any ordinary course transactions that are settled on a daily basis;

(v) involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets or shares or other equity interests of any Target Company or another Person in each case with an aggregate value in excess of $1,000,000;

(vi) relates to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other entity or its business or material assets or the sale of any Target Company, its business or material assets;

(vii) by its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Target Companies under such Contract or set of related Contracts of at least $500,000 per year or $5,000,000 over the life of such Contracts (excluding any Company Benefit Plans);

(viii) pursuant to which any Target Company has been granted from a third party any material license, right, immunity or authorization to use or otherwise exploit any material Intellectual Property, excluding (A) Incidental Licenses, and (B) licenses for “shrink wrap”, “click wrap”, and “off the shelf” software, and (C) licenses for uncustomized software that is commercially available to the public generally with one-time or annual license, maintenance, support and other fees of greater than $100,000;

(ix) pursuant to which any Target Company has (A) acquired from any third party any ownership right to any material Intellectual Property, excluding Contributor Agreements, or (B) transferred to any third party any ownership right to any material Intellectual Property;

39

(x) pursuant to which any Target Company has granted to any third party any material license, right, immunity or authorization to use or otherwise exploit any Company Owned IP, excluding Incidental Licenses;

(xi) obligates the Target Companies to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess of $250,000 other than indemnities or warranties provided in the ordinary course in connection with sales of the Company’s products;

(xii) each employment, severance, retention, change in control or other Contract (excluding customary form offer letters and other standard form agreements entered into in the ordinary course of business) with any employee or other individual independent contractor of the Company or any Target Company who receives annual base cash salary of $250,000 or more;

(xiii) is a labor agreement, collective bargaining agreement, or other labor-related agreement or arrangement with any labor union, labor organization, works council or other employee-representative body;

(xiv) other than under its Organizational Documents, is between any (A) Target Company and (B) any Company Shareholder or any directors, officers or employees of a Target Company (other than any agreement described in Section 7.12(a)(xii) or any other at-will employment, assignment of Intellectual Property or confidentiality arrangements entered into in the ordinary course of business) or any of their respective Affiliates or other Related Person, including all indemnification agreements;

(xv) obligates the Target Companies to make any capital commitment or expenditure in excess of $1,000,000 (including pursuant to any joint venture);

(xvi) relates to a settlement of any Action requiring payments in excess of $200,000 or under which any Target Company has outstanding obligations (other than customary confidentiality or non-disparagement obligations);

(xvii) provides another Person (other than another Target Company or any manager, director or officer of any Target Company) with a power of attorney;

(xviii) is with a Material Customer or Material Supplier; or

(xix) that will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to be filed by the Company as an exhibit for a Form F-1 pursuant to Items 601(b)(1), (2), (4), (9) or (10) of Regulation S-K under the Securities Act as if the Company was the registrant.

40

(b) Except where the failure, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on the Company, with respect to each Company Material Contract: (i) such Company Material Contract is valid and binding and enforceable against the Target Company party thereto and, to the Knowledge of the Company, each other party thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions), (ii) the consummation of the Transactions will not affect the validity or enforceability of any Company Material Contract, (iii) no Target Company is in breach or default, and to the Company’s Knowledge, no event has occurred that with the passage of time or giving of notice or both would constitute a breach or default by any Target Company, or permit termination or acceleration by the other party thereto, under such Company Material Contract, (iv) to the Knowledge of the Company, no other party to such Company Material Contract is in breach or default, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default by such other party, or permit termination or acceleration by any Target Company, under such Company Material Contract, (v) no Target Company has received or served written or, to the Knowledge of the Company, oral notice of an intention by any party to any such Company Material Contract to terminate such Company Material Contract or amend the terms thereof, other than modifications in the ordinary course of business that do not adversely affect the Target Companies and (vi) no Target Company has waived any rights under any such Company Material Contract.

7.13 Intellectual Property.

(a) Section 7.13(a) of the Company Disclosure Schedules sets forth a list of all registered, issued, and applied-for Intellectual Property owned by a Target Company (“Company Registered IP”), specifying as to each item, as applicable: (i) its title, (ii) its owner, (iii) the jurisdictions in which the item is issued, registered or applied-for, (iv) the issuance, registration or application numbers and dates of registration, issuance or application, and (v) for Internet domain-name registrations, the domain name, expiry date and registrar. All Company Registered IP is subsisting and all registered or issued Company Registered IP is valid and, to the Knowledge of the Company, enforceable except where the failure to be would not, individually or in the aggregate, reasonably be expected to be material to the Target Companies, taken as a whole. No Target Company is subject to any outstanding Order that would restrict its use or ownership of any Intellectual Property or would impair the validity or enforceability of any Company Owned IP, and no Action is pending or, to the Knowledge of the Company, threatened, against a Target Company that challenges the validity, enforceability or ownership of any Company Registered IP.

(b) At least one of the Target Companies (i) exclusively own all material Company Owned IP, free and clear of all Liens (other than Permitted Liens) and (ii) has the right to use all other Intellectual Property that is material to the conduct of the business of the Target Companies as currently conducted. The execution and delivery by the Company (or any other Target Company, as applicable) of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party, the consummation by any Target Company of the Transactions, and the compliance by any Target Company with any of the provisions hereof and thereof, will not result in the material loss, termination or impairment of any rights of the Target Companies in any material Intellectual Property.

(c) No Target Company is currently Infringing, or has, in the past three (3) years, Infringed any Intellectual Property of any other Person in any material respect. To the Knowledge of the Company, no third party is Infringing any material Company Owned IP. Since January 1, 2023, no Target Company has received any written or, to the Knowledge of the Company, oral, notice or claim, asserting that any Target Company has Infringed the Intellectual Property of any other Person in any material respect.

41

(d) All Contributors who have contributed to the development of material Intellectual Property for any Target Company have executed a Contributor Agreement. To the Knowledge of the Company, no Contributor has claimed any ownership interest in any material Intellectual Property purported to be owned by a Target Company. Each Target Company has taken commercially reasonable measures to protect and maintain the confidentiality of all Trade Secrets included in the Company Owned IP. No such Trade Secret has been disclosed (or authorized or threatened to be disclosed) to any Person (including any past or present employee, officer, advisor, consultant, independent contractor or other third party) other than pursuant to the terms of a valid, written confidentiality agreement with such Person that is sufficient to protect the confidentiality thereof and is in full force and effect, not breached, and legally enforceable by a Target Company. No Governmental Authority or educational or research institution owns or otherwise holds, or has the right to obtain, any rights to any material Company Owned IP.

(e) The IT Systems (i) operate in all material respects in accordance with their documentation and functional specifications and have not malfunctioned or failed in the last two (2) years in a manner that has had a material impact on the operations of any Target Company, and (ii) are sufficient in all material respects to permit the Target Companies to conduct their business as currently conducted. The Company has taken commercially reasonable actions designed to protect the confidentiality, integrity and security of the IT Systems against unauthorized use, access, interruption, modification and corruption. Since January 1, 2023, to the Knowledge of the Company, there has been no material unauthorized access to the IT Systems that has resulted in any material unauthorized use, access, misappropriation, deletion, corruption, or encryption of any material information or data stored therein. The Company has implemented commercially reasonable data backup, data storage, system redundancy and disaster avoidance and recovery procedures with respect to the IT Systems, except as would not, individually or in the aggregate, reasonably be expected to be material to the Target Companies, taken as a whole.

7.14 Taxes and Returns.

(a) Each Target Company has timely filed, or caused to be timely filed, all material Tax Returns required by applicable Tax Law to be filed by it, which such Tax Returns are true, accurate, correct and complete in all material respects. Each Target Company has timely paid, or caused to be timely paid, all material Taxes required by applicable Tax Law to be paid by it, other than such Taxes being contested in good faith by appropriate proceedings and for which adequate reserves have been established in the Company Financial Statements in accordance with IFRS.

(b) Each Target Company has complied in all material respects with all applicable Tax Laws relating to withholding and remittance of Taxes, and all material amounts of Taxes required by applicable Tax Laws to be withheld by a Target Company have been withheld and timely paid over to the appropriate Governmental Authority, including with respect to any amounts owing to or from any employee, independent contractor, shareholder, creditor, or other Person.

(c) There are no material claims, assessments, audits, examinations, investigations or other Actions pending, in progress or threatened in writing against any Target Company, in respect of Taxes, and no Target Company has been notified in writing of any material proposed Tax claims or assessments against any Target Company by a Governmental Authority.

(d) There are no material Liens with respect to any Taxes upon any Target Company’s assets, other than Permitted Liens. No Target Company has any outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding written requests by any Target Company for any extension of time within which to file any Tax Return or within which to pay any Taxes (other than customary extensions requested in the ordinary course of business). No written claim has been made by any Governmental Authority with respect to a jurisdiction in which a Target Company does not file a Tax Return that such Target Company is or may be subject to Tax in that jurisdiction that would be the subject of or covered by such Tax Return, which claim remains outstanding.

42

(e) No Target Company has a permanent establishment, branch or representative office in any country other than the country of its organization, and no Target Company is or has been treated for any Tax purpose as a resident in a country other than the country of its incorporation or formation, as applicable.

(f) No Target Company is or has ever been a member of any consolidated, combined, unitary or affiliated group of corporations for any Tax purposes (other than a group the common parent of which is or was the Company or of which the Target Companies were or are the only members). No Target Company has any Liability for the Taxes of another Person (other than a Target Company) under Treasury Regulation Section 1.1502-6 (or similar provision of state, local or non-U.S. Law), as a transferee or successor, or by Contract (other than, in each case, Liabilities for Taxes pursuant to customary commercial Contracts not primarily related to Taxes). No Target Company is a party to or bound by any Tax indemnity agreement, Tax sharing agreement, Tax allocation agreement or similar Contract with respect to Taxes (other than customary commercial Contracts not primarily related to Taxes).

(g) No Target Company is the subject of any private letter ruling, technical advice memorandum, closing agreement, settlement agreement or similar ruling, memorandum or agreement with any Governmental Authority with respect to Taxes, nor is there any written request by a Target Company outstanding for any such ruling, memorandum or agreement.

(h) Each Target Company has complied in all material respects with all applicable requirements concerning Value Added Tax.

(i) No Target Company incorporated or organized in a jurisdiction outside of the United States (i) is treated as a “domestic corporation” (as such term is defined in Section 7701 of the Code) for U.S. federal income tax purposes, (ii) is or was a “surrogate foreign corporation” within the meaning of Section 7874(a)(2)(B) of the Code or (iii) is treated as a “domestic corporation” under Section 7874(b) of the Code.

(j) Air Water US is the only Target Company that is incorporated or organized in the United States. Air Water US is not, and has never been, a “United States real property holding corporation” within the meaning of Section 897(c)(2) of the Code.

(k) No Target Company has distributed stock of another Person, or has had its shares distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 or Section 361 of the Code.

(l) No Target Company has been a party to a transaction that is a “listed transaction” as such term is defined in Treasury Regulations Section 1.6011-4(b)(2) (or any analogous or similar provision under any U.S. state or local or foreign Tax Law addressing tax avoidance transactions).

(m) No Target Company will be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any period (or any portion thereof) beginning after the Closing Date as a result of any (i) installment sale or open transaction disposition made by any Target Company prior to the Closing, (ii) change in any method of accounting of any Target Company for any taxable period (or portion thereof) ending on or prior to the Closing Date made or required to be made prior to the Closing, (iii) any “closing agreement” as described in Section 7121 of the Code (or any comparable, analogous or similar provision under any state, local or foreign Tax Law) executed by any Target Company prior to the Closing, or (iv) any prepaid amount or deferred revenue received or accrued prior to the Closing outside the ordinary course of business.

43

(n) No Target Company has taken, or agreed to take, any action that would reasonably be expected to prevent the relevant portions of the Transactions from qualifying for the Intended Tax Treatment. To the Knowledge of each Target Company, there are no facts or circumstances that would reasonably be expected to prevent the relevant portions of the Transactions from qualifying for the Intended Tax Treatment. No Target Company is aware of any current plan or intention to cause PubCo to be liquidated following the Second Merger.

(o) Neither the execution, nor the performance of any obligations under this Agreement, nor completion of this Agreement, will result in a material charge to Tax to arise on a Target Company or in any claw back of any material Tax relief previously given to a Target Company.

(p) All documents necessary to provide the title of each Target Company to its material assets or bring any material course of action in any court or tribunal have been properly stamped to the extent stamping is required by applicable Law in order to provide title to such assets or bring such course of action.

(q) None of the directors, officers, employees or former or proposed directors, officers or employees of the Target Companies has received any securities, interests in securities or securities options as defined in Part 7 of Income Tax (Earnings and Pensions) Act 2003 (“ITEPA”).

(r) All directors, officers or employees or former or proposed directors, officers or employees of the Target Companies who have received any securities or interests in securities falling within Chapter 2 of Part 7 of ITEPA have entered into elections jointly with the relevant Target Company under section 431 of ITEPA (or the equivalent election in any other jurisdiction).

(s) No Target Company is, nor has it been, party to any material transaction or arrangement under which it has been required by an applicable Governmental Authority to (i) compute its profits or losses for Tax purposes as if arm’s length terms had been made or imposed instead of the actual terms, or (ii) make any material adjustment for Tax purposes to the terms on which the transaction or arrangement took place, in each case, under applicable Tax Laws relating to transfer pricing.

(t) No employee benefit trust or other employee trust has been established for the benefit of any employee or former employee of any Target Company, and no employee benefit trust or other third party has: (i) made any payment or loan to, (ii) made available or transferred assets to, or (iii) earmarked any assets (howsoever informally) for the benefit of any employee or former employee (or associate of any such employee or former employee) of any Target Company such as would fall within Part 7A ITEPA.

(u) Except for Air Water US, no Target Company has ever filed an election pursuant to Treasury Regulations Section 301.7701-3. Air Water US has filed an election to be treated as a corporation for U.S. federal income tax purposes pursuant to Treasury Regulations Section 301.7701-3, effective as of the date of its formation.

(v) The Pre-Signing Reorganization qualified as a “reorganization” within the meaning of Section 368(a)(1)(F) of the Code, and none of the Target Companies was subject to any withholding or other Tax in connection with, or with respect to, the Pre-Signing Reorganization (the “Pre-Signing Reorganization Intended Tax Treatment”). Since the consummation of the Pre-Signing Reorganization, none of the cash or other assets of the Company or Air Water UK has been transferred to any other Target Company, except pursuant to an arm’s length loan.

44

7.15 Real Property. Section 7.15 of the Company Disclosure Schedules contains a complete and accurate list of all premises currently leased or subleased by a Target Company for the operation of the business of a Target Company, and of all current leases, lease guarantees, agreements and documents related thereto as of the date of this Agreement, including all amendments, terminations and modifications thereof or waivers thereto (collectively, the “Company Real Property Leases”). The Company has provided to SPAC a true and complete copy of each of the Company Real Property Leases. The Company Real Property Leases are valid, binding and enforceable against the Target Company party thereto and, to the Knowledge of the Company, each other party thereto, in accordance with their terms and are in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions). To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a material default on the part of a Target Company or any other party under any of the Company Real Property Leases, and no Target Company has received notice of any such condition. No Target Company owns any real property or any interest in real property (other than the leasehold interests in the Company Real Property Leases).

7.16 Personal Property. All items of Personal Property with a book value or fair market value of greater than $100,000 are in good operating condition and repair in all material respects (reasonable wear and tear excepted consistent with the age of such items), and are suitable for their intended use in the business of the Target Companies. Each Target Company has good and marketable title to, or a valid leasehold interest in or right to use, all of its assets, and with respect to assets owned by Target Companies, free and clear of all Liens other than Permitted Liens.

7.17 Employee Matters.

(a) (i) As of the date of this Agreement, no Target Company is a party to, or bound by, any labor agreement, collective bargaining agreement or other labor-related Contract, agreement or arrangement with any labor union, labor organization, works council, group of employees or other representative of any of the employees of any Target Company (a “Company Collective Bargaining Agreement”) and (ii) no employees of any Target Company are represented by any labor union, labor organization or works council with respect to their employment with any Target Company.

(b) The Company has no Knowledge of (i) any activities or proceedings of any labor union or other party to organize or represent any employees of any Target Company and (ii) any pending or threatened demand by any labor union, labor organization, works council, or group of employees of any Target Company for recognition or certification as a representative of employees of any Target Company in such capacities. Since January 1, 2022, there has not occurred or, to the Knowledge of the Company, been threatened any material strike, slow-down, picketing, work-stoppage, or other similar labor activity with respect to any employees of any Target Company in connection with the business of any Target Company.

(c) No Target Company has any legal or contractual obligation to provide notice to, or to enter into any consultation procedure with, any labor union, labor organization or works council, which is representing any employee of any Target Company, in connection with the consummation of the Transactions.

45

(d) Except as would not reasonably be expected to be material to any Target Company, to the Knowledge of the Company, each Target Company is and, since January 1, 2022, has been in compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment, health and safety and wages and hours, and other Laws relating to classification, discrimination, disability, labor relations, hours of work, payment of wages and overtime wages, pay equity, immigration, workers compensation, working conditions, employee scheduling, occupational safety and health, family and medical leave, and employee terminations, and has not received written or to the Knowledge of the Company, oral notice that there is any pending Action involving unfair labor practices against a Target Company. There are no material Actions pending or, to the Knowledge of the Company, threatened against a Target Company brought by or on behalf of any applicant for employment, any current or former employee, any Person alleging to be a current or former employee, or any Governmental Authority, relating to any such Law.

(e) No Target Company is party to a settlement agreement with a current or former officer of any Target Company that involves allegations relating to sexual harassment. To the Knowledge of the Company, since January 1, 2022, no written allegations of sexual harassment or other discrimination have been made against any officer of a Target Company.

(f) To the Knowledge of the Company, no employee of any Target Company is in any material respect in violation of any term of any employment agreement, non-disclosure agreement, non-competition agreement, restrictive covenant or other similar obligation: (i) to any Target Company or (ii) to a former employer of any such employee relating (A) to the right of any such employee to be employed by any Target Company or (B) to the knowledge or use of trade secrets or proprietary information.

(g) As of the date hereof, no current executive officer of the Company or a Target Company has, to the Knowledge of the Company, provided the Company or any Target Company written notice of his or her plan to terminate his or her employment with the Company or any Target Company.

(h) Since January 1, 2022, except as would not reasonably be expected to be material to any Target Company, the Target Companies have not engaged in any layoffs, furloughs or group employment terminations (excluding terminations for cause), whether temporary or permanent.

7.18 Benefit Plans.

(a) Set forth on Section 7.18(a) of the Company Disclosure Schedules is an accurate and complete list, as of the date hereof, of each material Benefit Plan of the Target Companies (each, a “Company Benefit Plan”). No Target Company maintains, sponsors, contributes to, has any obligation to contribute to, or has any Liability on account of an ERISA Affiliate under or with respect to: (1) any “multiemployer plan” as defined under Section 3(37) of ERISA, (2) any plan or arrangement subject to Code Sections 412 or 4971, ERISA Section 302 or Title IV of ERISA or similar non-U.S. Laws or (3) a plan that has two or more contributing sponsors at least two of whom are not under common control within the meaning of ERISA Section 4063.

46

(b) With respect to each material Company Benefit Plan, the Company has made available to SPAC accurate and complete copies of the current plan documents and all material non-routine communications in the past three (3) years with any Governmental Authority concerning any matter that is still pending or for which a Target Company has any outstanding material Liability.

(c) With respect to each material Company Benefit Plan: (i) such material Company Benefit Plan has been administered and enforced in all material respects in accordance with its terms and the requirements of all applicable Laws, and has been maintained, where required, in good standing in all material respects with applicable regulatory authorities and Governmental Authorities, (ii) no breach of fiduciary duty that would result in material Liability to any Target Company has occurred, (iii) no Action that would result in a material Liability to the Target Companies is pending, or to the Company’s Knowledge, threatened (other than routine claims for benefits arising in the ordinary course of administration); and (iv) all material contributions, premiums and other payments (including any special contribution, interest or penalty) required to be made with respect to such material Company Benefit Plan have been timely made or, to the extent not required to be made or paid on or before the date hereof, have been fully reflected on the books and records of the applicable Target Company. All non-U.S. Company Benefit Plans that are required by the applicable Law to be funded or book-reserved are funded or book-reserved, as appropriate, in all material respects in accordance with such applicable Law. No Target Company has incurred any material obligation in connection with the termination of, or withdrawal from, any Company Benefit Plan.

(d) Each Company Benefit Plan that is intended to meet the requirements of a “qualified plan” under Code Section 401(a) has received a current favorable determination or opinion or advisory letter from the Internal Revenue Service or is the subject of a current favorable determination or opinion or advisory letter issued by the Internal Revenue Service with respect to such Company Benefit Plan, and, to the Knowledge of the Company, nothing has occurred since the date of such determination, opinion or advisory letter that would be reasonably likely to adversely affect the qualified status of any such Company Benefit Plan. Each material Company Benefit Plan intended to qualify for special tax status in a jurisdiction outside of the United States is registered as such to the extent required by applicable Law and has been documented and operated in all material respects in compliance with all requirements of such special tax status.

(e) The consummation of the Transactions will not: (i) entitle any individual to material severance pay, unemployment compensation or other material benefits or compensation whether under a Company Benefit Plan or under applicable Law or otherwise; (ii) accelerate the time of payment, vesting or funding, or increase the amount of any material compensation or benefits, in respect of, any director, employee or independent contractor of a Target Company or (iii) cause an amount to be received by any director, employee or independent contractor of a Target Company under any Company Benefit Plan or otherwise to fail to be deductible by reason of Code Section 280G or be subject to an excise Tax under Code Section 4999. No Company Benefit Plan provides for the gross-up or reimbursement of Taxes under Code Sections 409A or 4999.

47

7.19 Environmental Matters.

(a) Each Target Company is, and since January 1, 2022 has been, in compliance in all material respects with all applicable Environmental Laws, including obtaining, maintaining in good standing, and complying in all material respects with all material Permits required under Environmental Laws for its business and operations (“Environmental Permits”) and no Action is pending or, to the Company’s Knowledge, threatened that would reasonably be expected to result in the revocation, modification, or termination of any such Environmental Permit.

(b) No Target Company is subject to, or has received written notice of an investigation that would lead to, any outstanding Order or Contract with any Governmental Authority in respect of any (i) Environmental Laws, (ii) Remedial Action or (iii) Release of a Hazardous Material, in each case, that has given rise or would reasonably be expected to give rise to any material Liability under Environmental Laws of any Target Company.

(c) No Target Company has assumed, contractually or by operation of Law, any outstanding Liabilities or obligations under any Environmental Laws of any other Person except, in each case, for such Liabilities or obligations that would not reasonably be expected to be material to the Target Companies, taken as a whole.

(d) No Action is pending, or to the Company’s Knowledge, threatened against any Target Company or any assets of a Target Company alleging that a Target Company is in violation in any material respect of any Environmental Law or material Environmental Permit or that a Target Company has any material Liability under any Environmental Law, and to the Company’s Knowledge, no fact, circumstance or condition exists that would reasonably be expected to give rise to any such Action.

(e) (i) No Target Company has manufactured, used, treated, stored, disposed of, arranged for or permitted the transportation or disposal of, generated, handled or released any Hazardous Material, or owned, leased or operated any property or facility, in a manner that has given or would reasonably be expected to give rise to any material Liability or material obligation of any Target Company under applicable Environmental Laws and (ii) to the Company’s Knowledge, no fact, circumstance, or condition exists in respect of any Target Company or any property currently or formerly owned, operated, or leased by any Target Company or any property to which a Target Company arranged for the disposal or treatment of Hazardous Materials that could reasonably be expected to result in a Target Company incurring any material Liability or material obligation of any Target Company under applicable Environmental Laws.

(f) To the Knowledge of the Company, there is not located at any of the properties of a Target Company any (i) underground storage tanks, (ii) asbestos-containing material, (iii) equipment containing polychlorinated biphenyls or (iv) per- and polyfluoroalkyl substances, in each case that could reasonably be expected to result in a Target Company incurring any material Liability or material obligation under applicable Environmental Laws.

(g) The Company has made available to SPAC all material environmental assessments and reports in its, or any of the Target Companies’, possession or control relating to the operations of the Target Companies, or the condition of their respective properties and assets, and their compliance with Environmental Laws and Environmental Permits.

48

7.20 Transactions with Related Persons. No Company Shareholder nor any officer or director of a Target Company or any of their respective Affiliates, nor any immediate family member of any of the foregoing (each of the foregoing, a “Related Person”) is presently, or since January 1, 2022, has been, a party to any transaction with a Target Company, including any Contract (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b) providing for the rental of real property or Personal Property from, or (c) otherwise requiring payments to (other than for services or expenses as directors, officers or employees of the Target Company in the ordinary course of business) any Related Person or any Person in which any Related Person has a position as an officer, manager, director, trustee or partner or in which any Related Person has any direct or indirect ownership interest (other than the ownership of securities representing no more than five percent of the outstanding voting power or economic interest of a publicly traded company), in each case, other than any Ancillary Document, the Shareholders Agreement or any Contract pursuant to which a Company Shareholder subscribed for or purchased equity interests in the Company. Except as contemplated by or provided for in any Ancillary Document, the Shareholders Agreement or any Contract pursuant to which a Company Shareholder subscribed for or purchased equity interests in the Company, no Target Company has outstanding any Contract or other arrangement or commitment with any Related Person, and no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual Property) which is used in the business of any Target Company. Except as contemplated by or provided for in any Ancillary Document, the assets of the Target Companies do not include any material receivable or other material obligation from a Related Person, and the Liabilities of the Target Companies do not include any material payable or other material obligation or commitment to any Related Person.

7.21 Insurance.

(a) Section 7.21(a) of the Company Disclosure Schedules lists all material insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) held by a Target Company relating to a Target Company or its business, properties, assets, directors, officers and employees (excluding those constituting or funding Company Benefit Plans), copies of which have been provided to SPAC. Except as would not, individually or in the aggregate, be material to the Target Companies, taken as a whole, all premiums due and payable under all such insurance policies have been timely paid and the Target Companies are otherwise in material compliance with the terms of such insurance policies. To the Company’s Knowledge and except as would not, individually or in the aggregate, be material to the Target Companies, taken as a whole, each such insurance policy (i) is valid, binding, enforceable and in full force and effect and (ii) will continue to be valid, binding, enforceable, and in full force and effect on identical terms following the Closing (except, in each case, as such enforcement may be limited by the Enforceability Exceptions). No Target Company has any self-insurance or co-insurance programs. Since January 1, 2022, to the Company’s Knowledge, no Target Company has received any notice from, or on behalf of, any insurance carrier relating to or involving any adverse change or any change other than in the ordinary course of business, in the conditions of insurance, any refusal to issue a material insurance policy or non-renewal of any such policy.

(b) Since January 1, 2022, no Target Company has made any insurance claim in excess of $250,000 and each Target Company has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to be material to the Target Companies, taken as a whole. To the Knowledge of the Company, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to (with or without notice or lapse of time) give rise to or serve as a basis for the denial of any such insurance claim. Since January 1, 2022, no Target Company has made any material claim against an insurance policy as to which the insurer is denying coverage.

49

7.22 Customers and Suppliers.

(a) Section 7.22(a) of the Company Disclosure Schedules sets forth a list of Contracts with the top five (5) customers of the Company and the other Target Companies based on revenue received by the Company or any Target Company from such customers during the calendar year 2024 (each such customer, a “Material Customer” and each such contract, a “Material Customer Agreement”). As of the date hereof, neither the Company nor any Target Company has received any written notice from any Material Customer that such Material Customer shall not continue as a customer of the Company or that such Material Customer intends to terminate or adversely modify in any material respect any existing Material Customer Agreement with the Company or the Target Companies.

(b) Section 7.22(b) of the Company Disclosure Schedules sets forth a list of the top five (5) suppliers of the Company and the other Target Companies based on expenditures made by the Company and the other Target Companies during the calendar year 2024 (each such supplier, a “MaterialSupplier” and each Contract pursuant to which the Company or a Target Company paid those amounts to the applicable Material Supplier, excluding any purchase orders, insertion orders or similar purchasing documents, a “Material Supplier Agreement”). As of the date hereof, neither the Company nor any other Target Company has received any written notice from any Material Supplier that such supplier shall not continue as a supplier to the Company or that such supplier intends to terminate or adversely modify in any material respect any existing Material Supplier Agreements with the Company or the other Target Companies.

7.23 Data Protection and Cybersecurity.

(a) For the purposes of this Section 7.23, the terms “personal data breach” and “processing” (and its cognates) shall have the meaning given to them under applicable Data Protection Laws.

(b) Each Target Company (i) has implemented and maintains commercially reasonable technical and organizational measures designed to protect IT Systems and Personal Data relating to the business of the Target Company against personal data breaches and cybersecurity incidents, (ii) complies in all material respects with all contractual obligations to which it is bound relating to the privacy, security, processing, transfer and confidentiality of Personal Data, except to the extent any non-compliance, either individually or in the aggregate, would not reasonably be expected to be material to the Target Companies, and (iii) has suffered no material incidents negatively affecting the integrity, or availability of its IT Systems, or the data thereon.

(c) Except as would not, individually or in the aggregate, be material to the Target Companies, taken as a whole, since January 1, 2022, no Target Company has (i) been subject to any actual, pending or, to the Knowledge of the Company, threatened in writing investigations, notices or requests from any Governmental Authority in relation to their data processing or cybersecurity activities, or (ii) received any actual, pending or, to the Knowledge of the Company, threatened claims from individuals alleging any breach of Data Protection Laws.

50

7.24 Certain Business Practices.

(a) For the past five (5) years, each Target Company has been in compliance with the FCPA and all other applicable anti-corruption and anti-bribery Laws, in all material respects. No Target Company is subject to any Action by any Governmental Authority involving any actual or, to the Knowledge of the Company, suspected violation of any applicable anti-corruption Law.

(b) For the past five (5) years, no Target Company nor any of its directors, officers or, to the Knowledge of each Target Company, employees or Representatives, when acting on behalf of a Target Company, has used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity.

(c) No Target Company or any of their respective directors, officers or employees or, to the Knowledge of the Company, any other Representative acting on behalf of a Target Company is currently, or has been since April 24, 2019, a Sanctioned Person, or is subject to debarment or any list-based designations under Customs & Export Control Laws. No Target Company has, directly or, knowingly, indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Company Subsidiary, joint venture partner or other Person, (i) to fund any activities or business of or with any Person that, at the time of such funding, is the subject of Sanctions, or in any country or territory, that, at the time of such funding, is a Sanctioned Jurisdiction or (ii) in any other manner that would reasonably be expected to result in a violation of Sanctions or Customs & Export Control Laws by any Person. No Target Company or any of their respective directors, officers employees or, to the Knowledge of the Company, any other Representative acting on behalf of a Target Company has, since April 24, 2019, engaged in (A) dealings with a Sanctioned Person or involving a Sanctioned Jurisdiction in a manner that would violate applicable Sanctions, (B) dealings that could reasonably be expected to result in the Target Company becoming a Sanctioned Person, or (C) conduct, activity, or practice that would constitute a violation or apparent violation of any applicable Sanctions or Customs & Export Control Laws. The Target Company has (1) where required by Law, secured and maintained all necessary permits, registrations, agreements or other authorizations, including amendments thereof pursuant to Sanctions and Customs & Export Control Laws and (2) not been the subject of or otherwise involved in investigations or enforcement actions by any Governmental Authority or other legal proceedings with respect to any actual or alleged violations of applicable Sanctions or Customs & Export Control Laws, and has not been notified of any such pending or threatened actions. The Target Company and its directors, officers and employees, and, to the Knowledge of the Company, any other Representative acting on behalf of a Target Company, are, and have been since April 24, 2019, in compliance with Sanctions and Customs & Export Control Laws.

7.25 Investment Company Act. No Target Company is an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of a Person subject to registration and regulation as an “investment company”, in each case within the meaning of the Investment Company Act.

7.26 Finders and Brokers. Other than as set forth on Schedule 7.26 of the Company Disclosure Schedules, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from SPAC, PubCo, the Target Companies or any of their respective Affiliates in connection with the Transactions based upon arrangements made by or on behalf of any Target Company.

51

7.27 Information Supplied. None of the information supplied or to be supplied by the Company in writing expressly for inclusion or incorporation by reference prior to Closing: (a) in any current report on Form 6-K or Form 8-K or report on Form 20-F, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) with respect to the Transactions, (b) in the Registration Statement or (c) in the mailings or other distributions to SPAC Shareholders and prospective investors (including any actual or prospective PIPE Investors) with respect to the consummation of the Transactions or in any amendment to any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation, warranty or covenant with respect to (i) any information supplied by or on behalf of SPAC, PubCo or any of its respective Affiliates specifically for inclusion in the Registration Statement, Proxy Statement or any of the other documents identified in clauses (a) through (c) above and (ii) any forward-looking statements supplied or to be supplied by or on behalf of the Company in writing expressly for inclusion or incorporation by reference prior to Closing in the Registration Statement or the Proxy Statement.

7.28 Company Acknowledgment. The Company acknowledges and agrees that the representations and warranties expressly set forth in (i) Article IV (as qualified by the SPAC Disclosure Schedules) (ii) the certificate delivered pursuant to Section 10.2(c) and (iii) any Ancillary Document, constitute the sole and exclusive representations and warranties of SPAC, respectively, to the Company in connection with or relating to SPAC, this Agreement, any Ancillary Document or the Transactions, and no other representations or warranties, oral or written, have been given by or on behalf of SPAC. Except for the representations and warranties expressly set forth in Article IV (as qualified by the SPAC Disclosure Schedules), the certificate delivered pursuant to Section 10.2(c) or in any Ancillary Document the Company (A) acknowledges that it is transacting with SPAC and PubCo on an “as is” condition and on a “where is” basis and (B) disclaims reliance on, and confirms and acknowledges that it has not relied on and should not rely on and will not rely on, any other representations or warranties, either express or implied, at law or in equity, including representations of merchantability, suitability or fitness for any particular purpose, or other statements, whether written or oral, made by or on behalf of any person (including SPAC or any Affiliate or Representative of SPAC) in respect of the business, assets, liabilities, operations, prospects or condition (financial or otherwise) of SPAC including with respect to the accuracy or completeness of any confidential information memoranda, documents, projections or other prediction or forward-looking statements, material, or other information (financial or otherwise) regarding SPAC furnished to the Company or any of its Representatives in any “data rooms”, “virtual data rooms”, management presentations, or in any other form or in expectation of, or in connection with, the Transactions, or in respect of any other matter or thing whatsoever or on any person providing or not providing any information not specifically required to be provided or disclosed pursuant to the specific representations and warranties in Article IV, in the certificate delivered pursuant to Section 10.2(c) or any Ancillary Document.

7.29 Dormant Entity. Eshara Water Asia SDN. BHD is a wholly-owned subsidiary of Air Water Units Trading Ltd. and does not (a) have or hold any assets of any kind or nature, (b) have any liabilities, obligations or Indebtedness of any kind, or (c) have any operations or employees.

52

Article VIII

COVENANTS

8.1 Access and Information.

(a) During the period from the date of this Agreement and continuing until the earlier of the termination of this Agreement in accordance with Section 11.1 or the Closing (the “Interim Period”), subject to Section 8.17, to the extent permitted by applicable Law and solely for the purpose of facilitating the consummation of the Transactions, each of the Company and PubCo shall give, and shall cause its Representatives to give, SPAC and its Representatives, at reasonable times during normal business hours and at reasonable intervals and upon reasonable advance notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, books and records, financial and operating data and other similar information (including Tax Returns, internal working papers, client files, client Contracts and director service agreements), of or pertaining to the Target Companies or PubCo, as SPAC or its Representatives may reasonably request regarding the Target Companies or PubCo and their respective businesses, assets, Liabilities, Tax affairs, financial condition, operations, management, employees and other aspects and cause each of the Representatives of the Company to reasonably cooperate with SPAC and its Representatives in their investigation; provided, however, that SPAC and its Representatives shall conduct any such activities in such a manner as not to unreasonably interfere with the business or operations of the Target Companies or PubCo. SPAC hereby agrees that, during the Interim Period, it shall not contact any employee (other than executive officers), customer, supplier, distributor or other material business relation of any Target Company regarding any Target Company, its business or the Transactions without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing, the Company shall not be required to provide access to any information (i) that is personally identifiable information of a third party which is prohibited from being disclosed pursuant to the terms of a written confidentiality agreement with a third party, (ii) the disclosure of which would violate any Law, (iii) the disclosure of which would jeopardize the protection of attorney-client, attorney work product or other legal privilege or (iv) that is directly related to the negotiation and execution of the Transactions (or any transactions that are or were alternatives to the Transactions).

(b) During the Interim Period, subject to Section 8.17, to the extent permitted by applicable Law and solely for the purpose of facilitating the consummation of the Transactions, SPAC shall give, and shall cause its Representatives to give, the Company and its Representatives, at reasonable times during normal business hours and at reasonable intervals and upon reasonable advance notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, books and records, financial and operating data and other similar information (including Tax Returns, internal working papers, client files, client Contracts and director service agreements), of or pertaining to SPAC, as the Company or its Representatives may reasonably request regarding SPAC and its business, assets, Liabilities, Tax affairs financial condition, operations, management, employees and other aspects and cause each of the Representatives of SPAC to reasonably cooperate with the Company and its Representatives in their investigation; provided, however, that the Company and its Representatives shall conduct any such activities in such a manner as not to unreasonably interfere with the business or operations of SPAC. Notwithstanding the foregoing, SPAC shall not be required to provide access to any information (i) that is personally identifiable information of a third party which is prohibited from being disclosed pursuant to the terms of a written confidentiality agreement with a third party, (ii) the disclosure of which would violate any Law, (iii) the disclosure of which would jeopardize the protection of attorney-client, attorney work product or other legal privilege or (iv) that is directly related to the negotiation and execution of the Transactions (or any transactions that are or were alternatives to the Transactions).

(c) During the Interim Period, each of the Company and SPAC shall, and shall cause their respective Representatives to, reasonably cooperate in a timely manner in connection with any financing arrangement the Parties mutually agree to seek in connection with the transactions contemplated by this Agreement (including, in connection with the PIPE Investment), including, (i) by providing such information and assistance as the other Party may reasonably request, (ii) granting such access to the other Party and its Representatives as may be reasonably necessary to facilitate due diligence by any investor, and (iii) participating in a reasonable number of meetings, presentations, road shows, drafting sessions, due diligence sessions with respect to such financing efforts (including direct contact between senior management and other Representatives of the Company at reasonable times and locations). All such cooperation, assistance and access shall be granted during normal business hours and shall be granted under conditions that shall not unreasonably interfere with the business and operations of the Company, SPAC or their respective Representatives.

(d) All information provided pursuant to this Section 8.1 shall be subject to the Confidentiality Agreement dated May 14, 2025 by and between SPAC and the Company (as amended from time to time, the “Confidentiality Agreement”).

53

8.2 Conduct of Business of the Company during the Interim Period.

(a) Unless SPAC shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period and subject to Section 8.5, except as contemplated by the terms of this Agreement or any Ancillary Document, as set forth on Section 8.2(a) of the Company Disclosure Schedules, or as required by applicable Law, the Company shall use its commercially reasonable efforts to, and shall cause the other Target Companies to use their respective commercially reasonable efforts to, (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practices and (ii) preserve intact, in all material respects, their respective business organizations, to keep available the services of their respective managers, directors, officers, employees and consultants, preserve the possession, control and condition of their respective material assets, and preserve intact its relationships with all material customers and suppliers, in each case consistent with past practice; provided that no action or inaction by the Company with respect to matters specifically addressed by clauses (b)(i) through (xxiii) below shall be deemed a breach of the foregoing unless such action or inaction would constitute a breach of such specific provision of (b)(i) through (xxiii) below.

(b) Without limiting the generality of Section 8.2(a) and except as contemplated by the terms of this Agreement or any Ancillary Document, or as set forth on Section 8.2(b) of the Company Disclosure Schedules, or as required by applicable Law, during the Interim Period and subject to Section 8.5, without the prior written consent of SPAC (such consent not to be unreasonably withheld, conditioned or delayed), the Company shall not, and shall cause the other Target Companies not to:

(i) amend, waive or otherwise change, the Organizational Documents of any of the Company or the Target Companies;

(ii) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities of any class and any other equity-based awards, or engage in any hedging transaction with a third party with respect to such securities;

(iii) split, combine, recapitalize, subdivide, reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;

(iv) (A) incur, create, assume or otherwise become liable for any Indebtedness of the type referred to in clause (a) of the definition thereof (directly, contingently or otherwise) in excess of $7,500,000 in the aggregate, (B) make a loan or advance to or investment in any third party (other than advancement of expenses to employees in the ordinary course of business), or (C) guarantee or endorse any Indebtedness of the type referred to in clause (A) in excess of $1,000,000 individually or $2,000,000 in the aggregate, in each case, except for (x) any such transactions among Target Companies and (y) hedging or over-the-counter derivatives transactions in the ordinary course of business;

54

(v) except as required pursuant to any Company Benefit Plan, Company Collective Bargaining Agreement or Law or other written agreement, (A) materially increase the wages, salaries or compensation of its employees other than in the ordinary course of business (B) make or commit to make any bonus payment (whether in cash, property or securities) to any employee other than in the ordinary course of business, (C) grant any severance, change in control or termination or similar pay, other than in the ordinary course of business or as required by applicable Law, (D) establish any trust or take any other action to secure the payment of any compensation payable by the Company, (E) materially increase other benefits of employees generally, or enter into, establish, materially amend or terminate any material Company Benefit Plan with, for or in respect of any current consultant, officer, manager director or employee other than in connection with the Transactions or, except with respect to a director, officer or manager, in the ordinary course of business, (F) hire any employee with an annual base salary greater than or equal to $200,000 or engage any person as an independent contractor with annual payments greater than or equal to $200,000, in each case other than in the ordinary course of business or (G) terminate the employment of any employee with an annual base salary greater than or equal to $200,000 or due to death or disability other than for cause or in the ordinary course of business;

(vi) waive any restrictive covenant obligations of any employee or individual independent contractor of any Target Company;

(vii) unless required by applicable Law, a Company Benefit Plan or a Company Collective Bargaining Agreement, (A) modify, extend or enter into any Company Collective Bargaining Agreement, or (B) recognize or certify any labor union, labor organization, works council or other employee-representative body as the bargaining representative for any employees of the Target Companies;

(viii) (A) make, change or rescind any material election in respect of Taxes, (B) settle any material Action in respect of Taxes, (C) make any material change to its methods of Tax accounting, (D) waive or extend any statute of limitations in respect of a period within which an assessment or reassessment of material Taxes may be issued (other than any extension resulting from an extension to file any Tax Return obtained in the ordinary course of business), (E) enter into a Tax sharing agreement, Tax indemnification agreement, Tax allocation agreement or similar Contract (other than customary commercial Contracts not primarily related to Taxes), (F) file any amended material Tax Return, (G) enter into any “closing agreement” as described in Section 7121 of the Code (or any comparable, analogous or similar provision under any state, local or non-U.S. Tax Law) pertaining to Taxes with any Governmental Authority or (H) change its jurisdiction of tax residence or establish a permanent establishment or other taxable presence in any jurisdiction outside its jurisdiction of incorporation or organization, as applicable;

(ix) (A) other than in the ordinary course of business or between Target Companies, (1) sell, assign, transfer or license any Company Owned IP to any Person, other than Incidental Licenses, or (2) abandon, permit to lapse, or otherwise dispose of any material Company Registered IP, or (B) disclose any material Trade Secrets owned or held by any Target Company to any Person who has not entered into a written confidentiality agreement or is not otherwise subject to enforceable confidentiality obligations;

(x) (A) modify or amend in a manner that is materially adverse to the applicable Target Company, or terminate, any Company Material Contract; (B) waive, delay the exercise of, release or assign any material rights or claims under any Company Material Contract or (C) enter into any Contract that would be the type of Material Contract set forth in Sections 7.12(a)(iii), (iv), (v), (vi), (ix), (xiii), (xvi) and (xvii) if entered into prior to the date hereof outside of the ordinary course of business;

55

(xi) fail to use commercially reasonable efforts to maintain its books, accounts, and records in all material respects in the ordinary course of business consistent with past practices;

(xii) enter into (A) any new line of business or (B) jurisdiction with respect to its current line of business;

(xiii) fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage as are currently in effect;

(xiv) waive, release, assign, settle or compromise any claim or Action (including any Action relating to this Agreement or the Transactions), other than waivers, releases, assignments, settlements or compromises that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, such Party or its Affiliates) not in excess of $200,000 (individually or in the aggregate), or otherwise pay, discharge or satisfy any Liabilities or obligations, unless such amount has been reserved in the Company Financial Statements, as applicable;

(xv) acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any of assets of any such Person in each case, if the aggregate amount of consideration paid or transferred by the Target Companies would exceed $2,000,000 in the aggregate;

(xvi) make any capital expenditures in excess of $5,000,000 (individually for any project (or set of related projects) or $10,000,000 in the aggregate);

(xvii) adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;

(xviii) sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose of any material portion of the properties, assets or rights of the Target Companies, taken as a whole, other than in the ordinary course of business;

(xix) enter into any agreement, understanding or arrangement with respect to the voting or transfer of equity securities of any Target Company;

(xx) make any change in accounting methods, principles or practices, except as required by IFRS or the Company’s auditors;

(xxi) (A) enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person or (B) enter into any Contract or arrangement that would have been required to be listed on Section 4.15 of the SPAC Disclosure Schedules if entered into prior to the date hereof (in the case of clauses (A) and (B), other than compensation and benefits and advancement of expenses, in each case, provided in the ordinary course of business);

(xxii) transfer any cash or other assets of the Company or Air Water UK to any other Target Company except pursuant to an arm’s length loan or take any other action or knowingly fail to take any action that would reasonably be expected to prevent or impede the Pre-Signing Reorganization from qualifying for the Pre-Signing Reorganization Intended Tax Treatment; or

(xxiii) authorize or agree to do any of the foregoing actions.

56

8.3 Conduct of Business of SPAC during the Interim Period.

(a) Unless the Company shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period and subject to Section 8.5, except as contemplated by the terms of this Agreement or any Ancillary Document, or as set forth on Section 8.3(a) of the SPAC Disclosure Schedules, or as required by applicable Law, SPAC shall use its commercially reasonable efforts to (i) conduct its business, in all material respects, in the ordinary course of business consistent with past practices and (ii) preserve intact, in all material respects, its business organization, to keep available the services of its managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of its material assets, in each case consistent with past practice. Notwithstanding anything to the contrary in this Section 8.3, nothing in this Agreement shall prohibit or restrict SPAC from extending one or more times, in accordance with the SPAC Charter and the IPO Prospectus, or by amendment to the SPAC Charter, the deadline by which it must complete its Business Combination (each, an “Extension”).

(b) Without limiting the generality of Section 8.3(a) and except as contemplated by the terms of this Agreement or any Ancillary Document, or as set forth on Section 8.3(b) of the SPAC Disclosure Schedules, or as required by applicable Law, during the Interim Period and subject to Section 8.5, without the prior written consent of the Company (such consent not to be unreasonably withheld, conditioned or delayed), SPAC shall not:

(i) amend, waive or otherwise change its Organizational Documents, other than for administrative or de minimis changes;

(ii) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities (including the SPAC Securities) or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its shares or other equity securities, or other securities, including any securities convertible into or exchangeable for any of its equity securities (including the SPAC Securities) or other security interests of any class and any other equity-based awards, or engage in any hedging transaction with a third party with respect to such securities;

(iii) split, combine, recapitalize, subdivide, reclassify any of its shares or other equity interests (including the SPAC Securities) or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities, except for redemptions from the Trust Account that are required in accordance with the IPO Prospectus;

(iv) (A) incur, create, assume or otherwise become liable for any Indebtedness of the type referred to in clause (a) of the definition thereof (directly, contingently or otherwise), (B) make a loan or advance to or investment in any third party, or (C) guarantee or endorse any Indebtedness of the type referred to in clause (A) above of any Person, provided that this Section 8.3(b)(iv) shall not prevent SPAC from borrowing up to $2,000,000 from the Sponsor to finance its ordinary course administrative costs and expenses and other costs, expenses and fees incurred in connection with the consummation of the Transactions, so long as any such loans are made on a non-interest bearing basis in a customary manner between Sponsor and SPAC;

57

(v) amend, waive or otherwise change the Trust Agreement in any manner;

(vi) terminate, waive or assign any material right under any material agreement (including any SPAC Material Contract) to which it is a party, or enter into any Contract that would be a SPAC Material Contract if entered into prior to the date hereof;

(vii) establish any Subsidiary or enter into any new line of business;

(viii) fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage as are currently in effect;

(ix) waive, release, assign, settle or compromise any claim or Action (including any Action relating to this Agreement or the Transactions), other than waivers, releases, assignments, settlements or compromises that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, SPAC) not in excess of $300,000 (individually or in the aggregate), unless such amount has been reserved in the SPAC Financials;

(x) acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any of assets of any such Person in each case, if the aggregate amount of consideration paid or transferred by SPAC would exceed $50,000 in the aggregate;

(xi) adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization (other than with respect to the Mergers);

(xii) enter into any agreement, understanding or arrangement with respect to the voting or transfer of its equity securities (including the SPAC Securities);

(xiii) (A) make, change or rescind any material election in respect of Taxes, (B) settle any material Action in respect of Taxes, (C) make any material change to its methods of Tax accounting, (D) waive or extend any statute of limitations in respect of a period within which an assessment or reassessment of material Taxes may be issued (other than any extension resulting from an extension to file any Tax Return obtained in the ordinary course of business), (E) enter into a Tax sharing agreement, Tax indemnification agreement, Tax allocation agreement or similar Contract (other than customary commercial Contracts not primarily related to Taxes), (F) file any amended material Tax Return, (G) enter into any “closing agreement” as described in Section 7121 of the Code (or any comparable, analogous or similar provision under any state, local or non-U.S. Tax Law) pertaining to Taxes with any Governmental Authority or (H) change its jurisdiction of tax residence or establish a permanent establishment or other taxable presence in any jurisdiction outside its jurisdiction of incorporation or organization, as applicable;

(xiv) adopt or enter into any Benefit Plan (including granting or establishing any form of compensation or benefits to any current or former employee, officer, director or other individual service provider of SPAC);

58

(xv) incur any expenses other than in connection with the implementation of the Transactions;

(xvi) (A) appoint any director to the board of directors of SPAC, (B) hire any employee or engage any individual independent contractor or other individual service provider, (C) enter into or amend any Contract or transaction with any current or former employee, officer, director or other individual service provider of SPAC or (D) enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person (other than advancement of expenses, in each case, provided in the ordinary course of business); or

(xvii) authorize or agree to do any of the foregoing actions.

8.4 Conduct of Business of PubCo during the Interim Period.

(a) Unless SPAC shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period and subject to Section 8.5, except as contemplated by the terms of this Agreement or any Ancillary Document, or as required by applicable Law, PubCo shall use its commercially reasonable efforts to (i) conduct its business, in all material respects, in the ordinary course of business consistent with past practices and (ii) preserve intact, in all material respects, its business organization, to keep available the services of its managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of its material assets, in each case consistent with past practice.

(b) Without limiting the generality of Section 8.4(a) and except as contemplated by the terms of this Agreement or any Ancillary Document, or as required by applicable Law, during the Interim Period and subject to Section 8.5, without the prior written consent of SPAC (such consent not to be unreasonably withheld, conditioned or delayed), PubCo shall not:

(i) amend, waive or otherwise change, its Organizational Documents, other than for administrative or de minimis changes;

(ii) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities of any class and any other equity-based awards, or engage in any hedging transaction with a third party with respect to such securities;

(iii) split, combine, recapitalize, subdivide, reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;

(iv) (A) incur, create, assume or otherwise become liable for any Indebtedness of the type referred to in clause (a) of the definition thereof (directly, contingently or otherwise), (B) make a loan or advance to or investment in any third party (other than advancement of expenses to employees in the ordinary course of business), or (C) guarantee or endorse any Indebtedness of the type referred to in clause (A), in each case, except for any such transactions with the Target Companies;

59

(v) establish any Subsidiary or enter into any new line of business;

(vi) acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets in each case;

(vii) make any capital expenditures;

(viii) adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;

(ix) enter into any agreement, understanding or arrangement with respect to its voting or transfer of equity securities;

(x) take any action or knowingly fail to take any action that would reasonably be expected to cause any representation in Section 6.5, Section 6.6, Section 6.10 or Section 6.11 not to be true, correct and complete in all respects as of immediately prior to the First Merger Effective Time; or

(xi) authorize or agree to do any of the foregoing actions.

8.5 Interim Period Control. Nothing contained in this Agreement shall give to any Party, directly or indirectly, the right to control SPAC, PubCo, the Company or any other Target Company or their respective Subsidiaries prior to the Closing Date. Prior to the Closing Date, each of SPAC, PubCo, the Company and each other Target Company shall exercise, consistent with the terms and conditions hereof, complete control and supervision of its respective operations, as required by Law.

8.6 Preparation and Delivery of Additional Company Financial Statements.

(a) The Company shall use commercially reasonable efforts to deliver, by no later than October 31, 2025, true and complete copies of audited consolidated balance sheets and statements of operations, comprehensive income, stockholders’ equity and cash flows of the Target Companies as of and for the years ended December 31, 2023 and December 31, 2024, each audited in accordance with the auditing standards of the PCAOB and which comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant (collectively, the “PCAOB Financial Statements”).

(b) The Company shall use commercially reasonable efforts to deliver, by no later than October 31, 2025, unaudited reviewed consolidated balance sheets and statements of operations, comprehensive income, stockholders’ equity and cash flows of the Target Companies as of and for the six-month periods ending June 30, 2025 and 2024, which comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant (the “InterimFinancial Statements”) and as soon as reasonably practicable, the Company shall deliver to SPAC any other audited or unaudited financial statements of the Target Companies that are required by applicable law to be included in the Registration Statement.

60

8.7 SPAC Public Filings. During the Interim Period, SPAC will keep current and timely file all of its public filings with the SEC (after giving effect to all applicable extension periods) and otherwise comply in all material respects with applicable securities Laws and shall use commercially reasonable efforts to ensure that SPAC remains listed as a public company on, and for the SPAC Securities to remain listed on, Nasdaq. Prior to the Closing Date, SPAC shall cooperate with the other parties and use reasonable best efforts to take such actions as are reasonably necessary or advisable to cause the SPAC Securities to be delisted from Nasdaq and deregistered under the Exchange Act with such delisting and deregistration effective as soon as practicable following the Closing.

8.8 Stock Exchange Listing. Each of SPAC, the Company and PubCo will use its commercially reasonable efforts to cause (a) PubCo’s initial listing application(s) with Nasdaq in connection with the Transactions to have been approved, (b) PubCo to satisfy all applicable initial listing requirements of Nasdaq and (c) the PubCo Ordinary Shares issuable in accordance with this Agreement to be approved for listing on Nasdaq, subject to official notice of issuance, in each case prior to the Closing Date.

8.9 Exclusivity.

(a) For purposes of this Agreement, (i) an “Acquisition Proposal” means any inquiry, proposal or offer, or any indication of interest in making an offer or proposal (whether written or oral), from any Person or group at any time relating to an Alternative Transaction, and (ii) an “Alternative Transaction” means (A) with respect to the Company and the other Target Companies, a transaction (other than the transactions contemplated by this Agreement) concerning the sale (whether directly or indirectly) of (x) all or any part of the business or assets (other than the sale of goods or services in the ordinary course of business consistent with past practice or other immaterial sales of assets) of the Target Companies on a consolidated basis, (y) any of the issued and outstanding shares or other equity interests or profits of the Company, in any case, whether such transaction takes the form of a sale of shares or other equity interests, assets, merger, consolidation, issuance of debt securities, management Contract, joint venture or partnership, or otherwise, or (z) a merger, consolidation, share exchange, business combination, reorganization, recapitalization, liquidation, dissolution or other similar transaction involving the sale or disposition of any of the Target Companies, and (B) with respect to SPAC, a transaction (other than the transactions contemplated by this Agreement) concerning a Business Combination for SPAC.

(b) During the Interim Period, in order to induce the other Parties to continue to commit to expend management time and financial resources in furtherance of the Transactions, each Party shall not, and shall cause its Representatives not to, without the prior written consent of the Company or SPAC, as applicable, directly or indirectly, (i) solicit, initiate or knowingly facilitate or assist the making, submission or announcement of, or intentionally encourage, any Acquisition Proposal, (ii) furnish any non-public information regarding such Party or its Affiliates (or, with respect to the Company, the other Target Companies) or their respective businesses, operations, assets, Liabilities, financial condition, prospects or employees to any Person or group (other than a Party to this Agreement or their respective Representatives) in connection with or in response to an Acquisition Proposal, (iii) engage or participate in discussions or negotiations with any Person or group with respect to, or that would reasonably be expected to lead to, an Acquisition Proposal, (iv) approve, endorse or recommend, or publicly propose to approve, endorse or recommend, any Acquisition Proposal, (v) negotiate or enter into any letter of intent, agreement in principle, acquisition agreement or other similar agreement in furtherance of any Acquisition Proposal, (vi) release any third party from, or waive any provision of, any confidentiality agreement to which such Party is a party, (vii) otherwise knowingly encourage or facilitate any such inquiries, proposals, discussions, or negotiations or any effort or attempt by any Person to consummate an Alternative Transaction or (viii) agree or otherwise commit to enter into or engage in any of the foregoing.

61

(c) Each Party shall notify the others as promptly as practicable (and in any event within forty-eight (48) hours) orally and in writing of the receipt by such Party or any of its Representatives of any bona fide inquiries, proposals or offers, requests for information or requests for discussions or negotiations regarding or constituting any Acquisition Proposal or any bona fide inquiries, proposals or offers, requests for information or requests for discussions or negotiations that would reasonably be expected to result in an Acquisition Proposal, specifying in each case, the material terms and conditions thereof (including a copy thereof if in writing or a written summary thereof if oral) and the identity of the party making such inquiry, proposal, offer or request for information. Each Party shall keep the others promptly informed of the status of any such inquiries, proposals, offers or requests for information. During the Interim Period, each Party shall, and shall cause its Representatives to, immediately cease and cause to be terminated any solicitations, discussions or negotiations with any Person with respect to any Acquisition Proposal and shall, and shall direct its Representatives to, cease and terminate any such solicitations, discussions or negotiations.

8.10 No Trading. The Company and PubCo each acknowledge and agree that it is aware, and that their respective Affiliates are aware (and each of their respective Representatives is aware or, upon receipt of any material non-public information of SPAC, will be advised) of the restrictions imposed by U.S. federal securities Laws and the rules and regulations of the SEC and Nasdaq promulgated thereunder or otherwise (the “Federal Securities Laws”) and other applicable foreign and domestic Laws on a Person possessing material non-public information about a publicly traded company. The Company and PubCo each hereby agree that, while it is in possession of such material non-public information, it shall not purchase or sell any securities of SPAC, communicate such information to any third party, take any other action with respect to SPAC in violation of such Laws, or cause or encourage any third party to do any of the foregoing.

8.11 Notification of Certain Matters. During the Interim Period, each Party shall give prompt notice to the other Parties if such Party or its Affiliates: (a) receives any notice or other communication in writing from any third party (including any Governmental Authority) alleging that the Consent of such third party is required in connection with the Transactions or (b) discovers any fact or circumstance that, or becomes aware of the occurrence of any event the occurrence of which, would cause or would reasonably be expected to cause or result in any of the conditions set forth in Article X not being satisfied or the satisfaction of those conditions being materially delayed. No such notice shall constitute an acknowledgement or admission by the Party providing the notice regarding whether or not any of the conditions to the Closing have been satisfied or in determining whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.

8.12 Regulatory Approvals.

(a) Subject to the terms and conditions of this Agreement, each of SPAC, PubCo and the Company shall use its reasonable best efforts, and shall cooperate fully with such other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws and regulations to consummate the Transactions (including the receipt of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental Authorities applicable to the Transactions, including using its commercially reasonable efforts to (i) prepare and promptly file all documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of information, applications and other documents, (ii) obtain all Permits, Consents, approvals, authorizations, registrations, waivers, qualifications and orders of, and the expiration or termination of waiting periods by, Governmental Authorities to satisfy the consummation of the Transactions and to fulfill the conditions to the Closing and (iii) execute and deliver any additional instruments necessary to consummate the Transactions.

62

(b) In furtherance and not in limitation of Section 8.12(a), to the extent required under the HSR Act or any other Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or that are designed to prohibit, restrict or regulate actions that may risk national security (collectively, “Antitrust Laws”), each of SPAC, PubCo and the Company agrees, and shall cause its Subsidiaries and Affiliates, to make any required filing or application under Antitrust Laws, as applicable, including preparing and making an appropriate filing pursuant to the HSR Act, with respect to the Transactions as promptly as practicable, to supply as promptly as reasonably practicable any additional information and documentary material that may be reasonably requested pursuant to Antitrust Laws and to take all other actions reasonably necessary, proper or advisable to cause the granting of approval or consent by the Governmental Authority as soon as practicable; provided, that, the applicable HSR Act filing fees and any filing fees in connection with any other Antitrust Law shall be paid 50% by SPAC and 50% by the Company. Each of SPAC, PubCo and the Company shall, in connection with its efforts to obtain all requisite approvals and authorizations for the Transactions under any Antitrust Law, use its commercially reasonable efforts to: (i) cooperate in all respects with each other of such Parties or their respective Affiliates in connection with any filing or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private Person, (ii) keep such other Parties reasonably informed of any material communication received by such Party or its Representatives from, or given by such Party or its Representatives to, any Governmental Authority and of any material communication received or given in connection with any proceeding by a private Person, in each case regarding any of the Transactions, (iii) permit a Representative of such other Parties and their respective outside counsel to review any material communication given by it to, and consult with each other in advance of any material meeting or conference with, any Governmental Authority or, in connection with any proceeding by a private Person, with any other Person, and to the extent permitted by such Governmental Authority or other Person, give a Representative or Representatives of such other Parties the opportunity to attend and participate in such meetings and conferences, (iv) in the event a Party’s Representative is prohibited from participating in or attending any meetings or conferences, each attending Party shall keep such Party promptly and reasonably apprised with respect thereto and (v) use reasonable best efforts to cooperate in the filing of any memoranda, white papers, filings, correspondence or other written communications explaining or defending the Transactions, articulating any regulatory, competitive or national security related argument, and responding to requests or objections made by any Governmental Authority.

(c) If any objections are asserted with respect to the Transactions under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable Governmental Authority or any private Person challenging any of the Transactions as violative of any applicable Law or which would otherwise prevent, materially impede or materially delay the consummation of the Transactions, each of SPAC, PubCo and the Company shall use its reasonable best efforts to resolve any such objections or Actions so as to timely permit consummation of the Transactions including in order to resolve such objections or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or materially delay the consummation of the Transactions. In the event any Action is instituted (or threatened to be instituted) by a Governmental Authority or private Person challenging the Transactions, each of SPAC, PubCo and the Company shall, and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective commercially reasonable efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the Transactions.

(d) Prior to the Closing, each of SPAC, PubCo and the Company shall use its reasonable best efforts to obtain any Consents of Governmental Authorities or other third party as may be necessary for the consummation by such Party or its Affiliates of the Transactions or required as a result of the execution or performance of, or consummation of the Transactions, by such Party or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts. With respect to PubCo, during the Interim Period, each of SPAC, PubCo and the Company shall use its commercially reasonable efforts to cause PubCo to qualify as “foreign private issuer” as such term is defined under Exchange Act Rule 3b-4 and to maintain such status through the Closing.

63

8.13 Further Assurances. The Parties shall further cooperate with each other and use their respective commercially reasonable efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their part under this Agreement, the Ancillary Documents and applicable Laws to consummate the Transactions as soon as reasonably practicable, including preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings (including any Tax filings).

8.14 Tax Matters.

(a) Tax Treatment. No Party shall, and no such Person shall cause its Affiliates to, take any action, or knowingly fail to take any action, that would reasonably be expected to prevent or impede the relevant portions of the Transactions from qualifying for the Intended Tax Treatment. Each Party hereby agrees to file, and to cause its Affiliates to file, all applicable Tax Returns on a basis consistent with the Intended Tax Treatment, unless otherwise required by a Governmental Authority as a result of a “determination” within the meaning of Section 1313(a) of the Code (or any similar provision of applicable state, local or non-U.S. Tax Law) or a change in applicable Law. The Parties shall reasonably cooperate with each other and their respective counsel to document and support the Tax treatment of the relevant portions of the Transactions consistent with the Intended Tax Treatment, including providing factual support letters. For the avoidance of doubt, except with respect to any breach of the covenant in Section 8.4(b)(x), the qualification of the relevant portions of the Transactions for the Intended Tax Treatment shall not be a condition to Closing.

(b) Notwithstanding anything to the contrary herein, if, in connection with the preparation and filing of the Registration Statement, the SEC requests or requires that a Tax opinion with respect to U.S. federal income tax consequences of the Transactions be prepared and submitted in connection therewith, and if such a Tax opinion is being provided by a Tax counsel, the Parties hereto shall, and shall cause their Affiliates to, (i) reasonably cooperate in order to facilitate the issuance of any such Tax opinion and (ii) deliver to such Tax counsel, to the extent requested by such counsel, customary Tax representation letters reasonably satisfactory to such counsel and such Party, dated and executed as of the date as determined reasonably necessary by such counsel in connection with the preparation and filing of the Registration Statement; provided, that, notwithstanding anything to the contrary in this Agreement, (x) nothing in this Agreement shall require (1) any counsel or Tax advisor to the Company to provide an opinion with respect to any Tax matters relating to or affecting SPAC or the SPAC Shareholders or (2) any counsel or Tax advisor to SPAC, PubCo or Merger Sub to provide an opinion with respect to any Tax matters relating to or affecting the Company or the holders or beneficial owners of equity or other securities of the Company, including the Company Shareholders and (y) no Party or their counsel or Tax advisors are obligated to provide any opinion that the relevant portions of the Transactions contemplated by this Agreement otherwise qualify for the Intended Tax Treatment (other than, to the extent required by the SEC, a customary opinion regarding the U.S. federal income tax considerations of such Transactions included in the Proxy Statement and Registration Statement as may be required to satisfy applicable rules and regulations promulgated by the SEC); provided, further, that, for the avoidance of doubt, neither this Section 8.14(b) nor any other provision in this Agreement shall require the provision of a Tax opinion by any Party’s counsel or advisors to be an express condition precedent to the Closing.

(c) Certain Pre-Closing and Post-Closing Tax Actions.

(i) Neither the Company (including, for the avoidance of doubt, the Second Surviving Company after the Second Merger) nor Air Water UK shall undertake (or cause to be undertaken) the transfer of any of their cash or other assets to (or for the benefit of) any Target Company (other than pursuant to an arm’s length loan) at least until after a date that is two (2) years after the date that includes the Second Merger Effective Time; provided, that each of the Company and Air Water UK may transfer any of their cash or other assets to (A) each other, in which case, the further transfer of such cash or other assets shall be subject to this Section 8.14(c)(i), and (B) after the Second Merger Effective Time, PubCo, in which case, the further transfer of such cash or other assets shall be subject to Section 8.14(c)(ii). For the avoidance of doubt, this Section 8.14(c)(i) shall not apply to any transfer that occurs solely by virtue of the Second Merger.

64

(ii) PubCo shall not undertake (or cause to be undertaken) the transfer of any of its cash or other assets (including, for the avoidance of doubt, any amount in the Trust Account) to (or for the benefit of) any Target Company (other than pursuant to an arm’s length loan) at least until after a date that is two (2) years after the date that includes the Second Merger Effective Time; provided, that PubCo may transfer any of its cash or other assets to the Second Surviving Company or Air Water UK, in which case, the further transfer of such cash or other assets shall be subject to Section 8.14(c)(i).

(iii) Neither Air Water UK nor Merger Sub (including, for the avoidance of doubt, the Second Surviving Company after the Second Merger) shall elect to be treated (or convert or otherwise reorganize into an entity treated) as a corporation for U.S. federal income tax purposes at least until after a date that is two (2) years after the date that includes the Second Merger Effective Time.

(d) Transfer Taxes. All transfer, documentary, sales, use, stamp, registration, excise, recording, registration, VAT, non-resident capital gains and other such similar Taxes, fees and costs (“Transfer Taxes”) that become payable by any of the Parties in connection with the Transactions shall constitute Company Transaction Expenses (if incurred by or on behalf of the Company or any other Target Company) or SPAC Transaction Expenses (if incurred by or on behalf of the SPAC). The Party responsible for filing any necessary Tax Returns with respect to Transfer Taxes under applicable Law shall cause such Tax Returns to be filed within the time limits required by applicable Law, and if required by applicable Law, the other Parties shall join in the execution of any such Tax Returns.

(e) Following the Closing Date, PubCo and the Company shall reasonably cooperate with the SPAC Shareholders to make available to any such SPAC Shareholder who so requests information reasonably necessary for such SPAC Shareholder (or its direct or indirect owners) to timely compute any income or gain arising (i) if applicable, as a result of the status of SPAC or PubCo as a “passive foreign investment company” within the meaning of Section 1297(a) of the Code or a “controlled foreign corporation” within the meaning of Section 957(a) of the Code for any taxable period ending in, with or prior to the taxable year in which Closing occurs, including timely (A) publicly posting a PFIC Annual Information Statement to enable such SPAC Shareholder (or their direct or indirect owners) to make a “Qualifying Electing Fund” election under Section 1295 of the Code for such taxable period, and (B) providing information to enable applicable SPAC Shareholders (or their direct or indirect owners) to report their allocable share of “subpart F” income under Section 951 of the Code for such taxable period and (ii) under Section 367(a) of the Code and the Treasury Regulations promulgated thereunder as a result of the Transactions.

(f) Any reference in this Section 8.14 to any Person shall be deemed to also include a reference to any successor of such Person.

65

8.15 The Registration Statement; Special Shareholder Meeting.

(a) As promptly as reasonably practicable after the date hereof, SPAC, the Company and PubCo shall jointly prepare, and PubCo shall file with the SEC a registration statement on Form F-4 (as amended or supplemented from time to time, and including the Proxy Statement contained therein, the “Registration Statement”) in connection with the registration under the Securities Act of the PubCo Ordinary Shares, PubCo Preferred Shares and PubCo Series A Investor Warrants to be issued in connection with the Mergers, which Registration Statement will also contain a proxy statement of SPAC (as amended or supplemented, including any prospectus contained therein, the “ProxyStatement”) for the purpose of soliciting proxies or votes from SPAC Shareholders for the matters to be acted upon at the Special Shareholder Meeting and providing SPAC Shareholders an opportunity in accordance with the SPAC Charter and the IPO Prospectus to exercise their Redemption Rights. The Proxy Statement shall include proxy materials for the purpose of soliciting proxies from SPAC Shareholders to vote, at an extraordinary general meeting of SPAC Shareholders to be called and held for such purpose (including any adjournment or postponement thereof, the “Special Shareholder Meeting”), in favor of resolutions approving (i) as an ordinary resolution, the adoption and approval of this Agreement, the Mergers and the other Transactions by SPAC Shareholders in accordance with SPAC’s Organizational Documents, the Cayman Companies Law and the rules and regulations of the SEC and Nasdaq (including any items required by Laws to effect the Mergers and any other proposals as are required to implement the foregoing), (ii) as a special resolution, the entry into the First Plan of Merger, (iii) as an ordinary resolution (or if required by applicable Law or the SPAC Charter, as a special resolution) the adoption and approval of any other proposals as the SEC may indicate are necessary in its comments to the Registration Statement or correspondence related thereto, (iv) as an ordinary resolution (or if required by applicable Law or the SPAC Charter, as a special resolution) the adoption and approval of such other matters as the Company and SPAC shall hereafter mutually determine to be necessary or appropriate in order to effect the Transactions (the approvals described in foregoing clauses (i) to (iv), collectively, the “Shareholder Approval Matters”) and (v) the adjournment of the Special Shareholder Meeting, if necessary or desirable in the reasonable determination of SPAC in consultation with PubCo.

(b) SPAC, acting through its board of directors (or a committee thereof), shall (i) make the SPAC Board Recommendation and include such SPAC Board Recommendation in the Proxy Statement, (ii) cause the Proxy Statement to be mailed to SPAC Shareholders in accordance with SPAC’s Organizational Documents as promptly as practicable following the date upon which the Registration Statement is declared effective under the Securities Act (the “Registration Statement Effective Date”) and (iii) use its commercially reasonable efforts to solicit from its shareholders proxies or votes in favor of the approval of the Shareholder Approval Matters. If, on the date for which the Special Shareholder Meeting is scheduled, SPAC has not received proxies and votes representing a sufficient number of shares to obtain the Shareholder Approval Matters, SPAC may, in consultation with PubCo and in accordance with the SPAC Charter, make one or more successive postponements, or with the consent of the Special Shareholder Meeting, adjournments of the Special Shareholder Meeting, subject to applicable Law and the SPAC Charter; provided that when the Special Shareholder Meeting is postponed or adjourned for thirty days or more, notice of the postponed or adjourned meeting shall be given as in the case of an original meeting. In connection with the Registration Statement, SPAC and PubCo will file with the SEC financial and other information about the Transactions in accordance with applicable Law, SPAC’s Organizational Documents, the Cayman Companies Law and the rules and regulations of the SEC and Nasdaq.

(c) SPAC, the Company and PubCo shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange Act and other applicable Laws in connection with the Registration Statement, the Special Shareholder Meeting and the Redemption Rights. Each of SPAC, PubCo and the Company shall, and shall cause each of its Subsidiaries to, make their respective directors, officers and employees, upon reasonable advance notice, available to the Company, PubCo, SPAC and their respective Representatives in connection with the drafting of the public filings with respect to the Transactions, including the Registration Statement, and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any information provided by it for use in the Registration Statement (and other related materials) if and to the extent that such information has become false or misleading in any material respect or as otherwise required by applicable Laws. SPAC, the Company and PubCo shall amend or supplement the Registration Statement and PubCo shall file the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated to SPAC Shareholders, in each case as and to the extent required by applicable Laws and subject to the terms and conditions of this Agreement and SPAC’s Organizational Documents. No filing of, or amendment or supplement to the Registration Statement will be made by SPAC, PubCo or the Company without the approval of the other of such Parties (such approval not to be unreasonably withheld, conditioned or delayed).

66

(d) Each of SPAC, PubCo and the Company shall, as promptly as practicable after receipt thereof, supply each other such Party or Parties with copies of all material written correspondence between it or any of its Representatives, on the one hand, and the SEC or its staff, on the other hand, or, if not in writing, a written summary of such material communication, with respect to the Registration Statement or the Transactions. No response to any comments from the SEC or its staff relating to the Registration Statement or the Transactions will be made by PubCo, the Company or SPAC without the prior consent of such other Parties (such consent not to be unreasonably withheld, conditioned or delayed), and without providing such other Parties a reasonable opportunity to review and comment thereon. Notwithstanding the foregoing, SPAC, the Company and PubCo, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall otherwise use their commercially reasonable efforts to cause the Registration Statement to “clear” comments from the SEC and become effective.

(e) SPAC, in consultation with PubCo, shall call the Special Shareholder Meeting in accordance with the SPAC’s Organizational Documents for a date that is no later than 30 Business Days following the effectiveness of the Registration Statement or such other date as agreed between SPAC and Company.

(f) SPAC shall comply with all applicable Laws, any applicable rules and regulations of Nasdaq, SPAC’s Organizational Documents and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder, the calling and holding of the Special Shareholder Meeting and the Redemption Rights.

(g) All expenses incident to the Company’s filing of the Registration Statement pursuant to this Section 8.15 (including, without limitation, all registration, qualification and filing fees, printing expenses, transfer agent fees and expenses, travel expenses, messenger and delivery expenses, fees and disbursements of custodians, and fees and disbursements of counsel, all independent certified public accountants, underwriters and other Persons retained by the Company and SPAC, in each case, including any VAT thereon), shall be paid 50% by the Company and 50% by SPAC.

8.16 Public Announcements.

(a) The Parties agree that, during the Interim Period, no public release, filing or announcement concerning this Agreement or the Ancillary Documents or the Transactions shall be issued by any Party or any of their Affiliates without the prior written consent (not be unreasonably withheld, conditioned or delayed) of SPAC, PubCo and the Company, except as such release, filing or announcement may be required by applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable efforts to allow the other Parties reasonable time to have the opportunity to comment on, and arrange for any required filing with respect to, such release, filing or announcement in advance of such issuance.

(b) SPAC and the Company shall mutually agree upon and, as promptly as practicable after the execution of this Agreement, issue a joint press release announcing the execution of this Agreement (the “Signing Press Release”). Promptly after the issuance of the Signing Press Release, SPAC shall file a current report on Form 8-K (the “Signing Filing”) with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall have the opportunity to review, comment upon and approve prior to filing (which approval shall not be unreasonably withheld, conditioned or delayed). SPAC and the Company shall mutually agree upon and, as promptly as practicable after the Closing, issue a joint press release announcing the consummation of the Transactions (the “Closing Press Release”). Promptly after the issuance of the Closing Press Release, PubCo shall file a shell company report on Form 20-F (the “Closing Filing”) with the Closing Press Release and a description of the Transactions as required by Federal Securities Laws which SPAC shall have the opportunity to review, comment upon and approve prior to filing (which approval shall not be unreasonably withheld, conditioned or delayed).

67

8.17 Confidential Information.

(a) The Company and PubCo agree that during the Interim Period and, in the event this Agreement is terminated in accordance with Article XI, for a period of two (2) years after such termination, they shall, and shall cause their respective Affiliates and Representatives to: (i) treat and hold in strict confidence any SPAC Confidential Information that is provided to such Person or its Affiliates or Representatives, and will not use for any purpose (except in connection with the consummation of the Transactions, performing their obligations hereunder or thereunder or enforcing their rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make available to any third party any of the SPAC Confidential Information without SPAC’s prior written consent, and (ii) in the event that the Company, PubCo or any of their respective Affiliates or Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with Article XI, for a period of two (2) years after such termination, becomes legally compelled to disclose any SPAC Confidential Information, (A) provide SPAC, to the extent legally permitted, with prompt written notice of such requirement so that SPAC may seek, at SPAC’s sole expense, a protective Order or other remedy or waive compliance with this Section 8.17(a), and (B) in the event that such protective Order or other remedy is not obtained, or SPAC waives compliance with this Section 8.17(a), furnish only that portion of such SPAC Confidential Information which is legally required to be provided as advised by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such SPAC Confidential Information. In the event that this Agreement is terminated and the Transactions are not consummated, the Company, and PubCo shall, and shall cause their respective Affiliates and Representatives to, promptly deliver to SPAC or destroy (at SPAC’s election) any and all copies (in whatever form or medium) of SPAC Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon. Notwithstanding the foregoing, (1) PubCo and its Representatives shall be permitted to disclose any and all SPAC Confidential Information to the extent required by the applicable Laws as advised by outside counsel, and (2) PubCo shall, and shall cause its Representatives to, treat and hold in strict confidence any Trade Secret of SPAC disclosed to such Person until such information ceases to be a Trade Secret.

(b) SPAC hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with Article XI, for a period of two (2) years after such termination, it shall, and shall cause its Affiliates and Representatives to: (i) treat and hold in strict confidence any Company Confidential Information that is provided to such Person or its Affiliates or Representatives, and will not use for any purpose (except in connection with the consummation of the Transactions, performing its obligations hereunder or thereunder or enforcing its rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make available to any third party any of the Company Confidential Information without the Company’s prior written consent, and (ii) in the event that SPAC or any of its Affiliates or Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with Article XI, for a period of two (2) years after such termination, becomes legally compelled to disclose any Company Confidential Information, (A) provide the Company to the extent legally permitted with prompt written notice of such requirement so that the Company may seek, at the Company’s sole expense, a protective Order or other remedy or waive compliance with this Section 8.17(b) and (B) **** in the event that such protective Order or other remedy is not obtained, or the Company waives compliance with this Section 8.17(b), furnish only that portion of such Company Confidential Information which is legally required to be provided as advised by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Company Confidential Information. In the event that this Agreement is terminated and the Transactions are not consummated, SPAC shall, and shall cause its Affiliates or Representatives to, promptly deliver to the Company or destroy (at SPAC’s election) any and all copies (in whatever form or medium) of Company Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon. Notwithstanding the foregoing, (1) SPAC and its Affiliates or Representatives shall be permitted to disclose any and all Company Confidential Information to the extent required by the applicable Laws as advised by outside counsel, and (2) SPAC shall, and shall cause its Affiliates or Representatives to, treat and hold in strict confidence any Trade Secret of the Company disclosed to such Person until such information ceases to be a Trade Secret.

68

8.18 Indemnification of Directors and Officers; Tail Insurance.

(a) The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former directors and officers of each Target Company, PubCo, and SPAC and each Person who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of the applicable Party (the “D&O Indemnified Persons”) as provided in the Organizational Documents of each Target Company, PubCo and SPAC or under any indemnification, employment or other similar agreements between any D&O Indemnified Person, on the one hand, and any Target Company, PubCo or SPAC, on the other hand, in each case as in effect on the date of this Agreement, shall survive the Closing and continue in full force and effect in accordance with their respective terms to the extent permitted by applicable Law. For a period of six (6) years after the Closing, PubCo shall cause the Organizational Documents of each Target Company, PubCo, and the Second Surviving Company to contain provisions no less favorable with respect to exculpation and indemnification of and advancement of expenses to D&O Indemnified Persons than are set forth as of the date of this Agreement in the Organizational Documents of the applicable Party to the extent permitted by applicable Law. The provisions of this Section 8.18 shall survive the Closing and are intended to be for the benefit of, and shall be enforceable by, each of the D&O Indemnified Persons and their respective heirs and Representatives.

(b) For the benefit of SPAC’s directors and officers, SPAC shall be permitted, prior to the Closing, to obtain and fully pay the premium for a “tail” insurance policy that provides coverage for up to a six (6) year period from and after the Closing for events occurring prior to the Closing (the “SPAC D&O Tail Insurance”) that is substantially equivalent to and in any event not less favorable in the aggregate than SPAC’s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, PubCo and the First Surviving Company shall, for a period of six (6) years after the Closing, maintain the SPAC D&O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and PubCo and the First Surviving Company shall timely pay or cause to be paid all premiums with respect to the SPAC D&O Tail Insurance.

(c) For the benefit of the Company’s directors and officers, the Company shall be permitted, prior to Closing, to obtain and fully pay the premium for a “tail” insurance policy that provides coverage for up to a six (6) year period from and after the Closing for events occurring prior to the Closing (the “Company D&O Tail Insurance”) that is substantially equivalent to and in any event not less favorable in the aggregate than the Company’s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, PubCo and the Second Surviving Company shall, for a period of six (6) years after the Closing, maintain the Company D&O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and PubCo and the Second Surviving Company shall timely pay or cause to be paid all premiums with respect to the Company D&O Tail Insurance.

8.19 SPAC Transaction Expenses; Trust Account Proceeds.

(a) No later than three (3) Business Days prior to the Closing, SPAC shall deliver to the Company a statement setting forth SPAC’s good faith calculation of (i) the aggregate amount of cash proceeds that will be required to satisfy any exercise of Redemption Rights, (ii) the estimated amount of SPAC’s cash on hand, including in the Trust Account, as of the Closing, and (iii) the estimated amount of unpaid SPAC Transaction Expenses as of the Closing. Following its delivery, SPAC shall reasonably cooperate with and provide the Company and its Representatives all information reasonably requested by the Company or any of its Representatives related to such statement.

69

(b) The Parties agree that, simultaneously with or as promptly as practicable after the Closing, the funds held by the Second Surviving Company either in or outside of the Trust Account, after taking into account payments by SPAC for the Redemption Rights (collectively, the “ClosingCash”), shall be used to pay (i) first, the accrued SPAC Transaction Expenses, including SPAC’s deferred expenses (including fees or commissions payable to the underwriters and any legal fees, in each case, including any VAT) of the IPO, without double-counting with any accrued SPAC Transaction Expenses that have already been paid prior to the Closing, (ii) second, any loans owed by SPAC to the Sponsor for SPAC Transaction Expenses (including deferred SPAC Transaction Expenses), other administrative costs and expenses (including any VAT) incurred by or on behalf of SPAC, and (iii) third, any remaining cash will be distributed to PubCo. PubCo will be permitted to use any remaining cash received for working capital and general corporate purposes, or for any other use as directed by PubCo; provided, that in no event shall PubCo (x) utilize any such remaining cash to pay any Company Transaction Expenses or (y) transfer any such remaining cash to any Target Company other than the Second Surviving Company or Air Water UK; provided, however, that PubCo may in any event loan amounts to any Target Company so long as such loan is made on arms-length terms. Such amounts, as well as any fees, costs and expenses that are required or permitted to be paid by the issuance of PubCo Securities, will be paid or issued, as applicable, at the Closing.

8.20 New Registration Rights Agreement. Concurrently with the Closing, (a) SPAC and the Sponsor shall terminate the registration rights agreement, dated as of April 24, 2025, as it may be amended, by and between SPAC and Sponsor and the other parties thereto pursuant to a termination agreement in a form reasonably acceptable to the Company and (b) PubCo, the Company Shareholders, the Sponsor and the other parties contemplated therein shall enter into a registration rights agreement in substantially the form attached as Exhibit I hereto (the “New Registration Rights Agreement”).

8.21 Lock-Up Agreements. At the Closing, (a) each holder of Company Ordinary Shares as of immediately prior to the Second Merger Effective Time shall enter into a Lock-Up Agreement with PubCo in substantially the form attached as Exhibit J-1 hereto, and (b) Sponsor shall enter into a Lock-Up Agreement with PubCo in substantially the form attached hereto as Exhibit J-2 (each, a “Lock-Up Agreement”).

8.22 PubCo Equity Incentive Plan; PubCo ESPP; Section 280G.

(a) As soon as reasonably practicable following the date of this Agreement, SPAC, the Company and PubCo shall use commercially reasonable efforts to agree to the material terms of a new equity incentive plan to be adopted no later than the Closing (the “PubCo Equity IncentivePlan”); provided that the material terms of such PubCo Equity Incentive Plan shall be agreed by no later than the date of filing of the Registration Statement with the SEC in accordance with Section 8.15(a).

(b) As soon as reasonably practicable following the date of this Agreement, SPAC, the Company and PubCo shall use commercially reasonable efforts to agree to the material terms of a new employee share purchase plan to be adopted no later than the Closing (the “PubCo ESPP”); provided that the material terms of such PubCo ESPP shall be agreed by no later than the date of filing of the Registration Statement with the SEC in accordance with Section 8.15(a).

70

(c) The PubCo Equity Incentive Plan and the PubCo ESPP, taken together, shall provide for an initial aggregate share reserve thereunder equal to an amount no greater than 5.0% of PubCo’s issued share capital as of immediately after Closing, increased by the number of PubCo Ordinary Shares reasonably necessary to settle Exchanged RSUs and Exchanged PSUs.

(d) To the extent required to avoid the imposition of Taxes under Section 4999 of the Code and/or the loss of deductions under Section 280G of the Code, in each case, with respect to any payment or benefit that could constitute a “parachute payment” under Section 280G of the Code with respect to the transactions contemplated by this Agreement and any events closely associated therewith, the Company shall use best efforts to ensure that each Person who is a “disqualified individual” (within the meaning of Section 280G of the Code and the Treasury Regulations promulgated thereunder) (each, a “Disqualified Individual”) shall execute a waiver of such Disqualified Individual’s right to receive any payments and/or benefits in connection with the transactions contemplated by this Agreement and any events closely associated therewith that could reasonably be expected to constitute “parachute payments” pursuant to Section 280G of the Code (such waived portion of any payments and/or benefits, “Waived 280G Benefits”), such that all remaining payments and/or benefits applicable to such Disqualified Individual shall not be deemed to be “parachute payments” pursuant to Section 280G of the Code (“Section 280G Payments”). No later than the day prior to the Closing, the Company shall submit to the applicable shareholders entitled to vote a written consent to the payments and benefits due in connection with the Transactions, as disclosed therein (the “Section 280G Vote”). Any such shareholder approval shall be sought in a manner that complies with Section 280G(b)(5)(B) of the Code and the Treasury Regulations thereunder. At least five (5) Business Days prior to Section 280G Vote, the Company shall provide SPAC with drafts of the documentation relating to the 280G Vote, including (i) the shareholder consent, (ii) the disclosure statement, (iii) the form of waiver, and (iv) a written analysis or spreadsheet showing the calculations of potential “parachute payments” (the “Section 280G Materials”). Upon delivery of the drafts of the Section 280G Materials, SPAC shall review and comment on all such materials, which comments the Company shall consider in good faith and incorporate any of SPAC’s reasonable comments thereto. To the extent that any arrangements are entered into at the direction of SPAC or between SPAC and its Affiliates, on the one hand, and a Disqualified Individual, on the other hand, following the date hereof (“SPAC Arrangements”), the Company shall include such SPAC Arrangements in the parachute payment analysis to the extent informed of such SPAC Arrangements at least five (5) Business Days prior to the Section 280G Vote and SPAC shall cooperate with the Company in good faith in order to calculate or determine the value (for the purposes of Section 280G of the Code) of any payments or benefits granted or contemplated therein, which may be paid or granted in connection with the transactions contemplated by this Agreement that could constitute a “parachute payment.” For the avoidance of doubt, (a) the Company shall not be required to provide any additional value to a Disqualified Individual in order to receive a waiver of the applicable payments and (b) the Company’s failure to obtain shareholder approval of the Waived 280G Benefits shall not constitute a breach of this Section 8.22. Prior to the Closing, the Company shall deliver to SPAC evidence that the Section 280G Vote was solicited in accordance with the foregoing provisions of this Section 8.22 and notification that either (i) shareholder approval was obtained, or (ii) shareholder approval was not obtained and, as a consequence, the Waived 280G Benefits shall not be made or provided. For clarity, to the extent that the preceding clause (ii) applies and all or any portion of the Waived 280G Benefits include the Company RSUs, then any Company RSUs which are not paid or provided on account of the preceding clause (ii) shall not be treated as issued and outstanding immediately prior to the Second Merger Effective Time, including for purposes of Section 2.2(a)(ii) and Section 22.2(e).

71

8.23 Litigation.

(a) In the event that any Action related to this Agreement or the Transactions is brought, or, to the Knowledge of SPAC, threatened, against SPAC or the SPAC Board by any of SPAC’s shareholders prior to the Closing, SPAC shall promptly notify the Company of any such Action and keep the Company reasonably informed with respect to the status thereof. SPAC shall provide the Company the opportunity to participate in (subject to a customary joint defense agreement), but not control, the defense of any such Action shall give due consideration to the Company’s advice with respect to such Action and shall not settle or agree to settle any such Action without the prior written consent of the Company, such consent not to be unreasonably withheld, conditioned or delayed.

(b) In the event that any Action related to this Agreement or the Transactions is brought, or, to the Knowledge of PubCo or the Company, threatened, against PubCo or the Company or the Company Board by any Company Shareholders prior to the Closing, PubCo or the Company shall promptly notify SPAC of any such Action and keep SPAC reasonably informed with respect to the status of thereof. The Company shall provide SPAC the opportunity to participate in (subject to a customary joint defense agreement), but not control, the defense of any such Action, shall give due consideration to SPAC’s advice with respect to such Action and shall not settle or agree to settle any such Action without the prior written consent of SPAC, such consent not to be unreasonably withheld, conditioned or delayed.

8.24 Termination of SPAC Agreements. Prior to the Closing, SPAC shall terminate pursuant to a Contract reasonably acceptable to the Company each Contract listed in Section 4.15 of the SPAC Disclosure Schedules and Section 8.24 of the SPAC Disclosure Schedules, without the payment of any consideration or the granting of any concession, and without any liability being imposed on PubCo, the Second Surviving Company or any of their respective Subsidiaries or any of them having any continuing obligations.

8.25 FIRPTA Certificate. Prior to the Second Merger Effective Time, (a) to the extent permitted under applicable Law, the Company shall deliver to PubCo a certificate signed by an officer of Air Water US, prepared in a manner consistent and in accordance with the requirements of Treasury Regulations Sections 1.897-2(g), (h) and 1.1445-2(c)(3), certifying that no interest in Air Water US is, or has been during the relevant period specified in Section 897(c)(1)(A)(ii) of the Code, a “United States real property interest” within the meaning of Section 897(c) of the Code, and a form of notice to the U.S. Internal Revenue Service prepared in accordance with the provisions of Treasury Regulations Section 1.897-2(h)(2), (b) if as of such date an interest in Air Water US is a USRPI, the Company shall prepare appropriate documentation, to the extent permitted under applicable Law, pursuant to which the Second Merger shall be treated as a nonrecognition transaction for purposes of Sections 897 and 1445 of the Code, and (c) if as of such date an interest in Air Water US is a USRPI and the Second Merger doesn’t qualify as a nonrecognition transaction for purposes of Section 897 and 1445 of the Code, the Company shall provide information regarding the amount of any resulting Tax pursuant to Sections 882 and 897 of the Code and any required withholding pursuant to Section 1445 of the Code; provided, that this Section 8.25 shall not apply to the extent the Air Water US Reorganization is consummated prior to the Second Merger and the Second Merger does not result in a transfer of any interest in Air Water US for U.S. federal income tax purposes.

72

8.26 PIPE Investment. Each of the Company and SPAC shall use, and shall cause its Affiliates to use their, commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary, proper or advisable to consummate the PIPE Investment, including using its, and causing its Affiliates to use their, commercially reasonable efforts to (a) enforce its or their rights under the PIPE Agreements, (b) cause the PIPE Investors to pay to (or as directed by) the Company, the applicable purchase price under each PIPE Investor’s applicable PIPE Agreement in accordance with its terms and (c) satisfy their obligations under each PIPE Investors’ applicable PIPE Agreement and the conditions of closing contained in each PIPE Investor’s applicable PIPE Agreement. The Company will not amend the PIPE Agreements or waive any provision thereto in any manner that is materially and disproportionately adverse to SPAC without the prior written consent of SPAC.

8.27 Company Shareholder Approval. The Company shall, in accordance with the Cayman Companies Law and the Organizational Documents of the Company, (i) promptly following the Registration Statement Effective Date (and in any event within five (5) Business Days after the Registration Statement Effective Date) use its reasonable best efforts to solicit and obtain the Company Shareholder Approval by way of unanimous written resolution (the “Written Resolution”) or (ii) in the event the Company is not able to obtain the Written Resolution, the Company shall duly and promptly convene a meeting of the Company Shareholders for the purpose of voting solely upon the Company Shareholder Matters. The Company shall promptly notify SPAC upon receipt of the Company Shareholder Approval. The Company covenants that the Company Board shall not (and no committee or subgroup thereof shall) withdraw or modify, or propose publicly or by formal action of the Company Board to withdraw or modify, in a manner adverse to SPAC, the Company Board Recommendation.

8.28 Other Matters. The Company shall use reasonable best efforts to effect the transfer of (a) all of the equity securities in (i) AWC Air Water LLC currently held by Alexander David Guy and (i) A1Rwater General Trading Co. LLC currently held by Robert Simpson Bain, in each case, in favor of Air Water Units Trading Ltd., to Air Water Units Trading Ltd. prior to the Closing, and (b) each domain name listed on item 9 of Schedule 6.20 from Alexander David Guy to the Company or one of its Subsidiaries prior to the Closing.

Article IX

SURVIVAL

9.1 Survival. None of the representations, warranties, covenants, obligations or other agreements in this Agreement, any Ancillary Document or in any certificate, statement or instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such representations, warranties, covenants, obligations, agreements and other provisions, shall survive the Closing and all such representations, warranties, covenants, obligations or other agreements shall terminate and expire upon the occurrence of the Closing (and there shall be no liability after the Closing in respect thereof), except for (a) those covenants, obligations and agreements contained herein or therein that by their terms expressly apply in whole or in part after the Closing (including, for the avoidance of doubt, Section 8.14) and then only with respect to any breaches occurring after the Closing, (b) Article XIII and any corresponding definitions set forth in Article XIV and (c) Fraud Claims.

73

Article X

CONDITIONS TO OBLIGATIONS OF THE PARTIES

10.1 Conditions to Each Party’s Obligations. The obligations of each Party to consummate the Transactions shall in all respects be subject to the satisfaction or written waiver (where permissible) by the Company and SPAC of the following conditions:

(a) RequiredSPAC Shareholder Approval. The Shareholder Approval Matters shall have been submitted to the vote of SPAC Shareholders at the Special Shareholder Meeting in accordance with the Proxy Statement and shall have been approved and adopted by the requisite vote of SPAC Shareholders at the Special Shareholder Meeting in accordance with the Proxy Statement, SPAC’s Organizational Documents and the applicable provisions of the Cayman Companies Law and Nasdaq (the “Required Shareholder Approval”).

(b) RequiredCompany Shareholder Approval. The Company Shareholder Approval shall have been obtained.

(c) NoLaw or Order. No Governmental Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) or Order that is then in effect and which has the effect of making the Transactions illegal or otherwise prohibiting consummation of the Transactions (a “Legal Restraint”).

(d) Antitrust. If applicable, the HSR waiting period has expired or been terminated.

(e) Listing. The PubCo Ordinary Shares shall have been conditionally approved for listing on Nasdaq, subject only to official notice thereof.

(f) RegistrationStatement. The Registration Statement shall have become effective in accordance with the provisions of the Securities Act, no stop order shall have been issued by the SEC which remains in effect with respect to the Registration Statement, and no proceeding seeking such a stop order shall have been threatened or initiated by the SEC and not withdrawn.

10.2 Conditions to Obligations of the Company. In addition to the conditions specified in Section 10.1, the obligations of the Company to consummate the Transactions are subject to the satisfaction or written waiver (by the Company, where permissible) of the following conditions:

(a) Representationsand Warranties.

(i) All of the SPAC Fundamental Warranties shall be true and correct in all material respects on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been so true and correct as of such date).

(ii) The representations and warranties of SPAC contained in Section 4.5 shall be true and correct (except for de minimis inaccuracies) on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been so true and correct as of such date).

74

(iii) All of the other representations and warranties of SPAC set forth in this Agreement shall be true and correct on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for (A) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been true and correct as of such date, subject to clause (B) of this Section 10.2(a)(iii)) and (B) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect or similar), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on SPAC.

(iv) All of the Merger Sub Fundamental Warranties shall be true and correct in all material respects on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been so true and correct as of such date).

(v) All of the other representations and warranties of Merger Sub set forth in this Agreement shall be true and correct on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for (A) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been true and correct as of such date, subject to clause (B) of this Section 10.2(a)(v)), and (B) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect or similar), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on Merger Sub.

(b) Agreementsand Covenants. SPAC shall have performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under this Agreement to be performed or complied with by it on or prior to the Closing Date.

(c) OfficerCertificate. SPAC shall have delivered to the Company a certificate, dated as of the Closing Date, signed by an officer of SPAC, certifying as to the satisfaction of the conditions specified in Section 10.2(a), Section 10.2(b) and Section 10.2(d).

(d) NoMaterial Adverse Effect. No Material Adverse Effect shall have occurred with respect to SPAC since the date of this Agreement which is continuing and uncured.

(e) TrustAccount. SPAC shall have made all necessary and appropriate arrangements with the Trustee to have all of the funds held in the Trust Account disbursed to SPAC in accordance with this Agreement on the Closing Date, and all such funds released from the Trust Account shall be available to the First Surviving Company.

(f) AncillaryDocuments. A counterpart to the Ancillary Documents required to be executed by SPAC at or prior to the Closing Date shall have been executed and delivered to the Company.

75

10.3 Conditions to Obligations of SPAC. In addition to the conditions specified in Section 10.1, the obligations of SPAC to consummate the Transactions are subject to the satisfaction or written waiver (by SPAC where permissible) of the following conditions:

(a) Representationsand Warranties.

(i) All of the Company Fundamental Warranties shall be true and correct in all material respects on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for those representations and warranties that address matters only as of particular date (which representations and warranties shall have been so true and correct as of the such date).

(ii) The representations and warranties of the Company contained in Section 7.3 shall be true and correct (except for de minimisinaccuracies) on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been so true and correct as of such date).

(iii) All of the other representations and warranties of the Company set forth in this Agreement shall be true and correct on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for (A) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been true and correct as of such date, subject to clause (B) of this Section 10.3(a)(iii)) and (B) other than representations and warranties set forth in Section 7.8(b), any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect or similar), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on the Company.

(iv) All of the PubCo Fundamental Warranties shall be true and correct in all material respects on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been so true and correct as of such date).

(v) All of the other representations and warranties of PubCo set forth in this Agreement shall be true and correct on and as of the date of this Agreement and the Closing Date as if made on the Closing Date, except for (A) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been true and correct as of such date, subject to clause (B) of this Section 10.3(a)(v)), and (B) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect or similar), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on PubCo.

(b) Agreementsand Covenants. Each of the Company and PubCo shall have performed in all material respects all of their respective obligations and complied in all material respects with all of their respective agreements and covenants under this Agreement to be performed or complied with by them on or prior to the Closing Date.

(c) OfficerCertificate. The Company shall have delivered to SPAC a certificate, dated as of the Closing Date, signed by an officer of each of the Company and PubCo, certifying as to the satisfaction of the conditions specified in Section 10.3(a), Section 10.3(b) and Section 10.3(d), but in each case, solely with respect to themselves.

76

(d) NoMaterial Adverse Effect. No Material Adverse Effect shall have occurred with respect to the Company since the date of this Agreement which is continuing and uncured.

(e) AncillaryDocuments. A counterpart to the Ancillary Documents required to be executed by the Company and PubCo at or prior to the Closing shall have been executed and delivered to the SPAC.

(f) Payoff. All of the indebtedness due and outstanding under the Contracts listed on Section 7.7(e) of the Company Disclosure Schedules will have been discharged in full.

10.4 Frustration of Conditions. Notwithstanding anything contained herein to the contrary, no Party may rely on the failure of any condition set forth in this Article X to be satisfied if such failure was caused by the failure of such Party or its Affiliates (or with respect to the Company, any Target Company, the Company Shareholders, or PubCo) to comply with or perform any of its covenants or obligations set forth in this Agreement.

Article XI

TERMINATION AND EXPENSES

11.1 Termination. This Agreement may be terminated and the Transactions may be abandoned at any time prior to the Closing Date, notwithstanding receipt of any requisite approval and adoption of this Agreement and the Transactions by the shareholders of any Party, as follows:

(a) by mutual written consent of SPAC and the Company;

(b) by written notice by either SPAC or the Company to the other if any of the conditions set forth in Article X have not been satisfied or waived by August 25, 2026 (the “Outside Date”); provided, however, that the right to terminate this Agreement under this Section 11.1(b) shall not be available to a Party if the breach or violation by such Party or its Affiliates (or with respect to the Company, the Company Shareholders or PubCo) of any representation, warranty, covenant or obligation under this Agreement was the principal cause of the failure of a condition set forth in Article X on or before the Outside Date; provided, further, that, the “Outside Date” shall automatically be extended by one (1) calendar day for each day after October 31, 2025 that the PCAOB Financial Statements or the Interim Financial Statements are not delivered pursuant to Section 8.6;

(c) by written notice by either SPAC or the Company to the other if a Legal Restraint has become final and non-appealable; provided, however, that the right to terminate this Agreement pursuant to this Section 11.1(c) shall not be available to a Party if the failure by such Party or its Affiliates (or with respect to the Company, the Company Shareholders or PubCo) to comply with any provision of this Agreement was the principal cause of such Legal Restraint;

(d) by written notice by the Company to SPAC if (i) there has been a breach by SPAC of any of its representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of SPAC shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in Section 10.2(a) or Section 10.2(b) to be satisfied (treating the Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach (or if the breach is curable, the date by which such breach is required to be cured in the succeeding clause (ii))), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) 30 days after written notice of such breach or inaccuracy is provided to SPAC by the Company or (B) the Outside Date; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section 11.1(d) if at such time SPAC would be entitled to terminate this Agreement pursuant to Section 11.1(e);

77

(e) by written notice by SPAC to the Company if (i) there has been a breach by the Company or PubCo of any of their respective representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in Section 10.3(a) or Section 10.3(b) to be satisfied (treating the Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach (or if the breach is curable, the date by which such breach is required to be cured in the succeeding clause (ii))), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) 30 days after written notice of such breach or inaccuracy is provided to the Company by SPAC or (B) the Outside Date; provided that SPAC shall not have the right to terminate this Agreement pursuant to this Section 11.1(e) if at such time the Company would be entitled to terminate this Agreement pursuant to Section 11.1(d);

(f) by written notice by the Company to SPAC if the Company Funding Threshold has not been achieved on or prior to the date that is two (2) Business Days following the date hereof; provided, however, that the Company shall have no right to terminate this Agreement pursuant to this Section 11.1(f) at any time following achievement of the Company Funding Threshold, even if the Company Funding Threshold has been achieved following such two (2) Business Day period;

(g) by written notice by the Company to SPAC if the SPAC Securities are no longer listed on Nasdaq or another national securities exchange;

(h) by written notice by either SPAC or the Company to the other if the Special Shareholder Meeting is held (including any adjournment or postponement thereof) and has concluded, SPAC Shareholders have duly voted, and the Required Shareholder Approval was not obtained; or

(i) by SPAC, by written notice to the Company, if the Company Shareholder Approval shall not have been obtained within ten (10) Business Days after the Registration Statement Effective Date; provided that SPAC shall have no right to terminate this Agreement pursuant to this Section 11.1(i) at any time following the delivery to SPAC of the Company Shareholder Approval, even if the Company Shareholder Approval is delivered following such ten (10) Business Day period after the Registration Statement Effective Date.

11.2 Effect of Termination. If this Agreement is terminated pursuant to Section 11.1, this Agreement shall thereupon become null and void and of no further force and effect and there shall be no Liability on the part of any Party to another Party, except that (a) the provisions of Sections 8.16, 8.17, 11.3, 12.1, Article XII, Article XIII and this Section 11.2 shall remain in full force and effect and (b) nothing in this Section 11.2 shall be deemed to (i) release any Party from any Liability for any willful and material breach by such Party of any term of this Agreement prior to the date of termination or pursuant to any Fraud Claim against such Party, (ii) impair the right of any Party to compel specific performance by any other Party of such other Party’s obligations under this Agreement in each case prior to the valid termination of this Agreement or (iii) terminate or otherwise modify the Confidentiality Agreement; provided further that nothing in this Section 11.2 shall, in any way, limit the waivers against the Trust Account as set forth in Section 12.1.

78

11.3 Fees and Expenses. Subject to Section 8.12(b), Section 8.14(d), Section 8.15(g) and Section 12.1, unless otherwise expressly provided for in this Agreement, all fees, costs and expenses, and Taxes incurred in connection with entering into this Agreement shall be paid by the Party incurring such fees, costs and expenses, and Taxes. For the avoidance of doubt, (a) if this Agreement is terminated in accordance with its terms, (i) the Company shall pay, or cause to be paid, all unpaid Company Transaction Expenses and (ii) SPAC shall pay, or cause to be paid, all unpaid SPAC Transaction Expenses and (b) if the Closing occurs, PubCo shall pay, or cause to be paid, any unpaid Company Transaction Expenses and SPAC Transaction Expenses.

Article XII

WAIVERS AND RELEASES

12.1 Waiver of Claims Against Trust. Each Party acknowledges and agrees that SPAC has established the Trust Account containing the proceeds of the IPO (including interest accrued from time to time thereon) for the benefit of SPAC Shareholders and that, except as otherwise described in the IPO Prospectus, SPAC may disburse monies from the Trust Account only in the manner described in the IPO Prospectus: (a) to SPAC Shareholders in the event they elect to redeem their shares of SPAC Shares (or PubCo Ordinary Shares upon the First Merger) in connection with the consummation of its initial business combination (as such term is used in the IPO Prospectus, the “Business Combination”) or in connection with an amendment to SPAC’s Organizational Documents to extend SPAC’s deadline to consummate a Business Combination, (b) to SPAC Shareholders if the SPAC fails to consummate a Business Combination within the time period specified in the SPAC Organizational Documents after the closing of the IPO, subject to further extension as described by the IPO Prospectus, (c) with respect to any interest earned on the amounts held in the Trust Account, amounts necessary to pay for any withholding or other Taxes and (d) to SPAC after or concurrently with the consummation of a Business Combination. For and in consideration of SPAC entering into this Agreement and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, each of PubCo and the Company, on behalf of themselves and the other Company Affiliates, acknowledge and agree that they do not and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom to SPAC’s public shareholders, or make any claim against the Trust Account (including any distributions therefrom to SPAC’s public shareholders), regardless of whether such claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between SPAC or any of its Representatives, on the one hand, and the Company or PubCo or any Company Affiliate, on the other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the “Trust Account Released Claims”). Each of the Company and PubCo, on behalf of itself and its Affiliates, hereby irrevocably waives any Trust Account Released Claims that any such Party or any of its Affiliates may have against the Trust Account (including any distributions therefrom to SPAC’s public shareholders) now or in the future as a result of, or arising out of, any negotiations, contracts or agreements with SPAC or its Representatives and will not seek recourse against the Trust Account for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with SPAC). The Company and PubCo each agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by SPAC to induce SPAC to enter in this Agreement, and each of the Company and PubCo further intends and understands such waiver to be valid, binding and enforceable against such Party and each of its Affiliates under applicable Law. To the extent the Company or PubCo or any of their respective Affiliates commences any action or proceeding based upon, in connection with, relating to or arising out of any matter relating to SPAC or its Representatives, which proceeding seeks, in whole or in part, monetary relief against SPAC or its Representatives, each of the Company and PubCo hereby acknowledges and agrees that its and its Affiliates’ sole remedy shall be against funds held outside of the Trust Account (including any funds that have been released from the Trust Account or any assets that have been purchased or acquired with any such funds) and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on any of their behalves or in lieu of them) to have any claim against the Trust Account (including any distributions therefrom to SPAC’s public shareholders) or any amounts contained therein. Notwithstanding the foregoing, the Trust Account Released Claims and related waivers will not limit or prohibit the Company from (i) pursuing a claim against SPAC, Merger Sub or any other person for (A) specific performance or other equitable relief in connection with the Transactions (including a claim for SPAC to specifically perform its obligations under this Agreement and cause the disbursement of the balance of the cash remaining in the Trust Account (after giving effect to any redemption pursuant to the Redemption Rights)) or (B) for damages (subject to the provisions of this Agreement) for breach of this Agreement against SPAC (or any successor entity) or Merger Sub in the event this Agreement is terminated for any reason and SPAC consummates a Business Combination with another Person or (ii) being entitled to the use of any remaining amounts in the Trust Account following the transactions contemplated by Section 8.19(b).

79

12.2 Mutual Releases.

(a) Effective as of the Closing, each of SPAC and PubCo, PubCo on behalf of all its Subsidiaries (including the Target Companies) and SPAC on behalf of each other SPAC Affiliate, hereby irrevocably releases and discharges, each other Company Affiliate or SPAC Affiliate, and each of their respective current and former directors, managers, officers, partners and employees from and against all liabilities, claims and obligations, whether accrued or contingent, whether known or unknown, whether arising under common law, statute, equity or otherwise, to the extent arising prior to the Closing and based upon, arising out of or related to the Target Companies or SPAC and their respective businesses, operations, assets and liabilities, the service by any such Company Affiliate or SPAC Affiliate as an officer, director, manager, employee or Representative of the Target Companies or SPAC or to the subject matter of this Agreement and the Ancillary Documents, including the Transactions (other than, and solely with respect to, any of the covenants in this Agreement that survive the Closing); provided, however, that this Section 12.2(a) shall not release or discharge (i) any liability of the Company or SPAC under this Agreement, any Ancillary Document or the Confidentiality Agreement, (ii) any liability of any current or former employee of the Target Companies or SPAC or any of their respective Subsidiaries to the extent (A) related to this Agreement, any Ancillary Document or the Transactions or (B) arising out of such employee’s service as an officer, director or employee of the Target Companies or SPAC or any of their respective Subsidiaries, (iii) any Fraud Claim by SPAC against the Company or SPAC or (iv) any claims that cannot be waived under applicable Law.

(b) The Parties acknowledge and agree that the Company Affiliates and the SPAC Affiliates are intended third-party beneficiaries of this Section 12.2.

Article XIII

MISCELLANEOUS

13.1 Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery (a) in person, (b) by e-mail (without receiving notice of non-receipt or other “bounce-back”), (c) by reputable, nationally recognized overnight courier service or (d) by registered or certified mail, pre-paid and return receipt requested; provided, however, that notice given pursuant to clauses (c) and (d) above shall not be effective unless a duplicate copy of such notice is also given in person or by e-mail (without receiving notice of non-receipt or other “bounce-back”); in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

If to SPAC or Merger Sub at or prior to the Closing, to: with a copy (which will not constitute notice) to:
Inflection Point Acquisition Corp. III White & Case LLP
167 Madison Avenue 1221 Avenue of the Americas
Suite 205 #1017 New York, New York 10020
New York, New York 10016 Attn: Joel Rubinstein and Jason Rocha
Attention: Michael Blitzer Email: joel.rubinstein@whitecase.com;
Email: blitzer@kingstowncapital.com jason.rocha@whitecase.com
If to the Company or, after the Closing, PubCo or SPAC, to: with a copy (which will not constitute notice) to:
c/o Air Water Ventures Ltd Morgan, Lewis & Bockius LLP
Unit 3, Kizad KLP FZ, Kizad 101 Park Avenue
Abu Dhabi, UAE New York, New York 10178
PO Box 109214 Attn: Russell Franklin
Attention: Andrea Mollica and Ryan Bibbo Email:
Email: andrea.mollica@taucapital.vc; Russell.franklin@morganlewis.com
ryan.bibbo@a1rwater.com
If, prior to the Closing, to PubCo, to: with a copy (which will not constitute notice) to:
c/o Air Water Ventures Ltd Morgan, Lewis & Bockius LLP
Unit 3, Kizad KLP FZ, Kizad 101 Park Avenue
Abu Dhabi, UAE New York, New York 10178
PO Box 109214 Attn: Russell Franklin
Attention: Andrea Mollica and Ryan Bibbo Email:
Email: andrea.mollica@taucapital.vc; Russell.franklin@morganlewis.com
ryan.bibbo@a1rwater.com 
80

13.2 Binding Effect; Assignment. Subject to Section 13.3, this Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit of the Parties and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or otherwise prior to the Closing without the prior written consent of SPAC, PubCo and the Company; provided, that in no event shall any Eligible Company Equityholder or PSU Holder be permitted to assign their rights under Section 2.10. Any assignment without such consent shall be null and void; provided that no such assignment shall relieve the assigning Party of its obligations hereunder. If a Party has transferred the benefit in whole or in part of this Agreement under this Section 13.2 or shall have changed its Tax residence then the liability of the other Parties shall be limited to that (if any) which it would have been had no such transfer or change taken place.

13.3 Third Parties. Except for (a) the rights of the D&O Indemnified Persons set forth in Section 8.18, (b) the rights of the Company Affiliates set forth in Section 12.2, (c) the rights of the SPAC Affiliates set forth in Section 12.2, (d) the rights of the Nonparty Affiliates set forth in Section 13.13, and (e) the rights of such relevant Persons set forth in Section 8.14(e), respectively, which the Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this Agreement or in any instrument or document executed by any party in connection with the Transactions shall create any rights in, or be deemed to have been executed for the benefit of, any Person that is not a Party or thereto or a successor or permitted assign of such a Party.

13.4 Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed in that State regardless of the law that might otherwise govern under applicable principles of conflicts of law thereof, except to the extent that the laws of the Cayman Islands are mandatorily applicable. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively in any Delaware Chancery Court; provided,however, that if jurisdiction is not then available in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware state court. The Parties hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought by any Party and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each Party further agrees that notice as provided herein shall constitute sufficient service of process and the Parties further waive any argument that such service is insufficient. Each Party hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out of or relating to this Agreement or the Transactions, (i) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (ii) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the Action in any such court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

13.5 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT, ANY ANCILLARY DOCUMENT OR THE TRANSACTIONS. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 13.5.

81

13.6 Specific Performance. Each Party acknowledges that the rights of each Party to consummate the Transactions are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching Parties may not have adequate remedy at law, and agree that irreparable damage may occur in the event that any of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise breached. Accordingly, each Party shall be entitled to seek an injunction, specific performance or other equitable remedy to prevent or remedy any breach of this Agreement and to seek to enforce specifically the terms and provisions hereof, in each case, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement, at law or in equity.

13.7 Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

13.8 Amendment. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by each of SPAC and the Company.

13.9 Waiver. Each of SPAC, PubCo and the Company may in its sole discretion (a) extend the time for the performance of any obligation or other act of any other Party, (b) waive any inaccuracy in the representations and warranties by such other Party contained herein or in any document delivered pursuant hereto and (c) waive compliance by such other Party with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the applicable Parties providing such extension or waiver, and any such extension or waiver shall only be binding upon the Party or Parties so providing (or on whose behalf it is so provided) the extension or waiver. Notwithstanding the foregoing, no failure or delay by a Party in exercising any right or remedy hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.

13.10 Entire Agreement. This Agreement, the Ancillary Documents and the Confidentiality Agreement collectively set out the entire agreement between the Parties in respect of the subject matter contained herein and therein and, save to the extent expressly set out in this Agreement, the Ancillary Document or the Confidentiality Agreement, supersede and extinguish any prior drafts, agreements, undertakings, representations, warranties, promises, assurances and arrangements of any nature whatsoever, whether or not in writing, relating thereto.

82

13.11 Interpretation. The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose of reference and shall not in any way affect the meaning or interpretation of this Agreement. In this Agreement, unless the context otherwise requires:

(a) references to the singular shall include the plural and vice versa and references to one gender include any other gender;

(b) references to a “Person” includes any individual, partnership, body corporate, corporation sole or aggregate, state or agency of a state, and any unincorporated association or organization, in each case whether or not having separate legal personality;

(c) reference to any Person includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity;

(d) any accounting term used and not otherwise defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with IFRS or any other accounting principles used by the applicable Person;

(e) general words shall not be given a restrictive meaning because they are followed by words which are particular examples of the acts, matters or things covered by the general words and the words “includes” and “including” shall be construed without limitation;

(f) the words “herein”, “hereto”, and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement;

(g) the words “date hereof” when used in this Agreement shall refer to the date of this Agreement;

(h) the word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and only if”;

(i) in Article IV through Article XII to (i) “SPAC” shall refer to Inflection Point Acquisition Corp. III for all periods prior to the completion of the First Merger and to the First Surviving Company for all periods after the completion of the First Merger; provided that the foregoing shall not apply to the representations and warranties set forth in Sections 4.2, 4.4 and 4.5, and (ii) “SPAC Class A Ordinary Shares”, “SPAC Class B Ordinary Shares” and “SPAC Shares” shall refer to such securities solely for periods prior to the First Merger;

(j) the term “or” shall be construed to have the same meaning and effect as the inclusive term “and/or”;

(k) the word “day” means calendar day unless Business Day is expressly specified;

83

(l) every reference to a particular Law shall be construed also as a reference to all other Laws made under the Law referred to and to all such Laws as amended, re-enacted, consolidated or replaced or as their application or interpretation is affected by other Laws from time to time and whether before or after Closing; provided that, as between the parties, no such amendment or modification shall apply for the purposes of this Agreement to the extent that it would impose any new or extended obligation, liability or restriction on, or otherwise adversely affect the rights of, any Party;

(m) any reference to a US legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than the United States, be deemed to include a reference to that which most nearly approximates to the US legal term in that jurisdiction;

(n) references to “Dollars” or “$” are references to the lawful currency from time to time of the United States of America;

(o) for the purposes of applying a reference to a monetary sum expressed in Dollars, an amount in a different currency shall be deemed to be an amount in Dollars translated at the Exchange Rate at the relevant date;

(p) references to a “company” includes any company, corporation or other body corporate wherever and however incorporated or established;

(q) references to writing shall include any modes of reproducing words in a legible and non-transitory form;

(r) the word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”;

(s) the word “will” shall be construed to have the same meaning and effect as the word “shall”;

(t) the table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement;

(u) unless the context of this Agreement otherwise requires, references to any statute shall include all regulations promulgated thereunder and references to any statute or regulation shall be construed as including all statutory and regulatory provisions consolidating, amending or replacing such statute or regulation;

(v) words introduced by the word “other” shall not be given a restrictive meaning because they are preceded by words referring to a particular class of acts, matters or things; and

(w) any reference in this Agreement to a Person’s directors shall include any member of such Person’s governing body and any reference in this Agreement to a Person’s officers shall include any Person filling a substantially similar position for such Person. Any reference in this Agreement or any Ancillary Document to a Person’s shareholders or stockholders shall include any applicable owners of the equity interests of such Person, in whatever form.

84

The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. To the extent that any Contract, document, certificate or instrument is represented and warranted to by PubCo or the Company to be given, delivered, provided or made available by PubCo or the Company, in order for such Contract, document, certificate or instrument to have been deemed to have been given, delivered, provided and made available to SPAC or its Representatives, such Contract, document, certificate or instrument shall have been posted to the electronic data site maintained on behalf of the Company for the benefit of SPAC and its Representatives and SPAC and its Representatives have been given access to the electronic folders containing such information (subject to access limitations as may be applicable to any individual electronic folders). If there is an inconsistency between any of the provisions of this Agreement and the provisions of any Ancillary Document or the Confidentiality Agreement, the provisions of this Agreement shall prevail as between the Parties to the extent of the inconsistency.

13.12 Counterparts. This Agreement may be executed and delivered (including by facsimile, email or other electronic transmission) in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

13.13 No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Parties acknowledge and agree that all claims, obligations, liabilities, or causes of action (whether in contract or in tort, in Law or in equity or otherwise, or granted by statute or otherwise, whether by or through attempted piercing of the corporate, limited partnership or limited liability company veil or any other theory or doctrine, including alter ego or otherwise) that may be based upon, in respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement or the Ancillary Documents, or the negotiation, execution, or performance or non-performance of this Agreement or the Ancillary Documents (including any representation or warranty made in, in connection with, or as an inducement to, this Agreement or the Ancillary Documents), may be made only against (and such representations and warranties are those solely of) the persons that are expressly identified as parties to this Agreement or the applicable Ancillary Document (the “Contracting Parties”) except as set forth in this Section 13.13. In no event shall any Contracting Party have any shared or vicarious liability for the actions or omissions of any other person. No person who is not a Contracting Party, including any current, former or future director, officer, employee, incorporator, member, partner, manager, shareholder, affiliate, agent, financing source, attorney or Representative or assignee of any Contracting Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager, shareholder, affiliate, agent, financing source, attorney or Representative or assignee of any of the foregoing (collectively, the “Nonparty Affiliates”), shall have any liability (whether in contract or in tort, in Law or in equity or otherwise, or granted by statute or otherwise, whether by or through attempted piercing of the corporate, limited partnership or limited liability company veil or any other theory or doctrine, including alter ego or otherwise) for any obligations or liabilities arising under, out of, in connection with, or related in any manner to this Agreement or the other Ancillary Documents or for any claim based on, in respect of, or by reason of this Agreement or the other Ancillary Documents or their negotiation, execution, performance, or breach; and each Party waives and releases all such liabilities, claims, causes of action and obligations against any such Nonparty Affiliates. Notwithstanding anything to the contrary herein, none of the Contracting Parties or any Nonparty Affiliate shall be responsible or liable for any multiple, consequential, indirect, special, statutory, exemplary or punitive damages which may be alleged as a result of this Agreement, the Ancillary Documents or any other agreement referenced herein or therein or the transactions contemplated hereunder or thereunder, or the termination or abandonment of any of the foregoing. The Parties acknowledge and agree that the Nonparty Affiliates are intended third-party beneficiaries of this Section 13.13.

85

13.14 Legal Representation.

(a) The Parties agree that, notwithstanding the fact that White & Case LLP (“W&C”) may have, prior to the Closing, jointly represented SPAC and the Sponsor in connection with this Agreement, the Ancillary Documents and the Transactions, and has also represented SPAC, Sponsor and their respective Affiliates in connection with matters other than the transaction that is the subject of this Agreement, W&C will be permitted in the future, after the Closing, to represent the Sponsor or its Affiliates in connection with matters in which such Persons are adverse to PubCo, SPAC or any of their respective Affiliates, including any disputes arising out of, or related to, this Agreement. The Company and PubCo, who are or have the right to be represented by independent counsel in connection with the Transactions, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with W&C’s future representation of one or more of the Sponsor or its Affiliates in which the interests of such Person are adverse to the interests of PubCo, SPAC and the Company or any of their respective Affiliates in connection with any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by W&C of the Sponsor, SPAC or any of their respective Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, the Sponsor shall be deemed the client of W&C with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence relating thereto shall belong solely to the Sponsor, shall be controlled by the Sponsor and shall not pass to or be claimed by PubCo or SPAC; provided further, that nothing contained herein shall be deemed to be a waiver by PubCo, SPAC or any of their respective Affiliates of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.

(b) The Parties agree that, notwithstanding the fact that Morgan, Lewis & Bockius LLP (“MLB”) may have, prior to the Closing, represented the Company in connection with this Agreement, the Ancillary Documents and the Transactions, and has also represented the Company and its Affiliates in connection with matters other than the transaction that is the subject of this Agreement, MLB will be permitted in the future, after the Closing, to represent PubCo, the Company or any of their respective Affiliates in connection with matters in which such Persons are adverse to Sponsor, SPAC or any of their respective Affiliates, including any disputes arising out of, or related to, this Agreement. The Sponsor and SPAC, who are or have the right to be represented by independent counsel in connection with the Transactions, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with MLB’s future representation of one or more of PubCo, the Company or its Affiliates in which the interests of such Person are adverse to the interests of the Sponsor and SPAC or any of their respective Affiliates in connection with any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by MLB of the Company or any of its Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, the Company shall be deemed the client of MLB with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence relating thereto shall belong solely to the Company, shall be controlled by the Company and shall not pass to or be claimed by SPAC or the Sponsor; provided further, that nothing contained herein shall be deemed to be a waiver by SPAC, the Sponsor or any of their respective Affiliates of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.

86

Article XIV

DEFINITIONS

14.1 Certain Definitions. For purpose of this Agreement, the following capitalized terms have the following meanings:

“Action” means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, enquiry, settlement, complaint, stipulation, assessment or arbitration, governmental inquiry or investigation, hearing, proceeding or investigation, by or before any Governmental Authority.

“Accrued Value” has the meaning set forth in the Company Charter.

“Affiliate” means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such Person. For the avoidance of doubt, Sponsor shall be deemed to be an Affiliate of SPAC prior to the Closing.

“Air Water US” means Air Water Company LLC, a Delaware limited liability company.

“Air Water USReorganization” means a transaction, structured in a manner intended to be tax-free for U.S. federal income tax purposes (including for purposes of Sections 897 and 1445 of the Code), pursuant to which Air Water UK transfers its entire interest in Air Water US to a newly-formed entity, incorporated or organized in a jurisdiction outside of the United States, that is directly and wholly-owned by Air Water UK and treated as a corporation for U.S. federal income tax purposes, provided, that such newly-formed entity is not and has never been treated as (i) a “domestic corporation” (as such term is defined in Section 7701 of the Code) for U.S. federal income tax purposes, (ii) a “surrogate foreign corporation” within the meaning of Section 7874(a)(2)(B) of the Code, or (iii) a “domestic corporation” under Section 7874(b) of the Code.

“Ancillary Documents” means each agreement, instrument, certificate or document including the SPAC Disclosure Schedules, the Company Disclosure Schedules, the First Plan of Merger, the Second Plan of Merger, the Lock-Up Agreements, the New Registration Rights Agreement, the Sponsor Support Agreement, the Pre-Funded PIPE Subscription Agreement, the PIPE Agreements and the other agreements, instruments, certificates and documents to be executed or delivered by any of the Parties in connection with or pursuant to this Agreement.

“Benefit Plans” of any Person means any and all deferred compensation, executive compensation, incentive compensation, phantom-equity, equity purchase, employment or individual consulting, severance or termination pay, holiday, vacation, bonus, hospitalization or other medical, life or other welfare benefit insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program, agreement, commitment or arrangement, and each other employee compensation or benefit plan, program, agreement or arrangement maintained or contributed to or required to be contributed to by such Person for the benefit of any employee or terminated employee of such Person, or with respect to which such Person has or could reasonably be expected to have any Liability.

“Business Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New York, London, England, or George Town, Cayman Islands, are authorized to close for business.

“Cayman CompaniesLaw” means the Companies Act (Revised) of the Cayman Islands.

“Code” means the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended.

87

“Company Affiliate” means (i) (A) any direct or indirect shareholder, member, general or limited partner or other equityholder of PubCo or the Company and (B) any past, present or future director, officer, employee, incorporator, manager, controlling person, affiliate, subsidiary, portfolio company or Representative of, and any financing source or lender to, (1) PubCo or (2) the Company or any of its Subsidiaries or (3) any person referred to in the foregoing clause (i)(A) or (ii) any of their respective heirs, executors, administrators, successors or assigns.

“Company Charter” means the second amended and restated memorandum and articles of association of the Company adopted by special resolution dated August 18, 2025, as the same may be amended or modified from time to time after the date hereof.

“Company ConfidentialInformation” means all confidential or proprietary documents and information concerning the Target Companies or PubCo or any of their respective Affiliates or Representatives, furnished in connection with this Agreement or the Transactions; provided, however, that Company Confidential Information shall not include any information which, at the time of the disclosure to SPAC or its Representatives (a) was generally available publicly and was not disclosed in breach of this Agreement or (b) was previously known by such receiving Party without violation of Law or any confidentiality obligation by the Person receiving such Company Confidential Information.

“Company ConvertibleSecurities” means, collectively, any other options, warrants or rights to subscribe for or purchase any shares of the Company or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital shares of the Company.

“Company ConsiderationShares” means that number of PubCo Ordinary Shares determined by dividing (x) $300,000,000 by (y) the Redemption Price.

“Company FundamentalWarranties” means the representations and warranties contained in Section 7.1(a) (Organization and Standing), Section 7.2 (Authorization; Binding Agreement), Section 7.4 (Company Subsidiaries), Section 7.6(a) (Non-Contravention) and Section 7.26 (Finders and Brokers).

“Company FundingThreshold” means an aggregate amount equal to $22,500,000.00 has been paid to the Company pursuant to the Pre-Signing PIPE Agreement and the Pre-Funded PIPE Agreements. Notwithstanding anything else in this Agreement to the contrary, if aggregate payments are made to the Company pursuant to the Pre-Signing PIPE Agreement and the Pre-Funded PIPE Agreements are equal to or greater than $22,500,000, then the Company Funding Threshold shall be deemed to be achieved.

“Company OrdinaryShares” means the ordinary shares of a nominal or par value of $0.01344 per share of the Company.

“Company OwnedIP” means any Intellectual Property owned by any Target Company, including the Company Registered IP.

“Company PSU” means each performance-based restricted stock unit granted to a PSU Holder that entitles such PSU Holder to a number of Earnout Shares, determined based on the pro-rata portion of Earnout Shares attributable to such PSU Holder’s Company RSUs, subject to achievement of the applicable Triggering Event.

88

“Company RSU” means each restricted stock unit with respect to Company Ordinary Shares.

“Company Securities” means the Company Ordinary Shares, Company Series A Preferred Shares and Company Warrants.

“Company SeriesA Preferred Shares” means the Company Series A1 Preferred Shares and the Company Series A2 Preferred Shares, collectively.

“Company SeriesA1 Preferred Shares” means the series A1 redeemable preference shares of a nominal or par value of $0.0001 per share of the Company.

“Company SeriesA2 Preferred Shares” means the series A2 redeemable preference shares of a nominal or par value of $0.0001 per share of the Company.

“Company Shareholder” means a holder of Company Shares.

“Company ShareholderApproval” means the vote of Company Shareholders (voting together as a single class and not as a separate series, and on an as-converted basis) required to approve the Company Shareholder Matters in accordance with the Cayman Companies Law and the applicable Organizational Documents of the Company.

“Company ShareholderMatters” means the approval of: (i) as an ordinary resolution, the adoption and approval of this Agreement and the Mergers, (ii) as a special resolution, the Second Plan of Merger and the execution thereof by a duly authorized signatory of the Company, and (iii) as an ordinary resolution (or if required by applicable Law or the Company Organizational Documents, as a special resolution) the other Transactions, by Company Shareholders in accordance with the Cayman Companies Law and the applicable Organizational Documents of the Company (including any items required by Laws to effect the Mergers and any other proposals as are required to implement the foregoing).

“Company Shares” means the Company Ordinary Shares and the Company Series A Preferred Shares.

“Company Subsidiaries” means Air Water UK, Air Water Units Trading Ltd, A1Rwater General Trading LLC, AWC Air Water LLC, Air Water US and Eshara Water Asia SDN. BHD.

“Company TransactionExpenses” means the aggregate amount of all fees, costs and expenses, in each case including any VAT thereon, (whether or not yet invoiced), that have been incurred prior to the Closing by or on behalf of the Company, which the Company has agreed to pay or is otherwise liable for (including, if applicable, fees, costs and expenses of the managers, directors, officers, employees and consultants of the Company which the Company has agreed to pay or is otherwise liable for) in connection with the negotiation, execution, performance or consummation of this Agreement and the Ancillary Documents and the Transactions and that constitute fees, costs and expenses of third-party counsel, advisors, brokers, finders, consultants, investment bankers, accountants, auditors and experts, excluding any payments or benefits under any Company Benefit Plan.

89

“Consent” means any consent, approval, waiver, authorization, waiting period expiration or termination, or Permit of, or notice to or declaration or filing with any Governmental Authority or any other Person.

“Contracts” means all binding contracts, agreements, arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses (and all other binding contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and other instruments or obligations of any kind, written or oral (including any amendments and other modifications thereto).

“Contributor” means all Persons who created, developed, or contributed to any Intellectual Property purported to be owned by a Target Company.

“Contributor Agreement” means a Contract with a Contributor, pursuant to which the Contributor assigns to a Target Company all of the Contributor’s right, title and interest in and to (i) the Intellectual Property conceived, developed created or reduced to practice by such Contributor in connection with and within the scope of the employment or engagement of such Contributor by such Target Company, or (ii) if such Contributor was not employed or engaged by a Target Company, the Intellectual Property purported to be owned by any Target Company that was conceived, developed, acquired, created, or reduced to practice by such Contributor.

“Control” of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled”, “Controlling” and “under common Control with” have correlative meanings. Without limiting the foregoing, a Person (the “Controlled Person”) shall be deemed Controlled by (a) any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange Act, securities entitling such Person to cast 50% or more of the votes for election of directors or equivalent governing authority of the Controlled Person or (ii) entitled to be allocated or receive 50% or more of the profits, losses, or distributions of the Controlled Person or (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other than a member having no management authority that is not a Person described in clause (a) above) of the Controlled Person.

“Copyrights” means any intellectual property rights in works of authorship, databases, collections of data, and mask works, including all copyrights and sui generis rights therein, and all registrations, renewals, extensions, or reversions thereof.

“Data ProtectionLaws” means the following legislations to the extent applicable: (a) national Laws implementing the Directive on Privacy and Electronic Communications (2002/58/EC), (b) the General Data Protection Regulation (2016/679) (the “GDPR”) and any national Law supplementing the GDPR or any successor laws arising out of the withdrawal of a member state from the European Union, including the UK Data Protection Act 2018 (“DPA”), the UK General Data Protection Regulation as defined by the DPA as amended by the Data Protection, Privacy and Electronic Communications (Amendments etc.) (EU Exit) Regulations 2019; (c) Section 5 of the Federal Trade Commission Act; and (d) all applicable Law concerning the privacy, protection, security, collection, storage, use, transfer, disclosure, destruction, alteration or other processing of Personal Data including the Data Protection Act (Revised) of the Cayman Islands.

“Earnout Period” means the time period beginning on the date that is the 6-month anniversary of the Closing Date and ending on the date that is the 18-month anniversary of the Closing Date.

“EBITDA” means the EBITDA of PubCo for a particular fiscal quarter, as EBITDA is defined and reported by Bloomberg L.P.

90

“Eligible CompanyEquityholders” means each holder of an issued and outstanding Company Share as of the date hereof, together with the Pre-Funded PIPE Investors, except as otherwise set forth on Schedule 2.10(b). For the avoidance of doubt, “Eligible Company Equity holders” shall not include the PIPE Investors.

“EnvironmentalLaw” means any Law in effect on or prior to the date hereof relating to (a) the protection of human health and safety (to the extent relating to exposure to Hazardous Materials), (b) the protection, preservation or restoration of the environment and natural resources (including air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource) to the extent relating to Releases of Hazardous Materials or (c) the use, storage, recycling, treatment, generation, transportation, processing, handling, labelling, production, Release or disposal of Hazardous Materials.

“EnvironmentalPermits” has meaning set forth in Section 7.19(a).

“Equitable Adjustment” means, in the event that, (a) following the date hereof but prior to the Closing (with respect to holders of Company Ordinary Shares) or (b) following the Closing but prior to an applicable Triggering Event (with respect to Eligible Company Equityholders and the PSU Holders), the number of outstanding PubCo Ordinary Shares shall have been changed into a different number of shares or a different class by reason of any reclassification, share split (including a reverse share split), reorganization, recapitalization, split-up, combination, exchange of shares, readjustment, or other similar transaction, or a share dividend or share distribution with a record date within said period, an equitable adjustment as necessary to provide the holders of Company Ordinary Shares or the Eligible Company Equityholders or PSU Holders, as applicable, with the same economic effect as contemplated by this Agreement prior to such event.

“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

“Exchange Rate” means with respect to a particular currency for a particular day, the closing rate of exchange for that currency into Dollars on such date as published by Bloomberg.

“Excluded Shares” means SPAC Shares, if any, held in the treasury of SPAC.

“Fraud Claim” means any claim based in whole or in part upon fraud (which means, with respect to any Person, the making of a statement of fact in the express representations and warranties set forth in this Agreement or any certificate delivered pursuant hereto, with the intent to deceive another Person and which requires the elements defined by Delaware common law) against the Person who committed a fraud, which such claim can only be brought by the Person alleged to have suffered from such alleged fraud. In no event shall fraud hereunder or a Fraud Claim include any claim for equitable fraud, promissory fraud, unfair dealings fraud, or any torts (including a claim for fraud) based on negligence or recklessness.

“GovernmentalAuthority” means any federal, state, local, foreign or other governmental, quasi-governmental, Tax, regulatory or administrative body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving panel or body.

“Hazardous Material” means any chemical, waste, gas, liquid or other substance or material that is defined, listed, designated or regulated as a “hazardous substance”, “pollutant”, “contaminant”, “hazardous waste”, “regulated substance”, “hazardous chemical”, or “toxic chemical” (or by any similar term) under any Environmental Law, or that could result in the imposition of Liability, or responsibility for Remedial Action, under any Environmental Law, including petroleum and petroleum by-products or derivatives, asbestos or asbestos-containing materials, per- and polyfluoroalkyl substances, polychlorinated biphenyls, radon, and urea formaldehyde insulation.

91

“HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the rules and regulations promulgated thereunder.

“IFRS” means International Financial Reporting Standards as promulgated by the International Accounting Standards Board.

“Incidental Licenses” means, with respect to a Target Company, any of the following Contracts entered into in the ordinary course of business: (a) an incidental permitted use right to confidential information in a non-disclosure agreement, (b) Contributor Agreements and (c) any non-exclusive license to Intellectual Property that is merely incidental to the transaction contemplated in such license, the commercial purpose of which is primarily for something other than such license, such as: (i) sales or marketing or similar Contract that includes a license to use the Trademarks of a Target Company for the purposes of promoting the goods or services thereof, (ii) a Contract with a vendor that allows the vendor to identify a Target Company as a customer, (iii) a Contract to purchase or lease equipment or materials, such as a photocopier, computer, or mobile phone that also contains an incidental license to Intellectual Property; or (iv) license for the use of software that is preconfigured, preinstalled, or embedded on hardware or other equipment.

“Indebtedness” of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables incurred in the ordinary course of business), including “earn-outs” and “seller notes” whether accrued or not, (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture, credit agreement or similar instrument, in each case to the extent drawn, (d) all obligations of such Person under leases that should be classified as capital leases in accordance with IFRS, or any other accounting principles used by such Person, (e) all obligations of such Person for the reimbursement of any obligor on any line or letter of credit, banker’s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed against and not settled, (f) all interest rate and currency swaps, caps, collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically or upon the happening of a contingency, (g) all obligations secured by a Lien on any property of such Person and (h) all obligation described in clauses (a) through (g) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against loss. For the avoidance of doubt, “Indebtedness” shall exclude (i) any amounts included in Company Transaction Expenses (with respect to Indebtedness the Company) or SPAC Transaction Expenses (with respect to Indebtedness of SPAC), (ii) accounts payable to trade creditors or accrued expenses, in each case, arising in the ordinary course of business and that are not yet due and payable or are being disputed in good faith or (iii) the endorsement of negotiable instruments for collection in the ordinary course of business.

“Infringement” means, directly or indirectly (including secondarily, contributorily, by inducement or otherwise), the infringement, misappropriation, dilution, or other violation of the Intellectual Property of any Person. “Infringed” and “Infringing” mean the correlative of Infringement.

“IntellectualProperty” means all intellectual property rights, including Patents, Trademarks, internet domain names, Copyrights, design rights, and Trade Secrets.

“Investment CompanyAct” means the U.S. Investment Company Act of 1940, as amended.

“IPO” means the initial public offering of the SPAC Public Units pursuant to the IPO Prospectus.

“IPO Prospectus” means the final prospectus of SPAC, dated as of April 24, 2025, and filed with the SEC on April 25, 2025 (File No. 333- 283427).

“IT Systems” means all computer hardware, telecommunications and network equipment, other informational technology assets and equipment, software and industrial control systems that

“JOBS Act” means the Jumpstart Our Business Startups Act of 2012.

92

“Knowledge” means, with respect to (a) the Company, the actual knowledge of any person set forth on Section 14.1 of the Company Disclosure Schedules, (b) SPAC, the actual knowledge of any person set forth on Section 14.1 of the SPAC Disclosure Schedules or (c) any other Party, (i) if an entity, the actual knowledge of its executive officers, directors or secretary, or (ii) if a natural person, the actual knowledge of such Party. No Party shall be deemed to have any other actual, imputed, or constructive knowledge regarding the subject matter of any of the relevant provisions.

“Law” means any federal, tribal, state, local, municipal, foreign or other law, statute, legislation, case law, principle of common law, ordinance, code, edict, decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority of any Governmental Authority.

“Liabilities” means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise, whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required to be recorded or reflected on a balance sheet under IFRS or other applicable accounting standards).

“Lien” means any mortgage, pledge, security interest, right of first refusal, option, proxy, voting trust, encumbrance, lien or charge of any kind (including any conditional sale or other title retention agreement in the nature thereof), restriction (whether on voting, sale, transfer, disposition or otherwise), or any filing or agreement to file a financing statement as debtor under applicable Law.

“Material AdverseEffect” means, with respect to any specified Person, any fact, event, occurrence, change or effect that has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, liabilities, results of operations or financial condition of such Person and its Subsidiaries, taken as a whole, or (b) the ability of such Person or any of its Subsidiaries to consummate the Transactions or to perform its obligations under this Agreement or the Ancillary Documents to which it is party; provided, however, that for purposes of clause (a) above, any fact, event, occurrence, change or effect directly or indirectly attributable to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any other, facts, events, occurrences, changes or effects) shall not be deemed to be, constitute, or be taken into account when determining whether there has or may or would have occurred a Material Adverse Effect: (i) general global, national, regional, state or local changes in the financial or securities markets (including changes in interest or exchange rates, prices of any security or market index or commodity or any disruption of such markets) or general economic or political or social conditions in the country or region in which such Person or any of its Subsidiaries do business, (ii) changes, conditions or effects that generally affect the industries in which such Person or any of its Subsidiaries operate, (iii) changes or proposed changed in GAAP, IFRS or other applicable accounting principles or mandatory changes in the regulatory accounting requirements (or any interpretation thereof) applicable to any industry in which such Person and its Subsidiaries principally operate, (iv) conditions caused by acts of God, epidemic, pandemics, terrorism, war (whether or not declared), natural or man-made disaster (including fires, flooding, earthquakes, hurricanes and tornados), civil unrest, terrorism or other force majeure or comparable events, (v) any failure in and of itself by such Person and its Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period (provided that the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not excluded by another exception herein), (vi) changes attributable to the public announcement or pendency of the Transactions (including the impact thereof on relationships with customers, suppliers or employees), (vii) changes or proposed changes in applicable Law (or any interpretation thereof) after the date of this Agreement, (viii) any actions required to be taken, or required not to be taken, pursuant to the terms of this Agreement, (ix) in respect of the Company, any action taken by, or at the written request of, SPAC and in respect of SPAC or PubCo, any action taken by, or at the written request of, the Company, (x) with respect to SPAC, the consummation and effects of the Redemption Rights and (xi) any breach of any covenants, agreements or obligations of any Pre-Funded PIPE Investor or Closing PIPE Investor under the Pre-Funded PIPE Subscription Agreement or the PIPE Agreements, as applicable (including any breach of such Person’s obligations to fund any amounts thereunder when required); provided further, however, that any event, occurrence, fact, condition, or change referred to in clauses (i)-(iv) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change has a disproportionate effect on such Person and its Subsidiaries, taken as a whole, compared to other participants in the industries and geographic location in which such Person or any of its Subsidiaries conducts its businesses (in which case only the incremental disproportionate impact may be taken into account). Notwithstanding the foregoing, with respect to SPAC, the aggregate amount redeemed pursuant to the Redemption Rights shall not be deemed to be a Material Adverse Effect on SPAC.

93

“Merger Sub FundamentalWarranties” means the warranties contained in Section 5.1 (Organization and Standing), Section 5.2 (Authorization; Binding Agreement), Section 5.5 (Capitalization) and Section 5.7 (Finders and Brokers).

“Merger Sub Shares” means the ordinary shares of US$1.00 par value per share of Merger Sub.

“Order” means any order, decree, ruling, judgment, injunction, writ, binding determination or decision, verdict or judicial award that is or has been entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.

“Ordinary SharePrice” means the share price equal to the closing sale price of one PubCo Ordinary Share as reported on Nasdaq (or the exchange on which the PubCo Ordinary Shares are then listed) for a period of at least twenty (20) days out of thirty (30) consecutive Trading Days ending on the Trading Day immediately prior to the date of determination, in each case subject to Equitable Adjustment.

“OrganizationalDocuments” means, with respect to any Person, its articles of incorporation and bylaws, memorandum and articles of association or similar organizational documents, in each case, as amended (including, solely with respect to the Company, the Shareholders Agreement).

“Patents” means any patents, utility models, and applications therefor (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof).

“PCAOB” means the U.S. Public Company Accounting Oversight Board (or any successor thereto).

“Permits” means all federal, state, local or foreign permits, grants, easements, consents, approvals, authorizations, exemptions, licenses, franchises, concessions, ratifications, permissions, clearances, confirmations, endorsements, waivers, certifications, designations, ratings, registrations, qualifications or orders issued by or filed with any Governmental Authority.

“Permitted Liens” means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not yet delinquent or (ii) being contested in good faith and by appropriate proceedings and for which adequate reserves have been established in accordance with IFRS or GAAP, as applicable, with respect thereto, (b) Liens imposed by operation of Law or non-monetary encumbrances that would not in the aggregate materially adversely affect the value of, or materially adversely interfere with the use of, the property subject thereto, (c) Liens incurred, pledges or deposits made in the ordinary course of business in connection with worker’s compensation, unemployment insurance and other social security legislation, (d) Liens on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, (e) Liens arising under this Agreement or any Ancillary Document, (f) such imperfections of title, easements, covenants, encumbrances, Liens, or other similar restrictions on real property that would not be reasonably expected to materially impair the current use or operations of the business of the Target Companies or any assets that are subject thereto, (g) materialmen’s, mechanic’s, carriers’, workmen’s, warehousemen’s, repairmen’s, landlord’s and other similar Liens, or deposits to obtain the release of such Liens, (h) restrictions on the transfer of securities imposed by applicable securities Laws, (i) zoning, building, land use, entitlement, conservation restrictions or other similar restrictions on real property, including rights of way and similar encumbrances identified on any surveys, and other land use and environmental regulations promulgated by Governmental Authorities, (j) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety, indemnity and appeal bonds, performance and fiduciary bonds and other obligations of a like nature, in each case in the ordinary course of business, (k) non-exclusive licenses (or sublicenses) of Intellectual Property owned by the Target Companies granted in the ordinary course of business, (l) any (i) statutory Liens in favor of any lessor or landlord, (ii) Liens set forth in leases, subleases, easements, licenses, rights of use, rights to access and rights-of-way or (iii) Liens benefiting or encumbering any superior estate, right or interest, (m) any Liens that are discharged or released at or prior to the Closing, (n) any purchase money Liens, equipment leases or similar financing arrangements, (o) the rights of lessors under leasehold interests or (p) Liens specifically identified on the consolidated statement of financial position of the Target Companies.

94

“Person” means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership), company, limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.

“Personal Data” means (a) any information relating to an identified or identifiable natural person or that is reasonable capable of being used to identify a natural person or (b) any piece of information considered “personally identifiable information”, “personal information”, “personal data” or other comparable term under applicable Data Protection Laws.

“Personal Property” means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts and other tangible personal property.

“Pre-Signing PIPEAgreement” means that certain Subscription Agreement Relating to Air Water UK, dated as of July 25, 2025, by and between Air Water UK and Inflection Point Fund.

“Pre-Signing Reorganization” has the meaning set forth in the Recitals hereto.

“Pre-Signing ReorganizationIntended Tax Treatment” has the meaning set forth in Section 7.14(v).

“PSU Holder” means each individual designated as a PSU Holder on Section 2.10(b) of the Company Disclosure Schedule.

“PubCo FundamentalWarranties” means the warranties contained in Section 6.1 (Organization and Standing), Section 6.2 (Authorization; Binding Agreement), Section 6.5 (Capitalization) and Section 6.7 (Finders andBrokers).

“PubCo OrdinaryShares” means the ordinary shares of US $0.001 par value per share of PubCo.

“PubCo PreferredShare Issue Price” means $1,000 per PubCo Preferred Share.

“PubCo PreferredShares” means the series A preferred shares of US $0.001 par value per share of PubCo.

“PubCo Securities” means the PubCo Ordinary Shares, PubCo Preferred Shares and the PubCo Series A Investor Warrants, collectively.

“Redeeming SPACShare” means each SPAC Class A Ordinary Share in respect of which the applicable holder thereof has validly exercised its Redemption Right (and not waived, withdrawn or otherwise lost such rights in accordance with the terms of the SPAC Charter and applicable Law).

“Redemption Amount” means the aggregate amount payable with respect to all Redeeming SPAC Shares.

“Redemption Price” means the product of (x) the Redemption Amount divided by (y) the total number of Redeeming SPAC Shares.

“Redemption Rights” means the right of an eligible (as determined in accordance with the SPAC Charter) holder of SPAC Class A Ordinary Shares to redeem all or a portion of its SPAC Class A Ordinary Shares (in connection with the Transactions or otherwise) as set forth in the SPAC Charter.

95

“Release” means any release, spill, emission, leaking, pumping, pouring, injection, deposit, disposal, discharge, dispersal, escaping, dumping, or leaching into or through the environment (including, without limitation, ambient air (indoor or outdoor), surface water, groundwater, land surface or subsurface strata).

“Remedial Action” means all actions required by Environmental Law to (a) clean up, remove, treat, or in any other way address any Release of Hazardous Material, (b) prevent the Release of any Hazardous Material so it does not substantially endanger or threaten to substantially endanger public health or welfare or the environment, (c) perform pre-remedial studies and investigations or post-remedial monitoring and care or (d) correct a condition of material noncompliance with Environmental Laws.

“Representatives” means, as to any Person, such Person’s Affiliates and the respective managers, directors, officers, employees, consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person or its Affiliates.

“Revenue” means revenue of PubCo from continuing operations, excluding extraordinary gains, all as determined in accordance with IFRS.

“SEC” means the U.S. Securities and Exchange Commission (or any successor Governmental Authority).

“Securities Act” means the U.S. Securities Act of 1933, as amended.

“ShareholdersAgreement” means the Amended and Restated Shareholders Agreement relating to the Company between the Investors, TAU, the Other Shareholders (each such term as defined therein) and the Company dated August 25, 2025.

“SOX” means the U.S. Sarbanes-Oxley Act of 2002, as amended.

“SPAC Affiliate” means (i) (A) any direct or indirect shareholder, member, general or limited partner, other equityholder of SPAC or any other Person that, directly or indirectly, controls, is controlled by or is under direct or indirect common control with SPAC, including the Sponsor, (B) after the Closing, PubCo, the Company or any of its Subsidiaries and (C) any past, present or future director, officer, employee, incorporator, manager, controlling person, affiliate, subsidiary, portfolio company or Representative of, and any financing source or lender to (1) SPAC, (2) after the Closing, PubCo or its Subsidiaries (including the Target Companies and their respective Subsidiaries) or (3) any person referred to in the foregoing clause (i)A) or (ii) any of their respective heirs, executors, administrators, successors or assigns. For purposes of this definition, “control” (including with correlative meanings, the terms “controlled by” and “common control with”), shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of SPAC or such Person.

“SPAC Charter” means the amended and restated memorandum and articles of association of SPAC dated April 24, 2025, as the same may be amended or modified from time to time after the date hereof.

“SPAC Class AOrdinary Share” means the Class A ordinary shares, par value $0.0001 per share, of SPAC.

“SPAC Class BOrdinary Share” means the Class B ordinary shares, par value $0.0001 per share, of SPAC.

96

“SPAC ConfidentialInformation” means all confidential or proprietary documents and information concerning SPAC or any of its Representatives; provided, however, that SPAC Confidential Information shall not include any information which, at the time of the disclosure to the Company, PubCo or any of their respective Affiliates or Representatives, (a) was generally available publicly and was not disclosed in breach of this Agreement or (b) was previously known by such receiving Party without violation of Law or any confidentiality obligation by the Person receiving such SPAC Confidential Information. For the avoidance of doubt, from and after the Closing, SPAC Confidential Information will include the confidential or proprietary information of the Target Companies.

“SPAC FundamentalWarranties” means the warranties contained in Section 4.1 (Organization and Standing), Section 4.2 (Authorization; Binding Agreement), Section 4.4(a) (Non-Contravention), Section 4.17 (Findersand Brokers), Section 4.22 (Trust Account) and Section 4.24 (Fairness Opinion).

“SPAC Public Unit” means a unit consisting of one SPAC Class A Ordinary Share and one SPAC Right issued in the SPAC IPO.

“SPAC Right” means a right to receive one-tenth (1/10) of one Class A Ordinary Share in accordance with the terms of the SPAC Rights Agreement.

“SPAC Rights Agreement” means the Rights Agreement between SPAC and Continental Stock Transfer & Trust Company, dated April 24, 2025.

“SPAC Securities” means the SPAC Units, SPAC Shares and the SPAC Rights, collectively.

“SPAC Shares” means the SPAC Class A Ordinary Shares and the SPAC Class B Ordinary Shares, collectively.

“SPAC TransactionExpenses” means the aggregate amount of all fees, costs and expenses, in each case including any VAT thereon, (whether or not yet invoiced), that have been incurred prior to the Closing by or on behalf of SPAC, which SPAC has agreed to pay or is otherwise liable for (including, if applicable, fees, costs and expenses of the managers, directors, officers, employees and consultants of SPAC which SPAC has agreed to pay or is otherwise liable for) in connection with the negotiation, execution, performance or consummation of this Agreement and the Ancillary Documents and the Transactions or the IPO and that constitute fees, costs and expenses of third-party counsel, advisors, brokers, finders, consultants, investment bankers, accountants, auditors and experts (including deferred expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO). For the avoidance of doubt, no fees, costs and expenses incurred by SPAC in connection with the negotiation, execution, performance or consummation of any transaction or other activities of SPAC other than the Transactions shall be considered SPAC Transaction Expenses hereunder.

“SPAC Unit” means a unit consisting of one SPAC Class A Ordinary Share and one SPAC Right, including the units initially issued in the SPAC IPO, the private placement conducted concurrently with the SPAC IPO, and any units issued upon conversion of SPAC working capital loans pursuant to the terms thereof.

97

“Subsidiary” means, with respect to any Person, any corporation, company, partnership, association or other business entity of which (a) if a corporation or company, a majority of the total voting power of capital shares entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, association or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.

“Target Companies” means, collectively, all of the Company and the Company Subsidiaries and “Target Company” means any of them.

“Tax Return” means any return, computation, self-assessment, submission, notice, election, form, declaration, report, claim for refund, information return or other documents (including any related or supporting schedules, statements or information) filed or submitted or required to be filed or submitted with a Governmental Authority in connection with the determination, assessment, payment or collection of any Taxes or the administration, implementation, or enforcement of, or compliance with, any Laws or administrative requirements relating to any Taxes.

“Taxes” or “Tax” means any and all national, federal, state, local, or other taxes imposed by any Governmental Authority, including all income, gross receipts, license, payroll, recapture, net worth, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, capital stock, ad valorem, Value Added Tax, inventory, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, personal property, escheat, unclaimed property, sales, use, transfer, or registration taxes and other governmental charges, duties, levies, alternative or add-on minimum, estimated and other similar charges, in each case, wherever and whenever imposed by a Governmental Authority, and including any interest, penalty, or addition thereto, whether disputed or not.

“Trade Secrets” means any trade secrets, and any other intellectual property rights arising under applicable Law, in confidential or proprietary information, concepts, ideas, designs, research or development information, processes, procedures, techniques, formulae technical information, specifications, methods, know-how, data, discoveries, and inventions (but excluding any Patents or Copyrights therein).

“Trading Day” means any day on which PubCo Ordinary Shares are actually traded on the principal securities exchange or securities market on which PubCo Ordinary Shares are then traded.

“Trademarks” means any trademarks, service marks, trade dress, trade names, brand names, designs, logos, or corporate names (including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications for registration and renewal thereof.

98

“Treasury Regulations” means the regulations (including temporary and proposed) promulgated by the U.S. Department of the Treasury pursuant to and in respect of provisions of the Code.

“Triggering Event” means either Triggering Event I, Triggering Event II, Triggering Event III or Triggering Event IV.

“Triggering EventI” shall occur if either (a) with respect to any full fiscal quarter of PubCo ending on or prior to June 30, 2026, the Revenue for such fiscal quarter exceeds $25,000,000, or (b) PubCo or any of its consolidated subsidiaries enters into a binding and definitive agreement on or prior to June 30, 2026 with the US Federal Emergency Management Agency (FEMA), the US Department of Defense or other US federal agency or Regenrate1 LLC that provides for minimum annual and recurring Revenue of at least $100,000,000.

“Triggering EventII” shall occur if, with respect to any full fiscal quarter of PubCo ending on or prior to December 31, 2026, the Revenue for such fiscal quarter exceeds $50,000,000.

“Triggering EventIII” shall occur if, with respect to any full fiscal quarter of PubCo ending on or prior to December 31, 2026, the EBITDA for such fiscal quarter exceeds $12,500,000.

“Triggering EventIV” shall occur if, within the Earnout Period, the Ordinary Share Price is greater than or equal to $20.00, subject to Equitable Adjustment.

“Trust Account” means the trust account established by SPAC for the benefit of its public shareholders with the proceeds from the IPO pursuant to the Trust Agreement in accordance with the IPO Prospectus.

“Trust Agreement” means that certain Investment Management Trust Agreement, dated as of April 24, 2025, as it may be amended (including to accommodate the First Merger), by and between SPAC and the Trustee.

“Trustee” means Continental Stock Transfer & Trust Company, a New York corporation, in its capacity as trustee under the Trust Agreement.

“Value Added Tax” or “VAT” means, in the United Kingdom, value added tax chargeable pursuant to the Value Added Tax Act 1994, and in relation to any jurisdiction within the European Union, value added tax provided for in Directive 2006/112/EC and charged under provisions of any national legislation implementing that directive or Directive 77/388/EEC together with legislation supplemental thereto, and, in relation to any other jurisdiction, the equivalent Tax (if any) in that jurisdiction, or any similar or replacement Tax.

99

14.2 Section References. The following capitalized terms, as used in this Agreement, have the respective meanings given to them in the Section as set forth below adjacent to such terms:

Term Section
2024 Unaudited Company Financial Statements 7.7(a)
Acquisition Proposal 8.9
Agreement Preamble
Air Water UK Preamble
Alternative Transaction 8.9
Audited Company Financial Statements 7.7(a)
Antitrust Laws 8.12(b)
Business Combination 12.1
Closing 3.1
Closing Cash 8.19(b)
Closing Date 3.1
Closing Filing 8.16(b)
Closing PIPE Investor Recitals
Closing PIPE Subscription Agreement Recitals
Closing Press Release 8.16(b)
Company Preamble
Company Benefit Plan 7.18(a)
Company Board Recitals
Company Board Recommendation Recitals
Company Collective Bargaining Agreement 7.17(a)
Company D&O Tail Insurance 8.18(c)
Company Disclosure Schedules Article VII
Company Financial Statements 7.7(a)
Company Material Contract 7.12(a)
Company Permits 7.10
Company Real Property Leases 7.15
Company Registered IP 7.13(a)
Company Support Agreements Recitals
Company Warrants Recitals
Confidentiality Agreement 8.1(c)
Contracting Parties 13.13
Customs & Export Control Laws 4.19(d)
D&O Indemnified Persons 8.18(a)
Disqualified Individual 8.22(d)
DTC 2.6
Earnout Shares 2.10(a)
Enforceability Exceptions 4.2
Environmental Permits 7.19(a)
Exchange Ratio 2.2(a)
Exchanged PSU 2.2(f)
Exchanged RSU 2.2(e)
Extension 8.3(a) 
100
Term Section
FCPA 4.19(a)
Federal Securities Laws 8.10
First Merger Recitals
First Merger Effective Time 1.2(a)
First Plan of Merger 1.1
First Surviving Company 1.1(a)
Future PIPE Agreements Recitals
Future PIPE Investor Recitals
Inflection Point Fund Recitals
Intended Tax Treatment 2.9
Interim Financial Statements 8.6(b)
Interim Unaudited Company Financial Statements 7.7(a)
Interim Period 8.1(a)
ITEPA 7.14(q)
Legal Restraint 10.1(c)
Lock-Up Agreement 8.21
Material Customer 7.22(a)
Material Customer Agreement 7.22(a)
Material Supplier 7.22(b)
Material Supplier Agreement 7.22(b)
Merger Recitals
Merger Sub Preamble
MLB 13.14(b)
Nasdaq 4.3
New Registration Rights Agreement 8.20
Nonparty Affiliates 13.13
OFAC 4.19(d)
Outside Date 11.1(b)
Parties Preamble
Party Preamble
PCAOB Financial Statements 8.6(a)
PIPE Agreements Recitals
PIPE Investment Recitals
PIPE Investors Recitals
Post-Closing PubCo Board 1.5(a)(i)
Post-Closing PubCo Directors 1.5(a)(i)
Post-Closing PubCo Officers 1.5(a)(ii)
Pre-Funded PIPE Investment Recitals
Pre-Funded PIPE Investors Recitals
Pre-Funded PIPE Subscription Agreement Recitals
Pre-Signing Reorganization Recitals
Pre-Signing Reorganization Intended Tax Treatment 7.14(v)
Proxy Statement 8.15(a)
PubCo Preamble
PubCo A&R Articles 1.4(a)
PubCo Board Recitals
PubCo Equity Incentive Plan 8.22(a)
PubCo ESPP 8.22(b)
PubCo Series A Investor Warrants 2.2(c)
PubCo Sole Shareholder Recitals 
101
Term Section
Registration Statement 8.15(a)
Registration Statement Effective Date 8.15(b)
Related Person 4.19(d)
Required Shareholder Approval 10.1(a)
Rights Conversion 2.1(c)
Sanctioned Jurisdiction 4.19(d)
Sanctioned Person 7.24(a)
Sanctions 4.19(d)
SEC Reports 4.6(a)
Second Merger Recitals
Second Merger Effective Time 1.2(b)
Second Plan of Merger 1.1(b)
Second Surviving Company 1.1(b)
Section 280G Materials 8.22(d)
Section 280G Payments 8.22(d)
Section 280G Vote 8.22(d)
Shareholder Approval Matters 8.15(a)
Signing Filing 8.16(b)
Signing Press Release 8.16(b)
SPAC Preamble
SPAC Arrangements 8.22(d)
SPAC Board Recitals
SPAC Board Recommendation Recitals
SPAC Class B Ordinary Share Conversion 2.1(b)
SPAC D&O Tail Insurance 8.18(b)
SPAC Disclosure Schedules Article IV
SPAC Dissenting Shares 2.1(i)
SPAC Financials 4.6(c)
SPAC Material Contract 4.14(a)
SPAC Permits 4.10
SPAC Per Share Merger Consideration Recitals
SPAC Shareholders Recitals
Special Shareholder Meeting 8.15(a)
Sponsor Preamble
Sponsor Support Agreement Recitals
Tau Capital Recitals
Transactions Recitals
Transfer Agent 2.6
Transfer Taxes 8.14(d)
Trust Account Released Claims 12.1
Unit Separation 2.1(a)
W&C 13.14(a)
Waived 280G Benefits 8.22(d)
Written Resolution 8.27

[Signature Pages Follow]

102

IN WITNESS WHEREOF, the following Parties have caused this Agreement to be duly executed as of the date first above written.

SPAC:
INFLECTION POINT ACQUISITION CORP. III
By: /s/ Michael Blitzer
Name: Michael Blitzer
Title: Chairman and Chief Executive Officer

[Signature Page to the Business Combination Agreement]

Merger Sub:
IPCX Merger sub LIMITED
By: /s/ Michael Blitzer
Name: Michael Blitzer
Title: Director

[Signature Page to the Business Combination Agreement]

PubCo:
AIR WATER VENTURES LIMITED
By: /s/ Andrea Mollica
Name: Andrea Mollica
Title: Director

[Signature Page to the Business Combination Agreement]

Company:
AIR WATER VENTURES HOLDINGS LIMITED
By: /s/ Andrea Mollica
Name: Andrea Mollica
Title: Director

[Signature Page to the Business Combination Agreement]

Exhibit A

Reserved

\[*Exhibit*
                                        A\]

Exhibit B

Company Warrants

\[*Exhibit*
                                        B\]

Exhibit C

Sponsor Support Agreement

\[*Exhibit* C\]

Exhibit D

Form of Company Support Agreement

\[*Exhibit*
                                        D\]

Exhibit E

Form of First Plan of Merger

\[*Exhibit*
                                        E\]

Exhibit F

Form of Second Plan of Merger

\[*Exhibit*
                                        F\]

Exhibit G

Reserved

\[*Exhibit*
                                        G\]

Exhibit H

PubCo Series A Investor Warrants

\[*Exhibit*
                                        H\]

Exhibit I

Form of New Registration Rights Agreement

\[*Exhibit*
                                        I\]

Exhibit J-1

Form of Lock-Up Agreement (Company)

J-1-1

Exhibit J-2

Form of Lock-Up Agreement (Sponsor)

J-2-1

Exhibit K

Form of PubCo A&R Articles

\[*Exhibit                                            K*\]

Exhibit 3.1

Final Form

Companies Act (Revised)<br><br> <br><br><br> <br>Company Limited by Shares<br><br> <br><br><br> <br>****
amended and restated<br><br> <br>memorandum of association OF AIR WATER VENTURES LIMITED<br><br> <br>****
Adopted by special resolution<br> on [   ] and effective on [   ]

Companies Act (Revised)

Company Limited by Shares

Amended and Restated

Memorandum of Association

of

Air Water Ventures Limited

Adopted by special resolution on [   ] and effective on [   ]

1 The name<br> of the Company is Air Water Ventures Limited.
2 The registered<br> office of the Company shall be at the offices of Ogier Global (Cayman) Limited, 89 Nexus<br> Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands or at such other place in the Cayman<br> Islands as the directors may at any time decide.
--- ---
3 Subject<br> to the following provisions of this Memorandum, the objects for which the Company is established<br> are unrestricted. As provided by section 7(4) of the Companies Act (Revised), the Company<br> has full power and authority to carry out any object not prohibited by any law of the Cayman<br> Islands.
--- ---
4 Subject<br> to the following provisions of this Memorandum, the Company has unrestricted corporate capacity.<br> Without limitation to the foregoing, as provided by section 27(2) of the Companies Act (Revised),<br> the Company has and is capable of exercising all the functions of a natural person of full<br> capacity irrespective of any question of corporate benefit.
--- ---
5 Nothing<br> in any of the preceding paragraphs permits the Company to carry on any of the following businesses<br> without being duly licensed, namely:
--- ---
(a) the business of a bank or trust company<br> without being licensed in that behalf under the Banks and Trust Companies Act (Revised);<br> or
--- ---
(b) insurance business from within the<br> Cayman Islands or the business of an insurance manager, agent, sub-agent or broker without<br> being licensed in that behalf under the Insurance Act (Revised); or
--- ---
(c) the business of company management<br> without being licensed in that behalf under the Companies Management Act (Revised).
--- ---
6 Unless<br> licensed to do so, the Company will not trade in the Cayman Islands with any person, firm<br> or corporation except in furtherance of its business carried on outside the Cayman Islands.<br> Despite this, the Company may effect and conclude contracts in the Cayman Islands and exercise<br> in the Cayman Islands any of its powers necessary for the carrying on of its business outside<br> the Cayman Islands.
--- ---
7 The Company<br> is a company limited by shares and accordingly the liability of each member is limited to<br> the amount (if any) unpaid on that member’s shares.
--- ---
8 The share<br>capital of the Company is US$[●] divided into [●] ordinary shares of US$[0.001] par value each and [●] series A redeemable<br>preference shares of US$[0.001] par value each.^1^<br>However, subject to the Companies Act (Revised) and the Company’s articles of association, the Company has power to do any one<br>or more of the following:
--- ---
(a) redeem or repurchase any of its shares;
--- ---
(b) increase or reduce its capital;
--- ---
(c) issue any part of its capital (whether<br> original, redeemed, increased or reduced):
--- ---
(i) with or without any preferential, deferred,<br> qualified or special rights, privileges or conditions; or
--- ---
(ii) subject to any limitations or restrictions
--- ---

and unless the condition of issue expressly declares otherwise, every issue of shares (whether declared to be ordinary, preference or otherwise) is subject to this power; and

(d) alter any of those rights, privileges,<br> conditions, limitations or restrictions.
9 The Company<br> has power to register by way of continuation as a body corporate limited by shares under<br> the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman<br> Islands.
--- ---
^1^ Note to draft: Details of authorised share capital to<br>be confirmed.
--- ---
Companies Act (Revised)<br><br> <br><br><br> <br><br><br> <br><br><br> <br>Company Limited By Shares<br><br> <br><br><br> <br>****
--- ---
AMENDED AND<br> RESTATED<br><br> articles of association<br><br> of<br><br> AIR WATER VENTURES LIMITED<br><br> <br>****
(Adopted by special resolution passed on [<br>   ] and effective on [   ])

Contents

1 Definitions, interpretation and exclusion of Table A 1
Definitions 1
Interpretation 7
Exclusion of Table A Articles 9
2 Shares 9
Rights attaching to Ordinary Shares and Series A Shares 9
Power to issue Shares and options, with or without special rights 9
Power to pay commissions and brokerage fees 10
Trusts not recognised 10
Security interests 10
Power to vary class rights 11
Effect of new Share issue on existing class rights 11
Capital contributions without issue of further Shares 11
No bearer Shares or warrants 12
Treasury Shares 12
Rights attaching to Treasury Shares and related matters 12
Register of Members 13
Annual Return 13
3 Share certificates 13
Issue of share certificates 13
Renewal of lost or damaged share certificates 14
4 Lien on Shares 14
Nature and scope of lien 14
Company may sell Shares to satisfy lien 14
Authority to execute instrument of transfer 15
Consequences of sale of Shares to satisfy lien 15
Application of proceeds of sale 15
5 Calls on Shares and forfeiture 16
Power to make calls and effect of calls 16
Time when call made 16
Liability of joint holders 16
Interest on unpaid calls 16
Deemed calls 17
Power to accept early payment 17
Power to make different arrangements at time of issue of Shares 17
Notice of default 17
Forfeiture or surrender of Shares 17
Disposal of forfeited or surrendered Share and power to cancel forfeiture or surrender 18
Effect of forfeiture or surrender on former Member 18
Evidence of forfeiture or surrender 18
Sale of forfeited or surrendered Shares 19
6 Transfer of Shares 19
Form of Transfer 19
Power to refuse registration for Shares not listed on a Designated Stock Exchange 19
Suspension of transfers 20
Company may retain instrument of transfer 20
Notice of refusal to register 20 
i
7 Transmission of Shares 20
Persons entitled on death of a Member 20
Registration of transfer of a Share following death or bankruptcy 20
Indemnity 21
Rights of person entitled to a Share following death or bankruptcy 21
8 Alteration of capital 21
Increasing, consolidating, converting, dividing and cancelling share capital 21
Dealing with fractions resulting from consolidation of Shares 22
Reducing share capital 22
9 Redemption and purchase of own Shares 22
Power to issue redeemable Shares and to purchase own Shares 22
Power to pay for redemption or purchase in cash or in specie 23
Effect of redemption or purchase of a Share 23
Redemption of Series A Shares – Put Option 23
Redemption of Series A Shares – Call Option 25
10 Conversion of Series A Shares 27
11 Adjustment of Conversion Price 31
12 Meetings of Members 38
Annual and extraordinary general meetings 38
Power to call meetings 38
Content of notice 39
Period of notice 39
Persons entitled to receive notice 39
Accidental omission to give notice or non-receipt of notice 40
13 Proceedings at meetings of Members 40
Quorum 40
Lack of quorum 40
Chairman 41
Right of a Director to attend and speak 41
Accommodation of Members at meeting 41
Security 41
Adjournment and Postponement 41
Method of voting 42
Taking of a poll 42
Chairman’s casting vote 42
Amendments to resolutions 43
Sole-Member Company 43
14 Voting rights of Members 43
Right to vote 43
Rights of joint holders 44
Representation of corporate Members 44
Member with mental disorder 44
Objections to admissibility of votes 45
Form of proxy 45
How and when proxy is to be delivered 45
Voting by proxy 47
15 Number of Directors 47 
ii
16 Appointment, disqualification and removal of Directors 47
No age limit 47
Corporate Directors 48
No shareholding qualification 48
Appointment of Directors 48
Board’s power to appoint Directors 48
Removal of Directors 49
Resignation of Directors 49
Termination of the office of Director 49
17 Alternate Directors 50
Appointment and removal 50
Notices 51
Rights of alternate Director 51
Appointment ceases when the appointor ceases to be a Director 51
Status of alternate Director 51
Status of the Director making the appointment 51
18 Powers of Directors 52
Powers of Directors 52
Directors below the minimum number 52
Appointments to office 52
Provisions for employees 53
Exercise of voting rights 53
Remuneration 53
Disclosure of information 54
19 Delegation of powers 54
Power to delegate any of the Directors’ powers to a committee 54
Local boards 55
Power to appoint an agent of the Company 55
Power to appoint an attorney or authorised signatory of the Company 55
Borrowing Powers 56
Corporate Governance 56
20 Meetings of Directors 56
Regulation of Directors’ meetings 56
Calling meetings 56
Notice of meetings 56
Use of technology 57
Quorum 57
Chairman or deputy to preside 57
Voting 57
Recording of dissent 57
Written resolutions 58
Validity of acts of Directors in spite of formal defect 58
21 Permissible Directors’ interests and disclosure 58
22 Minutes 59
23 Accounts and audit 59
Auditors 59
24 Record dates 60
25 Dividends 60
Source of dividends 60
Declaration of dividends by Members 60
Payment of interim dividends and declaration of final dividends by Directors 60
Apportionment of dividends 61
Right of set off 62
Power to pay other than in cash 62
How payments may be made 62
Dividends or other monies not to bear interest in absence of special rights 63
Dividends unable to be paid or unclaimed 63 
iii
26 Capitalisation of profits 63
Capitalisation of profits or of any share premium account or capital redemption reserve; 63
Applying an amount for the benefit of Members 64
27 Share Premium Account 64
Directors to maintain share premium account 64
Debits to share premium account 64
28 Seal 64
Company seal 64
Duplicate seal 65
When and how seal is to be used 65
If no seal is adopted or used 65
Power to allow non-manual signatures and facsimile printing of seal 65
Validity of execution 65
29 Indemnity 66
Release 66
Insurance 66
30 Notices 67
Form of notices 67
Electronic communications 67
Persons entitled to notices 68
Persons authorised to give notices 68
Delivery of written notices 69
Joint holders 69
Signatures 69
Giving notice to a deceased or bankrupt Member 69
Date of giving notices 70
Saving provision 70
31 Authentication of Electronic Records 70
Application of Articles 70
Authentication of documents sent by Members by Electronic means 70
Authentication of document sent by the Secretary or Officers of the Company by Electronic means 71
Manner of signing 71
Saving provision 71
32 Transfer by way of continuation 72
33 Winding up 72
Distribution of assets in specie 72
No obligation to accept liability 72
34 Liquidation preference and exit provisions 73
Liquidation preference 73
35 Amendment of Memorandum and Articles 74
Power to change name or amend Memorandum 74
Power to amend these Articles 74
36 Mergers and Consolidations 74
37 Certain Tax Filings 74
38 Business Opportunities 74
39 Exclusive Jurisdiction and Forum 75
40 Series A Majority reserved matters 76 
iv

Companies Act (Revised)

Company Limited by Shares

Amended and Restated

Articles of Association

of

Air Water Ventures Limited

(Adopted by special resolution passed on [ ] and effective on [ ])

1 Definitions, interpretation and exclusion of Table A

Definitions

1.1 In these Articles, the following definitions<br> apply:

Accrued Value means, in relation to any Series A Share, the Stated Value together with any unpaid Arrears in respect of that Series A Share (subject to Equitable Adjustment and any adjustment pursuant to Article 25.8);

Act means the Companies Act (Revised) of the Cayman Islands, including any statutory modification or re-enactment thereof for the time being in force;

Affiliate means any person that, directly or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with a person;

Applicable Law means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person;

Arrears means, in relation to any Share, all arrears of any dividend or other sums payable in respect of that Share, whether or not earned or declared and irrespective of whether or not the Company has had at any time sufficient Available Reserves to pay such dividend or sums, together with all other amounts payable on that Share;

Articles means, as appropriate:

(a) these amended and restated articles<br> of association as amended, restated, supplemented and/or otherwise modified from time to<br> time: or
(b) two or more particular articles of<br> these Articles;
--- ---

and Article refers to a particular article of these Articles;

Auditors means the auditor or auditors for the time being of the Company;

1

Available Proceeds means, as appropriate: (i) consideration received by the Company for such Deemed Liquidation Event (net of any retained liabilities associated with the assets sold or technology licensed, or any other expenses associated with the Deemed Liquidation Event or the dissolution of the Company), or (ii) Surplus Assets, in each case as determined in good faith by the Board, together with any other assets of the Company available for distribution to its Members, all to the extent permitted by the Act;

Available Reserves means any funds legally available for distribution in accordance with the Act, including out of the realised or unrealised profits of the Company, out of the share premium account, or as otherwise permitted by law;

Board means the board of Directors from time to time;

Business Combination Agreement means that certain Business Combination Agreement, dated as of August [•], 2025, by and among the Company, Inflection Point Acquisition Corp. III, IPCX Merger Sub, Inc. and Predecessor Air Water, as it may be further amended, modified or supplemented from time to time;

Business Day means a day when banks in Grand Cayman, the Cayman Islands are open for the transaction of normal banking business and for the avoidance of doubt, shall not include a Saturday, Sunday or public holiday in the Cayman Islands;

Cayman Islands means the British Overseas Territory of the Cayman Islands;

Clear Days, in relation to a period of notice, means that period of calendar days excluding:

(a) the calendar day when the notice is<br> given or deemed to be given; and
(b) the calendar day for which it is given<br> or on which it is to take effect;
--- ---

Commission means Securities and Exchange Commission of the United States of America or other federal agency for the time being administering the U.S. Securities Act;

Company means the above-named company;

Control means:

(a) the ability to control the composition<br> of the board of directors or equivalent body, directly or indirectly, whether through ownership<br> of voting capital, by contract or otherwise;
(b) the ownership of a majority of the<br> shares or the right to acquire a majority of the shares directly or indirectly; or
--- ---
(c) the power to directly or indirectly<br> exercise a majority of the total voting rights,
--- ---

and the terms Controlledby or under common Control with have corresponding meanings;

2

Controlling Interest means an interest in shares giving to the holder or holders Control;

Conversion Price means, in relation to each Series A Share, US$12.00 (subject to Equitable Adjustment and, if applicable, adjusted as referred to in Articles 11.3 to 11.7);

Conversion Ratio means, with respect to each Series A Share, the number of Ordinary Shares determined by dividing the Accrued Value by the Conversion Price;

Conversion Shares means, collectively, the Ordinary Shares issuable upon conversion of the Series A Shares in accordance with the terms hereof;

Date of Adoption means the date on which these Articles were adopted;

Deemed Liquidation Event means:

(a) a merger or consolidation in which:<br> (A) the Company is a constituent party; or (B) a subsidiary of the Company is a constituent<br> party and the Company issues Shares pursuant to such merger or consolidation; provided, that,<br> a Deemed Liquidation Event shall not include any such merger or consolidation involving the<br> Company or a subsidiary in which the Shares outstanding immediately prior to such merger<br> or consolidation continue to represent, or are converted into or exchanged for shares of<br> capital stock that represent, immediately following such merger or consolidation, at least<br> a majority, by voting power, of the capital stock of (1) the surviving or resulting corporation;<br> or (2) if the surviving or resulting corporation is a wholly owned subsidiary of another<br> company immediately following such merger or consolidation, the parent company of such surviving<br> or resulting company; or
(b) (A) the sale, in a single transaction<br> or series of related transactions, by the Company or any subsidiary of the Company of all<br> or substantially all of the assets of the Company and its subsidiaries taken as a whole;<br> or (B) the sale or disposition (whether by merger, consolidation or otherwise, and whether<br> in a single transaction or a series of related transactions) of one (1) or more subsidiaries<br> of the Company if substantially all of the assets of the Company and its subsidiaries taken<br> as a whole are held by such subsidiary or subsidiaries, except where such sale is to a wholly<br> owned subsidiary of the Company;
--- ---

Default Rate means ten per cent per annum;

Designated Stock Exchanges means the Nasdaq Stock Market LLC in the United States of America for so long as the Company’s Shares are there listed and any other stock exchange on which the Company’s Shares are listed for trading;

Designated Stock Exchange Rules means the relevant code, rules and regulations, as amended, from time to time, applicable as a result of the original and continued listing of any Shares on the Designated Stock Exchanges;

3

Directors means the directors for the time being of the Company and the expression Director shall be construed accordingly;

Disposal means the disposal by the Company of all, or a substantial part of, its business and assets (where disposal may include the grant by the Company of an exclusive licence of intellectual property not entered into in the ordinary course of business);

Effective Date means the date that the Registration Statement filed by the Company pursuant to the Registration Rights Agreement is first declared effective by the Commission;

Electronic has the meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;

Electronic Record has the meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;

Electronic Signature has the meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;

Equitable Adjustment means, in the event that the number of outstanding Series A Shares or Ordinary Shares, as applicable, shall have been changed into a different number of shares or a different class by reason of any reclassification, subdivision, consolidation, reorganisation, recapitalization, combination, exchange of shares, readjustment, or other similar transaction, or a share dividend or share distribution has been effectuated, an equitable adjustment as necessary to provide the holders of Series A Shares with the same economic effect as is contemplated by these Articles prior to such event;

Exchange Act means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder;

Family Trust means in relation to a Shareholder, a trust set up wholly for the benefit of that Shareholder and/or that Shareholder’s Privileged Relations;

Floor Price means the lesser of (i) $5.00 (subject to Equitable Adjustment) and (ii) the Conversion Price then in effect;

Fully Paid Up means:

(a) in relation to a Share with par value,<br> means that the par value for that Share and any premium payable in respect of the issue of<br> that Share, has been fully paid or credited as paid in money or money’s worth; and
(b) in relation to a Share without par<br> value, means that the agreed issue price for that Share has been fully paid or credited as<br> paid in money or money’s worth;
--- ---

General Meeting means a general meeting of the Company duly constituted in accordance with the Articles;

4

Group means, as regards any body corporate, partnership or unincorporated association carrying on a trade or business with or without a view to profit (other than a Qualifying Company) (a Principal Undertaking):

(a) such Principal Undertaking;
(b) each Parent Undertaking of such Principal<br> Undertaking; and
--- ---
(c) each subsidiary undertaking of (i)<br> such Principal Undertaking or (ii) any parent undertaking of such Principal Undertaking,
--- ---

(and in each case, with respect to the holding of interests in Shares, any nominee or custodian of such interests in Shares);

Group Company means the Company, any subsidiary from time to time of the Company, and any subsidiary from time to time of a subsidiary of the Company;

Independent Director means a Director who is an independent director as defined in the Designated Stock Exchange Rules as determined by the Board;

Inflection Point Entities means, collectively, Inflection Point Asset Management LLC, Newtyn Management LLC, Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B, and their respective Affiliates;

Member means any person or persons entered on the register of Members from time to time as the holder of a Share;

Memorandum means the amended and restated memorandum of association of the Company as amended, restated, supplemented and/or otherwise modified from time to time;

month means a calendar month;

New Securities means any Shares granted or issued (or to be granted or issued) by the Company after the Date of Adoption excluding for the avoidance of doubt any treasury shares transferred by the Company after the Date of Adoption;

Officer means a person appointed to hold an office in the Company including a Director, alternate Director or liquidator and excluding the Secretary;

Ordinary Resolution means a resolution of a General Meeting passed by a simple majority of the votes cast by, or on behalf of, the Members entitled to vote thereon in person or by proxy or, in the case of corporations, by their duly authorised representatives, at that General Meeting;

Ordinary Share means an ordinary share of a par value of US$[0.001] each in the capital of the Company, and having the rights provided for in these Articles;

5

Partly PaidUp means:

(a) in relation to a Share with par value,<br> that the par value for that Share and any premium payable in respect of the issue of that<br> Share, has not been fully paid or credited as paid in money or money’s worth; and
(b) in relation to a Share without par<br> value, means that the agreed issue price for that Share has not been fully paid or credited<br> as paid in money or money’s worth;
--- ---

Predecessor Air Water means Air Water Ventures Holdings Limited, a Cayman Islands exempted company;

Privileged Relation means the spouse of a Shareholder and the Shareholder’s children and grandchildren (including step and adopted children and grandchildren);

PurchaseAgreements means the several Subscription Agreements, between Predecessor Air Water and certain original Series A Shareholders, as amended, modified or supplemented from time to time in accordance with their respective terms;

Qualifying Company means as regards any individual, a company the entire issued share capital of which is held (legally and beneficially) by such individual (together with their Privileged Relations and Family Trusts) and over which that individual exercises Control;

RegistrationRights Agreement means the Registration Rights Agreement, dated as of the Date of Adoption, among the Company, the original Series A Shareholders and certain other Members;

RegistrationStatement means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale of the Conversion Shares by each original Series A Shareholder as provided for in the Registration Rights Agreement;

Rule 144 means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule;

Secretary means a person appointed to perform the duties of the secretary of the Company, including a joint, assistant or deputy secretary;

Series A Majority means the holders of more than 50%, by number, of the Series A Shares in issue from time to time;

Series A Majority Consent means the consent of the Series A Majority;

Series A Share means a series A redeemable preference share of a par value of US$[0.001] each in the capital of the Company, and having the rights provided for in these Articles;

Series A Shareholder means any holder of Series A Shares from time to time;

6

Share means a share in the share capital of the Company and the expression:

(a) includes stock (except where a distinction<br> between shares and stock is expressed or implied); and
(b) where the context permits, also includes<br> a fraction of a Share;
--- ---

Special Resolution has the meaning given to that term in the Act;

Stated Value means, in relation to each Series A Share, the aggregate amount, of US$1,000;

Surplus Assets means surplus assets of the Company remaining after payment of or provisioning form its liabilities, together with any other assets of the Company available for distribution to its Members, to the extent that the Company is lawfully permitted to do so;

Tax Filing Authorised Person means such person as any director shall designate from time to time, acting severally;

Trading Day means a day on which the Designated Stock Exchange is open for business.

Treasury Shares means Shares held in treasury pursuant to the Act and Article 2.19; and

U.S. Securities Act means the Securities Act of 1933 of the United States of America, as amended, or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

Interpretation

1.2 In the interpretation of these Articles,<br> the following provisions apply unless the context otherwise requires:
(a) A reference in these Articles to a<br> statute is a reference to a statute of the Cayman Islands as known by its short title, and<br> includes:
--- ---
(i) any statutory modification, amendment<br> or re-enactment; and
--- ---
(ii) any subordinate legislation or regulations<br> issued under that statute.
--- ---

Without limitation to the preceding sentence, a reference to a revised Act of the Cayman Islands is taken to be a reference to the revision of that Act in force from time to time as amended from time to time.

(b) Headings are inserted for convenience<br> only and do not affect the interpretation of these Articles, unless there is ambiguity. 
7
(c) If a day on which any act, matter<br> or thing is to be done under these Articles is not a Business Day, the act, matter or thing<br> must be done on the next Business Day.
(d) A word which denotes the singular<br> also denotes the plural, a word which denotes the plural also denotes the singular, and a<br> reference to any gender also denotes the other genders.
--- ---
(e) A reference to a person includes,<br> as appropriate, a company, trust, partnership, joint venture, association, body corporate<br> or government agency.
--- ---
(f) Where a word or phrase is given a<br> defined meaning another part of speech or grammatical form in respect to that word or phrase<br> has a corresponding meaning.
--- ---
(g) All references to time are to be calculated<br> by reference to time in the place where the Company’s registered office is located.
--- ---
(h) The words written and in writing include all modes of representing or reproducing words in a visible form, but<br> do not include an Electronic Record where the distinction between a document in writing and<br> an Electronic Record is expressed or implied.
--- ---
(i) The words including, include<br> and in particular or any similar expression are to be construed without limitation.
--- ---
(j) Any requirements as to execution or<br> signature under the Articles including the execution of the Articles themselves can be satisfied<br> in the form of an Electronic Signature.
--- ---
(k) Sections 8 and 19(3) of the Electronic<br> Transactions Act shall not apply.
--- ---
(l) The term “holder” in relation<br> to a Share means a person whose name is entered in the register of Members as the holder<br> of such Share.
--- ---
1.3 The headings in these Articles are intended<br> for convenience only and shall not affect the interpretation of these Articles.
--- ---
1.4 With respect to the calculation of any number of Shares:
--- ---
(a) each Ordinary Share shall be counted<br> as one Ordinary Share; and
--- ---
(b) each Series A Share shall be counted as a number of Ordinary<br>Shares (including fractional entitlements) equal to one multiplied by the then applicable Conversion Ratio (provided that if the relevant<br>calculation is being made when a doubt or dispute has arisen in relation to the adjustment to the Conversion Ratio, then the applicable<br>Conversion Ratio for the purposes of this Article shall be the Conversion Ratio as determined by the Board. If the Board has not determined<br>the applicable adjusted Conversion Ratio, then it shall be deemed to be the most recent determined applicable Conversion Ratio, or, in<br>the absence of the same, the unadjusted Conversion Ratio).
--- --- 
8

Exclusion of Table A Articles

1.5 The regulations contained in Table A in<br> the First Schedule of the Act and any other regulations contained in any statute or subordinate<br> legislation are expressly excluded and do not apply to the Company.
2 Shares
--- ---

Rights attaching to Ordinary Shares and Series A Shares

2.1 Subject to Article 2.5, the Memorandum of<br> Association and any resolution of the Members to the contrary, and without prejudice to any<br> special rights conferred thereby on the holders of any shares or class of shares, the share<br> capital of the Company shall be divided into Ordinary Shares and Series A Shares with the<br> following rights and restrictions attaching.
2.2 The Series A Shares and the Ordinary Shares<br> shall rank pari passu in all respects (other than Accrued Value) but, save where expressly<br> set out herein to the contrary, shall constitute separate classes of shares.
--- ---
2.3 Subject to the further provisions of these<br> Articles, the Ordinary Shares and the Series A Shares shall confer on each holder thereof<br> (in that capacity) the right to receive notice of and to attend, speak and vote at all general<br> meetings of the Company and to receive, vote on and constitute an eligible member for the<br> purposes of proposed written resolutions of the Company.
--- ---
2.4 Subject to Article 14.3, each Ordinary Share and each Series<br>A Share (for the avoidance of doubt, counted on an as-converted basis in accordance with Article 1.4(b)) shall carry a single vote and<br>for all matters (other than where a class consent is specifically required by these Articles) the Shares shall vote as a single class.
--- ---

Power to issue Shares and options, with or without special rights

2.5 Subject to the provisions, if any, in the Memorandum (and to<br>any direction that may be given by the Company in General Meeting), these Articles (including, without limitation, Article 40) and, where<br>applicable, the rules and regulations of the Designated Stock Exchanges, the Commission and/or any other competent regulatory authority<br>or otherwise under Applicable Law, and without prejudice to any rights attached to any existing Shares, the Directors have general and<br>unconditional authority to allot (with or without confirming rights of renunciation), issue, grant options over or otherwise deal with<br>any unissued Shares to such persons, at such times and on such terms and conditions as they may decide. No Share may be issued at a discount<br>except in accordance with the provisions of the Act.
2.6 Without limitation to the preceding Article,<br> but subject to Article 40, the Directors may so deal with the unissued Shares:
--- ---
(a) either at a premium or at par; or
--- --- 
9
(b) with or without preferred, deferred<br> or other special rights or restrictions, whether in regard to dividend, voting, return of<br> capital or otherwise.
2.7 Without limitation to the two preceding<br> Articles, the Directors may refuse to accept any application for Shares, and may accept any<br> application in whole or in part, for any reason or for no reason.
--- ---
2.8 Subject to Article 40, the Company may issue<br> rights, options, warrants or convertible securities or securities of similar nature conferring<br> the right upon the holders thereof to subscribe for, purchase or receive any class of Shares<br> or other securities in the Company at such times and on such terms and conditions as the<br> Directors may decide.
--- ---
2.9 Subject to Article 40, the Company may issue<br> units of securities in the Company, which may be comprised of Shares, rights, options, warrants<br> or convertible securities or securities of similar nature conferring the right upon the holders<br> thereof to subscribe for, purchase or receive any class of Shares or other securities in<br> the Company, on such terms and conditions as the directors may decide.
--- ---

Power to pay commissions and brokerage fees

2.10 The Company may, in so far as the Act permits,<br> pay a commission to any person in consideration of that person:
(a) subscribing or agreeing to subscribe,<br> whether absolutely or conditionally; or
--- ---
(b) procuring or agreeing to procure subscriptions,<br> whether absolute or conditional,
--- ---

for any Shares. That commission may be satisfied by the payment of cash or the allotment of Fully Paid Up or Partly Paid Up Shares or partly in one way and partly in another.

2.11 The Company may employ a broker in the<br> issue of its capital and pay him any proper commission or brokerage.

Trusts not recognised

2.12 Except as required by the Act:
(a) no person shall be recognised by the<br> Company as holding any Share on any trust; and
--- ---
(b) no person other than the Member shall<br> be recognised by the Company as having any right in a Share.
--- ---

Security interests

2.13 Notwithstanding the preceding Article,<br> the Company may (but shall not be obliged to) recognise a security interest of which it has<br> actual notice over shares. The Company shall not be treated as having recognised any such<br> security interest unless it has so agreed in writing with the secured party. 
10

Power to vary class rights

2.14 If the share capital is divided into different classes of Shares<br>then, unless the terms on which a class of Shares was issued state otherwise, the rights attaching to a class of Shares may only be varied<br>if one of the following applies:
(a) the Members holding not less than<br> two-thirds of the issued Shares of that class consent in writing to the variation; or
--- ---
(b) the variation is made with the sanction of a Special Resolution<br>passed at a separate general meeting of the Members holding the issued Shares of that class.
--- ---
2.15 For the purpose of Article 2.14(b), all the provisions of these<br>Articles relating to general meetings apply, mutatis mutandis, to every such separate meeting except that:
--- ---
(a) the necessary quorum shall be one<br> or more persons holding, or representing by proxy, not less than one third of the issued<br> Shares of the class; and
--- ---
(b) any Member holding issued Shares of<br> the class, present in person or by proxy or, in the case of a corporate Member, by its duly<br> authorised representative, may demand a poll.
--- ---

Effect of new Share issue on existing class rights

2.16 Unless the terms on which a class of Shares<br> was issued state otherwise, the rights conferred on the Member holding Shares of any class<br> shall not be deemed to be varied by the creation or issue of further Shares ranking pari passu with the existing Shares of that class.

Capital contributions without issue of further Shares

2.17 With the consent of a Member, the Directors<br> may accept a voluntary contribution to the capital of the Company from that Member without<br> issuing Shares in consideration for that contribution. In that event, the contribution shall<br> be dealt with in the following manner:
(a) It shall be treated as if it were<br> a share premium.
--- ---
(b) Unless the Member agrees otherwise:
--- ---
(i) if the Member holds Shares in a single<br> class of Shares, it shall be credited to the share premium account for that class of Shares;
--- ---
(ii) if the Member holds Shares of more<br> than one class, it shall be credited rateably to the share premium accounts for those classes<br> of Shares (in the proportion that the sum of the issue prices for each class of Shares that<br> the Member holds bears to the total issue prices for all classes of Shares that the Member<br> holds).
--- --- 
11
(c) It shall be subject to the provisions<br> of the Act and these Articles applicable to share premiums.

No bearer Shares or warrants

2.18 The Company shall not issue Shares or warrants<br> to bearers.

Treasury Shares

2.19 Shares that the Company purchases, redeems or acquires by way<br>of surrender in accordance with the Act shall be held as Treasury Shares and not treated as cancelled if:
(a) the Directors so determine prior to<br> the purchase, redemption or surrender of those shares; and
--- ---
(b) the relevant provisions of the Memorandum<br> and Articles and the Act are otherwise complied with.
--- ---

Rights attaching to Treasury Shares and related matters

2.20 No dividend may be declared or paid, and<br> no other distribution (whether in cash or otherwise) of the Company’s assets (including<br> any distribution of assets to Members on a winding up) may be made to the Company in respect<br> of a Treasury Share.
2.21 The Company shall be entered in the register of Members as the<br>holder of the Treasury Shares. However:
--- ---
(a) the Company shall not be treated as<br> a Member for any purpose and shall not exercise any right in respect of the Treasury Shares,<br> and any purported exercise of such a right shall be void; and
--- ---
(b) a Treasury Share shall not be voted,<br> directly or indirectly, at any meeting of the Company and shall not be counted in determining<br> the total number of issued shares at any given time, whether for the purposes of these Articles<br> or the Act.
--- ---
2.22 Nothing in Article 2.21 prevents an allotment<br> of Shares as Fully Paid Up bonus shares in respect of a Treasury Share and Shares allotted<br> as Fully Paid Up bonus shares in respect of a Treasury Share shall be treated as Treasury<br> Shares.
--- ---
2.23 Treasury Shares may be disposed of by the<br> Company in accordance with the Act and otherwise on such terms and conditions as the Directors<br> determine.
--- --- 
12

Register of Members

2.24 The Directors shall keep or cause to be<br> kept a register of Members as required by the Act and may cause the Company to maintain one<br> or more branch registers as contemplated by the Act, provided that where the Company is maintaining<br> one or more branch registers, the Directors shall ensure that a duplicate of each branch<br> register is kept with the Company’s principal register of Members and updated within such<br> number of days of any amendment having been made to such branch register as may be required<br> by the Act.
2.25 The title to Shares listed on a Designated<br> Stock Exchange may be evidenced and transferred in accordance with the laws applicable to<br> the rules and regulations of the Designated Stock Exchange and, for these purposes, the register<br> of Members may be maintained in accordance with Article 40B of the Act.
--- ---

Annual Return

2.26 The Directors in each calendar year shall<br> prepare or cause to be prepared an annual return and declaration setting forth the particulars<br> required by the Act and shall deliver a copy thereof to the registrar of companies for the<br> Cayman Islands.
3 Share certificates
--- ---

Issue of share certificates

3.1 A Member shall only be entitled to a share<br> certificate if the Directors resolve that share certificates shall be issued. Share certificates<br> representing Shares, if any, shall be in such form as the Directors may determine. If the<br> Directors resolve that share certificates shall be issued, upon being entered in the register<br> of Members as the holder of a Share, the Directors may issue to any Member:
(a) without payment, one certificate for<br> all the Shares of each class held by that Member (and, upon transferring a part of the Member’s<br> holding of Shares of any class, to a certificate for the balance of that holding); and
--- ---
(b) upon payment of such reasonable sum<br> as the Directors may determine for every certificate after the first, several certificates<br> each for one or more of that Member’s Shares.
--- ---
3.2 Every certificate shall specify the number,<br> class and distinguishing numbers (if any) of the Shares to which it relates and whether they<br> are Fully Paid Up or Partly Paid Up. A certificate may be executed under seal or executed<br> in such other manner as the Directors determine.
--- ---
3.3 Every certificate shall bear legends required<br> under the Applicable Laws, including the U.S. Securities Act (to the extent applicable).
--- --- 
13
3.4 The Company shall not be bound to issue<br> more than one certificate for Shares held jointly by several persons and delivery of a certificate<br> for a Share to one joint holder shall be a sufficient delivery to all of them.

Renewal of lost or damaged share certificates

3.5 If a share certificate is defaced, worn-out, lost or destroyed,<br>it may be renewed on such terms (if any) as to:
(a) evidence;
--- ---
(b) indemnity;
--- ---
(c) payment of the expenses reasonably<br> incurred by the Company in investigating the evidence; and
--- ---
(d) payment of a reasonable fee, if any<br> for issuing a replacement share certificate,
--- ---

as the Directors may determine, and (in the case of defacement or wearing-out) on delivery to the Company of the old certificate.

4 Lien on Shares

Nature and scope of lien

4.1 The Company has a first and paramount lien on all Shares (whether<br>Fully Paid Up or not) registered in the name of a Member (whether solely or jointly with others). The lien is for all monies payable<br>to the Company by the Member or the Member’s estate:
(a) either alone or jointly with any other<br> person, whether or not that other person is a Member; and
--- ---
(b) whether or not those monies are presently<br> payable.
--- ---
4.2 At any time the Board may declare any Share<br> to be wholly or partly exempt from the provisions of this Article.
--- ---

Company may sell Shares to satisfy lien

4.3 The Company may sell any Shares over which it has a lien if<br>all of the following conditions are met:
(a) the sum in respect of which the lien<br> exists is presently payable;
--- ---
(b) the Company gives notice to the Member<br> holding the Share (or to the person entitled to it in consequence of the death or bankruptcy<br> of that Member) demanding payment and stating that if the notice is not complied with the<br> Shares may be sold; and
--- --- 
14
(c) that sum is not paid within fourteen<br> Clear Days after that notice is deemed to be given under these Articles,

and Shares to which this Article 4.3 applies shall be referred to as Lien Default Shares.

4.4 The Lien Default Shares may be sold in such<br> manner as the Board determines.
4.5 To the maximum extent permitted by law,<br> the Directors shall incur no personal liability to the Member concerned in respect of the<br> sale.
--- ---

Authority to execute instrument of transfer

4.6 To give effect to a sale, the Directors may authorise any person<br>to execute an instrument of transfer of the Lien Default Shares sold to, or in accordance with the directions of, the purchaser.
4.7 The title of the transferee of the Lien<br> Default Shares shall not be affected by any irregularity or invalidity in the proceedings<br> in respect of the sale.
--- ---

Consequences of sale of Shares to satisfy lien

4.8 On a sale pursuant to the preceding Articles:
(a) the name of the Member concerned shall<br> be removed from the register of Members as the holder of those Lien Default Shares; and
--- ---
(b) that person shall deliver to the Company<br> for cancellation the certificate (if any) for those Lien Default Shares.
--- ---
4.9 Notwithstanding the provisions of Article<br> 4.8, such person shall remain liable to the Company for all monies which, at the date of<br> sale, were presently payable by him to the Company in respect of those Lien Default Shares.<br> That person shall also be liable to pay interest on those monies from the date of sale until<br> payment at the rate at which interest was payable before that sale or, failing that, at the<br> Default Rate. The Board may waive payment wholly or in part or enforce payment without any<br> allowance for the value of the Lien Default Shares at the time of sale or for any consideration<br> received on their disposal.
--- ---

Application of proceeds of sale

4.10 The net proceeds of the sale, after payment<br> of the costs, shall be applied in payment of so much of the sum for which the lien exists<br> as is presently payable. Any residue shall be paid to the person whose Lien Default Shares<br> have been sold:
(a) if no certificate for the Lien Default<br> Shares was issued, at the date of the sale; or
--- ---
(b) if a certificate for the Lien Default<br> Shares was issued, upon surrender to the Company of that certificate for cancellation
--- ---

but, in either case, subject to the Company retaining a like lien for all sums not presently payable as existed on the Lien Default Shares before the sale.

15
5 Calls on Shares and forfeiture

Power to make calls and effect of calls

5.1 Subject to the terms of allotment, the Board<br> may make calls on the Members in respect of any monies unpaid on their Shares including any<br> premium. The call may provide for payment to be by instalments. Subject to receiving at least<br> 14 Clear Days’ notice specifying when and where payment is to be made, each Member shall<br> pay to the Company the amount called on his Shares as required by the notice.
5.2 Before receipt by the Company of any sum<br> due under a call, that call may be revoked in whole or in part and payment of a call may<br> be postponed in whole or in part. Where a call is to be paid in instalments, the Company<br> may revoke the call in respect of all or any remaining instalments in whole or in part and<br> may postpone payment of all or any of the remaining instalments in whole or in part.
--- ---
5.3 A Member on whom a call is made shall remain<br> liable for that call notwithstanding the subsequent transfer of the Shares in respect of<br> which the call was made. He shall not be liable for calls made after he is no longer registered<br> as Member in respect of those Shares.
--- ---

Time when call made

5.4 A call shall be deemed to have been made<br> at the time when the resolution of the Directors authorising the call was passed.

Liability of joint holders

5.5 Members registered as the joint holders<br> of a Share shall be jointly and severally liable to pay all calls in respect of the Share.

Interest on unpaid calls

5.6 If a call remains unpaid after it has become<br> due and payable the person from whom it is due and payable shall pay interest on the amount<br> unpaid from the day it became due and payable until it is paid:
(a) at the rate fixed by the terms of<br> allotment of the Share or in the notice of the call; or
--- ---
(b) if no rate is fixed, at the Default<br> Rate.
--- ---

The Directors may waive payment of the interest wholly or in part.

16

Deemed calls

5.7 Any amount payable in respect of a Share,<br> whether on allotment or on a fixed date or otherwise, shall be deemed to be payable as a<br> call. If the amount is not paid when due the provisions of these Articles shall apply as<br> if the amount had become due and payable by virtue of a call.

Power to accept early payment

5.8 The Company may accept from a Member the<br> whole or a part of the amount remaining unpaid on Shares held by him although no part of<br> that amount has been called up.

Power to make different arrangements at time of issue of Shares

5.9 Subject to the terms of allotment, the Directors<br> may make arrangements on the issue of Shares to distinguish between Members in the amounts<br> and times of payment of calls on their Shares.

Notice of default

5.10 If a call remains unpaid after it has become due and payable<br>the Directors may give to the person from whom it is due not less than 14 Clear Days’ notice requiring payment of:
(a) the amount unpaid;
--- ---
(b) any interest which may have accrued;<br> and
--- ---
(c) any expenses which have been incurred<br> by the Company due to that person’s default.
--- ---
5.11 The notice shall state the following:
--- ---
(a) the place where payment is to be made;<br> and
--- ---
(b) a warning that if the notice is not<br> complied with the Shares in respect of which the call is made will be liable to be forfeited.
--- ---

Forfeiture or surrender of Shares

5.12 If the notice given pursuant to Article<br> 5.10 is not complied with, the Directors may, before the payment required by the notice has<br> been received, resolve that any Share the subject of that notice be forfeited. The forfeiture<br> shall include all dividends or other monies payable in respect of the forfeited Share and<br> not paid before the forfeiture. Despite the foregoing, the Board may determine that any Share<br> the subject of that notice be accepted by the Company as surrendered by the Member holding<br> that Share in lieu of forfeiture.
5.13 The directors may accept the surrender<br> for no consideration of any Fully Paid Up Share.
--- --- 
17

Disposal of forfeited or surrendered Share and power to cancel forfeiture or surrender

5.14 A forfeited or surrendered Share may be<br> sold, re-allotted or otherwise disposed of on such terms and in such manner as the Board<br> determine either to the former Member who held that Share or to any other person. The forfeiture<br> or surrender may be cancelled on such terms as the Directors think fit at any time before<br> a sale, re-allotment or other disposition. Where, for the purposes of its disposal, a forfeited<br> or surrendered Share is to be transferred to any person, the Directors may authorise some<br> person to execute an instrument of transfer of the Share to the transferee.

Effect of forfeiture or surrender on former Member

5.15 On forfeiture or surrender:
(a) the name of the Member concerned shall<br> be removed from the register of Members as the holder of those Shares and that person shall<br> cease to be a Member in respect of those Shares; and
--- ---
(b) that person shall surrender to the<br> Company for cancellation the certificate (if any) for the forfeited or surrendered Shares.
--- ---
5.16 Despite the forfeiture or surrender of<br> his Shares, that person shall remain liable to the Company for all monies which at the date<br> of forfeiture or surrender were presently payable by him to the Company in respect of those<br> Shares together with:
--- ---
(a) all expenses; and
--- ---
(b) interest from the date of forfeiture<br> or surrender until payment:
--- ---
(i) at the rate of which interest was payable<br> on those monies before forfeiture; or
--- ---
(ii) if no interest was so payable, at the<br> Default Rate.
--- ---

The Directors, however, may waive payment wholly or in part.

Evidence of forfeiture or surrender

5.17 A declaration, whether statutory or under<br> oath, made by a Director or the Secretary shall be conclusive evidence of the following matters<br> stated in it as against all persons claiming to be entitled to forfeited Shares:
(a) that the person making the declaration<br> is a Director or Secretary of the Company, and
--- ---
(b) that the particular Shares have been<br> forfeited or surrendered on a particular date.
--- ---

Subject to the execution of an instrument of transfer, if necessary, the declaration shall constitute good title to the Shares.

18

Sale of forfeited or surrendered Shares

5.18 Any person to whom the forfeited or surrendered<br> Shares are disposed of shall not be bound to see to the application of the consideration,<br> if any, of those Shares nor shall his title to the Shares be affected by any irregularity<br> in, or invalidity of the proceedings in respect of, the forfeiture, surrender or disposal<br> of those Shares.
6 Transfer of Shares
--- ---

Form of Transfer

6.1 Subject to the following Articles about<br> the transfer of Shares, and provided that such transfer complies with applicable rules of<br> the Designated Stock Exchange, the Commission and/or any other competent regulatory authority<br> or otherwise under Applicable Law, a Member may transfer Shares to another person by completing<br> an instrument of transfer in a common form or in a form prescribed by the Designated Stock<br> Exchange, the Commission and/or any other competent regulatory authority or otherwise under<br> Applicable Law or in any other form approved by the directors, executed:
(a) where the Shares are Fully Paid, by<br> or on behalf of that Member; and
--- ---
(b) where the Shares are partly paid,<br> by or on behalf of that Member and the transferee.
--- ---
6.2 The transferor shall be deemed to remain<br> the holder of a Share until the name of the transferee is entered into the Register of Members.
--- ---

Power to refuse registration for Shares not listed on a Designated Stock Exchange

6.3 Where the Shares in question are not listed<br> on or subject to the rules of any Designated Stock Exchange, the Directors may in their absolute<br> discretion decline to register any transfer of such Shares which are not Fully Paid Up or<br> on which the Company has a lien. The Directors may also, but are not required to, decline<br> to register any transfer of any such Share unless:
(a) the instrument of transfer is lodged<br> with the Company, accompanied by the certificate (if any) for the Shares to which it relates<br> and such other evidence as the Board may reasonably require to show the right of the transferor<br> to make the transfer;
--- ---
(b) the instrument of transfer is in respect<br> of only one class of Shares;
--- ---
(c) the instrument of transfer is properly<br> stamped, if required;
--- ---
(d) in the case of a transfer to joint<br> holders, the number of joint holders to whom the Share is to be transferred does not exceed<br> four;
--- ---
(e) the Shares transferred are Fully Paid<br> Up and free of any lien in favour of the Company; and
--- --- 
19
(f) any applicable fee of such maximum<br> sum as the Designated Stock Exchanges may determine to be payable, or such lesser sum as<br> the Board may from time to time require, related to the transfer is paid to the Company.

Suspension of transfers

6.4 The registration of transfers may, on 14<br> Clear Days’ notice being given by advertisement in such one or more newspapers or by<br> electronic means, be suspended and the register of Members closed at such times and for such<br> periods as the Directors may, in their absolute discretion, from time to time determine,<br> provided always that such registration of transfer shall not be suspended nor the register<br> of Members closed for more than 30 Clear Days in any year.

Company may retain instrument of transfer

6.5 All instruments of transfer that are registered<br> shall be retained by the Company.

Notice of refusal to register

6.6 If the Directors refuse to register a transfer<br> of any Shares not listed on a Designated Stock Exchange, they shall within one month after<br> the date on which the instrument of transfer was lodged with the Company send to each of<br> the transferor and the transferee notice of the refusal.
7 Transmission of Shares
--- ---

Persons entitled on death of a Member

7.1 If a Member dies, the only persons recognised<br> by the Company as having any title to the deceased Members’ interest are the following:
(a) where the deceased Member was a joint<br> holder, the survivor or survivors; and
--- ---
(b) where the deceased Member was a sole<br> holder, that Member’s personal representative or representatives.
--- ---
7.2 Nothing in these Articles shall release<br> the deceased Member’s estate from any liability in respect of any Share, whether the<br> deceased was a sole holder or a joint holder.
--- ---

Registration of transfer of a Share following death or bankruptcy

7.3 A person becoming entitled to a Share in<br> consequence of the death or bankruptcy of a Member may elect to do either of the following:
(a) to become the holder of the Share;<br> or
--- ---
(b) to transfer the Share to another person.
--- --- 
20
7.4 That person must produce such evidence of<br> his entitlement as the Directors may properly require.
7.5 If the person elects to become the holder<br> of the Share, he must give notice to the Company to that effect. For the purposes of these<br> Articles, that notice shall be treated as though it were an executed instrument of transfer.
--- ---
7.6 If the person elects to transfer the Share<br> to another person then:
--- ---
(a) if the Share is Fully Paid Up, the<br> transferor must execute an instrument of transfer; and
--- ---
(b) if the Share is nil or Partly Paid<br> Up, the transferor and the transferee must execute an instrument of transfer.
--- ---
7.7 All the Articles relating to the transfer of Shares shall apply<br>to the notice or, as appropriate, the instrument of transfer.
--- ---

Indemnity

7.8 A person registered as a Member by reason<br> of the death or bankruptcy of another Member shall indemnify the Company and the Directors<br> against any loss or damage suffered by the Company or the Directors as a result of that registration.

Rights of person entitled to a Share following death or bankruptcy

7.9 A person becoming entitled to a Share by reason of the death<br>or bankruptcy of a Member shall have the rights to which he would be entitled if he were registered as the holder of the Share. But,<br>until he is registered as Member in respect of the Share, he shall not be entitled to attend or vote at any meeting of the Company or<br>at any separate meeting of the holders of that class of Shares.
8 Alteration of capital
--- ---

Increasing, consolidating, converting, dividing and cancelling share capital

8.1 Subject to the rights of the holders of<br> Series A Shares contemplated by these Articles, to the fullest extent permitted by the Act,<br> the Company may by Ordinary Resolution do any of the following and amend its Memorandum for<br> that purpose:
(a) increase its share capital by new<br> Shares of the amount fixed by that Ordinary Resolution and with the attached rights, priorities<br> and privileges set out in that Ordinary Resolution;
--- ---
(b) consolidate and divide all or any<br> of its share capital into Shares of larger amount than its existing Shares;
--- --- 
21
(c) convert all or any of its Paid Up<br> Shares into stock, and reconvert that stock into Paid Up Shares of any denomination;
(d) sub-divide its Shares or any of them<br> into Shares of an amount smaller than that fixed by the Memorandum, so, however, that in<br> the sub-division, the proportion between the amount paid and the amount, if any, unpaid on<br> each reduced Share shall be the same as it was in case of the Share from which the reduced<br> Share is derived; and
--- ---
(e) cancel Shares which, at the date of<br> the passing of that Ordinary Resolution, have not been taken or agreed to be taken by any<br> person, and diminish the amount of its share capital by the amount of the Shares so cancelled<br> or, in the case of Shares without nominal par value, diminish the number of Shares into which<br> its capital is divided.
--- ---

Dealing with fractions resulting from consolidation of Shares

8.2 Whenever, as a result of a consolidation of Shares, any Members<br>would become entitled to fractions of a Share, the Directors may on behalf of those Members deal with the fractions as it thinks fit,<br>including (without limitation):
(a) sell the Shares representing the fractions<br> for the best price reasonably obtainable to any person (including, subject to the provisions<br> of the Act, the Company); and
--- ---
(b) distribute the net proceeds in due<br> proportion among those Members.
--- ---
8.3 For the purposes of Article 8.2, the Directors<br> may authorise some person to execute an instrument of transfer of the Shares to, in accordance<br> with the directions of, the purchaser. The transferee shall not be bound to see to the application<br> of the purchase money nor shall the transferee’s title to the Shares be affected by<br> any irregularity in, or invalidity of, the proceedings in respect of the sale.
--- ---

Reducing share capital

8.4 Subject to the Act and to any rights for<br> the time being conferred on the Members holding a particular class of Shares, the Company<br> may, by Special Resolution, reduce its share capital in any way.
9 Redemption and purchase of own Shares
--- ---

Power to issue redeemable Shares and to purchase own Shares

9.1 Subject to the Act and to any rights for the time being conferred<br>on the Members holding a particular class of Shares, the Commission and/or any other competent regulatory authority or otherwise under<br>Applicable Law the Company may by its Directors:
(a) issue Shares that are to be redeemed<br> or liable to be redeemed, at the option of the Company or the Member holding those redeemable<br> Shares, on the terms and in the manner its Directors determine before the issue of those<br> Shares;
--- --- 
22
(b) with the consent by Special Resolution<br> of the Members holding Shares of a particular class, vary the rights attaching to that class<br> of Shares so as to provide that those Shares are to be redeemed or are liable to be redeemed<br> at the option of the Company on the terms and in the manner which the Directors determine<br> at the time of such variation; and
(c) purchase all or any of its own Shares<br> of any class including any redeemable Shares on the terms and in the manner which the Directors<br> determine at the time of such purchase.
--- ---

The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner authorised by the Act, including out of any combination of the following: capital, its profits and the proceeds of a fresh issue of Shares.

Power to pay for redemption or purchase in cash or in specie

9.2 When making a payment in respect of the<br> redemption or purchase of Shares, the Directors may make the payment in cash or in specie<br> (or partly in one and partly in the other) if so authorised by the terms of the allotment<br> of those Shares or by the terms applying to those Shares in accordance with Article 9.1,<br> or otherwise by agreement with the Member holding those Shares.

Effect of redemption or purchase of a Share

9.3 Upon the date of redemption or purchase of a Share:
(a) the Member holding that Share shall<br> cease to be entitled to any rights in respect of the Share other than the right to receive:
--- ---
(i) the price for the Share; and
--- ---
(ii) any dividend declared in respect of<br> the Share prior to the date of redemption or purchase;
--- ---
(b) the Member’s name shall be removed<br> from the register of Members with respect to the Share; and
--- ---
(c) the Share shall be cancelled or held<br> as a Treasury Share, as the Directors may determine.
--- ---
9.4 For the purpose of Article 9.3, the date<br> of redemption or purchase is the date when the redemption or purchase falls due.
--- ---

Redemption of Series A Shares – Put Option

9.5 Subject to the Act, a notice in writing (a Put Notice)<br>may be delivered by a Series A Shareholder to the Company at any time on or after the fifth anniversary of the Date of Adoption, at a<br>redemption price per share equal to 100% of the Accrued Value attributable to such Series A Share specifying that the Company shall make<br>an offer to all of the Series A Shareholders to redeem all of the Series A Shares held by such Series A Shareholder on a date in accordance<br>with Article 9.6. 
23
9.6 The Put Date shall be not less than the date that is<br>20 days after the Put Notice is delivered. The Put Notice shall state:
(a) the Put Date and the redemption price<br> calculated in accordance with Article 9.5; and
--- ---
(b) for Series A Shares in certificated<br> form, that the Series A Shareholder is to surrender to the Company, in the manner and at<br> the place designated, his, her or its certificate or certificates representing the Series<br> A Shares to be redeemed (or deliver an indemnity for lost certificate in a form acceptable<br> to the Board, in respect of any lost certificate(s)).
--- ---
9.7 Within ten days of receipt of the Put Notice,<br> the Company shall deliver to each Series A Shareholder that has delivered a Put Notice, a<br> notice (the Put Offer Notice) that shall be open for acceptance by any Series A Shareholder<br> within 5 days of deemed service of the Put Offer Notice (the Put Acceptance Date)<br> specifying:
--- ---
(a) the terms of the Put Notice (including,<br> for the avoidance of doubt, the Put Date and the redemption price calculated in accordance<br> with Article 9.5); and
--- ---
(b) the address to which an acceptance<br> of the Put Offer Notice should be sent.
--- ---
9.8 On the Put Date, the Company shall redeem<br> for cash in U.S. dollars all of the Series A Shares held by those Series A Shareholders who<br> had accepted the Put Offer Notice by the Put Acceptance Date (the Accepting Shareholders),<br> and the Accepting Shareholders shall deliver to the Company at its registered office the<br> certificate(s) for the Series A Shares (or an indemnity for lost certificate in a form acceptable<br> to the Board, in respect of any lost certificate(s)) and on such delivery (and against the<br> receipt by Accepting Shareholder for the redemption moneys payable in respect of his Series<br> A Shares) the Company shall pay each Accepting Shareholder (or, in the case of joint holders,<br> to the holder of Series A Shares whose name stands first in the register of Shareholders<br> in respect of those Series A Shares) the Accrued Value for each Series A Share being redeemed.
--- ---
9.9 The Company shall cancel the share certificate of the Accepting<br>Shareholder concerned.
--- ---
9.10 Following receipt by the Company of a Put Notice, the Company<br>shall take all necessary steps to the extent permitted by Applicable Law to facilitate the creation of sufficient profits available for<br>distribution in order to complete the redemption of the Series A Shares pursuant to the Put Notice as soon as reasonably practicable.
--- ---
9.11 If, having complied with its obligations in Article 9.10, on<br>any due date for redemption of Series A Shares the Company is prohibited by law from redeeming all or any of the Series A Shares then<br>due to be redeemed, it shall on the due date, redeem that number of the Series A Shares as it may then lawfully redeem, and if there<br>is more than one holder whose Series A Shares are due to be redeemed then the Series A Shares shall be redeemed in proportion as nearly<br>as may be to their existing holdings of Series A Shares and the Company shall redeem the balance of those shares as soon as reasonably<br>practicable after it is not so prohibited and, for so long as the prohibition remains and any Series A Shares have not been redeemed<br>(and notwithstanding any other provisions of these Articles) the Preference Dividend shall continue to accrue up to the date of redemption<br>and the Company shall not pay any dividend or otherwise make any distribution of capital or otherwise (except in the ordinary course<br>of business) decrease its profits available for distribution. If the Company fails to make any partial redemption of Series A Shares<br>on any due date for redemption, then subsequent redemptions of Series A Shares shall be deemed to be of those Series A Shares which first<br>became due for redemption.
--- --- 
24
9.12 In the event that any portion of the redemption<br> price has not been paid within five (5) Business Days following the Put Date and the Company<br> is not prohibited by law from paying the redemption price, interest on such unpaid portion<br> of the redemption price shall accrue thereon until such amount is paid in full at a rate<br> equal to the lesser of (i) 24.0% per annum and (ii) the maximum rate permitted under Applicable<br> Law. Such interest shall be paid by the Company in cash.
9.13 Subject to Articles 9.5 to 9.10, the Company<br> authorises the Board to determine the manner or any of the terms of any redemption or purchase<br> to the extent permitted by the Act.
--- ---

Redemption of Series A Shares – Call Option

9.14 Subject to the Act, a notice in writing<br> (a Call Notice) may be delivered by the Company to all of the Series A Shareholders<br> at any time:
(a) after the Date of Adoption but before<br> the first anniversary of the Date of Adoption, at a redemption price per share equal to 150%<br> of the Accrued Value; or
--- ---
(b) after the first anniversary of the<br> Date of Adoption but before the second anniversary of the Date of Adoption, at a redemption<br> price per share equal to 140% of the Accrued Value; or
--- ---
(c) after the second anniversary of the<br> Date of Adoption but before the third anniversary of the Date of Adoption, at a redemption<br> price per share equal to 130% of the Accrued Value; or
--- ---
(d) after the third anniversary of the<br> Date of Adoption but before the fourth anniversary of the Date of Adoption, at a redemption<br> price per share equal to 120% of the Accrued Value; or
--- ---
(e) after the fourth anniversary of the<br> Date of Adoption but before the fifth anniversary of the Date of Adoption, at a redemption<br> price per share equal to 110% of the Accrued Value; or
--- ---
(f) after the fifth anniversary of the<br> Date of Adoption, at a redemption price per share equal to 100% of the Accrued Value;
--- ---

specifying that the Company shall redeem all or some of the Series A Shares on a date in accordance with Article 9.15.

25
9.15 The Call Date shall be not more<br> than the date that is 20 days after the Call Notice is delivered. The Call Notice shall state:
(a) the number of Series A Shares that<br> the Company shall redeem on the Call Date, provided always that where the Call Notice is<br> in respect of only some and not all of the Series A Shares in issue, the Call Notice shall<br> also specify the adjusted number of Series A Shares that the Company shall redeem from each<br> Series A Shareholder (such adjusted number to represent each Series A Shareholder’s pro rata<br> proportion of the total number of Series A Shares in issue, as a proportion of the total<br> number of Series A Shares the subject of the Call Notice);
--- ---
(b) the Call Date and the redemption price<br> calculated in accordance with Article 9.14; and
--- ---
(c) for Series A Shares in certificated<br> form, that the Series A Shareholder is to surrender to the Company, in the manner and at<br> the place designated, his, her or its certificate or certificates representing the Series<br> A Shares to be redeemed (or deliver an indemnity for lost certificate in a form acceptable<br> to the Board, in respect of any lost certificate(s)).
--- ---
9.16 On each Call Date, the Company shall redeem<br> the number of Series A Shares set out in the Call Notice and the relevant holder of Series<br> A Shares shall deliver to the Company at its registered office the certificate(s) for the<br> Series A Shares to be redeemed (or an indemnity for lost certificate in a form acceptable<br> to the Board, in respect of any lost certificate(s)) and on such delivery (and against the<br> receipt by the holder of Series A Shares for the redemption moneys payable in respect of<br> his Series A Shares) the Company shall pay each holder of Series A Shares (or, in the case<br> of joint holders, to the holder of Series A Shares whose name stands first in the register<br> of Shareholders in respect of those Series A Shares) the Accrued Value for each Series A<br> Share being redeemed.
--- ---
9.17 The Company shall, in the case of a redemption<br> in full, cancel the share certificate of the holder of Series A Shares concerned, and, in<br> the case of a redemption of part of the holding of Series A Shares included in a certificate,<br> either (a) note the amount and date of redemption on the original certificate; or (b) cancel<br> the original certificate and without charge issue a new certificate to the holder for the<br> balance of the Series A Shares not redeemed on that occasion.
--- ---
9.18 Following receipt, or in connection with the delivery (as the<br>case may be), by the Company of a Call Notice, the Company shall take all necessary steps to the extent permitted by Applicable Law to<br>facilitate the creation of sufficient profits available for distribution in order to complete the redemption of the Series A Shares pursuant<br>to the Call Notice as soon as reasonably practicable.
--- --- 
26
9.19 If, having complied with its obligations<br> in Article 9.18, on any due date for redemption of Series A Shares the Company is prohibited<br> by law from redeeming all or any of the Series A Shares then due to be redeemed, it shall<br> on the due date, redeem that number of the Series A Shares as it may then lawfully redeem,<br> and if there is more than one holder whose Series A Shares are due to be redeemed then the<br> Series A Shares shall be redeemed in proportion as nearly as may be to their existing holdings<br> of Series A Shares and the Company shall redeem the balance of those shares as soon as reasonably<br> practicable after it is not so prohibited and, for so long as the prohibition remains and<br> any Series A Shares have not been redeemed (and notwithstanding any other provisions of these<br> Articles) the Preference Dividend shall continue to accrue up to the date of redemption and<br> the Company shall not pay any dividend or otherwise make any distribution of capital or otherwise<br> (except in the ordinary course of business) decrease its profits available for distribution.<br> If the Company fails to make any partial redemption of Series A Shares on any due date for<br> redemption, then subsequent redemptions of Series A Shares shall be deemed to be of those<br> Series A Shares which first became due for redemption; and
9.20 Subject to Articles 9.14 to 9.18, the Company<br> authorises the Board to determine the manner or any of the terms of any redemption or purchase<br> to the extent permitted by the Act.
--- ---
9.21 To the extent permitted by the Act, the<br> Company may accept the surrender for no consideration of any fully paid share (including<br> a redeemable share) unless, as a result of the surrender, there would no longer be any issued<br> shares of the company other than shares held as treasury shares.
--- ---
9.22 For the avoidance of doubt, until a Series<br> A Share has been redeemed in full by the Company pursuant to this Article 9, such Series<br> A Shares may be converted, at any time and from time to time, in whole or in part, by any<br> Series A Shareholder into Ordinary Shares pursuant to Article 10.
--- ---
10 Conversion of Series A Shares
--- ---
10.1 Each fully paid Series A Share shall be<br> convertible, at any time and from time to time at the option of the holder thereof, into<br> that number of whole Ordinary Shares (subject to the limitations set forth in Article 10.3)<br> determined by dividing the Accrued Value of such Series A Share by the Conversion Price.<br> Holders shall effect conversions by providing the Company with the form of conversion notice<br> attached hereto as Annex A (a Notice of Conversion), unless the Company directs<br> holders that the Notice of Conversion shall be delivered to the Company’s transfer<br> agent. Each Notice of Conversion shall identify the Series A Shareholders electing to convert<br> some, or all, of their Series A Shares (the Converting Shareholder(s)), specify the<br> number of Series A Shares to be converted by the Converting Shareholder(s), the number of<br> Series A Shares owned by the Converting Shareholder(s) prior to the conversion at issue,<br> the number of Series A Shares owned by the Converting Shareholder(s) subsequent to the conversion<br> at issue and the date on which such conversion is to be effected, which date may not be prior<br> to the date the by the Converting Shareholder(s) deliver by e-mail attachment or by a nationally<br> recognized overnight courier service such Notice of Conversion to the Company (such date,<br> the Conversion Date). If no Conversion Date is specified in a Notice of Conversion,<br> the Conversion Date shall be the date that such Notice of Conversion to the Company is deemed<br> delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any<br> medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion<br> form be required. The calculations and entries set forth in the Notice of Conversion shall<br> control in the absence of manifest or mathematical error. To effect conversions of Series<br> A Shares, a holder shall not be required to surrender the certificate(s) representing the<br> Series A Shares to the Company unless all of the Series A Shares represented thereby are<br> so converted, in which case such holder shall deliver the certificate representing such Series<br> A Shares promptly following the Conversion Date at issue (or an indemnity for a lost certificate<br> in a form acceptable to the Board). Series A Shares converted into Ordinary Shares or redeemed<br> in accordance with the terms hereof shall be canceled and shall not be reissued, and all<br> rights (other than the right to receive the Conversion Shares) with respect to such shares<br> will terminate. The Company shall, in the case of all Series A Shares included in a certificate,<br> cancel the certificate so delivered and, in the case of a conversion of part of the holding<br> of Series A Shares included in a certificate, either (a) note the amount and date of conversion<br> on the original certificate, or (b) cancel the original certificate and without charge issue<br> a new certificate to the holder for the balance of the Series A Shares not converted. Notwithstanding<br> the foregoing, the Register of Members shall serve as the prima facie record of issued<br> and outstanding Series A Shares.
--- --- 
27
10.2 Not later than the number of Trading Days comprising the Standard<br>Settlement Period (as defined below) after each Conversion Date (the Share Delivery Date), the Company shall deliver, or cause<br>to be delivered, to the Converting Shareholder(s) the number of Conversion Shares being acquired upon the conversion of the relevant<br>Series A Shares, which on or after the earlier of (i) the one year anniversary of the Date of Adoption or (ii) the Effective Date, shall<br>be free of restrictive legends and trading restrictions. On or after the earlier of (i) the one year anniversary of the Date of Adoption<br>or (ii) the Effective Date, the Company shall deliver the Conversion Shares required to be delivered by the Company under this Article<br>10.2 electronically through the Depository Trust Company or another established clearing corporation performing similar functions. As<br>used herein, Standard Settlement Period means the standard settlement period, expressed in a number of Trading Days, on the Designated<br>Stock Exchange with respect to the Ordinary Shares as in effect on the date of delivery of the Notice of Conversion.
(a) If, in the case of any Notice of Conversion,<br> such Conversion Shares are not delivered to or as reasonably directed by the Converting Shareholder(s)<br> by the Share Delivery Date, the Converting Shareholder(s) shall be entitled to elect by written<br> notice to the Company at any time on or before its receipt of such Conversion Shares, to<br> rescind such conversion, in which event the Company shall promptly return to the relevant<br> Converting Shareholder(s) any original Series A Share certificate delivered to the Company<br> and the relevant Converting Shareholder(s) shall promptly return to the Company the Conversion<br> Shares issued to such Converting Shareholder(s) pursuant to the rescinded Notice of Conversion.
--- ---
(b) The Company’s obligation to<br> issue and deliver the Conversion Shares upon conversion of the Series A Shares in accordance<br> with the terms hereof are absolute and unconditional, irrespective of any action or inaction<br> by a holder to enforce the same, any waiver or consent with respect to any provision hereof,<br> the recovery of any judgment against any person or any action to enforce the same, or any<br> setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach<br> by such holder or any other person of any obligation to the Company or any violation or alleged<br> violation of law by such holder or any other person, and irrespective of any other circumstance<br> which might otherwise limit such obligation of the Company to such holder in connection with<br> the issuance of such Conversion Shares; provided, however, that<br> such delivery shall not operate as a waiver by the Company of any such action that the Company<br> may have against such holder. In the event a holder shall elect to convert any or all of<br> the Accrued Value of its Series A Shares, the Company may not refuse conversion based on<br> any claim that such holder or anyone associated or affiliated with such holder has been engaged<br> in any violation of law, agreement or for any other reason, unless an injunction from a court,<br> on notice to holder, restraining and/or enjoining conversion of all or part of Series A Shares<br> of such holder shall have been sought and obtained, and the Company posts a surety bond for<br> the benefit of such holder in the amount of 150% of the Accrued Value of Series A Shares<br> which is subject to the injunction, which bond shall remain in effect until the completion<br> of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable<br> to such holder to the extent it obtains judgment. In the absence of such injunction, the<br> Company shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion.<br> If the Company fails to deliver to a holder such Conversion Shares pursuant to Article 10.2(a)<br> by the 10^th^ Trading Day after the Share Delivery Date applicable to such conversion,<br> the Company shall pay to such holder, in cash, as liquidated damages and not as a penalty,<br> for each $5,000 of Accrued Value of Series A Shares being converted, $25 per Trading Day<br> (increasing to $50 per Trading Day on the third Trading Day and increasing to $100 per Trading<br> Day on the sixth Trading Day after such damages begin to accrue) for each Trading Day after<br> the 10^th^ Trading Day after the Share Delivery Date until such Conversion Shares<br> are delivered or holder rescinds such conversion. Nothing herein shall limit a holder’s<br> right to pursue actual damages for the Company’s failure to deliver Conversion Shares<br> within the period specified herein and such holder shall have the right to pursue all remedies<br> available to it hereunder, at law or in equity, including, without limitation, a decree of<br> specific performance and/or injunctive relief. The exercise of any such rights shall not<br> prohibit a Series A Shareholder from seeking to enforce damages pursuant to any other Article<br> hereof or under Applicable Law.
--- --- 
28
(c) In addition to any other rights available<br> to the holder, if the Company fails for any reason unrelated to the actions of the holder<br> or its Affiliates to deliver to a Converting Shareholder the applicable Conversion Shares<br> by the Share Delivery Date pursuant to Article 10.2(a) and if after such Share Delivery Date<br> such Converting Shareholder is required by its brokerage firm to purchase (in an open market<br> transaction or otherwise), or the Converting Shareholder’s brokerage firm otherwise<br> purchases, Ordinary Shares to deliver in satisfaction of a sale by such Converting Shareholder<br> of the Conversion Shares which such Converting Shareholder was entitled to receive upon the<br> conversion relating to such Share Delivery Date (a Buy-In), then the Company shall<br> (A) pay in cash to such Converting Shareholder (in addition to any other remedies available<br> to or elected by such Converting Shareholder) the amount, if any, by which (x) such Converting<br> Shareholder’s total purchase price (including any brokerage commissions) for the Ordinary<br> Shares so purchased exceeds (y) the product of (1) the aggregate number of Ordinary Shares<br> that such Converting Shareholder was entitled to receive from the conversion at issue multiplied<br> by (2) the actual sale price at which the sell order giving rise to such purchase obligation<br> was executed (excluding any brokerage commissions) and (B) at the option of such Converting<br> Shareholder, either reissue (if surrendered) the Converting Shares equal to the number of<br> Series A Shares submitted for conversion (in which case, such conversion shall be deemed<br> rescinded) or deliver to such Converting Shareholder the number of Ordinary Shares that would<br> have been issued if the Company had timely complied with its delivery requirements under<br> Article 10.2(a). For example, if a Converting Shareholder purchases Ordinary Shares having<br> a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion<br> of Series A Shares with respect to which the actual sale price of the Conversion Shares (including<br> any applicable brokerage commissions) giving rise to such purchase obligation was a total<br> of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be<br> required to pay such Converting Shareholder $1,000. The Converting Shareholder shall provide<br> the Company written notice indicating the amounts payable to such Converting Shareholder<br> in respect of the Buy-In and, upon the request of the Company, evidence of the amount of<br> such loss. If a Converting Shareholder purchases Ordinary Shares having a total purchase<br> price of $9,000 to cover a Buy-In with respect to an attempted conversion of Series A Shares<br> with respect to which the actual sale price of the Conversion Shares (including any applicable<br> brokerage commissions) giving rise to such purchase obligation was a total of $10,000, under<br> clause (A) of the preceding sentence, the Company shall not be required to pay Converting<br> Shareholder any amount. For the avoidance of doubt, in the event of a Buy-In, the Converting<br> Shareholder shall use commercially reasonable efforts to purchase shares at the lowest available<br> price, paying the lowest reasonably available brokerage commission. The Converting Shareholder<br> shall provide the Company written notice indicating the amounts payable to such Converting<br> Shareholder in respect of the Buy-In and evidence of the amount of such loss. Nothing herein<br> shall limit a Converting Shareholder’s right to pursue any other remedies available<br> to it hereunder, at law or in equity including, without limitation, a decree of specific<br> performance and/or injunctive relief with respect to the Company’s failure to timely<br> deliver Conversion Shares upon conversion of the Series A Shares as required pursuant to<br> the terms hereof.
(d) The Company covenants that it will<br> at all times reserve and keep available out of its authorized and unissued Ordinary Shares<br> for the sole purpose of issuance upon conversion of Series A Shares as herein provided, free<br> from preemptive rights or any other actual contingent purchase rights of persons other than<br> the Series A Shareholders (and the other Series A Shareholders), not less than such aggregate<br> number of Ordinary Shares as shall (subject to the terms and conditions set forth in the<br> Purchase Agreement) be issuable (taking into account the adjustments and restrictions of<br> Article 11) upon the conversion of the then outstanding Series A Shares (assuming for such<br> purpose a Conversion Price equal to the Floor Price and any such conversions are made without<br> regard to any limitations on conversion set forth herein). The Company covenants that all<br> Ordinary Shares that shall be so issuable shall, upon issue, be duly authorized, validly<br> issued, fully paid and nonassessable and, if a Registration Statement is then effective under<br> the Securities Act, shall be registered for public resale in accordance with such Registration<br> Statement (subject to such Series A Shareholder’s compliance with its obligations under<br> the Registration Rights Agreement).
--- ---
(e) No fractional shares or scrip representing<br> fractional shares shall be issued upon the conversion of the Series A Shares. As to any fraction<br> of a share which a Series A Shareholder would otherwise be entitled to purchase upon such<br> conversion, the Company shall at its election, either pay a cash adjustment in respect of<br> such final fraction in an amount equal to such fraction multiplied by the Conversion Price<br> or round up to the next whole share. Notwithstanding anything to the contrary contained herein,<br> but consistent with the provisions of this subsection with respect to fractional Conversion<br> Shares, nothing shall prevent any Series A Shareholder from converting fractional Series<br> A Shares.
--- ---
(f) The issuance of Conversion Shares<br> on conversion of Series A Shares shall be made without charge to any Series A Shareholder<br> for any documentary stamp or similar taxes that may be payable in respect of the issue or<br> delivery of such Conversion Shares, provided that the Company shall not be<br> required to pay any tax that may be payable in respect of any transfer involved in the issuance<br> and delivery of any such Conversion Shares upon conversion in a name other than that of the<br> Series A Shareholders of such Series A Shares and the Company shall not be required to issue<br> or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance<br> thereof shall have paid to the Company the amount of such tax or shall have established to<br> the satisfaction of the Company that such tax has been paid.
--- --- 
29
10.3 A Series A Shareholder may notify the Company in writing in the event it elects to be subject to the provisions<br>contained in this Article 10.3; however, no Series A Shareholder shall be subject to this Article 10.3 unless he, she or it makes such<br>election. If the election is made, (i) the Company shall not effect any conversion of Series A Shares, and such Series A Shareholder shall<br>not have the right to convert all or any portion of the Series A Shares, to the extent that, after giving effect to the conversion set<br>forth on the applicable Notice of Conversion, such Series A Shareholder (together with such Series A Shareholder’s Affiliates, and<br>any persons acting as a group together with such Series A Shareholder or any of such Series A Shareholder’s Affiliates (such persons,<br>Attribution Parties)) would beneficially own in excess of 4.9%, 9.9%, 19.9% of the Company’s Ordinary Shares (or such other<br>amount as a Series A Shareholder may specify) (the Beneficial Ownership Limitation) and (ii) the Company shall not permit the Series<br>A Shareholder to vote, and such Series A Shareholder shall not have the right to vote pursuant to these Articles, all or any portion<br>of the Series A Shares that such Series A Shareholder is not permitted to convert pursuant to the preceding clause (i) (provided, however,<br>that such Series A Shareholder shall retain the right to vote pursuant to Article 40 to the extent that retaining such right does not<br>cause such Series A Shareholder to be deemed to beneficially own Conversion Shares within the meaning of Rule 13d-3 promulgated under<br>the Exchange Act). For purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by such Series A Shareholder<br>and its Affiliates and Attribution Parties shall include the number of Ordinary Shares issuable upon conversion of Series A Shares with<br>respect to which such determination is being made, but shall exclude the number of Ordinary Shares which are issuable upon (i) conversion<br>of the remaining, unconverted Accrued Value of Series A Shares beneficially owned by such Series A Shareholder or any of its Affiliates<br>or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company<br>subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by such Shareholder<br>or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Article 10.3, beneficial<br>ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.<br>To the extent that the limitation contained in this Article 10.3 applies, the determination of whether the Series A Shares are convertible<br>(in relation to other securities owned by such Series A Shareholder together with any Affiliates and Attribution Parties) and of how many<br>Series A Shares are convertible shall be in the sole discretion of such Series A Shareholder, and the submission of a Notice of Conversion<br>shall be deemed to be such Series A Shareholder’s determination of whether the Series A Shares may be converted (in relation to<br>other securities owned by such Series A Shareholder together with any Affiliates and Attribution Parties) and how many Series A Shares<br>are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, each Series<br>A Shareholder will be deemed to represent to the Company each time it delivers a Notice of Conversion that such Notice of Conversion has<br>not violated the restrictions set forth in this Article 10.3 and the Company shall have no obligation to verify or confirm the accuracy<br>of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with<br>Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. The Series A Shareholder shall provide the Company<br>with any information reasonably requested by the Company in connection with this Beneficial Ownership Limitation and the provisions related<br>thereto, in each case with respect to the Company’s reporting obligations pursuant to the Securities Act, the Exchange Act, or other<br>federal or state securities regulations. For purposes of this Article 10.3, in determining the number of outstanding Ordinary Shares,<br>a Series A Shareholder may rely on the number of outstanding Ordinary Shares as stated in the most recent of the following: (i) the Company’s<br>most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Company<br>or (iii) a more recent written notice by the Company or the transfer agent setting forth the number of Ordinary Shares outstanding. Upon<br>the written or oral request (which may be via email) of a Series A Shareholder, the Company shall within two Trading Days confirm in writing<br>to such Series A Shareholder the number of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall<br>be determined after giving effect to the conversion or exercise of securities of the Company, including the Series A Shares, by such Series<br>A Shareholder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Ordinary Shares was reported.<br>By written notice to the Company, a Series A Shareholder may from time to time increase or decrease the Beneficial Ownership Limitation<br>applicable to such Series A Shareholder, provided, however, that any such increase in the Beneficial Ownership Limitation will not be<br>effective until the sixty-first (61^st^) day after such notice is delivered to the Company.<br>The provisions of this Article 10.3 shall be construed and implemented in a manner otherwise than in strict conformity with the terms<br>of this Article 10.3 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial<br>Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation.<br>The limitations contained in this paragraph shall apply to a successor Series A Shareholder. 
30
11 Adjustment of Conversion Price
11.1 For the purposes of this Article 11, the following definitions<br>shall apply:
--- ---
(a) Convertible Securities means any Shares or securities (other than Options) directly or indirectly<br>convertible into or exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any Ordinary Shares;
--- ---
(b) Exempt Issuance means the issuance of (a) any securities of the Company to employees, officers<br>or directors, consultants, contractors, vendors or other agents of the Company pursuant to any share or option plan duly adopted for such<br>purpose, by a majority of the non-employee members of the Board or a majority of the members of a committee of non-employee directors<br>established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any<br>securities issued pursuant to the Purchase Agreements or the Business Combination Agreement and/or other securities exercisable or exchangeable<br>for or convertible into Ordinary Shares issued and outstanding on the Date of Adoption, provided that such securities have not been amended<br>since the Date of Adoption to increase the number of such securities or to decrease the exercise price, exchange price or conversion price<br>of such securities (other than in connection with share splits or combinations and automatic adjustments to such terms pursuant to anti-dilution<br>or similar provisions of such securities which are not more favorable to the holder thereof than the anti-dilution and similar provisions<br>in favor of the Series A Holders set forth herein) or to extend the term of such securities, (c) the Conversion Shares, and (d) securities<br>issued pursuant to any merger, acquisition or strategic transaction or partnership approved by a majority of the directors of the Company,<br>provided that (i) such securities are issued as “restricted securities” (as defined in Rule 144) or are issued pursuant to<br>an effective registration statement pursuant to the Securities Act and (ii) any such issuance shall only be to a person (or to the equityholders<br>of a person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with<br>the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but any such<br>Exempt Issuance shall not include a transaction in which the Company is issuing securities (i) primarily for the purpose of raising capital,<br>including an at-the-market offering, or (ii) to an entity whose primary business is investing in securities.
--- ---
(c) Options means rights, options or warrants to subscribe for, purchase or otherwise acquire either<br>Ordinary Shares or Convertible Securities; and
--- ---
(d) Option Value means the value of an Option based on the Black-Scholes Option Pricing model obtained<br>from the “OV” function on Bloomberg determined as of (A) the Trading Day prior to the public announcement of the issuance<br>of the applicable Option, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance<br>of the applicable Option if the issuance of such Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free<br>interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable<br>date of determination, (ii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from<br>the HVT function on Bloomberg as of (A) the Trading Day immediately following the public announcement of the applicable Option if the<br>issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the<br>issuance of such Option is not publicly announced, (iii) the underlying price per share used in such calculation shall be the highest<br>weighted average price of the Ordinary Shares during the period beginning on the Trading Day prior to the execution of definitive documentation<br>relating to the issuance of the applicable Option and ending on (A) the Trading Day immediately following the public announcement of such<br>issuance, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable<br>Option if the issuance of such Option is not publicly announced, (iv) a zero cost of borrow and (v) a 360 day annualization factor, provided,<br>however, in case any Option is issued in connection with the issue or sale of other securities of the Company, together<br>comprising one integrated transaction, in no event shall the Option Value exceed a fraction of the aggregate consideration received (excluding<br>the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision<br>contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options, or in the<br>case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of<br>such Convertible Securities) equal to (1) the number of Ordinary Shares underlying such Option divided by (2) the total number of Ordinary<br>Shares issued or issuable in the integrated transaction (including the number of shares underlying such Option).
--- --- 
31
(e) Series A Issue Date shall mean the Date of Adoption.
11.2 Adjustment of Conversion Price upon issuance of Ordinary Shares. In the event the Company shall<br>at any time after the Series A Issue Date issue or sell, or in accordance with this Article 11.2 is deemed to have issued or sold, any<br>Ordinary Shares (including the issuance or sale of Treasury Shares and any other Ordinary Shares owned or held by or for the account of<br>the Company, but excluding Ordinary Shares issued or sold, or deemed to have been issued or sold, by the Company in connection with any<br>Exempt Issuance) for a consideration per share (the New Issuance Price) less than the lesser of (x) $10.00 (subject to Equitable<br>Adjustment) and (y) the Conversion Price then in effect (each such issue, sale or deemed issuance or sale, a Dilutive Issuance),<br>then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance<br>Price, save that the Conversion Price shall at all times be equal to or greater than the par value of the Ordinary Shares. For all purposes<br>of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance Price under this Article<br>11.2), the following shall be applicable:
--- ---
(a) Options and Convertible Securities. The consideration per share received by the Company for Ordinary<br>Shares deemed to have been issued pursuant to Article 11.2, relating to Options and Convertible Securities, shall be determined by dividing:
--- ---
(i) the total amount, if any, received or receivable by the Company as consideration for the issue of such<br>Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating<br>thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon<br>the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities,<br>the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by
--- ---
(ii) the maximum number of Ordinary Shares (as set forth in the instruments relating thereto, without regard<br>to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion<br>or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible<br>Securities and the conversion or exchange of such Convertible Securities.
--- ---
(b) Deemed issue of Ordinary Shares.
--- ---
(i) If the Company at any time or from time to time after the Series A Issue Date shall issue any Options<br>or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any<br>such Options or Convertible Securities, then the maximum number of Ordinary Shares (as set forth in the instrument relating thereto, assuming<br>the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained<br>therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities<br>and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Ordinary Shares issued as of the<br>time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date.
--- ---
(ii) If the terms of any Option or Convertible Security, the issuance of which resulted in an adjustment to<br>the Conversion Price pursuant to the terms of Article 11.2, are revised as a result of an amendment to such terms or any other adjustment<br>pursuant to the provisions of such Option or Convertible Security (but excluding (x) proportional changes in conversion or exercise prices,<br>as applicable, in connection with Article 11.3 and Article 11.4, or (y) automatic adjustments to such terms pursuant to anti-dilution<br>or similar provisions of such Option or Convertible Security which are not more favorable to the holder thereof than the anti-dilution<br>and similar provisions set forth herein) to provide for either: (1) any increase or decrease in the number of Ordinary Shares issuable<br>upon the exercise, conversion and/or exchange of any such Option or Convertible Security; or (2) any increase or decrease in the consideration<br>payable to the Company upon such exercise, conversion and/or exchange, then, effective upon such increase or decrease becoming effective,<br>the Conversion Price shall be readjusted to such Conversion Price as would have obtained had such revised terms been in effect upon the<br>original date of issuance of such Option or Convertible Security. For purposes of this Article 11.2(b), if the terms of any Option or<br>Convertible Security that was outstanding as of the date of first issuance of a Series A Share are increased or decreased in the manner<br>described in the immediately preceding sentence, then such Option or Convertible Security and the Ordinary Shares deemed issuable upon<br>exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. Notwithstanding<br>the foregoing, no readjustment pursuant to this Article 11.2(b)(ii) shall have the effect of increasing the Conversion Price then in effect.
--- --- 
32
(c) Calculation of Consideration Received.
(i) In case one or more Option is issued in connection with the issue or sale of other securities of the Company,<br>together comprising one integrated transaction, (x) each such Option will be deemed to have been issued for the Option Value of such Option<br>and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference<br>of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms<br>of such other securities of the Company, less (II) the Option Value of each such Option.
--- ---
(ii) If any Ordinary Shares, Options or Convertible Securities are issued or sold or deemed to have been issued<br>or sold for cash, the consideration other than cash received therefor will be deemed to be the net amount received by the Company therefor.<br>If any Ordinary Shares, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration<br>received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities,<br>in which case the amount of consideration received by the Company will be the closing sale price of such publicly traded securities on<br>the date of receipt. If any Ordinary Shares, Options or Convertible Securities are issued to the owners of the non-surviving entity in<br>connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the<br>fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Ordinary Shares, Options<br>or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly traded securities will<br>be determined jointly by the Company and the Series A Majority. If such parties are unable to reach agreement within ten (10) days after<br>the occurrence of an event requiring valuation (the Valuation Event), the fair value of such consideration will be determined within<br>five (5) Business Days after the tenth (10th) day following the Valuation Event by an independent, reputable appraiser jointly selected<br>by the Company and the Series A Majority. The determination of such appraiser shall be final and binding upon all parties absent manifest<br>error and the reasonable fees and expenses of such appraiser shall be borne by the Company.
--- ---
(d) Record Date. If the Company takes a record of the holders of Ordinary Shares for the purpose of<br>entitling them (A) to receive a dividend or other distribution payable in Ordinary Shares, Options or in Convertible Securities or (B)<br>to subscribe for or purchase Ordinary Shares, Options or Convertible Securities, then such record date will be deemed to be the date of<br>the issuance or sale of the Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of<br>such other distribution or the date of the granting of such right of subscription or purchase (as the case may be).
--- --- 
33
(e) Expiration or Termination of Options or Convertible Securities. Upon the expiration or termination<br>of any unexercised Option or unconverted or unexchanged Convertible Securities (or portion thereof) which resulted (either upon its original<br>issuance or upon a revision of its terms) in an adjustment to the Conversion Price pursuant to the terms of Article 11.2, the Conversion<br>Price shall be readjusted to such Conversion Price as would have obtained had such Option or Convertible Securities (or portion thereof)<br>never been issued.
11.3 Adjustment for share splits and combinations. If the Company shall at any time or from time to<br>time after the Series A Issue Date effect a subdivision of the outstanding Ordinary Shares, the Conversion Price in effect immediately<br>before that subdivision shall be proportionately decreased so that the number of Ordinary Shares issuable on conversion of each Series<br>A Share shall be increased in proportion to such increase in the aggregate number of Ordinary Shares outstanding. If the Company shall<br>at any time or from time to time after the Series A Issue Date consolidate the outstanding Ordinary Shares, the Conversion Price in effect<br>immediately before the consolidation shall be proportionately increased so that the number of Ordinary Shares issuable on conversion of<br>each Series A Share shall be decreased in proportion to such decrease in the aggregate number of Ordinary Shares outstanding. Any adjustment<br>under this Article 11.3 shall become effective at the close of business on the date the subdivision or consolidation becomes effective.
--- ---
11.4 Adjustment for certain dividends and distributions. In<br>the event the Company at any time or from time to time after the Series A Issue Date shall make or issue, or fix a record date for the<br>determination of holders of Ordinary Shares entitled to receive, a dividend or other distribution payable on the Ordinary Shares, then<br>and in each such event the Conversion Price in effect immediately before such event shall be decreased as of the time of such issuance<br>or, in the event such a record date shall have been fixed, as of the close of business on such record date, by multiplying the Conversion<br>Price then in effect by a fraction:
--- ---
(a) the numerator of which shall be the total number of Ordinary<br>Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and
--- ---
(b) the denominator of which shall be the total number of Ordinary<br>Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number<br>of Ordinary Shares issuable in payment of such dividend or distribution.
--- ---
(c) Notwithstanding the foregoing, (a) if such record date shall<br>have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Conversion<br>Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Conversion Price shall be adjusted<br>pursuant to this Article 11.4 as of the time of actual payment of such dividends or distributions; and (b) no such adjustment shall be<br>made if the holders of Series A Shares simultaneously receive a dividend or other distribution of Ordinary Shares in a number equal to<br>the number of Ordinary Shares as they would have received if all outstanding Series A Shares had been converted into Ordinary Shares<br>on the date of such event.
--- ---
11.5 Adjustments for other dividends and distributions. In<br>the event the Company at any time or from time to time after the Series A Issue Date shall make or issue, or fix a record date for the<br>determination of holders of Ordinary Shares entitled to receive, a dividend or other distribution payable in securities of the Company<br>(other than a distribution of Ordinary Shares in respect of outstanding Ordinary Shares) or in other property and the provisions of Articles<br>25.7 and 25.8 do not apply to such dividend or distribution, then and in each such event the holders of Series A Shares shall receive,<br>simultaneously with the distribution to the holders of Ordinary Shares, a dividend or other distribution of such securities or other<br>property in an amount equal to the amount of such securities or other property as they would have received if all outstanding Series<br>A Shares had been converted into Ordinary Shares on the date of such event.
--- --- 
34
11.6 Adjustment for merger or reorganisation, etc.
(a) If, at any time while any Series A Share is outstanding, (i) the Company, directly or indirectly, in one<br>or more related transactions effects any merger or consolidation of the Company with or into another person, (ii) the Company (and all<br>of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or<br>other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,<br>purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant to which holders of Ordinary<br>Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders<br>of 50% or more of the outstanding Ordinary Shares or 50% or more of the Shares entitled to vote,<br>(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization<br>of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares is effectively converted into or exchanged<br>for other securities, cash or property (other than as a result of a share split, reverse share split, combination or reclassification<br>of Ordinary Shares covered by Article 11.3 or any reorganization or parent-subsidiary merger not requiring shareholder approval), or (v)<br>the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business<br>combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another<br>person whereby such other person acquires 50% or more of the outstanding Ordinary Shares or 50% or more of the Shares entitled to vote,<br>and such event(s) do not constitute a Deemed Liquidation Event (each a Fundamental Transaction), the Series A Shareholders shall<br>have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence<br>of such Fundamental Transaction (without regard to any limitation in Article 10.3 on the conversion of the), the number of Series A Shares<br>of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the<br>“Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary<br>Shares for which the Series A Shares are convertible immediately prior to such Fundamental Transaction (without regard to any limitation<br>in Article 10.3 on the conversion of the Series A Shares).
--- ---
(b) For purposes of any such conversion, the determination of the Conversion Price shall be appropriately<br>adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share<br>in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable<br>manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares are given<br>any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Series A Shareholder shall be<br>given the same choice as to the Alternate Consideration it receives upon any conversion of the Series A Shares following such Fundamental<br>Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving entity in such<br>Fundamental Transaction shall file articles of association with the same terms and conditions and issue to the Series A Shareholders new<br>preference shares consistent with the foregoing provisions and evidencing the Series A Shareholders’ right to convert such preference<br>shares into Alternate Consideration.
--- --- 
35
(c) The Company shall require any successor entity in a Fundamental Transaction in which the Company is not<br>the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company with respect to the<br>Series A Shares under these Articles and the Registration Rights Agreement in accordance with the provisions of this Article 10.6 pursuant<br>to written agreements in form and substance reasonably satisfactory to the Series A Majority and approved by the Series A Majority (without<br>unreasonable delay) prior to such Fundamental Transaction and shall, at the option of any Series A Shareholder, deliver to the Series<br>A Shareholders in exchange for the Series A Shares a security of the Successor Entity evidenced by a written instrument substantially<br>similar in form and substance to the Series A Shares which is convertible for a corresponding number of shares of capital stock of such<br>Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable and receivable upon conversion of the Series A Shares<br>(without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction, and with a conversion<br>price which applies the Conversion Price hereunder to such shares of capital stock (but taking into account the relative value of the<br>Ordinary Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital<br>stock and such conversion price being for the purpose of protecting the economic value of the Series A Shares immediately prior to the<br>consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Series A Majority.
11.7 Conversion Price Reset. If the per Ordinary Share volume-weighted<br>average price for the twenty trading day period commencing on the date that is six months after the Date of Adoption (the Six MonthVWAP) is less than then the Conversion Price, the Conversion Price will be subject to a one-time downward adjustment equal to the<br>greater of: (i) the Six Month VWAP, and (ii) the Floor Price.
--- ---
11.8 Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant<br>to this Article 11, the Company at its expense shall, as promptly as reasonably practicable but in any event not later than ten days thereafter,<br>compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of Series A Shares a certificate<br>setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The<br>Company shall, as promptly as reasonably practicable after the written request at any time of any holder of Series A Shares (but in any<br>event not later than 10 days thereafter), furnish or cause to be furnished to such holder a certificate setting forth (i) the Conversion<br>Price then in effect, and (ii) the number of Ordinary Shares and the amount, if any, of other securities, cash or property which then<br>would be received upon the conversion of the Series A Shares.
--- --- 
36
11.9 Notice to Allow Conversion. If (A) the Company shall declare a dividend (or any other distribution<br>in whatever form) on the Ordinary Shares, (B) the Company shall declare a redemption of the Ordinary Shares, (C) the Company shall authorize<br>the granting to all holders of the Ordinary Shares of rights or warrants to subscribe for or purchase any shares of any class or of any<br>rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary<br>Shares, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of<br>the Company (and all of its subsidiaries, taken as a whole), or any compulsory share exchange whereby the Ordinary Shares are converted<br>into other securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding<br>up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or agency maintained for the<br>purpose of conversion of the Series A Shares, and shall cause to be delivered by email to each Series A Shareholder at its email address<br>as it shall appear upon the Register of Members, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter<br>specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,<br>rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled<br>to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,<br>merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders<br>of the Ordinary Shares of record shall be entitled to exchange their shares of the Ordinary Shares for securities, cash or other property<br>deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided, that, notwithstanding the foregoing,<br>any notice delivery requirement hereunder shall also be deemed satisfied by filing or furnishing such communication with the Commission<br>via the EDGAR system; provided further, that the failure to deliver such notice or any defect therein or in the delivery thereof shall<br>not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder<br>constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously<br>file or furnish such notice with the Commission pursuant to a Current Report on Form 6-K, unless determined by the Company that such filing<br>would be harmful to the Company at such time, in which case the Company shall file or furnish such 6-K as soon as is reasonably practicable<br>in its discretion. For the avoidance of doubt, and without limiting the conversion rights of any Series A Shareholder, each Series A Shareholder<br>shall remain entitled to convert the Accrued Value of the Series A Shares (or any part hereof) during the twenty (20)-day period commencing<br>on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth<br>herein. 
37
12 Meetings of Members

Annual and extraordinary general meetings

12.1 The Company may, but shall not (unless required by the Designated Stock Exchange Rules, the Commission<br>and/or any other competent regulatory authority or otherwise under Applicable Law) be obligated to, in each year hold a general meeting<br>as an annual general meeting, which, if held, shall be convened by the Board, in accordance with these Articles.
12.2 All general meetings other than annual general meetings shall be called extraordinary general meetings.
--- ---

Power to call meetings

12.3 The Directors may call a general meeting at any time.
12.4 If there are insufficient Directors to constitute a quorum and the remaining Directors are unable to agree<br>on the appointment of additional Directors, the Directors must call a general meeting for the purpose of appointing additional Directors.
--- ---
12.5 The Directors must also call a general meeting if requisitioned in the manner set out in the next two<br>Articles.
--- ---
12.6 The requisition must be in writing and given by one or more Members who together holder at least ten per<br>cent of the rights to vote at such general meeting.
--- ---
12.7 The requisition must also:
--- ---
(a) specify the purpose of the meeting;
--- ---
(b) be signed by or on behalf of each requisitioner (and for this purpose, each joint holder shall be obliged<br>to sign). The requisition may consist of several documents in line form signed by one or more of the requisitioners; and
--- ---
(c) be delivered in accordance with the notice provisions.
--- ---
12.8 Should the Directors fail to call a general meeting within 21 Clear Days’ from the date of receipt of<br>a requisition, the requisitioners or any of them may call a general meeting within three months after the end of that period.
--- ---
12.9 Without limitation to the foregoing, if there are insufficient Directors to constitute a quorum and the<br>remaining Directors are unable to agree on the appointment of additional Directors, any one or more Members who together hold at least<br>ten per cent of the rights to vote at a general meeting may call a general meeting for the purpose of considering the business specified<br>in the notice of meeting which shall include as an item of business the appointment of additional Directors.
--- --- 
38
12.10 Members seeking to bring business before the annual general meeting or to nominate candidates for election<br>as directors at the annual general meeting must deliver notice to the principal executive offices of the Company not later than the close<br>of business on the 90th day nor earlier than the close of business on the 120th day prior to the scheduled date of the annual general<br>meeting.
12.11 If the Members call a meeting under the above provisions, the Company shall reimburse their reasonable<br>expenses.
--- ---

Content of notice

12.12 Notice of a general meeting shall specify each of the following:
(a) the place, the date and the hour of the meeting;
--- ---
(b) if the meeting is to be held in two or more places, the technology that will be used to facilitate the<br>meeting;
--- ---
(c) subject to paragraph (d) and the requirements of the Designated Stock Exchange Rules (to the extent applicable),<br>the general nature of the business to be transacted; and
--- ---
(d) if a resolution is proposed as a Special Resolution, the text<br>of that resolution.
--- ---
12.13 In each notice there shall appear with reasonable prominence the following statements:
--- ---
(a) that a Member who is entitled to attend and vote is entitled to appoint one or more proxies to attend<br>and vote instead of that Member; and
--- ---
(b) that a proxyholder need not be a Member.
--- ---

Period of notice

12.14 At least five (5) Clear Days’ notice shall be given to Members for any general meeting.
12.15 Subject to the Act, a meeting may be convened on shorter notice, with the consent of the Member or Members<br>who, individually or collectively, hold not less than 75 per cent of the voting rights of all those who have a right to vote at that meeting.
--- ---

Persons entitled to receive notice

12.16 Subject to the provisions of these Articles and to any restrictions<br>imposed on any Shares, the notice shall be given to the following people:
(a) the Members
--- ---
(b) persons entitled to a Share in consequence of the death or bankruptcy of a Member;
--- ---
(c) the Directors; and
--- --- 
39
(d) the Auditors (if appointed).
12.17 The Board may determine that the Members entitled to receive notice of a meeting are those persons entered<br>on the register of Members at the close of business on a day determined by the Board.
--- ---

Accidental omission to give notice or non-receipt of notice

12.18 Proceedings at a meeting shall not be invalidated by the following:
(a) an accidental failure to give notice of the meeting to any person entitled to notice; or
--- ---
(b) non-receipt of notice of the meeting by any person entitled to notice.
--- ---
12.19 In addition, where a notice of meeting is published on a website proceedings at the meeting shall not<br>be invalidated merely because it is accidentally published:
--- ---
(a) in a different place on the website; or
--- ---
(b) for part only of the period from the date of the notification until the conclusion of the meeting to which<br>the notice relates.
--- ---
13 Proceedings at meetings of Members
--- ---

Quorum

13.1 Save as provided in the following Article, no business shall be transacted at any meeting unless a quorum<br>is present in person or by proxy. A quorum is as follows:
(a) if the Company has only one Member: that Member;
--- ---
(b) if the Company has more than one Member: one or more Members holding Shares that represent not less than<br>one-third of the outstanding Shares carrying the right to vote at such general meeting, being individuals present in person or by proxy<br>or if a corporation or other non-natural person by its duly authorised representative or proxy.
--- ---

Lack of quorum

13.2 If a quorum is not present within fifteen minutes of the time<br>appointed for the meeting, or if at any time during the meeting it becomes inquorate, then the following provisions apply:
(a) If the meeting was requisitioned by Members, it shall be cancelled.
--- ---
(b) In any other case, the meeting shall stand adjourned to the same time and place seven days hence, or to<br>such other time or place as is determined by the Directors. If a quorum is not present within fifteen minutes of the time appointed for<br>the adjourned meeting, then the Members present in person or by proxy shall constitute a quorum.
--- --- 
40

Chairman

13.3 The chairman of a general meeting shall be the chairman of the Board or such other Director as the Directors<br>have nominated to chair Board meetings in the absence of the chairman of the Board. Absent any such person being present within fifteen<br>minutes of the time appointed for the meeting, the Directors present shall elect one of their number to chair the meeting.
13.4 If no Director is present within fifteen minutes of the time appointed for the meeting, or if no Director<br>is willing to act as chairman, the Members present in person or by proxy and entitled to vote shall choose one of their number to chair<br>the meeting.
--- ---

Right of a Director to attend and speak

13.5 Even if a Director is not a Member, he shall be entitled to attend and speak at any general meeting and<br>at any separate meeting of Members holding a particular class of Shares.

Accommodation of Members at meeting

13.6 lf it appears to the chairman of the meeting that the meeting place specified in the notice convening<br>the meeting is inadequate to accommodate all Members entitled and wishing to attend, the meeting will be duly constituted and its proceedings<br>valid if the chairman is satisfied that adequate facilities are available to ensure that a Member who is unable to be accommodated is<br>able (whether at the meeting place or elsewhere):
(a) to participate in the business for which the meeting has been convened;
--- ---
(b) to hear and see all persons present who speak (whether by the use of microphones, loud-speakers, audio-visual<br>communications equipment or otherwise); and
--- ---
(c) to be heard and seen by all other persons present in the same way.
--- ---

Security

13.7 In addition to any measures which the Board may be required to take due to the location or venue of the<br>meeting, the Board may make any arrangement and impose any restriction it considers appropriate and reasonable in the circumstances to<br>ensure the security of a meeting including, without limitation, the searching of any person attending the meeting and the imposing of<br>restrictions on the items of personal property that may be taken into the meeting place. The Board may refuse entry to, or eject from,<br>a meeting a person who refuses to comply with any such arrangements or restrictions.

Adjournment and Postponement

13.8 The chairman may at any time adjourn a meeting with the consent of the Members constituting a quorum.<br>The chairman must adjourn the meeting if so directed by the meeting. No business, however, can be transacted at an adjourned meeting other<br>than business which might properly have been transacted at the original meeting. 
41
13.9 Should a meeting be adjourned for more than 20 Clear Days, whether because of a lack of quorum or otherwise,<br>Members shall be given at least five (5) Clear Days’ notice of the date, time and place of the adjourned meeting and the general nature<br>of the business to be transacted. Otherwise it shall not be necessary to give any notice of the adjournment.
13.10 If a notice is issued in respect of a general meeting and the Directors, in their absolute discretion,<br>consider that it is impractical or undesirable for any reason to hold that general meeting at the place, the day and the hour specified<br>in the notice calling such general meeting, the Directors may postpone the general meeting to another place, day and/or hour provided<br>that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members. No business shall be<br>transacted at any postponed meeting other than the business specified in the notice of the original meeting.
--- ---
13.11 When a general meeting is postponed for thirty days or more, notice of the postponed meeting shall be<br>given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of a postponed meeting. All proxy<br>forms submitted for the original general meeting shall remain valid for the postponed meeting. The Directors may postpone a general meeting<br>which has already been postponed.
--- ---

Method of voting

13.12 A resolution put to the vote of the meeting shall be decided on a poll.

Taking of a poll

13.13 A poll demanded on the question of adjournment shall be taken immediately.
13.14 A poll demanded on any other question shall be taken either immediately or at an adjourned meeting at<br>such time and place as the chairman directs, not being more than thirty Clear Days after the poll was demanded.
--- ---
13.15 The demand for a poll shall not prevent the meeting continuing to transact any business other than the<br>question on which the poll was demanded.
--- ---
13.16 A poll shall be taken in such manner as the chairman directs. He may appoint scrutineers (who need not<br>be Members) and fix a place and time for declaring the result of the poll. If, through the aid of technology, the meeting is held in more<br>than one place, the chairman may appoint scrutineers in more than one place; but if he considers that the poll cannot be effectively monitored<br>at that meeting, the chairman shall adjourn the holding of the poll to a date, place and time when that can occur.
--- ---

Chairman’s casting vote

13.17 In the case of an equality of votes, the Chairman shall be entitled to a second or casting vote. 
42

Amendments to resolutions

13.18 An Ordinary Resolution to be proposed at a general meeting may be amended by Ordinary Resolution if:
(a) not less than 48 hours before the meeting is to take place (or such later time as the chairman of the<br>meeting may determine), notice of the proposed amendment is given to the Company in writing by a Member entitled to vote at that meeting;<br>and
--- ---
(b) the proposed amendment does not, in the reasonable opinion of the chairman of the meeting, materially<br>alter the scope of the resolution.
--- ---
13.19 A Special Resolution to be proposed at a general meeting may be amended by Ordinary Resolution, if:
--- ---
(a) the chairman of the meeting proposes the amendment at the general meeting at which the resolution is to<br>be proposed, and
--- ---
(b) the amendment does not go beyond what the chairman considers is necessary to correct a grammatical or<br>other non-substantive error in the resolution.
--- ---
13.20 If the chairman of the meeting, acting in good faith, wrongly decides that an amendment to a resolution<br>is out of order, the chairman’s error does not invalidate the vote on that resolution.
--- ---

Sole-Member Company

13.21 If the Company has only one Member, and the Member records in writing his decision on a question, that<br>record shall constitute both the passing of a resolution and the minute of it.
14 Voting rights of Members
--- ---

Right to vote

14.1 Unless their Shares carry no right to vote, or unless a call or other amount presently payable has not<br>been paid, all Members are entitled to vote at a general meeting, and all Members holding Shares of a particular class of Shares are entitled<br>to vote at a meeting of the holders of that class of Shares.
14.2 Members may vote in person or by proxy.
--- ---
14.3 Subject to Article 2.4, every Member shall have one vote for<br>each Share he holds, unless any Share carries special voting rights.
--- ---
14.4 No Member is bound to vote on his Shares or any of them; nor is he bound to vote each of his Shares in<br>the same way.
--- --- 
43

Rights of joint holders

14.5 If Shares are held jointly, only one of the joint holders may vote. If more than one of the joint holders<br>tenders a vote, the vote of the holder whose name in respect of those Shares appears first in the register of Members shall be accepted<br>to the exclusion of the votes of the other joint holder.

Representation of corporate Members

14.6 Save where otherwise provided, a corporate Member must act by a duly authorised representative.
14.7 A corporate Member wishing to act by a duly authorised representative must identify that person to the<br>Company by notice in writing.
--- ---
14.8 The authorisation may be for any period of time, and must be delivered to the Company before the commencement<br>of the meeting at which it is first used.
--- ---
14.9 The Directors of the Company may require the production of any evidence which they consider necessary<br>to determine the validity of the notice.
--- ---
14.10 Where a duly authorised representative is present at a meeting that Member is deemed to be present in<br>person; and the acts of the duly authorised representative are personal acts of that Member.
--- ---
14.11 A corporate Member may revoke the appointment of a duly authorised representative at any time by notice<br>to the Company; but such revocation will not affect the validity of any acts carried out by the duly authorised representative before<br>the Directors of the Company had actual notice of the revocation.
--- ---
14.12 If a clearing house (or its nominee(s)), being a corporation, is a Member, it may authorise such persons<br>as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of Members provided that the<br>authorisation shall specify the number and class of Shares in respect of which each such representative is so authorised. Each person<br>so authorised under the provisions of this Article shall be deemed to have been duly authorised without further evidence of the facts<br>and be entitled to exercise the same rights and powers on behalf of the clearing house (or its nominee(s)) as if such person was the registered<br>holder of such Shares held by the clearing house (or its nominee(s)).
--- ---

Member with mental disorder

14.13 A Member in respect of whom an order has been made by any court<br>having jurisdiction (whether in the Cayman Islands or elsewhere) in matters concerning mental disorder may vote, by that Member’s<br>receiver, curator bonis or other person authorised in that behalf appointed by that court. 
44
14.14 For the purpose of the preceding Article, evidence to the satisfaction of the Directors of the authority<br>of the person claiming to exercise the right to vote must be received not less than 24 hours before holding the relevant meeting or the<br>adjourned meeting in any manner specified for the delivery of forms of appointment of a proxy, whether in writing or by Electronic means.<br>In default, the right to vote shall not be exercisable.

Objections to admissibility of votes

14.15 An objection to the validity of a person’s vote may only be raised at the meeting or at the adjourned<br>meeting at which the vote is sought to be tendered. Any objection duly made shall be referred to the chairman whose decision shall be<br>final and conclusive.

Form of proxy

14.16 An instrument appointing a proxy shall be in any common form or in any other form approved by the Directors.
14.17 The instrument must be in writing and signed in one of the following<br>ways:
--- ---
(a) by the Member; or
--- ---
(b) by the Member’s authorised attorney; or
--- ---
(c) if the Member is a corporation or other body corporate, under seal or signed by an authorised officer,<br>secretary or attorney.
--- ---

If the Directors so resolve, the Company may accept an Electronic Record of that instrument delivered in the manner specified below and otherwise satisfying the Articles about authentication of Electronic Records.

14.18 The Directors may require the production of any evidence which they consider necessary to determine the<br>validity of any appointment of a proxy.
14.19 A Member may revoke the appointment of a proxy at any time by<br>notice to the Company duly signed in accordance with Article 14.17.
--- ---
14.20 No revocation by a Member of the appointment of a proxy made in accordance with Article 14.19 will affect<br>the validity of any acts carried out by the relevant proxy before the Directors of the Company had actual notice of the revocation.
--- ---

How and when proxy is to be delivered

14.21 Subject to the following Articles, the Directors may, in the<br>notice convening any meeting or adjourned meeting, or in an instrument of proxy sent out by the Company, specify the manner by which<br>the instrument appointing a proxy shall be deposited and the place and the time (being not later than the time appointed for the commencement<br>of the meeting or adjourned meeting to which the proxy relates) at which the instrument appointing a proxy shall be deposited. In the<br>absence of any such direction from the Directors in the notice convening any meeting or adjourned meeting or in an instrument of proxy<br>sent out by the Company, the form of appointment of a proxy and any authority under which it is signed (or a copy of the authority certified<br>notarially or in any other way approved by the Directors) must be delivered so that it is received by the Company before the time for<br>holding the meeting or adjourned meeting at which the person named in the form of appointment of proxy proposes to vote. They must be<br>delivered in either of the following ways:
(a) In the case of an instrument in writing, it must be left at or sent by post:
--- --- 
45
(i) to the registered office of the Company; or
(ii) to such other place within the Cayman Islands specified in the notice convening the meeting or in any<br>form of appointment of proxy sent out by the Company in relation to the meeting.
--- ---
(b) If, pursuant to the notice provisions, a notice may be given to the Company in an Electronic Record, an<br>Electronic Record of an appointment of a proxy must be sent to the address specified pursuant to those provisions unless another address<br>for that purpose is specified:
--- ---
(i) in the notice convening the meeting; or
--- ---
(ii) in any form of appointment of a proxy sent out by the Company in relation to the meeting; or
--- ---
(iii) in any invitation to appoint a proxy issued by the Company in relation to the meeting.
--- ---
(c) Notwithstanding Article 14.21(a) and Article 14.21(b), the chairman of the Company may, in any event at<br>his discretion, direct that an instrument of proxy shall be deemed to have been duly deposited.
--- ---
14.22 Where a poll is taken:
--- ---
(a) if it is taken more than seven Clear Days after it is demanded, the form of appointment of a proxy and<br>any accompanying authority (or an Electronic Record of the same) must be delivered in accordance with Article 14.21 before the time appointed<br>for the taking of the poll;
--- ---
(b) if it to be taken within seven Clear Days after it was demanded, the form of appointment of a proxy and<br>any accompanying authority (or an Electronic Record of the same) must be delivered in accordance with Article 14.21 before the time appointed<br>for the taking of the poll.
--- ---
14.23 If the form of appointment of proxy is not delivered on time, it is (unless the chairman declares it to<br>be duly deposited) invalid.
--- --- 
46
14.24 When two or more valid but differing appointments of proxy are delivered or received in respect of the<br>same Share for use at the same meeting and in respect of the same matter, the one which is last validly delivered or received (regardless<br>of its date or of the date of its execution) shall be treated as replacing and revoking the other or others as regards that Share. lf<br>the Company is unable to determine which appointment was last validly delivered or received, none of them shall be treated as valid in<br>respect of that Share.
14.25 The Board may at the expense of the Company send forms of appointment of proxy to the Members by post<br>(that is to say, pre-paying and posting a letter), or by Electronic communication or otherwise (with or without provision for their return<br>by pre-paid post) for use at any general meeting or at any separate meeting of the holders of any class of Shares, either blank or nominating<br>as proxy in the alternative any one or more of the Directors or any other person. lf for the purpose of any meeting invitations to appoint<br>as proxy a person or one of a number of persons specified in the invitations are issued at the Company’s expense, they shall be<br>issued to all (and not to some only) of the Members entitled to be sent notice of the meeting and to vote at it. The accidental omission<br>to send such a form of appointment or to give such an invitation to, or the non-receipt of such form of appointment by, any Member entitled<br>to attend and vote at a meeting shall not invalidate the proceedings at that meeting.
--- ---

Voting by proxy

14.26 A proxy shall have the same voting rights at a meeting or adjourned meeting as the Member would have had<br>except to the extent that the instrument appointing him limits those rights. Notwithstanding the appointment of a proxy, a Member may<br>attend and vote at a meeting or adjourned meeting. If a Member votes on any resolution a vote by his proxy on the same resolution, unless<br>in respect of different Shares, shall be invalid.
14.27 The instrument appointing a proxy to vote at a meeting shall be deemed also to confer authority to demand<br>or join in demanding a poll and a demand by a person as proxy for a Member shall be the same as a demand by a Member. Such appointment<br>shall not confer any further right to speak at the meeting, except with the permission of the chairman of the meeting.
--- ---
15 Number of Directors
--- ---
15.1 There shall be a Board consisting of not less than one person provided however that the Company may by<br>Ordinary Resolution increase or reduce the limits in the number of Directors. Unless fixed by Ordinary Resolution, the maximum number<br>of Directors shall be six.
--- ---
16 Appointment, disqualification and removal of Directors
--- ---

No age limit

16.1 There is no age limit for Directors save that they must be at least eighteen years of age. 
47

Corporate Directors

16.2 Unless prohibited by law, a body corporate may be a Director. If a body corporate is a Director, the Articles<br>about representation of corporate Members at general meetings apply, mutatis mutandis, to the Articles about Directors’ meetings.

No shareholding qualification

16.3 Unless a shareholding qualification for Directors is fixed by Ordinary Resolution, no Director shall be<br>required to own Shares as a condition of his appointment.

Appointment of Directors

16.4 The Directors shall not be divided into classes. All Directors<br>shall hold office until the expiration of their terms of office and until their successors shall have been elected and qualified. A Director<br>elected to fill a vacancy resulting from the death, resignation or removal of a Director shall serve for the remainder of the full term<br>of the Director whose death, resignation or removal shall have created such vacancy and until his successor shall have been elected and<br>qualified.
16.5 A Director may be appointed by Ordinary Resolution or by the Directors. Any appointment may be to fill<br>a vacancy or as an additional Director.
--- ---
16.6 The remaining Director(s) may appoint a Director even though there is not a quorum of Directors.
--- ---
16.7 No appointment can cause the number of Directors to exceed the maximum (if one is set); and any such appointment<br>shall be invalid.
--- ---
16.8 For so long as Shares are listed on a Designated Stock Exchange, the Directors shall include at least<br>such number of Independent Directors as Applicable Law or the rules and regulations of the Designated Stock Exchange require, subject<br>to applicable phase-in rules of the Designated Stock Exchange rules or regulations or the Designated Stock Exchange Rules, as determined<br>by the Board.
--- ---

Board’s power to appoint Directors

16.9 Without prejudice to the Company’s power to appoint a person to be a Director pursuant to these<br>Articles, the Board shall have power at any time to appoint any person who is willing to act as a Director, either to fill a vacancy or<br>as an addition to the existing Board, subject to the total number of Directors not exceeding any maximum number fixed by or in accordance<br>with these Articles.
16.10 An appointment of a Director may be on terms that the Director shall automatically retire from office<br>(unless he has sooner vacated office) at the next or a subsequent annual general meeting or upon any specified event or after any specified<br>period in a written agreement between the Company and the Director, if any; but no such term shall be implied in the absence of express<br>provision. Each Director whose term of office expires shall be eligible for re-election at a meeting of the Shareholders or re-appointment<br>by the Board.
--- --- 
48

Removal of Directors

16.11 A Director may be removed by Ordinary Resolution.

Resignation of Directors

16.12 A Director may at any time resign office by giving to the Company notice in writing or, if permitted pursuant<br>to the notice provisions, in an Electronic Record delivered in either case in accordance with those provisions.
16.13 Unless the notice specifies a different date, the Director shall be deemed to have resigned on the date<br>that the notice is delivered to the Company.
--- ---

Termination of the office of Director

16.14 A Director may retire from office as a Director by giving notice in writing to that effect to the Company<br>at the registered office, which notice shall be effective upon such date as may be specified in the notice, failing which upon delivery<br>to the registered office.
16.15 Without prejudice to the provisions in these Articles for retirement (by rotation or otherwise), a Director’s<br>office shall be terminated forthwith if:
--- ---
(a) he is prohibited by the law of the Cayman Islands from acting as a Director; or
--- ---
(b) he is made bankrupt or makes an arrangement or composition with his creditors generally; or
--- ---
(c) he resigns his office by notice to the Company; or
--- ---
(d) he only held office as a Director for a fixed term and such term expires; or
--- ---
(e) in the opinion of a registered medical practitioner by whom he is being treated he becomes physically<br>or mentally incapable of acting as a Director; or
--- ---
(f) he is given notice by the majority of the other Directors (not being less than two in number) to vacate<br>office (without prejudice to any claim for damages for breach of any agreement relating to the provision of the services of such Director);<br>or
--- ---
(g) he is made subject to any law relating to mental health or incompetence, whether by court order or otherwise;<br>or
--- ---
(h) without the consent of the other Directors, he is absent from meetings of Directors for a continuous period<br>of six months.
--- --- 
49
17 Alternate Directors

Appointment and removal

17.1 Any Director may appoint any other person, including another Director, to act in his place as an alternate<br>Director. No appointment shall take effect until the Director has given notice of the appointment to the Board. Such notice must be given<br>to each other Director by either of the following methods:
(a) by notice in writing in accordance with the notice provisions;
--- ---
(b) if the other Director has an email address, by emailing to that address a scanned copy of the notice as<br>a PDF attachment (the PDF version being deemed to be the notice unless Article 31.7 applies), in which event notice shall be taken to<br>be given on the date of receipt by the recipient in readable form. For the avoidance of doubt, the same email may be sent to the email<br>address of more than one Director (and to the email address of the Company pursuant to Article 17.4(c)).
--- ---
17.2 Without limitation to the preceding Article, a Director may appoint an alternate for a particular meeting<br>by sending an email to his fellow Directors informing them that they are to take such email as notice of such appointment for such meeting.<br>Such appointment shall be effective without the need for a signed notice of appointment or the giving of notice to the Company in accordance<br>with Article 17.4.
--- ---
17.3 A Director may revoke his appointment of an alternate at any time. No revocation shall take effect until<br>the Director has given notice of the revocation to the Board. Such notice must be given by either of the methods specified in Article<br>17.1.
--- ---
17.4 A notice of appointment or removal of an alternate Director shall be effective only if given to the Company<br>by one or more of the following methods:
--- ---
(a) by notice in writing in accordance with the notice provisions contained in these Articles;
--- ---
(b) if the Company has a facsimile address for the time being, by sending by facsimile transmission to that<br>facsimile address a facsimile copy or, otherwise, by sending by facsimile transmission to the facsimile address of the Company’s registered<br>office a facsimile copy (in either case, the facsimile copy being deemed to be the notice unless Article 31.7 applies), in which event<br>notice shall be taken to be given on the date of an error-free transmission report from the sender’s fax machine;
--- ---
(c) if the Company has an email address for the time being, by emailing to that email address a scanned copy<br>of the notice as a PDF attachment or, otherwise, by emailing to the email address provided by the Company’s registered office a scanned<br>copy of the notice as a PDF attachment (in either case, the PDF version being deemed to be the notice unless Article 31.7 applies), in<br>which event notice shall be taken to be given on the date of receipt by the Company or the Company’s registered office (as appropriate)<br>in readable form; or
--- --- 
50
(d) if permitted pursuant to the notice provisions, in some other form of approved Electronic Record delivered<br>in accordance with those provisions in writing.

Notices

17.5 All notices of meetings of Directors shall continue to be given to the appointing Director and not to<br>the alternate.

Rights of alternate Director

17.6 An alternate Director shall be entitled to attend and vote at any Board meeting or meeting of a committee<br>of the Directors at which the appointing Director is not personally present, and generally to perform all the functions of the appointing<br>Director in his absence. An alternate Director, however, is not entitled to receive any remuneration from the Company for services rendered<br>as an alternate Director.

Appointment ceases when the appointor ceases to be a Director

17.7 An alternate Director shall cease to be an alternate Director if:
(a) the Director who appointed him ceases to be a Director; or
--- ---
(b) the Director who appointed him revokes his appointment by notice delivered to the Board or to the registered<br>office of the Company or in any other manner approved by the Board; or
--- ---
(c) in any event happens in relation to him which, if he were a Director of the Company, would cause his office<br>as Director to be vacated.
--- ---

Status of alternate Director

17.8 An alternate Director shall carry out all functions of the Director who made the appointment.
17.9 Save where otherwise expressed, an alternate Director shall be treated as a Director under these Articles.
--- ---
17.10 An alternate Director is not the agent of the Director appointing him.
--- ---
17.11 An alternate Director is not entitled to any remuneration for acting as alternate Director.
--- ---

Status of the Director making the appointment

17.12 A Director who has appointed an alternate is not thereby relieved from the duties which he owes the Company. 
51
18 Powers of Directors

Powers of Directors

18.1 Subject to the provisions of the Act, the Memorandum and these Articles the business of the Company shall<br>be managed by the Directors who may for that purpose exercise all the powers of the Company.
18.2 No prior act of the Directors shall be invalidated by any subsequent alteration of the Memorandum or these<br>Articles. However, to the extent allowed by the Act, Members may, by Special Resolution, validate any prior or future act of the Directors<br>which would otherwise be in breach of their duties.
--- ---

Directors below the minimum number

18.3 lf the number of Directors is less than the minimum prescribed in accordance with these Articles, the<br>remaining Director or Directors shall act only for the purposes of appointing an additional Director or Directors to make up such minimum<br>or of convening a general meeting of the Company for the purpose of making such appointment. lf there are no Director or Directors able<br>or willing to act, any two Members may summon a general meeting for the purpose of appointing Directors. Any additional Director so appointed<br>shall hold office (subject to these Articles) only until the dissolution of the annual general meeting next following such appointment<br>unless he is re-elected during such meeting.

Appointments to office

18.4 The Directors may appoint a Director:
(a) as chairman of the Board;
--- ---
(b) as managing Director;
--- ---
(c) to any other executive office,
--- ---

for such period, and on such terms, including as to remuneration as they think fit.

18.5 The appointee must consent in writing to holding that office.
18.6 Where a chairman is appointed he shall, unless unable to do so, preside at every meeting of Directors.
--- ---
18.7 If there is no chairman, or if the chairman is unable to preside at a meeting, that meeting may select<br>its own chairman; or the Directors may nominate one of their number to act in place of the chairman should he ever not be available.
--- ---
18.8 Subject to the provisions of the Act, the Directors may also appoint and remove any person, who need not<br>be a Director:
--- ---
(a) as Secretary; and
--- --- 
52
(b) to any office that may be required

for such period and on such terms, including as to remuneration, as they think fit. In the case of an Officer, that Officer may be given any title the Directors decide.

18.9 The Secretary or Officer must consent in writing to holding that office.
18.10 A Director, Secretary or other Officer of the Company may not hold the office, or perform the services,<br>of auditor.
--- ---

Provisions for employees

18.11 The Board may make provision for the benefit of any persons employed or formerly employed by the Company<br>or any of its subsidiary undertakings (or any member of his family or any person who is dependent on him) in connection with the cessation<br>or the transfer to any person of the whole or part of the undertaking of the Company or any of its subsidiary undertakings.

Exercise of voting rights

18.12 The Board may exercise the voting power conferred by the Shares in any body corporate held or owned by<br>the Company in such manner in all respects as it thinks fit (including, without limitation, the exercise of that power in favour of any<br>resolution appointing any Director as a Director of such body corporate, or voting or providing for the payment of remuneration to the<br>Directors of such body corporate).

Remuneration

18.13 Every Director may be remunerated by the Company for the services he provides for the benefit of the Company,<br>whether as Director, employee or otherwise, and shall be entitled to be paid for the expenses incurred in the Company’s business<br>including attendance at Directors’ meetings.
18.14 Until otherwise determined by the Company by Ordinary Resolution, the Directors (other than alternate<br>Directors) shall be entitled to such remuneration by way of fees for their services in the office of Director as the Directors may determine.
--- ---
18.15 Remuneration may take any form and may include arrangements to pay pensions, health insurance, death or<br>sickness benefits, whether to the Director or to any other person connected to or related to him.
--- ---
18.16 Unless his fellow Directors determine otherwise, a Director is not accountable to the Company for remuneration<br>or other benefits received from any other company which is in the same group as the Company or which has common shareholdings.
--- --- 
53

Disclosure of information

18.17 Subject to the compliance with Applicable Laws, including the federal securities laws of the United States,<br>the Directors may release or disclose to a third party any information regarding the affairs of the Company, including any information<br>contained in the register of Members relating to a Member, (and they may authorise any Director, Officer or other authorised agent of<br>the Company to release or disclose to a third party any such information in his possession) if:
(a) the Company or that person, as the case may be, is lawfully required to do so under the laws of any jurisdiction<br>to which the Company is subject; or
--- ---
(b) such disclosure is in compliance with the Designated Stock Exchange<br>Rules; or
--- ---
(c) such disclosure is in accordance with any contract entered into by the Company; or
--- ---
(d) the Directors are of the opinion such disclosure would assist or facilitate the Company’s operations.
--- ---
19 Delegation of powers
--- ---

Power to delegate any of the Directors’ powers to a committee

19.1 The Directors may delegate any of their powers to any committee consisting of one or more persons who<br>need not be Members. Persons on the committee may include non-Directors so long as the majority of those persons are Directors. For so<br>long as Shares are listed on a Designated Stock Exchange, any such committee shall be made up of such number of Independent Directors<br>as required from time to time by the Designated Stock Exchange Rules or otherwise required by Applicable Law.
19.2 The delegation may be collateral with, or to the exclusion of, the Directors’ own powers.
--- ---
19.3 The delegation may be on such terms as the Directors think fit, including provision for the committee<br>itself to delegate to a sub-committee; save that any delegation must be capable of being revoked or altered by the Directors at will.
--- ---
19.4 Unless otherwise permitted by the Directors, a committee must follow the procedures prescribed for the<br>taking of decisions by Directors.
--- ---
19.5 For so long as Shares are listed on a Designated Stock Exchange, the Board shall establish an audit committee,<br>a compensation committee and a nominating and corporate governance committee. Each of these committees shall be empowered to do all things<br>necessary to exercise the rights of such committee set forth in these Articles. Each of the audit committee, compensation committee and<br>nominating and corporate governance committee shall consist of at least three Directors (or such larger minimum number as may be required<br>from time to time by the Designated Stock Exchange Rules). The committees shall be made up of such number of Independent Directors as<br>required from time to time by the Designated Stock Exchange Rules or otherwise required by Applicable Law, subject to any exemptions permitted<br>under the Designated Stock Exchange Rules and other Applicable Laws.
--- --- 
54

Local boards

19.6 The Board may establish any local or divisional board or agency for managing any of the affairs of the<br>Company whether in the Cayman Islands or elsewhere and may appoint any persons to be members of a local or divisional Board, or to be<br>managers or agents, and may fix their remuneration.
19.7 The Board may delegate to any local or divisional board, manager or agent any of its powers and authorities<br>(with power to sub-delegate) and may authorise the members of any local or divisional board or any of them to fill any vacancies and to<br>act notwithstanding vacancies.
--- ---
19.8 Any appointment or delegation under this Article 19.8 may be<br>made on such terms and subject to such conditions as the Board thinks fit and the Board may remove any person so appointed, and may revoke<br>or vary any delegation.
--- ---

Power to appoint an agent of the Company

19.9 The Directors may appoint any person, either generally or in respect of any specific matter, to be the<br>agent of the Company with or without authority for that person to delegate all or any of that person’s powers. The Directors may<br>make that appointment:
(a) by causing the Company to enter into a power of attorney or agreement; or
--- ---
(b) in any other manner they determine.
--- ---

Power to appoint an attorney or authorised signatory of the Company

19.10 The Directors may appoint any person, whether nominated directly<br>or indirectly by the Directors, to be the attorney or the authorised signatory of the Company. The appointment may be:
(a) for any purpose;
--- ---
(b) with the powers, authorities and discretions;
--- ---
(c) for the period; and
--- ---
(d) subject to such conditions
--- ---

as they think fit. The powers, authorities and discretions, however, must not exceed those vested in, or exercisable, by the Directors under these Articles. The Directors may do so by power of attorney or any other manner they think fit.

55
19.11 Any power of attorney or other appointment may contain such provision for the protection and convenience<br>for persons dealing with the attorney or authorised signatory as the Directors think fit. Any power of attorney or other appointment may<br>also authorise the attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in that person.
19.12 The Board may remove any person appointed under Article 19.10 and may revoke or vary the delegation.
--- ---

Borrowing Powers

19.13 The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its<br>undertaking, property and assets both present and future and uncalled capital, or any part thereof, and to issue debentures and other<br>securities, whether outright or as collateral security for any debt, liability or obligation of the Company or its parent undertaking<br>(if any) or any subsidiary undertaking of the Company or of any third party.

Corporate Governance

19.14 The Board may, from time to time, and except as required by Applicable Law or the Designated Stock Exchange<br>Rules, adopt, institute, amend, modify or revoke the corporate governance policies or initiatives of the Company, which shall be intended<br>to set forth the guiding principles and policies of the Company and the Board on various corporate governance related matters as the Board<br>shall determine by resolution from time to time.
20 Meetings of Directors
--- ---

Regulation of Directors’ meetings

20.1 Subject to the provisions of these Articles, the Directors may regulate their proceedings as they think<br>fit.

Calling meetings

20.2 Any Director may call a meeting of Directors at any time. The Secretary must call a meeting of the Directors<br>if requested to do so by a Director.

Notice of meetings

20.3 Notice of a Board meeting may be given to a Director personally or by word of mouth or given in writing<br>or by Electronic communications at such address as he may from time to time specify for this purpose (or, if he does not specify an address,<br>at his last known address). A Director may waive his right to receive notice of any meeting either prospectively or retrospectively. 
56

Use of technology

20.4 A Director may participate in a meeting of Directors through the medium of conference telephone, video<br>or any other form of communications equipment providing all persons participating in the meeting are able to hear and speak to each other<br>throughout the meeting.
20.5 A Director participating in this way is deemed to be present in person at the meeting.
--- ---

Quorum

20.6 The quorum for the transaction of business at a meeting of Directors shall be two unless the Directors<br>fix some other number.

Chairman or deputy to preside

20.7 The Board may appoint a chairman and one or more deputy chairman or chairmen and may at any time revoke<br>any such appointment.
20.8 The chairman, or failing him any deputy chairman (the longest in office taking precedence if more than<br>one is present), shall preside at all Board meetings. If no chairman or deputy chairman has been appointed, or if he is not present within<br>five minutes after the time fixed for holding the meeting, or is unwilling to act as chairman of the meeting, the Directors present shall<br>choose one of their number to act as chairman of the meeting.
--- ---

Voting

20.9 A question which arises at a Board meeting shall be decided by a majority of votes. If votes are equal<br>the chairman may, if he wishes, exercise a casting vote.

Recording of dissent

20.10 A Director present at a meeting of Directors shall be presumed to have assented to any action taken at<br>that meeting unless:
(a) his dissent is entered in the minutes of the meeting; or
--- ---
(b) he has filed with the meeting before it is concluded signed dissent from that action; or
--- ---
(c) he has forwarded to the Company as soon as practical following the conclusion of that meeting signed dissent.
--- ---

A Director who votes in favour of an action is not entitled to record his dissent to it.

57

Written resolutions

20.11 The Directors may pass a resolution in writing without holding a meeting if all Directors sign a document<br>or sign several documents in the like form each signed by one or more of those Directors.
20.12 A written resolution signed by a validly appointed alternate Director need not also be signed by the appointing<br>Director.
--- ---
20.13 A written resolution signed personally by the appointing Director<br>need not also be signed by his alternate.
--- ---
20.14 A resolution in writing passed pursuant to Article 20.11, Article 20.12 and/or Article 20.13 shall be<br>as effective as if it had been passed at a meeting of the Directors duly convened and held; and it shall be treated as having been passed<br>on the day and at the time that the last Director signs (and for the avoidance of doubt, such day may or may not be a Business Day).
--- ---

Validity of acts of Directors in spite of formal defect

20.15 All acts done by a meeting of the Board, or of a committee of the Board, or by any person acting as a<br>Director or an alternate Director, shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment<br>of any Director or alternate Director or member of the committee, or that any of them were disqualified or had vacated office or were<br>not entitled to vote, be as valid as if every such person had been duly appointed and qualified and had continued to be a Director or<br>alternate Director and had been entitled to vote.
21 Permissible Directors’ interests and disclosure
--- ---
21.1 A Director who is in any way, whether directly or indirectly,<br>interested in a contract or transaction or proposed contract or transaction with the Company shall declare the nature of his interest<br>at a meeting of the Directors. A general notice given to the Directors by any Director to the effect that he is a member of any specified<br>company or firm and is to be regarded as interested in any contract or transaction which may thereafter be made with that company or<br>firm shall be deemed a sufficient declaration of interest in regard to any contract so made or transaction so consummated. Subject to<br>the Designated Stock Exchange Rules and disqualification by the chairman of the relevant Board meeting, a Director may vote in respect<br>of any contract or transaction or proposed contract or transaction notwithstanding that he may be interested therein and if he does so<br>his vote shall be counted and he may be counted in the quorum at any meeting of the Directors at which any such contract or transaction<br>or proposed contract or transaction shall come before the meeting for consideration.
--- ---
21.2 For the purposes of the preceding Article:
--- ---
(a) a general notice that a Director gives to the other Directors that he is to be regarded as having an interest<br>of the nature and extent specified in the notice in any transaction or arrangement in which a specified person or class of persons is<br>interested shall be deemed to be a disclosure that he has an interest in or duty in relation to any such transaction of the nature and<br>extent so specified; and
--- --- 
58
(b) an interest of which a Director has no knowledge and of which it is unreasonable to expect him to have<br>knowledge shall not be treated as an interest of his.
22 Minutes
--- ---
22.1 The Company shall cause minutes to be made in books of:
--- ---
(a) all appointments of Officers and committees made by the Board and of any such Officer’s remuneration;<br>and
--- ---
(b) the names of Directors present at every meeting of the Directors, a committee of the Board, the Company<br>or the holders of any class of shares or debentures, and all orders, resolutions and proceedings of such meetings.
--- ---
22.2 Any such minutes, if purporting to be signed by the chairman of the meeting at which the proceedings were<br>held or by the chairman of the next succeeding meeting or the Secretary, shall be prima facie evidence of the matters stated in them.
--- ---
23 Accounts and audit
--- ---
23.1 The Directors must ensure that proper accounting and other records are kept, and that accounts and associated<br>reports are distributed in accordance with the requirements of the Act.
--- ---
23.2 The books of account shall be kept at the registered office of the Company and shall always be open to<br>inspection by the Directors. No Member (other than a Director) shall have any right of inspecting any account or book or document of the<br>Company except as conferred by the Act or as authorised by the Directors or by Ordinary Resolution.
--- ---
23.3 Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31 December in<br>each year and begin on 1 January in each year.
--- ---

Auditors

23.4 The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors<br>determine.
23.5 At any general meeting convened and held at any time in accordance with these Articles, the Members may,<br>by Ordinary Resolution, remove the Auditor before the expiration of his term of office. If they do so, the Members shall, by Ordinary<br>Resolution, at that meeting appoint another Auditor in his stead for the remainder of his term.
--- ---
23.6 The Auditors shall examine such books, accounts and vouchers; as may be necessary for the performance<br>of their duties.
--- --- 
59
23.7 The Auditors shall, if so requested by the Directors, make a report on the accounts of the Company during<br>their tenure of office at the next annual general meeting following their appointment, and at any time during their term of office, upon<br>request of the Directors or any general meeting of the Company.
24 Record dates
--- ---
24.1 Except to the extent of any conflicting rights attached to Shares, the resolution declaring a dividend<br>on Shares of any class, whether it be an Ordinary Resolution of the Members or a Director’s resolution, may specify that the dividend<br>is payable or distributable to the persons registered as the holders of those Shares at the close of business on a particular date, notwithstanding<br>that the date may be a date prior to that on which the resolution is passed.
--- ---
24.2 If the resolution does so specify, the dividend shall be payable or distributable to the persons registered<br>as the holders of those Shares at the close of business on the specified date in accordance with their respective holdings so registered,<br>but without prejudice to the rights inter se in respect of the dividend of transferors and transferees of any of those Shares.
--- ---
24.3 The provisions of this Article apply, mutatis mutandis, to bonuses, capitalisation issues, distributions<br>of realised capital profits or offers or grants made by the Company to the Members.
--- ---
25 Dividends
--- ---

Source of dividends

25.1 Dividends may be declared and paid out of any funds of the Company lawfully available for distribution.
25.2 Subject to the requirements of the Act regarding the application of a company’s Share premium account<br>and with the sanction of an Ordinary Resolution, dividends may also be declared and paid out of any share premium account.
--- ---

Declaration of dividends by Members

25.3 Subject to the provisions of the Act, the Company may by Ordinary Resolution declare dividends in accordance<br>with the respective rights of the Members but no dividend shall exceed the amount recommended by the Directors.

Payment of interim dividends and declaration of final dividends by Directors

25.4 The Directors may declare and pay interim dividends or recommend final dividends in accordance with the<br>respective rights of the Members if it appears to them that they are justified by the financial position of the Company and that such<br>dividends may lawfully be paid.
25.5 Subject to the provisions of the Act, in relation to the distinction between interim dividends and final<br>dividends, the following applies:
--- ---
(a) Upon determination to pay a dividend or dividends described as interim by the Directors in the dividend<br>resolution, no debt shall be created by the declaration until such time as payment is made.
--- --- 
60
(b) Upon declaration of a dividend or dividends described as final by the Directors in the dividend resolution,<br>a debt shall be created immediately following the declaration, the due date to be the date the dividend is stated to be payable in the<br>resolution.

If the resolution fails to specify whether a dividend is final or interim, it shall be assumed to be interim.

25.6 In relation to Shares carrying differing rights to dividends or rights to dividends at a fixed rate, the<br>following applies:
(a) If the share capital is divided into different classes, the Directors may pay dividends on Shares which<br>confer deferred or non-preferred rights with regard to dividends as well as on Shares which confer preferential rights with regard to<br>dividends but no dividend shall be paid on Shares carrying deferred or non-preferred rights if, at the time of payment, any preferential<br>dividend is in arrears.
--- ---
(b) The Directors may also pay, at intervals settled by them, any dividend payable at a fixed rate if it appears<br>to them that there are sufficient funds of the Company lawfully available for distribution to justify the payment.
--- ---
(c) If the Directors act in good faith, they shall not incur any liability to the Members holding Shares conferring<br>preferred rights for any loss those Members may suffer by the lawful payment of the dividend on any Shares having deferred or non-preferred<br>rights.
--- ---

Apportionment of dividends

25.7 Subject to Articles 9.11, 9.19 and 25.8, any Available Reserves which the Company may determine to distribute<br>in respect of any Financial Year will be distributed among the holders of the Series A Shares and the Ordinary Shares as follows:

(a)      first to pay to each Series A Shareholder in respect of each Series A Share held a sum equal to any unpaid Arrears in respect of any Preference Dividend on such Series A Share; and

(b) second to apply the balance amongst the holders of the Ordinary Shares and the Series A Shares on a pro<br>rata basis (for the avoidance of doubt, counted on an as-converted basis in accordance with Article 1.4(b)).
25.8 The Company will, before application of any profits to reserve or for any other purpose, pay in respect<br>of each Series A Share a fixed cumulative preferential dividend (the Preference Dividend) at the Annual Rate of the Accrued Value<br>per Series A Share, accruing daily and compounding on a semi-annual basis and payable to the registered holder in two equal instalments<br>on 31 December and 30 June each year, or upon a conversion of the relevant Series A Shares into Ordinary Shares. The Board may elect from<br>time to time for any Preference Dividend to be satisfied by either (i) a cash payment to the registered holder of the relevant Series<br>A Share (Cash Option) or (ii) the Accrued Value of the relevant Series A Share being increased to include the value of the relevant<br>Preference Dividend (PIK Option). For the purposes of the foregoing, the Annual Rate, in respect of a particular period,<br>shall be: (a) 10% per annum where the Board elects to satisfy the relevant Preference Dividend via the Cash Option or (b) 12% per annum<br>where the Board elects to satisfy the relevant Preference Dividend via the PIK Option.
--- --- 
61

Right of set off

25.9 The Directors may deduct from a dividend or any other amount payable to a person in respect of a Share<br>any amount due by that person to the Company on a call or otherwise in relation to a Share.

Power to pay other than in cash

25.10 If the Directors so determine, any resolution declaring a dividend<br>may direct that it shall be satisfied wholly or partly by the distribution of assets. If a difficulty arises in relation to the distribution,<br>the Directors may settle that difficulty in any way they consider appropriate. For example, they may do any one or more of the following:
(a) issue fractional Shares;
--- ---
(b) fix the value of assets for distribution and make cash payments to some Members on the footing of the<br>value so fixed in order to adjust the rights of Members; and
--- ---
(c) vest some assets in trustees.
--- ---

How payments may be made

25.11 A dividend or other monies payable on or in respect of a Share<br>may be paid in any of the following ways:
(a) if the Member holding that Share or other person entitled to<br>that Share nominates a bank account for that purpose - by wire transfer to that bank account; or
--- ---
(b) by cheque or warrant sent by post to the registered address<br>of the Member holding that Share or other person entitled to that Share.
--- ---
25.12 For the purposes of Article 25.11(a), the nomination may be in writing or in an Electronic Record and<br>the bank account nominated may be the bank account of another person. For the purposes of Article 25.11(b), subject to any Applicable<br>Law or regulation, the cheque or warrant shall be made to the order of the Member holding that Share or other person entitled to the Share<br>or to his nominee, whether nominated in writing or in an Electronic Record, and payment of the cheque or warrant shall be a good discharge<br>to the Company.
--- --- 
62
25.13 If two or more persons are registered as the holders of the Share or are jointly entitled to it by reason<br>of the death or bankruptcy of the registered holder (Joint Holders), a dividend (or other amount) payable on or in respect of that<br>Share may be paid as follows:
(a) to the registered address of the Joint Holder of the Share who is named first on the register of Members<br>or to the registered address of the deceased or bankrupt holder, as the case may be; or
--- ---
(b) to the address or bank account of another person nominated by the Joint Holders, whether that nomination<br>is in writing or in an Electronic Record.
--- ---
25.14 Any Joint Holder of a Share may give a valid receipt for a dividend (or other amount) payable in respect<br>of that Share.
--- ---

Dividends or other monies not to bear interest in absence of special rights

25.15 Unless provided for by the rights attached to a Share and except with respect to the Series A Shares as<br>set forth in these Articles, no dividend or other monies payable by the Company in respect of a Share shall bear interest.

Dividends unable to be paid or unclaimed

25.16 If a dividend cannot be paid to a Member or remains unclaimed within six weeks after it was declared or<br>both, the Directors may pay it into a separate account in the Company’s name. If a dividend is paid into a separate account, the<br>Company shall not be constituted trustee in respect of that account and the dividend shall remain a debt due to the Member.
25.17 A dividend that remains unclaimed for a period of six years<br>after it became due for payment shall be forfeited to, and shall cease to remain owing by, the Company.
--- ---
26 Capitalisation of profits
--- ---

Capitalisation of profits or of any share premium account or capital redemption reserve;

26.1 The Directors may resolve to capitalise:
(a) any part of the Company’s profits not required for paying any preferential dividend (whether or<br>not those profits are available for distribution); or
--- ---
(b) any sum standing to the credit of the Company’s share premium account or capital redemption reserve, if<br>any.
--- ---
26.2 The amount resolved to be capitalised must be appropriated to the Members who would have been entitled<br>to it had it been distributed by way of dividend and in the same proportions. The benefit to each Member so entitled must be given in<br>either or both of the following ways::
--- ---
(a) by paying up the amounts unpaid on that Member’s Shares;
--- ---
(b) by issuing Fully Paid Up Shares, debentures or other securities of the Company to that Member or as that<br>Member directs. The Directors may resolve that any Shares issued to the Member in respect of Partly Paid Up Shares (Original Shares)<br>rank for dividend only to the extent that the Original Shares rank for dividend while those Original Shares remain Partly Paid Up.
--- --- 
63

Applying an amount for the benefit of Members

26.3 The amount capitalised must be applied to the benefit of Members in the proportions to which the Members<br>would have been entitled to dividends if the amount capitalised had been distributed as a dividend.
26.4 Subject to the Act, if a fraction of a Share, a debenture or other security is allocated to a Member,<br>the Directors may issue a fractional certificate to that Member or pay him the cash equivalent of the fraction.
--- ---
27 Share Premium Account
--- ---

Directors to maintain share premium account

27.1 The Directors shall establish a share premium account in accordance with the Act. They shall carry to<br>the credit of that account from time to time an amount equal to the amount or value of the premium paid on the issue of any Share or capital<br>contributed or such other amounts required by the Act.

Debits to share premium account

27.2 The following amounts shall be debited to any share premium<br>account:
(a) on the redemption or purchase of a Share, the difference between the nominal value of that Share and the<br>redemption or purchase price; and
--- ---
(b) any other amount paid out of a share premium account as permitted by the Act.
--- ---
27.3 Notwithstanding the preceding Article, on the redemption or purchase of a Share, the Directors may pay<br>the difference between the nominal value of that Share and the redemption purchase price out of the profits of the Company or, as permitted<br>by the Act, out of capital.
--- ---
28 Seal
--- ---

Company seal

28.1 The Company may have a seal if the Directors so determine. 
64

Duplicate seal

28.2 Subject to the provisions of the Act, the Company may also have a duplicate seal or seals for use in any<br>place or places outside the Cayman Islands. Each duplicate seal shall be a facsimile of the original seal of the Company. However, if<br>the Directors so determine, a duplicate seal shall have added on its face the name of the place where it is to be used.

When and how seal is to be used

28.3 A seal may only be used by the authority of the Directors. Unless the Directors otherwise determine, a<br>document to which a seal is affixed must be signed in one of the following ways:
(a) by a Director (or his alternate) and the Secretary; or
--- ---
(b) by a single Director (or his alternate).
--- ---

If no seal is adopted or used

28.4 If the Directors do not adopt a seal, or a seal is not used, a document may be executed in the following<br>manner:
(a) by a Director (or his alternate) or any other Officer to which authority has been delegated by resolution<br>duly adopted by the directors; or
--- ---
(b) by a single Director (or his alternate); or
--- ---
(c) in any other manner permitted by the Act.
--- ---

Power to allow non-manual signatures and facsimile printing of seal

28.5 The Directors may determine that either or both of the following applies:
(a) that the seal or a duplicate seal need not be affixed manually but may be affixed by some other method<br>or system of reproduction;
--- ---
(b) that a signature required by these Articles need not be manual but may be a mechanical or Electronic Signature.
--- ---

Validity of execution

28.6 If a document is duly executed and delivered by or on behalf of the Company, it shall not be regarded<br>as invalid merely because, at the date of the delivery, the Secretary, or the Director, or other Officer or person who signed the document<br>or affixed the seal for and on behalf of the Company ceased to be the Secretary or hold that office and authority on behalf of the Company. 
65
29 Indemnity
29.1 To the extent permitted by Applicable Law, the Company shall<br>indemnify each existing or former Director (including alternate Director), Secretary and other Officer of the Company (including an investment<br>adviser or an administrator or liquidator) and their personal representatives against:
--- ---
(a) all actions, proceedings, costs, charges, expenses, losses,<br>damages or liabilities incurred or sustained by the existing or former Director (including alternate Director), Secretary or Officer<br>in or about the conduct of the Company’s business or affairs or in the execution or discharge of the existing or former Director’s (including<br>alternate Director’s), Secretary’s or Officer’s duties, powers, authorities or discretions; and
--- ---
(b) without limitation to paragraph (a), all costs, expenses, losses or liabilities incurred by the existing<br>or former Director (including alternate Director), Secretary or Officer in defending (whether successfully or otherwise) any civil, criminal,<br>administrative or investigative proceedings (whether threatened, pending or completed) concerning the Company or its affairs in any court<br>or tribunal, whether in the Cayman Islands or elsewhere.
--- ---

No such existing or former Director (including alternate Director), Secretary or Officer, however, shall be indemnified in respect of any matter arising out of his own actual fraud, wilful default, or wilful neglect.

29.2 To the extent permitted by Act, the Company may make a payment, or agree to make a payment, whether by<br>way of advance, loan or otherwise, for any legal costs incurred by an existing or former Director (including alternate Director), Secretary<br>or Officer of the Company in respect of any matter identified in Article 29.1 on condition that the Director (including alternate Director),<br>Secretary or Officer must repay the amount paid by the Company to the extent that it is ultimately found not liable to indemnify the Director<br>(including alternate Director), Secretary or that Officer for those legal costs.

Release

29.3 To the extent permitted by Act, the Company may by Special Resolution<br>release any existing or former Director (including alternate Director), Secretary or other Officer of the Company from liability for<br>any loss or damage or right to compensation which may arise out of or in connection with the execution or discharge of the duties, powers,<br>authorities or discretions of his office; but there may be no release from liability arising out of or in connection with that person’s<br>own actual fraud, wilful default or wilful neglect.

Insurance

29.4 To the extent permitted by Act, the Company may pay, or agree<br>to pay, a premium in respect of a contract insuring each of the following persons against risks determined by the Directors, other than<br>liability arising out of that person’s own dishonesty:
(a) an existing or former Director (including alternate Director),<br>Secretary or Officer or auditor of:
--- ---
(i) the Company;
--- --- 
66
(ii) a company which is or was a subsidiary of the Company;
(iii) a company in which the Company has or had an interest (whether direct or indirect); and
--- ---
(b) a trustee of an employee or retirement benefits scheme or other trust in which any of the persons referred<br>to in paragraph (a) is or was interested.
--- ---
30 Notices
--- ---

Form of notices

30.1 Save where these Articles provide otherwise, and subject to<br>the Designated Stock Exchange Rules, and subject to the Designated Stock Exchange Rules, any notice to be given to or by any person pursuant<br>to these Articles shall be:
(a) in writing signed by or on behalf of the giver in the manner set out below for written notices; or
--- ---
(b) subject to the next Article, in an Electronic Record signed by or on behalf of the giver by Electronic<br>Signature and authenticated in accordance with Articles about authentication of Electronic Records; or
--- ---
(c) where these Articles expressly permit, by the Company by means of a website.
--- ---

Electronic communications

30.2 A notice may only be given to the Company in an Electronic Record if:
(a) the Directors so resolve;
--- ---
(b) the resolution states how an Electronic Record may be given and, if applicable, specifies an email address<br>for the Company; and
--- ---
(c) the terms of that resolution are notified to the Members for the time being and, if applicable, to those<br>Directors who were absent from the meeting at which the resolution was passed.
--- ---

If the resolution is revoked or varied, the revocation or variation shall only become effective when its terms have been similarly notified.

67
30.3 A notice may not be given by Electronic Record to a person other than the Company unless the recipient<br>has notified the giver of an Electronic address to which notice may be sent.
30.4 Subject to the Act, the Designated Stock Exchange Rules and<br>to any other rules which the Company is bound to follow, the Company may also send any notice or other document pursuant to these Articles<br>to a Member by publishing that notice or other document on a website where:
--- ---
(a) the Company and the Member have agreed to his having access to the notice or document on a website (instead<br>of it being sent to him);
--- ---
(b) the notice or document is one to which that agreement applies;
--- ---
(c) the Member is notified (in accordance with any requirements<br>laid down by the Act and, in a manner for the time being agreed between him and the Company for the purpose) of:
--- ---
(i) the publication of the notice or document on a website;
--- ---
(ii) the address of that website; and
--- ---
(iii) the place on that website where the notice or document may be accessed, and how it may be accessed; and
--- ---
(d) the notice or document is published on that website throughout the publication period, provided that,<br>if the notice or document is published on that website for a part, but not all of, the publication period, the notice or document shall<br>be treated as being published throughout that period if the failure to publish that notice of document throughout that period is wholly<br>attributable to circumstances which it would not be reasonable to have expected the Company to prevent or avoid. For the purposes of this<br>Article 30.4 “publication period” means a period of not less than twenty-one days, beginning on the day on which the notification<br>referred to in Article 30.4(c) is deemed sent.
--- ---

Persons entitled to notices

30.5 Any notice or other document to be given to a Member may be given by reference to the register of Members<br>as it stands at any time within the period of twenty-one days before the day that the notice is given or (where and as applicable) within<br>any other period permitted by, or in accordance with the requirements of, (to the extent applicable) the Designated Stock Exchange Rules<br>and/or the Designated Stock Exchanges. No change in the register of Members after that time shall invalidate the giving of such notice<br>or document or require the Company to give such item to any other person.

Persons authorised to give notices

30.6 A notice by either the Company or a Member pursuant to these Articles may be given on behalf of the Company<br>or a Member by a Director or company secretary of the Company or a Member. 
68

Delivery of written notices

30.7 Save where these Articles provide otherwise, a notice in writing<br>may be given personally to the recipient, or delivered by electronic record to the recipient’s electronic address or posted to or left<br>at (as appropriate) the Member’s or Director’s registered address (in each case, to the extent that such address has been<br>notified to the registered office of the Company or to the maintainer of the register of members of the Company) or the Company’s<br>registered office, or posted to that registered address or registered office.

Joint holders

30.8 Where Members are joint holders of a Share, all notices shall be given to the Member whose name first<br>appears in the register of Members.

Signatures

30.9 A written notice shall be signed when it is autographed by or on behalf of the giver, or is marked in<br>such a way as to indicate its execution or adoption by the giver.
30.10 An Electronic Record may be signed by an Electronic Signature.
--- ---

Evidence of transmission

30.11 A notice given by Electronic Record shall be deemed sent if an Electronic Record is kept demonstrating<br>the time, date and content of the transmission, and if no notification of failure to transmit is received by the giver.
30.12 A notice given in writing shall be deemed sent if the giver can provide proof that the envelope containing<br>the notice was properly addressed, pre-paid and posted, or that the written notice was otherwise properly transmitted to the recipient.
--- ---
30.13 A Member present, either in person or by proxy, at any meeting of the Company or of the holders of any<br>class of Shares shall be deemed to have received due notice of the meeting and, where requisite, of the purposes for which it was called.
--- ---

Giving notice to a deceased or bankrupt Member

30.14 A notice may be given by the Company to the persons entitled to a Share in consequence of the death or<br>bankruptcy of a Member by sending or delivering it, in any manner authorised by these Articles for the giving of notice to a Member, addressed<br>to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt or by any like description, at the address,<br>if any, supplied for that purpose by the persons claiming to be so entitled.
30.15 Until such an address has been supplied, a notice may be given in any manner in which it might have been<br>given if the death or bankruptcy had not occurred.
--- --- 
69

Date of giving notices

30.16 A notice is given on the date identified in the following table:
Method for giving notices When taken to be given
--- ---
(A) Personally At the time and date of delivery
(B) By leaving it at the Member’s registered address At the time and date it was left
(C) By posting it by prepaid post to the street or postal address of that recipient 48 hours after the date it was posted
(D) By Electronic Record (other than publication on a website), to recipient’s Electronic address 48 hours after the date it was sent
(E) By publication on a website 24 hours after the date on which the Member is deemed to have been notified of the publication of the notice or document on the website

Saving provision

30.17 None of the preceding notice provisions shall derogate from the Articles about the delivery of written<br>resolutions of Directors.

31      Authentication of Electronic Records

Application of Articles

31.1 Without limitation to any other provision of these Articles, any notice, written resolution or other document<br>under these Articles that is sent by Electronic means by a Member, or by the Secretary, or by a Director or other Officer of the Company,<br>shall be deemed to be authentic if either Article 31.2 or Article 31.4 applies.

Authentication of documents sent by Members by Electronic means

31.2 An Electronic Record of a notice, written resolution or other<br>document sent by Electronic means by or on behalf of one or more Members shall be deemed to be authentic if the following conditions<br>are satisfied:
(a) the Member or each Member, as the case may be, signed the original document, and for this purpose OriginalDocument includes several documents in like form signed by one or more of those Members; and
--- ---
(b) the Electronic Record of the Original Document was sent by Electronic means by, or at the direction of,<br>that Member to an address specified in accordance with these Articles for the purpose for which it was sent; and
--- --- 
70
(c) Article 31.7 does not apply.
31.3 For example, where a sole Member signs a resolution and sends the Electronic Record of the original resolution,<br>or causes it to be sent, by facsimile transmission to the address in these Articles specified for that purpose, the facsimile copy shall<br>be deemed to be the written resolution of that Member unless Article 30.7 applies.
--- ---

Authentication of document sent by the Secretary or Officers of the Company by Electronic means

31.4 An Electronic Record of a notice, written resolution or other<br>document sent by or on behalf of the Secretary or an Officer or Officers of the Company shall be deemed to be authentic if the following<br>conditions are satisfied:
(a) the Secretary or the Officer or each Officer, as the case may be, signed the original document, and for<br>this purpose Original Document includes several documents in like form signed by the Secretary or one or more of those Officers;<br>and
--- ---
(b) the Electronic Record of the Original Document was sent by Electronic means by, or at the direction of,<br>the Secretary or that Officer to an address specified in accordance with these Articles for the purpose for which it was sent; and
--- ---
(c) Article 31.7 does not apply.
--- ---

This Article 31.4 applies whether the document is sent by or on behalf of the Secretary or Officer in his own right or as a representative of the Company.

31.5 For example, where a sole Director signs a resolution and scans the resolution, or causes it to be scanned,<br>as a PDF version which is attached to an email sent to the address in these Articles specified for that purpose, the PDF version shall<br>be deemed to be the written resolution of that Director unless Article 31.7 applies.

Manner of signing

31.6 For the purposes of these Articles about the authentication of Electronic Records, a document will be<br>taken to be signed if it is signed manually or in any other manner permitted by these Articles.

Saving provision

31.7 A notice, written resolution or other document under these Articles<br>will not be deemed to be authentic if the recipient, acting reasonably:
(a) believes that the signature of the signatory has been altered after the signatory had signed the original<br>document; or
--- --- 
71
(b) believes that the original document, or the Electronic Record of it, was altered, without the approval<br>of the signatory, after the signatory signed the original document; or
(c) otherwise doubts the authenticity of the Electronic Record of the document
--- ---

and the recipient promptly gives notice to the sender setting the grounds of its objection. If the recipient invokes this Article, the sender may seek to establish the authenticity of the Electronic Record in any way the sender thinks fit.

32 Transfer by way of continuation
32.1 The Company may, by Special Resolution, resolve to be registered by way of continuation in a jurisdiction<br>outside:
--- ---
(a) the Cayman Islands; or
--- ---
(b) such other jurisdiction in which it is, for the time being, incorporated, registered or existing.
--- ---
32.2 To give effect to any resolution made pursuant to the preceding Article, the Directors may cause the following:
--- ---
(a) an application be made to the Registrar of Companies of the Cayman Islands to deregister the Company in<br>the Cayman Islands or in the other jurisdiction in which it is for the time being incorporated, registered or existing; and
--- ---
(b) all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation<br>of the Company.
--- ---
33 Winding up
--- ---

Distribution of assets in specie

33.1 If the Company is wound up the Members may, subject to these Articles and any other sanction required<br>by the Act, pass a Special Resolution allowing the liquidator to do either or both of the following:
(a) to divide in specie among the Members the whole or any part of the assets of the Company and, for that<br>purpose, to value any assets and to determine how the division shall be carried out as between the Members or different classes of Members;<br>and/or
--- ---
(b) to vest the whole or any part of the assets in trustees for the benefit of Members and those liable to<br>contribute to the winding up.
--- ---

No obligation to accept liability

33.2 No Member shall be compelled to accept any assets if an obligation attaches to them. 
72
33.3 The Directors are authorised to present a winding up petition.
33.4 The Directors have the authority to present a petition for the winding up of the Company to the Grand<br>Court of the Cayman Islands on behalf of the Company without the sanction of a resolution passed at a general meeting.
--- ---
34 Liquidation preference and exit provisions
--- ---

Liquidation preference

34.1 Upon a Deemed Liquidation Event, Disposal or on a distribution<br>of assets on a liquidation, dissolution or winding up of the Company (whether voluntarily or involuntarily) or a return of capital (other<br>than a conversion, redemption, buyback or purchase of Shares) the Available Proceeds shall be distributed (to the extent that the Company<br>is lawfully permitted to do so):
(a) first to each of the Series A Shareholders, in priority to any distribution pursuant to Article 34.1(b),<br>an amount per Series A Share held equal to the greater of (i) 100% of Accrued Value in respect of such Series A Share and (ii) the amount<br>per Share as would have been payable had all Series A Preferred Shares been converted into Ordinary Shares in accordance with these Articles<br>immediately prior to such liquidation, dissolution, winding up, Disposal or Deemed Liquidation Event based on the then effective rate<br>of conversion; and
--- ---
(b) thereafter, among the holders of Ordinary Shares pro rata to<br>the number of Shares held.
--- ---

If upon any such liquidation, dissolution or winding up of the Company, Disposal or Deemed Liquidation Event, the assets of the Company available for distribution to its Members shall be insufficient to pay the Series A Shareholders the full amount to which they shall be entitled under Article 34.1, the Series A Shareholders shall share rateably in any distribution of the assets available for distribution in proportion to the respective amounts that would otherwise be payable in respect of the Shares held by them upon such distribution if all amounts payable on or with respect to such Shares were paid in full.

34.2 In the event that any distributions under Article 34.1 are made<br>on more than one occasion:
(a) each distribution shall be made in accordance with Article 34.1 as if it were the only amount to be distributed<br>and without regard to the expected amount of any distributions expected to made on any further occasions; and
--- ---
(b) a distribution on any further occasion shall be made in accordance with Article 34.1 after taking into<br>account any previous distributions made under Article 34.1.
--- ---
34.3 If any distribution under Article 34.1 includes any non-cash<br>assets, proceeds or other amounts (Non-Cash Consideration) the cash equivalent value of any such Non-Cash Consideration shall<br>be determined in such manner as the Board (acting reasonably and in good faith and with Series A Majority Consent) may determine.
--- --- 
73
34.4 In the event of a Deemed Liquidation Event, the Available Proceeds<br>shall be distributed as if such Available Proceeds were Surplus Assets being applied in the order of priority set out in Article 34.1.
35 Amendment of Memorandum and Articles
--- ---

Power to change name or amend Memorandum

35.1 Subject to the Act, the Company may, by Special Resolution:
(a) change its name; or
--- ---
(b) change the provisions of its Memorandum with respect to its objects, powers or any other matter specified<br>in the Memorandum.
--- ---

Power to amend these Articles

35.2 Subject to the Act and as provided in these Articles, the Company may, by Special Resolution, amend these<br>Articles in whole or in part, provided that no consideration (including any modification of these Articles) shall be offered or paid to<br>any Shareholder to amend or consent to a waiver or modification of any provision of these Articles unless the same consideration is also<br>offered to all Shareholders.
36 Mergers and Consolidations
--- ---

The Company shall have the power to merge or consolidate with one or more constituent companies (as defined in the Law) upon such terms as the Directors may determine and (to the extent required by the Law) with the approval of a Special Resolution.

37 Certain Tax Filings

Each Tax Filing Authorised Person and any such other person, acting alone, as any director shall designate from time to time, are authorised to file tax forms SS-4, W-8 BEN, W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are customary to file with any US state or federal governmental authorities or foreign governmental authorities in connection with the formation, activities and/or elections of the Company and such other tax forms as may be approved from time to time by any director of the Company or any other Officer. The Company further ratifies and approves any such filing made by any Tax Filing Authorised Person or such other person prior to the date of these Articles.

38 Business Opportunities
38.1 To the fullest extent permitted by Applicable Law, individuals serving as Directors or other Officers<br>(Management) shall have no duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly<br>in the same or similar business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, the<br>Company renounces any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction<br>or matter which may be a corporate opportunity for either such a member of Management, on the one hand, and the Company, on the other.<br>Except to the extent expressly assumed by contract, to the fullest extent permitted by Applicable Law, such members of Management shall<br>have no duty to communicate or offer any such corporate opportunity to the Company and shall not be liable to the Company or its Members<br>for breach of any fiduciary duty as a Member, director and/or other Officer solely by reason of the fact that such party pursues or acquires<br>such corporate opportunity for itself, himself or herself, directs such corporate opportunity to another person, or does not communicate<br>information regarding such corporate opportunity to the Company, unless such opportunity is expressly offered to such member of Management<br>solely in their capacity as such and the opportunity is one the Company is permitted to complete on a reasonable basis.
--- --- 
74
38.2 Except as provided elsewhere in these Articles, the Company hereby renounces any interest or expectancy<br>of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate<br>opportunity for both the Company and any individual serving as a member of Management, about which a director and/or other Officer of<br>the Company who is also a member of Management acquires knowledge.
38.3 To the extent a court might hold that the conduct of any activity related to a corporate opportunity that<br>is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent permitted<br>by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted<br>by Applicable Law, the provisions of this Article apply equally to activities conducted in the future and that have been conducted in<br>the past.
--- ---
39 Exclusive Jurisdiction and Forum
--- ---
39.1 Unless the Company consents in writing to the selection of an alternative forum, the courts of the Cayman<br>Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with the Memorandum, the Articles<br>or otherwise related in any way to each Member’s shareholding in the Company, including but not limited to:
--- ---
(a) any derivative action or proceeding brought on behalf of the Company;
--- ---
(b) any action asserting a claim of breach of any fiduciary or other duty owed by any current or former director,<br>Officer or other employee of the Company to the Company or the Members;
--- ---
(c) any action asserting a claim arising pursuant to any provision of the Act, the Memorandum or the Articles;<br>or
--- ---
(d) any action asserting a claim against the Company governed by the “Internal Affairs Doctrine”<br>(as such concept is recognised under the laws of the United States of America).
--- ---
39.2 Each Member shall be deemed to have irrevocably submitted to the exclusive jurisdiction of the courts<br>of the Cayman Islands, and each person or entity purchasing or otherwise acquiring Ordinary Shares or any other equity security of the<br>Company shall be deemed to have notice of and consented to the provisions of this Article 36.
--- --- 
75
39.3 Without prejudice to any other rights or remedies that the Company may have, each Member acknowledges<br>that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum<br>and that accordingly the Company shall be entitled, without proof of special damages, to the remedies of injunction, specific performance<br>or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.
39.4 This Article 39 shall not apply to any action or suits brought to enforce any liability or duty created<br>by the U.S. Securities Act, the Securities Exchange Act of 1934, as amended, or any claim for which the federal district courts of the<br>United States of America are, as a matter of the laws of the United States, the sole and exclusive forum for determination of such a claim.
--- ---
40 Series A Majority reserved matters
--- ---

For as long as the Inflection Point Entities hold at least 20% of the Series A Shares on issue as of the Date of Adoption, the Company shall not, without Series A Majority Consent, take any of the following actions:

40.1 liquidate, dissolve or wind-up the affairs of the Company;
40.2 amending, altering or repealing the Memorandum or Articles in a manner that materially and adversely affects<br>the powers, preferences or rights attaching to the Series A Shares;
--- ---
40.3 create any equity security, authorise the creation of any equity security, classify any equity security,<br>reclassify any equity security, or issue any other security convertible into or exercisable for any equity security, unless such security<br>ranks junior to the Series A Shares with respect to its rights, preferences and privileges (including rights to receive dividends and<br>participate in distributions or payments upon liquidation, dissolution or winding up);
--- ---
40.4 increase the authorised share capital of the Series A Shares;
--- ---
40.5 purchase or redeem or pay any cash dividend on any Share ranking junior to the Series A Shares (with respect<br>to rights to receive dividends and participate in distributions or payments upon liquidation, dissolution or winding up), except for Shares<br>being repurchased by the Company at cost from Employees in connection with the cessation of their service or pursuant to the terms of<br>any equity incentive plan adopted by the Company;
--- ---
40.6 enter into any transaction with an Affiliate, other than the issuance of equity or awards to eligible<br>participants under an incentive plan, equity plan or equity-based compensation plan adopted by the Company, or with respect to employment,<br>consulting or award agreements with respect to executive officers or directors of the Company, in each case regardless of whether such<br>person (or such person’s Affiliates) would be considered an Affiliate of the Company; or
--- ---
40.7 incur or guarantee any new indebtedness other than equipment leases or trade payables incurred in the<br>ordinary course of business.
--- --- 
76

ANNEX A

NOTICE OF CONVERSION

(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SERIES A PREFERRED SHARES)

The undersigned hereby elects to convert the number of Series A Preferred Shares, indicated below into Ordinary Shares, of Air Water Holdings Limited, a Cayman Islands exempted company limited by shares (the “Company”), according to the conditions hereof, as of the date written below. If Ordinary Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as may be required by the Company in accordance with the Purchase Agreement. No fee will be charged to the Series A Shareholders for any conversion, except for any such transfer taxes.

Conversion calculations:

Date to Effect Conversion:_______________________________________________________________
Number of Series A Preferred Shares owned prior to Conversion:__________________________________
Number of Series A Preferred Shares to be Converted:__________________________________________
Accrued Value of Series A Preferred Shares to be Converted:_____________________________________
Number of Ordinary Shares to be Issued:____________________________________________________
Applicable Conversion Price:_____________________________________________________________
Number of Series A Preferred Shares subsequent to Conversion:__________________________________
Address for Delivery:__________________________________________________________________
or
DWAC Instructions:
---
Broker no:_____________
Account no:___________ 
A-1

Exhibit 4.1

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.

ORDINARY SHARE PURCHASE WARRANT

Original Issue Date: August 25,<br> 2025 Initial Exercise Date:

Number of Warrant Shares: [●]

FOR VALUE RECEIVED, Air Water Ventures Holdings Limited, a Cayman Islands exempted company (the “Company”), hereby certifies that [NAME OF HOLDER], a [JURISDICTION] [TYPE OF ENTITY], or its registered assigns (the “Holder”) is entitled to subscribe for and purchase from the Company [●] duly authorized and validly issued ordinary shares (the “Warrant Shares”), par value $0.01344 per share, of the Company (the “Ordinary Shares”) at a purchase price per share of $7,624.33 (subject to adjustment as provided herein, the “Exercise Price”), all subject to the terms, conditions, and adjustments set forth below in this Warrant.

This Ordinary Share Purchase Warrant (this “Warrant”) is one of a series of ordinary share purchase warrants (collectively, the “Warrants”) issued pursuant to that certain Subscription Agreement dated August 25, 2025 (as may be amended from time to time, the “SubscriptionAgreement”), by and among the Company and the purchasers named therein. The terms of the Warrants (including this Warrant) are and will be identical except as to the name of the Holder thereof, the date of issuance thereof (where applicable), and the original number of Warrant Shares thereof. Capitalized terms not defined herein have the meanings ascribed to such terms in the Subscription Agreement.

1. Definitions. As used in this Warrant, the following terms have the respective meanings set forth below:

“Aggregate ExercisePrice” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is then being exercised pursuant to Section 3 hereof, multiplied by (b) the Exercise Price in effect as of the Exercise Date in accordance with the terms of this Warrant.

“Board” means the board of directors of the Company.

“Business Combination” means the transactions contemplated by the Business Combination Agreement.

“BusinessCombination Agreement” means that certain business combination agreement, to be entered into on August 25, 2025, by and among the Company, Inflection Point Acquisition Corp. III, Air Water Ventures Limited (“PubCo”) and IPCX Merger Sub Limited.

“Business Day” means a day other than a Saturday, Sunday or other day on which commercial banks in the City of New York and the Cayman Islands are authorized or required to close.

“Ordinary ShareEquivalents” means any securities of the Company which would entitle the holder thereof to acquire at any time Ordinary Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares, and any securities of the Company that when paired with one or more other securities of the Company or another entity entitles the holder thereof to receive, Ordinary Shares.

“Convertible Securities” means any shares or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any and any securities of the Company that when paired with one or more other securities of the Company or another entity entitles the holder thereof to receive, Ordinary Shares.

“Exempt Issuance” means the issuance of (a) any securities of the Company to employees, officers or directors, consultants, contractors, vendors or other agents of the Company pursuant to any share or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any securities issued pursuant to the subscription agreements or the Business Combination Agreement, or in connection with the transactions contemplated thereby, including this Warrant and the other warrants to be entered into in connection with the Business Combination, and/other securities exercisable or exchangeable for or convertible into Ordinary Shares issued and outstanding on the Closing Date, provided that such securities have not been amended since the date hereof to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with share splits or combinations and automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such securities which are not more favorable to the holder thereof than the anti-dilution and similar provisions set forth herein) or to extend the term of such securities, and (c) the actions set forth on Schedule 8.2 attached to the Business Combination Agreement.

“Exercise Date” means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in Section 3 shall have been satisfied at or prior to 5:00 p.m., New York, New York time, on a Business Day, including, without limitation, the receipt by the Company of the Exercise Agreement, the Warrant, and the Aggregate Exercise Price.

“Fair Market Value” means, as of any particular date, the fair market value as determined by the Board in its good faith.

“Options” means any rights, warrants or options to subscribe for or purchase Ordinary Shares or Convertible Securities.

“Option Value” means the value of an Option based on the Black-Scholes model reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination, (ii) an expected volatility equal to 100%, (iii) the underlying price per share used in such calculation shall be equal to the highest price per share at which the Company has sold (or has been deemed to have sold) Ordinary Shares, (iv) a zero cost of borrow and (v) a 360 day annualization factor.

  1. Term of Warrant. If the Business Combination Agreement has been terminated in accordance with its terms, then at any time or from time to time after the date of such termination (the “Initial Exercise Date”) and prior to 5:00 p.m., New York, New York time, on the fifth (5th) anniversary of the date of the termination of the Business Combination Agreement or, if such day is not a Business Day, on the next preceding Business Day (the “Exercise Period”), the Holder of this Warrant may exercise this Warrant for all or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).

  2. Exercise of Warrant.

(a) ExerciseProcedure. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part of the unexercised Warrant Shares, upon:

(i) surrender of this Warrant to the Company at its then principal executive offices (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft, or destruction), together with an Exercise Agreement in the form attached hereto as Exhibit A (each, an “Exercise Agreement”), duly completed (including specifying the number of Warrant Shares to be purchased) and executed; and

(ii) payment to the Company of the Aggregate Exercise Price in accordance with Section 3(b).

(b) Paymentof the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as expressed in the Exercise Agreement, by the following methods:

(i) by delivery to the Company of a certified or official bank check payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company, in the amount of such Aggregate Exercise Price; or

(ii) by instructing the Company to withhold a number of Warrant Shares then issuable upon exercise of this Warrant with an aggregate Fair Market Value as of the Exercise Date equal to such Aggregate Exercise Price.

In the event of any withholding of Warrant Shares pursuant to clause (ii) above where the number of Ordinary Shares whose value is equal to the Aggregate Exercise Price is not a whole number, the number of Ordinary Shares withheld by or surrendered to the Company shall be rounded down to the nearest whole Ordinary Share.

2

(c) RecordKeeping of Exercise of Warrant. Upon receipt by the Company of the Exercise Agreement, surrender of this Warrant, and payment of the Aggregate Exercise Price (in accordance with Section 3(a) hereof), the Company shall, as promptly as practicable, and in any event within 5 Business Days thereafter, deliver (or cause to be delivered) a share certificate for such Warrant Shares and cash in lieu of any fraction of a share, as provided in Section 3(d) hereof and instruct the maintainer of the register of members of the Company to update the register of members to reflect the issuance of such Warrant Shares.

(d) FractionalShare. The Company shall not be required to issue a fractional Warrant Share upon exercise of any Warrant. As to any fraction of a Warrant Share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall pay to such Holder an amount in cash (by delivery of a certified or official bank check or by wire transfer of immediately available funds) equal to the product of (i) such fraction multiplied by (ii) the Fair Market Value of one Warrant Share on the Exercise Date.

(e) Deliveryof New Warrant. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised, the Company shall, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued in accordance with Section 3(c) hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.

(f) ValidIssuance of Warrant and Warrant Shares. With respect to the exercise of this Warrant, the Company hereby represents, covenants, and agrees that:

(i) this Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized and validly issued;

(ii) all Warrant Shares issuable upon the proper exercise of this Warrant pursuant to the terms hereof shall be, upon issuance and once registered in the Company’s register of members, and the Company shall take all such actions as may be necessary or reasonably appropriate in order that such Warrant Shares are, duly authorized, validly issued, and non-assessable, free and clear of all taxes, liens, and charges, and issued without violation of any preemptive or similar rights of any member of the Company;

(iii) the Company shall take all such actions as may be reasonably necessary to ensure that all such Warrant Shares are issued without violation by the Company of any applicable law or governmental regulation to the extent that such applicable law or governmental regulation would prevent the issuance of such Warrant Shares or materially and adversely impact the Company; and

(iv) the Company shall pay all taxes and other governmental charges that may be imposed with respect to, the issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not be required to pay any tax or governmental charge that may be imposed with respect to any applicable withholding or the issuance or delivery of the Warrant Shares to any Person other than the Holder, and no such issuance or delivery shall be made unless and until the Person requesting such issuance has paid to the Company the amount of any such tax, or has established to the satisfaction of the Company that such tax has been paid.

(g) ConditionalExercise. If an exercise of any portion of this Warrant is to be made in connection with a public offering or a sale of the Company (pursuant to a merger, sale of shares, or otherwise), such exercise may at the election of the Holder be conditioned upon the consummation of such transaction, in which case such exercise shall not be deemed to be effective until immediately prior to the consummation of such transaction.

(h) Reservationof Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but unissued Ordinary Shares or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and the par value per Warrant Share shall at all times be less than or equal to the applicable Exercise Price. The Company shall not increase the par value of any Warrant Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, and shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue Ordinary Shares upon the exercise of this Warrant.

3

4. Certain Adjustment to Exercise Price and Number of Warrant Shares.

(a) Dividendsand Share Splits. If the Company at any time while this Warrant is outstanding: (i) pays a dividend or otherwise makes a distribution or distributions on Ordinary Shares or any other equity or equity equivalent securities payable in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of the Warrants or any cash distributions), (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including by way of a reverse share split) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues by reclassification of Ordinary Shares any shares of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the Aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 4(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

(b) AdjustmentUpon Issuance of Ordinary Shares. If, while this Warrant is outstanding the Company issues or sells, or in accordance with this Section 4(b) is deemed to have issued or sold, Ordinary Shares (including the issuance or sale of Ordinary Shares owned or held by or for the account of the Company but excluding Ordinary Shares issued or sold, or deemed to have been issued or sold, by the Company in connection with any Exempt Issuance) for a consideration per share (the “New Issuance Price”) less than the Exercise Price then in effect (each such issue, sale or deemed issuance or sale, a “Dilutive Issuance”), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price; save that the Exercise Price shall at all times be equal to or greater than the par value of the Ordinary Shares. For purposes of determining the adjusted Exercise Price under this Section 4(b), the following shall be applicable:

(i) Options and Convertible Securities. The consideration per share received by the Company for Ordinary Shares deemed to have been issued pursuant to Section 4(b)(ii), relating to Options and Convertible Securities, shall be determined by dividing: (x) the total amount, if any, received or receivable by the Company as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by (y) the maximum number of Ordinary Shares (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) deemed to be issued pursuant to Section 4(b)(ii) upon the issuance of such Options or Convertible Securities.

(ii) Deemed Issuance of Options and Convertible Securities. If the Company at any time or from time to time shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of Ordinary Shares (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be outstanding and to have been issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date.

(iii) Change in Option Price. If, after the Original Issue Date, the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or exercisable or exchangeable for Ordinary Shares increases or decreases at any time, (other than (x) proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 4(a) above and (y) automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security which are not more favorable to the holder thereof than the anti-dilution and similar provisions set forth herein), the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 4(b)(iii), if the terms of any Option or Convertible Security that was outstanding as of the Original Issue Date are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the Ordinary Shares deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease.

4

(iv) Calculation of Consideration Received. In case one or more Options is issued in connection with the issue or sale of other securities of the Company, together comprising one integrated transaction, (x) each such Option will be deemed to have been issued for the Option Value of such Option and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms of such other securities of the Company, less (II) the Option Value of such Option. If any Ordinary Shares, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration other than cash received therefor will be deemed to be the net amount received by the Company therefor. If any Ordinary Shares, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company will be the closing sale price of such publicly traded securities on the date of receipt. If any Ordinary Shares, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Ordinary Shares, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the Company and the holders of a majority in interest of the Warrants then outstanding. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”), the fair value of such consideration will be determined within five (5) Business Days after the tenth (10th) day following the Valuation Event by an independent, reputable appraiser jointly selected by the Company and the holders of a majority in interest of the Warrants then outstanding. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.

(v) Record Date. If the Company takes a record of the holders of Ordinary Shares for the purpose of entitling them (A) to receive a dividend or other distribution payable in Ordinary Shares, Options or in Convertible Securities or (B) to subscribe for or purchase Ordinary Shares, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.

(vi) Expiration or Termination of Options or Convertible Securities. Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible Securities (or portion thereof) which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to the Exercise Price pursuant to the terms of Section 4(b), the Exercise Price shall be readjusted to such Exercise Price as would have obtained had such Option or Convertible Securities (or portion thereof) never been issued.

(vii) Except as set forth in Section 4(b)(vi), no adjustment pursuant to this Section 4(b) shall be made if such adjustment would result in an increase of the Exercise Price then in effect.

(c) SubsequentRights Offerings. In addition to any adjustments pursuant to Section 4(a) above, if at any time after the Original Issue Date the Company grants, issues or sells any Ordinary Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of Ordinary Shares (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of such Purchase Rights, provided, however, unless and until the Business Combination Agreement has been terminated without the Business Combination having closed, all Purchase Rights shall be held in abeyance for the Holder until such time, if ever, as the Termination Event occurs, provided, further, that the Purchase Rights shall not survive, and shall be extinguished upon, conversion upon closing of the Business Combination. To the extent that the issue price of such Purchase Rights would result in an adjustment of the Exercise Price pursuant to Section 4(b), such adjustment shall not occur to the extent the Holders were granted the right to acquire such Purchase Rights on the applicable terms.

(d) BusinessCombination. Upon the closing of the Business Combination, without any action on the part of the Holder, the Company or any other party to the Business Combination Agreement, this Warrant shall convert into a warrant of PubCo, in substantially the form attached hereto as Exhibit B, in accordance with Section 2.2(d) of the Business Combination Agreement.

5

(e) FundamentalTransaction. If the Business Combination Agreement has been terminated without the Business Combination having closed, and following such termination the Company closes a Change of Control, then, at the effective time of the Change of Control, the Holder shall be entitled to receive, in cash, the Option Value of this Warrant (the “CoC Price”). This Warrant shall terminate immediately upon a Change of Control, subject to Holder’s receipt of the CoC Price. As used herein, a “Change of Control” means: (i) a Deemed Liquidation Event (as defined in the Company’s amended and restated memorandum and articles of association as in effect on the initial issuance date of this Warrant) or (ii) the closing of the Company’s first firm commitment underwritten initial public offering of its Ordinary Shares pursuant to a registration statement filed under the Act; provided, that the Business Combination shall not constitute a Change of Control hereunder.

(f) Calculations. All calculations under this Section 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 4, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.

(g) Numberof Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 4, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).

(h) Noticeto Holder.

(i) Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 4, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

(ii) Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares, (C) the Company shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or purchase any shares of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company (or any of its subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Ordinary Shares is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the records of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Ordinary Shares of record shall be entitled to exchange their shares of the Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided, that, the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. This Section 4(h)(ii) shall not apply to the transactions contemplated by the Business Combination Agreement.

5. Shareholder Agreement. The Warrant Shares issuable upon exercise of this Warrant are and shall be subject to, and have the benefit of, that certain Amended and Restated Shareholders Agreement, dated as of August 25, 2025, (as amended, and as may be further amended or restated from time to time, the “Shareholder Agreement”) and the Holder shall be required, for so long as the Holder holds any Warrant Shares, to become and remain a party to the Shareholder Agreement.

6

  1. Transfer of Warrant. Subject to the transfer conditions referred to in the legend endorsed hereon and only after termination of the Business Combination Agreement pursuant to and in accordance with its terms, this Warrant and all rights hereunder shall be transferable, in whole or in part, by the Holder to an Affiliate of the Holder or if Holder is a partnership, corporation, trust, joint venture, unincorporated organization or other entity to its members, stockholders, partners and/or equityholders (or, with the Company’s prior written consent, to a non-Affiliate of the Holder), without charge to the Holder, upon surrender of this Warrant to the Company at its then principal executive offices with a properly completed and duly executed Assignment in the form attached hereto as Exhibit C. Upon such compliance, surrender, and delivery and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly be cancelled.

  2. Holder Not Deemed a Shareholder; Limitations on Liability. Prior to the issuance to the Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder shall not be entitled to vote or receive dividends or be deemed the holder of shares of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, as such, any of the rights of a member of the Company or any right to vote, give, or withhold consent to any action (whether any reorganization, issue of shares, reclassification of shares, consolidation, merger, conveyance, or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 7, the Company shall provide the Holder with copies of the same notices and other information given to the members of the Company generally, contemporaneously with the giving thereof to the members.

  3. Replacement on Loss; Division and Combination.

(a) Replacementof Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated, or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.

(b) Divisionand Combination of Warrant. Subject to compliance with the applicable provisions of this Warrant, this Warrant may be divided or, following any such division of this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then principal executive offices, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the respective Holders or their agents or attorneys. Subject to compliance with the applicable provisions of this Warrant and the Company Agreement as to any transfer or assignment which may be involved in such division or combination, the Company shall at its own expense execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance with such notice. Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable in the aggregate for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.

  1. No Impairment. The Company shall not, by amendment of its amended and restated memorandum and articles of association or Shareholders’ Agreement, or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed by it hereunder.

    7

  2. Compliance with the Securities Act.

(a) Agreementto Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant, agrees to comply in all respects with the provisions of this Section 10 and the restrictive legend requirements set forth on the face of this Warrant and further agrees that such Holder shall not offer, sell, or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act of 1933, as amended (the “Securities Act”). This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Securities Act) shall be stamped or imprinted with a legend in substantially the following form:

“THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

(b) Representations of the Holder. In connection with the issuance of this Warrant, the Holder specifically represents, as of the date hereof, to the Company by acceptance of this Warrant as follows:

(i) The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. The Holder is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment for its own account and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except pursuant to sales registered or exempted under the Securities Act.

(ii) The Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that, under such laws and applicable regulations, such securities may be resold without registration under the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule 144 under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act.

(iii) The Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant and the Warrant Shares. The Holder has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Warrant and the business, properties, prospects, and financial condition of the Company.

  1. Warrant Register. The Company shall keep and properly maintain at its principal executive offices books for the registration of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment, division, combination, or other transfer of the Warrant effected in accordance with the provisions of this Warrant.

  2. Notices. All notices, requests, consents, claims, demands, waivers, and other communications hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by email of a PDF document (with evidence or confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this Section 12). Actual notice is effective as notice in all instances.

    8

If to the Company: Air Water Ventures Ltd.<br> Unit 3, Kizad KLP FZ, Kizad<br> Abu Dhabi, UAE PO Box 109214
with a copy (which will not constitute notice) to: Morgan, Lewis & Bockius LLP<br><br>101 Park Avenue<br><br>New York, New York 10178<br><br>Attn: Russell Franklin<br><br><br><br>Email: Russell.franklin@morganlewis.com
If to the Holder: [HOLDER ADDRESS]<br> Email: [EMAIL ADDRESS]<br> Attention: [TITLE OF OFFICER]
with a copy (which will not constitute notice to): [HOLDER LAW FIRM]<br> Email: [EMAIL ADDRESS]<br> Attention: [ATTORNEY NAME]

  1. Cumulative Remedies. Except to the extent expressly provided in Section 7 to the contrary, the rights and remedies provided in this Warrant are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law, in equity or otherwise. Without limiting any other provision of this Warrant or the Subscription Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

  2. Equitable Relief. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any of its obligations under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages would not be an adequate remedy and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations, the other party hereto shall, in addition to any and all other rights and remedies that may be available to it in respect of such breach, be entitled to equitable relief, including a restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction.

  3. Entire Agreement. This Warrant, together with the Subscription Agreement, constitutes the sole and entire agreement of the parties to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements in the body of this Warrant and the Subscription Agreement, the statements in the body of this Warrant shall control.

  4. Successor and Assigns. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the parties hereto and the successors of the Company and the successors and permitted assigns of the Holder. Such successors and/or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder.

  5. No Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company and the Holder and their respective successors and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit, or remedy of any nature whatsoever, under or by reason of this Warrant.

  6. Headings. The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.

  7. Amendment and Modification; Waiver. Except as otherwise provided herein, this Warrant may only be amended, modified, or supplemented by an agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach, or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

    9

  8. Severability. If any term or provision of this Warrant is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Warrant or invalidate or render unenforceable such term or provision in any other jurisdiction.

  9. Governing Law. This Warrant, and all claims or causes of action based upon, arising out of, or related to this Warrant, shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to principles or rules of conflict of Laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction.

  10. Submission to Jurisdiction. Any proceeding or Legal Proceeding based upon, arising out of or related to this Warrant must be brought in the Court of Chancery of the State of Delaware (or, to the extent such court does not have jurisdiction, in the United States District Court for the District of Delaware and to the extent such court does not have subject matter jurisdiction, the Superior Court of the State of Delaware), and each of the parties irrevocably (i) submits to the exclusive jurisdiction of each such court in any such proceeding or Legal Proceeding, (ii) waives any objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, (iii) agrees that all claims in respect of the proceeding or Legal Proceeding shall be heard and determined only in any such court, and (iv) agrees not to bring any proceeding or Legal Proceeding arising out of or relating to this Warrant or the transactions contemplated hereby in any other court. Nothing herein contained shall be deemed to affect the right of any party to serve process in any manner permitted by Law or to commence Legal Proceedings or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments obtained in any Legal Proceeding, suit or proceeding brought pursuant to this Section 22.

  11. WAIVER OF JURY TRIAL. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS WARRANT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY, UNCONDITIONALLY AND VOLUNTARILY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS WARRANT.

  12. Counterparts. This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered by facsimile, email, or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.

25. No Strict Construction. This Warrant shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.

[signature page follows]

10

IN WITNESS WHEREOF, the Company has duly executed this Warrant on the Original Issue Date.

AIR WATER VENTURES HOLDINGS LIMITED
By:
Andrea Mollica
Director

[Signature Page to Warrant for Ordinary Shares – Air WaterVentures Holdings Limited]

11
Accepted and agreed,
[HOLDER NAME]
By:
[NAME]
[TITLE]

[Signature Page to Warrant for Ordinary Shares– Air Water Ventures Holdings Limited]

12

EXHIBIT A

NOTICE OF EXERCISE

To:
Attn:
Email:

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2) Payment shall take the form of (check applicable box):

☐ in lawful money of the United States; or

☐ if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 3(b), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 3(b).

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

The Warrant Shares shall be delivered to the following DWAC Account Number:

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity:___________________________________________________________________
Signature of Authorized Signatory of Investing Entity:___________________________________________________________________
Name of Authorized Signatory:________________________________________________________________
Title of Authorized Signatory:________________________________________________________________
Date:____________________________________________________________________ 
13

EXHIBIT B

FORM OF PUBCO WARRANT

14

EXHIBIT C

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this form and supplyrequired information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidencedthereby are hereby assigned to

Name:
Address:
Phone Number:
Email Address:
Dated: _______________ __, ______
Holder’s Signature:
Holder’s Address:

15

Exhibit 4.2

Final Form

[NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.]^1^

AIRWATER VENTURES LIMITED

ORDINARY SHARE PURCHASE WARRANT

Warrant Shares: [_______] Initial Exercise Date: [●], [●]

THIS ORDINARY SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [●], [●]^2^ (such time and date collectively, the “Termination Date”) but not thereafter, to subscribe for and purchase from Air Water Ventures Limited, a Cayman Islands exempted company (the “Company”), up to [______] ordinary shares (as subject to adjustment hereunder, the “Warrant Shares”), of a nominal par value of $0.001 per share, of the Company (the “OrdinaryShares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in Schedule A hereto.

Section 2. Exercise.

(a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in<br>whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the<br>Company (or such other office or agency that the Company may designate by notice in writing to the registered Holder at the address of<br>the Holder appearing on the books of the Company), as applicable, of a duly executed PDF copy submitted by e-mail (or e-mail attachment)<br>of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Not later than the number of Trading<br>Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid,<br>the Holder shall deliver to the Company the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by<br>wire transfer or cashier’s check drawn on a United States bank, in either case in immediately available funds, unless the cashless<br>exercise procedure specified in Section 2(c) below is available and specified in the applicable Notice of Exercise. No ink-original<br>Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of<br>Exercise be required. The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of any signatures<br>contained on any Notice of Exercise nor the authority of any person executing such Notice of Exercise. Notwithstanding anything herein<br>to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all<br>of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant<br>to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.<br>Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall<br>have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number<br>of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the<br>date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such<br>notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of thisparagraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunderat any given time may be less than the amount stated on the face hereof.
1 NTD: To be included on Warrants issued for new money on the Closing Date, but not on Warrants<br>issued in exchange for Company Pre-Funded Convertible Note Investor Warrants unless required by applicable securities law.
--- ---
2 NTD: five years after Initial Exercise Date.
--- ---
(b) Exercise Price. The exercise price per Ordinary Share under this Warrant shall be $12.00, subject<br>to Equitable Adjustment and, if applicable, adjustment hereunder (the “Exercise Price”).
--- ---
(c) Cashless Exercise. If at any time after the six (6) month anniversary of the Closing Date, (x)<br>the Warrants Shares issuable upon exercise of this Warrant would be (i) “restricted securities” as defined in Rule 144 or<br>(ii) the Holder is an Affiliate of the Company and (y) there is no effective registration statement registering, or the prospectus contained<br>therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,<br>at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares<br>equal to the quotient obtained by dividing ((A-B) multiplied by (X)) by (A), where:
--- ---
(d) (e) (A) = (f) as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day, (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day or (3) executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day), or (ii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
--- --- ---
(g) (h) (B) = (i) the Exercise Price of this Warrant, as adjusted hereunder; and
(j) (k) (X) = (l) the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.
(m) If Warrant Shares are issued in such a cashless exercise, the parties<br>acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics<br>of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this<br>Warrant. The Company agrees not to take any position contrary to this Section 2(c).
--- ---

In the event of any withholding of Warrant Shares pursuant to Section 2(c) where the number of Ordinary Shares whose value is equal to the Exercise Price is not a whole number, the number of Ordinary Shares withheld by or surrendered to the Company shall be rounded down to the nearest whole Ordinary Share.

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

2
(n) Mechanics of Exercise.
(i) Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased<br>hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s<br>balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system if the Company is then a participant<br>in such system and there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant<br>Shares by the Holder, and otherwise by physical delivery of a certificate, (or reasonable evidence of issuance by book entry of ownership<br>of the Warrant Shares) registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant<br>Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the<br>date that is the later of (i) the Standard Settlement Period after the delivery to the Company of the Notice of Exercise, and (ii) one<br>(1) Trading Day after delivery of the aggregate Exercise Price to the Company (such date, the “Warrant Share Delivery Date”);<br>provided, however, in any event, the Company shall not be obligated to deliver Warrant Shares until it has<br>received the aggregate Exercise Price therefor. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate<br>purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective<br>of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the<br>case of a cashless exercise) is received no later than the earlier of (i) the number of Trading Days comprising the Standard Settlement<br>Period following delivery of the Notice of Exercise and one (1) Trading Day. The Company agrees to maintain a transfer agent that is a<br>participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard SettlementPeriod” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading<br>Market with respect to the Ordinary Shares as in effect on the date of delivery of the Notice of Exercise. In addition to any other rights<br>available to the holder, if the Company fails for any reason unrelated to the actions of the holder or its Affiliates to deliver to the<br>Holder the applicable Warrant Shares by the Warrant Share Delivery Date and if after such Warrant Share Delivery Date the Holder is required<br>by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases,<br>Ordinary Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder was entitled to receive upon<br>the conversion relating to such Warrant Share Delivery Date (a Buy-In), then the Company shall (A) pay in cash to the Holder (in<br>addition to any other remedies available to or elected by the Holder) the amount, if any, by which (x) the Holder’s total purchase<br>price (including any brokerage commissions) for the Ordinary Shares so purchased exceeds (y) the product of (1) the aggregate number of<br>Ordinary Shares that the Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which<br>the sell order giving rise to such purchase obligation was executed (excluding any brokerage commissions) and (B) at the option of the<br>Holder, either reissue (if surrendered) this Warrant equal to the number of Warrant Shares submitted for exercise (in which case, such<br>exercise shall be deemed rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued if the Company<br>had timely complied with its delivery requirements hereunder. For example, if the Holder purchases Ordinary Shares having a total purchase<br>price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant with respect to which the actual sale price of<br>the Warrant Shares (including any applicable brokerage commissions) giving rise to such purchase obligation was a total of $10,000, under<br>clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the<br>Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon the request of the Company, evidence<br>of the amount of such loss. If the Holder purchases Ordinary Shares having a total purchase price of $9,000 to cover a Buy-In with respect<br>to an attempted exercise of this Warrant with respect to which the actual sale price of the Warrant Shares (including any applicable brokerage<br>commissions) giving rise to such purchase obligation was a total of $10,000, under clause (A) of the preceding sentence, the Company shall<br>not be required to pay Holder any amount. For the avoidance of doubt, in the event of a Buy-In, the Holder shall use commercially reasonable<br>efforts to purchase shares at the lowest available price, paying the lowest reasonably available brokerage commission. The Holder shall<br>provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and evidence of the amount of<br>such loss. Nothing herein shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity<br>including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to<br>timely deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof.
--- ---
(ii) Delivery of New Warrants Upon Exercise. Unless the purchase rights represented by this Warrant<br>shall have expired, if this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender<br>of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights<br>of the Holder to purchase the unpurchased and unexpired Warrant Shares that remain available under this Warrant, which new Warrant shall<br>in all other respects be identical with this Warrant.
--- --- 
3
(iii) Rescission Rights. If the Company fails, or fails to cause the Transfer Agent, to transmit to the<br>Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date (subject to receipt of the aggregate Exercise<br>Price for the applicable exercise (other than in the case of a cashless exercise)), then the Holder will have the right to rescind such<br>exercise prior to the delivery of the Warrant Shares.
(iv) No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall<br>be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon<br>such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to<br>such fraction multiplied by the Exercise Price or round up to the next whole share.
--- ---
(v) Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder<br>for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses<br>shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed<br>by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other<br>than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly<br>executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer<br>or withholding tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of<br>Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required<br>for same-day electronic delivery of the Warrant Shares pursuant to the terms of this Warrant.
--- ---
(vi) Closing of Books. The Company will not close its books or records in any manner which prevents<br>the timely exercise of this Warrant, pursuant to the terms hereof.
--- ---
(o) Holder’s Exercise Limitations. The Holder may notify the Company in writing in the event<br>it elects to be subject to the provisions contained in this Section 2(e); however, the Holder shall not be subject to this Section<br>2(e) unless he, she or it makes such election. If the election is made, the Company shall not effect any exercise of this Warrant,<br>and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent<br>that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with<br>the Holder’s Affiliates, and any Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such<br>Persons, “Attribution Parties”)) would beneficially own in excess of 4.9%, 9.9%, 19.9% (or such other amount as the<br>Holder may specify) (the “Beneficial Ownership Limitation”). For purposes of the foregoing sentence, the number of<br>Ordinary Shares beneficially owned by the Holder, its Affiliates and Attribution Parties shall include the number of Ordinary Shares issuable<br>upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Ordinary Shares<br>which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any<br>of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities<br>of the Company (including, without limitation, any other Ordinary Share Equivalents) subject to a limitation on conversion or exercise<br>analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except<br>as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance<br>with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that<br>the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder<br>is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this<br>Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder<br>together with any Affiliates and Attribution Parties) and, of which portion of this Warrant is exercisable up to the Beneficial Ownership<br>Limitation shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s<br>good faith determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any<br>Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case, subject to the Beneficial Ownership<br>Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability<br>for exercises of this Warrant that are not in compliance with the Beneficial Ownership Limitation. In addition, a determination as to<br>any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations<br>promulgated thereunder and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have<br>no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation. For purposes of this Section<br>2(e), in determining the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding Ordinary Shares as<br>reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent<br>public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of<br>Ordinary Shares outstanding. Upon the written or oral request of a Holder, the Company shall within two (2) Trading Days confirm in writing<br>to the Holder the number of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall be determined<br>after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates<br>or Attribution Parties since the date as of which such number of outstanding Ordinary Shares was reported. By written notice to the Company,<br>the Holder may from time to time increase or decrease the Beneficial Ownership Limitation applicable to the Holder, provided, however,<br>that any such increase in the Beneficial Ownership Limitation will not be effective until the sixty-first (61st) day after such notice<br>is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict<br>conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent<br>with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly<br>give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.
--- --- 
4

Section 3. Certain Adjustments.

(a) Share Dividends and Splits. If the Company at any time while this Warrant is outstanding: (i) pays<br>a share dividend or otherwise makes a distribution or distributions on Ordinary Shares or any other equity or equity equivalent securities<br>payable in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of<br>this Warrant or any cash distributions), (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including<br>by way of a reverse share split) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues by reclassification of Ordinary<br>Shares any shares of shares of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator<br>shall be the number of Ordinary Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the<br>denominator shall be the number of Ordinary Shares outstanding immediately after such event, and the number of shares issuable upon exercise<br>of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment<br>made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders<br>entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,<br>combination or re-classification.
(b) VWAP Reset. If the VWAP of the Ordinary Shares for the twenty trading day period commencing on<br>the date that is six months after the Closing Date (the “Measurement Price”) is less than the Exercise Price then in<br>effect, then the Exercise Price then in effect shall be reduced in a one-time downward adjustment to an amount equal to the greater of<br>(i) the Measurement Price and (ii) $5.00 (subject to Equitable Adjustment).
--- ---
(c) Adjustment Upon Issuance of Ordinary Shares. If and whenever on or after the Closing Date while<br>the Warrant is outstanding, the Company issues or sells, or in accordance with this Section 3(c) is deemed to have issued or sold,<br>any Ordinary Shares (including the issuance or sale of Treasury Shares and any other Ordinary Shares owned or held by or for the account<br>of the Company, but excluding Ordinary Shares issued or sold, or deemed to have been issued or sold, by the Company in connection<br>with any Exempt Issuance) for a consideration per share (the “New Issuance Price”) less than the lesser<br>of (x) $10.00 (subject to Equitable Adjustment) and (y) the Exercise Price then in effect (each such issue, sale or deemed issuance or<br>sale, a “Dilutive Issuance”), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall<br>be reduced to an amount equal to the New Issuance Price; save that the Exercise Price shall at all times be equal to or greater than the<br>par value of the Ordinary Shares.
--- ---

For purposes of determining the adjusted Exercise Price under this Section 3(c), the following shall be applicable:

(i) Options and Convertible Securities. The consideration per share received by the Company for Ordinary<br>Shares deemed to have been issued pursuant to Section 3(c)(ii), relating to Options and Convertible Securities, shall be determined<br>by dividing:
(1) the total amount, if any, received or receivable by the Company as consideration for the issue of such<br>Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating<br>thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon<br>the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities,<br>the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by
--- ---
(2) the maximum number of Ordinary Shares (as set forth in the instruments relating thereto, without regard<br>to any provision contained therein for a subsequent adjustment of such number) deemed to be issued pursuant to Section 3(c)(ii)<br>upon the issuance of such Options or Convertible Securities.
--- --- 
5
(ii) Deemed Issuance of Options and Convertible Securities.
(1) If the Company at any time or from time to time shall issue any Options or Convertible Securities or shall<br>fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities,<br>then the maximum number of Ordinary Shares (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions<br>to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment<br>of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion<br>or exchange of such Convertible Securities, shall be deemed to be outstanding and to have been issued as of the time of such issue or,<br>in case such a record date shall have been fixed, as of the close of business on such record date.
--- ---
(2) If the purchase price provided for in any Options, the additional consideration, if any, payable upon<br>the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible<br>into or exercisable or exchangeable for Ordinary Shares increases or decreases at any time, (other than (x) proportional changes in conversion<br>or exercise prices, as applicable, in connection with an event referred to in Section 3(a) above and (y) automatic adjustments<br>to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security which are not more favorable to the<br>holder thereof than the anti-dilution and similar provisions set forth herein), the Exercise Price in effect at the time of such increase<br>or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time had such Options or Convertible Securities<br>provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case<br>may be, at the time initially granted, issued or sold. For purposes of this Section 3(c)(ii)(2), if the terms of any Option or<br>Convertible Security that was outstanding as of the Initial Exercise Date are increased or decreased in the manner described in the immediately<br>preceding sentence, then such Option or Convertible Security and the Ordinary Shares deemed issuable upon exercise, conversion or exchange<br>thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(c)(i)(2)<br>shall be made if such adjustment would result in an increase of the Exercise Price then in effect.
--- ---
(iii) Calculation of Consideration Received.
--- ---
(1) In case one or more Option is issued in connection with the issue or sale of other securities of the Company,<br>together comprising one integrated transaction, (x) each such Option will be deemed to have been issued for the Option Value of such Option<br>and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference<br>of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms<br>of such other securities of the Company, less (II) the Option Value of each such Options.
--- ---
(2) If any Ordinary Shares, Options or Convertible Securities are issued or sold or deemed to have been issued<br>or sold for cash, the consideration other than cash received therefor will be deemed to be the net amount received by the Company therefor.<br>If any Ordinary Shares, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration<br>received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities,<br>in which case the amount of consideration received by the Company will be the closing sale price of such publicly traded securities on<br>the date of receipt. If any Ordinary Shares, Options or Convertible Securities are issued to the owners of the non-surviving entity in<br>connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the<br>fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Ordinary Shares, Options<br>or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly traded securities will<br>be determined jointly by the Company and the holders of a majority in interest of this Warrant and the other ordinary share purchase warrants<br>with substantially the same terms as this Warrant, with an initial exercise price of $12.00 per share, issued on the Initial Exercise<br>Date, and then outstanding. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring<br>valuation (the “Valuation Event”), the fair value of such consideration will be determined within five (5) Business<br>Days after the tenth (10th) day following the Valuation Event by an independent, reputable appraiser jointly selected by the Company and<br>the holders of a majority in interest of this Warrant and the other ordinary share purchase warrants, with an initial exercise price of<br>$12.00 per share, issued on the Initial Exercise Date, and then outstanding. The determination of such appraiser shall be final and binding<br>upon all parties absent manifest error and the reasonable fees and expenses of such appraiser shall be borne by the Company.
--- --- 
6
(iv) Record Date. If the Company takes a record of the holders of Ordinary Shares for the purpose of<br>entitling them (A) to receive a dividend or other distribution payable in Ordinary Shares, Options or in Convertible Securities or (B)<br>to subscribe for or purchase Ordinary Shares, Options or Convertible Securities, then such record date will be deemed to be the date of<br>the issuance or sale of the Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of<br>such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.
(v) Expiration or Termination of Options or Convertible Securities. Upon the expiration or termination<br>of any unexercised Option or unconverted or unexchanged Convertible Securities (or portion thereof) which resulted (either upon its original<br>issuance or upon a revision of its terms) in an adjustment to the Exercise Price pursuant to the terms of Section 3(c), the Exercise<br>Price shall be readjusted to such Exercise Price as would have obtained had such Option or Convertible Securities (or portion thereof)<br>never been issued.
--- ---
(d) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above,<br>if at any time after the Initial Exercise Date while this Warrant is outstanding, the Company grants, issues or sells any Ordinary Share<br>Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of Ordinary<br>Shares (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase<br>Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable<br>upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, any applicable<br>Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase<br>Rights, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant,<br>issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right<br>to participate in any such Purchase Right would result in the Holder exceeding any applicable Beneficial Ownership Limitation, then the<br>Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as<br>a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until<br>such time, if ever, as its right thereto would not result in the Holder exceeding any applicable Beneficial Ownership Limitation). To<br>the extent that the issue price of such Purchase Rights would result in an adjustment of the Exercise Price pursuant to Section 3(c),<br>such adjustment shall not occur to the extent the Holders were granted the right to acquire such Purchase Rights on the applicable terms.
--- ---
(e) Fundamental Transaction.
--- ---
(i) If, at any time while this Warrant is outstanding, (a) the Company, directly or indirectly, in one or<br>more related transactions effects any merger or consolidation of the Company with or into another Person, (b) the Company (and all of<br>its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other<br>disposition of all or substantially all of its assets in one or a series of related transactions, (c) any, direct or indirect, purchase<br>offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares<br>are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of<br>50% or more of the outstanding Ordinary Shares or 50% or more of the Shares entitled to vote, (d) the Company, directly or indirectly,<br>in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory<br>share exchange pursuant to which the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property<br>(other than as a result of a share split, reverse share split, combination or reclassification of Ordinary Shares covered by Section<br>3(a) or any reorganization or parent-subsidiary merger not requiring shareholder approval), or (e) the Company, directly or indirectly,<br>in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without<br>limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby<br>such other Person or group acquires 50% or more of the outstanding Ordinary Shares (not including any Ordinary Shares held by the other<br>Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share<br>purchase agreement or other business combination) or 50% or more of the Shares entitled to vote (each a “Fundamental Transaction”),<br>then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have<br>been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without<br>regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring<br>corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)<br>receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable<br>immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
--- --- 
7
(ii) For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted<br>to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such<br>Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting<br>the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares are given any choice as to<br>the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the<br>Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything<br>to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s<br>option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later,<br>the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the<br>Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation<br>of such Fundamental Transaction; provided, that if holders of Ordinary Shares of the Company are not offered or paid any<br>consideration in such Fundamental Transaction, such holders of Ordinary Shares will be deemed to have received common stock or ordinary<br>shares of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental<br>Transaction. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration)<br>within the later of (i) five Business Days of the Holder’s election and (ii) the date of consummation of the Fundamental Transaction.
(iii) The Company shall require any successor entity in a Fundamental Transaction in which the Company is not<br>the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant<br>and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form<br>and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental<br>Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity<br>evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding<br>number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable and receivable<br>upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,<br>and with an exercise price which applies the Exercise Price hereunder to such shares of capital stock (but taking into account the relative<br>value of the Ordinary Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares<br>of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the<br>consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
--- ---
(iv) This Section 3(e) shall not apply to the transactions contemplated by the Business Combination<br>Agreement or set forth in the remainder of Section 3.
--- ---
(f) Calculations. All calculations under this Section 3 shall be made to the nearest cent or<br>the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be<br>issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued<br>and outstanding.
--- ---
(g) Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to<br>this Section 3, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased<br>proportionately so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares<br>shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on<br>exercise contained herein).
--- --- 
8
(h) Notice to Holder.
(i) Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision<br>of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such<br>adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such<br>adjustment.
--- ---
(ii) Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution<br>in whatever form) on the Ordinary Shares, (B) the Company shall declare a redemption of the Ordinary Shares, (C) the Company shall authorize<br>the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or purchase any shares of any class or of any rights,<br>(D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares,<br>any consolidation or merger to which the Company (or any of its subsidiaries) is a party, any sale or transfer of all or substantially<br>all of its assets, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property,<br>or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,<br>then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the<br>Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice<br>stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,<br>or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled to such dividend,<br>distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger,<br>sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the<br>Ordinary Shares of record shall be entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon<br>such reclassification, consolidation, merger, sale, transfer or share exchange; provided, that, notwithstanding the foregoing,<br>any notice delivery requirement hereunder shall also be deemed satisfied by filing or furnishing such communication with the Commission<br>via the EDGAR system; provided, further, that the failure to deliver such notice or any defect therein or in the delivery thereof<br>shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided<br>to the Holder in accordance with the terms of this Warrant constitutes, or contains, material, non-public information regarding the Company<br>or any of the subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form<br>6-K, unless determined by the Company that such filing would be harmful to the Company at such time, in which case the Company shall file<br>such 6-K as soon as is reasonably practicable in its discretion. The Holder shall remain entitled to exercise this Warrant during the<br>period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly<br>set forth herein.
--- ---
(b) Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the<br>Company may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise<br>Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.
--- ---

Section 4. Transfer of Warrant.

(a) Transferability. Subject to compliance<br> with any applicable securities laws, the conditions set forth in Section 4(d) hereof,<br> and the Articles [and the transfer conditions referred to in the legend endorsed hereon]^3^,<br> this Warrant and all rights hereunder (including, without limitation, any registration rights)<br> are transferable, in whole or in part, upon surrender of this Warrant at the principal office<br> of the Company or its designated agent, together with a written assignment of this Warrant<br> substantially in the form attached hereto duly executed by the Holder or its agent or attorney<br> and funds sufficient to pay any transfer taxes payable upon the making of such transfer.<br> Upon such surrender and, if required, such payment, the Company shall execute and deliver<br> a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in<br> the denomination or denominations specified in such instrument of assignment, and shall issue<br> to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and<br> this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,<br> the Holder shall not be required to physically surrender this Warrant to the Company unless<br> the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this<br> Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers<br> an assignment form to the Company assigning this Warrant in full. The Warrant, if properly<br> assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant<br> Shares without having a new Warrant issued.
3 To be included for new money warrants.
--- --- 
9
(b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof<br>at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are<br>to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which<br>may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant<br>or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the<br>Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto, and<br>if applicable, shall reflect any adjustment to the Exercise Price prior to the date of such transfer or exchange.
(c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the<br>Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company<br>may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution<br>to the Holder, and for all other purposes, absent actual notice to the contrary.
--- ---
(d) Transfer Restrictions. This Warrant and the Warrant Shares may only be disposed of in compliance<br>with state and federal securities laws and the Articles. In connection with any transfer of this Warrant or the Warrant Shares other than<br>pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of the Holder or in connection with a pledge<br>in connection with a bona fide margin account with a registered broker-dealer or other loan with a financial institution that is an “accredited<br>investor” as defined in Rule 501(a) under the Securities Act or other loan secured by this Warrant or the Warrant Shares, the Company<br>may require the transferor to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the<br>Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does<br>not require registration of this Warrant or the Warrant Shares under the Securities Act.
--- ---
(e) [Representation<br> by the Holder. The Holder, by the acceptance hereof, represents and warrants that it<br> is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares<br> issuable upon such exercise, for its own account and not with a view to or for distributing<br> or reselling such Warrant Shares or any part thereof in violation of the Securities Act or<br> any applicable state securities law, except pursuant to sales registered or exempted under<br> the Securities Act.]^4^ / [Compliance with<br> the Securities Act.
--- ---
(i) Agreement to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant,<br>agrees to comply in all respects with the provisions of this Section 2 and the restrictive legend requirements set forth on the<br>face of this Warrant and further agrees that such Holder shall not offer, sell, or otherwise dispose of this Warrant or any Warrant Shares<br>to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act of 1933, as amended<br>(the “Securities Act”). This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered<br>under the Securities Act) shall be stamped or imprinted with a legend in substantially the following form:
--- ---

“THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

4 NTD: Version of provision to be included in Warrants issued in exchange for Company Pre-Funded<br>Convertible Note Investor Warrants. 
10
(ii) Representations of the Holder. In connection with the issuance of this Warrant, the Holder specifically<br>represents, as of the date hereof, to the Company by acceptance of this Warrant as follows:
(1) The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated<br>under the Securities Act. The Holder is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment<br>for its own account and not with a view towards, or for distribution or resale in connection with, the public sale or distribution of<br>this Warrant or the Warrant Shares, except pursuant to sales registered or exempted under the Securities Act.
--- ---
(2) The Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise<br>hereof are “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company<br>in a transaction not involving a public offering and that, under such laws and applicable regulations, such securities may be resold without<br>registration under the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with<br>Rule 144 under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities<br>Act.
--- ---
(3) The Holder acknowledges that it can<br> bear the economic and financial risk of its investment for an indefinite period, and has<br> such knowledge and experience in financial or business matters that it is capable of evaluating<br> the merits and risks of the investment in the Warrant and the Warrant Shares. The Holder<br> has had an opportunity to ask questions and receive answers from the Company regarding the<br> terms and conditions of the offering of the Warrant and the business, properties, prospects,<br> and financial condition of the Company.]^5^
--- ---

Section 5. Miscellaneous.

(a) No Rights as Shareholder Until Exercise. Prior to the issuance to the Holder of the Warrant Shares<br>to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder shall not be entitled to vote or receive<br>dividends or have any other rights as a shareholder or be deemed the holder of shares of the Company for any purpose, nor shall anything<br>contained in this Warrant be construed to confer upon the Holder, as such, any of the rights of a member of the Company or any right to<br>vote, give, or withhold consent to any action (whether any reorganization, issue of shares, reclassification of shares, consolidation,<br>merger, conveyance, or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise. Other than as expressly<br>set forth herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.
(b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the<br>Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate<br>relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,<br>in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate,<br>if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in<br>lieu of such Warrant or share certificate.
--- ---
(c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or<br>the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be<br>exercised on the next succeeding Business Day.
--- ---
^5^ NTD: Version of provision to be included on Warrants issued for new money on the Closing<br>Date.
--- --- 
11
(d) Authorized Shares.
(i) The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized<br>and unissued Ordinary Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any<br>purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to<br>its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this<br>Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided<br>herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares<br>may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented<br>by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance<br>herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company<br>in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).
--- ---
(ii) Except and to the extent as waived or consented to by the Holder, the Company shall not by any action,<br>including, without limitation, amending its memorandum or Articles or through any reorganization, transfer of assets, consolidation, merger,<br>dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of<br>the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such<br>actions as may be reasonably requested by the Holder to protect the rights of Holder as set forth in this Warrant against impairment.<br>Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount<br>payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or<br>appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this<br>Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory<br>body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.
--- ---
(iii) Before taking any action which would result in an adjustment in the number of Warrant Shares for which<br>this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents<br>thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof[, the Articles and the Shareholders’<br>Agreement].
--- ---
(e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation<br>of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without<br>regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement<br>and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or its respective Affiliates, directors,<br>officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting<br>in the State of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting<br>in the State of Delaware for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated<br>hereby or discussed herein (including with respect to the enforcement of this Warrant), and hereby irrevocably waives, and agrees not<br>to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action<br>or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process<br>and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight<br>delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such<br>service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit<br>in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce<br>any provisions of this Warrant, then, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party<br>for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of<br>such Action or Proceeding.
--- ---
(f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this<br>Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and<br>federal securities laws.
--- --- 
12
(g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder<br>on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without<br>limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,<br>which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover<br>any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred<br>by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
(h) Notices. Any and all notices or other communications or deliveries required or permitted to be<br>provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such<br>notice or communication is delivered via email at the e-mail address as set forth on the signature pages attached hereto, or to such other<br>address as the Company or the Holder may indicate by a notice delivered to the other from time to time, at or prior to 5:30 p.m. (New<br>York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered<br>via email attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later<br>than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S.<br>nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The<br>address for such notices and communications shall be as set forth on the signature pages attached hereto, or to such other address as<br>the Company or the Holder may indicate by a notice delivered to the other from time to time.
--- ---
(i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder<br>to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise<br>to any liability of the Holder for the purchase price of any Ordinary Shares or as a shareholder of the Company, whether such liability<br>is asserted by the Company or by creditors of the Company.
--- ---
(j) Remedies. Each party agrees that each of the parties, in addition to being entitled to exercise<br>all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The<br>parties agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions<br>of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would<br>be adequate.
--- ---
(k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and<br>obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and<br>the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time<br>to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.
--- ---
(l) Amendment. This Warrant may be modified, waived or amended or the provisions hereof waived with<br>the written consent of the Company and the Holder.
--- ---
(m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner<br>as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable<br>law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions<br>or the remaining provisions of this Warrant.
--- ---
(n) Headings. The headings used in this Warrant are for the convenience of reference only and shall<br>not, for any purpose, be deemed a part of this Warrant.
--- ---

********************

(Signature Page Follows)

13

IN WITNESS WHEREOF, the parties hereto have caused this Ordinary Share Purchase Warrant to be duly executed by their respective authorized signatories as of the date first indicated above.

AIR WATER VENTURES LIMITED Address for Notice:
By:
Name:
Title: Email:
With a copy to (which shall not constitute notice): 
14

IN WITNESS WHEREOF, the undersigned have caused this Ordinary Share Purchase Warrant to be duly executed by their respective authorized signatories as of the date first indicated above.

Name of Purchaser:

Signature of Authorized Signatory of Purchaser:

Name of Authorized Signatory:

Title of Authorized Signatory:

Email Address of Authorized Signatory:

Address for Notice to Purchaser:

Address for Delivery of Securities to Purchaser (if not same as address for notice):

Warrant Shares:

EIN Number:

15

SCHEDULE A

“Action” means any action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the applicable party, threatened against or affecting the applicable party or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign).

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Articles” means the second amended and restated articles of association of the Company, as adopted by special resolution on 18 August 2025.

“Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to Section 3(f), (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.

“Bloomberg” means Bloomberg L.P.

“Business Combination” means the transactions contemplated by the Business Combination Agreement.

“Business Combination Agreement” means that certain Business Combination Agreement, dated as of August 25, 2025, by and among Air Water Ventures Holdings Limited, Inflection Point Acquisition Corp. III, the Company and IPCX Merger Sub Limited, as it may be further amended, modified or supplemented from time to time.

“Business Day” means any day other than Saturday, Sunday or legal holiday on which commercial banks in New York, New York, London, England, or George Town, Cayman Islands, are authorized to close for business.

“Closing Date” means the Trading Day on which the Business Combination is consummated.

“Convertible Securities” means any shares or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any Ordinary Shares and any securities of the Company that when paired with one or more other securities of the Company or another entity entitles the holder thereof to receive, Ordinary Shares.

16

“Equitable Adjustment” means, in the event that the number of outstanding Ordinary Shares, as applicable, shall have been changed into a different number of shares or a different class by reason of any reclassification, subdivision, consolidation, reorganisation, recapitalization, combination, exchange of shares, readjustment, or other similar transaction, or a share dividend or share distribution has been effectuated, an equitable adjustment as necessary to provide the holders of Ordinary Shares with the same economic effect as is contemplated by this Warrant prior to such event;

“Exempt Issuance” means the issuance of (a) any securities of the Company to employees, officers or directors , consultants, contractors, vendors or other agents of the Company pursuant to any share or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any securities issued pursuant to the Purchase Agreements or the Business Combination Agreement, or in connection with the transactions contemplated thereby, including the Series A Shares, this Warrant and the other common share purchase warrants with an initial exercise price of $12.00 per share, and/other securities exercisable or exchangeable for or convertible into Ordinary Shares issued and outstanding on the Closing Date, provided that such securities have not been amended since the Closing Date to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with share splits or combinations and automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such securities which are not more favorable to the holder thereof than the anti-dilution and similar provisions set forth herein) or to extend the term of such securities, (c) the Underlying Shares, and (d) securities issued pursuant to any merger, acquisition or strategic transaction or partnership approved by a majority of the directors of the Company, provided that (i) such securities are issued as “restricted securities” (as defined in Rule 144) or are issued pursuant to an effective registration statement pursuant to the Securities Act and (ii) any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but any such Exempt Issuance shall not include a transaction in which the Company is issuing securities (i) primarily for the purpose of raising capital, including an at-the-market offering, or (ii) to an entity whose primary business is investing in securities.

“Options” means any rights, warrants or options to subscribe for or purchase Ordinary Shares or Convertible Securities.

“Option Value” means the value of an Option based on the Black-Scholes Option Pricing model obtained from the “OV” function on Bloomberg determined as of (A) the Trading Day prior to the public announcement of the issuance of the applicable Option, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination, (ii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of (A) the Trading Day immediately following the public announcement of the applicable Option if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iii) the underlying price per share used in such calculation shall be the highest weighted average price of the Ordinary Shares during the period beginning on the Trading Day prior to the execution of definitive documentation relating to the issuance of the applicable Option and ending on (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iv) a zero cost of borrow and (v) a 360 day annualization factor, provided, however, in case any Option is issued in connection with the issue or sale of other securities of the Company, together comprising one integrated transaction, in no event shall the Option Value exceed a fraction of the aggregate consideration received (excluding the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities) equal to (1) the number of Ordinary Shares underlying such Option divided by (2) the total number of Ordinary Shares issued or issuable in the integrated transaction (including the number of shares underlying such Option).

“Ordinary Share Equivalents” means any securities of the Company which would entitle the holder thereof to acquire at any time Ordinary Shares, including, without limitation, any debt, preferred share, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares, and any securities of the Company that when paired with one or more other securities of the Company or another entity entitles the holder thereof to receive, Ordinary Shares.

17

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Proceeding” means an action, claim, suit, investigation or proceeding, whether commenced or threatened.

“Purchase Agreements” means the several Subscription Agreements, between Air Water Ventures Holdings Limited and certain original holders of ordinary share purchase warrants, with an initial exercise price of $12.00 per share, issued on the Initial Exercise Date, as amended, modified or supplemented from time to time in accordance with its terms.

“Registration Rights Agreement” means the Amended and Restated Registration Rights Agreement among the Company, the initial Holder of this Warrant and the other parties thereto.

“Series A Shares” shall have the meaning given to it in the Articles.

“Trading Day” means a day on which the principal Trading Market is open for trading.

“Trading Market” means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).

“Transaction Documents” means this Warrant, the other ordinary share purchase warrants, with substantially the same terms as this Warrant, with an initial exercise price of $12.00 per share, issued on the Initial Exercise Date and the Registration Rights Agreement, and all exhibits and schedules thereto.

“Transfer Agent” means Continental Stock Transfer & Trust Company, the current transfer agent of the Company, and any successor transfer agent of the Company.

“Underlying Shares” means the Ordinary Shares issuable upon conversion of the Series A Shares or exercise of this Warrant and the other ordinary shares purchase warrants, with an initial exercise price of $12.00 per share, issued on the Initial Exercise Date.

“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Shares are then listed or quoted on a Trading Market, the daily volume weighted average price of the Ordinary Shares for the 20 Trading Day preceding such date (or the nearest preceding date) on the Trading Market on which the Ordinary Shares are then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Ordinary Shares for the 20 Trading Days preceding such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Ordinary Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the average of the highest closing bid price per share and the lowest closing ask price per Ordinary Share for the 20 Trading Days preceding such date, or (d) in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of this Warrant and the other ordinary share purchase warrants, with an initial exercise price of $12.00 per share, issued on the Initial Exercise Date and then outstanding, and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.

18

EXHIBIT A

NOTICE OF EXERCISE

To:
Attn:
Email:

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2) Payment shall take the form of (check applicable box):

☐ in lawful money of the United States; or

☐ if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

The Warrant Shares shall be delivered to the following DWAC Account Number:

[(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.]

[SIGNATURE OF HOLDER]

Name of Investing Entity:___________________________________________________________________
Signature of Authorized Signatory of Investing Entity:________________________________________________
Name of Authorized Signatory:_________________________________________________________________
Title of Authorized Signatory:___________________________________________________________________
Date:__________________________________________________________________________________________ 
19

EXHIBIT B

ASSIGNMENT FORM

(To assign the foregoingWarrant, execute this form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

Name:
(Please Print)
Address:
(Please Print)
Phone Number:
Email Address:
Dated: _______________ __, ______
Holder’s Signature:
Holder’s Address:
---

20

Exhibit 10.1

Execution Version

COMPANY SUPPORT AGREEMENT^1^

This Company Support Agreement (this “Company Support Agreement”) is dated as of August 25, 2025, by and among TAU Capital Holding Limited (formerly known as TAU Capital Holding – Sole Proprietorship L.L.C.), a limited liability company incorporated under the laws of Abu Dhabi (“Tau”), Inflection Point Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), Air Water Ventures Holdings Limited, a Cayman Islands exempted company (the “Company”), and Air Water Ventures Limited, a Cayman Islands exempted company (“PubCo”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

RECITALS

WHEREAS, as of the date hereof, Tau is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of certain Company Ordinary Shares as set forth on Schedule I attached hereto (all such securities or other equity securities, together with any classes of the Company’s shares, or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power of attorney) is hereafter acquired by Tau during the period from the date hereof through the Expiration Time (as defined below) are referred to herein as the “Subject Securities”);

WHEREAS, contemporaneously with the execution and delivery of this Company Support Agreement, SPAC, the Company, PubCo and IPCX Merger Sub Limited, a Cayman Islands exempted company (“Merger Sub”), have entered into a Business Combination Agreement (as amended, restated or otherwise modified from time to time, the “Business Combination Agreement”), pursuant to which, among other transactions: (i) SPAC will be merged with and into PubCo (the “First Merger”), as a result of which (a) PubCo shall continue as the surviving entity, and (b) each issued and outstanding SPAC Share as of immediately prior to the First Merger Effective Time shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive one (1) PubCo Ordinary Share subject to and on the terms and conditions set forth in the Business Combination Agreement; and (ii) one (1) Business Day after the First Merger Effective Date, the Company will be merged into Merger Sub (the “Second Merger,” and together with the First Merger, the “Mergers”), as a result of which (a) Merger Sub shall continue as the surviving entity and as a wholly owned subsidiary of PubCo, and (b) each issued and outstanding Company Ordinary Share, Company Series A Preferred Share, Company Warrant and Company RSU, in each case as of immediately prior to the Second Merger Effective Time, shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive new PubCo Ordinary Shares, PubCo Preferred Shares, PubCo Series A Investor Warrants and Exchanged RSUs, respectively, subject to and on the terms and conditions set forth in the Business Combination Agreement; and

WHEREAS, as a condition and inducement to SPAC and the willingness of Company to enter into the Business Combination Agreement and to consummate the Transactions, the parties hereto are entering into this Company Support Agreement for Tau to take certain actions as described herein.

^1^ Note to Draft: Form to be duplicated<br> for each of (i) The Bert E. Miller 2023 Family Trust, (ii) Andrea Mollica, (iii) Bill Murray,<br> (iv) Pete Carr and (v) Ryan Bibbo.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained herein, and for other good and valid consideration, the sufficiency of which is hereby acknowledged, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

Article I

COMPANY SUPPORT AGREEMENT; COVENANTS

Section 1.1 Interim Period Lock-Up Provisions.

(a) During the period commencing on the date hereof and ending on the earliest of (a) the Second Merger Effective Time and (b) such date and time as the Business Combination Agreement shall be validly terminated in accordance with Section 11.1 thereof (the earlier of (a) and (b), the “Expiration Time”), Tau shall not (except in a Permitted Transfer) (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, in each case, directly or indirectly, with respect to any Subject Securities (or PubCo Ordinary Shares received as consideration thereof) owned by Tau, (ii) file (or participate in the filing of) a registration statement with the SEC (other than the Registration Statement and any resale registration statement filed by PubCo relating to PubCo Ordinary Shares), (iii) deposit any Subject Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Company Support Agreement or otherwise transfer any voting or approval rights with respect to the Subject Securities, (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Securities (or PubCo Ordinary Shares received as consideration thereof) owned by Tau or (v) publicly announce any intention to effect any transaction specified in clause (i), (ii), (iii) or (iv) (clauses (i)-(v), collectively, “Transfer”).

(b) “PermittedTransfer” means any Transfer of Subject Securities (i) to (A) any officer or director of Tau, the Company or Pubco, (B) any Affiliates or family members of the officers or directors of Tau, the Company or Pubco, or (C) any direct or indirect partners, members or equity holders of Tau or any related investment funds or vehicles controlled or managed by such Persons or their respective Affiliates (including, for the avoidance of doubt, where such Person is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership); (ii) to a nominee or custodian of a Person to whom a Transfer would be permitted under clause (i); (iii) in connection with any legal, regulatory or other order; (iv) to a third party in connection with any non-redemption, backstop arrangement or other similar arrangement, (v) as otherwise mutually agreed upon between Tau, the Company or Pubco, or (vi) to the Company or Pubco; provided, however, that in the case of clauses (i) through (vi), as a precondition to such Transfer, such transferee must enter into a written agreement with the Company, SPAC and Pubco agreeing to assume all of the obligations under this Agreement with respect to such Subject Securities and to be bound by the transfer restrictions set forth in this Agreement (to the extent applicable); provided, further, that, no Transfer permitted under this Section 1.1(b) shall relieve Tau or any holder of Subject Securities pursuant to a Permitted Transfer of its obligations under this Agreement.

2

Section 1.2 New Shares. In the event that (a) any Subject Securities are issued to Tau after the date of this Company Support Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification, combination or exchange of Subject Securities of, on or affecting the Subject Securities owned by Tau or otherwise, (b) Tau purchases or otherwise acquires beneficial ownership of any Subject Securities after the date of this Company Support Agreement, or (c) Tau acquires the right to vote or share in the voting of any Subject Securities after the date of this Company Support Agreement (such equity securities of the Company, collectively the “New Securities”), then such New Securities acquired or purchased by Tau shall constitute Subject Securities and be subject to the terms of this Company Support Agreement to the same extent as if they constituted Subject Securities owned by Tau as of the date hereof.

Section 1.3 Binding Effect of the Business Combination Agreement. Tau hereby acknowledges that it has read the Business Combination Agreement and this Company Support Agreement and has had the opportunity to consult with its tax and legal advisors. Tau shall be bound by and comply with Sections 8.16 (Public Announcements) of the Business Combination Agreement (and any relevant definitions contained in any such Sections) as if Tau was an original signatory to the Business Combination Agreement with respect to such provisions.

Section 1.4 Waiver of Dissenters’ Rights. Tau hereby irrevocably waives, and agrees not to exercise or assert, any dissenters’ rights under Section 238 of the Cayman Act and any other similar statute in connection with the Transactions and the Business Combination Agreement.

Section 1.5 Tau Agreements.

(a) At any meeting of the shareholders of the Company, however called, or at any adjournment or postponement thereof, or in any other circumstance in which the vote, consent or other approval of the shareholders of the Company is sought (including any action by written resolution), Tau shall (i) appear at each such meeting or otherwise cause all of its Subject Securities entitled to vote, and any other Company shares that Tau has the right to vote, to be counted as present thereat for purposes of calculating a quorum and (ii) vote (or cause to be voted), or execute and deliver a written consent (or cause a written consent to be executed and delivered) covering, all of Tau’s Subject Securities:

(i) in favor of the Company Shareholder Matters (or any sub-matter or actions in furtherance thereof);

(ii) in favor of any proposal to adjourn or postpone the applicable meeting to a later date if and only if there are not sufficient votes for the approval of the Company Shareholder Approval (or any sub-matter or actions in furtherance thereof) and any other matters required to be approved as set forth in the Proxy Statement on the date on which such meeting is held; and

3

(iii) against any proposal, action, transaction or agreement that would or would reasonably be expected to (A) delay, postpone, impede, frustrate, prevent or nullify any provision of this Company Support Agreement, the Business Combination Agreement, any other Ancillary Document, or the Transactions, including the Second Merger, (B) constitute or lead to an Alternative Transaction for the Company, (C) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of the Company under the Business Combination Agreement or any other Ancillary Document, (D) result in any of the conditions set forth in Article IX of the Business Combination Agreement not being fulfilled, (E) amend the Company’s Organizational Documents, including any change in any manner to the dividend policy or capitalization of, including the voting rights of any class of capital stock of the Company, (F) result in a business combination agreement or merger (other than the Business Combination Agreement and the Mergers), consolidation, combination, sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by, or other change to the corporate structure or business of, the Company or (G) result in a change in the business of the Company or any change in the management or the Company’s board of directors (other than, in each case, in connection with the Business Combination Agreement, any Ancillary Document or the Company Shareholder Approval).

Tau hereby agrees not to commit or agree to take any action inconsistent with the foregoing.

(b) During the period commencing on the date hereof and ending on the Expiration Time, without the prior written consent of Inflection Point Holdings III LLC, Tau shall not modify or amend any contract between or among Tau or any Affiliate of Tau, on the one hand, and the Company or any of the Company’s subsidiaries, on the other hand.

(c) Solely to the extent that Tau fails to take any of the actions set forth in this Section 1.5 in accordance with the terms hereof, Tau hereby irrevocably appoints, as its proxy and attorney-in-fact, SPAC and any person designated in writing by SPAC, each of them individually, with full power of substitution and re-substitution, to vote and represent at any annual or special meeting of shareholders of the Company, and to execute and deliver any action by written consent of the shareholders of the Company in lieu of any such meeting with respect to, all of the Subject Securities that Tau is or may be entitled to vote, in each case, solely with respect to the matters contemplated by this Section 1.5. Tau acknowledges and agrees that such proxy and power of attorney granted hereunder shall be irrevocable and unconditional during the term of this Company Support Agreement and is coupled with an interest sufficient in law to support an irrevocable proxy. Tau agrees that the foregoing proxy and power of attorney shall, during the term of this Company Support Agreement, supersede in all respects any other proxy or power of attorney previously granted by Tau with respect to such Subject Securities. The proxy and power of attorney granted by or at the direction of Tau hereunder shall be automatically revoked upon the Effective Time. This irrevocable proxy and power of attorney is binding upon the heirs, estate, executors, personal representatives, successors, and assigns of Tau and, without limiting the effect of the restrictions on transfer and ownership with respect to the Subject Securities, any other holder of record of the Subject Securities as to which this proxy and power of attorney has been granted (including any transferee of any of the Subject Securities).

4

Section 1.6 Further Assurances. Tau shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably necessary under applicable Laws to consummate the Mergers and the other transactions contemplated by the Business Combination Agreement on the terms and subject to the conditions set forth therein and herein.

Section 1.7 No Inconsistent Agreement. Tau hereby represents and warrants that it has not entered into, and covenants and agrees it shall not enter into, any Contract that would delay, postpone, impede, frustrate, prevent, nullify, restrict, limit or interfere with the performance of Tau’s obligations hereunder or make any representation and warranty contained herein untrue. Prior to the Expiration Time, Tau shall not liquidate or dissolve.

Article II

ADDITIONAL REPRESENTATIONS AND WARRANTIES

Section 2.1 Representations and Warranties of Tau. Tau represents and warrants as of the date hereof to SPAC and the Company as follows:

(a) Organization; Due Authorization. Tau is duly organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or formation, and the execution, delivery and performance of this Company Support Agreement and the consummation of the transactions contemplated hereby are within Tau’s corporate powers and have been duly authorized by all necessary corporate actions on the part of Tau. This Company Support Agreement has been duly executed and delivered by Tau and, assuming due authorization, execution and delivery by the other parties to this Company Support Agreement, this Company Support Agreement constitutes a legally valid and binding obligation of Tau, enforceable against Tau in accordance with the terms hereof (subject to bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting the enforcement of creditors’ rights generally and subject to general principles of equity). If this Company Support Agreement is being executed in a representative or fiduciary capacity, the Person signing this Company Support Agreement has full power and authority to enter into this Company Support Agreement on behalf of Tau.

(b) Ownership. Tau is the record and beneficial owner (as defined in the Securities Act) of, and has good title to, all of the Subject Securities listed across from Tau’s name on Schedule 1 hereto, and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose of such Subject Securities (other than transfer restrictions under the Securities Act)) affecting any such Subject Securities, other than Liens pursuant to (i) this Company Support Agreement, (ii) the Company’s Organizational Documents, (iii) the Business Combination Agreement or (iv) any applicable securities Laws. The Subject Securities are the only equity securities in the Company owned of record or beneficially by Tau on the date of this Company Support Agreement, and none of the Subject Securities held by Tau are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Subject Securities, except as provided hereunder, or any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Securities. Tau has full voting power with respect to the Subject Securities held by Tau. Other than the Subject Securities held by Tau, Tau does not hold or own any rights to acquire (directly or indirectly) any equity securities of the Company or any equity securities convertible into, or which can be exchanged for equity securities of the Company. The Subject Securities held by constitute all of the Subject Securities beneficially owned by Tau as of the date of this Company Support Agreement.

5

(c) No Conflicts. The execution and delivery of this Company Support Agreement by Tau does not, and the performance by Tau of its obligations hereunder will not, (i) conflict with or result in a violation of the organizational documents of Tau, (ii) require any consent or approval that has not been given or other action that has not been taken by any Person (including under any contract binding upon Tau or Tau’s Subject Securities), in each case, to the extent such consent, approval or other action would prevent, enjoin or materially delay the performance by Tau of its obligations under this Company Support Agreement or (iii) conflict with or violate any material Contract to which Tau is party or Law.

(d) Litigation. There are no Actions pending against Tau, or to the knowledge of Tau threatened against Tau, before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Authority, except as has not and would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on Tau’s ability to perform its obligations under this Company Support Agreement.

(e) Acknowledgment. Tau understands and acknowledges that each of SPAC and the Company is entering into the Business Combination Agreement in reliance upon Tau’s execution and delivery of this Company Support Agreement.

Article III

MISCELLANEOUS

Section 3.1 Termination. This Company Support Agreement and all of its provisions shall terminate and be of no further force or effect upon the earlier of (a) the Expiration Time and (b) the execution and delivery of a written agreement providing for the termination of this Company Support Agreement executed by Tau, SPAC and the Company. Upon such termination of this Company Support Agreement, all obligations of the parties under this Company Support Agreement will terminate, without any liability or other obligation on the part of any party hereto to any Person in respect hereof or the transactions contemplated hereby, and no party hereto shall have any claim against another (and no person shall have any rights against such party), whether under contract, tort or otherwise, with respect to the subject matter hereof; provided, however, that the termination of this Company Support Agreement shall not relieve any party hereto from liability arising in respect of any breach of this Company Support Agreement prior to such termination. This Article III shall survive the termination of this Company Support Agreement.

Section 3.2  Governing Law; Jurisdiction. The terms of Section 13.4 of the Business Combination Agreement shall apply to this Company Support Agreement and are incorporated by reference herein mutatis mutandis.

6

Section 3.3 WAIVER OF JURY TRIAL. THE TERMS OF SECTION 13.5 OF THE BUSINESS COMBINATION AGREEMENT (WHICH FOR THE AVOIDANCE OF DOUBT CONTAIN A WAIVER OF ANY RIGHT TO A TRIAL BY JURY) SHALL APPLY TO THIS COMPANY SUPPORT AGREEMENT AND ARE INCORPORATED BY REFERENCE HEREIN MUTATISMUTANDIS.

Section 3.4 Binding Effect; Assignment; Third Parties. This Company Support Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors and permitted assigns. Neither this Company Support Agreement nor any of the rights, interests or obligations hereunder will be assigned (including by operation of law) without the prior written consent of the Company (with respect to an assignment by Tau or, prior to the Closing, SPAC or PubCo) or Tau (with respect to an Assignment by the Company or, after the Closing, SPAC or PubCo). Any assignment without such consent shall be null and void; provided that no such assignment shall relieve the assigning party of its obligations hereunder. Nothing contained in this Company Support Agreement shall create any rights in, or be deemed to have been executed for the benefit of, any Person that is not a party hereto or a successor or permitted assign of such a party.

Section 3.5 Specific Performance. Each party acknowledges that the rights of each party to consummate the transactions contemplated by this Company Support Agreement are unique, recognizes and affirms that in the event of a breach of this Company Support Agreement by any party, money damages may be inadequate and the non-breaching parties may not have adequate remedy at law, and agree that irreparable damage may occur in the event that any of the provisions of this Company Support Agreement were not performed by an applicable party in accordance with their specific terms or were otherwise breached. Accordingly, each party shall be entitled to seek an injunction, specific performance or other equitable remedy to prevent or remedy any breach of this Company Support Agreement and to seek to enforce specifically the terms and provisions hereof, in each case, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such party may be entitled under this Company Support Agreement, at law or in equity.

Section 3.6 Amendment and Modification. This Company Support Agreement may be amended, supplemented or modified only by execution of a written instrument signed by each of Tau, SPAC, Pubco and the Company.

Section 3.7 Waiver. Each of Tau, SPAC, PubCo and the Company may in its sole discretion (a) extend the time for the performance of any obligation or other act of any other party, (b) waive any inaccuracy in the representations and warranties by such other party contained herein or in any document delivered pursuant hereto and (c) waive compliance by such other party with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the applicable parties providing such extension or waiver, and any such extension or waiver shall only be binding upon the party or parties so providing (or on whose behalf it is so provided) the extension or waiver. Notwithstanding the foregoing, no failure or delay by a party in exercising any right or remedy hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.

7

Section 3.8 Severability. In case any provision in this Company Support Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

Section 3.9 Notices. All notices and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery (a) in person, (b) by e-mail (without receiving notice of non-receipt or other “bounce-back”), (c) by reputable, nationally recognized overnight courier service or (d) by registered or certified mail, pre-paid and return receipt requested; provided, however, that notice given pursuant to clauses (c) and (d) above shall not be effective unless a duplicate copy of such notice is also given in person or by e-mail (without receiving notice of non-receipt or other “bounce-back”); in each case to the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice made pursuant to this Section 3.9):

If to Tau:

TAU Capital Holding Limited (formerly known as TAU Capital Holding – Sole Proprietorship L.L.C.)

[Address]

Attention: [●]

Email: [●]

with a copy to (which shall not constitute notice):

[Name]

[Address]

Attention: [●]

Email: [●]

If to the Company or PubCo or, following the Closing, SPAC:

Air Water Ventures Ltd

Unit 3, Kizad KLP FZ, Kizad

Abu Dhabi, UAE

PO Box 109214

Attention:

Email:

with a copy to (which shall not constitute notice):

Morgan, Lewis & Bockius LLP

101 Park Avenue

New York, NY 10178-0060

Attention: Russell Franklin

Email: russell.franklin@morganlewis.com

8

If to SPAC at or prior to the Closing:

Inflection Point Acquisition Corp. III

167 Madison Avenue

Suite 205 #1017

New York, New York 10016

Attention: Michael Blitzer

Email: blitzer@kingstowncapital.com

with a copy to (which shall not constitute notice):

White & Case LLP

1221 Avenue of the Americas

New York, New York 10020

Attn: Joel Rubinstein and Jason Rocha

Email: joel.rubinstein@whitecase.com; jason.rocha@whitecase.com

Section 3.10  Counterparts. This Company Support Agreement may be executed in one or more counterparts (any of which may be delivered by electronic transmission), each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument.

Section 3.11 Non-Circumvention. Each party hereto agrees that it shall not, and shall cause its Affiliates not to, indirectly accomplish that which such party is not permitted to accomplish (or take any action that such party is not permitted to take) directly under this Company Support Agreement.

Section 3.12  Reserved.

Section 3.13  Interpretation. The terms of Section 13.11 of the Business Combination Agreement shall apply to this Company Support Agreement and are incorporated by reference herein mutatis mutandis.

Section 3.14 Consent to Disclosure. Tau hereby consents to the publication and disclosure in any announcement or disclosure required by applicable securities Laws, the SEC or any other securities authorities of Tau’s identity and ownership of Subject Securities (or the PubCo Ordinary Shares to which they convert), the nature of Tau’s obligations hereunder and the other matters set forth in the Business Combination Agreement and the Ancillary Documents, including the Transactions and the Mergers.

Section 3.15 Release; No Recourse. Effective as of the Closing, Tau hereby irrevocably releases and discharges the Company Shareholders and each other Company Affiliates and each of their respective current and former directors, managers, officers, partners and employees to the extent set forth in, and subject to the terms and conditions of, Section 12.2(a) of the Business Combination Agreement, which such terms and conditions of Section 12.2(a) of the Business Combination Agreement shall apply to this Company Support Agreement and are incorporated by reference herein mutatis mutandis (with Tau being understood to be “SPAC” for purposes of the incorporation of Section 12.2(a) of the Business Combination Agreement herein). The terms of Section 13.13 of the Business Combination Agreement shall apply to this Company Support Agreement and are incorporated by reference herein mutatismutandis.

Section 3.16 Entire Agreement. This Company Support Agreement and the agreements referenced herein (including the Business Combination Agreement and the other Ancillary Documents) constitute the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and, save to the extent expressly set out in this Company Support Agreement, the Business Combination Agreement, the other Ancillary Documents or the Confidentiality Agreement, supersede all prior drafts, agreements, undertakings, representations, warranties, promises, assurances and arrangements of any nature whatsoever, whether or not in writing, relating thereto.

[Signature pages follow.]

9

IN WITNESS WHEREOF, Tau, SPAC, PubCo and the Company have each caused this Company Support Agreement to be duly executed as of the date first written above.

TAU:
TAU Capital Holding LIMITED (FORMERLY KNOWN AS TAU CAPITAL HOLDING – Sole Proprietorship L.L.C.)
By:
Name:
Title:
SPAC:
Inflection Point Acquisition Corp. III
By:
Name:
Title:
PUBCO:
AIR WATER VENTURES LIMITED
By:
Name:
Title:
COMPANY:
AIR WATER VENTURES HOLDINGS LIMITED
By:
Name:
Title:

[Signature Page to Tau Support Agreement]

10

Schedule I

Subject Securities

Holder Common<br><br> Shares
TAU Capital Holding Limited (formerly known as TAU Capital Holding – Sole Proprietorship L.L.C.) 20,684 
11

Exhibit 10.2

Execution Version

SPONSOR SUPPORT AGREEMENT

This Sponsor Support Agreement (this “Sponsor Agreement”) is dated as of August 25, 2025, by and among Inflection Point Holdings III LLC, a Delaware limited liability company (the “Sponsor”), Inflection Point Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), Air Water Venture Holdings Limited, a Cayman Islands exempted company (the “Company”), and Air Water Ventures Limited, a Cayman Islands exempted company (“Pubco”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

RECITALS

WHEREAS, as of the date hereof, Sponsor is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of (i) 8,433,000 of SPAC’s Class B Ordinary Shares, par value $0.0001 per share (the “SPAC Class B Ordinary Shares”) and (ii) 500,000 private placement units, each consisting of one of SPAC’s Class A Ordinary Shares, par value $0.0001 per share (the “SPAC Class A Ordinary Shares” and, together with the SPAC Class B Ordinary Shares, the “SPACShares”) and one right to receive one-tenth (1/10) of one SPAC Class A Ordinary Share, subject to adjustment, upon the closing of SPAC’s initial business combination (all such securities or other equity securities, together with any classes of the SPAC’s ordinary shares, units, or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power of attorney) is hereafter acquired by Sponsor during the period from the date hereof through the Expiration Time (as defined below) are referred to herein as the “Subject Securities”);

WHEREAS, contemporaneously with the execution and delivery of this Sponsor Agreement, SPAC, the Company, Pubco and IPCX Merger Sub Limited, a Cayman Islands exempted company (“Merger Sub”), have entered into a Business Combination Agreement (as amended, restated or otherwise modified from time to time, the “Business Combination Agreement”), pursuant to which, among other transactions: (i) SPAC will be merged with and into Pubco (the “First Merger”), as a result of which (a) Pubco shall continue as the surviving entity, and (b) each issued and outstanding SPAC Share, including the SPAC Class A Ordinary Shares issuable in settlement of the SPAC Rights, immediately prior to the First Merger Effective Time shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive the SPAC Per Share Merger Consideration subject to and on the terms and conditions set forth in the Business Combination Agreement; and (ii) at least one Business Day following the First Merger, the Company will be merged into Merger Sub (the “Second Merger”, and together with the First Merger, the “Mergers”), as a result of which (a) Merger Sub shall continue as the surviving entity and as a wholly owned subsidiary of Pubco, and (b) each issued and outstanding Company Ordinary Share, Company Series A Preferred Share, Company Warrant and Company RSU immediately prior to the Second Merger Effective Time shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive new PubCo Ordinary Shares, PubCo Preferred Shares, PubCo Series A Investor Warrants and Exchanged RSUs, respectively, subject to and on the terms and conditions set forth in the Business Combination Agreement; and

WHEREAS, as an inducement to SPAC and the Company to enter into the Business Combination Agreement and to consummate the Transactions, the parties hereto desire to agree to certain matters as set forth herein.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements contained herein, and for other good and valid consideration, the sufficiency of which is hereby acknowledged, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

Article I

SPONSOR SUPPORT AGREEMENT; COVENANTS

Section 1.1 Interim Period Lock-Up Provisions.

(a) During the period commencing on the date hereof and ending on the earliest of (a) the Second Merger Effective Time and (b) such date and time as the Business Combination Agreement shall be validly terminated in accordance with Section 11.1 thereof (the earlier of (a) and (b), the “Expiration Time”), Sponsor shall not (except in a Permitted Transfer) (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, in each case, directly or indirectly, with respect to any Subject Securities owned by Sponsor, (ii) file (or participate in the filing of) a registration statement with the SEC (other than the Registration Statement and any resale registration statement filed by PubCo relating to PubCo Ordinary Shares), (iii) deposit any Subject Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Sponsor Agreement or otherwise transfer any voting or approval rights with respect to the Subject Securities, (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Securities owned by Sponsor or (v) publicly announce any intention to effect any transaction specified in clause (i), (ii), (iii) or (iv) (clauses (i)-(v), collectively, “Transfer”).

(b) “PermittedTransfer” means any Transfer of Subject Securities (i) to (A) any officer or director of the SPAC, the Company, Pubco or the Sponsor, (B) any Affiliates or family members of the officers or directors of SPAC, the Company, Pubco or the Sponsor, or (C) any direct or indirect partners, members or equity holders of the Sponsor or any related investment funds or vehicles controlled or managed by such Persons or their respective Affiliates (including, for the avoidance of doubt, where such Person is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership); (ii) to a nominee or custodian of a Person to whom a Transfer would be permitted under clause (i); (iii) in connection with any legal, regulatory or other order; (iv) to a third party in connection with any non-redemption, backstop arrangement or other similar arrangement, (v) as otherwise mutually agreed upon between the Sponsor, SPAC and the Company, or (vi) to SPAC, the Company, Pubco or the Sponsor; provided, however, that in the case of clauses (i) through (vi), as a precondition to such Transfer, such transferee must enter into a written agreement with the Company, SPAC and Pubco agreeing to assume all of the obligations under this Agreement with respect to such Subject Securities and to be bound by the transfer restrictions set forth in this Agreement (to the extent applicable); provided, further, that, no Transfer permitted under this Section 1.1(b) shall relieve Sponsor or any holder of Subject Securities pursuant to a Permitted Transfer of its obligations under this Agreement.

2

Section 1.2 New Shares. In the event that (a) any Subject Securities are issued to Sponsor after the date of this Sponsor Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification, combination or exchange of Subject Securities of, on or affecting the Subject Securities owned by Sponsor or otherwise, (b) Sponsor purchases or otherwise acquires beneficial ownership of any Subject Securities after the date of this Sponsor Agreement, or (c) Sponsor acquires the right to vote or share in the voting of any Subject Securities after the date of this Sponsor Agreement (such SPAC Shares, SPAC Rights or other equity securities of SPAC, collectively the “New Securities”), then such New Securities acquired or purchased by Sponsor shall constitute Subject Securities and be subject to the terms of this Sponsor Agreement to the same extent as if they constituted Subject Securities owned by Sponsor as of the date hereof.

Section 1.3 Binding Effect of the Business Combination Agreement. Sponsor hereby acknowledges that it has read the Business Combination Agreement and this Sponsor Agreement and has had the opportunity to consult with its tax and legal advisors. Sponsor shall be bound by and comply with Sections 8.16 (Public Announcements) of the Business Combination Agreement (and any relevant definitions contained in any such Sections) as if Sponsor was an original signatory to the Business Combination Agreement with respect to such provisions.

Section 1.4 Waiver of Anti-Dilution Provision. Subject to, and conditioned upon, the Closing, Sponsor hereby irrevocably relinquishes and waives, and agrees not to assert or perfect, to the fullest extent permitted by Law and the SPAC’s Organizational Documents, any and all rights Sponsor has or will have to any adjustment or anti-dilution protections that arise in connection with the Transactions (including, for the avoidance of doubt, but not limited to, any rights pursuant to Section 17.3 of the SPAC Charter).

Section 1.5 Waiver of Dissenters’ Rights. Sponsor hereby irrevocably waives, and agrees not to exercise or assert, any dissenters’ rights under Section 238 of the Cayman Act and any other similar statute in connection with the Transactions and the Business Combination Agreement.

Section 1.6 Closing Date Deliverables. On the Closing Date, Sponsor shall deliver to the Company (a) a duly executed copy of the New Registration Rights Agreement substantially in the form attached as Exhibit I to the Business Combination Agreement and (b) a duly executed copy of the Lock-Up Agreement substantially in the form attached as Exhibit J-2 to the Business Combination Agreement.

3

Section 1.7 Sponsor Agreements.

(a) At any meeting of the shareholders of SPAC, however called, or at any adjournment or postponement thereof, or in any other circumstance in which the vote, consent or other approval of the shareholders of SPAC is sought (including any action by written resolution), Sponsor shall (i) appear at each such meeting or otherwise cause all of its Subject Securities entitled to vote, and any other SPAC Shares that Sponsor has the right to vote, to be counted as present thereat for purposes of calculating a quorum and (ii) vote (or cause to be voted), or execute and deliver a written consent (or cause a written consent to be executed and delivered) covering, all of Sponsor’s Subject Securities or SPAC Shares:

(i) in favor of the Shareholder Approval Matters (or any sub-matter or actions in furtherance thereof);

(ii) in favor of any proposal to adjourn or postpone the applicable meeting to a later date if and only if there are not sufficient votes for the approval of the Shareholder Approval Matters (or any sub-matter or actions in furtherance thereof) and any other matters required to be approved as set forth in the Proxy Statement on the date on which such meeting is held; and

(iii) against any proposal, action, transaction or agreement that would or would reasonably be expected to (A) delay, postpone, impede, frustrate, prevent or nullify any provision of this Sponsor Agreement, the Business Combination Agreement, any other Ancillary Document, or the Transactions, including the First Merger, (B) constitute or lead to an Alternative Transaction for SPAC, (C) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of SPAC under the Business Combination Agreement or any other Ancillary Document, (D) result in any of the conditions set forth in Article IX of the Business Combination Agreement not being fulfilled, (E) amend the SPAC’s Organizational Documents (including the SPAC Charter) (other than, for the avoidance of doubt, any amendment to SPAC’s Organizational Documents in connection with an Extension), including any change in any manner to the dividend policy or capitalization of, including the voting rights of any class of capital stock of, SPAC, (F) result in a business combination agreement or merger (other than the Business Combination Agreement and the Mergers), consolidation, combination, sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by, or other change to the corporate structure or business of, SPAC or (G) result in a change in the business of SPAC or any change in the management or SPAC Board (other than, in each case, in connection with the Business Combination Agreement, any Ancillary Document or the Shareholder Approval Matters).

Sponsor hereby agrees not to commit or agree to take any action inconsistent with the foregoing.

(b) Sponsor shall comply with, and fully perform all of its obligations, covenants and agreements set forth in, that certain Letter Agreement, dated as of April 24, 2025, by and among Sponsor, SPAC and the other parties thereto (the “Letter Agreement”), including the obligations of Sponsor pursuant to Section 1 therein to not redeem any SPAC Shares owned by Sponsor in connection with the transactions contemplated by the Business Combination Agreement. For the avoidance of doubt, Sponsor shall not redeem, elect to redeem or tender or submit for redemption any Subject Securities pursuant to or in connection with the Redemption Rights or otherwise.

4

(c) Solely to the extent that Sponsor fails to take any of the actions set forth in this Section 1.5 in accordance with the terms hereof, Sponsor hereby irrevocably appoints, as its proxy and attorney-in-fact, the Company and any person designated in writing by the Company, each of them individually, with full power of substitution and re-substitution, to vote and represent at any annual or special meeting of shareholders of SPAC, and to execute and deliver any action by written consent of the shareholders of SPAC in lieu of any such meeting with respect to, all of the Subject Securities that Sponsor is or may be entitled to vote, in each case, solely with respect to the matters contemplated by this Section 1.5. Sponsor acknowledges and agrees that such proxy and power of attorney granted hereunder shall be irrevocable and unconditional during the term of this Sponsor Support Agreement and is coupled with an interest sufficient in law to support an irrevocable proxy. Sponsor agrees that the foregoing proxy and power of attorney shall, during the term of this Sponsor Support Agreement, supersede in all respects any other proxy or power of attorney previously granted by Sponsor with respect to such Subject Securities. The proxy and power of attorney granted by or at the direction of Sponsor hereunder shall be automatically revoked upon the Expiration Time. This irrevocable proxy and power of attorney is binding upon the heirs, estate, executors, personal representatives, successors, and assigns of Sponsor and, without limiting the effect of the restrictions on transfer and ownership with respect to the Subject Securities, any other holder of record of the Subject Securities as to which this proxy and power of attorney has been granted (including any transferee of any of the Subject Securities).

(d) During the period commencing on the date hereof and ending on the Expiration Time, without the prior written consent of the Company, Sponsor shall not modify or amend any contract between or among Sponsor or any Affiliate of Sponsor (other than SPAC or any of its subsidiaries), on the one hand, and SPAC or any of SPAC’s subsidiaries, on the other hand, including, for the avoidance of doubt, the Letter Agreement.

Section 1.8 Further Assurances. Sponsor shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably necessary under applicable Laws to consummate the Mergers and the other transactions contemplated by the Business Combination Agreement on the terms and subject to the conditions set forth therein and herein. Sponsor agrees to take any additional actions, if any, required or deemed to be practical or necessary in order for Sponsor to provide an effective grant of proxy pursuant to the SPAC’s Charter (including the execution and delivery of such proxies, and the delivery and lodgement of such proxies) in order to consummate the transactions contemplated by this Sponsor Agreement.

Section 1.9 No Inconsistent Agreement. Sponsor hereby represents and warrants that it has not entered into, and covenants and agrees it shall not enter into, any Contract that would delay, postpone, impede, frustrate, prevent, nullify, restrict, limit or interfere with the performance of Sponsor’s obligations hereunder or make any representation and warranty contained herein untrue. Prior to the Expiration Time, Sponsor shall not liquidate or dissolve.

5

Article II

ADDITIONAL REPRESENTATIONS AND WARRANTIES

Section 2.1 Representations and Warranties of Sponsor. Sponsor represents and warrants as of the date hereof to SPAC and the Company as follows:

(a) Organization; Due Authorization. Sponsor is duly organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or formation, and the execution, delivery and performance of this Sponsor Agreement and the consummation of the transactions contemplated hereby are within Sponsor’s powers and have been duly authorized by all necessary corporate actions on the part of Sponsor. This Sponsor Agreement has been duly executed and delivered by Sponsor and, assuming due authorization, execution and delivery by the other parties to this Sponsor Agreement, this Sponsor Agreement constitutes a legally valid and binding obligation of Sponsor, enforceable against Sponsor in accordance with the terms hereof (subject to bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting the enforcement of creditors’ rights generally and subject to general principles of equity). If this Sponsor Agreement is being executed in a representative or fiduciary capacity, the Person signing this Sponsor Agreement has full power and authority to enter into this Sponsor Agreement on behalf of Sponsor.

(b) Ownership. Sponsor is the record and beneficial owner (as defined in the Securities Act) of, and has good title to, all of the Subject Securities, and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose of such Subject Securities (other than transfer restrictions under the Securities Act)) affecting any such Subject Securities, other than Liens pursuant to (i) this Sponsor Agreement, (ii) the SPAC’s Organizational Documents, (iii) the Business Combination Agreement, (iv) the Letter Agreement or (v) any applicable securities Laws. The Subject Securities are the only equity securities in SPAC owned of record or beneficially by Sponsor on the date of this Sponsor Agreement, and none of the Subject Securities held by Sponsor are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Subject Securities, except as provided hereunder and under the Letter Agreement, or any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Securities. Sponsor has full voting power with respect to the Subject Securities held by Sponsor. Other than the Subject Securities held by Sponsor, Sponsor does not hold or own any rights to acquire (directly or indirectly) any equity securities of SPAC or any equity securities convertible into, or which can be exchanged for equity securities of SPAC. The Subject Securities held by constitute all of the Subject Securities beneficially owned by the Sponsor as of the date of this Sponsor Agreement.

(c) No Conflicts. The execution and delivery of this Sponsor Agreement by Sponsor does not, and the performance by Sponsor of its obligations hereunder will not, (i) conflict with or result in a violation of the Organizational Documents of Sponsor, (ii) require any consent or approval that has not been given or other action that has not been taken by any Person (including under any contract binding upon Sponsor or Sponsor’s Subject Securities), in each case, to the extent such consent, approval or other action would prevent, enjoin or materially delay the performance by Sponsor of its obligations under this Sponsor Agreement or (iii) conflict with or violate any material Contract to which Sponsor is party or Law.

6

(d) Litigation. There are no Actions pending against Sponsor, or to the knowledge of Sponsor threatened against Sponsor, before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Authority, except as has not and would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on Sponsor’s ability to consummate the Transactions or perform its obligations under this Agreement or the Business Combination Agreement.

(e) Brokerage Fees. Except as described on Schedule 4.17 of the SPAC Disclosure Schedules, no broker, finder, investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection with the transactions contemplated by the Business Combination Agreement or SPAC’s initial public offering based upon arrangements made by or on behalf of Sponsor or any of its Affiliates, for which SPAC or any of its Affiliates may become liable.

(f) Affiliate Arrangements. Except as set forth in Section 4.15 of the Business Combination Agreement and disclosed in the prospectus, dated April 24, 2025, filed in connection with SPAC’s initial public offering or any subsequent SEC filings, neither the Sponsor nor any of its Affiliates is party to, or has any rights with respect to or arising from, any material Contract with SPAC or any of its Subsidiaries.

(g) Information Supplied. None of the information supplied or to be supplied by Sponsor or its respective Affiliates and Representatives expressly for inclusion or incorporation by reference: (i) in any current report on Form 8-K, quarterly report on Form 10-Q, annual report on Form 10-K, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) with respect to the Transactions, (ii) in the Registration Statement or (iii) in the mailings or other distributions to SPAC Shareholders and prospective investors (including any actual or prospective PIPE Investors) with respect to the consummation of the Transactions or in any amendment to any of documents identified in (i) through (iii), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.

(h) Acknowledgment. Sponsor understands and acknowledges that each of SPAC and the Company is entering into the Business Combination Agreement in reliance upon Sponsor’s execution and delivery of this Sponsor Agreement.

Article III

MISCELLANEOUS

Section 3.1 Termination. This Sponsor Agreement and all of its provisions shall terminate and be of no further force or effect upon the earlier of (a) the Expiration Time and (b) the execution and delivery of a written agreement providing for the termination of this Sponsor Agreement executed by Sponsor, SPAC and the Company. Upon such termination of this Sponsor Agreement, all obligations of the parties under this Sponsor Agreement will terminate, without any liability or other obligation on the part of any party hereto to any Person in respect hereof or the transactions contemplated hereby, and no party hereto shall have any claim against another (and no person shall have any rights against such party), whether under contract, tort or otherwise, with respect to the subject matter hereof; provided, however, that the termination of this Sponsor Agreement shall not relieve any party hereto from liability arising in respect of any breach of this Sponsor Agreement prior to such termination. This Article III shall survive the termination of this Sponsor Agreement.

7

Section 3.2 Governing Law; Jurisdiction. The terms of Section 13.4 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis.

Section 3.3 WAIVER OF JURY TRIAL. THE TERMS OF SECTION 13.5 OF THE BUSINESS COMBINATION AGREEMENT (WHICH FOR THE AVOIDANCE OF DOUBT CONTAIN A WAIVER OF ANY RIGHT TO A TRIAL BY JURY) SHALL APPLY TO THIS SPONSOR AGREEMENT AND ARE INCORPORATED BY REFERENCE HEREIN MUTATISMUTANDIS.

Section 3.4 Binding Effect; Assignment; Third Parties. This Sponsor Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors and permitted assigns. Neither this Sponsor Agreement nor any of the rights, interests or obligations hereunder will be assigned (including by operation of law) without the prior written consent of the Company (with respect to an assignment by Sponsor or, prior to the Closing, SPAC or Pubco) or Sponsor (with respect to an Assignment by the Company or, after the Closing, SPAC or Pubco). Any assignment without such consent shall be null and void; provided that no such assignment shall relieve the assigning party of its obligations hereunder. Nothing contained in this Sponsor Agreement shall create any rights in, or be deemed to have been executed for the benefit of, any Person that is not a party hereto or a successor or permitted assign of such a party.

Section 3.5 Specific Performance. The terms of Section 13.6 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis.

Section 3.6 Amendment; Waiver. The terms of Section 13.8 and Section 13.9 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis.

Section 3.7 Severability. The terms of Section 13.7 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis.

8

Section 3.8 Notices. The terms of Section 13.1 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis, which notices hereunder addressed as follows:

If to SPAC at or prior to the Closing, or to Sponsor:

Inflection Point Holdings III LLC

167 Madison Avenue Suite 205 #1017

New York, New York 10016

Attention: Michael Blitzer

Email:

with a copy to (which will not constitute notice):

White & Case LLP

1221 Avenue of the Americas

New York, New York 10020

Attention: Joel Rubinstein

Email: joel.rubinstein@whitecase.com

and

White & Case LLP

609 Main Street, Suite 2900

Houston, Texas 77002

Attention: Jason A. Rocha

Email: Jason.rocha@whitecase.com

If to the Company or Pubco or, following the Closing, SPAC:

Air Water Ventures Ltd

Unit 3, Kizad KLP FZ, Kizad

Abu Dhabi, UAE

PO Box 109214

Attention:

Email:

with a copy to (which shall not constitute notice):

Morgan, Lewis & Bockius LLP

101 Park Avenue

New York, NY 10178-0060

Attention: Russell Franklin

Email: russell.franklin@morganlewis.com

Section 3.9 Counterparts. This Sponsor Agreement may be executed in one or more counterparts (any of which may be delivered by electronic transmission), each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument.

Section 3.10 Non-Circumvention. Each party hereto agrees that it shall not, and shall cause its Affiliates not to, indirectly accomplish that which such party is not permitted to accomplish (or take any action that such party is not permitted to take) directly under this Sponsor Agreement.

9

Section 3.11 Confidentiality. Sponsor agrees to be bound by and subject to Section 7.1(b) and Section 7.1(d) each of the Business Combination Agreement to the same extent such provisions apply to SPAC, mutatis mutandis, as if Sponsor were directly a party thereto for purposes thereof.

Section 3.12 Interpretation. The terms of Section 13.11 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis.

Section 3.13 Consent to Disclosure. Sponsor hereby consents to the publication and disclosure in any announcement or disclosure required by applicable securities Laws, the SEC or any other securities authorities of the Sponsor’s identity and ownership of Subject Securities (or the Pubco Ordinary Shares to which they convert), the nature of the Sponsor’s obligations hereunder and the other matters set forth in the Business Combination Agreement and the Ancillary Documents, including the Transactions and the Mergers.

Section 3.14 Release; No Recourse. Effective as of the Closing, Sponsor hereby irrevocably releases and discharges the Company Shareholders and each other Company Affiliates and each of their respective current and former directors, managers, officers, partners and employees to the extent set forth in, and subject to the terms and conditions of, Section 12.2(a) of the Business Combination Agreement, which such terms and conditions of Section 12.2(a) of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis (with Sponsor being understood to be “SPAC” for purposes of the incorporation of Section 12.2(a) of the Business Combination Agreement herein). The terms of Section 13.13 of the Business Combination Agreement shall apply to this Sponsor Agreement and are incorporated by reference herein mutatis mutandis.

Section 3.15 Entire Agreement. This Sponsor Agreement and the agreements referenced herein (including the Business Combination Agreement and the other Ancillary Documents) constitute the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and, save to the extent expressly set out in this Sponsor Agreement, the Business Combination Agreement, the other Ancillary Documents or the Confidentiality Agreement, supersede all prior drafts, agreements, undertakings, representations, warranties, promises, assurances and arrangements of any nature whatsoever, whether or not in writing, relating thereto.

[Signature pages follow.]

10

IN WITNESS WHEREOF, Sponsor, SPAC, Pubco and the Company have each caused this Sponsor Agreement to be duly executed as of the date first written above.

SPONSOR:
INFLECTION POINT HOLDINGS III LLC
By: /s/ Michael Blitzer
Name: Michael Blitzer
Title: Chief Investment Officer
SPAC:
INFLECTION POINT ACQUISITION CORP. III
By: /s/ Michael Blitzer
Name: Michael Blitzer
Title: Chief Executive Officer
PUBCO:
AIR WATER VENTURES LIMITED
By: /s/ Andrea Mollica
Name: Andrea Mollica
Title: Director
COMPANY:
AIR WATER VENTURES LTD
By: /s/ Andrea Mollica
Name: Andrea Mollica
Title: Director

Exhibit 10.3

Execution Version

FORM OF LOCK-UP AGREEMENT

(SPONSOR)

THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [●], among (i) Air Water Ventures Limited, a Cayman Islands exempted company (“PubCo”), (ii) Inflection Point Holdings III LLC, a Delaware limited company (the “Sponsor”) and (iii) the undersigned individuals, each of whom is a member of SPAC’s (as defined below) board of directors and/or management team (each of such undersigned individuals, an “Insider” and collectively, the “Insiders”).^1^ PubCo, the Sponsor and the Insiders are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Business Combination Agreement (as defined below).

WHEREAS, Inflection Point Acquisition Corp. III, a Cayman Islands exempted company, a Delaware corporation (“SPAC”), Air Water Venture Holdings Limited, a Cayman Islands exempted company (the “Company”) and PubCo, among others, entered into a business combination agreement, dated August [●], 2025 (the “Business Combination Agreement”), pursuant to which the parties thereto shall consummate a series of transactions, including the exchange of all of the SPAC Shares held by the Sponsor and the Insiders into a corresponding number of PubCo Ordinary Shares determined in accordance with the Business Combination Agreement and in accordance with the provisions of applicable Law;

WHEREAS, SPAC and Sponsor are parties to that certain Placement Unit Purchase Agreement, dated as of April 24, 2025, pursuant to which the Sponsor purchased, among other things, an aggregate of 500,000 units, each unit consisting of one SPAC Class A Ordinary Share and one SPAC Right to receive one-tenth of one SPAC Class A Ordinary Share upon the closing of SPAC’s initial business combination (such shares and rights collectively, the “Private Placement Securities”) in a private placement transaction that occurred simultaneously with the closing of SPAC’s initial public offering;

WHEREAS, pursuant to the Business Combination Agreement, and in view of the valuable consideration to be received by the Sponsor and the Insiders thereunder, the Parties desire to enter into this Agreement, pursuant to which certain PubCo Ordinary Shares to be received by the Sponsor and the Insiders pursuant to the Business Combination Agreement and in accordance with the provisions of applicable Law shall become subject to limitations on disposition as set forth herein; and

WHEREAS, as of immediately after the First Merger Effective Time, the Sponsor and each Insider will be the holder of record and beneficial owner (as such term is defined in Rule 13d-3 promulgated under the Exchange Act), with the sole power to dispose of (or sole power to cause the disposition of) and the sole power to vote (or sole power to direct the voting of) the Restricted Securities.

NOW, THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below, and intending to be legally bound hereby, the Parties hereby agree as follows:

1. Lock-Up Provisions.

(a) Subject to Section 1(b) and the other terms of this Agreement, Sponsor and each Insider agrees that it shall not effectuate a Transfer of (i) the General Restricted Securities during the period commencing on the Closing Date and ending on the date that is the earliest of (a) six (6) months after the Closing and (b) the date following the Closing on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property (the “General Lock-Up Period”) and (ii) the Private Placement Restricted Securities during the period commencing on the Closing Date and ending on the date that is the earliest of (x) thirty (30) days after the Closing and (y) the date following the Closing on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property (the “Private Placement Lock-Up Period,” and together with the General Lock-Up Period, as applicable, the “Lock-Up Period”. For purposes hereof, (A) the “GeneralRestricted Securities” shall mean the PubCo Ordinary Shares issued to the Sponsor or the Insiders in exchange for the SPAC Class A Ordinary Shares received by Sponsor or the Insiders upon conversion of the SPAC Class B Ordinary Shares, pursuant to the Business Combination Agreement (together with any dividends or distributions with respect to such securities or into which such securities are changed or exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions), (B) the “Private Placement Restricted Securities” shall mean the PubCo Ordinary Shares issued to the Sponsor pursuant to the Business Combination Agreement in exchange for the Private Placement Securities following the Unit Separation (together with any dividends or distributions with respect to such securities or into which such securities are changed or exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions) and (C) the “Restricted Securities” shall mean the General Restricted Securities and the Private Placement Restricted Securities, together.

1 Note to Draft: Insiders (Sponsor’s independent<br>directors) to be removed as parties to the extent all Restricted Securities are held by the Sponsor immediately following Closing.

(b) Notwithstanding the provisions set forth in Section 1(a), the following Transfers of the Restricted Securities that are held by the Sponsor or any of the Insiders (and that have complied with this Section 1(b)) are permitted during the applicable Lock-Up Period in the case of the Sponsor, any Insider or their respective permitted transferees:

(i) to PubCo’s officers or directors, any Affiliates or immediate family members of any of PubCo’s<br>officers or directors, any members or partners of the Sponsor or their Affiliates, any Affiliates of the Sponsor, or any employees of<br>such Affiliates;
(ii) in the case of an individual, to any immediate family members of such individual;
--- ---
(iii) to any investment funds or vehicles controlled or managed by the securityholder or any of its Affiliates;
--- ---
(iv) by gift to a trust, the beneficiary of which is a Person to whom a Transfer would be permitted under Section<br>1(b)(i), or to a charitable organization;
--- ---
(v) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual;
--- ---
(vi) in the case of an individual, pursuant to a qualified domestic relations order;
--- ---
(vii) in the case of an individual, to a partnership, limited liability company or other entity of which such<br>individual and/or the family members of such individual are the legal and beneficial owner of all of the outstanding equity securities<br>or similar interests;
--- ---
(viii) to a nominee or custodian of a Person to whom a Transfer would be permitted under Section 1(b)(i);
--- ---
(ix) pursuant to any legal, regulatory or other order;
--- ---
(x) in the case of an entity that is a trust, to a trustor or beneficiary of the trust or to the estate of<br>a beneficiary of such trust;
--- ---
(xi) in the case of an entity, as part of a distribution to members, partners, shareholders or equityholders<br>of the entity;
--- ---
(xii) by virtue of the laws of an entity’s jurisdiction of incorporation or organization, an entity’s<br>organizational documents or the rights attaching to the equity interests in the entity upon dissolution of such entity;
--- ---
(xiii) in connection with the exercise of any options, warrants or other convertible securities to purchase PubCo<br>Ordinary Shares (which exercises may be effected on a cashless basis to the extent the instruments representing such options or warrants<br>permit exercises on a cashless basis) to the extent that any PubCo Ordinary Shares issued upon such exercise are Restricted Securities<br>subject to the applicable restrictions under Section 1(a) of this Agreement,
--- ---
(xiv) to satisfy tax withholding obligations in connection with the Sponsor’s equity incentive plans or<br>arrangements;
--- ---
(xv) in connection with any bona fide mortgage, pledge or encumbrance to a financial institution, as<br>collateral or security in connection with any bona fide loan or debt transaction or enforcement thereunder, including foreclosure<br>thereof;
--- ---
(xvi) in connection with a transfer pursuant to a bona fide third party tender offer, merger, consolidation,<br>liquidation, share exchange or other similar transaction made to all holders of PubCo Ordinary Shares involving a change of control of<br>PubCo or which results in all of the holders of PubCo Ordinary Shares having the right to exchange their PubCo Ordinary Shares for cash,<br>securities or other property subsequent to the consummation of such transaction;
--- --- 
2
(xvii) the entry, by the securityholder, at any time on or after the Closing Date, of any trading plan providing<br>for the sale of Restricted Securities, which trading plan meets the requirements of Rule 10b5-1(c) under the Exchange Act; provided, however,<br>that such plan does not provide for, or permit, the sale of any Restricted Securities during the applicable Lock-Up Period and no public<br>announcement or filing is voluntarily made or required regarding such plan during the applicable Lock-Up Period; and
(xviii) to satisfy any U.S. federal, state, or local income tax obligations of a Securityholder (or its direct<br>or indirect owners) arising from a change in the U.S. Internal Revenue Code of 1986, as amended (the “Code”),<br>or the U.S. Treasury Regulations promulgated thereunder (the “Regulations”) after the date on which the Business<br>Combination Agreement was executed by the parties, and such change prevents the Business Combination from qualifying as a “reorganization”<br>pursuant to Section 368 of the Code (and the Business Combination does not qualify for similar tax-free treatment pursuant to any successor<br>or other provision of the Code or Regulations taking into account such changes), in each case solely and to the extent necessary to cover<br>any tax liability as a direct result of the transaction.
--- ---

provided, that in each of clauses (i) through (xii) and (xv), the transferee must enter into a written agreement in substantially the same form of this Agreement, agreeing to be bound by the terms of the applicable restrictions under Section 1(a) of this Agreement (unless the transferee is PubCo). If dividends are declared and payable on the Sponsor’s or any Insider’s Restricted Securities, such dividends will also be Restricted Securities subject to the applicable restrictions under Section 1(a) of this Agreement.

(c) If any Transfer is made or attempted contrary to the provisions of this Agreement, such Transfer shall be null and void ab initio, and PubCo shall refuse to recognize any such transferee of the Restricted Securities as one of its equity holders for any purpose. In order to enforce this Section 1, PubCo may impose stop-transfer instructions with respect to the Restricted Securities of the Sponsor or any of the Insiders (and any permitted transferees and assigns thereof) until the end of the applicable Lock-Up Period.

(d) During the applicable Lock-Up Period, each certificate and book entry position evidencing any Restricted Securities (if any are issued) shall be stamped or otherwise imprinted with a legend in substantially the following form, in addition to any other applicable legends:

“THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [●], 2025, BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE “ISSUER”) AND THE ISSUER’S SECURITY HOLDER NAMED THEREIN. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.”

(e) For the avoidance of any doubt, the Sponsor and each Insider shall retain all of its, his or her rights as a shareholder of PubCo with respect to the Restricted Securities during the applicable Lock-Up Period, including the right to receive dividends and the right to vote any Restricted Securities (subject to the other provisions hereof).

(f) For the purposes of this Section 1, “Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell (including, for the avoidance of doubt, through a distribution in specie), hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).

3

(g) Effective as of the Closing Date, the lock-up provisions in this Section 1 shall supersede the lock-up provisions applicable to the Restricted Securities in Section 7 of that certain letter agreement, dated as of April 24, 2025, by and among the Sponsor, the Insiders and SPAC.

2. Miscellaneous.

(a) Authorization. The Sponsor and each Insider hereby represents and warrants that it, he or she has full power and authority to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of the Sponsor or such Insider, enforceable in accordance with its terms. Upon request, the Sponsor and each Insider will execute any additional documents as may be necessary in connection with enforcement hereof. Any obligations of Sponsor or an Insider shall be binding upon the successors and assigns of Sponsor or such Insider from and after the date hereof.

(b) Termination. This Agreement shall automatically terminate upon the expiration of the Lock-Up Period, and all rights and obligations of the Parties hereunder shall be of no further force or effect.

(c) Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement shall not be assigned by operation of Law or otherwise without the prior written consent of all Parties hereto. Any assignment without such consent shall be null and void; provided, that no such assignment shall relieve the assigning Party of its obligations hereunder.

(d) Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity that is not a Party hereto or thereto or a successor or permitted assign of such a Party.

(e) Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively in any Delaware Chancery Court; provided, however, that if jurisdiction is not then available in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware state court. The Parties hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought by any Party and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each Party further agrees that notice as provided herein shall constitute sufficient service of process and the Parties further waive any argument that such service is insufficient. Each Party hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out of or relating to this Agreement or the transactions contemplated hereby, (i) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (ii) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the Action in any such court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

(f) WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREIN. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREIN, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(f).

4

(g) Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

(h) Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery (a) in person, (b) by e-mail (without receiving notice of non-receipt or other “bounce-back”), (c) by reputable, nationally recognized overnight courier service or (d) by registered or certified mail, prepaid and return receipt requested; provided, however, that notice given pursuant to clauses (c) and (d) above shall not be effective unless a duplicate copy of such notice is also given in person or by e-mail (without receiving notice of non-receipt or other “bounce-back”); in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

If to PubCo, to:<br><br> <br><br><br> <br>The Air Water Company<br><br> <br>c/o Air Water Ventures Ltd<br><br> <br>Unit 3, Kizad KLP FZ, Kizad<br><br> <br>Abu Dhabi, UAE<br><br> <br>PO Box 109214<br><br> <br>Attn: [●]<br><br> <br>Email: [●] with a copy (which will not constitute notice) to:<br><br> <br><br><br> <br>Morgan, Lewis & Bockius<br><br> <br>101 Park Avenue<br><br> <br>New York, NY 10178-0060<br><br> <br>Attention: Russel Franklin<br><br> <br>Email: russell.franklin@morganlewis.com
If to the Sponsor or Insider, to:<br><br> <br><br><br> <br>Inflection Point Holdings III LLC<br><br> <br>c/o Inflection Point Acquisition Corp. III,<br><br> <br>167 Madison Avenue,<br><br> <br>Suite 205 #1017<br><br> <br>New York, NY 10016<br><br> <br>Attn: Michael Blitzer<br><br> <br>Email: with a copy (which will not constitute notice) to:<br><br> <br><br><br> <br>White & Case LLP<br><br> 1221 Avenue of the Americas<br><br> <br>New York, New York 10020<br><br> Attn: Joel Rubinstein and Jason Rocha<br><br> Email: joel.rubinstein@whitecase.com; jason.rocha@whitecase.com

(i) Amendments and Waivers. This Agreement may be amended, supplemented, modified or waived only by execution of a written instrument signed by each of the Parties. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

(j) Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

5

(k) Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. The Parties further agree that each party shall be entitled to seek specific performance of the terms hereof and immediate injunctive relief and other equitable relief to prevent breaches, or threatened breaches, of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy and without bond or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. The Parties further agree (i) not to assert that a remedy of specific enforcement pursuant to this Section 2(k) is unenforceable, invalid, contrary to applicable law or inequitable for any reason and (ii) to waive any defenses in any action for specific performance, including the defense that a remedy at law would be adequate.

(l) No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship between the Parties, and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship between or among the Parties.

(m) Entire Agreement. This Agreement and the Business Combination Agreement constitute the full and entire understanding and agreement among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the Parties is expressly superseded; provided, that, for the avoidance of doubt, the foregoing shall not affect the rights and obligations of the Parties under the Business Combination Agreement or any Ancillary Document. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights, remedies or obligations of the Parties under any other agreement among the Parties or any certificate or instrument executed by the Sponsor or any Insider in favor of PubCo, and nothing in any other agreement, certificate or instrument shall limit any of the rights, remedies or obligations of the Parties under this Agreement.

(n) Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

(o) Counterparts; Facsimile. This Agreement may be executed and delivered (including by facsimile, email or other electronic transmission) in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

[Signature Pages Follow]

6

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

PUBCO

Air Water Ventures Limited
By:
Name:
Title:

[Signature Page to Lock-Up Agreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

SPONSOR

Inflection Point Holdings III LLC
By:
Name:
Title:

[Signature Page to Lock-Up Agreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

INSIDER

By:
Name:
Address:

[Signature Page to Lock-Up Agreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

INSIDER

By:
Name:
Address:

[Signature Page to Lock-UpAgreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

INSIDER

By:
Name:
Address:

[Signature Page to Lock-UpAgreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

INSIDER

By:
Name:
Address:

[Signature Page to Lock-UpAgreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

INSIDER

By:
Name:
Address:

[Signature Page to Lock-Up Agreement (Sponsor)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

INSIDER

By:
Name:
Address:

[Signature Page to Lock-UpAgreement (Sponsor)]

Exhibit 10.4

Execution Version

FORM OF LOCK-UP AGREEMENT

(COMPANY HOLDERS)

THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [●], between (i) Air Water Ventures Limited, a Cayman Islands exempted company (“PubCo”) and (ii) the undersigned, (each of such undersigned, a “Holder” and collectively, the “Holders”). Pubco and the Holders are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Business Combination Agreement (as defined below).

WHEREAS, Inflection Point Acquisition Corp. III, a Cayman Islands exempted company, a Delaware corporation (“SPAC”), Air Water Venture Holdings Limited, a Cayman Islands exempted company (the “Company”) and Pubco, among others, entered into a business combination agreement, dated August [●], 2025 (the “Business Combination Agreement”), pursuant to which the parties thereto shall consummate a series of transactions, including the exchange of all of the Company Shares held by the Holders into a corresponding number of Pubco Ordinary Shares determined in accordance with the Business Combination Agreement and in accordance with the provisions of applicable Law;

WHEREAS, pursuant to the Business Combination Agreement, and in view of the valuable consideration to be received by the Holders thereunder, the Parties desire to enter into this Agreement, pursuant to which the Pubco Ordinary Shares to be received by the Holders pursuant to the Business Combination Agreement and in accordance with the provisions of applicable Law, (together with any securities paid as bonus share issuance, dividends or distributions with respect to such securities or into which such securities are changed or exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions, the “Restricted Securities”) shall become subject to limitations on disposition as set forth herein; and

WHEREAS, as of immediately after the Second Merger Effective Time, each Holder will be the holder of record and beneficial owner (as such term is defined in Rule 13d-3 promulgated under the Exchange Act), with the sole power to dispose of (or sole power to cause the disposition of) and the sole power to vote (or sole power to direct the voting of) Restricted Securities.

NOW, THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below, and intending to be legally bound hereby, the Parties hereby agree as follows:

1. Lock-Up Provisions.

(a) Subject to Section 1(b) and the other terms of this Agreement, each Holder agrees that it shall not effectuate a Transfer of the Restricted Securities during the period commencing on the Closing Date and ending on the date that is the earliest of (x) six (6) months after the Closing and (y) the date following the Closing on which PubCo completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property (the “Lock-Up Period”).

(b) Notwithstanding the provisions set forth in Section 1(a), the following Transfers of the Restricted Securities that are held by any of the Holders (and that have complied with this Section 1(b)) are permitted during the Lock-Up Period in the case of any Holder or its permitted transferees:

(i) to PubCo’s officers or directors, any Affiliates or immediate family members of any of PubCo’s<br>officers or directors, any Affiliates of the Holders, or any employees of such Affiliates;
(ii) in the case of an individual, to any immediate family members of such individual;
--- ---
(iii) to any investment funds or vehicles controlled or managed by the securityholder or any of its Affiliates;
--- ---
(iv) by gift to a trust, the beneficiary of which is a Person to whom a Transfer would be permitted under Section<br>1(b)(i), or to a charitable organization;
--- ---
(v) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual;
--- ---
(vi) in the case of an individual, pursuant to a qualified domestic relations order;
--- ---
(vii) in the case of an individual, to a partnership, limited liability company or other entity of which such<br>individual and/or the family members of such individual are the legal and beneficial owner of all of the outstanding equity securities<br>or similar interests;
--- ---
(viii) to a nominee or custodian of a Person to whom a Transfer would be permitted under Section 1(b)(i);
--- ---
(ix) pursuant to any legal, regulatory or other order;
--- ---
(x) in the case of an entity that is a trust, to a trustor or beneficiary of the trust or to the estate of<br>a beneficiary of such trust;
--- ---
(xi) in the case of an entity, as part of a distribution to members, partners, shareholders or equityholders<br>of the entity;
--- ---
(xii) by virtue of the laws of an entity’s jurisdiction of incorporation or organization, an entity’s<br>organizational documents or the rights attaching to the equity interests in the entity upon dissolution of such entity;
--- ---
(xiii) in connection with the exercise of any options, warrants or other convertible securities to purchase PubCo<br>Ordinary Shares (which exercises may be effected on a cashless basis to the extent the instruments representing such options or warrants<br>permit exercises on a cashless basis) to the extent that any PubCo Ordinary Shares issued upon such exercise are Restricted Securities<br>subject to the applicable restrictions under Section 1(a) of this Agreement,
--- ---
(xiv) in the case of an entity, to satisfy tax withholding obligations in connection with such entity’s<br>equity incentive plans or arrangements;
--- ---
(xv) in connection with any bona fide mortgage, pledge or encumbrance to a financial institution, as<br>collateral or security in connection with any bona fide loan or debt transaction or enforcement thereunder, including foreclosure<br>thereof;
--- ---
(xvi) in connection with a transfer pursuant to a bona fide third party tender offer, merger, consolidation,<br>liquidation, share exchange or other similar transaction made to all holders of PubCo Ordinary Shares involving a change of control of<br>PubCo or which results in all of the holders of PubCo Ordinary Shares having the right to exchange their PubCo Ordinary Shares for cash,<br>securities or other property subsequent to the consummation of such transaction;
--- --- 
2
(xvii) the entry, by the securityholder, at any time on or after the Closing Date, of any trading plan providing<br>for the sale of Restricted Securities, which trading plan meets the requirements of Rule 10b5-1(c) under the Exchange Act; provided, however,<br>that such plan does not provide for, or permit, the sale of any Restricted Securities during the applicable Lock-Up Period and no public<br>announcement or filing is voluntarily made or required regarding such plan during the applicable Lock-Up Period; and
(xviii) to satisfy any U.S. federal, state, or local income tax obligations of a Securityholder (or its direct<br>or indirect owners) arising from a change in the U.S. Internal Revenue Code of 1986, as amended (the “Code”),<br>or the U.S. Treasury Regulations promulgated thereunder (the “Regulations”) after the date on which the Business<br>Combination Agreement was executed by the parties, and such change prevents the Business Combination from qualifying as a “reorganization”<br>pursuant to Section 368 of the Code (and the Business Combination does not qualify for similar tax-free treatment pursuant to any successor<br>or other provision of the Code or Regulations taking into account such changes), in each case solely and to the extent necessary to cover<br>any tax liability as a direct result of the transaction.
--- ---

provided, that in each of clauses (i) through (xii) and (xv), the transferee must enter into a written agreement in substantially the same form of this Agreement, agreeing to be bound by the terms of the applicable restrictions under Section 1(a) of this Agreement (unless the transferee is PubCo). If dividends are declared and payable on any Holder’s Restricted Securities, such dividends will also be Restricted Securities subject to the applicable restrictions under Section 1(a) of this Agreement.

(c) If any Transfer is made or attempted contrary to the provisions of this Agreement, such Transfer shall be null and void ab initio, and PubCo shall refuse to recognize any such transferee of the Restricted Securities as one of its equity holders for any purpose. In order to enforce this Section 1, PubCo may impose stop-transfer instructions with respect to the Restricted Securities of any of the PubCo (and any permitted transferees and assigns thereof) until the end of the Lock-Up Period.

(d) During the Lock-Up Period, each certificate and book entry position evidencing any Restricted Securities (if any are issued) shall be stamped or otherwise imprinted with a legend in substantially the following form, in addition to any other applicable legends:

“THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [●], 2025, BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE “ISSUER”) AND THE ISSUER’S SECURITY HOLDER NAMED THEREIN. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.”

(e) For the avoidance of any doubt, each Holder shall retain all of his or her rights as a shareholder of PubCo with respect to the Restricted Securities during the Lock-Up Period, including the right to receive dividends and the right to vote any Restricted Securities (subject to the other provisions hereof).

(f) For the purposes of this Section 1, “Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell (including, for the avoidance of doubt, through a distribution in specie), hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).

3

2. Miscellaneous.

(a) Authorization. Each Holder hereby represents and warrants that he or she has full power and authority to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of such Holder, enforceable in accordance with its terms. Upon request, each Holder will execute any additional documents as may be necessary in connection with enforcement hereof. Any obligations of a Holder shall be binding upon the successors and assigns of such Holder from and after the date hereof.

(b) Termination. This Agreement shall automatically terminate upon the expiration of the Lock-Up Period, and all rights and obligations of the Parties hereunder shall be of no further force or effect.

(c) Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement shall not be assigned by operation of Law or otherwise without the prior written consent of all Parties hereto. Any assignment without such consent shall be null and void; provided, that no such assignment shall relieve the assigning Party of its obligations hereunder.

(d) Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity that is not a Party hereto or thereto or a successor or permitted assign of such a Party.

(e) Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively in any Delaware Chancery Court; provided, however, that if jurisdiction is not then available in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware state court. The Parties hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought by any Party and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each Party further agrees that notice as provided herein shall constitute sufficient service of process and the Parties further waive any argument that such service is insufficient. Each Party hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out of or relating to this Agreement or the transactions contemplated hereby, (i) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (ii) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the Action in any such court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

4

(f) WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREIN. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREIN, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(f).

(g) Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

(h) Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery (a) in person, (b) by e-mail (without receiving notice of non-receipt or other “bounce-back”), (c) by reputable, nationally recognized overnight courier service or (d) by registered or certified mail, prepaid and return receipt requested; provided, however, that notice given pursuant to clauses (c) and (d) above shall not be effective unless a duplicate copy of such notice is also given in person or by e-mail (without receiving notice of non-receipt or other “bounce-back”); in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

5
If to PubCo, to:<br><br> <br><br><br> <br>The Air Water Company<br><br> <br>c/o Air Water Ventures Ltd<br><br> <br>Unit 3, Kizad KLP FZ, Kizad<br><br> <br>Abu Dhabi, UAE<br><br> <br>PO Box 109214<br><br> <br>Attn: [●]<br><br> <br>Email: [●] with a copy (which will not constitute notice) to:<br><br> <br><br><br> <br>Morgan, Lewis & Bockius LLP<br><br> <br>101 Park Avenue<br><br> <br>New York, New York 10178<br><br> <br>Attn: Russell Franklin<br><br> <br>Email: Russell.franklin@morganlewis.com
If to a Holder, to:<br><br> <br><br><br> <br>the address on such Holder’s signature page hereto with a copy (which will not constitute notice) to:<br><br> <br><br><br> <br>[●]<br><br>Attn: [●]<br><br>Email: [●];

(i) Amendments and Waivers. This Agreement may be amended, supplemented, modified or waived only by execution of a written instrument signed by each of the Parties. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

(j) Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

(k) Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. The Parties further agree that each party shall be entitled to seek specific performance of the terms hereof and immediate injunctive relief and other equitable relief to prevent breaches, or threatened breaches, of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy and without bond or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. The Parties further agree (i) not to assert that a remedy of specific enforcement pursuant to this Section 2(k) is unenforceable, invalid, contrary to applicable law or inequitable for any reason and (ii) to waive any defenses in any action for specific performance, including the defense that a remedy at law would be adequate.

6

(l) No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship between the Parties, and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship between or among the Parties.

(m) Entire Agreement. This Agreement and the Business Combination Agreement constitute the full and entire understanding and agreement among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the Parties is expressly superseded; provided, that, for the avoidance of doubt, the foregoing shall not affect the rights and obligations of the Parties under the Business Combination Agreement or any Ancillary Document. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights, remedies or obligations of the Parties under any other agreement among the Parties or any certificate or instrument executed by any Holder in favor of PubCo, and nothing in any other agreement, certificate or instrument shall limit any of the rights, remedies or obligations of the Parties under this Agreement.

(n) Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

(o) Counterparts; Facsimile. This Agreement may be executed and delivered (including by facsimile, email or other electronic transmission) in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

[Signature Pages Follow]

7

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

PUBCO
Air Water Ventures Limited
By:
Name: [●]
Title: [●]

[Signature Page to Lock-Up Agreement (CompanyHolders)]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

HOLDER
By:
Name: [●]
Address:

[Signature Page to Lock-Up Agreement (CompanyHolders)]

Exhibit 10.5

FORM OF

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2025 is made and entered into by and among Air Water Ventures Limited, a Cayman Islands exempted company (“PubCo”), Inflection Point Holdings III LLC, a Delaware limited liability company (the “Sponsor”), the members of the Sponsor identified on the signature pages hereto under “Other Sponsor Holders” (such members, together with the Sponsor, the “Sponsor Holders”), each of the undersigned parties listed on the signature pages hereto under “PIPE Holders” (the “PIPE Holders”), and each of the former shareholders of Air Water Ventures Holdings Limited, a Cayman Islands exempted company (the “Company”), designated as Legacy Company Holders on the signature pages hereto (each such party a “Legacy Company Holder”, and such holders together with the Sponsor Holders, the PIPE Holders and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”), and, for the limited purpose set forth in Section 5.4 of this Agreement, Inflection Point Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

RECITALS

WHEREAS, PubCo has entered into that certain Business Combination Agreement, dated as of August [●], 2025 (the “Business Combination Agreement”), by and among PubCo, SPAC, the Company and [●], a [●] (“Merger Sub”), pursuant to which, among other transactions: (i) SPAC will be merged with and into PubCo (the “First Merger”), as a result of which (a) PubCo shall continue as the surviving entity, and (b) each issued and outstanding SPAC Share, including the SPAC Class A Ordinary Shares issuable in settlement of the SPAC Rights, immediately prior to the First Merger Effective Time shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive the SPAC Per Share Merger Consideration subject to and on the terms and conditions set forth in the Business Combination Agreement; and (ii) at least one Business Day following the First Merger, the Company will be merged into Merger Sub (the “Second Merger”), as a result of which (a) Merger Sub shall continue as the surviving entity and as a wholly owned subsidiary of PubCo, and (b) each issued and outstanding Company Ordinary Share, Company Series A Preferred Share, Company Warrant and Company RSU immediately prior to the Second Merger Effective Time shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holder thereof to receive new PubCo Ordinary Shares, PubCo Preferred Shares, PubCo Series A Investor Warrants and Exchanged RSUs subject to and on the terms and conditions set forth in the Business Combination Agreement; and

WHEREAS, SPAC, Sponsor and Cantor Fitzgerald & Co. (“Cantor”) entered into that certain Registration Rights Agreement, dated as of April 24, 2025 (the “Prior Agreement”);

WHEREAS, Section 5.5 of the Prior Agreement provides that any provision, covenant or condition of the Prior Agreement can be amended or modified upon the written consent of PubCo (as successor to SPAC) and Holders (as such term is used in the Prior Agreement) of at least a majority in interest of the Registrable Securities (as such term in used in the Prior Agreement);

WHEREAS, Sponsor and Cantor own a majority in interest of the Registrable Securities (as such term is used in the Prior Agreement);

WHEREAS, each of PubCo and Sponsor intends for its entry into this Agreement to constitute written consent pursuant to Section 5.5 (Amendments and Modifications) of the Prior Agreement to amend the entirety of the Prior Agreement to provide for its termination without giving effect to the terms providing for the survival of certain provisions thereof as set forth in Section 5.7 (Term) of the Prior Agreement, with such termination effective as of the date hereof, in order to provide for the terms and conditions included herein;

WHEREAS, prior to the First Merger, Sponsor owned, in aggregate (i) 8,433,333 SPAC Class B Ordinary Shares and (ii) 500,000 private placement units of SPAC, each consisting of one SPAC Class A Ordinary Share, of SPAC and one SPAC Right to receive one SPAC Class A Ordinary Share upon consummation of SPAC’s initial business combination;

WHEREAS, on the date hereof, in connection with the consummation of the First Merger, Pubco issued [●] PubCo Ordinary Shares to Sponsor;

WHEREAS, on the date hereof, in connection with the consummation of the Second Merger, Pubco issued [●] PubCo Ordinary Shares to the Legacy Company Holders;

WHEREAS, on the date hereof, in connection with the consummation of the Second Merger, Pubco issued [●] Pubco Preferred Shares to the Legacy Company Holders;

WHEREAS, on the date hereof, in connection with the consummation of the Second Merger, the holders of Company Warrants received [●] PubCo Series A Investor Warrants in exchange for such Company Warrants;

WHEREAS, on the date hereof, in connection with the consummation of the Business Combination, PubCo issued an additional [●] PubCo Preferred Shares and additional PubCo Series A Investor Warrants to purchase an aggregate of [●] PubCo Ordinary Shares (subject to adjustment) to the PIPE Holders;

WHEREAS, the parties hereto are entering into this Agreement concurrently with and, effective as of and contingent upon, the Closing; and

WHEREAS, PubCo and the Holders desire to enter into this Agreement, pursuant to which PubCo shall grant the Holders certain registration rights with respect to certain securities of PubCo, as set forth in this Agreement.

NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

Article I

DEFINITIONS

1.1 Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

“Adverse Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer or Chief Financial Officer of PubCo or the Board, in each case, after consultation with counsel to PubCo, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements contained therein (in the case of any Prospectus and any preliminary Prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or used, as the case may be, and (iii) PubCo has a bona fide business purpose for not making such information public.

2

“Agreement” shall have the meaning given in the Preamble.

“Block Trade” has the meaning set forth in Section 2.5(a) of this Agreement.

“Board” shall mean the board of directors of PubCo.

“Business CombinationAgreement” shall have the meaning given in the Recitals.

“Business Days” shall have the meaning given in the Business Combination Agreement.

“Closing” shall have the meaning given in the Business Combination Agreement.

“Commission” shall mean the U.S. Securities and Exchange Commission.

“Company” shall have the meaning given in the Preamble.

“Demand Registration” shall have the meaning given in Section 2.1.1 of this Agreement.

“Demanding Holder” shall have the meaning given in Section 2.1.1 of this Agreement.

“Floor Price” shall mean $1.00.

“Form F-1” shall have the meaning given in Section 2.1.1 of this Agreement.

“Holder” or “Holders” shall have the meaning given in the Preamble.

“Legacy CompanyHolders” shall have the meaning given in the Preamble.

“Maximum Numberof Securities” shall have the meaning given in Section 2.1.4 of this Agreement.

“Merger Sub” shall have the meaning given in the Recitals.

“Misstatement” shall mean in the case of a Registration Statement, an untrue statement of a material fact or an omission to state a material fact required to be stated therein, or necessary to make the statements therein not misleading, and in the case of a Prospectus, an untrue statement of a material fact or an omission to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

“Permitted Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to the expiration of any lock-up period applicable between such Holder and PubCo, and to any transferee thereafter.

“Piggyback Registration” shall have the meaning given in Section 2.2.1 of this Agreement.

“PIPE Holders” shall have the meaning given in the Recitals.

“Prior Agreement” shall have the meaning given in the Recitals.

“Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

“PubCo” shall have the meaning given in the Preamble.

“PubCo OrdinaryShares” means the ordinary shares, with $0.001 par value per share, of PubCo.

3

“Registrable Security” shall mean (a) any PubCo Ordinary Shares held by a Holder immediately following the Closing, (b) any PubCo Ordinary Shares that may be acquired by Holders upon the exercise, conversion or redemption of any other security of PubCo or other right to acquire PubCo Ordinary Shares held by a Holder immediately following the Closing, (c) any outstanding PubCo Ordinary Shares or other equity securities (including the PubCo Ordinary Shares issued or issuable upon the exercise of any other equity security) of PubCo held by a Holder on or following the date of this Agreement to the extent such securities are “restricted securities” or are held by an “affiliate” (each as defined in Rule 144 under the Securities Act) and (d) any other equity security, including any warrants, shares of capital stock or other securities of PubCo, issued or issuable with respect to any securities referenced in clauses (a), (b) or (c) above by way of share dividend or share split or in connection with a combination of shares, recapitalization, merger, consolidation, spin-off, reorganization or similar transaction; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (i) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (ii) such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by PubCo and subsequent public distribution of such securities shall not require registration under the Securities Act; (iii) such securities shall have ceased to be outstanding; (iv) such securities may be sold without registration, including pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations including as to manner or timing of sale or current public information requirements under Rule 144(i) (to the extent applicable)); or (v) such securities have been sold to, or through, a broker, dealer or Underwriter in a public distribution or other public securities transaction.

“Registration” shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

“RegistrationExpenses” shall mean the documented, out-of-pocket expenses relating to a Registration, including, without limitation, the following:

(a) all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange on which PubCo’s Ordinary Shares are then listed;

(b) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities);

(c) printing, messenger, telephone and delivery expenses;

(d) reasonable fees and disbursements of counsel for PubCo;

(e) all of PubCo’s internal expenses (including all salaries and expenses of its officers and employees);

(f) all reasonable fees and expenses of any special experts retained by PubCo in connection with such registration;

(g) reasonable fees and disbursements of underwriters customarily paid by issuers of securities in a secondary offering, but excluding underwriting discounts, commissions and transfer taxes, if any, with respect to Registrable Securities sold by PubCo;

4

(h) reasonable fees and disbursements of all independent registered public accountants of PubCo incurred specifically in connection with such Registration; and

(i) reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand Registration to be registered for offer and sale in the applicable Registration not to exceed $75,000 without the consent of PubCo.

“RegistrationStatement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

“Requesting Holder” shall have the meaning given in Section 2.1.1 of this Agreement.

“Securities Act” shall mean the U.S. Securities Act of 1933, as amended from time to time.

“Shelf Offering”, “Shelf Offering Request” and “Shelf Offering Notice” shall have the meaning given in Section 2.5(b) of this Agreement.

“Shelf RegistrationStatement” shall have the meaning given in Section 2.5(a) of this Agreement.

“Sponsor” shall have the meaning given in the Preamble.

“Sponsor MajorityHolders” shall mean the Sponsor Holders holding in the aggregate a majority of the Registrable Securities then held by the Sponsor Holders on an as-converted to PubCo Ordinary Share basis.

“Suspension Event” shall have the meaning set forth in Section 3.4 of this Agreement.

“Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s market-making activities.

“UnderwrittenRegistration” or “Underwritten Offering” shall mean a Registration in which securities of PubCo are sold to one or more Underwriters in a firm commitment underwriting for distribution to the public.

Article II

REGISTRATIONS

2.1 Demand Registration.

2.1.1 Request for Registration. Subject to the provisions of Section 2.1.4 hereof and provided a Shelf Registration Statement has been filed pursuant to Section 2.3 hereof and been declared effective by the Commission, at any time and from time to time on or after the date on which the Shelf Registration Statement ceases to be effective, Holders of at least 25% of the then outstanding number of Registrable Securities (the “Demanding Holders”) may make a written demand for Registration under the Securities Act of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand Registration”). PubCo shall, promptly following PubCo’s receipt of a Demand Registration and, in any event, within twenty (20) days of its receipt of such Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such Registration, a “RequestingHolder”) shall so notify PubCo, in writing, within five (5) Business Days after the receipt by the Holder of the notice from PubCo. Upon receipt by PubCo of any such written notification from a Requesting Holder(s) to PubCo, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and PubCo shall effect, as soon thereafter as reasonably practicable, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. PubCo shall not be obligated to effect more than an aggregate of four (4) Registrations pursuant to a Demand Registration under this Section 2.1.1 with respect to any or all Registrable Securities; provided that, a Registration shall not be counted for such purpose unless a Form F-1 or any similar long-form registration statement that may be available at such time (“Form F-1”) has become effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form F-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

5

2.1.2 Effective Registration. Notwithstanding the provisions of Section 2.1.1 above or any other part of this Agreement, a Registration pursuant to a Demand Registration shall not count as a Registration unless and until (a) the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (b) PubCo has complied with all of its obligations under this Agreement with respect thereto; provided that if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental agency, the Registration Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until (i) such stop order or injunction is removed, rescinded or otherwise terminated and (ii) a majority-in-interest of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly notify PubCo in writing, but in no event later than five (5) days of such election; provided further that PubCo shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.

2.1.3 Underwritten Offering. Subject to the provisions of Section 2.1.4 hereof, if a majority-in-interest of the Demanding Holders so advise PubCo as part of their Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided herein; provided that PubCo shall only be obligated to effect an Underwritten Offering pursuant to this Section 2.1.3 if such offering shall include Registrable Securities proposed to be sold by such Holders with an anticipated aggregate offering price, before deduction of underwriting discounts and commissions, of at least $20 million. The applicable Holders shall have the right to select the underwriter(s) for such offering (which shall consist of one or more reputable nationally recognized investment banks), subject to PubCo’s prior approval which shall not be unreasonably withheld, conditioned or delayed.

2.1.4 Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration, in good faith, advises PubCo, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other PubCo Ordinary Shares or other equity securities that PubCo desires to sell and PubCo Ordinary Shares, if any, as to which a Registration has been requested pursuant to separate written contractual piggyback registration rights held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”), then PubCo shall include in such Underwritten Offering, as follows: (a) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “ProRata”)) that can be sold without exceeding the Maximum Number of Securities; (b) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (a), PubCo Ordinary Shares or other equity securities that PubCo desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (c) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (a) and (b), PubCo Ordinary Shares or other equity securities of other persons or entities that PubCo is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.

6

2.1.5 Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest of the Requesting Holders (if any), pursuant to a Registration under Section 2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to PubCo and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration at least three (3) Business Days prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, PubCo shall be responsible for the Registration Expenses incurred in connection with a Demand Registration prior to its withdrawal under this Section 2.1.5.

2.2 Piggyback Registration.

2.2.1 Piggyback Rights. If, at any time on or after the date hereof, PubCo proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities for its own account or for the account of persons other than the Holders of Registrable Securities, other than a Registration Statement (a) filed in connection with any employee or director share option, compensation or other benefit plan, (b) for an exchange offer or offering of securities solely to PubCo’s existing shareholders, (c) for an offering of debt that is convertible into equity securities of PubCo, (d) for an “at-the-market” or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal, (e) relating to a transaction pursuant to Rule 145 under the Securities Act or (f) for a dividend reinvestment plan, then PubCo shall give written notice of such proposed filing to all of the Holders of Registrable Securities as soon as reasonably practicable, but not less than ten (10) days (or, in the case of a Block Trade or Other Coordinated Offering, five (5) days), before the anticipated filing date of such Registration Statement, which notice shall (i) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (ii) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within three (3) Business Days (unless such offering is an overnight or bought Underwritten Offering, Block Trade or Other Coordinated Offering, then two (2) days), in each case after receipt of such written notice (such Registration a “Piggyback Registration”); provided, that if PubCo has been advised in writing by the managing Underwriter(s) that the inclusion of Registrable Securities for sale for the benefit of the Holders will have an adverse effect on the price, timing, or distribution method of the PubCo Ordinary Shares in, or probability of success of, an Underwritten Offering, then if no Registrable Securities can be included in the Underwritten Offering in the opinion of the managing Underwriter(s), PubCo shall not be required to offer such opportunity to such Holders. PubCo shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and, if applicable, shall use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this Section 2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities of PubCo included in such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this Section 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by PubCo. PubCo may postpone or withdraw the filing or the effectiveness of a Piggyback Registration at any time in its sole discretion.

7

2.2.2 Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration, in good faith, advises PubCo and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or number of PubCo Ordinary Shares that PubCo desires to sell, taken together with (a) PubCo Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (b) the Registrable Securities as to which registration has been requested pursuant to Section 2.2 hereof, and (c) PubCo Ordinary Shares, if any, as to which Registration has been requested pursuant to separate written contractual piggyback registration rights of other shareholders of PubCo, exceeds the Maximum Number of Securities, then:

(i) If the Registration is undertaken for PubCo’s account, PubCo shall include in any such Registration: (A) first, PubCo Ordinary Shares or other equity securities that PubCo desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to Section 2.2.1 hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), PubCo Ordinary Shares, if any, as to which Registration has been requested pursuant to written contractual piggyback registration rights of other shareholders of PubCo, which can be sold without exceeding the Maximum Number of Securities; or

(ii) If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then PubCo shall include in any such Registration: (A) first, PubCo Ordinary Shares or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to Section 2.2.1, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), PubCo Ordinary Shares or other equity securities that PubCo desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), PubCo Ordinary Shares or other equity securities for the account of other persons or entities that PubCo is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.

8

2.2.3 Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to PubCo and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration. PubCo (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (but subject to Section 3.2), PubCo shall be responsible for all Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this Section 2.2.3.

2.2.4 Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof or an Underwritten Takedown effected under Section 2.3 hereof.

2.3 Shelf Registrations.

(a) PubCo shall as soon as reasonably practicable, but in any event within thirty (30) days after the Closing Date (as defined in the Business Combination Agreement), file with the Commission a registration statement under the Securities Act for the shelf registration (a “Shelf Registration Statement”) covering, subject to Section 3.3, the public sale or resale of all of the Registrable Securities (determined as of two (2) Business Days prior to such filing and assuming that (i) all shares of Series A Preferred Stock are converted into PubCo Ordinary Shares at a conversion price equal to the Floor Price and (ii) all Series A Investor Warrants are exercised in full at an exercise price equal to the Floor Price) on a delayed or continuous basis. PubCo shall use its commercially reasonable efforts to cause any Shelf Registration Statement to be declared effective under the Securities Act as soon as reasonably practicable after the initial filing of such Shelf Registration Statement, but no later than the earlier of (a) the 90th calendar day following the filing date thereof if the Commission notifies PubCo that it will “review” the Shelf Registration Statement and (b) the tenth (10th) business day after the date PubCo is notified (orally or in writing, whichever is earlier) by the Commission that the Shelf Registration Statement will not be “reviewed” or will not be subject to further review. Such Shelf Registration Statement shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. Subject to Sections 2.3(c) and 3.4, PubCo shall maintain a Shelf Registration Statement in accordance with the terms hereof, and shall prepare and file with the Commission such amendments, including post-effective amendments, and supplements as may be necessary to keep a Shelf Registration Statement continuously effective, available for use to permit the Holders named therein to sell their Registrable Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. In the event PubCo files a Shelf Registration Statement on Form F-1, PubCo shall use its commercially reasonable efforts to convert such Shelf Registration Statement (and any Subsequent Shelf Registration) to a registration statement on Form F-3 as soon as reasonably practicable after PubCo is eligible to use Form F-3.

(b) If any Shelf Registration Statement ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding, PubCo shall, subject to Section 3.4, use its commercially reasonable efforts to, as promptly as is reasonably practicable, cause such Shelf Registration Statement to again become effective under the Securities Act (including using its commercially reasonable efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf Registration Statement), and shall use its commercially reasonable efforts to, as promptly as is reasonably practicable, amend such Shelf Registration Statement in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf Registration Statement or file an additional registration statement as a Shelf Registration Statement (a “Subsequent Shelf Registration”) registering the resale of all Registrable Securities under such Shelf Registration Statement (determined as of two (2) business days prior to such filing and assuming that (i) all shares of Series A Preferred Stock are converted into PubCo Ordinary Shares at a conversion price equal to the Floor Price and (ii) all Series A Investor Warrants are exercised in full at an exercise price equal to the Floor Price), and pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is filed, PubCo shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act) if PubCo is a well-known seasoned issuer (as defined in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration continuously effective, available for use to permit the Holders named therein to sell their Registrable Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be on Form F-3 to the extent that PubCo is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form.

9

(c) Subject to Section 3.4, in the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, PubCo shall, upon the written request of such Holder, promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to be covered by either, at PubCo’s option, any then-available Shelf Registration Statement (including by means of a post-effective amendment) or a Subsequent Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf Registration Statement or Subsequent Shelf Registration shall be subject to the terms hereof; provided, however, that PubCo shall only be required to cause such Registrable Securities to be so covered twice per calendar year for each of (i) the Sponsor Holders, collectively, (ii) the Legacy Company Holders, collectively and (iii) the PIPE Holders, collectively.

(d) At any time from time to time after the effectiveness of a Shelf Registration Statement, subject to any lock-up restrictions, Holders of Registrable Securities shall have the right at any time or from time to time to elect to sell pursuant to an offering (including an underwritten offering (an “Underwritten Takedown”)) Registrable Securities available for sale pursuant to such registration statement (“Shelf Registrable Securities”). The applicable Holders shall make such election by delivering to PubCo at least ten (10) Business Days prior to such offering a written request (a “ShelfOffering Request”) specifying the number of Shelf Registrable Securities that such Holders desire to sell pursuant to such offering and the expected price range (net of any underwriting discounts and commissions) of such offering (the “Shelf Offering”); provided that, in the event such Shelf Offering is an Underwritten Takedown, PubCo shall only be obligated to effect such Underwritten Takedown if such offering shall include Shelf Registrable Securities proposed to be sold by the Holder, either individually or together with other Holders, with an anticipated aggregate offering price, before deduction of underwriting discounts and commissions, of at least $20 million. The applicable Holders shall have the right to select the underwriter(s) for such offering (which shall consist of one or more reputable nationally recognized investment banks), subject to PubCo’s prior approval which shall not be unreasonably withheld, conditioned or delayed. In the case of an Underwritten Takedown, as promptly as reasonably practicable, but no later than five (5) Business Days after receipt of a Shelf Offering Request, PubCo shall give written notice (the “Shelf Offering Notice”) of such Shelf Offering Request to all other Holders of Shelf Registrable Securities. PubCo shall include in such Shelf Offering the Shelf Registrable Securities of any other Holder that shall have made a written request to PubCo for inclusion in such Shelf Offering (which request shall specify the maximum number of Shelf Registrable Securities intended to be sold by such Holder) within five (5) Business Days after the receipt of the Shelf Offering Notice. PubCo shall, as expeditiously as possible, use its commercially reasonable efforts to facilitate such Shelf Offering. Notwithstanding the foregoing, each of (i) the Sponsor Holders, collectively, (ii) the Legacy Company Holders, collectively, and (iii) the PIPE Holders, collectively, may demand Underwritten Takedowns pursuant to this Section 2.3(d) (x) not more than two (2) times in any 12-month period; provided that, an Underwritten Takedown shall not be counted for such purposes unless all of the Shelf Registrable Securities requested by the applicable Holders to be included in the Underwritten Takedown have been sold.

10

(e) Notwithstanding the foregoing, if any Holder desires to effect a sale of Shelf Registrable Securities that does not constitute an Underwritten Takedown, the Holder shall deliver to PubCo a Shelf Offering Request no later than two (2) Business Days prior to the expected date of the sale of such Shelf Registrable Securities, and PubCo shall use its reasonable efforts to file and effect an amendment or supplement to its Shelf Registration Statement for such purpose as soon as reasonably practicable to the extent necessary in order to enable such offering to take place in accordance with the terms of this Agreement.

(f) PubCo shall, at the reasonable request of Holders representing a majority of the Registrable Securities covered by a Shelf Registration Statement, file any prospectus supplement or, if the applicable Shelf Registration Statement is an Automatic Shelf Registration Statement, any post-effective amendments, or incorporation by reference any required information and otherwise take any action necessary to include therein all disclosure and language deemed reasonably necessary or advisable in the opinion of counsel of such Holders to effect such Shelf Offering.

2.4 Priority on Shelf Offerings. Subject to the provisions of Section 2.1.4 hereof, if the number of Registrable Securities which can be included on a Shelf Registration Statement is otherwise limited by Instruction I.B.5 to Form F-3 (or any successor provision thereto), PubCo shall include in such registration or offering prior to the inclusion of any securities which are not Registrable Securities the number of Registrable Securities requested to be included which can be included on such Shelf Registration Statement in accordance with the requirements of Form F-3, pro rata among the respective Holders thereof on the basis of the amount of Registrable Securities owned by each such Holder that such Holder of Registrable Securities shall have requested to be included therein.

2.5 Block Trades; Other Coordinated Offerings.

(a) Notwithstanding anything contained in this Section 2, following the expiration of the applicable lock-up period to such Holder, in the event of a sale of Registrable Securities in (a) an underwritten transaction requiring the involvement of PubCo but not involving any “road show” and which is commonly known as a “block trade” (a “Block Trade”) or (b) an “at the market” or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal, (an “Other Coordinated Offering”), (1) the Holder shall (i) give at least five Business Days prior notice in writing of such transaction to PubCo, (ii) identify the potential underwriter(s) in such notice with contact information for such underwriter(s) and (iii) the maximum number of Registrable Securities to be sold in such offering and the expected gross proceeds of such offering; and (2) PubCo shall cooperate with such requesting Holder or Holders to the extent it is reasonably able to effect such Block Trade or Other Coordinated Offering. Any Block Trade or Other Coordinated Offering shall be for at least $20 million in expected gross proceeds. For the avoidance of doubt, a Block Trade or Other Coordinated Offering shall not constitute an Underwritten Takedown. The Holders of at least a majority of the Registrable Securities being sold in any Block Trade or Other Coordinated Offering shall select the underwriter(s), brokers, sales agents or distribution agents to administer such Block Trade or Other Coordinated Offering, as applicable; provided that such underwriter(s), brokers, sales agents or distribution agents shall be reasonably acceptable to PubCo.

(b) Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated Offering, the Holder shall have the right to submit a written notice of withdrawal to PubCo of its intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, PubCo shall be responsible for the Registration Expenses incurred in connection with a Block Trade or Other Coordinated Offering prior to such Holder’s withdrawal under this Section 2.5(b).

11

(c) Notwithstanding anything to the contrary in this Agreement, Section 2.2 shall not apply to a Block Trade or Other Coordinated Offering initiated by a Holder pursuant to this Agreement.

Article III

PUBCO PROCEDURES

3.1 General Procedures. If at any time on or after the date hereof PubCo is required to effect the Registration of Registrable Securities, PubCo shall use its commercially reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof (and including all manners of distribution in such Registration Statement as Holders may reasonably request in connection with the filing of such Registration Statement and as permitted by law, including distribution of Registrable Securities to a Holder’s members, securityholders or partners), and pursuant thereto PubCo shall, as soon as reasonably possible:

3.1.1 prepare and file with the Commission a Registration Statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have been sold or are no longer outstanding or no longer constitute Registrable Securities (such period, the “Effectiveness Period”);

3.1.2 prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested by any Holder that holds at least five percent (5%) of the Registrable Securities registered on such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by PubCo or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus or are no longer outstanding or no longer constitute Registrable Securities;

3.1.3 prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, brokers, distribution agents, or sales agents, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters, brokers, distribution agents, or sales agents, if any, and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders; provided, that PubCo will not have any obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system;

3.1.4 prior to any public offering of Registrable Securities, use its commercially reasonable efforts to (a) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request (or provide evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration or qualification) and (b) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of PubCo and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that PubCo shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

12

3.1.5 use its commercially reasonable efforts to cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued by PubCo are then listed;

3.1.6 provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

3.1.7 advise each seller of such Registrable Securities, promptly after it shall receive notice of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening in writing of any proceeding for such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;

3.1.8 prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus (or such shorter period of time as may be (a) necessary in order to comply with the Securities Act, the Exchange Act and the rules and regulations promulgated under the Securities Act or Exchange Act, as applicable or (b) advisable in order to reduce the number of days that sales are suspended pursuant to Section 3.4), furnish a copy thereof to each Holder of such Registrable Securities and its counsel (excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein);

3.1.9 during the Effectiveness Period, furnish a conformed copy of each filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, promptly after such filing of such documents with the Commission to each Holder of such Registrable Securities or its counsel; provided, that PubCo will not have any obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system;

3.1.10 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, subject to the provisions of this Agreement, notify the Holders of the happening of any event as a result of which a Misstatement exists, and then to correct such Misstatement as set forth in Section 3.4 hereof;

3.1.11 permit a representative of the Holders (such representative to be selected by a majority-in-interest of the participating Holders), the Underwriters, or other financial institutions faciliting such offering, if any, and any attorney or accountant retained by such Holders or Underwriters or other financial institutions facilitating such offering to participate, at each such person’s own expense, in the preparation of the Registration Statement or the Prospectus, and cause PubCo’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, or other financial institutions facilitating such offering, attorney or accountant in connection with the Registration; provided, however, that such representatives, Underwriters or other financial institutions enter into a confidentiality agreement, in form and substance reasonably satisfactory to PubCo, prior to the release or disclosure of any such information; provided, further, that PubCo may not include the name of any Holder, Underwriter, or other financial institution that is facilitating or may facilitate an offering, in any Registration Statement or Prospectus, any amendment or supplement to such Registration Statement of Prospectus, any document that is to be incorporated by reference into such Registration Statement or Prospectus, any document that is to be incorporated by reference into such Registration Statement or Prospectus, or any response to any comment letter, without the prior written consent of such Holder, Underwriter, or other financial institution, and providing each such Holder, Underwriter, or other financial institution a reasonable amount of time to review and comment on such applicable document.

13

3.1.12 obtain a “cold comfort” letter (including a bring-down letter dated as of the date the Registrable Securities are delivered for sale pursuant to such Registration) from PubCo’s independent registered public accountants, in the event of an Underwritten Registration, a Block Trade, an Other Coordinated Offering or a sale by a broker, distribution agent or sales agent pursuant to a Registration Statement (subject to such Underwriter or other financial institution facilitating such offering providing such certification or representation as reasonably requested by PubCo’s independent registered public accountings and PubCo’s counsel) in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter or other similar type of sales agent or distribution agent may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

3.1.13 on the date the Registrable Securities are delivered for sale pursuant to such Registration, in the event of an Underwritten Registration, a Block Trade, an Other Coordinated Offering or a sale by a broker, distribution agent or sales agent pursuant to a Registration Statement obtain an opinion and negative assurance letter, dated such date, of counsel representing PubCo for the purposes of such Registration, addressed to the participating Holders, the broker, distribution agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the participating Holders, broker, distribution agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, provided, in each case, that such participating Holders provide such information to such counsel as is customarily required for, or is reasonably requested by such counsel for purposes of, such opinion or negative assurance letter;

3.1.14 in the event of any Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, distribution agent or sales agent pursuant to a Registration Statement, enter into and perform its obligations under an underwriting agreement, purchase agreement, sales agreement or distribution agreement, in usual and customary form, with the managing Underwriter or broker, sales agent or distribution agent of such offering or sale;

3.1.15 make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of PubCo’s first (1^st^) full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission);

3.1.16 with respect to an Underwritten Offering, use its commercially reasonable efforts to make available senior executives of PubCo to participate in customary “road show” presentations that may be reasonably requested by the Underwriter(s) in any Underwritten Offering; and

3.1.17 otherwise, in good faith, cooperate with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration.

3.2 Registration Expenses. All Registration Expenses of all Registrations in the aggregate shall be borne by PubCo. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable and documented fees and expenses of any external legal counsel representing the Holders.

14

3.3 Requirements for Participation . The Holders of Registrable Securities shall provide such information as may reasonably be requested by PubCo, or the managing Underwriter or distribution agent or sales agent, if any, in connection with the preparation of any Registration Statement or Prospectus, including amendments and supplements thereto, in order to effect the registration of any Registrable Securities under the Securities Act pursuant to Article II and in connection with PubCo’s obligation to comply with federal and applicable state securities Laws. Notwithstanding anything in this Agreement to the contrary, if any Holder does not timely provide PubCo with its requested Holder Information, PubCo may exclude such Holder’s Registrable Securities from the applicable Registration Statement or Prospectus if PubCo determines, based on the advice of counsel, that such information is necessary to effect the registration and such Holder continues thereafter to withhold such information. No person may participate in any Underwritten Offering, Block Trade or Other Coordinated Offering for equity securities of PubCo pursuant to a Registration initiated by PubCo hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any arrangements approved by PubCo and (ii) completes and executes all questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting or other agreements and other documents as may be required under the terms of such arrangements and that are reasonable or otherwise customary. The exclusion of a Holder’s Registrable Securities as a result of this Section 3.3 shall not affect the registration of the other Registrable Securities to be included in such Registration.

3.4 Suspension of Sales; Restrictions on Registration Rights.

(a) Notwithstanding anything to the contrary in this Agreement, PubCo shall be entitled to postpone the effectiveness of a Registration Statement, and from time to time to require Holders not to sell under a Registration Statement or to suspend the effectiveness thereof, for the shortest period of time determined in good faith by PubCo to be necessary for such purpose, if the Registration Statement or Prospectus (i) contains a Misstatement, or in the opinion of counsel for PubCo it is necessary to supplement or amend such Prospectus to comply with applicable law, (ii) would require the inclusion in such Registration Statement of financial statements that are unavailable to PubCo for reasons beyond PubCo’s control, (iii) in the good faith judgment of a majority of the Board, would be seriously detrimental to PubCo and the Board concludes, as a result, that it is necessary to defer such filing, initial effectiveness, or continued use at such time, (iv) require the Company to make an Adverse Disclosure, or (v) would otherwise render PubCo unable to comply with requirements under the Securities Act or Exchange Act (each, a “Suspension Event”); provided, however, that PubCo may not delay or suspend a Registration Statement on more than two (2) occasions or for more than sixty (60) consecutive calendar days in each case during any 12 month period. Upon notice from PubCo of the occurrence of a Suspension Event, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended Registration Statement or Prospectus correcting such Suspension Event (it being understood that PubCo hereby covenants to prepare and file such supplement or amendment as soon as reasonably practicable after the time of such notice), or until it is advised in writing by PubCo that the use of the Registration Statement or Prospectus may be resumed. If so directed by PubCo, the Holders will deliver to PubCo or, in Holders’ sole discretion destroy, all copies of each Prospectus covering Registrable Securities in Holders’ possession; provided, however, that this obligation to deliver or destroy shall not apply (i) to the extent the Holders are required to retain a copy of such Prospectus (A) to comply with applicable legal, regulatory, self-regulatory or professional requirements or (B) in accordance with a bona fide pre-existing document retention policy or (ii) to copies stored electronically on archival servers as a result of automatic data backup.

15

(b) If (a) during the period starting with the date sixty (60) days prior to PubCo’s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a PubCo-initiated Registration and provided that PubCo has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to Section 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become effective; or (b) the Holders have requested an Underwritten Registration and PubCo and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer, then in each case upon prompt written notice of such action to the Holders, PubCo shall have the right to defer such filing for a period of not more than thirty (30) days; provided, however, that PubCo shall not defer its obligation in this manner more than once in any 12-month period.

3.5 Reporting Obligations. As long as any Holder shall own Registrable Securities, PubCo, at all times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by PubCo after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act. PubCo further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell PubCo Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission, to the extent that such rule or such successor rule is available to PubCo), including providing any customary legal opinions. Upon the request of any Holder, PubCo shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

3.6 Restrictive Legend Removal. In connection with a Registration pursuant to Sections 2.1, 2.2, 2.3 or 2.5, or any sale or other disposition of the Registrable Securities by a Holder pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) upon the request of a Holder, PubCo shall (i) authorize PubCo’s transfer agent to remove any legend on share certificates of such Holder’s Registrable Securities restricting further transfer (or any similar restriction in book entry positions of such Holder), and cause PubCo’s counsel to issue an opinion to PubCo’s transfer agent in connection therewith, if such restrictions are no longer required by the Securities Act or any applicable state securities laws or any agreement with PubCo to which such Holder is a party, (ii) request PubCo’s transfer agent to issue in lieu thereof securities without such restrictions to the Holder upon, as applicable, surrender of any certificates or to update the applicable book entry position of such Holder so that it no longer is subject to such a restriction, and (iii) use its commercially reasonable efforts to cooperate with such Holder to have such Holder’s Registrable Securities transferred into a book entry position at The Depository Trust Company, in each case, subject to delivery of customer documentation, including any documentation required by such restrictive legend or book entry notation.

Article IV

INDEMNIFICATION AND CONTRIBUTION

4.1 Indemnification.

4.1.1 PubCo agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors, employees, advisors, agents, representatives and each person who controls (within the meaning of the Securities Act) such Holder against all losses, claims, damages, liabilities and expenses (including reasonable and documented external attorneys’ fees) caused by any Misstatement, except insofar as the same are arising out of, based on or contained in any information furnished in writing to PubCo by such Holder expressly for use therein. PubCo shall indemnify the Underwriters, their officers and directors and each person who controls (within the meaning of the Securities Act) such Underwriters to the same extent as provided in the foregoing with respect to the indemnification of the Holders.

16

4.1.2 In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to PubCo in writing such information and affidavits as PubCo reasonably requests for use in connection with any such Registration Statement or Prospectus (the “Holder Information”) and, to the extent permitted by law, shall indemnify PubCo, its directors, officers, employees, advisors, representatives and agents and each person who controls (within the meaning of the Securities Act) PubCo against any losses, claims, damages, liabilities and expenses (including without limitation reasonable and documented external attorneys’ fees) caused by any Misstatement to the extent contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls (within the meaning of the Securities Act) such Underwriters to the same extent as provided in the foregoing with respect to indemnification of PubCo.

4.1.3 Any person entitled to indemnification herein shall (a) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (b) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus one local counsel if necessary in the reasonable judgment of the indemnified party) for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

4.1.4 The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. PubCo and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event PubCo’s or such Holder’s indemnification is unavailable for any reason.

17

4.1.5 If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by in the case of an omission), such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this Section 4.1.5 shall be several, not joint and several, and shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability except in the case of fraud or willful misconduct by such Holder. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in Sections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this Section 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 4.1.5 from any person who was not guilty of such fraudulent misrepresentation. Notwithstanding the foregoing, the indemnity agreement contained in this Section 4 shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of PubCo, which consent shall not be unreasonably withheld, conditioned, or delayed.

4.2 Waiver of Medallion Guaranty. PubCo agrees to use commercially reasonable efforts to enter into that certain indemnification agreement, substantially in the form attached as Exhibit A to this Agreement, in favor of Continental Stock Transfer & Trust Company (or any successor transfer agent or warrant agent of PubCo) in connection with the waiver of any requirement to provide a medallion guarantee in connection with any transfer of any PubCo Ordinary Shares or other equity securities of PubCo by any Sponsor Holder, PIPE Holder, or any of their Permitted Transferees; provided that, in each case, as a prerequisite to PubCo’s entry into such indemnification agreement, such Sponsor Holder, PIPE Holder or Permitted Transferee enters into an indemnification agreement in favor of the Company, substantially in the form attached as Exhibit B to this Agreement.

Article V

MISCELLANEOUS

5.1 Notices. All notices, demands, requests, consents, approvals or waivers and other communications required or permitted to be given hereunder or which are given with respect to this Agreement shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery (a) in person, (b) by e-mail (having obtained electronic delivery confirmation thereof), (c) by reputable, nationally recognized overnight courier service providing evidence of delivery, or (d) by registered or certified mail, pre-paid and return receipt requested. Each notice or communication that is mailed, delivered or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the second (2nd) business day following the date on which it is mailed, in the case of notices delivered by courier service, hand delivery or overnight mail, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation, and in the case of notices delivered by email, at such time as it is successfully transmitted to the addressee. Any notice or communication under this Agreement must be addressed to the applicable party at their respective addresses set forth in Schedule A hereto.

18

5.2 Assignment; No Third Party Beneficiaries.

5.2.1 This Agreement and the rights, duties and obligations of PubCo hereunder may not be assigned or delegated by PubCo in whole or in part.

5.2.2 This Agreement and the rights, duties and obligations of the Holders hereunder may not be assigned or delegated by the Holders in whole or in part; provided, however, that, subject to Section 5.2.5, a Holder may assign the rights and obligations of such Holder hereunder relating to particular Registrable Securities in connection with the transfer of such Registrable Securities to a Permitted Transferee of such Holder (it being understood that no such transfer shall reduce any rights of the Holder with respect to Registrable Securities still held by such Holder). A Permitted Transferee receiving Registrable Securities from a Sponsor Holder shall become a Sponsor Holder, a Permitted Transferee receiving Registrable Securities from a Legacy Company Holder shall become a Legacy Company Holder, and a Permitted Transferee receiving Registrable Securities from a PIPE Holder shall become a PIPE Holder; provided that, as a precondition to such transfer, such Permitted Transferee enters into a written agreement with Pubco agreeing to be bound by the terms and conditions of this Agreement.

5.2.3 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders, which shall include Permitted Transferees.

5.2.4 This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 5.2 hereof.

5.2.5 No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate PubCo unless and until PubCo shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to PubCo, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.

5.3 Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof.

5.4 Entire Agreement. This Agreement (including all agreements entered into pursuant hereto and all certificates and instruments delivered pursuant hereto and thereto) and the Business Combination Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous agreements, representations, understandings, negotiations and discussions between the parties, whether oral or written. Without limiting the generality of the foregoing, SPAC and Sponsor hereby agree that the Prior Agreement is hereby terminated without giving effect to the terms providing for the survival of certain provisions thereof as set forth in Section 5.10 (Term) of the Prior Agreement and of no further force or effect.

19

5.5 Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the Supreme Court of the State of New York, New York County and to the jurisdiction of the United States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the above-named courts, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

5.6 WAIVER OF TRIAL BY JURY. EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES THE RIGHT TO A TRIAL BY JURY IN ANY ACTION, SUIT, COUNTERCLAIM OR OTHER PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF, CONNECTED WITH OR RELATING TO THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREBY, OR THE ACTIONS OF THE HOLDERS IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.

5.7 Amendments and Modifications. Upon the written consent of PubCo and the Holders of at least a majority in interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely effects the Sponsor Holders shall also require the written consent of the Sponsor Majority Holders so long as the Sponsor Holders and their respective affiliates hold, in the aggregate, at least one percent (1%) of the outstanding PubCo Ordinary Shares of the Company; and provided, further, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares of PubCo, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected; provided further that no consent of any holder of piggyback registration rights shall be required with respect to any such waiver, amendment or modification, except with respect to any waiver, amendment or modification that adversely affects such holder of Piggyback Registration rights, solely in its capacity as a holder of Registrable Securities, in a manner that is materially different from the other Holders (in such capacity). No course of dealing between any Holder or PubCo and any other party hereto or any failure or delay on the part of a Holder or PubCo in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or PubCo. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party. Any amendment, termination, or waiver effected in accordance with this Section 5.7 shall be binding on each party hereto and all of such party’s successors and permitted assigns, regardless of whether or not any such party, successor or assignee entered into or approved such amendment, termination, or waiver.

5.8 Other Registration Rights. PubCo represents and warrants that no person, other than a holder of [(i) Registrable Securities [or (ii) securities of PubCo that are registrable pursuant to the Future PIPE Agreements], has any right to require PubCo to register any securities of PubCo for sale or to include such securities of PubCo in any Registration by PubCo for the sale of securities for its own account or for the account of any other person. Further, PubCo represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

20

5.9 Scope of the Holders’ Obligations. In this Agreement, (a) any obligation, covenant, representation or warranty, indemnity, liability or other requirement provided by or in respect of any Holder shall be on a several basis (not jointly and not jointly and severally) as to such Holder and only pertain to it, (b) each Holder shall be liable for its own breaches and (c) no party hereto shall be entitled to recover more than once (i.e., “double recovery”) for the same loss or losses even in the event of breaches by multiple Holders.

5.10 Term. This Agreement shall terminate upon the earlier of (a) the tenth (10^th^) anniversary of the date of this Agreement and (b) the date as of which no Registrable Securities remain outstanding. The provisions of Section 3.5 and Article IV shall survive any termination.

[SIGNATURE PAGES FOLLOW]

21

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

PUBCO:
AIR WATER VENTURES LIMITED
By:
Name:
Title:
SPONSOR:
INFLECTION POINT HOLDINGS III LLC
By:
Name:
Title:
SPAC:
INFLECTION POINT ACQUISITION CORP. III
By:
Name:
Title:
LEGACY COMPANY HOLDERS:
[●]
By:
Name:
Title:
PIPE HOLDERS:
[●]
By:
Name:
Title:

[Signature Page to Registration Rights Agreement]

Schedule A

PUBCO:

Air Water Ventures Limited

Unit 3, Kizad KLP FZ, Kizad

Abu Dhabi, UAE

PO Box 109214

Attn:

Email:

with a required copy to (which copy shall not constitute notice):

Morgan, Lewis & Bockius LLP

101 Park Avenue

New York, New York 10178

Attn: Russell Franklin

Email: Russell.franklin@morganlewis.com

SPONSOR:

Inflection Point Holdings III LLC

c/o Inflection Point Acquisition Corp. III,

167 Madison Avenue,

Suite 205 #1017

New York, NY 10016

Attn: Michael Blitzer

Email:

with a required copy to (which copy shall not constitute notice):

White & Case LLP

609 Main Street, Suite 2900

Houston, TX 77002

Attn: Joel Rubinstein and Jason A. Rocha

Email: joel.rubinstein@whitecase.com; jason.rocha@whitecase.com

LEGACY COMPANY HOLDERS*:*

[______________]:

[______________]

c/o [______________]

[______________]

[______________]

[______________]:

[______________]

c/o [______________]

[______________]

[______________]

Exhibit A

[ ● ]

[ ● ]

[ ● ]

[  ], 2025

Continental Stock Transfer & Trust Company

1 State Street, 30^th^ Floor

New York, NY 10004

Re: Indemnification in-lieu-of Medallion Signature Guarantee

To whom it may concern:

This letter is in regards to the transfer by [Name of Holder] to [ ], of [ ] [ordinary shares / Series A Preference Shares] of [● ] (formerly known as Inflection Point Acquisition Corp. III) (the “Company”). Please be advised that the Company authorizes Continental Stock Transfer & Trust Company to process the subject transfer, which includes securities that have been duly endorsed by the registered holder but do not bear a customary medallion signature guarantee. The Company agrees to indemnify Continental Stock Transfer & Trust Company against all losses, damages, costs, charges and expenses that it may in any way sustain, incur, or become liable for by reason related to the above referenced transaction.

I, [ ● ], a duly authorized officer of the Company, have the authority to execute this indemnification on behalf of the Company.

Very truly yours,
[ ● ]
By:
Name:
Title:

[ Name of Holder]

[●]

[●]

[  ], 2025

[●]

[●]

[●]

Re: Indemnification in-lieu-of Medallion Signature Guarantee

To whom it may concern:

This letter is in regards to the transfer by [Name of Holder] (the “Transferor”) to [ ], of [ ] [ordinary shares / Series A Preference Shares] of [●] (the “Company”). Please be advised that the Transferor authorizes the Company and Continental Stock Transfer & Trust Company to process the subject transfer, which includes securities that have been duly endorsed by the Transferor but do not bear a customary medallion signature guarantee. The Transferor agrees to indemnify the Company against all losses, liability or costs that may ensue as a result of its processing the above referenced transaction.

I, [ ● ], a duly authorized officer of the Company, have the authority to execute this indemnification on behalf of the Company.

Very truly yours,
[Name of Holder]
By:
Name:
Title:

Exhibit 10.6

Final Form

Dated  25 August 2025
THE INVESTORS<br><br> <br><br><br> <br>and<br><br> <br><br><br> <br>THE COMPANY
SUBSCRIPTION AGREEMENT<br><br> <br>****<br><br> <br>relating to Series A1 Preferred Shares and Warrants of Air Water Ventures Holdings Limited

Index

Clause No. Page No.
1. Definitions 1
2. Interpretation 4
3. Subscriptions 6
4. Completion 7
5. Warranties and Indemnity 7
6. Limitations on Claims 9
7. Announcements 10
8. Costs and expenses 10
9. Cumulative remedies 10
10. Waiver 10
11. Entire agreement 11
12. Variation and termination 11
13. No partnership 12
14. Assignment and transfer 12
15. Rights of third parties 12
16. Counterparts; No originals 13
17. Notices 13
18. Severance 13
19. Governing law 14
20. Jurisdiction 14
21. Regulatory matters 14
22. US securities laws requirements 14
23. Information and taxation matters 15
24. Business Combination 15
25. RSUs 16
Schedule 5 Execution Date Warranties 17 
i

DATE 25 August 2025

PARTIES

(1) The persons whose names and addresses are set out in Schedule 1 (each, an “Investor”<br>and together, the “Investors”); and
(2) AIR WATER VENTURES HOLDINGS LIMITED, an exempted company incorporated in the Cayman Islands having<br>its registered office at Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands (the “Company”).
--- ---

INTRODUCTION

(A) The Company is an exempted company limited by shares, brief particulars of which are set out in Part 1<br>of Schedule 2.
(B) Details of the legal ownership of the share capital of the Company are set out in Schedule 3.
--- ---
(C) Following the execution and delivery of this agreement, it is anticipated that the Company, Inflection<br>Point Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), Air Water Ventures Limited, a Cayman Islands<br>exempted company (“PubCo”), and IPCX Merger Sub Limited, a Cayman Islands exempted Company and wholly-owned subsidiary<br>of SPAC (“Merger Sub”), will enter into a Business Combination Agreement (the “Business Combination Agreement,”<br>and the transactions contemplated by the Business Combination Agreement, the “Business Combination”), pursuant to which,<br>among other things, (i) SPAC will merge with and into PubCo (the “First Merger”), with PubCo surviving the First Merger,<br>and (ii) one (1) day after the date of the First Merger becoming effective, the Company will merge with and into Merger Sub (the “SecondMerger”), with Merger Sub surviving the Second Merger.
--- ---
(D) In anticipation of PubCo, SPAC and the Company entering into the Business Combination Agreement, the Company<br>desires to issue and allot to the Investors, and the Investors wish to subscribe for, shares in the capital of the Company on and subject<br>to the terms of this agreement.
--- ---

AGREED TERMS

1. Definitions

In this agreement, except where a different interpretation is necessary in the context, the words and expressions set out below shall have the following meanings:

“Act” means the Cayman Islands Companies Act (as revised);

“Accounts” means the unaudited statement of financial position, statement of comprehensive income, statement of changes in equity and statement of cash flows of the Company for the period ended on the Accounts Date;

“Accounts Date” means December 31, 2024;

“Affiliate” means, with respect to an Investor, any other person who, directly or indirectly, controls, is controlled by, or is under common control with such Investor, including, any general partner, managing member, officer or director of the Investor or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management or advisory company with, the Investor;

1

“Air Water UK” means Air Water Ventures Ltd, a private company limited by shares incorporated under the laws of England and Wales with registration number 14442057 whose registered office is at c/o Acuity Law Limited, 3 Assembly Square, Britannia Quay, Cardiff, CF10 4PL, United Kingdom;

“Amended and Restated Shareholders’Agreement” means amended and restated shareholders’ agreement between (i) the Company; and (ii) the Shareholders (as defined therein) to be entered into on or around the date hereof, and to take effect as of Completion, in substantially the form attached hereto as Exhibit B;

“Board” means the board of directors of the Company as constituted from time to time;

“Business Day” means a day on which the clearing banks are ordinarily open for the transaction of normal banking business in the Cayman Islands (other than a Saturday or Sunday or public or bank holiday in the Cayman Islands);

“Claim” means any claim for breach of a Warranty;

“Code” means the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended.

“Company Real Property Leases” means all current leases, lease guarantees, agreements and documents related thereto as of the date of this agreement, including all amendments, terminations and modifications thereof or waivers thereto for all premises currently leased or subleased by a Target Company for the operation of the business of a Target Company;

“Completion” has the meaning given in clause 4.2;

“Disclosed” means fairly disclosed to the Investors in the Disclosure Schedules with sufficient detail to enable the Investor to identify the nature and scope of the matters disclosed;

“Disclosure Schedules” means the disclosure schedules attached hereto as Exhibit 2;

“Encumbrance” means any mortgage, charge, security interest, lien, pledge, assignment by way of security, equity, claim, right of pre-emption, option, covenant, restriction, reservation, lease, trust, order, decree, judgment, title defect (including retention of title claim), conflicting claim of ownership or any other encumbrance of any nature whatsoever (whether or not perfected other than liens arising by operation of law);

“Execution Conditions” means the conditions set out in Schedule 4;

“Execution Date” means the date of this agreement;

“Existing Articles” means the memorandum and articles of association of the Company as of the date of this agreement;

“Existing Shareholders’Agreement” means the Shareholders’ Agreement dated 17 August 2025 between the Company and the Shareholders (as defined therein) (as amended or varied from time to time);

“Fundamental Warranties” means the Warranties set out in paragraphs 4, 7, 8, 10, and 24 of Schedule 5;

“Group Companies” means the Company and each and any of the subsidiaries from time to time and “Group Company” means any of them;

“HMRC” means HM Revenue & Customs;

“Intellectual Property” means copyrights and related rights, trade marks and service marks, business and trade names, rights in logos and get-up and trade dress, goodwill and the right to sue for passing off or unfair competition, rights in inventions, rights to use and protect the confidentiality of confidential information (including trade secrets and Know How), registered designs, design rights, Patents, utility models, semi-conductor topographies, all rights of whatsoever nature in computer software and data, all rights of privacy and all other intellectual property or other intangible rights and privileges, and rights of a nature similar or allied to any of the foregoing, in every case which subsists now or in the future in any part of the world and whether or not registered, and including all granted registrations and all applications for registration, and rights to apply for and be granted, renewals and extensions of, and rights to claim priority from, any such rights;

2

“Lead Investor” means Inflection Point Fund I, LP;

“Longstop Date” means the date that is five Business Days after the date of this agreement (or such later time and date as may be agreed in writing by the Company and the Lead Investor);

“NASDAQ” means the NASDAQ Stock Market of the NASDAQ OMX Group Inc.;

“New Articles” means the amended and restated memorandum and articles of association of the Company in the agreed form to be adopted on or prior to Completion, as amended or superseded from time to time, in substantially the form attached hereto as Exhibit C;

“New Shares” means the Series A1 Shares to be subscribed by the Investors pursuant to clause 3.1;

“Non-US Subsidiary” means any subsidiary of the Company that is formed or organised outside of the United States;

“Ordinary Shares” has the meaning set out in the New Articles;

“PFIC” means a “passive foreign investment company” as defined Section 1297 of the U.S. Internal Revenue Code of 1986, as amended;

“Prior Inflection SubscriptionAgreement” means the Subscription Agreement entered into on 25 July 2025 by the Lead Investor and Air Water UK;

“Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by any Governmental Authority of the United States, (including those administered by the Office of Foreign Assets Control of the U.S. Treasury Department or the U.S. Department of State), the United Nations Security Council, the European Union, any European Union member state, or the United Kingdom;

“Securities” means, collectively, the New Shares, the Warrants, and the Ordinary Shares issuable upon conversion of the New Shares and upon exercise of the Warrants;

“Series A1 Shares” means series A1 redeemable preference shares of US$0.0001 each in the capital of the Company from time to time having the rights set out in the New Articles;

“Series A2 Shares” means series A2 redeemable preference shares of US$0.0001 each in the capital of the Company from time to time having the rights set out in the New Articles;

“Share Incentive Plan” means any plan to be established by the Company pursuant to which the Company grants certain rights to acquire Ordinary Shares to its directors, employees, contractors and consultants;

“Shareholder” means any shareholder of the Company from time to time (but excludes the Company holding Treasury Shares from time to time) and the term “Shareholders” shall be construed accordingly;

“Shares” means the Ordinary Shares, the Series A1 Shares and the Series A2 Shares;

“Subscriber Majority” means Investors who have subscribed, in aggregate, for at least 50 per cent of the New Shares under clause 3.1;

“Subscription Price” means US$6,480.68 per New Share;

“Subscription Threshold” has the meaning given in clause 4.2;

3

“Subsidiary” means, with respect to any Person, any corporation, company, partnership, association or other business entity of which (a) if a corporation or company, a majority of the total voting power of capital shares entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, association or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.

“Taxation” means and includes all forms of taxation, and statutory and governmental, state, provincial, local governmental or municipal charges, duties, rates, levies, contributions, withholdings, deductions, liabilities to account, and imposts, VAT and any other taxes, whether imposed in the United Kingdom, United States or elsewhere in the world and whenever imposed and together with all related interest, penalties, charges, surcharges, or costs;

“Taxing Authority” means HMRC and any other governmental, state, federal, provincial, local governmental or municipal authority, body or official whether of the United Kingdom, United States or elsewhere in the world, which is competent to impose or collect Taxation;

“Treasury Shares” means shares in the capital of the Company held by the Company as treasury shares;

“VAT” means (i) value added tax as defined under the VATA (ii) any tax imposed in compliance with the Council Directive of 28 November 2006 on the common system of value added tax (EC Directive 2006/112); and (iii) all Tax of a similar nature levied in any jurisdiction and whether in addition to or in substitution for it;

“VATA” means the Value Added Tax Act 1994;

“Warranties” means the warranties given pursuant to clause 5 (references to a particular warranty being to a statement set out in Schedule 5) and “Warranty” shall be construed accordingly; and

“Warrants” means the warrants to purchase Ordinary Shares to be subscribed by the Investors pursuant to clause 3.1 in the form attached hereto as Exhibit A.

2. Interpretation
2.1. Unless otherwise defined in this agreement or the context otherwise requires, words and expressions defined<br>in the New Articles have the same respective meanings in this agreement.
--- ---
2.2. Words and expressions which are defined in the Act (to the extent applicable) shall have the meanings<br>attributed to them therein when used in this agreement unless otherwise defined (in this agreement or in the New Articles) or the context<br>otherwise requires.
--- ---
2.3. Clause and paragraph headings and the table of contents are used for convenience only and shall not affect<br>the construction or interpretation of this agreement.
--- ---
2.4. References to persons shall include individuals, bodies corporate, unincorporated associations, trusts,<br>joint ventures and partnerships, in each case whether or not having a separate legal personality.
--- ---
2.5. Reference to a “party” or “parties” is to a party or parties to<br>the agreement and any person that has entered into an adherence agreement to this agreement.
--- ---
2.6. References to documents “in the agreed form” are to documents in terms agreed on behalf<br>of the Company and the Lead Investor.
--- --- 
4
2.7. References to any statute or other legislation or legal term for any action, remedy, method of judicial<br>proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than<br>the Cayman Islands, be deemed to include a reference to that which most nearly approximates to the Cayman Islands legal term in that jurisdiction.
2.8. References to those of the parties that are individuals include their respective legal personal representatives.
--- ---
2.9. References to “writing” or “written” includes any non-transitory<br>form of visible reproduction of words.
--- ---
2.10. The words “include”, “including” and “in particular”<br>(or any similar term) are to be construed as being by way of illustration or emphasis only and not to be construed so as to limit generally<br>any words preceding them and general words introduced by the word “other” (or any similar term) shall not be given a restrictive<br>meaning by reason of the fact that they are preceded or followed by words indicating a particular class of acts, matters or things.
--- ---
2.11. Reference to “issued Shares” of any class shall exclude any Shares of that class held<br>as Treasury Shares from time to time, unless stated otherwise.
--- ---
2.12. Reference to the “holders” of Shares or a class of Share shall exclude the Company<br>holding Treasury Shares from time to time, unless stated otherwise.
--- ---
2.13. Words denoting the singular include the plural and vice versa and reference to one gender includes the<br>other gender and neuter and vice versa.
--- ---
2.14. References to statutory provisions or enactments shall include references to any amendment, modification,<br>extension, consolidation, replacement or re-enactment of any such provision or enactment (whether before or after the Execution Date),<br>instrument or order or other subordinate legislation made under such provision or enactment unless any such change imposes upon any party<br>any liabilities or obligations which are more onerous than as at the Execution Date.
--- ---
2.15. Reference to a time of day is unless otherwise specifically stated a reference to the time in the Cayman<br>Islands.
--- ---
2.16. References to the time of day or date shall unless otherwise specifically stated be construed as references<br>to the time or date prevailing in the Cayman Islands.
--- ---
2.17. References in clause 1 (Definitions) (in so far as they are used in the clauses and schedules referred<br>to in this clause), clause 5 (Warranties) and Schedule 5 (Execution Date Warranties) to the Company and the Board shall include, where<br>appropriate in the context, each of the subsidiaries and any holding company and the directors for the time being of those subsidiaries<br>and any holding company respectively.
--- --- 
5
3. Subscriptions
3.1. Subject to the provisions of clauses 4.1 to 4.3 (inclusive), each Investor set out below applies for the<br>allotment and issue to it at Completion of the following New Shares and a Warrant exercisable for the following number of Ordinary Shares<br>as set out in the table below at the Subscription Price and the Company accepts such application:
--- ---
Investor No. of<br> <br>New Shares No. of Ordinary Shares Issuable Upon Exercise of Warrant Total subscription monies ()
--- --- --- --- --- ---
Inflection Point Fund I, LP 1,697 1,697
[***] [***] [***]
[***] [***] [***]
[***] [***] [***]
[***] [***] [***]
[***] [***] [***]
Total: 4,012 4,012

All values are in US Dollars.

3.2. Subject to Completion having occurred in respect of the Lead Investor’s<br>subscription pursuant to clause 3.1, the Lead Investor shall have the option, prior to the consummation of the Business Combination, to<br>subscribe at the Subscription Price for (i) up to an additional number of New Shares and (ii) a Warrant exercisable for an additional<br>number of Ordinary Shares, in each case in an equal ratio to the number of New Shares and number of Ordinary Shares issuable upon exercise<br>of a Warrant per Subscription Price paid as outlined in the table above (an “Additional Subscription”). The Additional<br>Subscription shall be capped at a maximum aggregate subscription amount of $30,000,000. In order to exercise its option pursuant to this<br>clause 3.2, the Lead Investor shall deliver written notice thereof to the Company of the Additional Subscription amount and number of<br>New Shares and Ordinary Shares issuable upon exercise of a Warrant upon such Additional Subscription, provided that the Company shall<br>not be required to accept an Additional Subscription where, upon receipt of such notice, the Company reasonably anticipates that consummation<br>of the Business Combination will occur within the following 10 Business Days.
3.3. Each Investor shall be entitled to direct that its New Shares or Warrant be issued and registered in the<br>name of any nominee or custodian holding such New Shares or Warrant on its behalf as bare nominee and the provisions of clauses 3.1 and<br>4 (Completion) shall be interpreted accordingly.
--- --- 
6
4. Completion
4.1. Upon and with effect from the Execution Date, the parties acknowledge and agree that the Execution Conditions<br>have been satisfied or waived in full and that subject to clauses 4.2 to 4.3 (inclusive), each Investor subscribing for New Shares and<br>a Warrant pursuant to clause 3.1 shall, on or prior to the Longstop Date, pay the sum set out against its name in column 4 of the table<br>in clause 3.1 (being the aggregate Subscription Price for its New Shares and Warrant), by electronic funds transfer to the bank account<br>of the Company as set out below and payment made in accordance with this clause 4.1 shall constitute a good discharge for such Investor<br>of its obligations under this clause 4.1:
--- ---
Account name : [***]
--- --- ---
Accountholder address : [***]
: [***]
Bank : [***]
Account number : [***]
Routing number : [***]
Swift Code : [***]
4.2. Upon receipt by the Company of subscription monies equalling the total set forth in column 4 of the table<br>in clause 3.1 (such aggregate amount, or such lesser amount as agreed between the Company and the Lead Investor, the “SubscriptionThreshold”), paid in accordance with clause 4.1 from:
--- ---
(a) the Lead Investor; and
--- ---
(b) each other Investor,
--- ---

the Company shall issue the New Shares and Warrants listed in the table in clause 3.1 to each Investor whose subscription monies have been received by the Company, credited as fully paid and enter its name in the register of members in respect of such New Shares and Warrants (“Completion”).

4.3. Without prejudice to all other rights and remedies available to the parties, including the right to bring<br>a claim for breach of contract:
(a) if the Subscription Threshold is not satisfied by the Longstop Date, the Company and/or the Lead Investor<br>shall each be entitled to determine that this agreement shall terminate with effect from such determination (or such other specified date)<br>and the parties shall have no further rights or obligations under this agreement, other than accrued rights and obligations at that time;<br>and
--- ---
(b) without prejudice to clause 4.3(a), if an Investor (other than the Lead Investor) does not pay its subscription<br>monies in accordance with clause 4.1 by the Longstop Date, the Company and the Lead Investor shall be jointly entitled to determine that<br>such Investor who has failed to pay its subscription monies shall be deemed not to have made any application for New Shares or Warrants<br>under this agreement (but without prejudice to the applications made by any other Investors under this agreement) and upon such determination<br>this agreement shall be deemed varied, without the consent of any other party, or action required, so as to remove all references to such<br>Investor who has failed to pay its subscription monies (who shall cease to be a party to this agreement) and to make any associated changes.
--- ---
4.4. Within two (2) Business Days following Completion, the Company shall deliver to each Investor who has<br>completed their subscription for New Shares and a Warrant a capitalisation table of the Company as of Completion including details of<br>all: (i) issued Shares; (ii) options, both allocated and unallocated under the Share Incentive Plan(s) (if any); (iii) warrants (including<br>the Warrants); and (iv) any and all other rights to subscribe for shares or convertible securities, if any.
--- ---
5. Warranties and Indemnity
--- ---
5.1. The Company warrants to each Investor that each Warranty is true, accurate and not misleading at the Execution<br>Date subject only to:
--- ---
(a) the matters Disclosed; and
--- ---
(b) any exceptions expressly provided for under this agreement.
--- --- 
7
5.2. Each Warranty is a separate and independent warranty, and, save as otherwise expressly provided, no Warranty<br>shall be limited by reference to any other Warranty or by the other terms of this agreement.
5.3. The rights and remedies of the Investors in respect of any breach of any of the Warranties shall not be<br>affected by Completion, any investigation made by or on behalf of the Investors into the affairs of the Company or any other event or<br>matter whatsoever which otherwise might have affected such rights and remedies except a specific and duly authorised written waiver or<br>release.
--- ---
5.4. No information relating to the Company of which an Investor has knowledge (actual or constructive) other<br>than by reason of it being Disclosed in accordance with clause 5.1(a) shall prejudice any Claim which such Investor shall be entitled<br>to bring or shall operate to reduce any amount recoverable by such Investor under this agreement.
--- ---
5.5. Where any Warranty is qualified by the expression “so far as the Company is aware”<br>or words having similar effect, such Warranty shall be deemed to include a statement that such awareness means the actual knowledge of<br>either the Chief Executive Officer or Chief Operating Officer of the Company.
--- ---
5.6. Without limiting anything to the contrary in clause 5.7, the Investors agree among themselves that the<br>following provisions shall (unless they subsequently agree amongst themselves to the contrary acting by way of a Subscriber Majority)<br>apply in relation to the bringing of any Claim:
--- ---
(a) no Claim shall be brought by any of the Investors without the prior written consent of a Subscriber Majority;
--- ---
(b) unless otherwise agreed among the Investors, the costs incurred by any Investor(s) in bringing a Claim<br>shall be borne by all of the Investors participating in such Claim proportionately to the amounts subscribed by each of them for New Shares<br>and Warrants pursuant to this agreement; and
--- ---
(c) unless otherwise agreed among the Investors, any damages obtained as a result of any Claim will, after<br>deduction of all costs and expenses, be divided amongst the Investors in such proportions.
--- ---
5.7. The Company undertakes to indemnify and hold harmless each Investor, its Affiliates and each of its and<br>their directors, officers and employees (the “Indemnified Persons”) from and against, and shall pay to such Investor<br>or the relevant Indemnified Person(s) (as applicable) (by way of telegraphic transfer of immediately available cleared funds to such account<br>as may be notified to the Company by such Indemnified Person from time to time) a sum equal to: (i) any and all Losses directly suffered<br>or incurred by any Indemnified Person(s); and (ii) the Relevant Percentage of any Losses directly suffered or incurred by any Group Company,<br>in each case arising out of and/or relating to a breach of any of the Warranties made by the Company in this agreement (unless such Losses<br>are primarily based upon a material breach of such Indemnified Person’s representations, warranties or covenants under this agreement<br>or any conduct by such Indemnified Person which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
--- ---
5.8. For the purposes of clause 5.7:
--- ---
(a) “Losses” means any and all liabilities, damages, losses, Taxation, fines (including<br>all interest and penalties), expenses and costs reasonably and properly incurred (including all reasonably and properly incurred legal<br>costs and other reasonably and properly incurred professional costs and expenses); and
--- ---
(b) “Relevant Percentage” means the percentage of the Company’s issued share capital<br>that the New Shares of such Investor represent immediately following Completion.
--- ---
5.9. The indemnity in clause 5.7 applies whether or not any Indemnified Person has been negligent or at fault.
--- --- 
8
5.10. If a payment due from the Company under clause 5.7 is subject to Taxation (whether by way of direct assessment<br>or withholding at its source), the amount of the payment shall be increased to ensure that the net receipt, after Taxation, to the Indemnified<br>Person is the same as it would have been were the payment not subject to Taxation.
5.11. Aside from any claim for injunctive or other equitable relief and any claim alleging fraud, the parties<br>agree that the indemnification provided in clause 5.7 shall be the sole and exclusive remedy for any breach of any of the Warranties.
--- ---
6. Limitations on Claims
--- ---
6.1. The limitations set out in this clause 6 shall not apply to any Claim which is:
--- ---
(a) the consequence of fraud, dishonesty, wilful concealment or wilful misrepresentation by or on behalf of<br>the Company; or
--- ---
(b) a result of a breach of any Fundamental Warranty.
--- ---
6.2. No Claim may be made by an Investor against the Company unless written notice of such Claim is served<br>by such Investor on the Company, giving reasonable details of the Claim, on or prior to the earlier of within the 12 month period after<br>the Execution Date.
--- ---
6.3. The aggregate liability of the Company in respect of all and any Claims shall be limited to an amount<br>equal to the aggregate amount subscribed for the New Shares and Warrants by the Investor pursuant to this agreement.
--- ---
6.4. Without prejudice to the overall cap set out in clause 6.3 above, in respect of any Claim(s) that is or<br>are brought by only some Investors, the aggregate liability of the Company in respect of all such Claims shall be limited to an amount<br>equal to the aggregate amount subscribed for the New Shares pursuant to this agreement by those Investors bringing the Claim(s).
--- ---
6.5. No liability of the Company in respect of any breach of any Warranty shall arise:
--- ---
(a) to the extent that such breach occurs by reason of any matter which would not have arisen but for the<br>coming into force of any legislation not in force at the Execution Date or by reason of any change to existing legislation, HMRC’s<br>practice (or that of any other relevant Taxing Authority) or in rates of Taxation occurring after the Execution Date; and/or
--- ---
(b) to the extent that such breach or claim arises as a result of any change in the accounting bases or policies<br>in accordance with which the Company values its assets or calculate its liabilities or any other change in accounting practice from the<br>treatment or application of the same used in preparing the Accounts (save to the extent that such changes are required to correct errors<br>or because relevant generally accepted accounting principles have not been complied with).
--- ---
6.6. The Investors shall be entitled to make a Claim in respect of liability which is contingent or unascertained<br>provided that written notice of the Claim (giving as far as practical the amount and details of the Claim) is given by such Investors<br>to the Company before the expiry of the relevant period specified in clause 6.2 and the Company shall not be liable to make any payment<br>in respect of such Claim unless and until the liability becomes an actual liability or (as the case may be) becomes capable of being quantified.
--- ---
6.7. Notwithstanding anything to the contrary in this agreement, except in the case of fraud or willful misconduct,<br>the Company shall not be obligated to indemnify any Indemnified Person under clause 5.7, unless the aggregate Losses incurred by the Indemnified<br>Person seeking indemnity as a result of all Losses that would otherwise be subject to indemnification under clause 5.7 exceeds US$100,000,<br>in which case such Indemnified Person shall only be entitled to indemnification for the portion of its Losses that exceeds US$100,000.
--- --- 
9
6.8. Notwithstanding anything in this Agreement to the contrary, for purposes of determining whether an Indemnified<br>Person is entitled to indemnification under clause 5.7, as well as the amount of Losses recoverable by an Indemnified Person pursuant<br>to clause 5.7, each of the qualifications as to “material”, “materiality” or “material adverse effect”<br>and words of similar import (other than specific monetary thresholds) in the terms of such warranties listed on Schedule 5 shall be disregarded.
6.9. Nothing in this agreement shall prejudice an Investor’s duty under common law to mitigate any loss<br>or liability which is the subject of a Claim.
--- ---
7. Announcements
--- ---
7.1. Except in accordance with clause 7.2, the parties shall not make any public announcement or issue a press<br>release or respond to any enquiry from the press or other media concerning or relating to this agreement or its subject matter (including<br>the Investors’ investment in the Company) or any ancillary matter.
--- ---
7.2. Notwithstanding clause 7.1, any party (or in the case of an Investor, the general partner or investment<br>manager of the Investor) may make or permit to be made an announcement concerning or relating to this agreement or its subject matter<br>or any ancillary matter with:
--- ---
(a) the prior written approval of the Lead Investor and the Board; or
--- ---
(b) if and to the extent required by:
--- ---
(i) law;
--- ---
(ii) any securities exchange on which such party’s securities are listed or traded;
--- ---
(iii) any regulatory or governmental or other authority with relevant powers to which such party is subject<br>or submits, whether or not the requirement has the force of law, including (but without prejudice to the terms of the Business Combination<br>Agreement) submissions and filings to the U.S. Securities and Exchange Commission and/or Nasdaq in furtherance of the Business Combination;
--- ---
(iv) any Taxing Authority in the ordinary course of the disclosing party’s Taxation affairs; or
--- ---
(v) any court order.
--- ---
8. Costs and expenses
--- ---

The parties shall bear their own costs and disbursements incurred in the negotiations leading up to and in the preparation of this agreement and of matters incidental to this agreement.

9. Cumulative remedies

The rights, powers, privileges and remedies conferred upon the Investors in this agreement are cumulative and are not exclusive of any other rights, powers, privileges or remedies provided by law.

10. Waiver
10.1. The express or implied waiver by any party to this agreement of any of its rights or remedies arising<br>under this agreement or by law shall not constitute a continuing waiver of the right or remedy waived or a waiver of any other right or<br>remedy.
--- ---
10.2. Any waiver of any breach of, or any default under, any of the terms of this agreement will not be deemed<br>a waiver of any subsequent breach or default and will in no way affect the other terms of this agreement.
--- --- 
10
10.3. In no event will any delay, failure or omission (in whole or part) in enforcing, exercising or pursuing<br>any right, power, privilege, claim or remedy conferred by or arising under this agreement or by law, be deemed to be or be construed as<br>a waiver of that or any other right, power, privilege, claim or remedy in respect of the circumstances in question, or operate so as to<br>bar the enforcement of that, or any other right, power, privilege, claim or remedy, in any other instance at any time or times subsequently.
11. Entire agreement
--- ---
11.1. This agreement and the documents referred to or incorporated in it constitute the entire agreement between<br>the parties relating to the subject matter of this agreement and supersede and extinguish any prior drafts, agreements, undertakings,<br>representations, warranties and arrangements of any nature whatsoever, whether or not in writing, between the parties in relation to the<br>subject matter of this agreement.
--- ---
11.2. Each of the parties acknowledges and agrees that it has not entered into this agreement in reliance on<br>any statement or representation of any person (whether a party or not) other than as expressly incorporated in this agreement and the<br>documents referred to or incorporated in this agreement.
--- ---
11.3. Without limiting the generality of the foregoing, each of the parties irrevocably and unconditionally<br>waives any right or remedy it may have to claim damages and/or to rescind this agreement by reason of any misrepresentation (other than<br>a fraudulent misrepresentation) having been made to it by any person (whether party or not) and upon which it has relied in entering into<br>this agreement.
--- ---
11.4. Each of the parties acknowledges and agrees that the only cause of action available to it under the terms<br>of this agreement and the documents referred to or incorporated in this agreement in respect of a Claim shall be for breach of contract.
--- ---
11.5. Other than in respect of a Claim, each of the parties acknowledges and agrees that damages alone may not<br>be an adequate remedy for the breach of any of the undertakings or obligations as set out in this agreement. Accordingly, without prejudice<br>to any other rights and remedies the parties may have, the parties shall be entitled to seek the remedies of injunction, specific performance<br>or other equitable relief for any threatened or actual breach of the terms of this agreement.
--- ---
11.6. Nothing contained in this agreement or in any other document referred to or incorporated in it shall be<br>read or construed as excluding any liability or remedy as a result of fraud.
--- ---
12. Variation and termination
--- ---
12.1. All and any of the provisions of this agreement may be deleted, varied, supplemented, amended and restated<br>or otherwise changed in any way at any time with the prior written consent of the Company and the Subscriber Majority, in which event<br>such change(s) shall be binding against all of the parties hereto provided that if any such change would impose any new obligations on<br>a party, vary or remove an express contractual right of a party under this agreement or increase any existing obligation under this agreement<br>on a party or would result in a disproportionate and adverse effect on an Investor relative to other similarly situated Investors, the<br>consent of any affected party to such change shall be specifically required.
--- ---
12.2. This agreement may be terminated with the prior written consent of the Company and the Subscriber Majority,<br>in which event such termination shall be binding against all of the parties hereto save that nothing in this clause shall release any<br>party from liability for breaches of this agreement which occurred prior to its termination provided that if a party has an express contractual<br>right under this agreement that is not incorporated into any replacement or successor subscription agreement, that party’s consent shall<br>be specifically required for the termination of that right.
--- --- 
11
12.3. No consideration (including any modification of any Transaction Document) shall be offered or paid to<br>any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration<br>is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate<br>right granted to each Investor by the Company and negotiated separately by each Investor, and is intended for the Company to treat the<br>Investors as a class and shall not in any way be construed as the Investors acting in concert or as a group with respect to the purchase,<br>disposition or voting of securities or otherwise.
13. No partnership
--- ---

Nothing in this agreement is intended to or shall be construed as establishing or implying any partnership of any kind between the parties. The obligations of each Investor under any Transaction Document are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance or non-performance of the obligations of any other Investor under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any Proceeding for such purpose. Each Investor has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.

14. Assignment and Transfer
14.1. Subject to clause 14.3, this agreement is personal to the parties and no party shall:
--- ---
(a) assign any of its rights under this agreement;
--- ---
(b) transfer any of its obligations under this agreement;
--- ---
(c) sub-contract or delegate any of its obligations under this agreement; or
--- ---
(d) charge or deal in any other manner with this agreement or any of its rights or obligations,
--- ---

save that each Investor shall be entitled to delegate any of its obligations under this agreement to its general partner or the management company authorised from time to time to act on behalf of that Investor.

14.2. Any purported assignment, transfer, sub-contracting, delegation, charging or dealing in contravention<br>of clause 14.1 shall be ineffective.
14.3. Each Investor may assign the whole or part of any of its rights in this agreement to any person who has<br>received a transfer of New Shares from such Investor in accordance with the New Articles and has executed an adherence agreement to this<br>agreement, in a form satisfactory to the Board, acting reasonably (provided that the amount of loss recoverable by the assignee shall<br>be no greater than it would have been had the assignment not taken place).
--- ---
15. Rights of third parties
--- ---
15.1. Subject to clause 15.2, this agreement does not confer any rights on any person or party (other than the<br>parties to this agreement) pursuant to the Contracts (Rights of Third Parties) Act, 2014.
--- --- 
12
15.2. The general partner of an Investor (or any member of the same Fund Group (as defined in the New Articles)<br>of the Investor) or the management company authorised from time to time to act on behalf of the Investor or another person or persons<br>nominated by the Investor, shall be entitled to enforce all of the rights and benefits of the Investor under this agreement at all times<br>as if party to this agreement. The Company and/or Air Water UK shall be entitled to enforce all of its rights and benefits under clause<br>24 of this agreement.
16. Counterparts; No originals
--- ---
16.1. This agreement may be executed by each of the parties in any number of counterparts, each of which shall<br>constitute an original counterpart of this agreement, and all the counterparts shall together constitute one and the same agreement.
--- ---
16.2. The exchange of a fully executed version of this agreement (in counterparts or otherwise) by electronic<br>means using DocuSign or other electronic transmission in PDF format shall be sufficient to bind the parties to the terms and conditions<br>of this agreement and no exchange of originals is necessary.
--- ---
17. Notices
--- ---
17.1. Any communication and/or information to be given in connection with this agreement shall be in writing<br>in English and shall either be delivered by hand or sent by first class post or reputable courier or email:
--- ---
(a) to the Company at its registered office or to the email address shown in Schedule 2 (with a copy, which<br>shall not constitute notice, to mark.geday@morganlewis.com and russell.franklin@morganlewis.com)~~; or~~
--- ---
(b) to an Investor at the address or to the email address of such Investor shown in Schedule 1,
--- ---

(or in each such case such other address or email address as the recipient may notify to the other parties for such purpose).

17.2. A communication sent according to clause 17.1 shall be deemed to have been received:
(a) if delivered by hand, at the time of delivery;
--- ---
(b) if sent by pre-paid first class post or reputable courier, on the second day after posting; or
--- ---
(c) if sent by email, at the time of completion of transmission by the sender insofar as no automatic response<br>other than a temporary “out of office” reply is received by the sender within six (6) hours of transmission,
--- ---

except that if a communication is deemed received outside business hours in the place of receipt (which, in the case of service of a notice by email shall be deemed to be the same place as is specified for service of notices on the relevant party by hand or post), it shall be deferred until business hours resume. In this clause, business hours means 9:30 a.m. to 5:30 p.m. Monday to Friday on a day that is not a public holiday in the place of receipt.

18. Severance
18.1. If any provision of this agreement is held to be invalid or unenforceable by any judicial or other competent<br>authority, all other provisions of this agreement will remain in full force and effect and will not in any way be impaired.
--- ---
18.2. If any provision of this agreement is held to be invalid or unenforceable but would be valid or enforceable<br>if some part of the provision were deleted, the provision in question will apply with the minimum modifications necessary to make it valid<br>and enforceable as long as no fundamental aspect of the transactions contemplated hereby are materially affected.
--- --- 
13
19. Governing law

This agreement (and any dispute or claim relating to it or its subject matter (including non-contractual claims)) is governed by and is to be construed in accordance with Cayman Islands law.

20. Jurisdiction

The parties irrevocably agree that the courts of the Cayman Islands shall have exclusive jurisdiction to settle any claim, dispute or issue (including non-contractual claims) which may arise out of or in connection with this agreement.

21. Regulatory matters

Neither the Investors nor any general partner of an Investor or management company authorised from time to time to act on behalf of an Investor is acting for or advising any other party to the transaction that is the subject of this agreement or undertaking any other activity in relation to that other party that implies in any way that the other party is a client and accordingly no such Investor, general partner of such Investor and/or management company of such Investor (as appropriate) shall be responsible to any other party for providing any protection afforded to any client (as defined in the Glossary to the FCA Handbook of rules and guidance) for such Investor.

22. US securities laws requirements

Each Investor acknowledges and warrants separately for itself and in respect of its own position, to the Company, for the purpose of compliance with the United States Securities Act of 1933, as amended (the “Securities Act”) and state securities laws, as follows:

(a) the Investor acknowledges that the Securities have not been registered under the Securities Act, or any<br>state securities laws on the basis that the Company is relying on an exemption from registration under such laws that depends in part<br>on the representations made by the Investor pursuant to this clause, and that the transferability of the Securities is therefore subject<br>to restrictions imposed by those laws;
(b) the Investor agrees not to sell or otherwise transfer the Securities insofar as the Securities Act restricts<br>such sale or transfer unless they are registered under the Securities Act and United States state securities laws of the applicable jurisdiction<br>or unless an exemption from registration is available;
--- ---
(c) the Investor has either a residence or business address as set out in Schedule 1; all offers of the Securities<br>were made to the Investor at that address or elsewhere outside of the United States; no offer or solicitation was made to the Investor<br>in any jurisdiction other than that jurisdiction or elsewhere outside of the United States; and the Investor accepted the offer to purchase<br>Securities by executing this agreement or an adherence agreement to this Agreement within that jurisdiction; and prior to such acceptance,<br>the Investor did not accept the offer in any other jurisdiction, orally, in writing, or otherwise;
--- ---
(e) the Investor that is a “U.S. Person” (within the meaning of Rule 902 of Regulation S promulgated<br>under the Securities Act) is an “accredited investor” within the definition set forth in Rule 501(a) under the Securities Act;
--- ---
(f) the Investor that is a “U.S. Person” acknowledges that the Investor has experience in making<br>investments such as those in the Company and is able to bear the economic risk of the investment for an indefinite period of time because<br>the Securities have not been registered under the Securities Act, and therefore, must (to the extent the Securities Act restricts a transfer<br>of the Securities) be held unless they are subsequently registered under the Securities Act or an exemption from such registration is<br>available;
--- --- 
14
(g) the Investor acquired the Securities for its own account for investment and not for the account of another<br>nor with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities<br>Act, the state securities laws of any applicable jurisdiction, or the rules and regulations promulgated thereunder and, if the Investor<br>is an entity, the Investor was not formed for the specific purpose of acquiring the Securities.
23. Information and taxation matters
--- ---
23.1. The Company shall keep the Investors reasonably informed in a timely manner of all material developments<br>concerning the affairs, business and prospects of the Group Companies.
--- ---
23.2. The Company shall provide to each Investor such information as the Investor may reasonably request at<br>any time or from time to time in order to permit the Investor to determine whether the Company or any Non-US Subsidiary has been or may<br>become a PFIC or a “controlled foreign corporation” as defined in Section 957 of the Code (“CFC”), in each<br>case, or any similar or analogous provisions of the laws of the United States, any state or other jurisdiction thereof, or any non-US<br>jurisdiction, and to determine the consequences to the Investors or any of its direct or indirect owners of such status, and all such<br>other information that is reasonably requested or necessary for an Investor in order to satisfy any applicable tax reporting or tax compliance<br>requirements, reduce or eliminate withholding or other taxes, duly complete and file its tax returns or make any claims or elections in<br>respect of tax. If the Company or any Non-US Subsidiary is determined to be a PFIC, the Company shall timely provide, and shall cause<br>any such Non-US Subsidiary to timely provide, to the Investors such information reasonably necessary to make or maintain any election<br>available under the Code related to such PFIC status, including making and maintaining a “qualified electing fund” (“QEF”)<br>election with respect to the Company or such Non-US Subsidiary. Information necessary or desirable to permit an Investor or its direct<br>or indirect owners to make a QEF election with respect to the Company or any Non-US Subsidiary shall be provided to the Investors within<br>ninety (90) days after the end of each fiscal year or at such other times as an Investor may request.
--- ---
24. Business Combination
--- ---

Each of the Lead Investor and the Company (on behalf of itself and Air Water UK) acknowledge and agree that, upon execution of the Business Combination Agreement, the Lead Investor shall not be entitled to bring a claim, and hereby irrevocably and unconditionally waives any right to bring a claim, for breach of warranty pursuant to the Prior Inflection Subscription Agreement, provided that the Lead Investor shall have the benefit of the Warranties and related indemnification under clause 5.7 in respect of its investment pursuant to the Prior Inflection Subscription Agreement.

15
25. RSUs
25.1. It is acknowledged by the Investors that the Company intends to enter into definitive documentation relating<br>to the agreed term sheet in the form appended to this agreement as Exhibit 1 in respect of the grant of certain restricted stock unit<br>awards (the RSU Awards and each, an RSU Award) to Peter Carr and Ryan Bibbo (the Grantees and each, a Grantee),<br>as may be approved by the board of directors of the Company from time to time, over certain Ordinary Shares (in such number as may be<br>agreed by the board of directors of the Company from time to time, and up to a maximum of 3,499 Ordinary Shares in aggregate and including<br>the right to receive Earnout Shares as defined in and pursuant to the Business Combination Agreement (subject to customary equitable adjustment<br>for events such as Ordinary Share splits and combinations)) in accordance with the terms of the RSU Awards. Each of the Investors hereby:
--- ---
(a) consents to, for all purposes of the New Articles, the Amended and Restated Shareholders’ Agreement, and<br>applicable law, the RSU Grants and to any director or officer, or such other person(s) as may be authorised by the directors or officers<br>from time to time, doing all such further actions or procuring that such further actions are taken, as they may consider necessary or<br>convenient, to effect the RSU Grants;
--- ---
(b) acknowledges and confirms, for the avoidance of doubt, that signatures to this agreement shall constitute<br>Series A Majority Consent for purposes of the New Articles, to the extent such Series A Majority Consent is required in connection with<br>the implementation of the foregoing;
--- ---
(c) acknowledges and confirms, for the avoidance of doubt, that signatures to this agreement shall constitute<br>Requisite Majority Consent for purposes of the Amended and Restated Shareholders’ Agreement, to the extent such Requisite Majority Consent<br>is required in connection with the implementation of the foregoing; and
--- ---
(d) acknowledges and confirms that:
--- ---
(i) they have no claim or right of any kind in any capacity or in any jurisdiction, whether arising under<br>the New Articles (as amended or restated from time to time), the Amended and Restated Shareholders’ Agreement (as amended or restated<br>from time to time), or otherwise against the Company or any of its officers or employees in connection with the issuance of any and all<br>Ordinary Shares arising as a result of the Company effecting the RSU Grants; and
--- ---
(ii) if any such claim or right of action exists or may exist, whether in law or in equity and whether or not<br>presently known to any party or to the law, they hereby irrevocably waive such claim and release and forever discharge the Company, its<br>officers and employees from all and any liability in respect of it.
--- ---
26. Registration Statement. To the extent permissible under applicable securities laws and in accordance<br>with the Business Combination Agreement, the Company shall cause the registration statement on Form S-4 or Form F-4 filed in connection<br>with the consummation of the closing of the Business Combination to register the exchange of the Series A1 Shares of the Company for the<br>series A1 shares of PubCo and the exchange of the Warrants of Company for warrants in PubCo. 
16

Schedule 5

Execution Date Warranties

1. Valid Issuance
1.1. As of the date of the Completion, the New Shares and Warrants will be duly authorized and, when issued,<br>paid for and delivered in accordance with this agreement, will be validly issued, fully paid and non-assessable, free and clear of any<br>mortgage, pledge, security interest, right of first refusal, option, proxy, voting trust, Encumbrance, lien or charge of any kind (including<br>any conditional sale or other title retention agreement in the nature thereof), restriction (whether on voting, sale, transfer, disposition<br>or otherwise), or any filing or agreement to file a financing statement as debtor under applicable law (collectively, “Liens”)<br>or other restrictions (other than those arising under this agreement, the Business Combination Agreement, the Organizational Documents,<br>the New Articles, the Amended and Restated Shareholders’ Agreement or applicable securities laws), and will not have been issued<br>in violation of any preemptive or similar rights created under the New Articles, the Amended and Restated Shareholders’ Agreement<br>or the laws of the Company’s jurisdiction of incorporation.
--- ---
1.2. As of the date of the Completion and as of the applicable date of issuance, the Ordinary Shares issuable<br>upon conversion of the Series A1 Shares and exercise of the Warrants will be duly authorized and, when issued, paid for and delivered<br>in accordance with the New Articles and, as applicable, the Warrants, will be validly issued, fully paid and non-assessable, free and<br>clear of all Liens or other restrictions (other than those arising under this agreement, the Business Combination Agreement, the Organizational<br>Documents, the New Articles, the Amended and Restated Shareholders’ Agreement or applicable securities laws), and will not have<br>been issued in violation of any preemptive or similar rights created under the Company’s New Articles, the Amended and Restated<br>Shareholders’ Agreement or applicable securities laws or the laws of Company’s jurisdiction of incorporation.
--- ---
2. No General Solicitation. Neither the Company nor any person acting on its behalf has engaged in<br>any form of general solicitation or general advertising (within the meaning of Regulation D promulgated under the Securities Act) in connection<br>with any offer or sale of the Securities. The Securities are not being offered in a manner involving a public offering under, or in a<br>distribution in violation of, the Securities Act or any state securities laws. Neither the Company nor any person acting on the Company’s<br>behalf has, directly or indirectly, at any time within the past six (6) months, made any offer or sale of any security or solicitation<br>of any offer to buy any security under circumstances that would cause the offering of the Securities pursuant to this agreement to be<br>integrated with prior offerings by the Company for purposes of the Securities Act or any applicable shareholder approval provisions. Neither<br>the Company nor any person acting on the Company’s behalf has offered or sold any securities, or has taken any other action, which<br>would reasonably be expected to subject the offer, issuance or sale of the Securities, as contemplated hereby, to the registration provisions<br>of the Securities Act.
--- ---
3. Disqualification Events. No Disqualification Event is applicable to the Company, except for a Disqualification<br>Event as to which Rule 506(d)(2)(ii–iv) or (d)(3) is applicable. For the purposes of the foregoing, “Disqualification Event”<br>means a ‘bad actor’ disqualifying events described in Rule 506(d)(1)(i)-(viii) promulgated under the Securities Act.
--- --- 
17
4. Organization and Standing.
4.1. The Company is an exempted company duly organized, validly existing and in good standing under the laws<br>of the Cayman Islands and has all requisite corporate or other entity power and authority to own, lease and operate its properties and<br>to carry on its business as now being conducted, in each case, except where the failure to be in good standing or to have such corporate<br>power and authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect<br>on the Company. “Material Adverse Effect” means, with respect to any specified Person, any fact, event, occurrence,<br>change or effect that has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon<br>(a) the business, assets, liabilities, results of operations or financial condition of such Person and its Subsidiaries, taken as a whole,<br>or (b) the ability of such Person or any of its Subsidiaries to consummate the transactions contemplated hereby or in connection with<br>the Business Combination (the “Transactions”) or to perform its obligations under this agreement, the Business Combination<br>Agreement, the Amended and Restated Shareholders’ Agreement, the New Articles, or the Warrants (the “Transaction Documents”)<br>to which it is party; provided, however, that for purposes of clause (a) above, any fact, event, occurrence, change or effect directly<br>or indirectly attributable to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any<br>other, facts, events, occurrences, changes or effects) shall not be deemed to be, constitute, or be taken into account when determining<br>whether there has or may or would have occurred a Material Adverse Effect: (i) general global, national, regional, state or local changes<br>in the financial or securities markets (including changes in interest or exchange rates, prices of any security or market index or commodity<br>or any disruption of such markets) or general economic or political or social conditions in the country or region in which such Person<br>or any of its Subsidiaries do business, (ii) changes, conditions or effects that generally affect the industries in which such Person<br>or any of its Subsidiaries operate, (iii) changes or proposed changed in GAAP, IFRS or other applicable accounting principles or mandatory<br>changes in the regulatory accounting requirements (or any interpretation thereof) applicable to any industry in which such Person and<br>its Subsidiaries principally operate, (iv) conditions caused by acts of God, epidemic, pandemics, terrorism, war (whether or not declared),<br>natural or man-made disaster (including fires, flooding, earthquakes, hurricanes and tornados), civil unrest, terrorism or other force<br>majeure or comparable events, (v) any failure in and of itself by such Person and its Subsidiaries to meet any internal or published budgets,<br>projections, forecasts or predictions of financial performance for any period (provided that the underlying cause of any such failure<br>may be considered in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent<br>not excluded by another exception herein), (vi) changes attributable to the public announcement or pendency of the Transactions (including<br>the impact thereof on relationships with customers, suppliers or employees), (vii) changes or proposed changes in applicable law (or any<br>interpretation thereof) after the date of this agreement, (viii) any actions required to be taken, or required not to be taken, pursuant<br>to the terms of this agreement, and (ix) in respect of the Company, any action taken by, or at the written request of, Investor and in<br>respect of Investor, any action taken by, or at the written request of, the Company; provided further, however, that any event, occurrence,<br>fact, condition, or change referred to in clauses (i)-(iv) immediately above shall be taken into account in determining whether a Material<br>Adverse Effect has occurred or would reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change<br>has a disproportionate effect on such Person and its Subsidiaries, taken as a whole, compared to other participants in the industries<br>and geographic location in which such Person or any of its Subsidiaries conducts its businesses (in which case only the incremental disproportionate<br>impact may be taken into account).
--- ---
4.2. Each subsidiary of the Company (each a “Company Subsidiary” and, together with the<br>Company, the “Target Companies”) is a corporation or other entity duly formed, validly existing and in good standing<br>under the laws of its jurisdiction of organization and has all requisite corporate or other entity power and authority to own, lease and<br>operate its properties and to carry on its business as now being conducted. Each Target Company (other than the Company) is qualified<br>or licensed and in good standing (to the extent such concept exists) to do business in each jurisdiction in which the character of the<br>property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary,<br>except in each case where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, has not had<br>and would not reasonably be expected to have a Material Adverse Effect on the Company.
--- --- 
18
4.3. No Target Company is in violation of any provision of its Organizational Documents in any material respect.
5. Capitalization.
--- ---
5.1. As of the date of this agreement, the issued share capital of the Company consists of 39,348 Ordinary<br>Shares, 0 Series A1 Shares, and 0 Series A2 Shares. The Company has also issued 2,893 warrants, and there are no other issued or outstanding<br>equity interests of the Company.
--- ---
5.2. On the date of this agreement, the Company shareholders listed in the Disclosure Schedules are the legal<br>and beneficial owners of all of the Ordinary Shares, with each such Company shareholder owning the Ordinary Shares set forth opposite<br>the name of such Company shareholder in the corresponding column of the Disclosure Schedules. The Ordinary Shares are owned by each such<br>Company shareholder free from any Liens other than those imposed under the Company’s Organizational Documents, which can be removed<br>by the Company and its shareholders without penalty or applicable securities laws.
--- ---
5.3. On the date of this agreement, the Company shareholders listed in the Disclosure Schedules are the legal<br>and beneficial owners of all of the Series A1 Shares, with each such Company shareholder owning the Series A1 Shares set forth opposite<br>the name of such Company shareholder in the corresponding column of the Disclosure Schedules. The Series A1 Shares are owned by each such<br>Company shareholder free from any Liens other than those imposed under the Company’s Organizational Documents, which can be removed<br>by the Company and its shareholderswithout penalty or applicable securities laws.
--- ---
5.4. All of the Company’s issued Shares have been duly authorized and are fully paid and not in violation<br>of any purchase option, right of first refusal, pre-emptive right, subscription right or any similar right under any provision of the<br>Cayman Companies Law, any other applicable law, the Company’s Organizational Documents or any contract to which the Company is a<br>party or by which the Company or its securities are bound.
--- ---
6. As of the date of this agreement, no Target Company currently has any stock option or other equity incentive<br>plans. As of the date of this agreement, other than the securities contemplated in connection with this agreement and the other Transaction<br>Documents, there are no Company convertible securities or pre-emptive rights or rights of first refusal or first offer, except for those<br>rights as provided in the Company’s Organizational Documents which have been disapplied and waived by the Company shareholders,<br>nor are there any contracts, commitments, arrangements or restrictions to which the Company or any of the Company shareholders or any<br>of their respective Affiliates are a party or bound relating to any equity securities of the Company, whether or not outstanding, other<br>than the Company’s Organizational Documents. As of the date of this agreement, other than this agreement and the other Transaction<br>Documents, there are no outstanding or authorized equity appreciation, phantom equity or similar rights with respect to the Company and<br>there are no voting trusts, proxies, shareholder agreements or any other written agreements or understandings with respect to the voting<br>or transfer of any of Ordinary Shares other than the Company’s Organizational Documents. As of the date of this agreement, other<br>than this agreement or as set forth in the Company’s Organizational Documents, there are no outstanding contractual obligations<br>of the Company to repurchase, redeem or otherwise acquire any of its equity interests or securities, nor has the Company granted any registration<br>rights to any Person with respect to its equity securities. As of the date of this agreement, all of the issued and outstanding securities<br>of the Company have been granted, offered, sold and issued in compliance with all applicable laws. As a result of the consummation of<br>the Transactions, no equity interests of the Company are issuable and no rights in connection with any interests, warrants, rights, options<br>or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or<br>otherwise).
--- --- 
19
7. Due Authorization and Enforceability. The execution and delivery of this agreement and each of<br>the other Transaction Documents by the Company and the consummation by the Company of the transactions contemplated hereby and<br>thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company,<br>its Board of Directors, or its stockholders in connection herewith or therewith. This agreement and each other Transaction Document<br>to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when duly executed by the<br>other parties thereto and delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation<br>of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and<br>applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’<br>rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies<br>and (iii) insofar as indemnification and contribution provisions may be limited by applicable law (collectively, the “EnforceabilityExceptions”).
8. Company Subsidiaries. The Disclosure Schedules set forth the name of each Company Subsidiary, and<br>with respect to each Company Subsidiary on the date of this agreement (a) its jurisdiction of organization, (b) the class(es) of its authorized<br>shares or other equity interests (if applicable), and (c) the ownership percentage of issued and outstanding shares or other equity interests<br>by the record holders thereof. The foregoing represents all of the issued and outstanding equity interests of the Company Subsidiaries<br>as of the date of this agreement. All of the outstanding equity securities of each Company Subsidiary are duly authorized and validly<br>issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered in compliance with all applicable laws, and<br>owned by one or more of the Target Companies free and clear of all Liens (other than those, if any, imposed by such Company Subsidiary’s<br>Organizational Documents or applicable laws), except where the failure to be would not, individually or in the aggregate, reasonably be<br>expected to be material to the Target Companies, taken as a whole. As of the date of this agreement, there are no contracts to which the<br>Company or any of the Company Subsidiaries is a party or bound with respect to the voting (including voting trusts or proxies) or transfer<br>of the equity interests of any Company Subsidiary other than the Organizational Documents of any such Company Subsidiary. As of the date<br>of this agreement, there are no outstanding or authorized options, warrants, rights, agreements, subscriptions, convertible securities<br>or commitments to which any Company Subsidiary is a party or which are binding upon any Company Subsidiary providing for the issuance<br>or redemption of any equity interests of any Company Subsidiary. As of the date of this agreement, there are no outstanding equity appreciation,<br>phantom equity, profit participation or similar rights granted by any Company Subsidiary. No Company Subsidiary has any limitation, whether<br>by contract, order, or applicable law, on its ability to make any distributions or dividends to its equity holders or repay any debt owed<br>to another Target Company. As of the date of this agreement, other than the Company Subsidiaries, no Target Company has any Subsidiaries.<br>Except for the equity interests of the Company Subsidiaries listed in the Disclosure Schedules, as of the date of this agreement: (i)<br>no Target Company owns or has any rights to acquire, directly or indirectly, any equity interests of, or otherwise control, any Person,<br>(ii) no Target Company is a participant in any joint venture, partnership or similar arrangement and (iii) there are no outstanding contractual<br>obligations of a Target Company to provide funds to or make any loan or capital contribution to any other Person.
--- --- 
20
9. No Consent. No Consent of or with any Governmental Authority on the part of any Target Company<br>is required to be obtained or made in connection with the execution, delivery or performance by the Company or any Target Company of this<br>agreement or any other Transaction Documents to which the Company or any Target Company is or required to be a party or otherwise bound,<br>or the consummation by the Company or the Target Companies of the Transactions other than (a) any filings required with Nasdaq or the<br>United States Securities and Exchange Commission with respect to the Transactions, (b) applicable requirements, if any, of the Securities<br>Act, the U.S. Securities Exchange Act of 1934, as amended, and any state “blue sky” securities laws, and the rules and regulations<br>thereunder, (c) applicable requirements of any antitrust laws and the expiration or termination of the required waiting periods, or the<br>receipt of other Consents, thereunder, and (d) where the failure to obtain such Consents, or to make such filings or notifications, individually<br>or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on the Company.
10. Non-Contravention. The execution and delivery by the Company (or any other Target Company, as applicable)<br>of this agreement and each Transaction Document to which any Target Company is or is required to be a party, and the consummation by any<br>Target Company of the Transactions and compliance by any Target Company with any of the provisions hereof and thereof, will not (a) conflict<br>with or violate any provision of such Target Company’s articles of incorporation and bylaws, memorandum and articles of association<br>or similar organizational documents (the “Organizational Documents”), (b) assuming the accuracy of each Investor’s<br>warranties set forth in this agreement, subject to obtaining any consent, approval, waiver, authorization, waiting period expiration or<br>termination, or permit of, or notice to or declaration or filing with any Governmental Authority or any other Person (the “Consents”)<br>from any federal, state, local, foreign or other governmental, quasi-governmental, tax, regulatory or administrative body, instrumentality,<br>department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving<br>panel or body (“Governmental Authorities”) and any condition precedent to such Consent having been satisfied, conflict<br>with or violate any law, order or Consent applicable to such Target Company or any of its properties or assets, or (c) assuming the accuracy<br>of each Investor’s warranties set forth in this agreement, (i) violate, conflict with or result in a breach of, (ii) constitute<br>a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination,<br>withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by such Target Company under, (v) result<br>in a right of termination or acceleration under, (vi) give rise to any obligation to make or increase payments or provide compensation<br>under, (vii) result in the creation of any Lien upon any of the properties or assets of such Target Company under, (viii) give rise to<br>any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default,<br>exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel,<br>terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of any material contract,<br>except for any deviations from any of the foregoing clauses (b) or (c) that, individually or in the aggregate, would not reasonably be<br>expected to have a Material Adverse Effect on the Company.
--- --- 
21
11. Financial Statements.
11.1. The Company has made available to the Investor true, correct and complete copies of (i) the audited consolidated<br>financial statement of financial position of Air Water Units Trading Limited and its subsidiaries, and the related audited consolidated<br>statements of comprehensive income, changes in equity and cash flows of Air Water Units Trading Limited and its wholly-owned subsidiaries<br>as of and for the year ended December 31, 2023 (the “Audited Company Financial Statements”), (ii) the unaudited consolidated<br>financial statement of financial position of Air Water Ventures Limited and its subsidiaries, and the related unaudited consolidated statements<br>of comprehensive income, changes in equity and cash flows of Air Water Ventures Limited and its subsidiaries as of and for the year ended<br>December 31, 2024 (the “2024 Unaudited Company Financial Statements”) and (iii) the unaudited consolidated financial<br>statement of financial position of Air Water Ventures Limited and its subsidiaries, and the related unaudited consolidated statements<br>of comprehensive income, changes in equity and cash flows of Air Water Ventures Limited and its subsidiaries as of and for the three-month<br>period ended March 31, 2025 (the “Interim Unaudited Company Financial Statements” and, collectively with the Audited<br>Company Financial Statements and the 2024 Unaudited Company Financial Statements, the “Company Financial Statements”).
--- ---
11.2. The Company Financial Statements (i) fairly present in all material respects the consolidated financial<br>position of the applicable Target Companies, as at the respective dates thereof, and the consolidated results of their operations, their<br>consolidated incomes, their consolidated changes in shareholders’ equity and their consolidated cash flows for the respective periods<br>then ended, subject to adjustments which are not expected to have a Material Adverse Effect, (ii) were prepared in conformity with<br>IFRS applied on a consistent basis during the periods involved, except as may be indicated in the notes thereto and with respect to the<br>2024 Unaudited Company Financial Statements and the Interim Unaudited Company Financial Statements, subject to the absence of footnotes<br>and normal year-end adjustments (none of which would be material, individually or in the aggregate), (iii) were prepared from, and<br>are in accordance with, in all material respects, the books and records of the applicable Target Companies and (iv) with respect to the<br>Audited Company Financial Statements, contain an unqualified report of the Company’s auditor in connection with such Audited Company<br>Financial Statements, Grant Thornton UAE. The audited consolidated balance sheets and statements of operations, comprehensive income,<br>stockholders’ equity and cash flows of the Target Companies as of and for the years ended December 31, 2023 and December 31, 2024,<br>each audited in accordance with the auditing standards of the PCAOB and which comply in all material respects with the applicable accounting<br>requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant (collectively,<br>the “PCAOB Financial Statements”), when delivered after the date hereof by the Company for inclusion in the Form F-4<br>registration statement to be filed by PubCo in connection with the Business Combination (the “Registration Statement”)<br>and the proxy statement of SPAC (the “Proxy Statement”) for filing with the SEC following the date of this agreement,<br>will comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange<br>Act and the Securities Act applicable to a registrant in effect as of the respective dates thereof.
--- ---
11.3. The Company has not identified, and has not received from any independent auditor of the Company any written<br>notification of, (i) any significant deficiency or material weakness in the system of internal accounting controls utilized by the<br>Target Companies, (ii) any fraud, whether or not material, that involves the management or other employees of the Target Companies<br>who have a role in the preparation of financial statements or the internal accounting controls utilized by the Target Companies or (iii) any<br>written claim or allegation regarding any of the foregoing.
--- ---
11.4. As of the date hereof, the Target Companies do not have any of the following types of indebtedness: (a)<br>all indebtedness of such Person for borrowed money (including the outstanding principal and accrued but unpaid interest), (b) all obligations<br>for the deferred purchase price of property or services (other than trade payables incurred in the ordinary course of business), including<br>“earn-outs” and “seller notes” whether accrued or not, (c) any other indebtedness of such Person that is evidenced<br>by a note, bond, debenture, credit agreement or similar instrument, in each case to the extent drawn, (d) all obligations of such Person<br>under leases that should be classified as capital leases in accordance with IFRS, or any other accounting principles used by such Person,<br>(e) all obligations of such Person for the reimbursement of any obligor on any line or letter of credit, banker’s acceptance, guarantee<br>or similar credit transaction, in each case, that has been drawn or claimed against and not settled.
--- --- 
22
11.5. Except for those that will be reflected or reserved on or provided for in the statement of financial position<br>of the Target Companies contained in the Company Financial Statements, no Target Company has any liabilities of a nature required to be<br>disclosed on a balance sheet in accordance with IFRS, except for (i) those that were incurred after March 31, 2025 in the ordinary course<br>of business, none of which are material, individually or in the aggregate, (ii) obligations for future performance under any contract<br>to which any Target Company is a party, (iii) liabilities incurred for transaction expenses in connection with this agreement or any other<br>Transaction Document or (iv) liabilities which would not, individually or in the aggregate, reasonably be expected to have a Material<br>Adverse Effect.
12. Absence of Certain Changes. Except for actions expressly contemplated by this agreement, and the<br>other Transaction Documents, since December 31, 2024 and through the date of this Agreement, (a) the Target Companies have conducted their<br>business only in the ordinary course of business and (b) there has not been a Material Adverse Effect; and (c) the Company has not declared<br>or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or otherwise acquired any equity<br>interests of the Company, and the Board has not authorized any of the foregoing.
--- ---
13. Compliance with Laws. (a) Each Target Company is in compliance in all material respects with, and<br>not in conflict, default or violation in each case in any material respect of, any applicable laws and (b) no Target Company has received,<br>since December 31, 2024, any written or, to the knowledge of the Company, oral notice of any material conflict or material non-compliance<br>with, or material default or material violation of, any applicable laws by which it is or was bound.
--- ---
14. Company Permits. The applicable Target Company holds all permits necessary to lawfully conduct<br>in all material respects its business as presently conducted, and to own, lease and operate its assets and properties (collectively, the<br>“Company Permits”), except where the failure to obtain or maintain the same, individually or in the aggregate, has<br>not had and would not reasonably be expected to be material to the Target Companies, taken as a whole or otherwise limit the ability of<br>any Target Company to perform on a timely basis its obligations under this agreement or the other Transaction Documents to which it is<br>or required to be a party or otherwise bound. As of the date of this agreement, each material Company Permit is in full force and effect,<br>and (a) no suspension or cancellation of any of the material Company Permits is pending or, to the Company’s knowledge, threatened,<br>(b) no Target Company is in violation in any material respect of the terms of any material Company Permit and (c) since December 31, 2024,<br>no Target Company has received any written, or to the knowledge of the Company, oral notice of any actions relating to the revocation<br>or material modification of any material Company Permit.
--- ---
15. Litigation. There is no (a) material action of any nature currently pending or, to the Company’s<br>knowledge, threatened or (b) material order, decree, ruling, judgment, injunction, writ, binding determination or decision, verdict or<br>judicial award that is or has been entered, rendered, or otherwise put into effect now pending or outstanding in either case of (a) or<br>(b) by or against any Target Company.
--- ---
16. Intellectual Property.
--- ---
16.1. All registered, issued, and applied-for intellectual property owned by a Target Company (“CompanyRegistered IP”) is subsisting and all registered or issued Company Registered IP is valid and, to the knowledge of the Company,<br>enforceable except where the failure to be would not, individually or in the aggregate, reasonably be expected to be material to the Target<br>Companies, taken as a whole. No Target Company is subject to any outstanding order that would restrict its use or ownership of any intellectual<br>property or would impair the validity or enforceability of any Company’s owned intellectual property, and no action is pending or,<br>to the knowledge of the Company, threatened, against a Target Company that challenges the validity, enforceability or ownership of any<br>Company Registered IP.
--- --- 
23
16.2. At least one of the Target Companies (x) exclusively owns all material Company owned intellectual property,<br>free and clear of all Liens (other than Permitted Liens (as defined below)) and (y) has the right to use all other intellectual property<br>that is material to the conduct of the business of the Target Companies as currently conducted. The execution and delivery by the Company<br>(or any other Target Company, as applicable) of this agreement and each other Transaction Document to which any Target Company is or is<br>required to be a party, the consummation by any Target Company of the Transactions, and the compliance by any Target Company with any<br>of the provisions hereof and thereof, will not result in the material loss, termination or impairment of any rights of the Target Companies<br>in any material intellectual property. “Permitted Liens” means (a) Liens for taxes or assessments and similar governmental<br>charges or levies, which either are (i) not yet delinquent or (ii) being contested in good faith and by appropriate proceedings and for<br>which adequate reserves have been established in accordance with IFRS or GAAP, as applicable, with respect thereto, (b) Liens imposed<br>by operation of law or non-monetary Encumbrances that would not in the aggregate materially adversely affect the value of, or materially<br>adversely interfere with the use of, the property subject thereto, (c) Liens incurred, pledges or deposits made in the ordinary course<br>of business in connection with worker’s compensation, unemployment insurance and other social security legislation, (d) Liens on<br>goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, (e) Liens<br>arising under this agreement or any other Transaction Document, (f) such imperfections of title, easements, covenants, Encumbrances, Liens,<br>or other similar restrictions on real property that would not be reasonably expected to materially impair the current use or operations<br>of the business of the Target Companies or any assets that are subject thereto, (g) materialmen’s, mechanic’s, carriers’,<br>workmen’s, warehousemen’s, repairmen’s, landlord’s and other similar Liens, or deposits to obtain the release<br>of such Liens, (h) restrictions on the transfer of securities imposed by applicable securities laws, (i) zoning, building, land use, entitlement,<br>conservation restrictions or other similar restrictions on real property, including rights of way and similar Encumbrances identified<br>on any surveys, and other land use and environmental regulations promulgated by Governmental Authorities, (j) deposits to secure the performance<br>of bids, trade contracts, leases, statutory obligations, surety, indemnity and appeal bonds, performance and fiduciary bonds and other<br>obligations of a like nature, in each case in the ordinary course of business, (k) non-exclusive licenses (or sublicenses) of intellectual<br>property owned by the Target Companies granted in the ordinary course of business, (l) any (i) statutory Liens in favor of any lessor<br>or landlord, (ii) Liens set forth in leases, subleases, easements, licenses, rights of use, rights to access and rights-of-way or (iii)<br>Liens benefiting or encumbering any superior estate, right or interest, (m) any Liens that are discharged or released at or prior to the<br>closing of the Business Combination, (n) any purchase money Liens, equipment leases or similar financing arrangements, (o) the rights<br>of lessors under leasehold interests or (p) Liens specifically identified on the consolidated statement of financial position of the Target<br>Companies.
16.3. To the knowledge of the Company, (i) no Target Company is currently infringing, or has, in the past three<br>years, infringed any intellectual property of any other Person in any material respect, and (ii) no third party is infringing any material<br>Company owned intellectual property.
--- --- 
24
16.4. All contributors who have contributed to the development of material intellectual property for any Target<br>Company have executed a contributor agreement. To the knowledge of the Company, no contributor has claimed any ownership interest in any<br>material intellectual property purported to be owned by a Target Company. Each Target Company has taken commercially reasonable measures<br>to protect and maintain the confidentiality of all trade secrets included in the material Company owned intellectual property. No such<br>trade secret has been disclosed (or authorized or threatened to be disclosed) to any Person (including any past or present employee, officer,<br>advisor, consultant, independent contractor or other third party) other than pursuant to the terms of a valid, written confidentiality<br>agreement with such Person that is sufficient to protect the confidentiality thereof and is in full force and effect. No Governmental<br>Authority or educational or research institution owns or otherwise holds, or has the right to obtain, any rights to any material Company<br>owned intellectual property.
17. Taxes and Returns.
--- ---
17.1. Each Target Company has filed, or caused to be filed, all material tax returns required by applicable<br>tax law to be filed by it, which such tax returns are true, accurate, correct and complete in all material respects. Each Target Company<br>has paid, or caused to be paid, all material taxes required by applicable tax law to be paid by it, other than such taxes being contested<br>in good faith by appropriate proceedings and for which adequate reserves have been established in the Company Financial Statements in<br>accordance with IFRS.
--- ---
17.2. Air Water Company LLC, a Delaware limited liability company (“Air Water US”), is the<br>only Target Company that is incorporated or organized in the United States. Air Water US is not, and has never been, a “United States<br>real property holding corporation” within the meaning of Section 897(c)(2) of the Code.
--- ---
17.3. Each Target Company has complied in all material respects with all applicable tax laws relating to withholding<br>and remittance of taxes, and all material amounts of taxes required by applicable tax laws to be withheld by a Target Company have been<br>withheld and timely paid over to the appropriate Governmental Authority, including with respect to any amounts owing to or from any employee,<br>independent contractor, shareholder, creditor, or other Person.
--- ---
17.4. There are no material claims, assessments, audits, examinations, investigations or other actions pending,<br>in progress or threatened in writing against any Target Company, in respect of taxes, and no Target Company has been notified in writing<br>of any material proposed tax claims or assessments against any Target Company by a Governmental Authority.
--- ---
17.5. There are no material Liens with respect to any taxes upon any Target Company’s assets, other than<br>Permitted Liens.
--- ---
17.6. No Target Company has a permanent establishment, branch or representative office in any country other<br>than the country of its organization, and no Target Company is or has been treated for any tax purpose as a resident in a country other<br>than the country of its incorporation or formation, as applicable.
--- ---
17.7. No UK directors, officers, employees or former or proposed directors, officers or employees of the Target<br>Companies hold any securities, interests in securities or securities options as defined in Part 7 of Income Tax (Earnings and Pensions)<br>Act 2003 (“ITEPA”).
--- ---
17.8. Real Property. All current leases, lease guarantees, agreements and documents as of the date of<br>this agreement related to the premises currently leased or subleased by a Target Company for the operation of the business of a Target<br>Company are valid, binding and enforceable against the Target Company party thereto and, to the knowledge of the Company, each other party<br>thereto, in accordance with their terms and are in full force and effect (except, in each case, as such enforcement may be limited by<br>the Enforceability Exceptions). To the knowledge of the Company, no event has occurred which (whether with or without notice, lapse of<br>time or both or the happening or occurrence of any other event) would constitute a material default on the part of a Target Company or<br>any other party under any of the Company Real Property Leases, and no Target Company has received written notice of any such condition.<br>No Target Company owns any real property or any interest in real property (other than the leasehold interests in the Company Real Property<br>Leases).
--- --- 
25
18. Environmental Matters.
18.1. Each Target Company is in compliance in all material respects with all applicable laws in effect on or<br>prior to the date hereof relating to (a) the protection of human health and safety (to the extent relating to exposure to hazardous materials),<br>(b) the protection, preservation or restoration of the environment and natural resources (including air, water vapor, surface water, groundwater,<br>drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource) to the extent relating to releases<br>of hazardous materials or (c) the use, storage, recycling, treatment, generation, transportation, processing, handling, labelling, production,<br>release or disposal of hazardous materials (“Environmental Laws”), including obtaining, maintaining in good standing,<br>and complying in all material respects with all material permits required under Environmental Laws for its business and operations (“EnvironmentalPermits”) and no action is pending or, to the Company’s knowledge, threatened that would reasonably be expected to result<br>in the revocation, modification, or termination of any such Environmental Permit.
--- ---
18.2. No Target Company has assumed, contractually or by operation of law, any outstanding liabilities or obligations<br>under any Environmental Laws of any other Person except, in each case, for such liabilities or obligations that would not reasonably be<br>expected to be material to the Target Companies, taken as a whole.
--- ---
18.3. No action is pending, or to the Company’s knowledge, threatened against any Target Company or any<br>assets of a Target Company alleging that a Target Company is in violation in any material respect of any Environmental Law or material<br>Environmental Permit or that a Target Company has any material liability under any Environmental Law, and to the Company’s knowledge,<br>no fact, circumstance or condition exists that would reasonably be expected to give rise to any such action.
--- ---
19. Transactions with Related Persons. No Company shareholder nor any officer or director of a Target<br>Company or any of their respective Affiliates, nor, to the knowledge of the Company, any immediate family member of any of the foregoing<br>(each of the foregoing, a “Related Person”) is presently a party to any transaction with a Target Company, including<br>any contract (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b)<br>providing for the rental of real property or personal property from, or (c) otherwise requiring payments to (other than for services or<br>expenses as directors, officers or employees of the Target Company in the ordinary course of business) any Related Person or any Person<br>in which any Related Person has a position as an officer, manager, director, trustee or partner or in which any Related Person has any<br>direct or indirect ownership interest (other than the ownership of securities representing no more than five percent of the outstanding<br>voting power or economic interest of a publicly traded company), in each case, other than any other Transaction Document, the Shareholders<br>Agreement or any contract pursuant to which a Company shareholder subscribed for or purchased equity interests in the Company.
--- --- 
26
20. Insurance.
20.1. Except as would not, individually or in the aggregate, result in a Material Adverse Effect, to the Target<br>Companies, taken as a whole, the Target Companies are in compliance with the terms of its insurance policies. To the Company’s knowledge<br>and except as would not, individually or in the aggregate, be material to the Target Companies, taken as a whole, each such insurance<br>policy (i) is valid, binding, enforceable and in full force and effect and (ii) will continue to be valid, binding, enforceable, and in<br>full force and effect on identical terms following the closing of the Business Combination (except, in each case, as such enforcement<br>may be limited by the enforceability exceptions).
--- ---
21. Certain Business Practices.
--- ---
21.1. For the past five (5) years, each Target Company has been in compliance with the U.S. Foreign Corrupt<br>Practices Act of 1977 and all other applicable anti-corruption and anti-bribery laws, in all material respects.
--- ---
21.2. For the past five (5) years, no Target Company nor, to the knowledge of each Target Company, any of its<br>directors, officers, employees or representatives, when acting on behalf of a Target Company, has used any funds for unlawful contributions,<br>gifts, entertainment or other unlawful expenses relating to political activity.
--- ---
21.3. No Target Company or, to the knowledge of the Company, any of their respective directors, officers, employees<br>or any other representative acting on behalf of a Target Company is currently a person organized, resident, or located in a country, region<br>or territory that is the subject of comprehensive territorial Sanctions (a “Sanctioned Person”). No Target Company<br>has, directly or, knowingly, indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary,<br>joint venture partner or other Person, (i) to fund any activities or business of or with any Person that, at the time of such funding,<br>is the subject of Sanctions, or in Cuba, Iran, North Korea, and the Crimea region of Ukraine, the so-called Donetsk People’s Republic,<br>and the so-called Luhansk People’s Republic regions of Ukraine, as this list may be amended from time to time (a “SanctionedJurisdiction”) or (ii) in any other manner that would reasonably be expected to result in a violation of Sanctions or Customs<br>& Export Control Laws by any Person. No Target Company or any of their respective directors, officers employees or, to the knowledge<br>of the Company, any other representative acting on behalf of a Target Company has, since April 24, 2019, engaged in (A) dealings with<br>a Sanctioned Person or involving a Sanctioned Jurisdiction in a manner that would violate applicable Sanctions, (B) dealings that could<br>reasonably be expected to result in the Target Company becoming a Sanctioned Person, or (C) conduct, activity, or practice that would<br>constitute a violation or apparent violation of any applicable Sanctions or Customs & Export Control Laws. The Target Company has<br>(1) where required by law, secured and maintained all necessary permits, registrations, agreements or other authorizations, including<br>amendments thereof pursuant to Sanctions and Customs & Export Control Laws and (2) not been the subject of or otherwise involved in<br>investigations or enforcement actions by any Governmental Authority or other legal proceedings with respect to any actual or alleged violations<br>of applicable Sanctions or Customs & Export Control Laws, and has not been notified of any such pending or threatened actions. The<br>Target Company and its directors, officers and employees, and, to the knowledge of the Company, any other representative acting on behalf<br>of a Target Company, are, and have been since April 24, 2019, in compliance with Sanctions and Customs & Export Control Laws.
--- ---
22. Investment Company Act. To the knowledge of the Company, no Target Company is an “investment<br>company” or a Person directly or indirectly “controlled” by or acting on behalf of a Person subject to registration<br>and regulation as an “investment company”, in each case within the meaning of the Investment Company Act.
--- --- 
27
23. Finders and Brokers. Other than as set forth on the Disclosure Schedules, no broker, finder or<br>investment banker is entitled to any brokerage, finder’s or other fee or commission from the Target Companies or any of their respective<br>Affiliates in connection with the Transactions based upon arrangements made by or on behalf of any Target Company.
24. No Registration. Assuming the accuracy of each Investor’s warranties set forth in this agreement,<br>no registration under the Securities Act or any state securities (or Blue Sky) laws is required for the offer and sale of the Securities by<br>the Company to each Investor.
--- ---
25. Money Laundering Laws. The operations of the Target Companies are and have been conducted at all<br>times in material compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions<br>Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively,<br>the “Money Laundering Laws”), and no action or proceeding by or before any court or governmental<br>agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws<br>is pending or, to the knowledge of the Company, threatened.
--- ---
26. Registration Rights. Except as (i) disclosed in the Disclosure Schedules, (ii) have been waived<br>and (iii) as provided for in the Company’s Registration Rights Agreement with the Investors, no Person has any<br>right to cause the Company to effect the registration under the Securities Act of any securities of the Company.
--- ---
27. Market Activities. Subject to the non-disclosure agreements entered into by the Investor with respect<br>to the Business Combination and the other transactions contemplated by the Transaction Documents, anything in this agreement or elsewhere<br>herein to the contrary notwithstanding, it is understood and acknowledged by the Company that: (i) none of the Investors has been asked<br>by the Company to agree, nor has any Investor agreed, to desist from purchasing or selling, long and/or short, securities of the Company,<br>or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified<br>term; (ii) past or future open market or other transactions by any Investor, specifically including, without limitation, short sales or<br>“derivative” transactions, before or after the closing of this or future private placement transactions, may negatively impact<br>the market price of the Company’s publicly-traded securities; (iii) any Investor, and counter-parties in “derivative”<br>transactions to which any such Investor is a party, directly or indirectly, presently may have a “short” position in the Ordinary<br>Shares, and (iv) each Investor shall not be deemed to have any affiliation with or control over any arm’s length counter-party in<br>any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Investors may engage in<br>hedging activities at various times during the period that the Securities are outstanding, and (z) such hedging activities (if<br>any) would reduce the value of the Investors’ equity interests in the Company at and after the time that the hedging activities<br>are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction<br>Documents.
--- ---
28. No Stabilization or Manipulation. The Company has not, and to its knowledge no one acting on its<br>behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price<br>of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid<br>any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation<br>for soliciting another to purchase any other securities of the Company.
--- --- 
28

Schedule 6

Business Combination Agreement

See attached.

29

Execution

This Agreement has been executed on the date shown at the start.

SIGNED<br> by a director for and on behalf
Print<br> name: Andrea Mollica
of<br> Air Water Ventures Holdings Limited Director

[Signature Page to Subscription Agreement]

SIGNED by
Inflection Point Fund I, LP
By:
Name: Michael Blitzer
Title: Manager<br> of General Partner

[Signature Page to Subscription Agreement]

[Execution blocks for other Investors tobe inserted]

[Signature Page to Subscription Agreement]

Exhibit 1: RSU Awards

Exhibit 10.7

Final Form

Dated 25 August 2025

THE INVESTORS

and

THE COMPANY

SUBSCRIPTION AGREEMENT

relating to Series A2 Preferred Shares and Warrants of Air Water VenturesHoldings Limited

Index

Clause No. Page No.
1. Definitions 1
2. Interpretation 5
3. Subscriptions 6
4. Completion 6
5. Warranties and Indemnity 8
6. Limitations on Claims 9
7. Announcements 10
8. Costs and expenses 11
9. Cumulative remedies 11
10. Waiver 11
11. Entire agreement 11
12. Variation and termination 12
13. No partnership 12
14. Assignment and transfer 12
15. Rights of third parties 13
16. Counterparts; No originals 13
17. Notices 13
18. Severance 13
19. Governing law 14
20. Jurisdiction 14
21. Regulatory matters 14
22. US securities laws requirements 14
23. Information and taxation matters 15
24. RSUs. 16
Schedule 1 The Investors 17
Schedule 2 Particulars 18
Schedule 3 Members of the Company   Part 1: Members of the Company pre-Completion 19
Schedule 4 Warranties 20 
i

DATE ___ August 2025

PARTIES

(1) The persons whose names and addresses are set out in Schedule 1 (each, an “Investor”<br>and together, the “Investors”); and
(2) AIR WATER VENTURES HOLDINGS LIMITED, an exempted company incorporated in the Cayman Islands having<br>its registered office at Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands (the “Company”).
--- ---

INTRODUCTION

(A) The Company is an exempted company limited by shares, brief particulars of which are set out in Part 1<br>of Schedule 2.
(B) Details of the legal ownership of the share capital of the Company are set out in Schedule 3.
--- ---
(C) Following the execution and delivery of this agreement, it is anticipated that the Company, Inflection<br>Point Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), Air Water Ventures Limited, a Cayman Islands<br>exempted company (“PubCo”), and IPCX Merger Sub Limited, a Cayman Islands exempted Company and wholly-owned subsidiary<br>of SPAC (“Merger Sub”), will enter into a Business Combination Agreement (the “Business Combination Agreement,”<br>and the transactions contemplated by the Business Combination Agreement, the “Business Combination”), pursuant to which,<br>among other things, (i) SPAC will merge with and into PubCo (the “First Merger”), with PubCo surviving the First Merger,<br>and (ii) one (1) day after the date of the First Merger becoming effective, the Company will merge with and into Merger Sub (the “SecondMerger”), with Merger Sub surviving the Second Merger. The date of the closing of the Business Combination is herein referred<br>to as the “Transaction Closing”).
--- ---
(D) In anticipation of PubCo, SPAC and the Company entering into the Business Combination Agreement, the Company<br>desires to issue and allot to the Investors, and the Investors wish to subscribe for, shares in the capital of the Company on and subject<br>to the terms of this agreement.
--- ---

AGREED TERMS

1. Definitions

In this agreement, except where a different interpretation is necessary in the context, the words and expressions set out below shall have the following meanings:

“Act” means the Cayman Islands Companies Act (as revised);

“Accounts” means the unaudited statement of financial position, statement of comprehensive income, statement of changes in equity and statement of cash flows of the Company for the period ended on the Accounts Date;

“Accounts Date” means December 31, 2024;

1

“Affiliate” means, with respect to an Investor, any other person who, directly or indirectly, controls, is controlled by, or is under common control with such Investor, including, any general partner, managing member, officer or director of the Investor or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management or advisory company with, the Investor;

“Amended and Restated Shareholders’ Agreement” means the amended and restated shareholders’ agreement between (i) the Company; and (ii) the Shareholders (as defined therein) entered into on or around 25 August 2025, and in effect from, as of 25 August 2025;

“Board” means the board of directors of the Company as constituted from time to time;

“Business Day” means a day on which the clearing banks are ordinarily open for the transaction of normal banking business in the Cayman Islands (other than a Saturday or Sunday or public or bank holiday in the Cayman Islands);

“Claim” means any claim for breach of a Warranty;

“Code” means the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended.

“Company Real Property Leases” means all current leases, lease guarantees, agreements and documents related thereto as of the date of this agreement, including all amendments, terminations and modifications thereof or waivers thereto for all premises currently leased or subleased by a Target Company for the operation of the business of a Target Company;

“Completion” has the meaning given in clause 4.1;

“Disclosed” means fairly disclosed to the Investors in the Disclosure Schedules with sufficient detail to enable the Investor to identify the nature and scope of the matters disclosed;

“Disclosure Schedules” means the disclosure schedules attached hereto as Exhibit 2;

“Encumbrance” means any mortgage, charge, security interest, lien, pledge, assignment by way of security, equity, claim, right of pre-emption, option, covenant, restriction, reservation, lease, trust, order, decree, judgment, title defect (including retention of title claim), conflicting claim of ownership or any other encumbrance of any nature whatsoever (whether or not perfected other than liens arising by operation of law);

“Execution Date” means the date of this agreement;

“Fundamental Warranties” means the Warranties set out in paragraphs 4, 7, 8, 10, and 24 of Schedule 4;

2

“Group Companies” means the Company and each and any of the subsidiaries from time to time and “Group Company” means any of them;

“HMRC” means HM Revenue & Customs;

“Intellectual Property” means copyrights and related rights, trade marks and service marks, business and trade names, rights in logos and get-up and trade dress, goodwill and the right to sue for passing off or unfair competition, rights in inventions, rights to use and protect the confidentiality of confidential information (including trade secrets and Know How), registered designs, design rights, Patents, utility models, semi-conductor topographies, all rights of whatsoever nature in computer software and data, all rights of privacy and all other intellectual property or other intangible rights and privileges, and rights of a nature similar or allied to any of the foregoing, in every case which subsists now or in the future in any part of the world and whether or not registered, and including all granted registrations and all applications for registration, and rights to apply for and be granted, renewals and extensions of, and rights to claim priority from, any such rights;

“NASDAQ” means the NASDAQ Stock Market of the NASDAQ OMX Group Inc.;

“ New Shares” means the Series A2 Shares to be subscribed for by the Investors pursuant to clause 3.1;

“Non-US Subsidiary” means any subsidiary of the Company that is formed or organised outside of the United States;

“Ordinary Shares” has the meaning set out in the Articles;

“PFIC” means a “passive foreign investment company” as defined Section 1297 of the U.S. Internal Revenue Code of 1986, as amended;

“Registration Rights Agreement” means the Amended and Restated Registration Rights Agreement among the Company, the Investors and the other parties thereto, in the form of Exhibit 1 attached hereto.

“Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by any Governmental Authority of the United States, (including those administered by the Office of Foreign Assets Control of the U.S. Treasury Department or the U.S. Department of State), the United Nations Security Council, the European Union, any European Union member state, or the United Kingdom;

“Securities” means, collectively, the New Shares, the Warrants, and the Ordinary Shares issuable upon conversion of the New Shares and upon exercise of the Warrants;

“Series A1 Shares” means series A1 redeemable preference shares of US$0.0001 each in the capital of the Company from time to time having the rights set out in the Articles

3

“Series A2 Shares” means series A2 redeemable preference shares of US$0.0001 each in the capital of the Company from time to time having the rights set out in the Articles;

“Shareholder” means any shareholder of the Company from time to time (but excludes the Company holding Treasury Shares from time to time) and the term “Shareholders” shall be construed accordingly;

“Shares” means the Ordinary Shares, the Series A1 Shares and the Series A2 Shares;

“Subscriber Majority” means Investors who have subscribed, in aggregate, for at least 50 per cent of the New Shares under clause 3.1;

“Subscription Price” means US$6,480.68 per New Share;

“Subsidiary” means, with respect to any Person, any corporation, company, partnership, association or other business entity of which (a) if a corporation or company, a majority of the total voting power of capital shares entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, association or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.

“Taxation” means and includes all forms of taxation, and statutory and governmental, state, provincial, local governmental or municipal charges, duties, rates, levies, contributions, withholdings, deductions, liabilities to account, and imposts, VAT and any other taxes, whether imposed in the United Kingdom, United States or elsewhere in the world and whenever imposed and together with all related interest, penalties, charges, surcharges, or costs;

“Taxing Authority” means HMRC and any other governmental, state, federal, provincial, local governmental or municipal authority, body or official whether of the United Kingdom, United States or elsewhere in the world, which is competent to impose or collect Taxation;

“Treasury Shares” means shares in the capital of the Company held by the Company as treasury shares;

“VAT” means (i) value added tax as defined under the VATA (ii) any tax imposed in compliance with the Council Directive of 28 November 2006 on the common system of value added tax (EC Directive 2006/112); and (iii) all Tax of a similar nature levied in any jurisdiction and whether in addition to or in substitution for it;

“VATA” means the Value Added Tax Act 1994;

“Warranties” means the warranties given pursuant to clause 5 (references to a particular warranty being to a statement set out in 4) and “Warranty” shall be construed accordingly; and

“Warrants” means the warrants to purchase Ordinary Shares to be subscribed by the Investors pursuant to clause 3.1.

4
2. Interpretation
2.1. Unless otherwise defined in this agreement or the context otherwise requires, words and expressions defined<br>in the Articles have the same respective meanings in this agreement.
--- ---
2.2. Words and expressions which are defined in the Act (to the extent applicable) shall have the<br> meanings attributed to them therein when used in this agreement unless otherwise defined (in this agreement or in the Articles) or<br> the context otherwise requires.
--- ---
2.3. Clause and paragraph headings and the table of contents are used for convenience only and shall not affect<br>the construction or interpretation of this agreement.
--- ---
2.4. References to persons shall include individuals, bodies corporate, unincorporated associations, trusts,<br>joint ventures and partnerships, in each case whether or not having a separate legal personality.
--- ---
2.5. Reference to a “party” or “parties” is to a party or parties to<br>the agreement and any person that has entered into an adherence agreement to this agreement.
--- ---
2.6. References to documents “in the agreed form” are to documents in terms agreed on behalf<br>of the Company and the Lead Investor.
--- ---
2.7. References to any statute or other legislation or legal term for any action, remedy, method of judicial<br>proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than<br>the Cayman Islands, be deemed to include a reference to that which most nearly approximates to the Cayman Islands legal term in that jurisdiction.
--- ---
2.8. References to those of the parties that are individuals include their respective legal personal representatives.
--- ---
2.9. References to “writing” or “written” includes any non-transitory<br>form of visible reproduction of words.
--- ---
2.10. The words “include”, “including” and “in particular”<br>(or any similar term) are to be construed as being by way of illustration or emphasis only and not to be construed so as to limit generally<br>any words preceding them and general words introduced by the word “other” (or any similar term) shall not be given a restrictive<br>meaning by reason of the fact that they are preceded or followed by words indicating a particular class of acts, matters or things.
--- ---
2.11. Reference to “issued Shares” of any class shall exclude any Shares of that class held<br>as Treasury Shares from time to time, unless stated otherwise.
--- ---
2.12. Reference to the “holders” of Shares or a class of Share shall exclude the Company<br>holding Treasury Shares from time to time, unless stated otherwise.
--- ---
2.13. Words denoting the singular include the plural and vice versa and reference to one gender includes the<br>other gender and neuter and vice versa.
--- ---
2.14. References to statutory provisions or enactments shall include references to any amendment, modification,<br>extension, consolidation, replacement or re-enactment of any such provision or enactment (whether before or after the Execution Date),<br>instrument or order or other subordinate legislation made under such provision or enactment unless any such change imposes upon any party<br>any liabilities or obligations which are more onerous than as at the Execution Date.
--- ---
2.15. Reference to a time of day is unless otherwise specifically stated a reference to the time in the Cayman<br>Islands.
--- ---
2.16. References to the time of day or date shall unless otherwise specifically stated be construed as references<br>to the time or date prevailing in the Cayman Islands.
--- --- 
5
2.17. References in clause 1 (Definitions) (in so far as they are used in the clauses and schedules referred<br>to in this clause), clause 5 (Warranties) and Schedule 4 (Warranties) to the Company and the Board shall include, where appropriate in<br>the context, each of the subsidiaries and any holding company and the directors for the time being of those subsidiaries and any holding<br>company respectively.
3. Subscriptions
3.1. Subject to the provisions of clauses 4.1 to 4.2 (inclusive), each Investor set out below applies for the<br>allotment and issue to it at Completion of the following New Shares and a Warrant exercisable for the following number of Ordinary Shares<br>as set out in the table below at the Subscription Price and the Company accepts such application:
--- ---
Investor No. of New Shares No. of Ordinary Shares Issuable Upon Exercise of Warrant Total subscription monies (USD)
--- --- --- ---
3.2. Each Investor shall be entitled to direct that its New Shares or Warrant be issued and registered in the<br>name of any nominee or custodian holding such New Shares or Warrant on its behalf as bare nominee and the provisions of clauses 3.1 and<br>4 (Completion) shall be interpreted accordingly.
--- ---
4. Completion
4.1. The closing of the purchase and sale of New Shares and Warrants hereunder (the “Completion”)<br>shall occur on the date of, and immediately prior to, the Transaction Closing. Not less than five Business Days prior to the anticipated<br>date of the Transaction Closing, the Company shall provide written notice to the Investors (the “Closing Notice”) of<br>such anticipated Transaction Closing date. The Investors shall deliver, at least one Business Day prior to the anticipated date<br>of the Transaction Closing (or such other date as the Company and Investors may agree upon in writing), the aggregate Subscription Price<br>to the Company, by wire transfer of immediately available funds, in accordance with instructions set forth in the Closing Notice. In<br>the event the Transaction Closing does not occur within ten Business Days after the anticipated date identified in the Closing Notice,<br>the Company shall promptly (but not later than two Business Days thereafter unless an Investor has not provided or confirmed its account<br>details within such period) return the Subscription Price to the Investors by wire transfer in immediately available funds to the account<br>specified by the Investors. Notwithstanding such return, unless and until this agreement has been terminated in accordance with its<br>terms, the Investors shall remain obligated to redeliver the Subscription Price to the Company following the Company’s delivery<br>to the Investors of a new Closing Notice; provided that only one new Closing Notice may be issued unless otherwise agreed in writing by<br>the Investors.
--- --- 
6
4.2. At Completion, upon satisfaction (or, if applicable, waiver) of the conditions set forth in this Section<br>4, the Company will issue the New Shares and Warrants listed in the table in clause 3.1 to each Investor, credited as fully paid and enter<br>its name in the register of members in respect of such New Shares and Warrants and at the Transaction Closing the New Shares and Warrants<br>will be converted into shares and warrants of PubCo and delivered to the Investor in book entry form in accordance with the provisions<br>of the Business Combination Agreement.
4.3. At Completion, each Investor will, upon execution and delivery thereof, become party to the Registration<br>Rights Agreement.
--- ---
4.4. The Company’s obligations to issue the New Shares and Warrants at Completion are subject to the<br>fulfillment or (to the extent permitted by applicable law) written waiver by the Company and PubCo, at or prior to Completion, of each<br>of the following conditions:
--- ---
(a) the Investors shall have performed, satisfied and complied in all material respects with the covenants,<br>agreements and conditions required by this agreement to be performed, satisfied or complied with by the Investors at or prior to the Completion;
--- ---
(b) all conditions precedent to the Transaction Closing set forth in the Business Combination Agreement shall<br>have been satisfied or waived as determined by the parties to the Business Combination Agreement (other than those conditions which, by<br>their nature, are to be satisfied by a party to the Business Combination Agreement at the Transaction Closing, but subject to satisfaction<br>or waiver by such party of such conditions as of the Transaction Closing) and the Transaction Closing shall have been or will be scheduled<br>to occur promptly after the Completion;
--- ---
(c) there shall not be in force any law, rule, regulation, order, judgment, injunction, decree, writ, stipulation,<br>determination or award, in each case, entered by or with any governmental authority, statute, rule or regulation enjoining or prohibiting<br>the consummation of the sale of the Securities pursuant hereto; and
--- ---
(d) the Investors shall have delivered the aggregate Subscription Price and counterpart signatures to the<br>Registration Rights Agreement and the Warrant and any other Transaction Documents required to be executed by the Investors pursuant hereto.
--- ---
4.5. The Investors’ obligations to purchase the Securities at the Completion are subject to the fulfillment<br>or (to the extent permitted by applicable law) written waiver by the Investors, at or prior to the Completion, of each of the following<br>conditions:
--- ---
(a) the warranties made by the Company in Schedule 4 hereof shall be true and correct in all material respects<br>(other than warranties that are qualified as to materiality or Material Adverse Effect, which warranties shall be true and correct in<br>all respects) at and as of the Completion with the same force and effect as if they had been made at and as of the Completion (except<br>to the extent that any such warranty expressly speaks as of an earlier date, in which case such warranty shall be true and correct in<br>all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect, which<br>representations and warranties shall be true and correct in all respects) as of such earlier date) and consummation of the Completion<br>shall constitute a reaffirmation by the Company of each of the warranties and agreements of the Company contained in Schedule 4 as of<br>the Completion, but without giving effect to consummation of the Transaction, or as of such earlier date, as applicable;
--- ---
(b) the Company shall have performed, satisfied and complied in all material respects with the covenants,<br>agreements and conditions required by this agreement to be performed, satisfied or complied with by the Investors at or prior to the Completion;
--- --- 
7
(c) all conditions precedent to the Transaction Closing set forth in the Business Combination Agreement shall<br>have been satisfied or waived as determined by the parties to the Business Combination Agreement (other than those conditions which, by<br>their nature, are to be satisfied by a party to the Business Combination Agreement at the Transaction Closing, but subject to satisfaction<br>or waiver by such party of such conditions as of the Transaction Closing) and the Transaction Closing shall have been or will be scheduled<br>to occur promptly after the Completion;
(d) there shall not be in force any law, rule, regulation, order, judgment, injunction, decree, writ, stipulation,<br>determination or award, in each case, entered by or with any governmental authority, statute, rule or regulation enjoining or prohibiting<br>the consummation of the sale of the Securities pursuant hereto; and
--- ---
(e) the Business Combination Agreement shall not have been amended, modified, supplemented or waived in a<br>manner that would reasonably be expected to materially and adversely affect the economic benefits that the Investor would reasonably expect<br>to receive under this agreement.
--- ---
5. Warranties and Indemnity
5.1. The Company warrants to each Investor that each Warranty is true, accurate and not misleading at the Execution<br>Date and at Completion, subject only to:
--- ---
(a) the matters Disclosed; and
--- ---
(b) any exceptions expressly provided for under this agreement.
--- ---
5.2. Each Warranty is a separate and independent warranty, and, save as otherwise expressly provided, no Warranty<br>shall be limited by reference to any other Warranty or by the other terms of this agreement.
--- ---
5.3. The rights and remedies of the Investors in respect of any breach of any of the Warranties shall not be<br>affected by Completion, any investigation made by or on behalf of the Investors into the affairs of the Company or any other event or<br>matter whatsoever which otherwise might have affected such rights and remedies except a specific and duly authorised written waiver or<br>release.
--- ---
5.4. No information relating to the Company of which an Investor has knowledge (actual or constructive) other<br>than by reason of it being Disclosed in accordance with clause 5.1(a) shall prejudice any Claim which such Investor shall be entitled<br>to bring or shall operate to reduce any amount recoverable by such Investor under this agreement.
--- ---
5.5. Where any Warranty is qualified by the expression “so far as the Company is aware”<br>or words having similar effect, such Warranty shall be deemed to include a statement that such awareness means the actual knowledge of<br>either the Chief Executive Officer or Chief Operating Officer of the Company.
--- ---
5.6. Without limiting anything to the contrary in clause 5.7, the Investors agree among themselves that the<br>following provisions shall (unless they subsequently agree amongst themselves to the contrary acting by way of a Subscriber Majority)<br>apply in relation to the bringing of any Claim:
--- ---
(a) no Claim shall be brought by any of the Investors without the prior written consent of a Subscriber Majority;
--- ---
(b) unless otherwise agreed among the Investors, the costs incurred by any Investor(s) in bringing a Claim<br>shall be borne by all of the Investors participating in such Claim proportionately to the amounts subscribed by each of them for New Shares<br>and Warrants pursuant to this agreement; and
--- --- 
8
(c) unless otherwise agreed among the Investors, any damages obtained as a result of any Claim will, after<br>deduction of all costs and expenses, be divided amongst the Investors in such proportions.
5.7. The Company undertakes to indemnify and hold harmless each Investor, its Affiliates and each of its and<br>their directors, officers and employees (the “Indemnified Persons”) from and against, and shall pay to such Investor<br>or the relevant Indemnified Person(s) (as applicable) (by way of telegraphic transfer of immediately available cleared funds to such account<br>as may be notified to the Company by such Indemnified Person from time to time) a sum equal to: (i) any and all Losses directly suffered<br>or incurred by any Indemnified Person(s); and (ii) the Relevant Percentage of any Losses directly suffered or incurred by any Group Company,<br>in each case arising out of and/or relating to a breach of any of the Warranties made by the Company in this agreement (unless such Losses<br>are primarily based upon a material breach of such Indemnified Person’s representations, warranties or covenants under this agreement<br>or any conduct by such Indemnified Person which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
--- ---
5.8. For the purposes of clause 5.7:
--- ---
(a) “Losses” means any and all liabilities, damages, losses, Taxation, fines (including<br>all interest and penalties), expenses and costs reasonably and properly incurred (including all reasonably and properly incurred legal<br>costs and other reasonably and properly incurred professional costs and expenses); and
--- ---
(b) “Relevant Percentage” means the percentage of the Company’s issued share capital<br>that the New Shares of such Investor represent immediately following Completion.
--- ---
5.9. The indemnity in clause 5.7 applies whether or not any Indemnified Person has been negligent or at fault.
--- ---
5.10. If a payment due from the Company under clause 5.7 is subject to Taxation (whether by way of direct assessment<br>or withholding at its source), the amount of the payment shall be increased to ensure that the net receipt, after Taxation, to the Indemnified<br>Person is the same as it would have been were the payment not subject to Taxation.
--- ---
5.11. Aside from any claim for injunctive or other equitable relief and any claim alleging fraud, the parties<br>agree that the indemnification provided in clause 5.7 shall be the sole and exclusive remedy for any breach of any of the Warranties.
--- ---
6. Limitations on Claims
6.1. The limitations set out in this clause 6 shall not apply to any Claim which is:
--- ---
(a) the consequence of fraud, dishonesty, wilful concealment or wilful misrepresentation by or on behalf of<br>the Company; or
--- ---
(b) a result of a breach of any Fundamental Warranty.
--- ---
6.2. No Claim may be made by an Investor against the Company unless written notice of such Claim is served<br>by such Investor on the Company, giving reasonable details of the Claim, on or prior to the earlier of within the 12 month period after<br>Completion.
--- ---
6.3. The aggregate liability of the Company in respect of all and any Claims shall be limited to an amount<br>equal to the aggregate amount subscribed for the New Shares and Warrants by the Investor pursuant to this agreement.
--- ---
6.4. Without prejudice to the overall cap set out in clause 6.3 above, in respect of any Claim(s) that is or<br>are brought by only some Investors, the aggregate liability of the Company in respect of all such Claims shall be limited to an amount<br>equal to the aggregate amount subscribed for the New Shares pursuant to this agreement by those Investors bringing the Claim(s).
--- --- 
9
6.5. No liability of the Company in respect of any breach of any Warranty shall arise:
(a) to the extent that such breach occurs by reason of any matter which would not have arisen but for the<br>coming into force of any legislation not in force at the Execution Date or by reason of any change to existing legislation, HMRC’s<br>practice (or that of any other relevant Taxing Authority) or in rates of Taxation occurring after the Execution Date; and/or
--- ---
(b) to the extent that such breach or claim arises as a result of any change in the accounting bases or policies<br>in accordance with which the Company values its assets or calculate its liabilities or any other change in accounting practice from the<br>treatment or application of the same used in preparing the Accounts (save to the extent that such changes are required to correct errors<br>or because relevant generally accepted accounting principles have not been complied with).
--- ---
6.6. The Investors shall be entitled to make a Claim in respect of liability which is contingent or unascertained<br>provided that written notice of the Claim (giving as far as practical the amount and details of the Claim) is given by such Investors<br>to the Company before the expiry of the relevant period specified in clause 6.2 and the Company shall not be liable to make any payment<br>in respect of such Claim unless and until the liability becomes an actual liability or (as the case may be) becomes capable of being quantified.
--- ---
6.7. Notwithstanding anything to the contrary in this agreement, except in the case of fraud or willful misconduct,<br>the Company shall not be obligated to indemnify any Indemnified Person under clause 5.7, unless the aggregate Losses incurred by the Indemnified<br>Person seeking indemnity as a result of all Losses that would otherwise be subject to indemnification under clause 5.7 exceeds US$100,000,<br>in which case such Indemnified Person shall only be entitled to indemnification for the portion of its Losses that exceeds US$100,000.
--- ---
6.8. Notwithstanding anything in this Agreement to the contrary, for purposes of determining whether an Indemnified<br>Person is entitled to indemnification under clause 5.7, as well as the amount of Losses recoverable by an Indemnified Person pursuant<br>to clause 5.7, each of the qualifications as to “material”, “materiality” or “material adverse effect”<br>and words of similar import (other than specific monetary thresholds) in the terms of such warranties listed on Schedule 4 shall be disregarded.
--- ---
6.9. Nothing in this agreement shall prejudice an Investor’s duty under common law to mitigate any loss<br>or liability which is the subject of a Claim.
--- ---
7. Announcements
7.1. Except in accordance with clause 7.2, the parties shall not make any public announcement or issue a press<br>release or respond to any enquiry from the press or other media concerning or relating to this agreement or its subject matter (including<br>the Investors’ investment in the Company) or any ancillary matter.
--- ---
7.2. Notwithstanding clause 7.1, any party (or in the case of an Investor, the general partner or investment<br>manager of the Investor) may make or permit to be made an announcement concerning or relating to this agreement or its subject matter<br>or any ancillary matter with:
--- ---
(a) the prior written approval of the Board; or
--- ---
(b) if and to the extent required by:
--- ---
(i) law;
--- ---
(ii) any securities exchange on which such party’s securities are listed or traded;
--- --- 
10
(iii) any regulatory or governmental or other authority with relevant powers to which such party is subject<br>or submits, whether or not the requirement has the force of law, including (but without prejudice to the terms of the Business Combination<br>Agreement) submissions and filings to the U.S. Securities and Exchange Commission and/or Nasdaq in furtherance of the Business Combination;
(iv) any Taxing Authority in the ordinary course of the disclosing party’s Taxation affairs; or
--- ---
(v) any court order.
--- ---
8. Costs and expenses

The parties shall bear their own costs and disbursements incurred in the negotiations leading up to and in the preparation of this agreement and of matters incidental to this agreement.

9. Cumulative remedies

The rights, powers, privileges and remedies conferred upon the Investors in this agreement are cumulative and are not exclusive of any other rights, powers, privileges or remedies provided by law.

10. Waiver
10.1. The express or implied waiver by any party to this agreement of any of its rights or remedies arising<br>under this agreement or by law shall not constitute a continuing waiver of the right or remedy waived or a waiver of any other right or<br>remedy.
--- ---
10.2. Any waiver of any breach of, or any default under, any of the terms of this agreement will not be deemed<br>a waiver of any subsequent breach or default and will in no way affect the other terms of this agreement.
--- ---
10.3. In no event will any delay, failure or omission (in whole or part) in enforcing, exercising or pursuing<br>any right, power, privilege, claim or remedy conferred by or arising under this agreement or by law, be deemed to be or be construed as<br>a waiver of that or any other right, power, privilege, claim or remedy in respect of the circumstances in question, or operate so as to<br>bar the enforcement of that, or any other right, power, privilege, claim or remedy, in any other instance at any time or times subsequently.
--- ---
11. Entire agreement
11.1. This agreement and the documents referred to or incorporated in it constitute the entire agreement between<br>the parties relating to the subject matter of this agreement and supersede and extinguish any prior drafts, agreements, undertakings,<br>representations, warranties and arrangements of any nature whatsoever, whether or not in writing, between the parties in relation to the<br>subject matter of this agreement.
--- ---
11.2. Each of the parties acknowledges and agrees that it has not entered into this agreement in reliance on<br>any statement or representation of any person (whether a party or not) other than as expressly incorporated in this agreement and the<br>documents referred to or incorporated in this agreement.
--- ---
11.3. Without limiting the generality of the foregoing, each of the parties irrevocably and unconditionally<br>waives any right or remedy it may have to claim damages and/or to rescind this agreement by reason of any misrepresentation (other than<br>a fraudulent misrepresentation) having been made to it by any person (whether party or not) and upon which it has relied in entering into<br>this agreement.
--- ---
11.4. Each of the parties acknowledges and agrees that the only cause of action available to it under the terms<br>of this agreement and the documents referred to or incorporated in this agreement in respect of a Claim shall be for breach of contract.
--- --- 
11
11.5. Other than in respect of a Claim, each of the parties acknowledges and agrees that damages alone may not<br>be an adequate remedy for the breach of any of the undertakings or obligations as set out in this agreement. Accordingly, without prejudice<br>to any other rights and remedies the parties may have, the parties shall be entitled to seek the remedies of injunction, specific performance<br>or other equitable relief for any threatened or actual breach of the terms of this agreement.
11.6. Nothing contained in this agreement or in any other document referred to or incorporated in it shall be<br>read or construed as excluding any liability or remedy as a result of fraud.
--- ---
12. Variation and termination
12.1. All and any of the provisions of this agreement may be deleted, varied, supplemented, amended and restated<br>or otherwise changed in any way at any time with the prior written consent of the Company and the Subscriber Majority, in which event<br>such change(s) shall be binding against all of the parties hereto provided that if any such change would impose any new obligations on<br>a party, vary or remove an express contractual right of a party under this agreement or increase any existing obligation under this agreement<br>on a party, the consent of any affected party to such change shall be specifically required.
--- ---
12.2. This agreement will be terminated upon the earlier to occur of (i) termination of the Business Combination<br>Agreement or (ii) 25 August 2026. This agreement may also be terminated with the prior written consent of the Company and all Investors,<br>in which event such termination shall be binding against all of the parties hereto save that nothing in this clause shall release any<br>party from liability for breaches of this agreement which occurred prior to its termination provided that if a party has an express contractual<br>right under this agreement that is not incorporated into any replacement or successor subscription agreement, that party’s consent shall<br>be specifically required for the termination of that right.
--- ---
13. No partnership

Nothing in this agreement is intended to or shall be construed as establishing or implying any partnership of any kind between the parties.

14. Assignment and transfer
14.1. Subject to clause 14.3, this agreement is personal to the parties and no party shall:
--- ---
(a) assign any of its rights under this agreement;
--- ---
(b) transfer any of its obligations under this agreement;
--- ---
(c) sub-contract or delegate any of its obligations under this agreement; or
--- ---
(d) charge or deal in any other manner with this agreement or any of its rights or obligations,
--- ---

save that each Investor shall be entitled to delegate any of its obligations under this agreement to its general partner or the management company authorised from time to time to act on behalf of that Investor.

14.2. Any purported assignment, transfer, sub-contracting, delegation, charging or dealing in contravention<br>of clause 14.1 shall be ineffective.
14.3. Each Investor may assign the whole or part of any of its rights in this agreement to any person who has<br>received a transfer of New Shares from such Investor in accordance with the Articles and has executed an adherence agreement to this<br>agreement, in a form satisfactory to the Board, acting reasonably (provided that the amount of loss recoverable by the assignee shall<br>be no greater than it would have been had the assignment not taken place).
--- --- 
12
15. Rights of third parties
15.1. Subject to clause 15.2, this agreement does not confer any rights on any person or party (other than the<br>parties to this agreement) pursuant to the Contracts (Rights of Third Parties) Act, 2014.
--- ---
15.2. The general partner of an Investor (or any member of the same Fund Group (as defined in the Articles)<br>of the Investor) or the management company authorised from time to time to act on behalf of the Investor or another person or persons<br>nominated by the Investor, shall be entitled to enforce all of the rights and benefits of the Investor under this agreement at all times<br>as if party to this agreement.
--- ---
16. Counterparts; No originals
16.1. This agreement may be executed by each of the parties in any number of counterparts, each of which shall<br>constitute an original counterpart of this agreement, and all the counterparts shall together constitute one and the same agreement.
--- ---
16.2. The exchange of a fully executed version of this agreement (in counterparts or otherwise) by electronic<br>means using DocuSign or other electronic transmission in PDF format shall be sufficient to bind the parties to the terms and conditions<br>of this agreement and no exchange of originals is necessary.
--- ---
17. Notices
17.1. Any communication and/or information to be given in connection with this agreement shall be in writing<br>in English and shall either be delivered by hand or sent by first class post or reputable courier or email:
--- ---
(a) to the Company at its registered office or to the email address shown<br>in Schedule 2 (with a copy, which shall not constitute notice, to crystal.fang@morganlewis.com and russell.franklin@morganlewis.com)~~;or~~
--- ---
(b) to an Investor at the address or to the email address of such Investor shown in Schedule 1,
--- ---

(or in each such case such other address or email address as the recipient may notify to the other parties for such purpose).

17.2. A communication sent according to clause 17.1 shall be deemed to have been received:
(a) if delivered by hand, at the time of delivery;
--- ---
(b) if sent by pre-paid first class post or reputable courier, on the second day after posting; or
--- ---
(c) if sent by email, at the time of completion of transmission by the sender insofar as no automatic response<br>other than a temporary “out of office” reply is received by the sender within six (6) hours of transmission,
--- ---

except that if a communication is deemed received outside business hours in the place of receipt (which, in the case of service of a notice by email shall be deemed to be the same place as is specified for service of notices on the relevant party by hand or post), it shall be deferred until business hours resume. In this clause, business hours means 9:30 a.m. to 5:30 p.m. Monday to Friday on a day that is not a public holiday in the place of receipt.

18. Severance
18.1. If any provision of this agreement is held to be invalid or unenforceable by any judicial or other competent<br>authority, all other provisions of this agreement will remain in full force and effect and will not in any way be impaired.
--- --- 
13
18.2. If any provision of this agreement is held to be invalid or unenforceable but would be valid or enforceable<br>if some part of the provision were deleted, the provision in question will apply with the minimum modifications necessary to make it valid<br>and enforceable.
19. Governing law

This agreement (and any dispute or claim relating to it or its subject matter (including non-contractual claims)) is governed by and is to be construed in accordance with Cayman Islands law.

20. Jurisdiction

The parties irrevocably agree that the courts of the Cayman Islands shall have exclusive jurisdiction to settle any claim, dispute or issue (including non-contractual claims) which may arise out of or in connection with this agreement.

21. Regulatory matters

Neither the Investors nor any general partner of an Investor or management company authorised from time to time to act on behalf of an Investor is acting for or advising any other party to the transaction that is the subject of this agreement or undertaking any other activity in relation to that other party that implies in any way that the other party is a client and accordingly no such Investor, general partner of such Investor and/or management company of such Investor (as appropriate) shall be responsible to any other party for providing any protection afforded to any client (as defined in the Glossary to the FCA Handbook of rules and guidance) for such Investor.

22. US securities laws requirements

Each Investor acknowledges and warrants separately for itself and in respect of its own position, to the Company, for the purpose of compliance with the United States Securities Act of 1933, as amended (the “Securities Act”) and state securities laws, as follows:

(a) the Investor acknowledges that the Securities have not been registered under the Securities Act, or any<br>state securities laws on the basis that the Company is relying on an exemption from registration under such laws that depends in part<br>on the representations made by the Investor pursuant to this clause, and that the transferability of the Securities is therefore subject<br>to restrictions imposed by those laws;
(b) the Investor agrees not to sell or otherwise transfer the Securities insofar as the Securities Act restricts<br>such sale or transfer unless they are registered under the Securities Act and United States state securities laws of the applicable jurisdiction<br>or unless an exemption from registration is available;
--- ---
(c) the Investor has either a residence or business address as set out in Schedule 1; all offers of the Securities<br>were made to the Investor at that address or elsewhere outside of the United States; no offer or solicitation was made to the Investor<br>in any jurisdiction other than that jurisdiction or elsewhere outside of the United States; and the Investor accepted the offer to purchase<br>Securities by executing this agreement or an adherence agreement to this Agreement within that jurisdiction; and prior to such acceptance,<br>the Investor did not accept the offer in any other jurisdiction, orally, in writing, or otherwise;
--- ---
(d) no ‘bad actor’ disqualifying events described in Rule 506(d)(1)(i)-(viii) promulgated under the Securities<br>Act (each, a “Disqualification Event”) is applicable to the Investor or any of its Rule 506(d) Related Parties, except,<br>if applicable for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For the purposes of this agreement,<br>“Rule 506(d) Related Party” shall mean a person or entity covered by the “Bad Actor disqualification” provision<br>of Rule 506(d) of the Securities Act;
--- --- 
14
(e) the Investor hereby agrees that it shall notify the Company promptly in writing in the event a Disqualification<br>Event becomes applicable to the Investor or any of its Rule 506(d) Related Parties, except, if applicable, for a Disqualification Event<br>as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable;
(f) the Investor that is a “U.S. Person” (within the meaning of Rule 902 of Regulation S promulgated<br>under the Securities Act) is an “accredited investor” within the definition set forth in Rule 501(a) under the Securities Act;
--- ---
(g) the Investor that is a “U.S. Person” acknowledges that the Investor has experience in making<br>investments such as those in the Company and is able to bear the economic risk of the investment for an indefinite period of time because<br>the Securities have not been registered under the Securities Act, and therefore, must (to the extent the Securities Act restricts a transfer<br>of the Securities) be held unless they are subsequently registered under the Securities Act or an exemption from such registration is<br>available;
--- ---
(h) the Investor acquired the Securities for its own account for investment and not for the account of another<br>nor with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities<br>Act, the state securities laws of any applicable jurisdiction, or the rules and regulations promulgated thereunder and, if the Investor<br>is an entity, the Investor was not formed for the specific purpose of acquiring the Securities; and
--- ---
(i) the Investor believes that it has received all the information it considers necessary or appropriate for<br>deciding whether to purchase the Securities pursuant to this agreement. The Investor has had an opportunity to ask questions and receive<br>answers from the Company regarding the terms and conditions of the issue of the Securities and the business, properties and financial<br>condition of the Company. The foregoing, however, does not in any way limit or modify the Warranties.
--- ---
23. Information and taxation matters
23.1. The Company shall keep the Investors reasonably informed in a timely manner of all material developments<br>concerning the affairs, business and prospects of the Group Companies.
--- ---
23.2. The Company shall provide to each Investor such information as the Investor may reasonably request at<br>any time or from time to time in order to permit the Investor to determine whether the Company or any Non-US Subsidiary has been or may<br>become a PFIC or a “controlled foreign corporation” as defined in Section 957 of the Code (“CFC”), in each<br>case, or any similar or analogous provisions of the laws of the United States, any state or other jurisdiction thereof, or any non-US<br>jurisdiction, and to determine the consequences to the Investors or any of its direct or indirect owners of such status, and all such<br>other information that is reasonably requested or necessary for an Investor in order to satisfy any applicable tax reporting or tax compliance<br>requirements, reduce or eliminate withholding or other taxes, duly complete and file its tax returns or make any claims or elections in<br>respect of tax. If the Company or any Non-US Subsidiary is determined to be a PFIC, the Company shall timely provide, and shall cause<br>any such Non-US Subsidiary to timely provide, to the Investors such information reasonably necessary to make or maintain any election<br>available under the Code related to such PFIC status, including making and maintaining a “qualified electing fund” (“QEF”)<br>election with respect to the Company or such Non-US Subsidiary. Information necessary or desirable to permit an Investor or its direct<br>or indirect owners to make a QEF election with respect to the Company or any Non-US Subsidiary shall be provided to the Investors within<br>ninety (90) days after the end of each fiscal year or at such other times as an Investor may request.
--- --- 
15
24. RSUs.
24.1. It is acknowledged by the Investors that the Company intends to enter into definitive documentation relating<br>to the agreed term sheet in the form appended to this agreement as Exhibit 2 in respect of the grant of certain restricted stock unit<br>awards (the RSU Awards and each, an RSU Award) to Peter Carr and Ryan Bibbo (the Grantees and each, a Grantee),<br>as may be approved by the board of directors of the Company from time to time, over certain Ordinary Shares (in such number as may be<br>agreed by the board of directors of the Company from time to time, and up to a maximum of 3,499 Ordinary Shares in aggregate and including<br>the right to receive Earnout Shares as defined in and pursuant to the Business Combination Agreement (subject to customary equitable adjustment<br>for events such as Ordinary Share splits and combinations)) in accordance with the terms of the RSU Awards. Each of the Investors hereby:
--- ---
(a) consents to, for all purposes of the Articles, the Amended and Restated Shareholders’ Agreement, and<br>applicable law, the RSU Grants and to any director or officer, or such other person(s) as may be authorised by the directors or officers<br>from time to time, doing all such further actions or procuring that such further actions are taken, as they may consider necessary or<br>convenient, to effect the RSU Grants;
--- ---
(b) acknowledges and confirms, for the avoidance of doubt, that signatures to this agreement shall constitute<br>Series A Majority Consent for purposes of the Articles, to the extent such Series A Majority Consent is required in connection with<br>the implementation of the foregoing;
--- ---
(c) acknowledges and confirms, for the avoidance of doubt, that signatures to this agreement shall constitute<br>Requisite Majority Consent for purposes of the Amended and Restated Shareholders’ Agreement, to the extent such Requisite Majority Consent<br>is required in connection with the implementation of the foregoing; and
--- ---
(d) acknowledges and confirms that:
--- ---
(i) they have no claim or right of any kind in any capacity or in any jurisdiction, whether arising under<br>the Articles (as amended or restated from time to time), the Amended and Restated Shareholders’ Agreement (as amended or restated<br>from time to time), or otherwise against the Company or any of its officers or employees in connection with the issuance of any and all<br>Ordinary Shares arising as a result of the Company effecting the RSU Grants; and
--- ---
(ii) if any such claim or right of action exists or may exist, whether in law or in equity and whether or not<br>presently known to any party or to the law, they hereby irrevocably waive such claim and release and forever discharge the Company, its<br>officers and employees from all and any liability in respect of it.
--- --- 
16

1. Schedule 1

The Investors

17

2. Schedule 2

Particulars

18

Schedule 3Members of the Company

19

Schedule4Warranties

Except as set forth in any report of PubCo (the “SEC Reports”) filed or submitted to the U.S. Securities and Exchange Commission (the “SEC”) on or prior to Completion, as applicable, and provided that no representation or warranty by the Company shall apply to any statement or information in the SEC Reports that relates to changes to historical accounting policies of the Company in connection with any order, directive, guideline, comment or recommendation from the SEC or the Company’s auditor or accountant that is applicable to the Company (collectively, the “SEC Guidance”), nor shall any correction, amendment, revision or restatement of the Company’s financial statements due wholly or in part to the SEC Guidance or any other accounting matters, nor any other effects that relate to or arise out of, or are in connection with or in response to, any of the foregoing or any changes in accounting or disclosure related thereto, be deemed to be a breach of any representation or warranty by the Company, the Company represents and warrants to the Issuers, as of the date of this agreement and as of Completion (or, if such representations and warranties are made with respect to a specified date, as of such date):

1. Valid Issuance
1.1. As of the date of the Completion, the New Shares and Warrants will be duly authorized and, when issued,<br>paid for and delivered in accordance with this agreement, will be validly issued, fully paid and non-assessable, free and clear of any<br>mortgage, pledge, security interest, right of first refusal, option, proxy, voting trust, Encumbrance, lien or charge of any kind (including<br>any conditional sale or other title retention agreement in the nature thereof), restriction (whether on voting, sale, transfer, disposition<br>or otherwise), or any filing or agreement to file a financing statement as debtor under applicable law (collectively, “Liens”)<br>or other restrictions (other than those arising under the Transaction Documents (as hereinafter defined) or applicable securities laws),<br>and will not have been issued in violation of any preemptive or similar rights created under the Articles, the Amended and Restated<br>Shareholders’ Agreement or the laws of the Company’s jurisdiction of incorporation.
--- ---
1.2. As of the date of Completion, the Ordinary Shares issuable upon conversion of the Series A1 Shares, Series<br>A2 Shares and exercise of the Warrants will be duly authorized and, when issued, paid for and delivered in accordance with the Articles<br>and, as applicable, the Warrants, will be validly issued, fully paid and non-assessable, free and clear of all Liens or other restrictions<br>(other than those arising under the Transaction Documents (as hereinafter defined) or applicable securities laws), and will not have been<br>issued in violation of any preemptive or similar rights created under the Company’s Articles, the Amended and Restated Shareholders’<br>Agreement or applicable securities laws or the laws of Company’s jurisdiction of incorporation.
--- ---
2. No General Solicitation. Neither the Company nor any person acting on its behalf has engaged in<br>any form of general solicitation or general advertising (within the meaning of Regulation D promulgated under the Securities Act) in connection<br>with any offer or sale of the Securities. The Securities are not being offered in a manner involving a public offering under, or in a<br>distribution in violation of, the Securities Act or any state securities laws. Neither the Company nor any person acting on the Company’s<br>behalf has, directly or indirectly, at any time within the past six (6) months, made any offer or sale of any security or solicitation<br>of any offer to buy any security under circumstances that would cause the offering of the Securities pursuant to this agreement to be<br>integrated with prior offerings by the Company for purposes of the Securities Act or any applicable shareholder approval provisions. Neither<br>the Company nor any person acting on the Company’s behalf has offered or sold any securities, or has taken any other action, which<br>would reasonably be expected to subject the offer, issuance or sale of the Securities, as contemplated hereby, to the registration provisions<br>of the Securities Act.
--- --- 
20
3. Disqualification Events. No Disqualification Event is applicable to the Company, except for a Disqualification<br>Event as to which Rule 506(d)(2)(ii–iv) or (d)(3) is applicable. For the purposes of the foregoing, “Disqualification Event”<br>means a ‘bad actor’ disqualifying events described in Rule 506(d)(1)(i)-(viii) promulgated under the Securities Act.
4. Organization and Standing.
--- ---
4.1. The Company is an exempted company duly incorporated, validly existing and in good standing under the<br>laws of the Cayman Islands and has all requisite corporate or other entity power and authority to own, lease and operate its properties<br>and to carry on its business as now being conducted, in each case, except where the failure to be in good standing or to have such corporate<br>power and authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect<br>on the Company. “Material Adverse Effect” means, with respect to any specified Person, any fact, event, occurrence,<br>change or effect that has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon<br>(a) the business, assets, liabilities, results of operations or financial condition of such Person and its Subsidiaries, taken as a whole,<br>or (b) the ability of such Person or any of its Subsidiaries to consummate the transactions contemplated hereby or in connection with<br>the Business Combination (the “Transactions”) or to perform its obligations under this agreement, the Business Combination<br>Agreement, the Amended and Restated Shareholders’ Agreement, the Articles, the Warrants, or the subscription agreement dated<br>as of the date hereof between the Company and the investors named therein for the purchase of certain Series A1 Shares and warrants exercisable<br>for Ordinary Shares (the “Pre-Funded Subscription Agreement” and, together with this agreement, the Business Combination<br>Agreement, the Amended and Restated Shareholders’ Agreement, the Articles, the Warrants, the “Transaction Documents”)<br>to which it is party; provided, however, that for purposes of clause (a) above, any fact, event, occurrence, change or effect directly<br>or indirectly attributable to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any<br>other, facts, events, occurrences, changes or effects) shall not be deemed to be, constitute, or be taken into account when determining<br>whether there has or may or would have occurred a Material Adverse Effect: (i) general global, national, regional, state or local changes<br>in the financial or securities markets (including changes in interest or exchange rates, prices of any security or market index or commodity<br>or any disruption of such markets) or general economic or political or social conditions in the country or region in which such Person<br>or any of its Subsidiaries do business, (ii) changes, conditions or effects that generally affect the industries in which such Person<br>or any of its Subsidiaries operate, (iii) changes or proposed changed in GAAP, IFRS or other applicable accounting principles or mandatory<br>changes in the regulatory accounting requirements (or any interpretation thereof) applicable to any industry in which such Person and<br>its Subsidiaries principally operate, (iv) conditions caused by acts of God, epidemic, pandemics, terrorism, war (whether or not declared),<br>natural or man-made disaster (including fires, flooding, earthquakes, hurricanes and tornados), civil unrest, terrorism or other force<br>majeure or comparable events, (v) any failure in and of itself by such Person and its Subsidiaries to meet any internal or published budgets,<br>projections, forecasts or predictions of financial performance for any period (provided that the underlying cause of any such failure<br>may be considered in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent<br>not excluded by another exception herein), (vi) changes attributable to the public announcement or pendency of the Transactions (including<br>the impact thereof on relationships with customers, suppliers or employees), (vii) changes or proposed changes in applicable law (or any<br>interpretation thereof) after the date of this agreement, (viii) any actions required to be taken, or required not to be taken, pursuant<br>to the terms of this agreement, and (ix) in respect of the Company, any action taken by, or at the written request of, Investor and in<br>respect of Investor, any action taken by, or at the written request of, the Company; provided further, however, that any event, occurrence,<br>fact, condition, or change referred to in clauses (i)-(iv) immediately above shall be taken into account in determining whether a Material<br>Adverse Effect has occurred or would reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change<br>has a disproportionate effect on such Person and its Subsidiaries, taken as a whole, compared to other participants in the industries<br>and geographic location in which such Person or any of its Subsidiaries conducts its businesses (in which case only the incremental disproportionate<br>impact may be taken into account).
--- --- 
21
4.2. Each subsidiary of the Company (each a “Company Subsidiary” and, together with the<br>Company, the “Target Companies”) is a corporation or other entity duly formed, validly existing and in good standing<br>under the laws of its jurisdiction of organization and has all requisite corporate or other entity power and authority to own, lease and<br>operate its properties and to carry on its business as now being conducted. Each Target Company (other than the Company) is qualified<br>or licensed and in good standing (to the extent such concept exists) to do business in each jurisdiction in which the character of the<br>property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary,<br>except in each case where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, has not had<br>and would not reasonably be expected to have a Material Adverse Effect on the Company.
4.3. No Target Company is in violation of any provision of its Organizational Documents in any material respect.
--- ---
5. Capitalization.
--- ---
5.1. As of the date of this agreement, the issued share capital of the Company<br>is as set forth in Part 1 of Schedule 2. The Company has also issued warrants as set forth in Part 1 of Schedule 2, and there are no other<br>issued or outstanding equity interests of the Company.
--- ---
5.2. On the date of this agreement, the Company shareholders listed in the Disclosure Schedules are the legal<br>and beneficial owners of all of the Ordinary Shares, with each such Company shareholder owning the Ordinary Shares set forth opposite<br>the name of such Company shareholder in the corresponding column of the Disclosure Schedules. The Ordinary Shares are owned by each such<br>Company shareholder free from any Liens other than those imposed under the Company’s Organizational Documents, which can be removed<br>by the Company and its shareholders without penalty or applicable securities laws.
--- ---
5.3. On the date of this agreement, the Company shareholders listed in the Disclosure Schedules are the legal<br>and beneficial owners of all of the Series A1 Shares, with each such Company shareholder owning the Series A1 Shares set forth opposite<br>the name of such Company shareholder in the corresponding column of the Disclosure Schedules. The Series A1 Shares are owned by each such<br>Company shareholder free from any Liens other than those imposed under the Company’s Organizational Documents, which can be removed<br>by the Company and its shareholderswithout penalty or applicable securities laws.
--- ---
5.4. All of the Company’s issued Shares have been duly authorized and are fully paid and not in violation<br>of any purchase option, right of first refusal, pre-emptive right, subscription right or any similar right under any provision of the<br>Cayman Companies Law, any other applicable law, the Company’s Organizational Documents or any contract to which the Company is a<br>party or by which the Company or its securities are bound.
--- ---
6. As of the date of this agreement, no Target Company currently has any stock option or other equity incentive<br>plans. As of the date of this agreement, other than the securities contemplated in connection with this agreement and the other Transaction<br>Documents, there are no Company convertible securities or pre-emptive rights or rights of first refusal or first offer, except for those<br>rights as provided in the Company’s Organizational Documents which have been disapplied and waived by the Company shareholders,<br>nor are there any contracts, commitments, arrangements or restrictions to which the Company or any of the Company shareholders or any<br>of their respective Affiliates are a party or bound relating to any equity securities of the Company, whether or not outstanding, other<br>than the Company’s Organizational Documents. As of the date of this agreement, other than this agreement and the other Transaction<br>Documents, there are no outstanding or authorized equity appreciation, phantom equity or similar rights with respect to the Company and<br>there are no voting trusts, proxies, shareholder agreements or any other written agreements or understandings with respect to the voting<br>or transfer of any of Ordinary Shares other than the Company’s Organizational Documents. As of the date of this agreement, other<br>than this agreement or as set forth in the Company’s Organizational Documents, there are no outstanding contractual obligations<br>of the Company to repurchase, redeem or otherwise acquire any of its equity interests or securities, nor has the Company granted any registration<br>rights to any Person with respect to its equity securities. As of the date of this agreement, all of the issued and outstanding securities<br>of the Company have been granted, offered, sold and issued in compliance with all applicable laws. As a result of the consummation of<br>the Transactions, no equity interests of the Company are issuable and no rights in connection with any interests, warrants, rights, options<br>or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or<br>otherwise).
--- --- 
22
7. Due Authorization and Enforceability. The execution and delivery of this agreement and each of<br>the other Transaction Documents by the Company and the consummation by the Company of the transactions contemplated hereby and<br>thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company,<br>its Board of Directors, or its stockholders in connection herewith or therewith. This agreement and each other Transaction Document<br>to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when duly executed by the<br>other parties thereto and delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation<br>of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and<br>applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’<br>rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies<br>and (iii) insofar as indemnification and contribution provisions may be limited by applicable law (collectively, the “EnforceabilityExceptions”).
8. Company Subsidiaries. The Disclosure Schedules set forth the name of each Company Subsidiary, and<br>with respect to each Company Subsidiary on the date of this agreement (a) its jurisdiction of organization, (b) the class(es) of its authorized<br>shares or other equity interests (if applicable), and (c) the ownership percentage of issued and outstanding shares or other equity interests<br>by the record holders thereof. The foregoing represents all of the issued and outstanding equity interests of the Company Subsidiaries<br>as of the date of this agreement. All of the outstanding equity securities of each Company Subsidiary are duly authorized and validly<br>issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered in compliance with all applicable laws, and<br>owned by one or more of the Target Companies free and clear of all Liens (other than those, if any, imposed by such Company Subsidiary’s<br>Organizational Documents or applicable laws), except where the failure to be would not, individually or in the aggregate, reasonably be<br>expected to be material to the Target Companies, taken as a whole. As of the date of this agreement, there are no contracts to which the<br>Company or any of the Company Subsidiaries is a party or bound with respect to the voting (including voting trusts or proxies) or transfer<br>of the equity interests of any Company Subsidiary other than the Organizational Documents of any such Company Subsidiary. As of the date<br>of this agreement, there are no outstanding or authorized options, warrants, rights, agreements, subscriptions, convertible securities<br>or commitments to which any Company Subsidiary is a party or which are binding upon any Company Subsidiary providing for the issuance<br>or redemption of any equity interests of any Company Subsidiary. As of the date of this agreement, there are no outstanding equity appreciation,<br>phantom equity, profit participation or similar rights granted by any Company Subsidiary. No Company Subsidiary has any limitation, whether<br>by contract, order, or applicable law, on its ability to make any distributions or dividends to its equity holders or repay any debt owed<br>to another Target Company. As of the date of this agreement, other than the Company Subsidiaries, no Target Company has any Subsidiaries.<br>Except for the equity interests of the Company Subsidiaries listed in the Disclosure Schedules, as of the date of this agreement: (i)<br>no Target Company owns or has any rights to acquire, directly or indirectly, any equity interests of, or otherwise control, any Person,<br>(ii) no Target Company is a participant in any joint venture, partnership or similar arrangement and (iii) there are no outstanding contractual<br>obligations of a Target Company to provide funds to or make any loan or capital contribution to any other Person.
--- --- 
23
9. No Consent. No Consent of or with any Governmental Authority on the part of any Target Company<br>is required to be obtained or made in connection with the execution, delivery or performance by the Company or any Target Company of this<br>agreement or any other Transaction Documents to which the Company or any Target Company is or required to be a party or otherwise bound,<br>or the consummation by the Company or the Target Companies of the Transactions other than (a) any filings required with Nasdaq or the<br>United States Securities and Exchange Commission with respect to the Transactions, (b) applicable requirements, if any, of the Securities<br>Act, the U.S. Securities Exchange Act of 1934, as amended, and any state “blue sky” securities laws, and the rules and regulations<br>thereunder, (c) applicable requirements of any antitrust laws and the expiration or termination of the required waiting periods, or the<br>receipt of other Consents, thereunder, and (d) where the failure to obtain such Consents, or to make such filings or notifications, individually<br>or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect on the Company.
10. Non-Contravention. The execution and delivery by the Company (or any other Target Company, as applicable)<br>of this agreement and each Transaction Document to which any Target Company is or is required to be a party, and the consummation by any<br>Target Company of the Transactions and compliance by any Target Company with any of the provisions hereof and thereof, will not (a) conflict<br>with or violate any provision of such Target Company’s articles of incorporation and bylaws, memorandum and articles of association<br>or similar organizational documents (the “Organizational Documents”), (b) assuming the accuracy of each Investor’s<br>warranties set forth in this agreement, subject to obtaining any consent, approval, waiver, authorization, waiting period expiration or<br>termination, or permit of, or notice to or declaration or filing with any Governmental Authority or any other Person (the “Consents”)<br>from any federal, state, local, foreign or other governmental, quasi-governmental, tax, regulatory or administrative body, instrumentality,<br>department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving<br>panel or body (“Governmental Authorities”) and any condition precedent to such Consent having been satisfied, conflict<br>with or violate any law, order or Consent applicable to such Target Company or any of its properties or assets, or (c) assuming the accuracy<br>of each Investor’s warranties set forth in this agreement, (i) violate, conflict with or result in a breach of, (ii) constitute<br>a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination,<br>withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by such Target Company under, (v) result<br>in a right of termination or acceleration under, (vi) give rise to any obligation to make or increase payments or provide compensation<br>under, (vii) result in the creation of any Lien upon any of the properties or assets of such Target Company under, (viii) give rise to<br>any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default,<br>exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel,<br>terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of any material contract,<br>except for any deviations from any of the foregoing clauses (b) or (c) that, individually or in the aggregate, would not reasonably be<br>expected to have a Material Adverse Effect on the Company.
--- --- 
24
11. Financial Statements.
11.1. The Company has made available to the Investor true, correct and complete copies of (i) the audited consolidated<br>financial statement of financial position of Air Water Units Trading Limited and its subsidiaries, and the related audited consolidated<br>statements of comprehensive income, changes in equity and cash flows of Air Water Units Trading Limited and its wholly-owned subsidiaries<br>as of and for the year ended December 31, 2023 (the “Audited Company Financial Statements”), (ii) the unaudited consolidated<br>financial statement of financial position of Air Water Ventures Limited and its subsidiaries, and the related unaudited consolidated statements<br>of comprehensive income, changes in equity and cash flows of Air Water Ventures Limited and its subsidiaries as of and for the year ended<br>December 31, 2024 (the “2024 Unaudited Company Financial Statements”) and (iii) the unaudited consolidated financial<br>statement of financial position of Air Water Ventures Limited and its subsidiaries, and the related unaudited consolidated statements<br>of comprehensive income, changes in equity and cash flows of Air Water Ventures Limited and its subsidiaries as of and for the three-month<br>period ended March 31, 2025 (the “Interim Unaudited Company Financial Statements” and, collectively with the Audited<br>Company Financial Statements and the 2024 Unaudited Company Financial Statements, the “Company Financial Statements”).
--- ---
11.2. The Company Financial Statements (i) fairly present in all material respects the consolidated financial<br>position of the applicable Target Companies, as at the respective dates thereof, and the consolidated results of their operations, their<br>consolidated incomes, their consolidated changes in shareholders’ equity and their consolidated cash flows for the respective periods<br>then ended, subject to adjustments which are not expected to have a Material Adverse Effect, (ii) were prepared in conformity with<br>IFRS applied on a consistent basis during the periods involved, except as may be indicated in the notes thereto and with respect to the<br>2024 Unaudited Company Financial Statements and the Interim Unaudited Company Financial Statements, subject to the absence of footnotes<br>and normal year-end adjustments (none of which would be material, individually or in the aggregate), (iii) were prepared from, and<br>are in accordance with, in all material respects, the books and records of the applicable Target Companies and (iv) with respect to the<br>Audited Company Financial Statements, contain an unqualified report of the Company’s auditor in connection with such Audited Company<br>Financial Statements, Grant Thornton UAE. The audited consolidated balance sheets and statements of operations, comprehensive income,<br>stockholders’ equity and cash flows of the Target Companies as of and for the years ended December 31, 2023 and December 31, 2024,<br>each audited in accordance with the auditing standards of the PCAOB and which comply in all material respects with the applicable accounting<br>requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant (collectively,<br>the “PCAOB Financial Statements”), when delivered after the date hereof by the Company for inclusion in the Form F-4<br>registration statement to be filed by PubCo in connection with the Business Combination (the “Registration Statement”)<br>and the proxy statement of SPAC (the “Proxy Statement”) for filing with the SEC following the date of this agreement,<br>will comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange<br>Act and the Securities Act applicable to a registrant in effect as of the respective dates thereof.
--- --- 
25
11.3. The Company has not identified, and has not received from any independent auditor of the Company any written<br>notification of, (i) any significant deficiency or material weakness in the system of internal accounting controls utilized by the<br>Target Companies, (ii) any fraud, whether or not material, that involves the management or other employees of the Target Companies<br>who have a role in the preparation of financial statements or the internal accounting controls utilized by the Target Companies or (iii) any<br>written claim or allegation regarding any of the foregoing.
11.4. As of the date hereof and the date of Completion, the Target Companies do not have any of the following<br>types of indebtedness: (a) all indebtedness of such Person for borrowed money (including the outstanding principal and accrued but unpaid<br>interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables incurred in the ordinary<br>course of business), including “earn-outs” and “seller notes” whether accrued or not, (c) any other indebtedness<br>of such Person that is evidenced by a note, bond, debenture, credit agreement or similar instrument, in each case to the extent drawn,<br>(d) all obligations of such Person under leases that should be classified as capital leases in accordance with IFRS, or any other accounting<br>principles used by such Person, (e) all obligations of such Person for the reimbursement of any obligor on any line or letter of credit,<br>banker’s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed against and not settled.
--- ---
11.5. Except for those that will be reflected or reserved on or provided for in the statement of financial position<br>of the Target Companies contained in the Company Financial Statements, no Target Company has any liabilities of a nature required to be<br>disclosed on a balance sheet in accordance with IFRS, except for (i) those that were incurred after March 31, 2025 in the ordinary course<br>of business, none of which are material, individually or in the aggregate, (ii) obligations for future performance under any contract<br>to which any Target Company is a party, (iii) liabilities incurred for transaction expenses in connection with this agreement or any other<br>Transaction Document or (iv) liabilities which would not, individually or in the aggregate, reasonably be expected to have a Material<br>Adverse Effect.
--- ---
12. Absence of Certain Changes. Except for actions expressly contemplated by this agreement, and the<br>other Transaction Documents, since December 31, 2024 and through the Completion, (a) the Target Companies have conducted their business<br>only in the ordinary course of business and (b) there has not been a Material Adverse Effect; and (c) the Company has not declared or<br>paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or otherwise acquired any equity<br>interests of the Company, and the Board has not authorized any of the foregoing.
--- ---
13. Compliance with Laws. (a) Each Target Company is in compliance in all material respects with, and<br>not in conflict, default or violation in each case in any material respect of, any applicable laws and (b) no Target Company has received,<br>since December 31, 2024, any written or, to the knowledge of the Company, oral notice of any material conflict or material non-compliance<br>with, or material default or material violation of, any applicable laws by which it is or was bound.
--- ---
14. Company Permits. The applicable Target Company holds all permits necessary to lawfully conduct<br>in all material respects its business as presently conducted, and to own, lease and operate its assets and properties (collectively, the<br>“Company Permits”), except where the failure to obtain or maintain the same, individually or in the aggregate, has<br>not had and would not reasonably be expected to be material to the Target Companies, taken as a whole or otherwise limit the ability of<br>any Target Company to perform on a timely basis its obligations under this agreement or the other Transaction Documents to which it is<br>or required to be a party or otherwise bound. As of the date of this agreement and at Completion, each material Company Permit is in full<br>force and effect, and (a) no suspension or cancellation of any of the material Company Permits is pending or, to the Company’s knowledge,<br>threatened, (b) no Target Company is in violation in any material respect of the terms of any material Company Permit and (c) since December<br>31, 2024, no Target Company has received any written, or to the knowledge of the Company, oral notice of any actions relating to the revocation<br>or material modification of any material Company Permit.
--- --- 
26
15. Litigation. There is no (a) material action of any nature currently pending or, to the Company’s<br>knowledge, threatened or (b) material order, decree, ruling, judgment, injunction, writ, binding determination or decision, verdict or<br>judicial award that is or has been entered, rendered, or otherwise put into effect now pending or outstanding in either case of (a) or<br>(b) by or against any Target Company.
16. Intellectual Property.
--- ---
16.1. All registered, issued, and applied-for intellectual property owned by a Target Company (“CompanyRegistered IP”) is subsisting and all registered or issued Company Registered IP is valid and, to the knowledge of the Company,<br>enforceable except where the failure to be would not, individually or in the aggregate, reasonably be expected to be material to the Target<br>Companies, taken as a whole. No Target Company is subject to any outstanding order that would restrict its use or ownership of any intellectual<br>property or would impair the validity or enforceability of any Company’s owned intellectual property, and no action is pending or,<br>to the knowledge of the Company, threatened, against a Target Company that challenges the validity, enforceability or ownership of any<br>Company Registered IP.
--- ---
16.2. At least one of the Target Companies (x) exclusively owns all material Company owned intellectual property,<br>free and clear of all Liens (other than Permitted Liens (as defined below)) and (y) has the right to use all other intellectual property<br>that is material to the conduct of the business of the Target Companies as currently conducted. The execution and delivery by the Company<br>(or any other Target Company, as applicable) of this agreement and each other Transaction Document to which any Target Company is or is<br>required to be a party, the consummation by any Target Company of the Transactions, and the compliance by any Target Company with any<br>of the provisions hereof and thereof, will not result in the material loss, termination or impairment of any rights of the Target Companies<br>in any material intellectual property. “Permitted Liens” means (a) Liens for taxes or assessments and similar governmental<br>charges or levies, which either are (i) not yet delinquent or (ii) being contested in good faith and by appropriate proceedings and for<br>which adequate reserves have been established in accordance with IFRS or GAAP, as applicable, with respect thereto, (b) Liens imposed<br>by operation of law or non-monetary Encumbrances that would not in the aggregate materially adversely affect the value of, or materially<br>adversely interfere with the use of, the property subject thereto, (c) Liens incurred, pledges or deposits made in the ordinary course<br>of business in connection with worker’s compensation, unemployment insurance and other social security legislation, (d) Liens on<br>goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, (e) Liens<br>arising under this agreement or any other Transaction Document, (f) such imperfections of title, easements, covenants, Encumbrances, Liens,<br>or other similar restrictions on real property that would not be reasonably expected to materially impair the current use or operations<br>of the business of the Target Companies or any assets that are subject thereto, (g) materialmen’s, mechanic’s, carriers’,<br>workmen’s, warehousemen’s, repairmen’s, landlord’s and other similar Liens, or deposits to obtain the release<br>of such Liens, (h) restrictions on the transfer of securities imposed by applicable securities laws, (i) zoning, building, land use, entitlement,<br>conservation restrictions or other similar restrictions on real property, including rights of way and similar Encumbrances identified<br>on any surveys, and other land use and environmental regulations promulgated by Governmental Authorities, (j) deposits to secure the performance<br>of bids, trade contracts, leases, statutory obligations, surety, indemnity and appeal bonds, performance and fiduciary bonds and other<br>obligations of a like nature, in each case in the ordinary course of business, (k) non-exclusive licenses (or sublicenses) of intellectual<br>property owned by the Target Companies granted in the ordinary course of business, (l) any (i) statutory Liens in favor of any lessor<br>or landlord, (ii) Liens set forth in leases, subleases, easements, licenses, rights of use, rights to access and rights-of-way or (iii)<br>Liens benefiting or encumbering any superior estate, right or interest, (m) any Liens that are discharged or released at or prior to the<br>closing of the Business Combination, (n) any purchase money Liens, equipment leases or similar financing arrangements, (o) the rights<br>of lessors under leasehold interests or (p) Liens specifically identified on the consolidated statement of financial position of the Target<br>Companies.
--- --- 
27
16.3. To the knowledge of the Company, (i) no Target Company is currently infringing, or has, in the past three<br>years, infringed any intellectual property of any other Person in any material respect, and (ii) no third party is infringing any material<br>Company owned intellectual property.
16.4. All contributors who have contributed to the development of material intellectual property for any Target<br>Company have executed a contributor agreement. To the knowledge of the Company, no contributor has claimed any ownership interest in any<br>material intellectual property purported to be owned by a Target Company. Each Target Company has taken commercially reasonable measures<br>to protect and maintain the confidentiality of all trade secrets included in the material Company owned intellectual property. No such<br>trade secret has been disclosed (or authorized or threatened to be disclosed) to any Person (including any past or present employee, officer,<br>advisor, consultant, independent contractor or other third party) other than pursuant to the terms of a valid, written confidentiality<br>agreement with such Person that is sufficient to protect the confidentiality thereof and is in full force and effect. No Governmental<br>Authority or educational or research institution owns or otherwise holds, or has the right to obtain, any rights to any material Company<br>owned intellectual property.
--- ---
17. Taxes and Returns.
--- ---
17.1. Each Target Company has filed, or caused to be filed, all material tax returns required by applicable<br>tax law to be filed by it, which such tax returns are true, accurate, correct and complete in all material respects. Each Target Company<br>has paid, or caused to be paid, all material taxes required by applicable tax law to be paid by it, other than such taxes being contested<br>in good faith by appropriate proceedings and for which adequate reserves have been established in the Company Financial Statements in<br>accordance with IFRS.
--- ---
17.2. Air Water Company LLC, a Delaware limited liability company (“Air Water US”), is the<br>only Target Company that is incorporated or organized in the United States. Air Water US is not, and has never been, a “United States<br>real property holding corporation” within the meaning of Section 897(c)(2) of the Code.
--- ---
17.3. Each Target Company has complied in all material respects with all applicable tax laws relating to withholding<br>and remittance of taxes, and all material amounts of taxes required by applicable tax laws to be withheld by a Target Company have been<br>withheld and timely paid over to the appropriate Governmental Authority, including with respect to any amounts owing to or from any employee,<br>independent contractor, shareholder, creditor, or other Person.
--- ---
17.4. There are no material claims, assessments, audits, examinations, investigations or other actions pending,<br>in progress or threatened in writing against any Target Company, in respect of taxes, and no Target Company has been notified in writing<br>of any material proposed tax claims or assessments against any Target Company by a Governmental Authority.
--- --- 
28
17.5. There are no material Liens with respect to any taxes upon any Target Company’s assets, other than<br>Permitted Liens.
17.6. No Target Company has a permanent establishment, branch or representative office in any country other<br>than the country of its organization, and no Target Company is or has been treated for any tax purpose as a resident in a country other<br>than the country of its incorporation or formation, as applicable.
--- ---
17.7. No UK directors, officers, employees or former or proposed directors, officers or employees of the Target<br>Companies hold any securities, interests in securities or securities options as defined in Part 7 of Income Tax (Earnings and Pensions)<br>Act 2003 (“ITEPA”).
--- ---
18. Real Property. All current leases, lease guarantees, agreements and documents as of the date of<br>this agreement related to the premises currently leased or subleased by a Target Company for the operation of the business of a Target<br>Company are valid, binding and enforceable against the Target Company party thereto and, to the knowledge of the Company, each other party<br>thereto, in accordance with their terms and are in full force and effect (except, in each case, as such enforcement may be limited by<br>the Enforceability Exceptions). To the knowledge of the Company, no event has occurred which (whether with or without notice, lapse of<br>time or both or the happening or occurrence of any other event) would constitute a material default on the part of a Target Company or<br>any other party under any of the Company Real Property Leases, and no Target Company has received written notice of any such condition.<br>No Target Company owns any real property or any interest in real property (other than the leasehold interests in the Company Real Property<br>Leases).
--- ---
19. Environmental Matters.
--- ---
19.1. Each Target Company is in compliance in all material respects with all applicable laws in effect on or<br>prior to the date hereof relating to (a) the protection of human health and safety (to the extent relating to exposure to hazardous materials),<br>(b) the protection, preservation or restoration of the environment and natural resources (including air, water vapor, surface water, groundwater,<br>drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource) to the extent relating to releases<br>of hazardous materials or (c) the use, storage, recycling, treatment, generation, transportation, processing, handling, labelling, production,<br>release or disposal of hazardous materials (“Environmental Laws”), including obtaining, maintaining in good standing,<br>and complying in all material respects with all material permits required under Environmental Laws for its business and operations (“EnvironmentalPermits”) and no action is pending or, to the Company’s knowledge, threatened that would reasonably be expected to result<br>in the revocation, modification, or termination of any such Environmental Permit.
--- ---
19.2. No Target Company has assumed, contractually or by operation of law, any outstanding liabilities or obligations<br>under any Environmental Laws of any other Person except, in each case, for such liabilities or obligations that would not reasonably be<br>expected to be material to the Target Companies, taken as a whole.
--- ---
19.3. No action is pending, or to the Company’s knowledge, threatened against any Target Company or any<br>assets of a Target Company alleging that a Target Company is in violation in any material respect of any Environmental Law or material<br>Environmental Permit or that a Target Company has any material liability under any Environmental Law, and to the Company’s knowledge,<br>no fact, circumstance or condition exists that would reasonably be expected to give rise to any such action.
--- ---
20. Transactions with Related Persons. No Company shareholder nor any officer or director of a Target<br>Company or any of their respective Affiliates, nor, to the knowledge of the Company, any immediate family member of any of the foregoing<br>(each of the foregoing, a “Related Person”) is presently a party to any transaction with a Target Company, including<br>any contract (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b)<br>providing for the rental of real property or personal property from, or (c) otherwise requiring payments to (other than for services or<br>expenses as directors, officers or employees of the Target Company in the ordinary course of business) any Related Person or any Person<br>in which any Related Person has a position as an officer, manager, director, trustee or partner or in which any Related Person has any<br>direct or indirect ownership interest (other than the ownership of securities representing no more than five percent of the outstanding<br>voting power or economic interest of a publicly traded company), in each case, other than any other Transaction Document, the Shareholders<br>Agreement or any contract pursuant to which a Company shareholder subscribed for or purchased equity interests in the Company.
--- --- 
29
21. Insurance.
21.1. Except as would not, individually or in the aggregate, result in a Material Adverse Effect, to the Target<br>Companies, taken as a whole, the Target Companies are in compliance with the terms of its insurance policies. To the Company’s knowledge<br>and except as would not, individually or in the aggregate, be material to the Target Companies, taken as a whole, each such insurance<br>policy (i) is valid, binding, enforceable and in full force and effect and (ii) will continue to be valid, binding, enforceable, and in<br>full force and effect on identical terms following the closing of the Business Combination (except, in each case, as such enforcement<br>may be limited by the enforceability exceptions).
--- ---
22. Certain Business Practices.
--- ---
22.1. For the past five (5) years, each Target Company has been in compliance with the U.S. Foreign Corrupt<br>Practices Act of 1977 and all other applicable anti-corruption and anti-bribery laws, in all material respects.
--- ---
22.2. For the past five (5) years, no Target Company nor, to the knowledge of each Target Company, any of its<br>directors, officers, employees or representatives, when acting on behalf of a Target Company, has used any funds for unlawful contributions,<br>gifts, entertainment or other unlawful expenses relating to political activity.
--- ---
22.3. No Target Company or, to the knowledge of the Company, any of their respective directors, officers, employees<br>or any other representative acting on behalf of a Target Company is currently a person organized, resident, or located in a country, region<br>or territory that is the subject of comprehensive territorial Sanctions (a “Sanctioned Person”). No Target Company<br>has, directly or, knowingly, indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary,<br>joint venture partner or other Person, (i) to fund any activities or business of or with any Person that, at the time of such funding,<br>is the subject of Sanctions, or in Cuba, Iran, North Korea, and the Crimea region of Ukraine, the so-called Donetsk People’s Republic,<br>and the so-called Luhansk People’s Republic regions of Ukraine, as this list may be amended from time to time (a “SanctionedJurisdiction”) or (ii) in any other manner that would reasonably be expected to result in a violation of Sanctions or Customs<br>& Export Control Laws by any Person. No Target Company or any of their respective directors, officers employees or, to the knowledge<br>of the Company, any other representative acting on behalf of a Target Company has, since April 24, 2019, engaged in (A) dealings with<br>a Sanctioned Person or involving a Sanctioned Jurisdiction in a manner that would violate applicable Sanctions, (B) dealings that could<br>reasonably be expected to result in the Target Company becoming a Sanctioned Person, or (C) conduct, activity, or practice that would<br>constitute a violation or apparent violation of any applicable Sanctions or Customs & Export Control Laws. The Target Company has<br>(1) where required by law, secured and maintained all necessary permits, registrations, agreements or other authorizations, including<br>amendments thereof pursuant to Sanctions and Customs & Export Control Laws and (2) not been the subject of or otherwise involved in<br>investigations or enforcement actions by any Governmental Authority or other legal proceedings with respect to any actual or alleged violations<br>of applicable Sanctions or Customs & Export Control Laws, and has not been notified of any such pending or threatened actions. The<br>Target Company and its directors, officers and employees, and, to the knowledge of the Company, any other representative acting on behalf<br>of a Target Company, are, and have been since April 24, 2019, in compliance with Sanctions and Customs & Export Control Laws.
--- --- 
30
23. Investment Company Act. To the knowledge of the Company, no Target Company is an “investment<br>company” or a Person directly or indirectly “controlled” by or acting on behalf of a Person subject to registration<br>and regulation as an “investment company”, in each case within the meaning of the Investment Company Act.
24. Finders and Brokers. Other than as set forth on the Disclosure Schedules, no broker, finder or<br>investment banker is entitled to any brokerage, finder’s or other fee or commission from the Target Companies or any of their respective<br>Affiliates in connection with the Transactions based upon arrangements made by or on behalf of any Target Company.
--- ---
25. No Registration. Assuming the accuracy of each Investor’s warranties set forth in this agreement,<br>no registration under the Securities Act or any state securities (or Blue Sky) laws is required for the offer and sale of the Securities by<br>the Company to each Investor.
--- ---
26. Money Laundering Laws. The operations of the Target Companies are and have been conducted at all<br>times in material compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions<br>Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively,<br>the “Money Laundering Laws”), and no action or proceeding by or before any court or governmental<br>agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws<br>is pending or, to the knowledge of the Company, threatened.
--- ---
27. Registration Rights. Except as (i) disclosed in the Disclosure Schedules, (ii) have been waived<br>and (iii) as provided for in the Company’s Registration Rights Agreement with the Investors, no Person has any<br>right to cause the Company to effect the registration under the Securities Act of any securities of the Company.
--- ---
28. Market Activities. Subject to the non-disclosure agreements entered into by the Investor with respect<br>to the Business Combination and the other transactions contemplated by the Transaction Documents, anything in this agreement or elsewhere<br>herein to the contrary notwithstanding, it is understood and acknowledged by the Company that: (i) none of the Investors has been asked<br>by the Company to agree, nor has any Investor agreed, to desist from purchasing or selling, long and/or short, securities of the Company,<br>or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified<br>term; (ii) past or future open market or other transactions by any Investor, specifically including, without limitation, short sales or<br>“derivative” transactions, before or after the closing of this or future private placement transactions, may negatively impact<br>the market price of the Company’s publicly-traded securities; (iii) any Investor, and counter-parties in “derivative”<br>transactions to which any such Investor is a party, directly or indirectly, presently may have a “short” position in the Ordinary<br>Shares, and (iv) each Investor shall not be deemed to have any affiliation with or control over any arm’s length counter-party in<br>any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Investors may engage in<br>hedging activities at various times during the period that the Securities are outstanding, and (z) such hedging activities (if<br>any) would reduce the value of the Investors’ equity interests in the Company at and after the time that the hedging activities<br>are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction<br>Documents.
--- ---
29. No Stabilization or Manipulation. The Company has not, and to its knowledge no one acting on its<br>behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price<br>of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid<br>any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation<br>for soliciting another to purchase any other securities of the Company.
--- --- 
31

Execution

This Agreement has been executed on the date shown at the start.

SIGNED by a director for and on behalf <br><br>of Air Water Ventures Holdings Limited …………………………………
Print name:
Director 
32

Exhibit 1

Form of Registration Rights Agreement

(attached)

33

Exhibit 2

RSU Awards

34

Exhibit 99.1

A1R WATER, the GroundbreakingAtmospheric Water Generation Company, to Go Public on Nasdaq through Business Combination

with Inflection Point Acquisition Corp. III

● A1R WATER builds, owns and operates water farms and bottling plants where<br>they package and sell finished beverage products to a marquee list of hotels, real estate developers, events venues and sports teams
● Proposed transaction values A1R WATER at a pro forma enterprise value of<br>$419 million
--- ---
● Proposed transaction includes a fully committed PIPE investment $63.5 million,<br>$32.5 million of which was funded at signing of the Business Combination Agreement
--- ---
● PIPE investment led by SPAC sponsor Inflection Point Asset Management includes<br>strategic investment from new shareholders including Southern Glazer’s Wine & Spirits through its corporate growth, venture,<br>and strategic acquisitions arm, SG Ventures; these partners join existing investors including Tau Capital, anchored by the Royal Group<br>of Abu Dhabi, which has been A1R WATER’s largest investor since February 2024
--- ---
● Transaction use of proceeds primarily focused on the expansion of the A1R<br>WATER USA business including a second US-based water plant as well as the launch of consumer and government services businesses
--- ---

Miami, FL and New York, NY, Aug. 25, 2025(GLOBE NEWSWIRE) -- A1R WATER, a global leader in atmospheric water generation, and Inflection Point Acquisition Corp. III, a publicly traded special purpose acquisition company (Nasdaq: IPCX) today announced that they have entered into a definitive agreement for a business combination. Upon closing of the business combination, the combined company will be named Air Water Ventures Limited, and its ordinary shares will be listed on the Nasdaq Stock Market under the symbol “WATR”. Additional context and commentary, including a Transaction Overview, can be found at A1RWATER.com.

Founded in 2018, A1R WATER has spent eight years evolving decades-old dehumidification technology into a commercial scale native source of drinking water, with over 30 million gallons of BPA- and microplastic-free water expected to be generated, distributed and sold in 2025.

Today, most drinking water is modified for consumption via complex desalination and groundwater purification processes – all of which require significant power, infrastructure, transportation and logistical investment. Rising costs, increased government and public scrutiny of purity standards, and outdated infrastructure has led the drinkable water industry to a crucial tipping point. By current estimates, demand for fresh water will outpace global supplies by 40% within the next five years.

Through proprietary technology and a proven ability to scale, A1R WATER is uniquely situated to be a leader in the $500 billion air-to-water market via its fully vertically integrated ecosystem of water generation systems, water farms, bottling plants and distribution channels.

Since its founding, A1R WATER has successfully expanded in the United Arab Emirates, with more than 60 million gallons of water per year generated since January 2024 by A1R WATER systems for a marquee list of hotel groups, office and event venues. With proof of concept established, A1R WATER is now broadening its focus to the world’s largest consumer beverage market – the United States. In 2025, A1R WATER began production at its first US-based water farm in Fort Lauderdale; announced a landmark partnership with the Miami HEAT; and took meaningful action to broaden those domestic activities beyond finished beverage sales to include consumer, commercial and industrial sales of the A1R WATER machine product line, which ranges from counter-top consumer units to 3,000 liter/day industrial systems that can supply utility-scale water farms.

1

“A1R WATER has made incredible progress over the past few years, particularly in proving out our proprietary technology, asset mix and ability to scale,” said Peter Carr, Chief Executive Officer of A1R WATER. “The vastness of the problem we are confronting is humbling. But A1R WATER sits at an inimitable flashpoint at the intersection of need, technological advancement, consumer non-durable demand and branding. Our partnership with Inflection Point provides not only crucial capital, but a true strategic partner with an enviable track record of success. We look forward to working alongside their team to make A1R WATER a household name – in both the consumer product and clean technology industries.”

“Inflection Point has a proven history of investing in strategically important assets in rapidly growing markets,” said Michael Blitzer, Chairman of Inflection Point Asset Management. “We’re pleased to be joined by our industry-leading co-investors, including Southern Glazer’s Wine and Spirits and the Royal Group of Abu Dhabi, in facilitating A1R WATER’s continued success in commercializing their proprietary technology, providing critical sustainable solutions for government and commercial customers, and establishing a new segment in the consumer beverage industry.”

Proposed Business Combination & PIPE Financing Overview

The proposed business combination (the “Transaction”) implies a pro forma combined enterprise value of $419 million, excluding additional earnout consideration. This assumes a $300 million pre-money valuation of A1R WATER, including a 100% rollover of A1R WATER equity and excludes any amounts in the IPCX trust account.

The Transaction is accompanied by a fully committed PIPE investment $63.5 million led by Inflection Point, existing A1R WATER investors and new strategic investors including Southern Glazer’s Wine & Spirits through its corporate growth, venture, and strategic acquisitions arm, SG Ventures (the “PIPE Financing”), reflecting the Company’s focus on advancing sustainable beverage solutions for businesses and hospitality partners, with $32.5 million of the PIPE Financing pre-funded on or prior to signing of the Business Combination Agreement to accelerate A1R WATER’s 2025 business plan, with approximately $31 million of the PIPE Financing to fund at close of the Transaction. A1R WATER, Inflection Point and their advisors may seek to upsize the PIPE Financing with additional funding in connection with closing.

Under the terms of the Business Combination Agreement, A1R WATER’s existing shareholders will convert 100% of their equity ownership stakes into PubCo and are expected to own approximately 62.6% (excluding the affiliates of IPCX) of PubCo upon consummation of the Transaction, excluding any IPCX investors who do not choose to redeem their shares.

The Transaction is expected to be completed by the end of the first quarter of 2026, subject to customary closing conditions, including regulatory and shareholder approvals. PubCo is expected to be named “Air Water Ventures Limited” and will list its ordinary shares on the Nasdaq Stock Market under the symbol “WATR”, subject to satisfaction of Nasdaq’s listing requirements. The Transaction has been unanimously approved by the board of directors and management of A1R WATER and the board of directors of IPCX.

Advisors

Jett Capital Advisors, LLC is acting as exclusive financial advisor to A1R WATER, as well as lead capital markets advisor and placement agent in the PIPE Financing. Morgan, Lewis & Bockius LLP is acting as legal advisor to A1R WATER. White & Case LLP is acting as legal advisor to Inflection Point. Cantor Fitzgerald & Co., Inc. is acting as lead capital markets advisor to Inflection Point.

About A1R WATER

Working at the intersection of tech and engineering, A1R WATERdesigns and manufactures air-to-water technology to create clean water from humidity in the air. A1R WATER manufactures and sells systems ranging from counter-top consumer units to 3,000 liter/day industrial systems that can supply utility-scale water farms**. A1RWATER also builds and operates on-balance sheet water farms and bottling sites, delivering** finished canned and bottled water products to marquee global brands including Conrad (Hilton) Abu Dhabi, Fairmont Hotels & Resorts, Le Meridian, and the Miami HEAT.

2

For more information, please visit https://a1rwater.com/

About Inflection Point Asset Management

Inflection Point Acquisition Corp. III was listed on the Nasdaq Stock Market in April of 2025 and is the third SPAC vehicle of Inflection Point Asset Management. Led by Wall Street veteran Michael Blitzer, Inflection Point has been a successful repeat SPAC sponsor in the SPAC asset class. In February 2023, Inflection Point I combined with $2.0B space exploration company Intuitive Machines, Inc. (Nasdaq: LUNR). In March 2025, Inflection Point II combined with the $1.4B vertically integrated rare earth magnet company USA Rare Earth, Inc. (Nasdaq: USAR). The keystone in Inflection Point’s strategy and continued success is leading committed-capital investments into their business combinations, ensuring their combined businesses debut as well funded public companies, and not relying on the volatile new issuance follow-on market that the SPAC asset class has become known for.

For more information, please visit https://inflectionpointacquisition.com/home/default.aspx

Additional Information and Where to Find It

In connection with the Transaction, Inflection Point and A1R WATER are expected to prepare a registration statement on Form F-4 (the “Registration Statement”) to be filed with the SEC by PubCo, which will be the surviving public company of the business combination. The Registration Statement will include preliminary and definitive proxy statements to be distributed to Inflection Point’s shareholders in connection with Inflection Point’s solicitation for proxies for the vote by Inflection Point’s shareholders in connection with the Transaction and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to the A1R WATER’s shareholders in connection with the completion of the Transaction. After the Registration Statement has been filed and declared effective, Inflection Point will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the Transaction. Inflection Point’s shareholders and other interested persons are advised to read, once available, the preliminary proxy statement/prospectus and any amendments thereto and, once available, the definitive proxy statement/prospectus, in connection with Inflection Point’s solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the Transaction, because these documents will contain important information about Inflection Point, A1R WATER, and the Transaction. This communication is not a substitute for the Registration Statement, the definitive proxy statement/prospectus, or any other document that Inflection Point will send to its shareholders in connection with the Transaction. Shareholders may also obtain a copy of the preliminary or definitive proxy statement, once available, as well as other documents filed with the SEC regarding the Transaction and other documents filed with the SEC by Inflection Point, without charge, at the SEC’s website located at www.sec.gov or by directing a request to Inflection Point Acquisition Corp III., 167 Madison Avenue Suite 205 #1017, New York, NY 10016.

INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, DEFINITIVE PROXY STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION AND THE PARTIES TO THE TRANSACTION. Investors and security holders will be able to obtain copies of these documents (if and when available) and other documents filed with the SEC free of charge at www.sec.gov. The definitive proxy statement/prospectus (if and when available) will be mailed to shareholders of Inflection Point as of a record date to be established for voting on the Transaction. Shareholders of Inflection Point will also be able to obtain copies of the proxy statement/prospectus without charge, once available, at the SEC’s website at www.sec.gov.

Participants in the Solicitation

Inflection Point, A1R WATER, PubCo and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Inflection Point’s shareholders in connection with the Transaction. Investors and security holders may obtain more detailed information regarding Inflection Point’s directors and executive officers in Inflection Point’s filings with the SEC, including Inflection Point’s final prospectus for its initial public offering, and amendments thereto, as filed with the SEC. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to Inflection Point’s shareholders in connection with the Transaction, including a description of their direct and indirect interests, which may, in some cases, be different than those of Inflection Point’s shareholders generally, will be set forth in the Registration Statement. Shareholders, potential investors, and other interested persons should read the Registration Statement carefully when it becomes available before making any voting or investment decisions.

3

No Offer or Solicitation

This press release does not constitute (i) a solicitation of a proxy, consent, or authorization in any jurisdiction with respect to any securities or in respect of the Transaction, or (ii) an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security of IPCX, A1R WATER, PubCo or any of their respective affiliates. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom, nor shall any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction be effected. No securities commission or securities regulatory authority in the United States or any other jurisdiction has in any way passed upon the merits of the Transaction or the accuracy or adequacy of this press release.

Cautionary Note Regarding Forward-Looking Statements

Certain statements included herein are not historical facts but are forward-looking statements, within the meaning of Section 27A of the Securities Act, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “according to estimates,” “assume,” “believe,” “could,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “is of the opinion,” “to the knowledge of,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” “target” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the ability of the parties to complete the transactions contemplated by the Transaction in a timely manner or at all; the risk that the Transaction or other business combination may not be completed by Inflection Point’s business combination deadline and the potential failure to obtain an extension of the business combination deadline; the outcome of any legal proceedings or government or regulatory action on inquiry that may be instituted against Inflection Point, A1R WATER, PubCo or others following the announcement of the Transaction and any definitive agreements with respect thereto; the inability to satisfy the conditions to the consummation of the Transaction, including the approval of the Transaction by the shareholders of Inflection Point; the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement relating to the Transaction; the ability of PubCo to meet stock exchange listing standards following the consummation of the Transaction; the effect of the announcement or pendency of the Transaction on A1R WATER’s, Inflection Point’s and PubCo’s business relationships, operating results, current plans and operations; the ability to recognize the anticipated benefits of the Transaction, which may be affected by, among other things, competition, the ability of PubCo to grow and manage growth profitably; the possibility that PubCo, A1R WATER and Inflection Point may be adversely affected by other economic, business, and/or competitive factors; PubCo’s and A1R WATER’s estimates of expenses and profitability; expectations with respect to future operating and financial performance and growth, including the timing of the completion of the Transaction; and other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Inflection Point’s final prospectus relating to its initial public offering dated April 25, 2025, and in subsequent filings with the SEC, including the Registration Statement relating to the Transaction by Inflection Point, A1R WATER, and/or one or more of their affiliates, and periodic Exchange Act reports filed by Inflection Point with the SEC such as its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

These statements are based on various assumptions, whether or not identified in herein, and on the current expectations of Inflection Point’s and A1R WATER’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of A1R WATER. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. The risks and uncertainties above are not exhaustive, and there may be additional risks that neither Inflection Point nor A1R WATER presently know or that Inflection Point and A1R WATER currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward looking statements reflect Inflection Point’s and A1R WATER’s expectations, plans or forecasts of future events and views as of the date hereof. Inflection Point and A1R WATER anticipate that subsequent events and developments will cause Inflection Point’s and A1R WATER’s assessments to change. However, while Inflection Point and A1R WATER may elect to update these forward-looking statements at some point in the future, Inflection Point and A1R WATER specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Inflection Point’s and A1R WATER’s assessments as of any date subsequent to the date hereof. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Contacts

Investors

ir@a1rwater.com

Media

press@a1rwater.com

4

Exhibit99.2

TRANSACTION OVERVIEW AUGUST 2025 Private & Confidential 1

STRICTLY CONFIDENTIAL | 2 Basis of Presentation These Presentation Materials are provided for informational purposes only and have been prepared to assist interested parties in a proposed private placement in making their own evaluation with respect to an investment in connection with a potential business combination among Air Water Ventures Limited (“Air Water”), Inflection Point Acquisition Corp . III (“Inflection Point”) and the other parties thereto, including, if applicable, a holding company (“Pubco”) and related transactions (the “Potential Business Combination”) and for no other purpose . By accepting, reviewing or reading these Presentation Materials, you will be deemed to have agreed to the obligations and restrictions set out below . If these Presentation Materials have been received in error they must be returned immediately to Air Water or Jett Capital Advisors . No Offer or Solicitation These Presentation Materials and any oral statements made in connection with these Presentation Materials do not constitute an offer to sell, or a solicitation of an offer to buy, or a recommendation to purchase, any securities in any jurisdiction, or the solicitation of any vote, consent or approval in any jurisdiction in connection with the Potential Business Combination or any related transactions, nor shall there be any sale, issuance or transfer of any securities in any jurisdiction where, or to any person to whom, such offer, solicitation or sale may be unlawful under the laws of such jurisdiction . These Presentation Materials do not constitute either advice or a recommendation regarding any securities . No offering of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933 , as amended (the “Securities Act”) or an exemption therefrom . The dissemination, receipt and/or communication of this presentation is restricted by law ; it is not intended for distribution to, or use by any person in, any jurisdiction where such distribution or use would be contrary to local law or regulation . These Presentation Materials are not directed to or intended for distribution, or transfer, either directly or indirectly to, or use by, any person or entity that is a citizen or resident or located in any locality, state, country or jurisdiction where such distribution, transfer, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction . Recipients of this presentation should inform themselves about and comply with all applicable laws, regulations and legal requirements in their respective jurisdiction(s), and Air Water does not accept any liability whatsoever to any person or otherwise in relation thereto . Neither the U . S . Securities and Exchange Commission (the “SEC”) nor any other regulatory authority of any state or other jurisdiction of the United States has approved or disapproved of an investment in the securities or passed on the accuracy or adequacy of the contents of this presentation . Any representation to the contrary is a criminal offence in the United States . This presentation is directed at (i) persons outside the United Kingdom, or, if this presentation is intended for distribution in the United Kingdom, (ii) solely to (a) persons who have professional experience in matters relating to investments falling within Article 19 ( 5 ) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 , as amended (the “Order”) ; (b) members or creditors of a corporate body within the meaning of Article 43 of the Order ; (c) those persons falling within Article 49 ( 2 )(a) to (d) of the Order ; or (d) those persons to whom it can otherwise be distributed without contravention of Article 21 of the Financial Services and Markets Act 2000 or to whom it may otherwise lawfully be distributed (each, a “relevant person”) . This presentation is not directed at and must not be acted or relied upon by persons other than relevant persons . Any investment or investment activity to which this presentation refers or otherwise relates is directed at and only available to (i) relevant persons in the United Kingdom, and, (ii) “qualified investors” within the meaning of Article 2 ( 1 )(e) of the Prospectus Directive (Directive 2003 / 71 /EC) in any member state of the European Economic Area . No Representations and Warranties No representations or warranties, express, implied or statutory, are given in, or in respect of, these Presentation Materials, and no person may rely on the information contained in these Presentation Materials . Any data on past performance or modeling contained herein is not an indication as to future performance . This data is subject to change . Each recipient agrees and acknowledges that these Presentation Materials are not intended to form the basis of any investment decision by such recipient and do not constitute investment tax or legal advice . Recipients of these Presentation Materials are not to construe its contents, or any prior or subsequent communications from or with Inflection Point, Air Water, Pubco or their respective representatives as investment legal or tax advice . Each recipient should seek independent third party legal, regulatory, accounting and/or tax advice regarding these Presentation Materials . In addition, these Presentation Materials do not purport to be all - inclusive or to contain all of the information that may be required to make a full analysis of Air Water or the Potential Business Combination . Recipients of these Presentation Materials should each make their own evaluation of Air Water, and of the relevance and adequacy of the information and should make such other investigations as they deem necessary . Inflection Point, Air Water and Pubco assume no obligation to update the information in these Presentation Materials . Each recipient also acknowledges and agrees that the information contained in these Presentation Materials (i) is preliminary in nature and is subject to change, and any such changes may be material and (ii) should be considered in the context of the circumstances prevailing at the time and has not been, and will not be, updated to reflect material developments which may occur after the date of these Presentation Materials . To the fullest extent permitted by law, in no circumstances will Air Water, Inflection Point or Pubco or any of their respective subsidiaries, stockholders, affiliates, representatives, planers, directors, officers, employee, advisers or agents be responsible or liable for any direct, indirect or consequential loss or loss of profit arising from the use of these Presentation Materials, its contents, its omissions, reliance on the information contained within it or on opinions communicated in relation thereto or otherwise arising in connection therewith . These Presentation Materials discuss trends and markets that Air Water’s leadership team believes will impact the development and success of Air Water based on its current understanding of the marketplace and each recipient acknowledges this information is preliminary in nature and subject to change . Industry and Market Data Industry and market data used in these Presentation Materials, including information about Air Water’s total addressable market, has been obtained from third - party industry publications and sources as well as from research reports prepared for other purposes . Some data is also based on estimates of Air Water and/or Inflection Point, which are derived from their respective review of internal sources as well as third - party sources including those described above . Neither Inflection Point nor Air Water has independently verified the data obtained from these sources and cannot assure you of the reasonableness of any assumptions used by these sources or the data’s accuracy or completeness . DISCLAMERS

STRICTLY CONFIDENTIAL | 3 Forward Looking Statements Certain statements included in these Presentation Materials are not historical facts but are forward - looking statements, within the meaning of Section 27 A of the Securities Act, Section 21 E of the Securities Exchange Act of 1934 , as amended, and the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995 . Forward - looking statements generally are accompanied by words such as “according to estimates,” “assume,” “believe,” “could,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “is of the opinion,” “to the knowledge of,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” “target” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward - looking . These forward - looking statements include, but are not limited to, ( 1 ) statements regarding estimates and forecasts of financial, performance and operational metrics and projections of market opportunity ; ( 2 ) references with respect to the anticipated benefits of the Potential Business Combination and the projected future financial and operational performance of Pubco following the Potential Business Combination ; ( 3 ) the sources and uses of cash of the Potential Business Combination ; ( 4 ) the anticipated capitalization and enterprise value of Pubco following the consummation of the Potential Business Combination ; ( 5 ) statements regarding Pubco’s operations following the Potential Business Combination ; ( 6 ) the amount of redemption requests made by Inflection Point’s public shareholders, ( 7 ) current and future potential commercial relationships ; ( 8 ) the ability of Pubco to issue equity or equity - linked securities in the future ; and ( 9 ) expectations related to the terms and timing of the Potential Business Combination . Factors that may cause actual results to differ materially from current expectations include, but are not limited to : ( 1 ) risks relating to the successful implementation of Air Water’s business strategy and operational plan ; ( 2 ) the ability of key personnel to execute Air Water’s growth strategy and effectively manage Air Water’s operations ; ( 3 ) the risk that the Potential Business Combination disrupts current plans and operations of Air Water as a result of the announcement and/or consummation of the Potential Business Combination ; ( 4 ) regulatory or other developments that negatively impact demand for the products and services provided by Air Water ; ( 5 ) changes in business, market, financial, and/or political conditions, and in applicable laws and regulations ; ( 6 ) the outcome of any event, change, or other circumstances that could give rise to the termination of negotiations with respect to the Potential Business Combination or the inability to consummate the Potential Business Combination ; ( 7 ) the outcome of any legal proceedings that may be instituted against Air Water, Inflection Point, their respective affiliates, or others ; ( 8 ) changes to the proposed structure of the Potential Business Combination that may be required or appropriate as a result of applicable laws or regulations ; ( 9 ) the ability to meet stock exchange listing standards following the consummation of the Potential Business Combination ; ( 10 ) the risk that the Potential Business Combination disrupts current plans and operations of Air Water or Inflection Point as a result of the announcement and consummation of the Potential Business Combination ; ( 11 ) the ability to recognize the anticipated benefits of the Potential Business Combination, which may be affected by, among other things : competition, the ability of the combined company to grow and manage growth profitably, the ability of the combined company to build or maintain relationships with customers and retain its management and key employees, capital expenditures and requirements for additional capital, and timing of future cash flow provided by operating activities ; ( 12 ) costs related to the Potential Business Combination ; ( 13 ) estimates of expenses and profitability and underlying assumptions with respect to shareholder redemptions and purchase price and other adjustments ; and ( 14 ) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward - Looking Statements” in Inflection Point’s final prospectus relating to its initial public offering dated April 25 , 2025 , and in subsequent filings with the SEC, including the Registration Statement (as defined below) relating to the Potential Business Combination by Inflection Point, Air Water, and/or one or more of their affiliates, and periodic Exchange Act reports filed by Inflection Point with the SEC, such as its Annual Reports on Form 10 - K, Quarterly Reports on Form 10 - Q, and Current Reports on Form 8 - K . These statements are based on various assumptions, whether or not identified in these Presentation Materials, and on the current expectations of Inflection Point’s and Air Water’s management and are not predictions of actual performance . These forward - looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability . Actual events and circumstances are difficult or impossible to predict and will differ from assumptions . Many actual events and circumstances are beyond the control of Air Water . If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward - looking statements . The risks and uncertainties above are not exhaustive, and there may be additional risks that neither Inflection Point nor Air Water presently know or that Inflection Point and Air Water currently believe are immaterial that could also cause actual results to differ from those contained in the forward - looking statements . In addition . forward looking statements reflect Inflection Point’s and Air Water’s expectations, plans or forecasts of future events and views as of the date of these Presentation Materials . Inflection Point and Air Water anticipate that subsequent events and developments will cause Inflection Points’ and Air Water’s assessments to change . However, while Inflection Point and Air Water may elect to update these forward - looking statements at some point in the future, Inflection Point and Air Water specifically disclaim any obligation to do so . These forward - looking statements should not be relied upon as representing Inflection Point’s and Air Water’s assessments as of any date subsequent to the date of these Presentation Materials . Accordingly, undue reliance should not be placed upon the forward - looking statements . Trademarks These Presentation Materials contain trademarks, service marks, trade names and copyrights of third parties, which are the property of their respective owners . The use or display of third parties’ trademarks, service marks, trade names or products in these Presentation Materials are not intended to, and do not imply, a relationship with Inflection Point or Air Water, an endorsement or sponsorship by or of Inflection Point or Air Water, or a guarantee that Air Water or Inflection Point will work or will continue to work with such third parties . Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in these Presentation Materials may appear without the TM, SM, ® or © symbols, but such references are not intended to indicate, in any way, that Inflection Point, Air Water, or any third - party will not assert to the fullest extent under applicable law, their rights or the right of the applicable licensor to these trademarks, service marks, trade names and copyrights . Financial Information Summarized financial data in this presentation is provided solely for informational purposes, and should not be relied upon for the purpose of making an investment decision or otherwise entering into any transaction whatsoever . Furthermore, the financial information and data contained in these Presentation Materials are unaudited and do not conform to Regulation S - X promulgated under the Securities Act . Accordingly, such information and data may be adjusted in or may be presaged differently in any proxy statement or registration statement to be filed by Pubco with the SEC . Important Information for Investors and Stockholders In connection with a Potential Business Combination, Inflection Point, Air Water and Pubco are expected to prepare a registration statement on Form F - 4 (the “Registration Statement”) to be filed with the SEC by Pubco, which will include preliminary and definitive proxy statements to be distributed to Inflection Point’s shareholders in connection with Inflection Point’s solicitation for proxies for the vote by Inflection Point’s shareholders in connection with the Potential Business Combination and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued by Pubco’s security holders in connection with the completion of the Potential Business Combination . After the Registration Statement has been filed and declared effective, Inflection Point will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the Potential Business Combination . Inflection Point’s shareholders and other interested persons are advised to read, once available, the preliminary proxy statement/prospectus and any amendments thereto and, once available, the definitive proxy statement/prospectus, in connection with Inflection Point’s solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the Potential Business Combination, because these documents will contain important information about Inflection Point, Air Water, Pubco and the Potential Business Combination . Shareholders may also obtain a copy of the preliminary or definitive proxy statement, once available, as well as other documents filed with the SEC regarding the Potential Business Combination and other documents filed with the SEC by Inflection Point, without charge, at the SEC’s website located at www . sec . gov or by directing a request to Inflection Point Acquisition Corp . III at 167 Madison Avenue Suite 205 # 1017 , New York, NY 10016 . These Presentation Materials are not a substitute for the Registration Statement or for any other document that Inflection Point and/or Pubco may file with the SEC in connection with the Potential Business Combination. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of other documents filed with the SEC by Inflection Point through the website maintained by the SEC at http://www.sec.gov. DISCLAMERS

STRICTLY CONFIDENTIAL | 4 Participants In Solicitation Inflection Point, Air Water and Pubco and their respective directors and executive officers, under SEC rules, may be deemed to be participants in the solicitation of proxies of Inflection Point’s shareholders in connection with the Potential Business Combination . Investors and security holders may obtain more detailed information regarding Inflection Point’s directors and executive officers in Inflection Point’s filings with the SEC, including Inflection Point’s final prospectus for its IPO, and amendments thereto, as filed with the SEC . Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to Inflection Point’s shareholders in connection with the Potential Business Combination, including a description of their direct and indirect interests, which may, in some cases, be different than those of Inflection Point’s shareholders generally . will be set forth in the Registration Statement . Shareholders, potential investors and other interested investors should read the Registration Statement carefully when it becomes available before making any voting or investment decisions . Changes and Additional Information In Connection with SEC Filings The information in these Presentation Materials has not been reviewed by the SEC and certain information may not comply in certain respects with SEC rules . As a result, the information in the Registration Statement may differ from these Presentation Materials to comply with SEC rules . The Registration Statement will include substantial additional information about Air Water, Inflection Point and Pubco not contained in these Presentation Materials . Once filed, the information in the Registration Statement will update and supersede the information presented in these Presentation Materials . INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE POTENTIAL BUSINESS COMBINATION OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN . ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE . All references to the “company,” “we,” “us” or “our” refer to Air Water and its consolidated entities prior to the Potential Business Combination . The risks presented below are non - exhaustive descriptions of certain of the general risks related to the business of Air Water, Inflection Point and Pubco and the Potential Business Combination among Air Water, Inflection Point and Pubco . and such list is not exhaustive . The list below has been prepared solely for purposes of inclusion in these Presentation Materials and not for any other purpose . You should carefully consider these risks and uncertainties and should carry out your own diligence and consult with your own financial and legal auditors concerning the risks presented by the Potential Business Combination . Risks relating to the business of Air Water, the Potential Business Combination and the business of Pubco will be disclosed in future documents filed or furnished by Air Water, Inflection Point or Pubco with the SEC, including the documents filed or furnished in connection with the Potential Business Combination among Air Water, Inflection Point and Pubco . The risks presented in such filings will be continent with SEC filings typically relating to a public company, including with respect to the business and securities of Air Water, Inflection Point and Pubco and the Potential Business Combination among Air Water, Inflection Point and Pubco, and may differ significantly from, and be more extensive than, those presented below . DISCLAMERS

STRICTLY CONFIDENTIAL | INTRODUCTION Private & Confidential Section 1. Company Introduction 5

“Water stress is the biggest crisis no one is talking about. Its consequences are in plain sight in the form of food insecurity, conflict and migration and financial instability.” 1 - President and CEO of the World Resources Institute Creating accessible water from air at scale is ambitious, but we are making it a reality. INDUSTRIAL •COMMERCIAL •GOVERNMENT •RESIDENTIAL OPPORTUNITY STRICTLY CONFIDENTIAL | 6 1. Source: RELEASE: Updated Global Water Risk Atlas Reveals Top Water - Stressed Countries and States: https://www.wri.org/news/release - updated - global - water - risk - atlas - reveals - top - water - stressed - countries - and - states .

01 02 03 Extremely high >80% High 40% - 80% Medium to high 20% - 39% Low to medium 10% - 19% Low <10% Solving global water challenges is a strategic imperative. PROBLEM The world is predicted to face a water shortfall of 40% by 2030. 1 Companies in key industries are already losing billions — $15.5 billion has been stranded or is at risk due to changes in water regulations, high levels of pollution, and community opposition, leading to high - quality water supplies growing scarce. 2 Market vulnerability + volatility Water - intensive industries face operational disruptions and increased costs, with more volatile water pricing if market - based and dynamic pricing mechanisms are implemented . Mounting pressure Communities, governments, corporate ESG programs, financial reporting requirements and consumers demand change. 1. Source: World Economic Forum, Global freshwater demand will exceed supply 40% by 2030, experts warn: https://www.weforum.org/stories/2023/03/global - freshwater - demand - will - exceed - supply - 40 - by - 2030 - experts - warn/ . 2. Source: Carbon Disclosure Project, High and dry: how water issues are stranding assets: https://www.preventionweb.net/news/high - and - dry - how - water - issues - are - stranding - assets . 3. Source: World Resources Institute, Ranking the World’s Most Water - Stressed Countries in 2040: https://www.wri.org/insights/ranking - worlds - most - water - stressed - countries - 2040 . WHERE WATER STRESS WILL BE HIGHEST BY 2040 3 Projected ratio of water withdrawals to water supply in 2040 A new reality Water access will impact the global economy in new and unexpected ways, with natural disasters and shortages disrupting supply chains. STRICTLY CONFIDENTIAL | 7

01 02 Costly 03 04 Challenges with traditional water solutions Complex More than half of our water comes from desalination and groundwater . These sources require significant power, infrastructure, transportation and logistics . 1 , 2 Water costs are rising, as infrastructure is estimated to need $6.7 trillion by 2030 and $22.6 trillion by 2050. 3 Governments and businesses face added costs from regulation and public scrutiny . Outdated Water collection and treatment methods have remained largely unchanged despite a deepening crisis. Outdated infrastructure has meant water is often lost to leaks and faulty systems. 4 Unsustainable By 2030, demand for fresh water will outpace global supplies by 40%. 5 PROBLEM STRICTLY CONFIDENTIAL | 8 1. Source: United Nations, UN World Water Development Report 2022 ‘Groundwater: making the invisible visible’: https://www.unwater.org/news/un - world - water - development - report - 2022 - ‘groundwater - making - invisible - visible ’. 2. Source: Kleinman Center for Energy Policy, Sea Change: Desalination and the Water - Energy Nexus: https://kleinmanenergy.upenn.edu/research/publications/sea - change - desalination - and - the - water - energy - nexus/ . 3. Source: United Nations, Water Infrastructure and Investment: https://sustainabledevelopment.un.org/content/documents/hlpwater/08 - WaterInfrastInvest.pdf . 4. Source: Fluence, What is Non - Revenue Water?: https://www.fluencecorp.com/what - is - non - revenue - water/ . 5. Source: World Economic Forum, Global freshwater demand will exceed supply 40% by 2030, experts warn: https://www.weforum.org/stories/2023/03/global - freshwater - demand - will - exceed - supply - 40 - by - 2030 - experts - warn/ .

STRICTLY CONFIDENTIAL | Regions / geographies worldwide 20 - 43 ƒ C temperatures (63 - 104 ƒ F) 25 - 100% relative humidity A simple power source (electric, fuel, solar, wind) Renewable water, on site, at scale A1R WATER MAKES IT POSSIBLE TO Augment existing water supplies without overtaxing traditional water sources, ecosystems and infrastructure. SOLUTION With more water in the atmosphere than in rivers worldwide, 1 air - to - water technology (atmospheric water generation) may be a solution to create clean, accessible, scalable water. 9 1. Source: U.S. Geological Survey, How Much Water is There on Earth: https://www.usgs.gov/water - science - school/science/how - much - water - there - earth .

STRICTLY CONFIDENTIAL | INTRODUCTION Investment Highlight s This transformation will not only challenge our expectations but also catalyze a surge in investment. As we enter this new era, the ability to gather and generate potable water demands immediate and decisive action. Large addressable market By 2031, the air - to - water market is forecasted to reach $12.5B. 1 Proven product viability Strong early traction in commercial and consumer segment in UAE with regional and international market leaders. Transformative technology Unique Alpha Airflow along with purification IP creates water from air in a range of diverse temperatures and humidity levels, improving energy efficiency. Market expansion potential Scaling up to major bottled water distribution, exploring new industrial uses and developing large - scale water farms, unlocking vast growth opportunities. Robust R&D pipeline By developing off - grid solutions and expanding our consumer product range, we're pushing the boundaries of technology and market engagement. Strong Management With over a century of collective expertise, our team excels in engineering, commercial and brand expertise, water quality/purification, finance, operations and manufacturing – positioning us at the forefront of innovation and efficiency. In the next 10 years, the illusion of water's infinite availability will confront its most significant test. 10 1. Source: Transparency Market Research, Atmospheric Water Generator Market: https://www.transparencymarketresearch.com/atmospheric - water - generator - market.htm l .

A1R05 2 Applications: Individual, homes, hotel suites, offices 5 litres / day 20 litres / day A1R20 2 Applications: Homes, small offices, hotels A1R30 Applications : Offices, hotels and homes 30 litres / day A1R100 Applications: Schools, hotels and offices 100 litres / day A1R1000 Applications: Industrial or high - volume consumption, such as remote communities or commercial enterprises 1,000 litres / day A1R3000 Applications: Industrial or high - volume consumption, such as industrial or manufacturing facilities 3,000 litres / day STRICTLY CONFIDENTIAL | Air - to - water generators and dispensers A1R FLEET PRODUCTS INDOOR USE OUTDOOR USE 11 1. Source: A1R WATER, Explore the Fleet: https://A1R WATER.com/solutions/awg - water - generators/#fleet . 2. Product is currently in research and development phase.

Replenish water as it's consumed, meeting exact needs without waste or plastic bottles. 5 Pull air from the atmosphere and HEPA filters clear out impurities. 1 Condense the air into water over cooling coils. 2 Purify, mineralize and sanitize the water, removing contaminants and enhancing taste and mineral profiles as needed. 3 Deliver clean, high - quality water on site, continuously recirculating for freshness and sanitation. 4 WELCOME TO A1R WATER Creating water from air Engineered for the demanding conditions of desert environments, our air - to - water technology transforms humidity in the air into high - quality drinking water. Our intensive filtration process purifies, sanitizes and enriches water with natural minerals as needed for diverse applications. OUR TECHNOLOGY STRICTLY CONFIDENTIAL | 12

Large - scale configurable solutions PRODUCTS BOTTLING FACILITIES 1 Designed to meet specific needs and sustainability goals with cost - effective on - site bottling facilities, complete with water treatment, automation, bottle sanitation and more . WATER FARMS 2 Our renewable water farms generate consistent, self - sufficient water supply at scale, reducing dependency on traditional water sources. Produces 100,000+ litres of water per day on site Reduces or eliminates dependence on traditional water sources, large - scale water transportation and single - use plastic Long - term contracted offtake for large - scale water production at a competitive price point Healthy rate of return on internally funded projects with long - term contracted cash flow STRICTLY CONFIDENTIAL | Capable of producing approximately one million litres of water per farm per day Flexible and secure with renewable water, hybrid power generation and underground water storage Self - sufficient, independent from coastal water and main power grids Optimised to serve remote, urban and inland populations, agricultural areas and unused desert spaces Water can be channeled into municipality infrastructure or used for emergency / military response 13 1. Source: A1R WATER, Announcing our new 100,000+ litre air - to - water bottling facility: https://A1R WATER.com/company - updates/dubai - industrial - city - air - to - water - bottling - facility/ . 2. Source: Revolutionise water supply with large - scale water farms: https://A1R WATER.com/solutions/water - farms/ .

PRODUCTS STRICTLY CONFIDENTIAL | Price per Liter = $0.04 3000L (or 792 G) = $120 Price per Liter = $0.02 30L (or 7.9 G) = $.60 14

600 500 400 300 200 100 0 Bottled water market size 2024 to 2034 (USD billion) 1 The $335.5B bottled water market — a single use case MARKET OPPORTUNITY The global bottled water market reached $335.5 billion in 2024, and is poised to hit $565.2 billion by 2034 with a CAGR of 5.35%. 1 A1R WATER is positioned as a sustainable alternative for this high - consumption market, tapping into rising demand. STRICTLY CONFIDENTIAL | 15 $336 $354 $373 $393 $436 $414 $460 $485 $539 $511 $565 $100 $0 $200 $300 $400 $500 $600 2024 25 26 27 28 29 30 31 32 33 34 5.35% CAGR (2025 - 2034) 1 1. Source: Precedence Research, Bottled Water Market Size, Share, and Trends 2025 to 2034: https://www.precedenceresearch.com/bottled - water - market .

Elevating the Game with the Miami HEAT NBA’s First Team to harness Air - to - Water technology The Heat partnering with A1R WATER sets a new standard as the first NBA team to produce water directly from air, reinforcing the Heat’s commitment to both innovation and sustainability. Sustainable water reduces plastics while turning water into a potential new revenue opportunity with Miami Heat - branded bottles and cans, available across the arena and retail channels. In 2025, A1R WATER will be the Official Water of the Miami HEAT 1. Source: A1R WATER, A1R WATER is Teaming up with The Miami HEAT to Keep Fans Hydrated in The Coolest Way Possible: https://a1rwater.com/company - updates/a1rwater - miamiheat/.

PARTNERSHIPS STRICTLY CONFIDENTIAL | 17 A1R WATER x Hilton for Sustainable Change Where Innovation Meets Hospitality Effective July 2025, A1R WATER and Hilton partner to bring innovative water technology to Conrad Abu Dhabi Etihad Towers New partnership between A1R WATER and the Hilton Group of Hotels In a signing ceremony held at Conrad Abu Dhabi Towers, Hilton’s flagship property in Abu Dhabi, we formalized a collaboration that introduces A1R WATER’s advanced Air - to - Water technology and reusable glass bottles, a first - of - its - kind initiative in the UAE hotel sector aimed at drastically reducing plastic consumption. As part of this collaboration, Conrad Abu Dhabi Etihad Towers will: • Eliminate thousands of single - use plastic water bottles annually. • Offer mineral - balanced drinking water produced from atmospheric moisture. • Deliver a premium in - room experience using glass - bottled water. 1. Source: A1RWATER, Conrad Hilton Abu Dhabi Lead with A1RWATER in Pioneering Plastic - Free Guest Experience: https://a1rwater.com/company - updates/a1rwater - hilton - partnership - conrad - abu - dhabi/ . 17

Partnered with BBH – Global Marketing and Creative Agency • BBH has led extensive Consumer Research, Brand/Product desire research, Creative and Brand Marketing activity and all Brand Architecture work for the Consumer offering for A1R WATER SALES & MARKETING STRICTLY CONFIDENTIAL | 18 Water has always been born from the earth. Harvested from rivers, carved from glaciers, pulled from streams. But what if water could break free? Free from its beginnings to forge a new path. A path not bound by place or scarcity, but possibility. Meet A1R WATER. Our innovative process harnesses humid air, purifies it and transforms it into water. From air. No land. No limits. No microplastics. Finally, water finds its freedom. A1R WATER. Water reborn.

MARKET OPPORTUNITY 16.3% CAGR (2023 - 2031) The global atmospheric water generator market The air - to - water market is currently growing at a 16.3% CAGR. 1 Global forces driving innovation and adoption: Growth of the population, straining finite water supplies where it is needed; droughts Cost and environmental impact of water transportation; deficient water management systems that cannot accommodate the escalating demand The need to enhance agricultural productivity while conserving and augmenting natural resources Government mandates to meet stringent environmental standards and reduce single - use plastics STRICTLY CONFIDENTIAL | The air - to - water market forecast: 1 $12.5B (By the end of 2031) Water scarcity concerns: 1 Agriculture consumes about 70% of freshwater worldwide, reaching 95% in some areas. With global population growth, water shortages are poised to become a major future challenge without sustainable solutions. Increasing freshwater shortages worldwide are prompting the search for alternative water sources. Alternative water sources are gaining momentum as governments and institutions increasingly turn to AWGs to strengthen water security and address shortages. 19 1. Source: Transparency Market Research, Atmospheric Water Generator Market: https://www.transparencymarketresearch.com/atmospheric - water - generator - market.htm l .

B2G B2B B2C STRICTLY CONFIDENTIAL | TRACTION +GROWTH AREAS OF FOCUS We believe the greatest demands for air - to - water technology are in the MEA regions and in North America. 1,2 We have built brand awareness in the UAE and continue to grow our market share. We are also expanding in the GCC and North America, where there is growing demand and urgency due to government mandates, single - use plastic bans and ESG efforts. TARGET MARKETS • UAE is where we started and MEA/GCC region is where the foundation of our company is currently. • The U.S. consumer market, as well as the B2B/B2G market, presents an opportunity for significant growth. • We believe the opportunity the opportunity exists NOW to build our U.S. business and secure a "1st mover advantage" in the competitive, U.S. consumer market. 20 1. Source: Abdul Latif Jameel, Thirst for investment: solving the Middle East’s Water Challenges: https://alj.com/en/perspective/thirst - for - investment - solving - the - middle - easts - water - challenges/ . 2. Grandview Research, U.S. Bottled Water Market Size, Share & Trends Analysis Report By Product (Spring Water, Sparkling Water), By Distribution Channel (On - Trade, Off - Trade), By Packaging, And Segment Forecasts, 2025 – 2030: https://www.grandviewresearch.com/industry - analysis/us - bottled - water - market - report .

STRICTLY CONFIDENTIAL | SECTION 2 TRANSACTION OVERVIEW Private & Confidential 21

A1R WATER LEADERSHIP STRICTLY CONFIDENTIAL | Pete Carr – Chief Executive Officer (CEO) • Over 35 years of cross - functional and diverse geographical experience in consumer - packaged goods and manufacturing businesses. • Pete has been raising standards in the beverage industry for the past three decades. He makes it a priority to remain knowledgeable about consumer trends. • Prior to joining A1R WATER in 2024, over the last 15 years Pete held significant leadership roles in large beverage organizations (both private and public): • Global Chief Growth Officer – Bacardi Limited • President & CEO – Bacardi North America • President – Glazer’s Inc. (Now Southern Glazer’s Wine & Spirits) • President U.S. Spirits – Diageo North America • President – Diageo Guinness USA • SVP, Sales – Diageo North America • His expertise is in Sales, Marketing, route - to market strategy, and revenue creation within the CPG and beverage sector. Ryan Bibbo – Chief Operating Officer (COO) • Over 25 years as a senior executive with extensive international experience across business operations and organizational management arena, Ryan has proven leadership through a variety of businesses and markets. • In the beverages industry for 20+ years, Ryan has a unique blend of functional expertise and a comprehensive understanding of business strategy and execution along the commercial and consumer environment. • Prior to joining A1R WATER in 2024, over the last 15 years Ryan held significant leadership roles in large organizations (both private and public): • Global VP of People & Talent – Bacardi Limited • VP, Chief of Staff & Human Capital – Bacardi North America • Vice President – Glazer’s Inc. (Now Southern Glazer’s Wine & Spirits • VP Commercial Capability & Talent Mgmt. – Diageo North America • Vice President – Diageo Guinness USA • Ryan has overseen significant organizational change initiatives including Route - to - Market projects that transformed the way Bacardi distributes its products. For example, Ryan played a major role in designing and executing the new organizational strategy and structure of Bacardi and its North America distribution partners. • He has been recognized by both employers and business leaders as a strategic partner who brings a strong sense of urgency and an ability to lead teams and organizations through times of significant change into growth. Mr. Bibbo is a recipient of the 2017 South Florida “Power Leader” Award and was selected as a University of Miami Business School ”Executive Education Advisory Committee – Member”. • His expertise is in organizational strategy, leading business operating activities, and value creation within the CPG and beverage sector. 22

STRICTLY CONFIDENTIAL | INFLECTION POINT ACQUISITION CORP. III LEADERSHIP Michael Blitzer – Chairman & Chief Executive Officer (CEO) • Mr. Blitzer has been Chairman and CEO since October 2024, with prior CEO and director roles at IPXX (2023 – 2025) and IPAX (2021 – 2023). • He was the founder and Co - CEO of Kingstown Capital Management, which Mr. Blitzer grew into a multi - billion dollar asset manager. • Mr. Blitzer currently sits on the Board of Directors of Intuitive Machines, Inc. (Nasdaq: LUNR) and is the Chair of the Board of Directors of USA Rare Earth, Inc. (Nasdaq: USAR). • He began his career at J.P. Morgan Securities and Gotham Asset Management. • Mr. Blitzer holds an M.B.A. from Columbia Business School and a B.S. from Cornell University and is actively involved in educational philanthropy. Kevin Shannon – Chief Operating Officer (COO) • Kevin Shannon has been COO since November 2024, after serving as Chief of Staff at both IPXX (2023 – 2025) and IPAX (2021 – 2023), where he was deeply involved in target search, negotiations, and due diligence. • He co - founded Inflection Point Asset Management in 2024 with Michael Blitzer, focusing on SPAC sponsor and PIPE investments. • Mr. Shannon is currently Capital Markets Advisor for Intuitive Machines, Inc. and Board Advisor to USA Rare Earth, Inc. • Previously, he was a Principal at The Venture Collective (2023 – 2024), sourcing and diligence later - stage venture investments, and a Senior Analyst at Kingstown Capital (2021 – 2023). • He began his career in Equity Capital Markets at Bank of America, working across multiple sectors and product teams. 23

STRICTLY CONFIDENTIAL | Summary of Terms Deal Structure • Existing A1R WATER shareholders rolling 100% of their equity and will have a pro forma equity ownership of 62.9% at Transaction Close • SPAC Sponsor, Inflection Point to retain a pro forma equity ownership of 17.7% at Transaction Close • A1R WATER shareholders to have 4 milestone earn - outs as follows: 1. 7.5M shares to vest upon quarterly run - rate revenue surpassing $25.0M by the quarter ending June 30th, 2026 (12 months from LOI) or PubCo or any of its consolidated subsidiaries enters into an agreement on or prior to June 30, 2026 with certain public and private sector clients that provides for minimum annual and recurring revenue of at least $100M 2. 7.5M shares to vest upon quarterly run - rate revenue surpassing $50.0M by the quarter ending December 31 st , 2026 (18 months from LOI) 3. 7.5M shares to vest upon quarterly run - rate EBITDA surpassing $12.5M by the quarter ending December 31 st , 2026 (18 months from LOI) 4. 7.5M shares to vest upon the post - combination share price trading above $20.00 for any 20 out of 30 consecutive trading days in the 12 - month period commencing 6 - months from Transaction Close Valuation • Inflection Point to value A1R WATER at a pre - money Enterprise Value of $300.0M • Transaction implies a $416.7M pro forma Enterprise Value at Close Financing • Agreements signed with SPAC Sponsor; Inflection Point to lead a Convertible Preferred Share Private Investment in Public Equity (“PIPE”) • Existing A1R WATER shareholders and strategic investors to participate • Targeting a $75.0M total PIPE raise as follows: 1. $25.0M pre - funded portion to fund at or prior to signing of the Business Combination Agreement 2. $50.0M to fund at Transaction Close Ownership % Shares (M) 62.9% 30.0 A1R WATER 17.7% 8.4 Inflection Point 2 12.4% 5.9 PIPE Investors 3,4 7.0% 3.3 Rights & Other Investors 3,4 1 2 3 1 2 3 47.7 PF Shares Outstanding (M) 30.0 A1R WATER Shareholders 8.4 SPAC Sponsor 2 5.9 PIPE Investors 3,4 3.3 Rights & Other Investors 3,4 $10.00 Share Price ($) $476.7 PF Equity Value ($M) $0.0 (+) PF Debt ($M) ($60.0) ( - ) PF Cash 5 ($M) $416.7 PF Enterprise Value ($M) 6 Pro Forma Capitalization 1 Pro Forma Ownership 24 Assumptions: 1. 0% Trust Retention 2. "SPAC Sponsor" does not include shares Inflection Point also owns through prefund, PIPE, IPCX Private Placement, or Rights 3. "PIPE Investors" includes Prefund investors, at - close PIPE Investors & 83k shares for Sandia's $1.0M loan amortization 4. "Rights & Other Holders" includes shares underlying all IPO Rights as well as shares & rights in the 740k share IPCX private placement 5. PF Cash rounded to $60.0M (as some fees/expenses are not yet known or negotiated) 6. No warrants are listed or included as they have no impact on the EV or EQV at the time of DeSPAC TRANSACTION OVERVIEW 4 4

STRICTLY CONFIDENTIAL | Summary of Proposed Financing Terms Air Water Ventures Holdings Limited, a Cayman limited company and parent of Air Water Ventures Limited Issuer $75.0M target total, with $25.0M target to prefund substantially concurrent with signing of Business Combination Agreement Issuance Amount $300.0M (excluding 30.0M share earn - out), 15.0% Original Issue Discount for prefunded portion Pre - Money Valuation Series A Convertible Preferred Unit Security $12.00 per Unit Unit Price 1 Series A Cumulative Convertible Preferred Share (the “Series A Share”); and 1 Warrant to Purchase 1 Share of Common Stock (the “Series A Warrant”) Unit Composition Conversion Price: $12.00 per Share Dividend: Semi - annual dividend payable as 10.0% Cash, or 12.0% PIK Price Protection: 1 - time VWAP - Based Reset with price floor of $5.00 Other Terms: 1 st Ranking, Liquidation Preference, Put Right, other standard protective provisions Series A Share Terms Strike Price: $12.00 per Share Expiry: 5 - years from Business Combination Price Protection: 1 - time VWAP - Based Reset with price floor of $5.00 Other Terms: Subject to adjustments for stock dividends, splits, combinations and similar events Series A Warrant Terms Substantially concurrent with the closing of the Business Combination (with exception to the prefunded portion) Closing 25 PIPE FINANCING

STRICTLY CONFIDENTIAL | $0.30 $0.18 $0.47 $0.76 $1.06 $1.40 $1.95 $2.77 0 0.5 1 1.5 2 2.5 3 Airwater Alani Nu Consolidated Water Ene rgy Recove ry Source Global Liquid Death Poppi T PureCycle echnologies Valuation (US$B) Private Company 2 Public Company 1 30 Select Comparable Water, Technology & Beverage Valuations 26 $32.36 1. Source: Market Capitalization as of 07/25/2025, source: Yahoo Finance 2. Source: Pitchbook VALUATION BENCHMARKING

STRICTLY CONFIDENTIAL | Comparable Valuation Driver Core Focus Valuation Company Sets the upper ceiling for mature, diversified water platforms Scale plus recurring utility - style cash flow Global water - tech & infrastructure US$32.3B Market Cap 1 Shows pre - scale sustainability plays can hold multi - B values Patented ESG tech in early roll - out Circular polymer up - cycling US$2.77B Market Cap 1 Brand - led wellness story can deliver 10 î revenue exits Viral growth + strategic buyer Prebiotic soda brand US$1.95B Pepsi Acquisition 2 Bold branding wins unicorn status before profitability Viral marketing, repeat purchase traction Disruptive canned water brand US$1.4B Series F Valuation 2 Closest tech analogue – valuation baseline for novel water making Proprietary hardware + climate narrative Atmospheric water generators US$1.06M Series D Valuation 2 Hardware suppliers to water infra trade mid - hundreds Proven EBITDA + niche dominance Desalination energy - saving tech US$756.5M Market Cap 1 Establishes the valuation floor for asset - heavy water plays Regulated utility cash flows Desalination plant operator US$472.1M Market Cap 1 Lifestyle engagement commands premium multiples Influencer community + strong margins Fitness energy drinks US$180M Celsius Acquisition 2 27 1. Source: Market Capitalization as of 07/25/2025, source: Yahoo Finance 2. Source: Pitchbook VALUATION BENCHMARKING

A BOLD FUTURE PARTNER WITH US TO PIONEER A FUTURE WHERE WATER IS SUSTAINABLY SOURCED, TRANSFORMING ACCESS AND CONSUMPTION FOR GENERATIONS TO COME. A1RWATER.COM A SI M PL E T R U T H : WATER IS ESSENTIAL TO OUR EVERYDAY LIVES, SURVIVAL AND PLANET. STRICTLY CONFIDENTIAL | 28

STRICTLY CONFIDENTIAL | 29 Risk Factors All references to the “company,” “we,” “us” or “our” refer to Air Water Ventures Limited and its consolidated entities prior to the Potential Business Combination. The risks presented below are non - exhaustive descriptions of certain of the general risks related to the business of Air Water, Inflection Point and Pubco and the Potential Business Combination among Air Water, Inflection Point and Pubco, and such list is not exhaustive. The list below has been prepared solely for purposes of inclusion in this Presentation and not for any other purpose. You should carefully consider these risks and uncertainties and should carry out your own diligence and consult with your own financial and legal advisors concerning the risks presented by the Potential Business Combination. Risks relating to the business of Air Water, the Potential Business Combination and the business of Pubco will be disclosed in future documents filed or furnished by Air Water, Inflection Point or Pubco with the SEC, including the documents filed or furnished in connection with the Potential Business Combination among Air Water, Inflection Point and Pubco. The risks presented in such filings will be consistent with SEC filings typically relating to a public company, including with respect to the business and securities of Air Water, Inflection Point and Pubco and the Potential Business Combination among Air Water, Inflection Point and Pubco, and may differ significantly from, and be more extensive than, those presented below. Risks Related to Our Business and Our Industry • Our financial results depend on successful project execution and may be adversely affected by cost overruns, failure to meet customer schedules, failure of our subcontractors to fulfill their obligations to us, or other execution issues. • In order to successfully implement our plans and strategies, we will need to grow the size of our organization and may experience difficulties in managing this growth. • Our sales and profitability may be impacted by, and we may incur liabilities as a result of, warranty claims, product defects, recalls, improper use of our products, or our failure to meet performance guarantees or customer safety standards, or treat emerging contaminants. • We may in the future enter into long - term supply agreements that could result in insufficient inventory and negatively affect our results of operations. • We lack sufficient funds to achieve our planned business objectives. Our ability to continue as a going concern is dependent on (i) continued financial support from our shareholders and other related parties, (ii) raising capital via external financing, and/or (iii) attaining profitable operations. • We face supply chain competition, including competition from businesses in other industries, which could result in insufficient inventory and negatively affect our results of operations. • A loss of, or material cancellation, reduction, or delay in purchases by or delivery of products to, one or more of our largest customers could harm our business. • Mergers in our industry among our current or potential competitors may adversely affect our competitive position. • Consumer preferences for our products are difficult to predict and may change, and, if we are unable to respond quickly to new trends, our business may be adversely affected. • Our business is subject to evolving sustainability regulatory requirements and expectations, which exposes us to increased costs and legal and reputational risks. • A reduction in consumer concerns about the environmental impact of plastic bottles and other packaging materials could result in reduced demand for our products and could harm our business. • We are subject to risks associated with changing technology, product innovation, manufacturing techniques, operational flexibility and business continuity, which could place us at a competitive disadvantage. • We may face opposition to the operation and expansion of our facilities from various individuals and groups. • We expect to incur research and development costs and devote resources to identifying and commercializing new products and services, which could reduce our profitability and may never result in revenue to us. • Our future performance is difficult to evaluate because we have a limited operating history. • Our long - term success will depend ultimately on implementing our business strategy and operational plan, as well as our ability to generate revenues, achieve and maintain profitability and develop positive cash flows. • We have a history of losses and may not be able to achieve or maintain profitability in the future. • Our long - term success depends, in part, on our ability to negotiate and enter into sales agreements with, and deliver our products to, third party customers on commercially viable terms. There can be no assurance that we will be successful in securing such agreements. • We may seek to raise further funds through equity or debt financing, joint ventures, production sharing arrangements or other means. Any inability to access the capital or financial markets may limit our ability to fund our ongoing operations, execute our business plan or pursue investments that we may rely on for future growth. • If we fail to retain our key personnel or if we fail to attract additional qualified personnel, we may not be able to achieve our anticipated level of growth and our business could suffer. • We currently face and will continue to face significant competition from established companies with longer operating histories, customer incumbency advantages, access to and influence with governmental authorities, and more capital resources than we do. We could experience customers diverted to our competition, downward pricing pressures, and significant reductions to our revenue. • Any failure by management to manage growth properly could have a material adverse effect on our business, operating results and financial condition. • Damage to our reputation or brand image can adversely affect our business. • Our reliance on distributors, retailers and brokers could affect our ability to efficiently and profitably distribute and market our products, maintain our existing markets and expand our business into other geographic markets, which can adversely affect our growth, business, financial condition and results of operations. • The holders of our preferred shares have certain approval rights over actions taken by us, including related to incurring debt. RISK FACTORS

STRICTLY CONFIDENTIAL | 30 Risks Related to Legal, Compliance and Regulations • The legal and regulatory environment in the jurisdictions in which we operate, changes thereto and our ability to comply with the same could negatively affect our results of operations, adversely affect demand for our products and services or result in litigation. • We conduct business in markets with high - risk legal compliance environments which exposes us to increased legal and reputational risk. • Uncertainties in the interpretation and application of existing, new, and proposed tax laws and regulations could materially affect our tax obligations and effective tax rate. • Failure to comply with laws and regulations applicable to our business can adversely affect our business. • Failure by suppliers or co - packers to comply with applicable laws and regulations, or with specifications and other requirements for our products, may adversely impact our business. • We are subject to environmental, health and safety laws and regulations, and labor laws in multiple jurisdictions, which impose substantial compliance requirements on our operations. Our operating costs could be significantly increased in order to comply with new or stricter regulatory standards imposed by any governmental agency in which we operate. • Unforeseen environmental costs could adversely affect our business and results of operations. • Delays in enactment or repeals of environmental laws and regulations may make our products, services, and solutions unnecessary or less economically beneficial to our customers, adversely affecting demand for our products, services, and solutions. • Advertising inaccuracies and product mislabeling may have an adverse effect on our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings. • Regional hostilities, terrorist attacks, communal disturbances, civil unrest and other acts of violence or war may result in a loss of investor confidence and a decline in the value of our equity shares and trading price of our shares following our business combination. • Our business may be adversely affected by changes in government policies, laws and regulations in the UAE. • Increased scrutiny and changing expectations from investors regarding environmental, social and governance considerations may result in the decrease of the trading price of our securities. In particular, we may suffer reputational harm due to our business dealings in certain countries that have previously been associated, or perceived to have been associated, with human rights issues. • The reduction, elimination, or expiration of government subsidies, economic incentives, tax incentives, and other support for our products, or other public policies could negatively impact our operations. • Our businesses require numerous permits, licenses, franchises and other approvals from various governmental agencies, and the failure to obtain or maintain any of them, or lengthy delays in obtaining them, could materially adversely affect us. • Any failure by us to comply with the anti - corruption, anti - bribery, privacy/personal data, consumer protection, environmental and similar laws could result in legal penalties and fines, and/or negatively impact our reputation and results of operations. • The requirements of being a public company in the U.S. may strain our resources and divert management’s attention, and the increases in legal, accounting and compliance expenses that will result from being a public company in the U.S. may be greater than we anticipate. • As a private company, we have not been required to document and test our internal controls over financial reporting nor has our management been required to certify the effectiveness of our internal controls and our auditors have not been required to opine on the effectiveness of our internal control over financial reporting. Failure to maintain adequate financial, information technology and management processes and controls could impair our ability to comply with the financial reporting and internal controls requirements for publicly traded companies, which could lead to errors in our financial reporting and adversely affect our business. Economic and External Risks • The occurrence of significant events against which we may not be fully insured could have a material adverse effect on our business, financial condition and results of operations. • The threat of global economic, capital markets and credit disruptions pose risks to our business. • Inflation has increased our operating costs, and we expect to continue to experience inflationary conditions. • Our business could be adversely affected by recent and further changes in the tariff and trade policies of the United States or of other countries. • Our business may be adversely affected by force majeure events outside our control, including labor unrest, civil disorder, war, subversive activities or sabotage, extreme weather conditions, fires, floods, explosions or other catastrophes, epidemics or quarantine restrictions. For example, a hurricane or tropical storm could cause major damage to our facilities, equipment and properties and adversely affect our supply chain and operations. • Geopolitical conditions, including trade disputes and direct or indirect acts of war or terrorism could adversely affect our business, financial condition and results of operations. • Turmoil in the banking industry may negatively impact our business, results of operations and financial condition. Risks Related to Intellectual Property and Technology • Our patent applications may not result in issued patents, and any issued patents may not provide adequate protection, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours. • Our failure to protect our intellectual property rights may undermine our competitive position, and litigation to protect our intellectual property rights may be costly. • We may need to defend ourselves against claims that we infringe, have misappropriated, or otherwise violate the intellectual property rights of others, which may be time - consuming and would cause us to incur substantial costs. • Cyber - attacks or a failure in our information technology and data security infrastructure could adversely affect our business and operations. RISK FACTORS

STRICTLY CONFIDENTIAL | 31 Risks Related to Our Projections • Our financial projections included in this presentation rely in large part upon assumptions and analyses developed by us. If these assumptions prove to be incorrect, our actual operating results may differ materially from the forecasted results. • Demand for our products may not grow or may grow at a slower rate than we anticipate. • The rapidly evolving and competitive nature of our industry makes it difficult to evaluate our future prospects. • If our estimates and assumptions we use to determine the size of our total addressable market are inaccurate, our future growth rate may be affected and the potential growth of our business may be limited. Risks Related to Inflection Point and the Potential Business Combination • Directors and officers of Inflection Point, its sponsor and their affiliates, have interests in the Potential Business Combination and the related transactions that are different from, or in addition to and/or in conflict with, those of the Inflection Point’s shareholders generally. • Past performance by Inflection Point’s management team, its advisors and their respective affiliates, including investments and transactions in which they have participated and businesses with which they have been associated, may not be indicative of future performance of an investment in the Company. • Inflection Point’s sponsor and Inflection Point’s directors and officers have agreed to vote in favor of the Potential Business Combination, which will increase the likelihood that Inflection Point will receive the requisite shareholder approval for the Potential Business Combination and the transactions contemplated thereby regardless of how Inflection Point’s public shareholders vote. • The ability of Inflection Point’s public shareholders to exercise redemption rights with respect to a large number of public shares could deplete Inflection Point’s trust account prior to the Potential Business Combination and thereby diminish the amount of working capital of the combined company. • Securities of companies formed through combinations with special purpose acquisition companies such as Inflection Point may experience a material decline in price relative to the share price prior to such combinations. • Inflection Point’s sponsor, directors, officers, and affiliates of Inflection Point’s management team may receive a positive return on their investment in Inflection Point’s 8,433,333 founder shares, even if Inflection Point’s public shareholders experience a negative return on their investment after consummation of the Potential Business Combination. Similarly, certain directors, officers, and affiliates of Inflection Point’s management team may receive a positive return on their investments in preferred equity and related securities of the Company and of the combined company, even if Inflection Point’s public shareholders experience a negative return on their investment after consummation of the Potential Business Combination. • Inflection Point cannot assure you that its diligence review has identified all material risks associated with the Potential Business Combination, and you may be less protected as an investor from any material issues with respect to the Company’s business, than an investor in an underwritten initial public offering. • Subsequent to the consummation of the Potential Business Combination, the combined company may be required to take write - downs or write - offs, restructuring and impairment or other charges that could have a significant negative effect on the combined company’s financial condition, results of operations and stock price, which could cause you to lose some or all of your investment. • The net cash available to the combined company from Inflection Point’s trust account and the financings associated with the Potential Business Combination with respect of each public share that is not redeemed will be materially less than price per share implied in the business combination agreement to the ordinary shares of the combined company to be issued to the Company’s securityholders. • Inflection Point’s shareholders will experience significant dilution due as a consequence of the Potential Business Combination and the associated financing transactions. • Because Inflection Point is incorporated under the laws of the Cayman Islands, and the combined company will be incorporated under the laws of the Cayman Islands, their respective shareholders may face difficulties in protecting their interests and their ability to protect their rights through the U.S. federal courts may be limited. • Inflection Point may be a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. investors. • If Inflection Point is deemed to be an investment company under the Investment Company Act of 1940, as amended, it may be required to institute burdensome compliance requirements and its activities may be restricted, which may make it more difficult to complete the Potential Business Combination or cause the parties to abandon their efforts to complete the Potential Business Combination. • The Company and Inflection Point will incur significant transaction costs in connection with the Potential Business Combination, which may exceed current estimates and expectations, and those costs will be paid using the proceeds from the Potential Business Combination and the related financings, diminishing the amount of working capital of the combined company. • The consummation of the Potential Business Combination is subject to a number of conditions and, if those conditions are not satisfied or waived, the agreement governing the Potential Business Combination may be terminated in accordance with its terms and the Potential Business Combination may not be completed. • During the pre - closing period, Inflection Point and the Company are prohibited from entering into certain transactions that might otherwise be beneficial to them or their respective stakeholders. • The Potential Business Combination may result in adverse tax consequences for the holders of Inflection Point’s securities. • There can be no assurance that the combined company will be able to meet the initial listing standards of Nasdaq, or following the closing of the Potential Business Combination, continued listing standards of Nasdaq • If the benefits of the Potential Business Combination do not meet the expectations of investors or securities analysts, the market price of the combined company’s securities may decline. • An active trading market for the combined company’s ordinary shares may not be available on a consistent basis to provide shareholders with adequate liquidity. The market price of the combined company’s ordinary shares could decline significantly and the trading volume could decline significantly or become volatile following the consummation of the Potential Business Combination. • The holders of preferred shares issued in connection with the Potential Business Combination will have certain approval rights over actions taken by the combined company, including related to incurring debt. • After completion of the Potential Business Combination, the combined company may be at an increased risk of securities class action litigation. • Future sales and issuances of shares or other equity securities by the combined company (such as pursuant to the combined company’s equity incentive plan and the terms of the preferred shares and associated warrants to be issued in the financings associated with the Potential Business Combination), could result in additional dilution of the percentage ownership of the combined company’s shareholders and cause the market price of the combined company’s ordinary shares to decline even if the business is doing well. • Because there are no current plans for the combined company to pay cash dividends for the foreseeable future, shareholders may not receive any return on investment unless shares are sold for a price greater than that which was initially paid. RISK FACTORS

Exhibit 99.3

Projected Financial Information

In connection with Inflection Point’s consideration of the potential business combination and certain investors’ assessment of a potential investment in the Company, the Company provided its internally-derived forecasts for its operations to Inflection Point and such investors for use as a component of their overall evaluation of the Company. Those forecasts included certain performance metrics for 2025 and 2026 (the “Projections”).

The Projections are disclosed herein solely to make publicly available certain information made available to certain investors in their assessment of a potential investment in the Company or the combined company. The Projections should not be viewed as public guidance. Furthermore, the Projections do not take into account any circumstances or events occurring after the date on which the Projections were prepared, which was July 2025.

The Projections were prepared in good faith by the Company’s management team and are based on the Company’s management’s belief that the estimates and assumptions with respect to the expected future financial performance of the Company were reasonable at the time the Projections were prepared and such Projections speak only as of that time. The Projections do not take into account the costs of consummating the Business Combination and other effects on PubCo, which will become the parent of the Company in the Business Combination. The Projections do not include the expenses that have been or may be incurred by PubCo, the Company or Inflection Point in preparation for or in connection with the Business Combination, or the effect on the Company of any business or strategic decision or action that will or may be taken by the combined company as a result of the Business Combination having been closed.

The Projections reflect numerous estimates and assumptions including with respect to industry performance, general business, economic, regulatory, market and financial conditions and other future events, as well as matters specific to the Company’s business, all of which are difficult to predict and many of which are beyond PubCo’s, the Company’s and Inflection Point’s control and are subject to significant economic, competitive, and other uncertainties. As a result, there can be no assurance that the Projections will be realized or that actual results will not be significantly higher or lower than the Projections. There undoubtedly will be differences between actual and projected results, and the differences may be material. The risk that these uncertainties and contingencies could cause the assumptions to fail to be reflective of actual results is further increased by the length of time over which these assumptions apply. Since the Projections cover multiple years, such information by its nature becomes less predictive with each successive year. These Projections are subjective in many respects and thus are susceptible to multiple interpretations and are subject to periodic changes based on actual experience, events and business developments, and changes in the Company’s capital requirements and net working capital needs.

The disclosure of these Projections should not be regarded as an indication that the Company’s or Inflection Point’s board of directors, or their respective affiliates, advisors or other representatives considered, or now consider, such Projections necessarily to be predictive of actual future results or to support or fail to support any decision with respect to the Business Combination. Multiple unknown factors, as well as the known factors described herein could cause the forecasts or the underlying assumptions to be inaccurate. As a result, the Projections may not be realized, and actual results may significantly differ from the Projections. The Projections are forward-looking statements that are inherently subject to significant uncertainties and contingencies, many of which are beyond PubCo’s, the Company’s and Inflection Point’s control. See the sections entitled “Risk Factors” and “Forward-Looking Statements” of the investor presentation filed as a separate exhibit to the Current Report on Form 8-K to which this document is attached.

In arriving at the Projections, the material assumptions considered, included, but were not limited to, the following:

· Current and forecasted U.S. premium packaged water market<br>data, including actual consumer sales and point of purchase data, distribution costs and product pricing. The Company also considered<br>the current and forecasted premium packaged water market in Florida where the Company will begin its U.S.-based production and commercial<br>operations.
· Revenue forecasts are based on standard Consumer Packaged<br>Goods (CPG) metrics, including, but not limited to production and material costs, distributor/retail margin levels, marketing costs,<br>costs of goods sold and competitive retail pricing information. These metrics assist the Company in arriving at appropriate product pricing<br>at wholesale and retail levels and support the Company’s competitiveness in the premium packaged water market.
--- ---
· Third-party consumer research studies informed the Company’s<br>belief that consumers across demographics may purchase the Company’s products at premium prices as compared with its peers in the<br>premium packaged water market. If the Company’s products are well-received by consumers at anticipated pricing levels, the Company<br>believes such demand will drive higher revenue through its value chain.
--- ---
· Commercial channel data that described the various channels<br>in which premium water is sold “off-premises” (e.g., grocery, convenience stores and specialty retail) and “on-premises”<br>(e.g., restaurants, bars, hotels and events) to gain an understanding of current and potential future market size, opportunity and consumer<br>pricing environments.
--- ---

The Projections were not prepared with a view toward public disclosure or toward complying with generally accepted accounting principles (“GAAP”), the published guidelines of the U.S. Securities and Exchange Commission (the “SEC”) regarding projections or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information. The Projections were prepared by the Company’s management in connection with the Business Combination and not for the purpose of providing such Projections publicly or at any other time. Neither the independent registered public accounting firms of the Company or Inflection Point nor any other registered public accounting firms, have compiled, examined or performed any procedures with respect to the Projections contained herein, nor have they expressed any opinion or any other form of assurance on such information or their accuracy or achievability, and the independent registered public accounting firms of the Company and Inflection Point assume no responsibility for, and disclaim any association with, the Projections.

No person has made or makes any representation or warranty to any person regarding the information included in these Projections. The Projections are not fact and are not necessarily indicative of future results, and readers are cautioned not to place undue, or any, reliance on this information.

In connection with the Business Combination, PubCo, the Company and Inflection Point intend to file a registration statement on Form F-4 with the SEC which will include a proxy statement/prospectus of PubCo, the Company and Inflection Point (the “Proxy Statement/Prospectus”). PubCo, Inflection Point and the Company urge you to review the financial statements of the Company which will be included in the Proxy Statement/Prospectus, as well as the financial information in the section of the Proxy Statement/Prospectus entitled “Unaudited Pro Forma Condensed Combined Financial Information” and to not rely on any single financial measure or Projections taken as a whole. The Projections are being provided for information purposes only, have not been affirmed by the Company’s management or the Company’s board of directors and are not and should not be viewed as public guidance regarding the future performance of the Company or the combined company following the consummation of the Business Combination.

The Company uses certain financial measures in the Projections that are not prepared in accordance with GAAP as supplemental measures to evaluate operational performance. While the Company believes that non-GAAP financial measures provide useful supplemental information, there are limitations associated with the use of non-GAAP financial measures. Non-GAAP financial measures are not prepared in accordance with GAAP, are not reported by all of the Company’s competitors and may not be directly comparable to similarly titled measures of the Company’s competitors. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in accordance with GAAP. Financial measures included in the Projections provided to a board of directors or financial advisor in connection with a business combination transaction are excluded from the definition of “non-GAAP financial measures” under the rules of the SEC, and therefore the Projections are not subject to SEC rules regarding disclosures of non-GAAP financial measures, which would otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure. Accordingly, no reconciliation of the financial measures included in the Projections were prepared.

2

Below is a summary of the Projections.

Income Statement
(USD 000’s) 2025E^(1)^ **** 2026E ****
Revenue:
Bottling Sales 7,648 92,458
Canning Sales 5,271 90,095
Machine Sales 1,546 11,374
Total Revenue 14,464 193,926
Total Cost of Sales (7,810 ) (83,567 )
Gross Profit 6,655 110,359
Gross Margin (%) 46 % 57 %
Total Operating Expenses (8,728 ) (27,653 )
Operating Income (2,074 ) 82,705
Pre-Tax Profit (3,074 ) 82,705
Net Profit (Loss) (3,185 ) 62,425
Net Margin (%) (22.02 )% 32.19 %
D&A 548 1,230
EBITDA (1,526 ) 83,935
EBITDA Margin (%) (10.6 )% 43.3 %
Balance Sheet
--- --- --- --- ---
(USD 000’s) 2025E^(1)^ 2026E
Total Current Assets 35,963 102,772
Total Fixed Assets 6,648 11,131
Total Assets 42,611 113,902
Total Liabilities 1,626 10,492
Total Assets Less Liabilities 40,985 103,410
Equity:
Shareholders Capital / Capital Raise 36,439 36,439
Share Premium 43 43
Retained Earnings and Distributable Reserves 4,503 66,928
Total Equity 40,985 103,410
Cash Flow Statement
--- --- --- --- --- --- ---
(USD 000’s) 2025E^(1)^ **** 2026E ****
Cash flow from Operations (2,174 ) 48,182
Cash flow from Investing (2,137 ) (5,713 )
Cash flow from Financing 35,439 –
Closing Cash Balance 31,697 74,167
FCF (4,311 ) 42,469
FCF Conversion (%) 283 % 51 %
(1) Represents the nine months ending September 30, 2025.
--- ---

3

Report a Problem

Category
Description
Email (optional, for follow-up)